Clustering O 0 6.665884910717068e-08
of O 0 1.257211668104219e-09
missense O 0 2.616519800824335e-08
mutations O 0 9.106407468373323e-12
in O 0 6.884199156911852e-13
the O 0 6.039281852388001e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 1.532311777463491e-10
in O 0 6.485078858468885e-13
a O 0 5.5548773046643074e-14
sporadic B-Disease 0 1.2587322850698968e-10
T I-Disease 0 3.300581363774313e-09
- I-Disease 0 3.980501706024597e-09
cell I-Disease 0 2.6640769590358104e-09
leukaemia I-Disease 0 3.303822268208023e-06
. O 0 1.6807379932259892e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 8.114419074445323e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.571644456165136e-15
is O 0 2.4094838183938736e-17
a O 0 4.939453441323241e-17
recessive B-Disease 0 2.0685230871925198e-12
multi I-Disease 0 0.00016375986160710454
- I-Disease 1 0.9938368201255798
system I-Disease 0 2.887657899464102e-07
disorder I-Disease 0 1.760310830434264e-08
caused O 0 9.297626552126279e-15
by O 0 5.3495090394061934e-17
mutations O 0 1.470997226750339e-15
in O 0 9.940022692071044e-16
the O 0 6.764693785601267e-14
ATM O 0 2.2412220967993335e-09
gene O 0 4.802177061493003e-14
at O 0 2.063078874403601e-11
11q22 O 0 3.63907197709068e-08
- O 0 1.566399632224602e-08
q23 O 0 1.1701737889779906e-07
( O 0 3.840890008387915e-13
ref O 0 1.4623902089283547e-10
. O 0 1.8406801148389274e-13
3 O 0 1.1083035530989882e-12
) O 0 8.905226003223105e-14
. O 0 7.021645764826445e-11

The O 0 3.824070393676493e-09
risk O 0 4.801237185603213e-09
of O 0 1.996253162772632e-09
cancer B-Disease 0 4.4760838591173524e-08
, O 0 1.0410759060386354e-11
especially O 0 5.749293402468325e-11
lymphoid B-Disease 0 7.720447570136457e-07
neoplasias I-Disease 1 0.9249375462532043
, O 0 9.548384652391384e-12
is O 0 2.196054075349549e-13
substantially O 0 5.952684178911483e-11
elevated O 0 2.157472984987141e-12
in O 0 2.168719847803202e-12
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.7555176746195684e-09
and O 0 1.5200803127075196e-13
has O 0 1.6131349404231065e-16
long O 0 3.152983796156383e-16
been O 0 6.927088382204872e-16
associated O 0 4.952680518303942e-13
with O 0 6.95235373177755e-13
chromosomal O 1 1.0
instability O 1 1.0
. O 0 8.112284888284194e-08

By O 0 9.391618342388663e-13
analysing O 0 3.463112241419708e-09
tumour B-Disease 1 1.0
DNA O 0 2.932387133114389e-08
from O 0 2.1959829245819795e-13
patients O 0 5.8500203447176165e-15
with O 0 1.8307465719489028e-17
sporadic B-Disease 0 9.27826045160618e-12
T I-Disease 0 1.0412869178022532e-10
- I-Disease 0 1.255500703400969e-09
cell I-Disease 0 6.064758140134074e-10
prolymphocytic I-Disease 0 4.435511300471262e-07
leukaemia I-Disease 0 0.0013420241884887218
( O 0 3.9085997893123503e-13
T B-Disease 0 7.921938660615524e-10
- I-Disease 0 3.157087258287561e-09
PLL I-Disease 0 4.110895588382846e-07
) O 0 8.57387958915802e-14
, O 0 1.4217592015264464e-14
a O 0 8.882664433640039e-14
rare O 0 2.6365331359107236e-12
clonal B-Disease 0 8.678885388135882e-10
malignancy I-Disease 0 1.6817190973128504e-09
with O 0 1.1307827165406813e-14
similarities O 0 2.645942276044422e-13
to O 0 2.436172357594968e-12
a O 0 3.650632747487226e-12
mature B-Disease 0 4.81451545297773e-09
T I-Disease 0 3.3574596436380943e-09
- I-Disease 0 3.067012199764463e-09
cell I-Disease 0 1.423488438234699e-09
leukaemia I-Disease 0 1.8673994190976373e-06
seen O 0 3.4232566867992142e-12
in O 0 7.848802445649394e-13
A B-Disease 1 1.0
- I-Disease 0 3.225911859772168e-05
T I-Disease 1 0.9995627999305725
, O 0 1.039041492819151e-13
we O 0 4.7847120891535665e-15
demonstrate O 0 5.95226653881363e-14
a O 0 1.662761991997805e-15
high O 0 3.077633015718061e-15
frequency O 0 2.8033204555431845e-13
of O 0 2.205832088167381e-12
ATM O 0 1.43321239320926e-08
mutations O 0 1.3483782666801059e-11
in O 0 4.705515421754569e-10
T B-Disease 0 4.283174916963617e-07
- I-Disease 0 1.06672575839184e-06
PLL I-Disease 0 1.540720768389292e-05
. O 0 1.7946600650020628e-08

In O 0 4.558828592404751e-10
marked O 0 1.4344497811791257e-10
contrast O 0 1.2372181187533804e-12
to O 0 1.178087466989497e-12
the O 0 7.7660404149138e-12
ATM O 0 4.26427988031719e-07
mutation O 0 4.1286292960796e-12
pattern O 0 2.90416649062486e-12
in O 0 8.26094921635434e-12
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 1.0186497912539894e-12
the O 0 1.6706570209277377e-13
most O 0 8.650251976034026e-16
frequent O 0 2.3508798057650555e-15
nucleotide O 0 5.361553215288417e-13
changes O 0 1.1321250096521952e-14
in O 0 5.320516163059841e-14
this O 0 1.409389206903644e-12
leukaemia B-Disease 0 5.11265739078226e-07
were O 0 1.5056873525765013e-09
missense O 0 1.451827102982861e-07
mutations O 0 1.1264437160818375e-09
. O 0 7.865078366364742e-09

These O 0 1.272275618191543e-10
clustered O 0 4.1617687074335663e-10
in O 0 9.410531300610772e-14
the O 0 5.568681908825479e-13
region O 0 1.3718946985374902e-11
corresponding O 0 1.9559754857456646e-11
to O 0 1.136470952067814e-11
the O 0 5.745358008790724e-11
kinase O 0 4.0811795609663193e-10
domain O 0 1.437545416038688e-09
, O 0 8.8943622974548e-14
which O 0 1.2108819848571342e-15
is O 0 4.277208063641416e-15
highly O 0 2.5980153358501346e-12
conserved O 0 7.2176513897515004e-12
in O 0 3.85930957330638e-12
ATM O 0 2.475486780895153e-06
- O 0 1.0101363079328962e-09
related O 0 1.6823672455146266e-09
proteins O 0 1.5853443774763165e-12
in O 0 1.5608254706062086e-12
mouse O 0 5.8389486821963654e-12
, O 0 3.208141692296988e-14
yeast O 0 1.0877047960239361e-12
and O 0 5.37775553255404e-13
Drosophila O 0 8.233048270911425e-11
. O 0 2.265763410225219e-10

The O 0 4.2194933658201705e-10
resulting O 0 2.5394872871231655e-09
amino O 0 3.0245639326409446e-09
- O 0 7.440209559561595e-11
acid O 0 4.117281602461498e-12
substitutions O 0 2.1498830493626997e-11
are O 0 1.984759470489983e-14
predicted O 0 2.8958695250796973e-12
to O 0 6.18383436904596e-13
interfere O 0 5.926449331283834e-10
with O 0 3.597702376897244e-13
ATP O 0 1.5621249360719958e-07
binding O 0 4.1131886785450433e-10
or O 0 6.6138219033395895e-12
substrate O 0 8.142159863000487e-11
recognition O 0 3.941478532443199e-10
. O 0 8.04273625476526e-09

Two O 0 1.4046994123440015e-10
of O 0 3.8542502522886934e-11
seventeen O 0 3.5108496665436917e-10
mutated O 0 7.462714799420789e-13
T B-Disease 0 4.0699988518300145e-11
- I-Disease 0 3.86227161364161e-11
PLL I-Disease 0 1.603585531029239e-08
samples O 0 4.3583647975353745e-12
had O 0 4.0524244929781433e-14
a O 0 2.3944594391430525e-15
previously O 0 6.302045067437326e-14
reported O 0 1.137899887163063e-12
A B-Disease 1 1.0
- I-Disease 0 0.00016750014037825167
T I-Disease 1 0.9998321533203125
allele O 0 4.030235256635706e-09
. O 0 1.2163068330295346e-09

In O 0 7.221019338032875e-10
contrast O 0 6.737380098265078e-11
, O 0 6.794075393425081e-13
no O 0 2.4941813480013064e-13
mutations O 0 1.2237981895230066e-12
were O 0 1.6936654986463018e-12
detected O 0 1.1940860626669103e-12
in O 0 4.369914125652505e-14
the O 0 4.146140462207848e-12
p53 O 0 5.391787710751217e-12
gene O 0 5.685111669623266e-14
, O 0 5.2908246089399674e-14
suggesting O 0 5.3406528331689795e-12
that O 0 7.825058079258783e-15
this O 0 4.617649578680938e-12
tumour B-Disease 1 1.0
suppressor O 0 1.9605566059510693e-09
is O 0 2.926170861606431e-14
not O 0 9.900959311312865e-14
frequently O 0 9.857944538796404e-13
altered O 0 5.443401805693693e-12
in O 0 1.2599102533830675e-12
this O 0 3.064255099660684e-11
leukaemia B-Disease 0 3.7531285670411307e-06
. O 0 8.00162336389576e-09

Occasional O 0 9.24603682506131e-08
missense O 0 7.605206775451734e-08
mutations O 0 4.098276232267217e-11
in O 0 8.844399171370476e-12
ATM O 0 2.750612566160271e-06
were O 0 2.2547572142705974e-10
also O 0 4.2507782639948297e-14
found O 0 3.1100068267203573e-14
in O 0 2.1173896511995915e-13
tumour B-Disease 1 1.0
DNA O 0 3.592135255914286e-09
from O 0 9.071626913201292e-13
patients O 0 3.840243417317299e-14
with O 0 4.762893261586125e-16
B B-Disease 0 1.9711621224161036e-11
- I-Disease 0 4.866143078763319e-12
cell I-Disease 0 1.3652935726415905e-10
non I-Disease 0 7.039382126095006e-07
- I-Disease 0 9.78211119218031e-06
Hodgkins I-Disease 1 0.9999985694885254
lymphomas I-Disease 0 1.6687337067722297e-09
( O 0 1.0717102364585164e-15
B B-Disease 0 2.2737192337252132e-11
- I-Disease 0 9.98766282352126e-13
NHL I-Disease 0 1.1824881074318228e-09
) O 0 2.0295396460157707e-16
and O 0 1.51881451302389e-16
a O 0 1.4560193125506306e-14
B B-Disease 0 3.0651609722598394e-11
- I-Disease 0 6.757929719297673e-12
NHL I-Disease 0 6.835006338690164e-09
cell O 0 7.286848902054999e-10
line O 0 6.433639732073004e-10
. O 0 2.5945712245345476e-10

The O 0 1.2862347298359111e-10
evidence O 0 1.3727401160235075e-11
of O 0 4.917928911329916e-12
a O 0 1.1358588494683047e-13
significant O 0 1.3832624011066857e-13
proportion O 0 1.4492050138051327e-12
of O 0 1.1884466934869442e-12
loss O 0 3.0454059413154155e-11
- O 0 5.348810630523282e-11
of O 0 2.1742319056272663e-09
- O 0 2.6421034804435806e-10
function O 0 2.9313298750138772e-12
mutations O 0 5.731380251443969e-15
and O 0 4.98693724807848e-17
a O 0 8.526800762089754e-17
complete O 0 6.196160663544947e-13
absence O 0 4.475605216297529e-12
of O 0 1.947704963891489e-13
the O 0 3.480638628879096e-14
normal O 0 1.0138717122798457e-12
copy O 0 1.6996078155973038e-11
of O 0 1.2302815884102092e-11
ATM O 0 6.7465166786462305e-09
in O 0 5.228749291180668e-13
the O 0 2.449956253494645e-12
majority O 0 1.776436419839711e-12
of O 0 2.89197953778908e-11
mutated O 0 8.736333878545111e-10
tumours B-Disease 1 1.0
establishes O 0 1.27182379211499e-11
somatic O 0 1.1193880544713153e-10
inactivation O 0 3.7290417975732737e-10
of O 0 1.916246605837557e-10
this O 0 1.267880006712574e-12
gene O 0 3.715707890027467e-14
in O 0 9.859142988772815e-14
the O 0 4.898482335903565e-13
pathogenesis O 0 1.2814156680196476e-10
of O 0 3.161036710164211e-11
sporadic B-Disease 0 7.147387748318579e-08
T I-Disease 0 7.293029824495534e-08
- I-Disease 0 7.931017620421699e-08
PLL I-Disease 0 1.995165348489536e-06
and O 0 4.299017196916777e-13
suggests O 0 1.282264631930971e-13
that O 0 6.638908715307645e-16
ATM O 0 4.0304968251803075e-09
acts O 0 4.877061428321117e-12
as O 0 1.2613921192283772e-11
a O 0 7.538893398439939e-10
tumour B-Disease 1 1.0
suppressor O 0 1.5537733588644187e-07
. O 0 2.7842390615262502e-09

As O 0 9.961950708792244e-11
constitutional O 0 2.935081344634938e-10
DNA O 0 1.223333789823755e-08
was O 0 1.5844655448793432e-11
not O 0 5.827105562395546e-14
available O 0 9.687749734366147e-12
, O 0 2.3016062051573784e-14
a O 0 1.6943633995847307e-12
putative O 0 1.628847634549402e-08
hereditary O 0 0.0006150944973342121
predisposition O 0 5.859331508872856e-07
to O 0 1.1468636330391746e-05
T B-Disease 1 0.9999843835830688
- I-Disease 1 0.9999822378158569
PLL I-Disease 1 0.9998099207878113
will O 0 2.712134856974746e-11
require O 0 3.88637472897857e-12
further O 0 3.148541269284294e-13
investigation O 0 4.5092627548593e-12
. O 0 4.7200724231921676e-12
. O 0 3.087094191389639e-10

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 8.659875447847298e-07
kinase O 0 9.72948055455447e-10
is O 0 1.513806949530929e-14
involved O 0 1.0916969232907178e-13
in O 0 2.947147463138594e-14
the O 0 6.738320567755557e-14
modulation O 0 7.926491494419929e-13
of O 0 4.447156076552161e-13
the O 0 2.212936051852049e-13
Ca2 O 0 3.051545821586288e-11
+ O 0 3.050232288970278e-10
homeostasis O 0 2.0540109613165214e-09
in O 0 8.61349325198546e-11
skeletal O 0 4.0803553247314994e-07
muscle O 0 6.9853323125812494e-09
cells O 0 1.5656647534001422e-08
. O 0 1.4144117876924156e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.1663394988991058e-07
DM B-Disease 1 1.0
) O 0 6.172293232076242e-11
, O 0 3.6542673726401576e-13
the O 0 6.863248576231828e-13
most O 0 3.686294433764836e-13
prevalent O 0 1.0610263245780516e-07
muscular B-Disease 0 1.1694420010144313e-07
disorder I-Disease 0 1.5450414281303892e-08
in O 0 1.612501256652299e-12
adults O 0 2.939617993469312e-11
, O 0 4.6239528590612256e-15
is O 0 3.916997191365717e-16
caused O 0 2.5201942380312543e-14
by O 0 3.743293381427287e-14
( O 0 3.831741917032297e-14
CTG O 0 4.882707016484744e-10
) O 0 1.1891295434969334e-15
n O 0 1.1287269675776951e-14
- O 0 4.033393356719234e-14
repeat O 0 5.195856376036647e-15
expansion O 0 2.3428328233595502e-14
in O 0 8.125504344949248e-17
a O 0 3.707108184213165e-17
gene O 0 8.376910175703102e-18
encoding O 0 1.8822030929286845e-14
a O 0 2.4155731668390468e-12
protein O 0 1.3402297500964e-11
kinase O 0 6.993453559311913e-12
( O 0 1.912976287793411e-12
DM B-Disease 1 1.0
protein O 0 1.0491061352979614e-09
kinase O 0 9.104288503647417e-12
; O 0 1.228334247467197e-13
DMPK O 0 0.0038390755653381348
) O 0 6.907960260673501e-15
and O 0 2.0273195726610172e-15
involves O 0 1.7667983775223467e-13
changes O 0 1.7804881578971886e-14
in O 0 2.1487984460354104e-13
cytoarchitecture O 0 6.412669062427767e-09
and O 0 4.193688105114113e-11
ion O 0 6.175610423042599e-08
homeostasis O 0 6.546169970533811e-07
. O 0 7.224001308259176e-08

To O 0 5.718826523448683e-10
obtain O 0 3.0969211639586547e-09
clues O 0 1.2057738141280083e-09
to O 0 4.838126969365641e-13
the O 0 1.0385051108993681e-12
normal O 0 7.112522376617747e-11
biological O 0 3.5511199016069472e-12
role O 0 1.1090647714442903e-12
of O 0 1.5005345577190354e-10
DMPK O 1 0.9999011754989624
in O 0 2.759591000156547e-09
cellular O 0 4.283376764391278e-09
ion O 0 1.107552938250933e-09
homeostasis O 0 3.0454205823815528e-09
, O 0 1.8528969591286026e-12
we O 0 7.581507578853508e-13
have O 0 1.067113282774649e-14
compared O 0 1.346988926648196e-13
the O 0 9.410117948532512e-14
resting O 0 2.4030888390313976e-11
[ O 0 3.7387001589235525e-13
Ca2 O 0 3.2566448994984787e-13
+ O 0 7.308803085318005e-13
] O 0 5.875793775145244e-12
i O 0 1.0958929076709811e-12
, O 0 1.9063221866951613e-15
the O 0 3.643504175801374e-15
amplitude O 0 2.9122788436451025e-14
and O 0 1.4454539953138198e-15
shape O 0 1.0383941970171229e-12
of O 0 1.0316003606902768e-10
depolarization O 0 2.0472472328503244e-10
- O 0 6.304726740680167e-10
induced O 0 3.693153075023936e-11
Ca2 O 0 8.710020552027409e-12
+ O 0 1.1819097783805077e-11
transients O 0 6.690280968113527e-11
, O 0 3.905046879968939e-16
and O 0 2.1439224458173994e-17
the O 0 2.9327795820674983e-15
content O 0 2.081336676357931e-13
of O 0 2.4907536428329935e-13
ATP O 0 1.1210546380091557e-10
- O 0 1.8369222809511143e-11
driven O 0 3.194420075680604e-11
ion O 0 1.273775702970159e-11
pumps O 0 8.02103175545632e-12
in O 0 1.0992325973069317e-11
cultured O 0 3.465876119435052e-08
skeletal O 0 6.464643576009621e-08
muscle O 0 2.899293582991902e-10
cells O 0 5.844957851053323e-11
of O 0 9.955948565565365e-11
wild O 0 3.5644794407763136e-13
- O 0 6.398873943734562e-13
type O 0 5.352007153972861e-14
and O 0 8.962122222729713e-14
DMPK O 0 5.158848921382742e-07
[ O 0 2.4613389451588752e-11
- O 0 1.1165195504259096e-11
/ O 0 2.528913710386771e-11
- O 0 5.165774925874889e-12
] O 0 1.6898191830191922e-12
knockout O 0 2.449659641801105e-10
mice O 0 1.599071916547068e-11
. O 0 1.3717298998072724e-11

In O 0 6.748447134441449e-09
vitro O 0 7.007016744609018e-09
- O 0 2.6893380855597115e-09
differentiated O 0 7.895209486186161e-10
DMPK O 0 1.3424956932794885e-06
[ O 0 6.42441516651715e-11
- O 0 6.793512280500735e-11
/ O 0 2.711091628970763e-10
- O 0 1.721681130995023e-10
] O 0 2.4592506850384943e-11
myotubes O 0 1.7198473756252497e-09
exhibit O 0 4.55013190482894e-14
a O 0 1.2805920976139817e-14
higher O 0 2.4554063209752952e-12
resting O 0 9.21071552362207e-11
[ O 0 1.1881547828940242e-11
Ca2 O 0 2.4962873781952943e-11
+ O 0 2.6860237992143432e-11
] O 0 6.417018305615585e-11
i O 0 2.182392721400417e-12
than O 0 3.747594275920266e-14
do O 0 3.597172405322806e-14
wild O 0 4.1992863179796114e-13
- O 0 3.2488399991092987e-13
type O 0 5.615366028069446e-13
myotubes O 0 2.4527790909445457e-09
because O 0 9.387870797579467e-14
of O 0 4.66980013685836e-12
an O 0 3.811519513636369e-15
altered O 0 1.5183186197025023e-13
open O 0 3.319970708938469e-13
probability O 0 2.5080740435889926e-12
of O 0 7.441384314299526e-12
voltage O 0 6.006604501979096e-12
- O 0 2.8578398328371613e-11
dependent O 0 5.735273714280176e-11
l O 0 7.50839887768591e-14
- O 0 4.1319752524041076e-13
type O 0 1.4392400980852912e-14
Ca2 O 0 1.1953843947684617e-13
+ O 0 4.0089061085525624e-13
and O 0 1.3983750951889612e-13
Na O 0 7.303417592918748e-11
+ O 0 4.550015312437816e-12
channels O 0 4.5783977303814893e-11
. O 0 9.609449347358634e-11

The O 0 1.0065940969639087e-08
mutant O 0 1.9603847434268573e-09
myotubes O 0 8.683811358878302e-08
exhibit O 0 2.71368582986653e-12
smaller O 0 8.646928388155589e-14
and O 0 9.690488903392296e-15
slower O 0 4.385100269010955e-11
Ca2 O 0 3.1972365727162e-11
+ O 0 3.676994125845212e-11
responses O 0 1.9262503308452132e-14
upon O 0 1.5462528176260482e-12
triggering O 0 4.3072327388787857e-13
by O 0 4.97271664221411e-14
acetylcholine O 0 1.1078058609337305e-10
or O 0 2.5605788323002088e-11
high O 0 8.525622569033331e-11
external O 0 5.602785346781047e-09
K O 0 4.112923779331368e-09
+ O 0 1.2746397271001797e-09
. O 0 9.096972064526199e-10

In O 0 4.862149571849272e-10
addition O 0 3.2628344470708726e-11
, O 0 3.607432278243672e-13
we O 0 2.660141529796378e-13
observed O 0 3.9600907866506677e-14
that O 0 8.72594482543414e-17
these O 0 2.0584836088563974e-15
Ca2 O 0 1.272117394063299e-11
+ O 0 1.8068238571977702e-10
transients O 0 7.435574378433785e-10
partially O 0 1.745140837394743e-11
result O 0 9.030573597940128e-13
from O 0 9.620773145160855e-13
an O 0 1.2676828919813525e-14
influx O 0 1.3661616868158866e-13
of O 0 2.2931075441268156e-12
extracellular O 0 3.576869703203478e-12
Ca2 O 0 1.4839709322478356e-12
+ O 0 1.2359868987663059e-12
through O 0 1.4465704025259929e-12
the O 0 4.901267109183594e-13
l O 0 1.9812733539296273e-13
- O 0 5.378216860578433e-13
type O 0 5.789483069383941e-14
Ca2 O 0 6.358048636190272e-12
+ O 0 5.459219534764692e-11
channel O 0 1.470883137510981e-10
. O 0 7.716580152639096e-11

Neither O 0 9.707944670367397e-09
the O 0 1.781428650426964e-11
content O 0 2.0851296383961326e-11
nor O 0 1.0963822081114238e-12
the O 0 2.9984502158747137e-14
activity O 0 3.330931179750668e-13
of O 0 3.0417224186445047e-13
Na O 0 7.1679884250386294e-12
+ O 0 8.881687160906815e-13
/ O 0 1.0759973641250031e-11
K O 0 9.950874325925785e-12
+ O 0 2.313359573347107e-12
ATPase O 0 3.284670452297078e-11
and O 0 6.599906168455738e-13
sarcoplasmic O 0 1.1333723959339181e-09
reticulum O 0 2.094666440299875e-09
Ca2 O 0 3.56311202764914e-10
+ O 0 5.581567430468226e-10
- O 0 3.880675225609309e-10
ATPase O 0 6.157926391026081e-10
are O 0 2.0676609567300136e-14
affected O 0 7.896157008411772e-14
by O 0 9.990287405930304e-14
DMPK O 0 0.00941221509128809
absence O 0 2.0879184603472822e-08
. O 0 4.942451337086595e-09

In O 0 7.855224248842774e-10
conclusion O 0 2.3719570751978836e-09
, O 0 1.4567375083984757e-12
our O 0 2.0039112730296793e-11
data O 0 6.254869452243517e-12
suggest O 0 1.1600037607990138e-13
that O 0 1.8639247995532945e-15
DMPK O 0 1.9012583152289153e-06
is O 0 1.266324759353725e-14
involved O 0 7.441919259651431e-13
in O 0 5.836016891101747e-13
modulating O 0 7.744798725950464e-12
the O 0 2.3201281390897166e-13
initial O 0 4.974369440663429e-13
events O 0 3.0639522901254254e-14
of O 0 5.323770070619904e-12
excitation O 0 1.3232969386933746e-08
- O 0 4.209642057162455e-08
contraction O 0 1.4893886124411893e-10
coupling O 0 4.014226017562406e-12
in O 0 3.4400915276122657e-12
skeletal O 0 1.6465209640159628e-08
muscle O 0 3.8750760933403683e-10
. O 0 9.440136172766955e-11
. O 0 1.3008089050359217e-09

Constitutional O 0 7.102215136001178e-07
RB1 O 0 0.00035348712117411196
- O 0 3.2645206715642416e-07
gene O 0 1.4425429600839479e-11
mutations O 0 7.179564234793823e-12
in O 0 2.61984417449998e-13
patients O 0 1.4888927764300508e-12
with O 0 3.470496256368673e-14
isolated O 0 3.3472259686195827e-11
unilateral B-Disease 0 1.5161976119060228e-09
retinoblastoma I-Disease 0 0.0697416439652443
. O 0 6.610983973587281e-07

In O 0 6.681434294719679e-10
most O 0 3.3789631249253604e-12
patients O 0 1.2150621220979874e-12
with O 0 5.84397591760601e-15
isolated O 0 1.62569708129362e-12
unilateral B-Disease 0 8.418516751762528e-12
retinoblastoma I-Disease 0 5.87906197324628e-06
, O 0 3.0057247923237496e-12
tumor B-Disease 0 5.669637537231154e-10
development O 0 1.5282407561656441e-09
is O 0 2.8438813566707914e-15
initiated O 0 1.6843607942868682e-13
by O 0 2.51460407468926e-15
somatic O 0 7.876009740226397e-12
inactivation O 0 1.270773850731155e-11
of O 0 3.969116701973974e-12
both O 0 9.890414225458e-13
alleles O 0 2.619359536128879e-13
of O 0 5.516408510541915e-12
the O 0 9.65652210971335e-11
RB1 O 0 6.263883278734284e-07
gene O 0 1.448162006978393e-10
. O 0 3.217887956097343e-09

However O 0 4.306617729099571e-09
, O 0 1.7228126477503158e-12
some O 0 4.19777873485877e-14
of O 0 9.502541982453483e-13
these O 0 3.099668687955165e-13
patients O 0 6.995664355961828e-13
can O 0 2.119524391067107e-12
transmit O 0 1.9971289066944564e-09
retinoblastoma B-Disease 0 4.792236651951498e-08
predisposition O 0 2.8130211493504476e-09
to O 0 2.448749647498971e-09
their O 0 1.5511831819026156e-08
offspring O 0 9.408727663640093e-08
. O 0 2.3393571524366052e-08

To O 0 4.693773147934621e-10
determine O 0 4.026491362552065e-10
the O 0 6.979035405141332e-12
frequency O 0 9.126930461400562e-11
and O 0 4.963241054039766e-14
nature O 0 6.19391528084573e-13
of O 0 1.1097928132031143e-12
constitutional O 0 6.337614461005003e-11
RB1 O 0 1.3002213563595433e-06
- O 0 1.260515580803201e-09
gene O 0 2.2891048865464336e-12
mutations O 0 3.0226964594509687e-12
in O 0 2.9864253973423127e-13
patients O 0 1.2769154223574164e-12
with O 0 4.732706468477815e-14
isolated O 0 3.0691157948403713e-11
unilateral B-Disease 0 7.758611808572624e-11
retinoblastoma I-Disease 0 1.1495619673951296e-06
, O 0 4.716776557008029e-13
we O 0 1.390250626209441e-13
analyzed O 0 1.8974160350543334e-12
DNA O 0 2.0599577599256236e-10
from O 0 2.9088398356691414e-12
peripheral O 0 1.261489690485007e-09
blood O 0 1.3844410860774925e-11
and O 0 7.873967103333435e-12
from O 0 7.271243607220867e-10
tumor B-Disease 0 6.691821852200519e-08
tissue O 0 2.430413204024262e-08
. O 0 1.0130966288102172e-08

The O 0 1.3301787449293556e-10
analysis O 0 6.887214409889708e-11
of O 0 2.079578953484429e-09
tumors B-Disease 1 1.0
from O 0 2.4760168915172187e-10
54 O 0 1.17167797686335e-09
( O 0 6.518111652633815e-14
71 O 0 2.409296095962077e-09
% O 0 2.826934242250445e-10
) O 0 5.0329812576420645e-15
of O 0 9.884906478421773e-13
76 O 0 2.558022127452375e-10
informative O 0 2.6631901545171033e-11
patients O 0 2.259588458182471e-13
showed O 0 6.083717730975824e-12
loss O 0 3.2667327176660876e-11
of O 0 2.173318608411634e-10
constitutional O 0 2.1959841944863e-08
heterozygosity O 1 0.8808121085166931
( O 0 7.475767347386864e-07
LOH O 0 0.005571119021624327
) O 0 8.911557256019442e-12
at O 0 6.334958668752222e-10
intragenic O 0 6.827295351286011e-08
loci O 0 1.2387453285356287e-09
. O 0 2.902315943131839e-09

Three O 0 2.4297073242252054e-09
of O 0 8.319557820435364e-10
13 O 0 9.002765644083865e-09
uninformative O 0 2.9070988603052683e-05
patients O 0 1.1095615537470849e-09
had O 0 9.325850508501432e-11
constitutional O 0 1.4981454299345387e-08
deletions O 0 2.760929795897482e-08
. O 0 1.820607842262234e-08

For O 0 2.1813013617588695e-09
39 O 0 2.501219142914124e-08
randomly O 0 2.1881436662596343e-09
selected O 0 3.8331201324126596e-08
tumors B-Disease 1 1.0
, O 0 6.580630484975813e-11
SSCP O 0 0.11847316473722458
, O 0 5.6928021324731404e-11
hetero O 0 1.5281250043130967e-08
- O 0 1.6190548901562352e-10
duplex O 0 3.5063191239359526e-10
analysis O 0 1.059159595966086e-12
, O 0 6.017187590814173e-16
sequencing O 0 4.424888840753871e-12
, O 0 4.879212590463413e-15
and O 0 1.978522936305939e-14
Southern O 0 2.153339451194114e-10
blot O 0 3.0713676046900673e-09
analysis O 0 7.863386157491714e-12
were O 0 1.9177730150449213e-12
used O 0 2.951999972591879e-12
to O 0 5.551602580422532e-11
identify O 0 1.9736820178195558e-08
mutations O 0 2.749840710691842e-08
. O 0 3.485950728077114e-08

Mutations O 0 6.026696475203153e-09
were O 0 2.0266135991597878e-10
detected O 0 1.6954698062177087e-11
in O 0 8.718305482928457e-14
21 O 0 4.867322257046114e-12
( O 0 2.622365935579557e-15
91 O 0 1.1515096515202217e-10
% O 0 6.594980117569094e-11
) O 0 4.1510655454440534e-14
of O 0 3.154297309460041e-11
23 O 0 1.94098288375244e-06
tumors B-Disease 1 1.0
with O 0 0.17641818523406982
LOH O 1 0.9999992847442627
. O 0 2.2361114133673254e-06

In O 0 1.0168886843686664e-09
6 O 0 2.379033081645332e-10
( O 0 4.409954389508752e-14
38 O 0 1.260967025240589e-10
% O 0 4.710434126087293e-11
) O 0 4.348811146804611e-14
of O 0 4.0619646535233755e-11
16 O 0 3.2594036269983917e-07
tumors B-Disease 1 1.0
without O 1 0.9998606443405151
LOH O 1 0.9997705817222595
, O 0 1.1918840914226791e-11
one O 0 4.079618587393696e-12
mutation O 0 5.345643632609365e-13
was O 0 4.180843605344764e-12
detected O 0 5.162593009339078e-12
, O 0 3.057190722569026e-15
and O 0 3.3278541716335068e-15
in O 0 1.922052740490482e-13
9 O 0 1.0472698229457844e-11
( O 0 7.478038845164063e-15
56 O 0 2.1163795715928302e-10
% O 0 7.184101924462283e-11
) O 0 5.795205623975591e-14
of O 0 2.766449916369318e-11
the O 0 8.500107284703518e-09
tumors B-Disease 1 1.0
without O 0 0.08977829664945602
LOH O 1 0.7996652126312256
, O 0 1.6250964116060196e-11
both O 0 6.842172661780666e-11
mutations O 0 7.233283416674396e-11
were O 0 1.791341103229982e-10
found O 0 2.50244651389675e-11
. O 0 5.070853181798896e-10

Thus O 0 3.702431250474092e-09
, O 0 8.036218717387411e-13
a O 0 2.0528240565753642e-13
total O 0 3.5294306539868092e-12
of O 0 1.742861389063266e-12
45 O 0 1.1305822944507327e-10
mutations O 0 5.413850791280428e-12
were O 0 6.017429176469191e-12
identified O 0 6.183936002157608e-11
in O 0 2.3185345310317018e-10
tumors B-Disease 1 1.0
of O 0 1.322106584211724e-07
36 O 0 1.9280998913018266e-06
patients O 0 1.511114078311948e-08
. O 0 1.8245121680138254e-07

Thirty O 0 3.325721706914919e-07
- O 0 7.669570534218906e-10
nine O 0 8.203641238546666e-11
of O 0 4.016232225262373e-12
the O 0 3.0222007622177083e-12
mutations O 0 8.511932478305617e-13
- O 0 4.598539431188708e-13
including O 0 1.1778212513104385e-14
34 O 0 1.4672671078130861e-08
small O 0 2.2680453001799883e-11
mutations O 0 4.1724668164988543e-10
, O 0 9.043332922786806e-12
2 O 0 4.2410062128794834e-09
large O 0 5.229272570517196e-11
structural O 0 1.051169647325878e-06
alterations O 0 1.656557770957079e-07
, O 0 1.989955769610141e-11
and O 0 4.3152877104990495e-11
hypermethylation O 0 5.903884357394418e-06
in O 0 1.1306006797440205e-08
3 O 0 3.2127570648299297e-07
tumors O 1 1.0
- O 0 1.5585669421724901e-09
were O 0 8.354537894827985e-11
not O 0 1.55327546614778e-13
detected O 0 1.0037124126630048e-12
in O 0 8.08827864981574e-15
the O 0 4.920654270330893e-14
corresponding O 0 6.652764710651793e-12
peripheral O 0 2.3323065700964207e-10
blood O 0 9.359137076447865e-11
DNA O 0 5.982422379702257e-08
. O 0 3.6206419196105344e-08

In O 0 2.235296614472304e-09
6 O 0 2.378016950022044e-10
( O 0 3.7092497720244214e-14
17 O 0 3.1415846486748666e-12
% O 0 2.6430990642672958e-12
) O 0 4.515940805814133e-16
of O 0 4.25261056566633e-14
the O 0 2.1370027329745828e-13
36 O 0 4.5940579118664004e-10
patients O 0 7.51594272929701e-12
, O 0 1.6932512521012494e-13
a O 0 1.916847756910922e-12
mutation O 0 8.53202328666286e-13
was O 0 2.283084138410274e-11
detected O 0 3.98225202813407e-11
in O 0 2.681112439267136e-13
constitutional O 0 4.943691289671648e-11
DNA O 0 8.521794825355755e-09
, O 0 8.336032059942655e-13
and O 0 8.156385858599027e-14
1 O 0 6.586629679172784e-12
of O 0 4.109953263137234e-12
these O 0 6.11069517469226e-13
mutations O 0 2.0315925591124495e-12
is O 0 5.10376356587937e-15
known O 0 1.5631118903576546e-14
to O 0 4.744189416316935e-12
be O 0 5.87413537950221e-12
associated O 0 1.8774311272284905e-10
with O 0 2.5511105814640667e-12
reduced O 0 7.603360607788545e-09
expressivity O 0 5.55471387997386e-07
. O 0 7.329367335273673e-09

The O 0 9.80382552917547e-10
presence O 0 7.132475166038432e-12
of O 0 2.9844866161754524e-11
a O 0 8.147993456157632e-13
constitutional O 0 2.046602123884078e-11
mutation O 0 1.0149198240725146e-13
was O 0 7.389834593861042e-14
not O 0 6.116166037678798e-16
associated O 0 3.688662466834816e-14
with O 0 1.8013677635689794e-16
an O 0 6.907320089053834e-17
early O 0 1.1195129025198813e-12
age O 0 1.1688153049582706e-11
at O 0 4.321067809121004e-12
treatment O 0 1.4922575675146987e-10
. O 0 1.961200091216142e-09

In O 0 1.204707222868251e-09
1 O 0 1.419730333296343e-09
patient O 0 2.9796094480616375e-09
, O 0 8.677795895056795e-13
somatic O 0 1.2245238156793903e-09
mosaicism O 0 3.181971308663378e-08
was O 0 2.1433553716587728e-12
demonstrated O 0 2.117579522105048e-13
by O 0 7.306032393960724e-16
molecular O 0 1.5993806553129576e-14
analysis O 0 6.807480553788986e-15
of O 0 4.1412674071233946e-14
DNA O 0 8.603112146288172e-12
and O 0 1.7108628966658324e-13
RNA O 0 4.2659833998648367e-10
from O 0 1.46361811559359e-10
peripheral O 0 7.93089682815662e-08
blood O 0 8.803883844166194e-09
. O 0 1.2938778581883525e-07

In O 0 7.059369755424427e-10
2 O 0 4.419158095014808e-10
patients O 0 4.602490697586115e-12
without O 0 1.077778231245441e-11
a O 0 6.566359001675126e-12
detectable O 0 3.176693796902441e-09
mutation O 0 1.1931845485604886e-12
in O 0 1.05953733200298e-12
peripheral O 0 2.3658617287480865e-09
blood O 0 4.804266984237415e-10
, O 0 1.4692729671805793e-11
mosaicism O 0 2.6408977760183916e-07
was O 0 8.94162938136489e-11
suggested O 0 1.6333927483139221e-12
because O 0 1.0396297741416781e-14
1 O 0 6.241827801151123e-13
of O 0 1.0433157159386863e-12
the O 0 1.6625044440068959e-12
patients O 0 3.10996259127172e-12
showed O 0 1.105467717366082e-09
multifocal O 1 0.9999802112579346
tumors B-Disease 1 1.0
and O 0 1.6177021527896684e-11
the O 0 1.6561510496337917e-10
other O 0 1.7597836165714198e-12
later O 0 7.728157003228375e-11
developed O 0 1.8648899091644466e-10
bilateral B-Disease 0 7.985478987393435e-06
retinoblastoma I-Disease 0 1.4897109394951258e-05
. O 0 2.5533989145287705e-08

In O 0 2.414096977876312e-10
conclusion O 0 1.018791162543664e-09
, O 0 1.8428941098852514e-12
our O 0 1.7004442992574198e-11
results O 0 2.1285423510569723e-12
emphasize O 0 1.607181054907869e-11
that O 0 7.023600163247974e-15
the O 0 7.896643408611403e-13
manifestation O 0 5.118418466842911e-10
and O 0 1.90477343099682e-12
transmissibility O 0 3.349964572407771e-08
of O 0 6.07219760584421e-11
retinoblastoma B-Disease 0 3.6909171274857044e-09
depend O 0 2.2235507879386773e-10
on O 0 2.3981113969617773e-11
the O 0 1.4902310071715497e-12
nature O 0 2.280176264815581e-12
of O 0 3.3170165832790977e-12
the O 0 6.544012835958679e-13
first O 0 5.6479161625322405e-12
mutation O 0 2.0552294946202948e-13
, O 0 1.3820486028932703e-14
its O 0 4.85809563557189e-15
time O 0 2.4258232141777247e-12
in O 0 6.591201109212852e-13
development O 0 1.5870470493339894e-09
, O 0 9.347722791132329e-14
and O 0 3.255792377777726e-14
the O 0 1.171919874511096e-12
number O 0 6.361125818796221e-13
and O 0 5.827038477386123e-14
types O 0 8.098000568723673e-12
of O 0 1.5983613738113078e-11
cells O 0 2.812035109975297e-12
that O 0 3.695803632206528e-14
are O 0 3.6753054348829736e-14
affected O 0 2.0572543234925744e-12
. O 0 1.2348235281511855e-11
. O 0 1.9057537770095223e-09

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 0 7.013733556959778e-05
fifth I-Disease 0 0.005181570071727037
component I-Disease 0 4.8585180323357235e-09
of I-Disease 0 1.424902973390374e-10
complement I-Disease 0 3.079659097182663e-11
in O 0 1.533881181792207e-11
man O 0 2.61338617413287e-09
. O 0 7.143732272396619e-09

I O 0 0.00034870230592787266
. O 0 1.6170112360214262e-07

Clinical O 0 2.4198581627388194e-07
, O 0 4.370054318414418e-11
immunochemical O 0 1.5490107898585848e-06
, O 0 1.912224718847444e-12
and O 0 4.2478461069819784e-13
family O 0 1.7125712740290178e-12
studies O 0 2.3057574946583337e-11
. O 0 1.2148176908866049e-10

The O 0 1.3991216518682847e-10
first O 0 1.2646033525909317e-11
recognized O 0 3.614851907390859e-12
human O 0 1.3183539546504641e-12
kindred O 0 9.848477589002869e-08
with O 0 1.4582719797331944e-12
hereditary B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
of I-Disease 1 0.9999995231628418
the I-Disease 0 7.863953896958265e-07
fifth I-Disease 0 0.00038068389403633773
component I-Disease 0 9.194288281832996e-07
of I-Disease 0 1.7172778825624846e-05
complement I-Disease 0 1.4086562316606432e-07
( O 0 8.418360453177343e-11
C5 O 0 7.42293650546344e-06
) O 0 4.39467646301539e-12
is O 0 4.048733733257731e-13
described O 0 5.598368643666696e-11
. O 0 8.084818148290651e-09

The O 0 3.776710499892033e-08
proband O 0 5.000016699341359e-06
, O 0 1.0440861500024545e-12
a O 0 2.516928993782225e-13
20 O 0 4.3270446362271564e-13
- O 0 1.2125604441695897e-14
year O 0 3.423646728530766e-13
- O 0 1.0405180189687613e-11
old O 0 2.0233460740204379e-10
black O 0 1.2152515864276292e-13
female O 0 1.7378158374131703e-12
with O 0 2.37677195633057e-12
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 0.007097654510289431
age O 0 1.4537893093802268e-06
11 O 0 1.8937309498312516e-09
, O 0 5.168896452349692e-13
lacked O 0 7.886690744918212e-10
serum O 0 5.039305084331147e-10
hemolytic O 0 3.3428126933188196e-10
complement O 0 9.068833878300708e-11
activity O 0 1.8867142570488937e-10
, O 0 1.2286998946498678e-13
even O 0 1.5546685304141522e-13
during O 0 2.589143066611399e-10
remission O 0 6.614806125071482e-08
. O 0 6.288657927733254e-10

C5 O 0 3.240746082155965e-05
was O 0 9.368650921715016e-08
undetectable O 0 7.466118390198062e-09
in O 0 6.144495177419496e-13
her O 0 2.913591676950711e-13
serum O 0 4.1996709387003006e-13
by O 0 3.8106614692608e-15
both O 0 1.6074069159044413e-12
immunodiffusion O 0 1.923392645153399e-08
and O 0 6.778731048706632e-11
hemolytic O 0 6.000855989896081e-08
assays O 0 4.004628806342225e-08
. O 0 1.5230160954615712e-07

Other O 0 8.47773413970021e-12
complement O 0 8.283432099964738e-12
components O 0 3.334750531269748e-10
were O 0 1.045189976234262e-12
normal O 0 3.373581622390098e-11
during O 0 2.5244702162030563e-11
remission O 0 4.764018957104099e-09
of O 0 2.902401582960401e-11
lupus O 0 1.7750013264761222e-11
, O 0 8.153329573989954e-12
but O 0 1.8495868725487696e-10
C1 O 0 3.285238108219346e-06
, O 0 8.537082152315634e-10
C4 O 0 1.0858683481274056e-06
, O 0 7.742557289747154e-11
C2 O 0 2.3558175143989502e-07
, O 0 9.15583928118302e-11
and O 0 6.890870651865555e-10
C3 O 0 6.585139635717496e-05
levels O 0 2.9513256549762446e-07
fell O 0 3.1403450861944293e-07
during O 0 2.9813739388373506e-07
exacerbations O 0 0.0007206480368040502
. O 0 1.774728843884077e-07

A O 0 1.0755951507235295e-07
younger O 0 2.4869941661620487e-09
half O 0 1.3447114255438208e-10
- O 0 3.065798309664913e-11
sister O 0 1.443390632710484e-11
, O 0 4.7469542402769904e-14
who O 0 2.6243601475989253e-13
had O 0 1.23197233664607e-11
no O 0 1.1720964910449938e-12
underlying O 0 4.778133000371554e-09
disease O 0 2.0172731540757383e-10
, O 0 2.586048339174845e-14
was O 0 2.0078683160562605e-10
also O 0 2.213832199157717e-12
found O 0 4.6280829862910267e-11
to O 0 3.862187014647134e-09
lack O 0 0.0027996781282126904
immunochemically O 0 0.09457401931285858
detectable O 0 3.492596442811191e-05
C5 O 0 1.3187989679863676e-05
. O 0 2.2170063118664984e-07

By O 0 6.480118108775912e-10
hemolytic O 0 5.363597210816806e-07
assay O 0 8.519161376341344e-09
, O 0 1.0850531410866449e-11
she O 0 3.169545789022399e-13
exhibited O 0 1.3380166115697922e-13
1 O 0 5.861172549907756e-13
- O 0 5.876878302578381e-13
2 O 0 5.949791847354932e-14
% O 0 1.2047628519806786e-12
of O 0 9.497988468854315e-14
the O 0 2.0133721079229616e-13
normal O 0 1.66794383860136e-10
serum O 0 2.3235005933153197e-11
C5 O 0 6.312006473052634e-10
level O 0 8.614680080398784e-10
and O 0 1.1060607724849847e-12
normal O 0 2.478445504383586e-10
concentrations O 0 1.2601272456058688e-11
of O 0 3.308492802639451e-12
other O 0 2.8999637977436543e-13
complement O 0 5.032655889247728e-11
components O 0 1.1106080499700965e-08
. O 0 7.788243827633323e-09

C5 O 0 4.995770268578781e-06
levels O 0 1.3801396692159074e-09
of O 0 7.285372305432247e-11
other O 0 1.7488811234703944e-13
family O 0 1.2683171841335744e-13
members O 0 2.0780750574099158e-14
were O 0 9.51570961783832e-13
either O 0 5.565233603815889e-12
normal O 0 7.488591413640222e-10
or O 0 5.660088283482301e-13
approximately O 0 1.280832861647041e-12
half O 0 1.1762446919250102e-11
- O 0 2.2999201501616717e-11
normal O 0 2.1421396600995735e-10
, O 0 1.2696241898525057e-13
consistent O 0 1.0608199214889869e-11
with O 0 3.13528398393232e-14
autosomal O 0 5.890570253797023e-09
codominant O 0 1.6322687201864028e-08
inheritance O 0 6.111077199832948e-10
of O 0 9.474571821543876e-11
the O 0 3.2972069519132674e-10
gene O 0 3.0319626809216516e-09
determining O 0 1.8589682440506294e-05
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.5493343425987405e-06

Normal O 0 6.8409694904403295e-06
hemolytic O 0 1.3083487147014239e-06
titers O 0 1.1450394055145807e-07
were O 0 6.327830620600494e-11
restored O 0 1.82634810053095e-10
to O 0 8.682498079878864e-13
both O 0 3.2294731125426246e-12
homozygous O 0 1.4041009244181168e-08
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 4.2097525465578656e-09
C5D B-Disease 1 1.0
) O 0 9.570442311909733e-13
sera O 0 9.907013577559187e-12
by O 0 2.0346945032443032e-16
addition O 0 2.423415980422946e-14
of O 0 8.946162387279966e-12
highly O 0 2.0080570539704468e-09
purified O 0 5.058751195718969e-09
human O 0 4.97473728877651e-10
C5 O 0 9.031764420797117e-06
. O 0 3.648677093792685e-08

In O 0 4.034534928365474e-09
specific O 0 7.437176430258319e-10
C5 O 0 1.8532688272898667e-07
titrations O 0 1.9867350431468367e-08
, O 0 3.143752890389512e-13
however O 0 1.4323978201474796e-12
, O 0 2.290080627844089e-14
it O 0 7.904165768455533e-16
was O 0 4.107067604845055e-13
noted O 0 4.637468794393973e-14
that O 0 3.473392537301043e-16
when O 0 8.089266290232239e-15
limited O 0 2.3822987311149235e-13
amounts O 0 6.7649033076711e-13
of O 0 1.3729495838832317e-11
C5 O 0 3.7083678350313676e-09
were O 0 3.8630840193398797e-10
assayed O 0 8.281185515102152e-09
in O 0 1.6801392091828071e-12
the O 0 3.500154810084921e-12
presence O 0 2.197366637604614e-12
of O 0 7.366653814733226e-11
low O 0 5.928009194633432e-10
dilutions O 0 1.649135938919244e-08
of O 0 1.387127857022108e-09
either O 0 1.0885334233989852e-07
C5D B-Disease 1 1.0
serum O 0 3.0580299181792725e-08
, O 0 5.086916131380459e-13
curving O 0 3.3225063325592608e-12
rather O 0 1.6373159067700066e-13
than O 0 1.7502951602725407e-14
linear O 0 2.2335553545582698e-11
dose O 0 8.025994452376395e-11
- O 0 1.4816828319830222e-12
response O 0 1.0347276556627386e-14
plots O 0 1.4292981728725174e-11
were O 0 1.1651088080433247e-12
consistently O 0 3.9786723178211747e-13
obtained O 0 5.123021147926399e-13
, O 0 2.0419045482764943e-14
suggesting O 0 1.0575647345703598e-12
some O 0 7.215717145970732e-14
inhibitory O 0 1.0717845361218892e-10
effect O 0 2.3837192636433358e-11
. O 0 5.633947974814646e-09

Further O 0 5.822228810181684e-10
studies O 0 2.9634138892786765e-11
suggested O 0 1.4586169728644793e-12
that O 0 8.378040997774911e-15
low O 0 3.213952715075408e-11
dilutions O 0 2.9765381270863145e-08
of O 0 1.4614492727105244e-08
C5D B-Disease 1 1.0
serum O 0 1.907369373554957e-08
contain O 0 4.297658583174435e-12
a O 0 2.6641221780726587e-13
factor O 0 4.582167436283091e-13
( O 0 6.470221680345478e-15
or O 0 2.5215802211021876e-13
factors O 0 1.7536352144714717e-12
) O 0 5.967385060482583e-14
interfering O 0 9.602181272327925e-10
at O 0 3.570466144964257e-10
some O 0 5.889544087882628e-14
step O 0 1.1662277914215036e-11
in O 0 6.951929808728108e-13
the O 0 1.889789019715593e-11
hemolytic O 0 3.859683239681999e-09
assay O 0 7.643372046395314e-10
of O 0 2.7157108561937093e-08
C5 O 0 3.880050485349784e-07
, O 0 1.1878755357824788e-12
rather O 0 4.340387858153827e-12
than O 0 9.217397624241425e-14
a O 0 4.659373147725132e-12
true O 0 3.835515238748144e-10
C5 O 0 9.227186126281595e-08
inhibitor O 0 1.7671010488218286e-10
or O 0 5.6110893709160337e-11
inactivator O 0 2.514987897939136e-07
. O 0 1.578537478508224e-08

Of O 0 3.4134053805701114e-08
clinical O 0 2.2144448053040833e-08
interest O 0 2.35642561019489e-10
are O 0 1.0476163122760673e-13
( O 0 1.6694299412377094e-14
a O 0 1.5578563558518027e-13
) O 0 4.409111422319645e-15
the O 0 3.8888345126573964e-13
documentation O 0 1.6743841868560594e-08
of O 0 8.905889914423426e-10
membranous O 0 1.293131208512932e-05
glomerulonephritis B-Disease 1 1.0
, O 0 9.664449240887052e-10
vasculitis B-Disease 1 1.0
, O 0 2.5897456401580143e-10
and O 0 5.72866254433535e-10
arthritis B-Disease 1 1.0
in O 0 1.5621866467085965e-08
an O 0 4.28942634449897e-13
individual O 0 1.6864650301262607e-11
lacking O 0 0.0003597862087190151
C5 O 0 8.053059900703374e-06
( O 0 3.525701594824654e-13
and O 0 3.6232423853733986e-14
its O 0 5.882740719250282e-14
biologic O 0 1.4990005764436987e-11
functions O 0 5.976385835868014e-13
) O 0 1.902036623498528e-15
, O 0 2.6307121747253274e-15
and O 0 6.7657476639942406e-15
( O 0 3.052366446417939e-15
b O 0 1.2127554819760245e-13
) O 0 1.4767657328793775e-15
a O 0 1.1003158562235271e-13
remarkable O 0 5.4806909011162475e-11
propensity O 0 8.830741471399506e-09
to O 0 5.136004510575276e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 2.131305895658464e-11
the O 0 1.65237962201914e-11
proband O 0 1.544345984427764e-08
, O 0 5.023633147926282e-14
even O 0 7.526605173260783e-15
during O 0 7.382728109406322e-12
periods O 0 1.7500859650354528e-09
of O 0 2.746424095090294e-11
low O 0 8.794342337692385e-11
- O 0 2.8497391078852186e-12
dose O 0 8.369632569470153e-13
or O 0 1.603681549805936e-14
alternate O 0 1.2916678837626705e-10
- O 0 2.1137372407942223e-10
day O 0 2.957977196516026e-10
corticosteroid O 0 2.806228280860523e-07
therapy O 0 1.3108644836279382e-08
. O 0 1.3153286793077257e-10

Other O 0 2.4536153664378446e-10
observations O 0 1.1828844848071896e-10
indicate O 0 3.202752299480416e-12
that O 0 5.906029339563623e-16
the O 0 3.499585603944366e-13
C5D B-Disease 1 1.0
state O 0 1.590481912838726e-11
is O 0 3.368250866953959e-15
compatible O 0 1.3947040744533012e-10
with O 0 1.6617736104274777e-14
normal O 0 1.9776442983232556e-10
coagulation O 0 2.0077448384392405e-11
function O 0 2.8770531096400376e-11
and O 0 2.9364867064644515e-14
the O 0 1.5028303037775692e-12
capacity O 0 7.110053518166737e-11
to O 0 4.314662169213612e-11
mount O 0 7.773479637762648e-08
a O 0 3.4235232426738094e-09
neutrophilic O 0 0.0011578525882214308
leukocytosis O 0 4.838323548028711e-06
during O 0 2.1442569959617686e-06
pyogenic B-Disease 0 6.038846549927257e-05
infection I-Disease 0 1.6905552513435396e-07
. O 0 7.048065603365572e-11
. O 0 1.1462161220165967e-09

Susceptibility O 0 2.2378330868377816e-06
to O 0 8.01560020136094e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 8.875426260601671e-08
twins O 0 4.3726747223082896e-10
: O 0 4.4221798172067986e-16
the O 0 5.046843375340355e-15
role O 0 1.3802895187497305e-13
of O 0 3.452211823698481e-12
genes O 0 5.484407958160353e-13
, O 0 3.7449950367370033e-13
HLA O 0 2.546398869540667e-09
, O 0 9.191962512325458e-13
and O 0 1.2951402103555942e-12
the O 0 2.1096691060762396e-10
environment O 0 1.074309263771056e-08
. O 0 3.333410214523269e-09

OBJECTIVE O 0 9.529298404231668e-05
To O 0 2.623363193343664e-10
determine O 0 1.7239321081774506e-10
the O 0 3.198149861258215e-12
relative O 0 5.383264389813291e-10
effects O 0 1.318970800634478e-11
of O 0 3.0368544051001534e-12
genetic O 0 7.055540179878861e-12
and O 0 2.526200379253645e-14
environmental O 0 1.7316606048395355e-13
factors O 0 2.6017367446107102e-14
in O 0 9.197477611607666e-15
susceptibility O 0 3.304733873707444e-12
to O 0 1.6318942863691177e-09
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 1.1734028859677892e-08
AS B-Disease 1 1.0
) O 0 3.186933572943418e-12
. O 0 8.211750723852163e-11

METHODS O 0 6.44707256469701e-07
Twins O 0 7.937627444221107e-09
with O 0 3.809006875101634e-14
AS B-Disease 1 0.9999997615814209
were O 0 1.596443382221105e-13
identified O 0 2.5922855509852467e-14
from O 0 1.4712273020746369e-15
the O 0 1.7063744690783318e-14
Royal O 0 1.9748086846349544e-11
National O 0 2.723956338268607e-10
Hospital O 0 1.1100155461463146e-07
for O 0 4.587700774827397e-10
Rheumatic B-Disease 1 0.9281938672065735
Diseases I-Disease 0 0.01594131626188755
database O 0 1.0137311079461142e-07
. O 0 6.359516646625707e-08

Clinical O 0 7.054100592540635e-08
and O 0 9.890531969813932e-12
radiographic O 0 8.029064524350815e-09
examinations O 0 1.5585557733288624e-08
were O 0 1.479345465571491e-11
performed O 0 2.619790669122768e-12
to O 0 4.3260486339014026e-12
establish O 0 5.940618552635613e-10
diagnoses O 0 3.2768330271437662e-09
, O 0 1.6431796244845143e-12
and O 0 1.2667662925569534e-11
disease O 0 2.767241369383555e-07
severity O 0 1.2413549299594706e-08
was O 0 2.0042857998281427e-11
assessed O 0 1.8056034098434814e-11
using O 0 4.854395422963786e-13
a O 0 1.8209644404333647e-13
combination O 0 5.016062435206359e-13
of O 0 1.839445696455444e-12
validated O 0 7.095057180661613e-11
scoring O 0 4.069939107953502e-10
systems O 0 1.7336114765953425e-08
. O 0 4.693112565234969e-09

HLA O 0 1.0427407914903597e-06
typing O 0 2.8502668669716513e-08
for O 0 6.699193977333096e-11
HLA O 0 2.1230205149436188e-08
- O 0 1.106809532913644e-09
B27 O 0 2.9918421073915624e-09
, O 0 1.9679697528160976e-14
HLA O 0 4.004852005579096e-11
- O 0 3.4471258313073516e-12
B60 O 0 9.218625168783134e-11
, O 0 1.3079869536611105e-16
and O 0 5.449343055721994e-16
HLA O 0 1.0065719785457006e-10
- O 0 1.6462868568378752e-10
DR1 O 0 0.00019997416529804468
was O 0 1.020919676922305e-12
performed O 0 5.407694149243969e-14
by O 0 7.162015617103812e-16
polymerase O 0 1.5848416058238807e-13
chain O 0 7.635338792699817e-15
reaction O 0 8.080468661934921e-17
with O 0 6.293506414169675e-17
sequence O 0 4.279446263501241e-14
- O 0 1.52515312526599e-14
specific O 0 1.4734907858679372e-15
primers O 0 7.855347232063603e-13
, O 0 3.0733389821919555e-15
and O 0 3.4358648061004124e-14
zygosity O 0 2.3048365438427254e-09
was O 0 6.454011370476964e-12
assessed O 0 3.19007910365432e-11
using O 0 1.337071339063689e-11
microsatellite O 0 1.3315051283768753e-08
markers O 0 3.4512690483268216e-09
. O 0 1.3572488022361995e-08

Genetic O 0 1.3396236120399863e-08
and O 0 6.16668500118267e-13
environmental O 0 2.890498712777856e-13
variance O 0 1.1066679934642124e-13
components O 0 1.3628420440781053e-11
were O 0 1.9504001549670164e-13
assessed O 0 3.4073490556840724e-12
with O 0 1.631920463597092e-15
the O 0 4.382902528865702e-14
program O 0 9.649920836365955e-13
Mx O 0 2.4123686988980486e-12
, O 0 1.3498416309118037e-16
using O 0 4.0495480537925625e-15
data O 0 1.7269875850559058e-12
from O 0 2.6029129345612675e-14
this O 0 5.62024656414889e-15
and O 0 3.55669981585028e-15
previous O 0 1.111390493524489e-11
studies O 0 4.0510663942318337e-13
of O 0 3.796142274224007e-13
twins O 0 9.180840983280536e-12
with O 0 4.1645414330590547e-13
AS B-Disease 1 1.0
. O 0 3.360908706895316e-08

RESULTS O 0 1.6635362953820731e-07
Six O 0 4.673962195056447e-08
of O 0 8.553234787100905e-10
8 O 0 9.073370943468717e-10
monozygotic O 0 2.5561032401810735e-08
( O 0 1.7667596552417564e-11
MZ O 0 1.1615574067036505e-06
) O 0 8.534952800932916e-13
twin O 0 1.0823211077370942e-10
pairs O 0 5.226946479808259e-12
were O 0 2.0111454168691978e-10
disease O 0 3.620003186100007e-10
concordant O 0 5.3326298932177e-09
, O 0 1.3985485675365589e-13
compared O 0 7.915950013537287e-12
with O 0 1.444005166633365e-14
4 O 0 4.37747667975108e-12
of O 0 9.231182658553383e-12
15 O 0 1.258712405138862e-11
B27 O 0 7.53410722698078e-10
- O 0 1.5693878488431956e-11
positive O 0 1.3512734225833156e-13
dizygotic O 0 2.987210201421675e-10
( O 0 1.8170222135715716e-14
DZ O 0 1.821659267875475e-09
) O 0 2.9031596869349627e-15
twin O 0 7.449829598701885e-13
pairs O 0 1.243562815656657e-13
( O 0 3.638600702069719e-15
27 O 0 4.5697775424846654e-11
% O 0 4.116569238266088e-11
) O 0 2.1396759520154584e-15
and O 0 2.112684993041316e-14
4 O 0 3.7232031693812395e-12
of O 0 1.0528180410807053e-10
32 O 0 1.664023474567955e-09
DZ O 0 1.5153604238093976e-07
twin O 0 1.0563037944333331e-10
pairs O 0 3.939625969201499e-12
overall O 0 1.649947556359166e-08
( O 0 2.9363981406994866e-13
12 O 0 2.480463577592129e-11
. O 0 5.790898901895936e-13
5 O 0 2.573061772329077e-12
% O 0 3.711787387866705e-12
) O 0 5.530984199288158e-14
. O 0 4.292229766056366e-11

Nonsignificant O 0 5.6161665270337835e-05
increases O 0 3.925623714984283e-11
in O 0 2.6168525896555495e-13
similarity O 0 1.3850478923493892e-12
with O 0 5.0936491454562065e-15
regard O 0 1.1567350376162633e-11
to O 0 9.91251438570151e-12
age O 0 8.309566923436762e-10
at O 0 4.1139473772044965e-11
disease O 0 5.202273334337093e-11
onset O 0 1.949280042934376e-10
and O 0 7.406979895966184e-14
all O 0 3.0434286818134537e-13
of O 0 8.181885724489746e-12
the O 0 1.6053183088393652e-11
disease O 0 2.9958990149792086e-11
severity O 0 9.966235735986428e-13
scores O 0 2.6666134036144873e-13
assessed O 0 9.563002299761703e-12
were O 0 7.577348470899636e-12
noted O 0 1.5967357102318613e-13
in O 0 5.530965767851226e-13
disease O 0 1.0105052211661913e-11
- O 0 1.2596467272030232e-11
concordant O 0 6.306326016947139e-10
MZ O 0 1.2908029134450771e-07
twins O 0 8.747066959635674e-11
compared O 0 2.870151382186603e-12
with O 0 1.3581646115916335e-13
concordant O 0 7.464910822818638e-08
DZ O 0 6.216623205546057e-06
twins O 0 4.602148706567277e-08
. O 0 1.2950588157423226e-08

HLA O 0 5.657016663462855e-05
- O 0 7.225089007079077e-07
B27 O 0 2.2369914631781285e-07
and O 0 4.385413473334543e-13
B60 O 0 5.44882228226129e-09
were O 0 8.260955802882539e-14
associated O 0 1.1228482878732071e-13
with O 0 7.709087727955763e-16
the O 0 1.175738786928296e-13
disease O 0 1.6914895048861234e-12
in O 0 1.1833950160945739e-13
probands O 0 7.57026938913441e-08
, O 0 1.0033673111115027e-13
and O 0 9.074304621516788e-14
the O 0 8.813148821840144e-11
rate O 0 1.0604932487723318e-09
of O 0 2.4040285387383342e-11
disease O 0 1.0599143784872922e-10
concordance O 0 5.800334518246686e-11
was O 0 4.163162002635001e-12
significantly O 0 1.1790996998217729e-11
increased O 0 3.36122414623663e-11
among O 0 7.529631432245942e-12
DZ O 0 3.959528882546692e-08
twin O 0 7.104076354957911e-11
pairs O 0 8.303755361267762e-13
in O 0 2.11739089803209e-12
which O 0 3.3801849259060615e-14
the O 0 6.18084272999142e-12
co O 0 2.251863626123729e-11
- O 0 1.1794505476447892e-11
twin O 0 5.375932338180789e-12
was O 0 1.0012453241720412e-13
positive O 0 4.508247099675104e-16
for O 0 7.345715358143996e-16
both O 0 1.0148424391424535e-13
B27 O 0 2.5330098019082925e-09
and O 0 9.092054366333091e-12
DR1 O 0 0.00010185258724959567
. O 0 7.81487941026171e-09

Additive O 0 4.333611247631097e-09
genetic O 0 4.1849943649419075e-11
effects O 0 6.023190301553127e-13
were O 0 8.060715181272549e-14
estimated O 0 4.052471249196832e-14
to O 0 2.708749531914103e-14
contribute O 0 3.5641344476450287e-12
97 O 0 7.132975987644841e-09
% O 0 1.1111668252183904e-09
of O 0 1.1431904685041405e-12
the O 0 6.022202593373993e-13
population O 0 2.0795726116606614e-15
variance O 0 8.23258019914952e-14
. O 0 1.1963852131202657e-10

CONCLUSION O 0 2.7996920834993944e-06
Susceptibility O 0 3.197095210794032e-08
to O 0 4.801328667980442e-09
AS B-Disease 1 1.0
is O 0 2.783507365572424e-12
largely O 0 1.1274549002737722e-11
genetically O 0 1.1098847196660232e-14
determined O 0 1.267322271431004e-11
, O 0 1.3777382555126005e-13
and O 0 1.8656910326549092e-13
the O 0 6.057410649462636e-12
environmental O 0 7.378589059192642e-12
trigger O 0 3.2698355741794805e-12
for O 0 5.838452415756964e-14
the O 0 1.4224338720780771e-11
disease O 0 6.191016449497155e-11
is O 0 9.33587313901342e-14
probably O 0 5.613423267880613e-11
ubiquitous O 0 2.1999784216575335e-09
. O 0 4.661335761824148e-09

HLA O 0 9.865989341051318e-06
- O 0 1.6084935339222284e-07
B27 O 0 8.726016886839716e-08
accounts O 0 3.6713416595030024e-13
for O 0 6.2533329649703834e-15
a O 0 4.458857328498711e-14
minority O 0 1.2251801678221652e-13
of O 0 1.3881574383901862e-13
the O 0 6.322214344926802e-13
overall O 0 3.896398759195563e-10
genetic O 0 1.2682556393972533e-11
susceptibility O 0 8.280731135512642e-12
to O 0 6.123211382380589e-10
AS B-Disease 1 1.0
. O 0 2.232614633612684e-06

Cell O 0 1.3601254345019242e-08
cycle O 0 1.2932074966442997e-08
- O 0 6.829893872684067e-10
dependent O 0 1.3900618156537092e-10
colocalization O 0 2.3708997431981516e-08
of O 0 2.0911125608868986e-10
BARD1 O 1 0.8789159655570984
and O 0 2.659586093023414e-11
BRCA1 O 0 2.823844803823139e-11
proteins O 0 1.1622095701189356e-13
in O 0 2.5894702506377987e-13
discrete O 0 7.631892895432202e-10
nuclear O 0 5.225940569175691e-08
domains O 0 5.470881347946488e-08
. O 0 5.37302913272697e-09

Germ O 0 2.2000140234013088e-05
- O 0 5.678891170646239e-07
line O 0 1.8851360472638135e-09
mutations O 0 8.931909031839602e-12
of O 0 2.6391706528516856e-11
the O 0 1.7595605528164526e-10
BRCA1 O 0 1.369187124788951e-10
gene O 0 6.988353174136944e-14
predispose O 0 5.232043964742417e-12
women O 0 2.108320274615762e-15
to O 0 4.800556179245137e-14
early O 0 2.209958438470494e-09
- O 0 7.223463427408205e-08
onset O 1 0.7945951819419861
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 1.8239278143372673e-11
compromising O 0 2.981678903779539e-09
the O 0 1.603992980103719e-11
genes O 0 6.008002255419864e-12
presumptive O 0 7.248524003244938e-09
function O 0 3.204410001234059e-11
as O 0 1.1317504008609425e-12
a O 0 2.1015834905657726e-11
tumor B-Disease 0 5.311019624087976e-09
suppressor O 0 8.85587425614176e-09
. O 0 2.450473823856214e-09

Although O 0 2.5146020821154025e-09
the O 0 2.7430124838190295e-10
biochemical O 0 1.7515887629215854e-09
properties O 0 8.03736577292824e-10
of O 0 4.964936239915119e-10
BRCA1 O 0 9.682729618099017e-11
polypeptides O 0 3.3566240065230346e-11
are O 0 2.0995719065782827e-15
not O 0 4.918399722735186e-15
understood O 0 4.663238111629608e-13
, O 0 7.104382965977037e-16
their O 0 1.2748260902321375e-14
expression O 0 2.6446189734115853e-14
pattern O 0 1.2633917891892443e-13
and O 0 1.2526558498707034e-14
subcellular O 0 9.223413144354708e-10
localization O 0 2.1095464930454e-08
suggest O 0 2.6649482967600058e-11
a O 0 1.7809622049683171e-12
role O 0 6.250194372475759e-12
in O 0 2.5951045132255324e-11
cell O 0 3.880990107063553e-08
- O 0 3.968766648654309e-09
cycle O 0 1.0603643296747123e-08
regulation O 0 5.203873443271334e-10
. O 0 4.6070272596843154e-10

When O 0 3.4877181143144753e-09
resting O 0 2.7657820282911416e-06
cells O 0 1.994570730801115e-09
are O 0 6.316392721361641e-13
induced O 0 8.671947882010755e-11
to O 0 2.377107408482737e-12
proliferate O 0 9.871125444815831e-11
, O 0 6.5550867583638334e-15
the O 0 6.676532156996151e-13
steady O 0 1.090103229905992e-09
- O 0 1.1231702417083267e-12
state O 0 1.806910605297793e-13
levels O 0 8.065737314155719e-12
of O 0 1.8494368363153324e-12
BRCA1 O 0 6.03795713514238e-14
increase O 0 3.094303852317799e-14
in O 0 1.1286968132047728e-14
late O 0 2.0503333406085567e-11
G1 O 0 5.33524169288313e-10
and O 0 1.594614333156122e-13
reach O 0 3.053007152642451e-11
a O 0 8.196497273222844e-14
maximum O 0 1.7942457415653923e-12
during O 0 1.1232827862306394e-10
S O 0 8.199128487262897e-09
phase O 0 4.147097598661276e-08
. O 0 2.2929505405500095e-08

Moreover O 0 6.946551422970515e-08
, O 0 3.4841027632404042e-12
in O 0 1.8475399161943518e-12
S O 0 3.4772762447232708e-09
phase O 0 1.4763712030685383e-08
cells O 0 1.0689488877391184e-10
, O 0 2.386866312237279e-12
BRCA1 O 0 1.397270233544079e-11
polypeptides O 0 8.805146715917811e-12
are O 0 2.0775805934566266e-13
hyperphosphorylated O 0 2.1803572280987282e-09
and O 0 3.0997292406464982e-12
accumulate O 0 2.8406778665446275e-11
into O 0 1.0799223494617483e-11
discrete O 0 9.071817963501871e-09
subnuclear O 0 9.382167149851739e-07
foci O 0 2.425939840122737e-07
termed O 0 8.131149975554308e-09
" O 0 1.5067712411109824e-08
BRCA1 O 0 1.7116112971393704e-08
nuclear O 0 8.652761351868321e-08
dots O 0 1.7194546231280583e-08
. O 0 9.08556696543883e-09

" O 0 1.2343780220192002e-08
BRCA1 O 0 2.8468980062257287e-08
associates O 0 8.962533493139802e-10
in O 0 1.2057748896565634e-11
vivo O 0 1.8800756784731476e-10
with O 0 1.2334752122966034e-14
a O 0 8.146936359039458e-13
structurally O 0 1.3227076378630187e-10
related O 0 5.613928766301512e-10
protein O 0 8.632510817285777e-10
termed O 0 1.1595570059697025e-09
BARD1 O 0 0.004116687923669815
. O 0 1.3131666420918009e-08

Here O 0 1.11532498792144e-08
we O 0 4.718902352207621e-12
show O 0 1.5711002377544192e-12
that O 0 2.724041547106477e-16
the O 0 3.569818662137354e-14
steady O 0 2.951304756138029e-10
- O 0 5.337249197288896e-13
state O 0 2.921649467496623e-13
levels O 0 2.370945800800328e-11
of O 0 8.994307902632226e-12
BARD1 O 0 1.8019406979874475e-06
, O 0 3.509048452743184e-14
unlike O 0 1.316514036458702e-13
those O 0 2.836147522345886e-14
of O 0 4.229673902789166e-12
BRCA1 O 0 2.508888756469485e-11
, O 0 1.1021222725681595e-13
remain O 0 7.088212655714798e-11
relatively O 0 4.168406071702879e-12
constant O 0 8.185065038940342e-13
during O 0 9.756272179028969e-11
cell O 0 8.460651623742876e-10
cycle O 0 2.0999548766553744e-09
progression O 0 5.886546250444269e-10
. O 0 1.1122440746191842e-09

However O 0 1.5959229493489602e-09
, O 0 1.0115697342272245e-11
immunostaining O 0 6.926745754753938e-08
revealed O 0 3.4748215416158246e-10
that O 0 2.1347661594180167e-13
BARD1 O 0 0.000575886748265475
resides O 0 2.652232045097236e-10
within O 0 9.497386904699923e-11
BRCA1 O 0 3.141394436245726e-11
nuclear O 0 4.694650224124075e-10
dots O 0 2.6764403193713093e-11
during O 0 2.1763880975189664e-10
S O 0 5.231909350200681e-10
phase O 0 1.4865916497797116e-08
of O 0 5.850794293493777e-10
the O 0 1.1515530716488254e-11
cell O 0 8.758447959944515e-12
cycle O 0 1.4580392448948487e-11
, O 0 1.325548011300501e-15
but O 0 7.778476666994835e-16
not O 0 1.5024898058501354e-15
during O 0 9.3258456512757e-12
the O 0 5.728569528462568e-12
G1 O 0 4.352606275404014e-09
phase O 0 1.2080073830134097e-08
. O 0 8.986124733212364e-09

Nevertheless O 0 3.441982698859647e-07
, O 0 2.7340960051525087e-10
BARD1 O 0 0.0012346277944743633
polypeptides O 0 6.785334960568434e-09
are O 0 1.8129173563839057e-13
found O 0 9.020515996487066e-14
exclusively O 0 1.7957145102484584e-12
in O 0 2.314504822878167e-14
the O 0 1.9400191902160108e-13
nuclear O 0 7.149859176935891e-11
fractions O 0 2.5283650173513195e-10
of O 0 7.364739026960443e-12
both O 0 8.919085088543444e-13
G1 O 0 1.38577405106588e-09
- O 0 5.448670681307277e-11
and O 0 5.692883230795642e-13
S O 0 5.334735764250809e-09
- O 0 2.8479147859417075e-11
phase O 0 1.9348052049394937e-09
cells O 0 7.563143861188948e-11
. O 0 2.8712534086428043e-11

Therefore O 0 3.7590702772760665e-10
, O 0 1.0205570655057172e-13
progression O 0 4.24422042649697e-12
to O 0 3.333409936967513e-13
S O 0 1.0502848590832059e-10
phase O 0 3.822772320916101e-09
is O 0 1.1571524615513074e-14
accompanied O 0 4.191652179432598e-13
by O 0 1.2101155259189875e-15
the O 0 1.12042014934529e-13
aggregation O 0 7.289118310674358e-13
of O 0 1.2146126118772749e-12
nuclear O 0 2.2899206975068864e-09
BARD1 O 0 2.3095866708899848e-05
polypeptides O 0 1.7803807317307019e-09
into O 0 8.403797657763334e-10
BRCA1 O 0 3.582514951361304e-09
nuclear O 0 3.59953027384563e-08
dots O 0 1.5761518312729095e-08
. O 0 1.6185287776693258e-08

This O 0 2.23003941701716e-11
cell O 0 4.2087527907241906e-11
cycle O 0 1.0921630266835791e-10
- O 0 8.662950565230254e-12
dependent O 0 8.016382696540703e-12
colocalization O 0 4.6499670780519864e-10
of O 0 1.1564526246343743e-11
BARD1 O 0 0.0003148780670017004
and O 0 4.048247197532828e-13
BRCA1 O 0 3.934061843652303e-12
indicates O 0 8.389206755492207e-14
a O 0 4.0008580588855435e-15
role O 0 2.6765178953920034e-14
for O 0 2.93537899065735e-13
BARD1 O 0 1.2343433809292037e-05
in O 0 4.855273405546257e-10
BRCA1 O 0 1.952981065755921e-08
- O 0 1.0090680291341414e-08
mediated O 0 6.427868726177621e-08
tumor B-Disease 0 3.735345543987023e-08
suppression O 0 2.9548225199960143e-08
. O 0 2.713493207906481e-09

Ethnic O 0 3.002327630952095e-08
differences O 0 1.986014241950329e-09
in O 0 4.8181367749700055e-12
the O 0 1.692009900244873e-11
HFE O 0 5.82233440127311e-07
codon O 0 9.324542915578604e-09
282 O 0 1.9939555784276308e-08
( O 0 7.509069060995799e-11
Cys O 0 0.00010964535613311455
/ O 0 1.0343700296289171e-07
Tyr O 0 1.457994081022207e-08
) O 0 7.279753514409515e-13
polymorphism O 0 4.301552447572021e-09
. O 0 1.307387975657548e-09

Recent O 0 2.96682990674757e-11
studies O 0 1.1050886768171342e-12
have O 0 1.850760637003542e-15
shown O 0 8.901444034994932e-13
that O 0 6.98404225077387e-12
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 1.3848862057130873e-09
HH B-Disease 1 0.9999208450317383
) O 0 6.828241856486617e-13
is O 0 1.286973220322122e-14
likely O 0 3.5801713698692395e-13
to O 0 7.330708306010902e-13
be O 0 1.2277071720356858e-12
caused O 0 2.988455403279966e-12
by O 0 1.055416062704928e-13
homozygosity O 0 1.2992946274437145e-08
for O 0 9.242188177965849e-13
a O 0 6.877653394715688e-12
Cys282Tyr O 0 3.462545805632544e-08
mutation O 0 1.5301109988416495e-12
in O 0 1.6645469995846957e-13
the O 0 6.662698170956105e-11
HFE O 0 1.2723682630166877e-05
gene O 0 1.4830557615308493e-10
located O 0 2.712196960075186e-11
4 O 0 6.636346472355115e-10
. O 0 4.508349249476851e-09

5 O 0 2.1597749366719654e-08
Mb O 0 1.5069471146489377e-06
telomeric O 0 1.6770088961948204e-07
to O 0 1.4227989897364068e-09
HLA O 0 6.824013780715177e-07
- O 0 6.93626418524218e-08
A O 0 2.7832316007447844e-08
. O 0 8.432731180008091e-10

Population O 0 9.911418040464692e-12
studies O 0 8.071180442742465e-13
of O 0 3.7151355668056663e-13
this O 0 8.437122392878846e-14
polymorphism O 0 1.2149428685326313e-10
are O 0 5.027342474608898e-14
facilitated O 0 3.0019563224126244e-11
by O 0 4.218913223332302e-14
the O 0 2.904637251208153e-12
fact O 0 3.1604544827555647e-13
that O 0 1.791603220692591e-15
the O 0 1.8464125627754013e-12
Cys282Tyr O 0 2.2101676222519018e-06
mutation O 0 1.0215050333384212e-10
creates O 0 5.199502720737437e-12
a O 0 3.4579075713914165e-11
Rsal O 0 1.039737867358781e-06
restriction O 0 4.4179021552182007e-10
site O 0 1.84306581108018e-09
. O 0 3.034010598312875e-09

We O 0 3.7645950246023574e-10
have O 0 1.654203710859184e-13
studied O 0 3.645092311755499e-13
the O 0 9.223904192529053e-14
codon O 0 1.0275354178634899e-10
282 O 0 3.442485629889802e-09
( O 0 5.850501333393154e-11
Cys O 0 0.00012661708751693368
/ O 0 2.7652470180328237e-07
Tyr O 0 5.271902736581069e-08
) O 0 2.9266077950819425e-13
polymorphism O 0 9.976992149107744e-11
in O 0 3.197610023444007e-14
different O 0 7.449484686885763e-14
ethnic O 0 2.6350551515091913e-12
groups O 0 1.2327138821429523e-13
. O 0 7.385421441075124e-11

In O 0 7.665472423479258e-11
agreement O 0 4.794425967347138e-10
with O 0 2.324260575670145e-13
previous O 0 1.0516966186813193e-09
observations O 0 5.186441207061243e-11
the O 0 2.2831265957673486e-12
Tyr O 0 5.249381485050719e-10
allele O 0 1.5153055893391e-11
appeared O 0 4.6734001217518806e-12
to O 0 6.272252248834542e-12
be O 0 1.378118019007557e-11
rare O 0 7.598134621478181e-11
or O 0 1.0549528611791814e-10
absent O 0 1.1222821427736562e-07
in O 0 2.5622398300284566e-11
Asiatic O 0 2.8084212733148206e-09
( O 0 1.8599767789861422e-14
Indian O 0 1.2188508882737814e-11
, O 0 1.6569628021002522e-14
Chinese O 0 1.2499846643865276e-11
) O 0 1.992886107873848e-13
populations O 0 8.5486386849562e-13
. O 0 6.531936103115754e-11

The O 0 3.3815311661911096e-11
highest O 0 5.921226703398119e-11
allele O 0 1.488571852586995e-12
frequency O 0 2.920492190097712e-12
( O 0 6.5940323803665205e-16
7 O 0 1.5948616125666115e-12
. O 0 3.366801127713086e-14
5 O 0 7.929394987837846e-13
% O 0 2.1776898860570437e-12
) O 0 1.2394364184211424e-15
was O 0 8.133708550434049e-13
found O 0 3.8223563854009046e-13
in O 0 4.576858423505081e-12
Swedes O 0 9.300121064370614e-07
. O 0 2.0399687628014362e-07

Saamis O 0 0.0018522270256653428
( O 0 1.097907680568111e-12
2 O 0 9.307613707543183e-12
% O 0 1.9467228176694995e-11
) O 0 1.824668845854557e-15
and O 0 1.2715848339561742e-13
Mordvinians O 0 2.58214095083531e-06
( O 0 1.0554537895523988e-14
1 O 0 1.1969586563229107e-13
. O 0 1.3966871109910139e-14
8 O 0 2.520080227396554e-13
% O 0 5.251296359559676e-13
) O 0 4.160406931835817e-16
had O 0 3.247840771282082e-14
significantly O 0 8.934255245340861e-13
lower O 0 1.6079413842073897e-11
frequencies O 0 3.9877243868113865e-11
of O 0 3.234196591095362e-11
the O 0 4.3977502195424734e-10
Tyr O 0 6.791992746002506e-08
allele O 0 6.60310517375251e-09
. O 0 2.438567037188477e-08

Comparisons O 0 4.258220165365145e-10
with O 0 2.0737285586630572e-13
allele O 0 6.2290819204113834e-12
frequencies O 0 4.42733072425483e-11
based O 0 2.5271063656940283e-14
on O 0 1.6363426455848207e-12
prevalence O 0 2.813252885855433e-12
estimates O 0 1.3999977392653573e-13
of O 0 1.2253256135436041e-12
HH B-Disease 0 0.00016548368148505688
showed O 0 1.8043038174653248e-09
some O 0 4.553138465215878e-13
disagreements O 0 4.0284828806136375e-09
with O 0 2.6907475406861073e-14
the O 0 9.046887371189083e-12
RFLP O 0 1.9995464839439592e-08
data O 0 8.791664063423354e-10
, O 0 1.6239678872487229e-12
particularly O 0 3.472525652442604e-12
in O 0 6.432618326890349e-11
Finns O 0 2.4558337372582173e-06
. O 0 4.263393194037235e-08

The O 0 1.1691086987397625e-09
newly O 0 3.6088916299803486e-09
described O 0 8.397448708619137e-11
HFE O 0 0.0001194546275655739
marker O 0 5.755805165819083e-09
provides O 0 4.992895745285775e-13
a O 0 2.3891868708046313e-14
new O 0 8.848666796950385e-16
approach O 0 5.310296541144628e-14
to O 0 4.3899135899767155e-14
the O 0 9.791863500585585e-14
screening O 0 4.528025523975465e-12
of O 0 8.249753311040386e-12
HH B-Disease 0 0.0003814315132331103
as O 0 1.9816446660686493e-12
well O 0 1.0705332020161107e-12
as O 0 2.1333851230194954e-14
studies O 0 8.587517090659358e-13
of O 0 2.5526523711634497e-13
the O 0 3.0779412764185554e-13
relationship O 0 6.373565737682885e-12
between O 0 2.391096175224927e-11
the O 0 1.109442468449906e-10
HFE O 0 5.538823302231322e-07
Tyr O 0 2.49158071952138e-09
allele O 0 1.438570651490778e-10
and O 0 5.037567585297609e-13
different O 0 1.6958265347533086e-10
disorders O 0 2.8772430596291088e-05
including O 0 2.743812954619784e-10
cancer B-Disease 0 0.23266558349132538

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 0 0.24298600852489471
associated O 0 7.639757160227134e-10
with O 0 1.9299425474622947e-14
a O 0 2.541444431205381e-13
missense O 0 6.737569269860133e-12
mutation O 0 5.0361624592820675e-14
encoding O 0 1.1216513828848917e-10
Gly23 O 0 1.0325777566322358e-06
- O 0 1.776517137841438e-07
- O 0 6.462486368263853e-08
> O 0 1.1061917604138216e-08
Val O 0 6.350322490078497e-10
in O 0 3.278272184964459e-12
neurophysin O 0 3.11024805910165e-08
II O 0 2.3172187866293825e-06
. O 0 3.241254020736051e-08

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.3146114752338178e-10
ADNDI B-Disease 1 1.0
) O 0 6.592231643377799e-13
is O 0 8.422394861618346e-14
an O 0 1.0580327846482218e-12
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 5.534351310565455e-10
by O 0 2.0883593248796628e-13
progressive O 0 5.696139169231174e-07
degeneration O 1 0.9999762773513794
of O 0 4.4311287972220725e-09
the O 0 2.6690790203010017e-11
magnocellular O 0 6.134866503693104e-10
neurons O 0 2.0636740927226782e-10
of O 0 3.657981209603811e-11
the O 0 3.8508994604224966e-11
hypothalamus O 0 1.0674004735644615e-10
leading O 0 1.8204453569592438e-11
to O 0 1.8065162213365404e-11
decreased O 0 1.1231676699807736e-09
ability O 0 6.817057335295473e-11
to O 0 2.8688719802549834e-11
produce O 0 1.4742958243108006e-10
the O 0 1.3770309892358057e-10
hormone O 0 1.1102971840537545e-11
arginine O 0 1.403329119575858e-09
vasopressin O 0 2.0628605490458085e-09
( O 0 2.5979359722511086e-12
AVP O 0 3.499247114291393e-08
) O 0 6.797163526472971e-12
. O 0 1.4357368627315736e-09

Affected O 0 5.855463669490746e-09
individuals O 0 1.2378271151136655e-12
are O 0 3.459777494878302e-13
not O 0 2.7443860985826296e-12
symptomatic O 0 7.994601647354216e-10
at O 0 3.986961802371347e-12
birth O 0 8.445540100598947e-11
, O 0 2.946305851202202e-13
but O 0 6.19360790952983e-13
usually O 0 8.141243929005171e-11
develop O 0 9.887645546768908e-08
diabetes B-Disease 0 9.444468673791562e-07
insipidus I-Disease 0 1.5497081449211692e-06
at O 0 4.151624466430803e-08
1 O 0 1.3047381841602146e-08
- O 0 2.4628405981275137e-08
6 O 0 2.3435895446510813e-09
yr O 0 3.7615851056216343e-07
of O 0 1.242587699401554e-10
age O 0 8.478388546784288e-10
. O 0 6.385569850664297e-10

The O 0 3.68244906789883e-10
genetic O 0 6.482550607422866e-11
locus O 0 1.7865155535479182e-11
of O 0 3.4779096269588194e-11
the O 0 6.661287493825441e-11
disease O 0 1.1008192274397643e-10
is O 0 4.144552539706026e-15
the O 0 5.5372173859979945e-12
AVP O 0 1.5173493011388928e-05
- O 0 2.3553986466140486e-05
neurophysin O 0 2.244294955744408e-05
II O 1 0.9891681671142578
( O 0 4.1343681950190003e-11
NPII O 1 0.9999750852584839
) O 0 3.0981494496609696e-13
gene O 0 5.800580556245688e-14
, O 0 1.2901190159849297e-14
and O 0 8.162050137323906e-14
mutations O 0 1.2081178071832177e-12
that O 0 1.4293287961628792e-14
cause O 0 9.528286493143412e-11
ADNDI B-Disease 1 0.8194421529769897
have O 0 4.738598294133645e-13
been O 0 4.80177692312872e-13
found O 0 1.2801379185476639e-14
in O 0 2.32743901598274e-15
both O 0 7.601916566667057e-15
the O 0 3.120071611012812e-14
signal O 0 7.017906655110151e-12
peptide O 0 4.830639469162457e-13
of O 0 1.4738085751808683e-11
the O 0 2.508564744818642e-10
prepro O 0 4.900633939541876e-06
- O 0 2.6177908694080543e-06
AVP O 0 0.0002856581413652748
- O 0 8.608992357039824e-05
NPII O 1 0.9997846484184265
precursor O 0 5.843032169217111e-10
and O 0 5.771403862632474e-13
within O 0 9.328416927800731e-10
NPII O 0 0.1815769076347351
itself O 0 4.5831855671751853e-11
. O 0 5.377989165111785e-10

An O 0 3.2268208938202037e-11
affected O 0 5.903386113281783e-11
girl O 0 3.0136326767404853e-10
who O 0 2.1142904592895417e-13
presented O 0 1.4115198810130125e-12
at O 0 9.783188799003528e-13
9 O 0 7.37428022291875e-13
months O 0 4.176601013823611e-13
of O 0 1.5774679468488068e-13
age O 0 1.6013602119682724e-12
and O 0 1.3151862953732218e-13
her O 0 1.129796451705689e-12
similarly O 0 4.569999977402373e-13
affected O 0 1.6597700861278875e-12
younger O 0 8.302730031273242e-12
brother O 0 3.186467062432641e-11
and O 0 3.828456106823308e-13
father O 0 1.474042693461186e-10
were O 0 4.345716841935854e-11
all O 0 2.7352290354540343e-13
found O 0 3.346557040273708e-14
to O 0 2.5707732858172398e-14
have O 0 7.305530526939476e-16
a O 0 2.2283001622537286e-15
novel O 0 2.4137180037483e-15
missense O 0 2.2133265706325567e-11
mutation O 0 2.3709016317590738e-14
( O 0 1.1732331702966935e-15
G1758 O 0 1.460845749923223e-10
- O 0 4.7435402827922246e-11
- O 0 2.974246543496761e-11
> O 0 6.621218330560286e-12
T O 0 2.833672424311373e-13
) O 0 8.862812611129002e-18
encoding O 0 5.404260955302158e-14
the O 0 7.737053727731313e-14
amino O 0 4.88944659499807e-13
acid O 0 3.158440170644358e-14
substitution O 0 1.9499139716078195e-12
Gly23 O 0 3.945296001006682e-08
- O 0 2.9146772106969365e-08
- O 0 3.911891255370392e-08
> O 0 7.384361566664666e-08
Val O 0 9.201682082959906e-09
within O 0 8.718626709480759e-09
NPII O 1 0.9991039633750916
. O 0 1.380530001426905e-08

The O 0 1.226651002994572e-09
mutation O 0 3.2391708672946384e-12
was O 0 2.7916726005536296e-13
confirmed O 0 1.3270115529432497e-13
by O 0 1.1601884393925036e-15
restriction O 0 1.0097316456266284e-13
endonuclease O 0 7.521335117222083e-12
analysis O 0 1.6021369994567713e-11
. O 0 3.8195346885316894e-10

A O 0 3.0003985074245065e-08
T1 O 0 1.6967801741429867e-07
- O 0 7.654805955770172e-11
weighted O 0 5.366515066530797e-13
magnetic O 0 1.551804366430043e-12
resonance O 0 2.8901157508864905e-11
imaging O 0 2.5866876640634473e-08
of O 0 1.2987555475518775e-10
the O 0 5.19283782640656e-10
fathers O 0 1.990569842291734e-08
pituitary O 0 1.4809491233336303e-07
gland O 0 1.89309923293024e-09
demonstrates O 0 1.68402292111125e-10
an O 0 1.8036198619689192e-12
attenuated O 0 7.971780568993836e-09
posterior O 0 1.8717106513577164e-06
pituitary O 0 3.61671372957062e-05
bright O 0 1.1172203784326484e-07
spot O 0 5.645154942612862e-06
. O 0 6.248883011039652e-08

This O 0 2.223339734541696e-09
mutation O 0 1.4851872509602515e-10
may O 0 1.46480624938633e-12
be O 0 1.0202266548936523e-12
valuable O 0 1.7504389604461323e-10
for O 0 1.0660377203382254e-13
developing O 0 8.393157002739571e-11
models O 0 7.608982194318159e-11
of O 0 1.7149887066025826e-10
dominantly B-Disease 0 1.0030361409008037e-05
inherited I-Disease 1 0.7928876876831055
neurodegeneration I-Disease 1 1.0
, O 0 4.501588771882448e-12
as O 0 1.6139367471049333e-14
the O 0 3.89352314495231e-14
early O 0 3.4645934125082656e-12
age O 0 9.328033137578906e-12
of O 0 3.4140171158852928e-12
onset O 0 1.2812390082217462e-07
of O 0 8.252079020110159e-09
symptoms O 0 7.168343785224351e-08
suggests O 0 3.289025952632474e-12
that O 0 5.8269912129476666e-15
this O 0 5.393183729468509e-13
mutation O 0 1.1114308258453054e-11
may O 0 2.4453950149549986e-12
be O 0 5.020661664190129e-11
particularly O 0 2.0358498220574006e-10
deleterious O 0 1.059837995143198e-09
to O 0 1.174501190748245e-10
the O 0 1.302184138296525e-09
magnocellular O 0 4.2730729887807684e-07
neuron O 0 3.1694131763515543e-09
. O 0 6.341289993105903e-11
. O 0 3.439532436644299e-09

Frequent O 0 2.4882276239424073e-09
inactivation O 0 2.6009804088289457e-08
of O 0 5.078679237158212e-07
PTEN O 0 0.00024266533728223294
/ O 0 0.10785138607025146
MMAC1 O 1 0.9999992847442627
in O 0 1.4626978517284783e-09
primary O 0 0.0466882586479187
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.080527903875918e-07

Sporadic B-Disease 1 0.9999998807907104
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 6.267874823606689e-07
the O 0 2.909889040836333e-08
most O 0 1.57234815445495e-11
common O 0 1.7644974370512045e-10
male B-Disease 0 3.1259082128309856e-11
cancer I-Disease 0 2.0225800201334465e-12
in O 0 7.046785030495606e-12
the O 0 2.1473964273432955e-10
Western O 0 1.7549762754143217e-09
world O 0 7.01898717099525e-13
, O 0 4.862955741216646e-14
yet O 0 2.6815268755475685e-13
many O 0 1.1528692276952792e-15
of O 0 9.108482739751678e-14
the O 0 9.461103910946358e-14
major O 0 3.200796832442121e-13
genetic O 0 1.3921140715883462e-12
events O 0 1.7718706818610486e-13
involved O 0 5.609588314692271e-12
in O 0 4.206166231285335e-12
the O 0 1.4583339744134172e-11
progression O 0 2.7548474612615337e-09
of O 0 2.7480748579500336e-11
this O 0 1.0283505817720862e-11
often O 0 1.3500775497554685e-10
fatal O 0 1.1840526212836266e-06
cancer B-Disease 0 2.627387516440649e-07
remain O 0 1.8444737293066282e-07
to O 0 9.551308632893551e-10
be O 0 3.453942909459329e-09
elucidated O 0 1.0239551556878723e-05
. O 0 1.042574169218824e-07

Numerous O 0 1.5505552397598876e-09
cytogenetic O 0 4.4887542571814265e-07
and O 0 2.1759304427715342e-11
allelotype O 0 1.0776076209140228e-07
studies O 0 1.1447292766475492e-11
have O 0 8.389459001903899e-15
reported O 0 1.9969040255998077e-13
frequent O 0 1.3049987251847334e-13
loss O 0 7.832479803626669e-11
of O 0 2.087093164959697e-09
heterozygosity O 0 6.711239166179439e-06
on O 0 5.561955163102539e-08
chromosomal O 0 1.462171712773852e-05
arm O 0 2.410949036857346e-06
10q O 0 6.182544893817976e-06
in O 0 9.476618378911894e-10
sporadic B-Disease 1 0.999911904335022
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.275692499002616e-07

Deletion O 0 7.674420317016484e-07
mapping O 0 2.6838463895728637e-08
studies O 0 2.7497434884615757e-10
have O 0 2.1899848471132466e-13
unambiguously O 0 2.5057849892262674e-11
identified O 0 3.3462984987131517e-12
a O 0 4.1606196027506315e-13
region O 0 1.3047567193336107e-10
of O 0 2.8627827539096096e-11
chromosome O 0 3.1754507356929196e-10
10q23 O 0 6.596825841143072e-08
to O 0 9.482504191582475e-12
be O 0 1.8290341029930657e-12
the O 0 4.122294953307071e-12
minimal O 0 4.247174612004301e-09
area O 0 5.377678857776402e-11
of O 0 2.0265390060503208e-11
loss O 0 4.256695440574276e-09
. O 0 3.715151919436721e-08

A O 0 1.2511218301369809e-06
new O 0 2.3768106927057886e-10
tumor B-Disease 0 7.431504855937021e-10
suppressor O 0 1.6702995930817366e-10
gene O 0 1.0949402192220181e-12
, O 0 2.0766587234544165e-12
PTEN O 0 1.836780114672365e-07
/ O 0 1.5138250546442578e-06
MMAC1 O 1 0.9999926090240479
, O 0 3.583397684484013e-12
was O 0 5.720143109178011e-11
isolated O 0 1.394325713915956e-11
recently O 0 1.255426291353265e-13
at O 0 1.0575601402636539e-13
this O 0 1.1230999371266716e-15
region O 0 4.3165614312112854e-12
of O 0 2.8358205540757186e-12
chromosome O 0 3.675633408750656e-11
10q23 O 0 1.2055077824868476e-08
and O 0 8.092144575949645e-13
found O 0 4.1396686425998475e-12
to O 0 3.2059307465692743e-12
be O 0 2.2108264654749354e-13
inactivated O 0 6.975279186714756e-13
by O 0 5.7014185785172165e-15
mutation O 0 2.6259838487724396e-12
in O 0 4.548705162532585e-12
three O 0 1.0344347600721449e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 8.186975009039088e-08
lines O 0 1.6876114394825947e-10
. O 0 6.622967729796869e-10

We O 0 4.858833335674717e-09
screened O 0 1.4404336390327899e-08
80 O 0 3.6583216456165246e-08
prostate B-Disease 0 0.00013859158207196742
tumors I-Disease 1 1.0
by O 0 6.202746649641711e-13
microsatellite O 0 1.0622341894972465e-09
analysis O 0 9.0973105784653e-12
and O 0 1.9893314155260827e-13
found O 0 6.212869845326208e-13
chromosome O 0 9.62154921707592e-12
10q23 O 0 5.121135959740286e-09
to O 0 1.6498255886454594e-11
be O 0 4.545671825062492e-11
deleted O 0 6.880337410919424e-10
in O 0 2.9638080184524185e-12
23 O 0 5.271273972873303e-10
cases O 0 9.912118001387249e-12
. O 0 3.780585622337185e-09

We O 0 2.727996162299462e-10
then O 0 3.425737070319318e-13
proceeded O 0 9.59036582787176e-12
with O 0 3.8640279860091694e-17
sequence O 0 2.5930868441533493e-14
analysis O 0 3.539755429960226e-14
of O 0 6.24282526714981e-14
the O 0 8.74922747098883e-13
entire O 0 7.906425736337042e-09
PTEN O 0 5.559504643315449e-07
/ O 0 1.4901293354796508e-07
MMAC1 O 0 0.00048190142842940986
coding O 0 5.226518737799779e-07
region O 0 1.1260634646959033e-09
and O 0 9.447903749496347e-14
tested O 0 6.344767918518845e-13
for O 0 2.4570479318134462e-14
homozygous O 0 2.018356402150312e-12
deletion O 0 1.1751117657068932e-12
with O 0 5.944457318556419e-15
new O 0 4.917692229995663e-13
intragenic O 0 7.3327228733433e-09
markers O 0 2.810980094525295e-11
in O 0 7.034480420040068e-13
these O 0 7.393627268585667e-14
23 O 0 3.565684856751683e-12
cases O 0 1.470560327156145e-14
with O 0 9.773298571260844e-14
10q23 O 0 7.873562424265401e-08
loss O 0 3.2069078503838e-09
of O 0 4.446454582307524e-08
heterozygosity O 0 6.824301090091467e-05
. O 0 1.393588036080473e-06

The O 0 1.3157120358486818e-11
identification O 0 1.6594277063575191e-09
of O 0 2.5911292556024534e-10
the O 0 1.1067070870840467e-11
second O 0 1.3193665604482874e-10
mutational O 0 1.0708466752218371e-10
event O 0 2.084615466357853e-12
in O 0 1.0368346806122197e-12
10 O 0 6.995187849107021e-12
( O 0 1.8542313545049163e-14
43 O 0 2.680969890533902e-09
% O 0 1.1291438895000283e-08
) O 0 2.131632370616643e-10
tumors B-Disease 1 1.0
establishes O 0 8.603514567440129e-10
PTEN O 0 4.5831663442186255e-07
/ O 0 2.4076696718111634e-05
MMAC1 O 1 0.9999992847442627
as O 0 6.0384930562762396e-12
a O 0 5.258112196517006e-13
main O 0 1.581674786803322e-12
inactivation O 0 1.5671285883561703e-12
target O 0 1.331636949146453e-12
of O 0 5.370308711616367e-11
10q O 0 6.954226705602196e-07
loss O 0 2.424596301509041e-09
in O 0 4.0651754185105915e-10
sporadic B-Disease 1 0.9895154237747192
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.089580116887873e-10
. O 0 4.888838223138237e-10

Risk O 0 5.303875241224887e-07
reversals O 0 1.3155382561080842e-08
in O 0 8.262366485434214e-12
predictive O 0 3.3045373104556575e-09
testing O 0 3.596120970450478e-11
for O 0 8.315016730708891e-11
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.2832894181211714e-09

The O 0 3.798746386896035e-11
first O 0 3.0820414579843525e-13
predictive O 0 3.0927978927897115e-11
testing O 0 4.0609922651209385e-13
for O 0 3.429020305548147e-12
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 3.6605977241934394e-15
HD B-Disease 0 1.3126808973140669e-08
) O 0 2.3620174419885023e-15
was O 0 3.655080998607972e-14
based O 0 3.6567299070584802e-16
on O 0 7.940469028827613e-14
analysis O 0 3.296837358234689e-13
of O 0 3.1560209090217284e-13
linked O 0 2.404652171827948e-11
polymorphic O 0 1.45945807522585e-11
DNA O 0 5.992950136146646e-09
markers O 0 4.329236968914074e-11
to O 0 9.171180308242821e-12
estimate O 0 3.031462580960209e-11
the O 0 8.164140479112458e-13
likelihood O 0 7.089429737705544e-11
of O 0 8.545435886686548e-11
inheriting O 0 1.6433771676815923e-08
the O 0 3.372785384314625e-10
mutation O 0 1.0044120049568228e-11
for O 0 2.3238329663333168e-11
HD B-Disease 0 1.3076453797111753e-05
. O 0 5.747394737909417e-08

Limits O 0 1.9113807758763812e-10
to O 0 2.1614602468966737e-12
accuracy O 0 3.4695962769504263e-10
included O 0 1.0685645077113115e-12
recombination O 0 4.98199658610643e-12
between O 0 2.400810670058484e-12
the O 0 1.626671128525381e-12
DNA O 0 3.315168584094863e-09
markers O 0 7.409167029903685e-11
and O 0 1.0812182312663898e-12
the O 0 3.334742204597063e-11
mutation O 0 7.437964306966638e-12
, O 0 3.090754106642446e-13
pedigree O 0 1.0381080717269953e-10
structure O 0 3.1447094928083175e-11
, O 0 8.36373952408688e-14
and O 0 1.616185450173304e-14
whether O 0 2.022122771419728e-14
DNA O 0 1.7524834361459796e-10
samples O 0 1.5892257128335974e-12
were O 0 1.0233404835330306e-13
available O 0 1.113868654430139e-12
from O 0 1.576355148844022e-13
family O 0 3.792986703800988e-13
members O 0 4.158566720147139e-12
. O 0 3.164683404222046e-09

With O 0 1.8815374605574142e-12
direct O 0 4.6831353898990624e-12
tests O 0 1.8057883747341075e-12
for O 0 1.5328383907216997e-13
the O 0 1.4022298946980705e-12
HD B-Disease 0 9.915123655446223e-08
mutation O 0 6.049741328555125e-13
, O 0 8.861912804058666e-15
we O 0 1.9160783121816363e-14
have O 0 2.8176305350859597e-15
assessed O 0 5.392535918670449e-13
the O 0 4.014727122254001e-14
accuracy O 0 1.5785930895795275e-10
of O 0 8.60389559077801e-13
results O 0 1.0971995203666249e-13
obtained O 0 2.085096635282002e-12
by O 0 5.540402528035268e-14
linkage O 0 9.561292729776127e-11
approaches O 0 3.6019819939225872e-12
when O 0 3.4845973220613835e-14
requested O 0 7.315222212700423e-12
to O 0 1.6223493035094627e-11
do O 0 5.689998385655093e-12
so O 0 8.177290631737263e-14
by O 0 1.2305847970673928e-14
the O 0 2.766014142990131e-13
test O 0 4.394911084365516e-12
individuals O 0 1.2780606651122128e-12
. O 0 1.2226333279130586e-09

For O 0 1.2960360562530582e-10
six O 0 1.8738026755227288e-11
such O 0 8.601556898929323e-15
individuals O 0 1.1503620864043718e-13
, O 0 3.866784347686565e-14
there O 0 5.329179616044358e-14
was O 0 8.804575991894215e-12
significant O 0 6.390400795336371e-12
disparity O 0 7.520736117205828e-11
between O 0 2.7659526145168423e-12
the O 0 1.0037053653488837e-11
tests O 0 7.650340083653617e-11
. O 0 1.6731542817893796e-09

Three O 0 1.5393428753895932e-09
went O 0 3.0083446844741957e-09
from O 0 1.1131300742261985e-11
a O 0 4.940238756273585e-12
decreased O 0 1.5091231597708088e-09
risk O 0 8.526951714160624e-12
to O 0 2.5327271530040107e-11
an O 0 4.1722140607831915e-13
increased O 0 1.1694731988365348e-11
risk O 0 3.0822783561590406e-12
, O 0 1.7357470305902692e-14
while O 0 1.1226341579441412e-13
in O 0 1.0017878995967344e-13
another O 0 4.843611406055159e-13
three O 0 5.212179971479658e-13
the O 0 1.2122010209850154e-12
risk O 0 8.909823399905203e-12
was O 0 3.956337341071148e-11
decreased O 0 8.780339122438363e-09
. O 0 4.3909129665564706e-09

Knowledge O 0 1.234850878972793e-05
of O 0 8.845914223343243e-09
the O 0 4.110002616020125e-11
potential O 0 2.5671255485942845e-12
reasons O 0 2.8080191167081936e-13
for O 0 1.637496290906454e-14
these O 0 1.4862922700854993e-14
changes O 0 9.297308067738111e-15
in O 0 2.021490376621308e-14
results O 0 2.194137666694518e-12
and O 0 3.4940900541825803e-13
impact O 0 8.482068346304938e-12
of O 0 6.6417214610037245e-12
these O 0 5.209098668905454e-13
risk O 0 1.5275507638315422e-12
reversals O 0 2.2526454659943518e-11
on O 0 1.4393164611548048e-11
both O 0 2.2959787283199917e-12
patients O 0 2.784123192406396e-12
and O 0 5.672460046709897e-14
the O 0 7.7510350568466e-12
counseling O 0 2.3422019532204352e-11
team O 0 2.0299800523263661e-13
can O 0 9.401632711280097e-14
assist O 0 1.1249765702325831e-10
in O 0 1.6429978037801884e-12
the O 0 2.692978435733795e-12
development O 0 3.79938580596928e-10
of O 0 2.9668453024184194e-12
strategies O 0 2.9044284338697324e-11
for O 0 6.933731068687124e-14
the O 0 3.453184732517961e-13
prevention O 0 1.1531883087334549e-11
and O 0 5.8147337991679496e-15
, O 0 9.150194114909563e-16
where O 0 1.5581697283961336e-15
necessary O 0 4.0534509776479766e-11
, O 0 1.628389162064165e-14
management O 0 2.7214413014786665e-11
of O 0 3.840452261760774e-12
a O 0 8.230186497593106e-12
risk O 0 1.4264658031171162e-11
reversal O 0 1.1544933412044323e-11
in O 0 4.3526971306787066e-13
any O 0 8.860907342068958e-13
predictive O 0 2.286018041530724e-10
testing O 0 2.859610768665699e-12
program O 0 9.405373181670118e-12
. O 0 2.3868480976407813e-12
. O 0 2.977506297074939e-10

A O 0 6.857086454203909e-09
novel O 0 4.4670403443955453e-13
common O 0 1.7280322138490956e-12
missense O 0 4.18790280232173e-10
mutation O 0 1.2352987556474293e-12
G301C O 0 1.9954335406247026e-10
in O 0 9.850290478034471e-14
the O 0 2.2284821557527756e-12
N O 0 4.079078463892216e-10
- O 0 2.7317190176567863e-10
acetylgalactosamine O 0 4.449322332789052e-08
- O 0 8.357505798528564e-10
6 O 0 1.854242176468901e-10
- O 0 6.012063763494169e-11
sulfate O 0 5.155478908364097e-12
sulfatase O 0 9.453758609279106e-11
gene O 0 3.53036962727829e-14
in O 0 9.485032117367842e-13
mucopolysaccharidosis B-Disease 0 3.0572022069463856e-07
IVA I-Disease 1 0.9985315799713135
. O 0 7.91283071066573e-07

Mucopolysaccharidosis B-Disease 0 0.007847939617931843
IVA I-Disease 1 1.0
( O 0 7.530005063927092e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.322123882070315e-10
is O 0 1.8397228185307313e-12
an O 0 1.521196363318822e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 1.081930012247767e-08
by O 0 2.839201584340506e-13
a O 0 3.9934122675333583e-10
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 5.798498139975017e-11
N O 0 5.314137463408031e-10
- O 0 7.567529936025608e-11
acetylgalactosamine O 0 1.2185900288841367e-08
- O 0 9.570890607824012e-11
6 O 0 3.772377896171797e-11
- O 0 3.0198857303709303e-11
sulfate O 0 5.076612958135329e-13
sulfatase O 0 1.4196692432744129e-11
( O 0 4.356995179140982e-15
GALNS O 0 1.5391961483146588e-07
) O 0 3.627448276651013e-13
. O 0 9.765040165365946e-11

In O 0 3.8183253781021165e-10
previous O 0 9.244847665179634e-10
studies O 0 5.8930221813469075e-12
, O 0 1.8215401179056366e-14
we O 0 2.26214006023278e-14
have O 0 3.598789730032293e-15
found O 0 1.0962639216544057e-14
two O 0 7.225519688862717e-15
common O 0 4.314310139610228e-14
mutations O 0 4.105796377797816e-14
in O 0 1.8503602784106926e-13
Caucasians O 0 5.1254497174246794e-11
and O 0 2.705281474096183e-13
Japanese O 0 5.478773434930417e-09
, O 0 1.4417169715008615e-12
respectively O 0 9.037898429653524e-09
. O 0 7.883867780833498e-09

To O 0 1.2237846647167316e-07
characterize O 0 5.945861403233721e-07
the O 0 3.847012486346557e-09
mutational O 0 2.7415671866037883e-07
spectrum O 0 4.259292363251177e-10
in O 0 2.609823029344968e-14
various O 0 5.573853892001414e-14
ethnic O 0 5.546939860559541e-13
groups O 0 2.5140956431626707e-15
, O 0 5.743658841047368e-15
mutations O 0 9.243736283142887e-14
in O 0 1.443064282435555e-13
the O 0 3.455191341372732e-11
GALNS O 0 4.398234887048602e-05
gene O 0 1.846962036436417e-12
in O 0 8.421632315125382e-12
Colombian O 0 2.331073801542516e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 3.771475132197111e-09
were O 0 4.201614056675851e-11
investigated O 0 1.5146120468934043e-11
, O 0 3.3770271870786975e-14
and O 0 1.9828448372160093e-14
genetic O 0 3.4868464994682047e-13
backgrounds O 0 2.873646199469393e-12
were O 0 1.2252157838635314e-12
extensively O 0 2.4045548538409456e-12
analyzed O 0 1.1116868059782292e-12
to O 0 2.161294147123849e-13
identify O 0 1.3426502097624304e-11
racial O 0 2.057182549308756e-13
origin O 0 4.324619004916763e-13
, O 0 4.220381893759546e-16
based O 0 1.2886323831652477e-16
on O 0 6.737960748159563e-14
mitochondrial O 0 1.3265871691078845e-12
DNA O 0 1.6394183233181536e-10
( O 0 3.2552975072486223e-13
mtDNA O 0 1.8016171887680343e-10
) O 0 1.6939110704383697e-12
lineages O 0 2.0867857442041782e-10
. O 0 3.2028244500992287e-09

Three O 0 7.547426017495695e-10
novel O 0 1.0939972018564337e-11
missense O 0 3.635464551621226e-08
mutations O 0 1.6669006452918467e-10
never O 0 8.861220784917023e-11
identified O 0 2.614536642742138e-10
previously O 0 4.994853836093327e-11
in O 0 2.757859587400324e-13
other O 0 1.6708897178190074e-13
populations O 0 4.0353171379490377e-14
and O 0 8.811954800829608e-15
found O 0 1.108264887739012e-13
in O 0 3.911991512521064e-14
16 O 0 2.3796308673551536e-11
out O 0 6.764645267554048e-13
of O 0 3.973274400465021e-12
19 O 0 2.8845220656492643e-10
Colombian O 0 2.6708355562732322e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 5.9905271854177045e-09
alleles O 0 5.135752066676158e-12
account O 0 5.960812897963519e-13
for O 0 2.4267395818539095e-12
84 O 0 1.145316286255138e-08
. O 0 5.2904777447793094e-08

2 O 0 4.155552346674085e-09
% O 0 4.720997814899874e-09
of O 0 1.1034022653899633e-11
the O 0 3.4064068839961825e-12
alleles O 0 3.4865272019284077e-13
in O 0 1.9449097551655498e-13
this O 0 4.713862221568388e-13
study O 0 2.7411319741821316e-12
. O 0 5.38322331156138e-10

The O 0 2.522096487211911e-08
G301C O 0 1.8538092945163953e-06
and O 0 2.2193462345665438e-11
S162F O 0 7.854228556425369e-08
mutations O 0 8.263847939282698e-12
account O 0 5.078927729773586e-13
for O 0 1.6401171870281117e-12
68 O 0 1.7793503559460078e-07
. O 0 8.844045140676826e-08

4 O 0 6.455560530582716e-09
% O 0 1.4582713925292978e-09
and O 0 4.496197522369655e-13
10 O 0 6.567388993738987e-11
. O 0 6.838223320926318e-10

5 O 0 2.0870016825824678e-09
% O 0 1.4519628832587728e-09
of O 0 1.6665722621378443e-11
mutations O 0 4.3494770502264246e-13
, O 0 3.4276045407987885e-14
respectively O 0 6.851889888803697e-11
, O 0 5.497915694214171e-14
whereas O 0 1.8386739613490688e-12
the O 0 4.70942555785836e-12
remaining O 0 3.8140786529083925e-08
F69V O 1 0.9990392923355103
is O 0 5.104371786357476e-13
limited O 0 3.648502940739595e-12
to O 0 2.5500207414402842e-12
a O 0 3.786685374984611e-12
single O 0 6.79742651055193e-11
allele O 0 2.1551238571504427e-09
. O 0 4.450117607746051e-09

The O 0 8.922523164756058e-09
skewed O 0 1.5860553759239338e-08
prevalence O 0 6.156047338556903e-10
of O 0 1.3733110135194515e-11
G301C O 0 1.1005369060512749e-08
in O 0 1.7275171907121106e-13
only O 0 5.728760971461175e-14
Colombian O 0 4.911081541436602e-10
patients O 0 3.532690416238604e-12
and O 0 4.8644214470285746e-14
haplotype O 0 8.656607548840345e-12
analysis O 0 1.1786375369617075e-13
by O 0 1.3697922479047374e-15
restriction O 0 4.1973785964944874e-14
fragment O 0 1.7673385541497333e-12
length O 0 3.925127584070154e-12
polymorphisms O 0 4.023617897197518e-11
in O 0 5.193942064635193e-12
the O 0 3.88643034421321e-10
GALNS O 1 0.9551811218261719
gene O 0 4.870835332293488e-11
suggest O 0 2.2110776751183003e-11
that O 0 5.558353866693018e-14
G301C O 0 1.6383822298848827e-08
originated O 0 2.2051350329066466e-11
from O 0 1.1438905378469144e-12
a O 0 1.1331415406684586e-12
common O 0 1.904322836573935e-12
ancestor O 0 1.1586396286844547e-09
. O 0 1.1384384102086642e-08

Investigation O 0 3.2558148177486146e-08
of O 0 9.794690392084249e-09
the O 0 2.4711008239641785e-10
genetic O 0 1.3945544372062635e-11
background O 0 1.0778886463946868e-12
by O 0 2.251781821375749e-15
means O 0 9.607575152115189e-12
of O 0 4.635521480556015e-11
mtDNA O 0 3.6888971877147014e-09
lineages O 0 1.0611335594934435e-11
indicate O 0 2.8813848008957255e-12
that O 0 8.291307365074913e-15
all O 0 5.756935726741741e-13
our O 0 2.352339156797001e-10
patients O 0 2.6854386769858962e-12
are O 0 6.4050708706579924e-15
probably O 0 1.9873263191333423e-12
of O 0 1.282104457323019e-11
native O 0 1.1254567590379683e-11
American O 0 7.021528358741591e-10
descent O 0 1.2077826795575675e-05

Low O 0 1.3155885270066392e-08
frequency O 0 2.4115615060438245e-10
of O 0 1.8715175242878246e-10
BRCA1 O 0 2.0371938858065874e-10
germline O 0 4.458307500954106e-09
mutations O 0 7.693880797222941e-13
in O 0 1.3835895591122332e-13
45 O 0 3.136415016591343e-10
German O 1 0.9997239708900452
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.0130309924250014e-08
. O 0 1.709623442813779e-09

In O 0 3.687179173095245e-10
this O 0 7.589001584269728e-13
study O 0 4.285016352162385e-14
we O 0 6.841010353006048e-15
investigated O 0 2.40891914705596e-13
45 O 0 1.2174707422762943e-11
German O 0 2.7111260351375677e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.5303168454661176e-10
for O 0 1.0350647422496806e-11
germline O 0 4.194732117213107e-09
mutations O 0 1.3929958532152287e-12
in O 0 3.4913052809025513e-13
the O 0 1.4388991734226586e-11
BRCA1 O 0 7.870126772502317e-11
gene O 0 2.1669254932077386e-12
. O 0 1.033941043893094e-09

We O 0 7.296083737173831e-10
identified O 0 3.706103202105737e-10
four O 0 7.791218191444127e-12
germline O 0 4.220254012921032e-08
mutations O 0 4.484836460538766e-11
in O 0 2.6714203765765276e-12
three O 0 4.8437084204655534e-11
breast B-Disease 0 3.0138799789192205e-10
cancer I-Disease 0 1.6727737250921138e-10
families O 0 4.8718942075032245e-11
and O 0 1.0035593233162499e-12
in O 0 4.0444736448819185e-09
one O 1 0.9991430044174194
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 7.350727804222856e-10
. O 0 2.1639504424464384e-13
among O 0 2.7695047170613713e-16
these O 0 7.268777502660316e-17
were O 0 2.3682802341939112e-14
one O 0 6.660997979319322e-14
frameshift O 0 6.860183532353403e-10
mutation O 0 2.1701516451921865e-12
, O 0 2.458943422142812e-13
one O 0 8.691714882547164e-12
nonsense O 0 1.0390817095640159e-08
mutation O 0 3.2702111851801163e-11
, O 0 2.7317148651624656e-13
one O 0 3.1898203696478777e-13
novel O 0 9.76467713111051e-13
splice O 0 1.3011346666758072e-08
site O 0 1.853885100988606e-10
mutation O 0 9.25471765195196e-12
, O 0 1.565030928202954e-13
and O 0 1.6912121659704016e-12
one O 0 2.39795738821158e-10
missense O 0 7.483485546799784e-07
mutation O 0 4.223472682696183e-09
. O 0 1.3974108981074096e-08

The O 0 3.480501442609807e-09
missense O 0 1.3697416534341755e-07
mutation O 0 1.4496757093362955e-11
was O 0 3.9080003122471396e-11
also O 0 2.35312556115877e-13
found O 0 4.777549341382359e-13
in O 0 1.4486771157673495e-12
2 O 0 8.78333350495808e-10
. O 0 1.1821279954915553e-08

8 O 0 1.5028792432758564e-08
% O 0 1.8099852283626205e-08
of O 0 1.9228724515429896e-11
the O 0 7.449037914275536e-12
general O 0 4.5031001497108925e-12
population O 0 1.3444471162987574e-14
, O 0 1.0843722143496657e-15
suggesting O 0 2.1889783009213654e-13
that O 0 1.495684637272776e-15
it O 0 2.5479555734709246e-15
is O 0 1.6919849039637863e-14
not O 0 6.683059054074514e-12
disease O 0 9.116565280464783e-10
associated O 0 3.567105499868717e-09
. O 0 7.561509818287959e-08

The O 0 4.3482145661855043e-10
average O 0 1.790506631849098e-11
age O 0 2.1287303517136813e-11
of O 0 4.642731078058349e-12
disease O 0 1.1988156300990482e-10
onset O 0 3.22664422958141e-10
in O 0 7.854133467731506e-13
those O 0 1.142750065581677e-12
families O 0 1.0771677820542447e-11
harbouring O 0 1.2261486936893107e-08
causative O 0 3.480805088607042e-10
mutations O 0 3.41929713709721e-11
was O 0 6.451934125850656e-11
between O 0 1.6883164311032317e-10
32 O 0 2.487479200397047e-08
. O 0 1.3928579178923428e-08

3 O 0 4.623985194740499e-09
and O 0 8.469446671766079e-11
37 O 0 7.767047804918548e-08
. O 0 1.0855391252562185e-08

4 O 0 2.431251200363249e-09
years O 0 6.128092477908353e-11
, O 0 7.965923385332141e-14
whereas O 0 1.7426552822302765e-12
the O 0 4.434281446804439e-13
family O 0 6.557381590846512e-13
harbouring O 0 8.764941550332139e-10
the O 0 2.993995242700498e-12
missense O 0 2.105168261934409e-09
mutation O 0 3.89805982631275e-12
had O 0 3.479551716201179e-13
an O 0 1.5859045517045548e-15
average O 0 2.3145854265334276e-13
age O 0 1.6834303048773869e-12
of O 0 3.4952912959795857e-12
onset O 0 3.2619791312527013e-09
of O 0 2.7179374306740556e-09
51 O 0 1.3997134828969138e-07
. O 0 1.1329152016514854e-07

2 O 0 7.785718736386116e-09
years O 0 1.2050634934368532e-09
. O 0 3.6920930757133874e-09

These O 0 3.389848471369028e-11
findings O 0 5.1363102139545536e-12
show O 0 1.007760064633545e-12
that O 0 2.29655873582469e-14
BRCA1 O 0 7.794417195006176e-11
is O 0 7.960213028014931e-14
implicated O 0 2.8812270277955854e-11
in O 0 6.117426877561005e-12
a O 0 3.3496829442147824e-12
small O 0 1.897726360821153e-13
fraction O 0 7.870037260770957e-11
of O 0 9.801198075365392e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.7856435080565447e-11
suggesting O 0 2.4406022789227357e-14
the O 0 1.8990205509315924e-15
involvement O 0 1.801858358699282e-13
of O 0 4.320554330972115e-13
another O 0 7.41034363320632e-14
susceptibility O 0 9.663072208718204e-13
gene O 0 1.376926459135952e-13
( O 0 3.016635606676449e-13
s O 0 1.1115866005440012e-09
) O 0 6.736483593172693e-10

Paternal O 0 3.681809903355315e-05
transmission O 1 0.9999991655349731
of O 0 1.5633750081178732e-05
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.03423124924302101

We O 0 1.2228059675933878e-09
report O 0 1.0700947940256444e-11
a O 0 1.0040029246351223e-13
rare O 0 3.599615587155866e-14
case O 0 1.1838211244890196e-14
of O 0 3.31167628042639e-11
paternally O 1 0.9998753070831299
transmitted O 1 0.9999971389770508
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.0750394352498915e-07
DM B-Disease 1 1.0
) O 0 7.877320323812498e-11
. O 0 5.398461122574361e-10

The O 0 1.1131083610393944e-08
proband O 0 1.583194716658909e-05
is O 0 8.545883727235914e-13
a O 0 8.245733604380842e-14
23 O 0 1.2507781269044393e-12
year O 0 1.8020448414729495e-12
old O 0 1.4605296527747669e-08
, O 0 1.2368743182444852e-11
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 1.553578599100547e-08
who O 0 6.28674751146363e-11
suffers O 0 0.010089000687003136
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999974966049194

He O 0 5.049860529737771e-10
presented O 0 3.146367333339839e-10
with O 0 9.415190849182409e-12
respiratory O 0 0.0005588542553596199
and O 0 7.169806848922322e-12
feeding O 0 3.787252733644664e-10
difficulties O 0 1.7659404605296913e-08
at O 0 1.0510869952184976e-09
birth O 0 3.0053183053269095e-08
. O 0 9.575487069923838e-08

His O 0 4.1801023087373324e-08
two O 0 2.0101453834797667e-09
sibs O 0 6.867395131848752e-05
suffer O 0 4.614964410620814e-08
from O 0 6.976300648275924e-10
childhood O 0 4.001641718787141e-05
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 8.179464998647745e-07

Their O 0 4.240888543116661e-11
late O 0 9.339953255249611e-10
father O 0 6.053256507154714e-11
had O 0 2.6671525231447557e-13
the O 0 3.77790712870695e-15
adult O 0 8.495639664039909e-15
type O 0 2.2456322351237408e-14
of O 0 4.241145195454932e-12
DM B-Disease 1 1.0
, O 0 5.404204861392259e-12
with O 0 8.303497185625439e-14
onset O 0 3.2609650535420087e-09
around O 0 1.4263724749941087e-12
30 O 0 1.0935590974425757e-11
years O 0 1.2369190741101654e-11
. O 0 5.509852574192564e-10

Only O 0 1.0240645831327555e-10
six O 0 3.5307637889780974e-12
other O 0 4.500600509743766e-16
cases O 0 6.45550014184308e-16
of O 0 1.8877517008342865e-13
paternal O 0 4.529241426354247e-09
transmission O 1 0.9999994039535522
of O 0 2.4297625600411266e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 1.5761479899012443e-09
been O 0 6.575984982243321e-12
reported O 0 2.1160423673699524e-12
recently O 0 1.0900641283714818e-12
. O 0 2.7780402978017094e-11

We O 0 1.0716925957776624e-10
review O 0 1.6631070435743633e-12
the O 0 5.186848604159071e-14
sex O 0 2.1499698587201452e-14
related O 0 6.256234815144382e-14
effects O 0 1.5795303704314173e-13
on O 0 3.526387623749294e-13
transmission O 0 2.0342181983323826e-07
of O 0 7.278597724535985e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 7.1289236984739546e-06

Decreased O 0 8.226875536365696e-08
fertility O 0 4.315174884084172e-10
of O 0 7.772185672827447e-13
males O 0 7.614196680929761e-14
with O 0 3.115797130712898e-17
adult O 0 5.722360790511721e-14
onset O 0 8.735329820597215e-11
DM B-Disease 1 1.0
and O 0 2.7816232390370788e-12
contraction O 0 1.1193602988956997e-10
of O 0 5.097214317295595e-12
the O 0 4.935094216965141e-13
repeat O 0 1.6485224643703056e-12
upon O 0 2.6259135924716626e-12
male O 0 2.3846911858388387e-12
transmission O 0 9.482034081520485e-12
contribute O 0 1.6861415963551757e-13
to O 0 3.827828082714896e-13
the O 0 2.728576262503446e-12
almost O 0 1.3784519532766826e-11
absent O 0 3.535201575921576e-10
occurrence O 0 4.978569986824333e-11
of O 0 3.4260721430007246e-12
paternal O 0 3.850095353641336e-09
transmission O 0 5.16488717039465e-06
of O 0 1.2482258782142708e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 8.895065548131242e-06

Also O 0 6.549463749117024e-11
the O 0 2.2399719232235604e-11
fathers O 0 4.5029327488954607e-10
of O 0 8.4745647999096e-12
the O 0 2.2825738694998154e-12
reported O 0 1.062893870140691e-11
congenitally O 0 5.98594951384257e-08
affected O 0 4.165552885265766e-12
children O 0 8.57116501796866e-14
showed O 0 5.187239960485757e-12
, O 0 4.731711120061497e-15
on O 0 1.3363236298774561e-12
average O 0 6.3789654981827315e-12
, O 0 5.390962199217086e-13
shorter O 0 5.491652022016069e-09
CTG O 0 8.636847610432596e-07
repeat O 0 3.437890805368937e-10
lengths O 0 3.0015030461072456e-08
and O 0 1.9745826501660346e-11
hence O 0 9.610150453198685e-10
less O 0 4.960106284035426e-11
severe O 0 2.689983236159321e-10
clinical O 0 1.863986603956036e-10
symptoms O 0 1.1964645420248221e-11
than O 0 7.413106887614325e-16
the O 0 1.7361642790200867e-14
mothers O 0 9.594306956978854e-14
of O 0 9.412829131590084e-14
children O 0 3.3608359151227063e-13
with O 0 1.464209309354203e-11
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 4.763387914863415e-05

We O 0 1.510195614395915e-11
conclude O 0 6.965371612821514e-10
that O 0 7.706416715435715e-15
paternal O 0 2.42815434425836e-10
transmission O 0 8.266090844699647e-06
of O 0 2.0176511572600475e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 1.0283163209834356e-09
rare O 0 1.2872845150946333e-11
and O 0 6.744093944324042e-14
preferentially O 0 2.4288696054419745e-12
occurs O 0 9.157536789419427e-14
with O 0 3.081931231469344e-16
onset O 0 2.442987201423108e-10
of O 0 1.9650041593877177e-09
DM B-Disease 1 1.0
past O 0 5.662918134419215e-09
30 O 0 1.0182073933995284e-11
years O 0 1.1462249064394386e-13
in O 0 2.913255049116813e-15
the O 0 1.6246044494492434e-14
father O 0 1.253386066810136e-12
. O 0 4.4785681239944974e-12
. O 0 5.055411089749384e-10

The O 0 6.056053991621013e-10
RB1 O 0 3.916528328318236e-07
gene O 0 3.0821137742692573e-12
mutation O 0 8.385291701447362e-13
in O 0 1.0186634522013627e-12
a O 0 1.5929874086495488e-10
child O 0 5.87464001000626e-07
with O 0 3.195345499307223e-08
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.0018141770269721746

The O 0 3.6361680333385493e-10
RB1 O 0 1.4616492194363673e-07
gene O 0 1.6774174280489995e-12
mutation O 0 4.542988977628698e-13
was O 0 1.1200511004783031e-12
investigated O 0 9.54169902811497e-13
in O 0 4.719134154632099e-13
a O 0 6.566246244649188e-12
child O 0 2.805348175982658e-09
with O 0 5.452912774095431e-11
ectopic B-Disease 0 2.1708036001655273e-05
intracranial I-Disease 0 1.2837957683586865e-06
retinoblastoma I-Disease 0 7.613203223399978e-08
using O 0 1.0927792525039504e-11
DNA O 0 1.304790497869135e-08
obtained O 0 1.8968751569481412e-10
from O 0 6.522209855530647e-12
both O 0 1.1859240802922222e-12
the O 0 1.8939351822955253e-11
pineal B-Disease 0 5.4768324986298467e-08
and I-Disease 0 9.820982915798027e-11
retinal I-Disease 0 0.00012346824223641306
tumours I-Disease 1 1.0
of O 0 3.700215893331915e-05
the O 0 7.3567512970385e-08
patient O 0 1.5808402054062753e-07
. O 0 1.865151411095667e-08

A O 0 3.157221613037109e-07
nonsense O 0 2.3398084181280865e-07
mutation O 0 3.400857720436967e-11
in O 0 2.5306411480241486e-11
exon O 0 6.620214376695799e-10
17 O 0 7.34259666956838e-11
( O 0 1.641900591181633e-13
codon O 0 7.691603465254104e-10
556 O 0 6.801398333422526e-10
) O 0 1.0410867724549092e-13
of O 0 5.703319327227119e-12
the O 0 2.206973839791182e-11
RB1 O 0 7.163368422880012e-07
gene O 0 4.116009616472738e-12
was O 0 3.0023917380050946e-11
found O 0 7.013166089531175e-13
to O 0 1.1996608133973963e-12
be O 0 3.500829183836207e-12
present O 0 3.2745448019788626e-10
homozygously O 0 1.5750121065138956e-06
in O 0 4.1017796797993e-11
both O 0 2.689767852892544e-10
the O 0 2.6029889355072555e-09
retinal B-Disease 0 1.1000861377397086e-07
and I-Disease 0 1.946331318336547e-09
the I-Disease 0 4.6008500476091285e-07
pineal I-Disease 1 0.9596107006072998
tumours I-Disease 1 1.0
. O 0 2.193334012190462e-06

The O 0 4.932539099389288e-11
same O 0 2.462366031560914e-12
mutation O 0 4.2990502650830376e-13
was O 0 1.6957010069099804e-13
present O 0 7.154107493044515e-13
heterozygously O 0 1.0039685749418936e-09
in O 0 6.213389178166828e-14
the O 0 1.642981269697058e-13
DNA O 0 1.3338855020528229e-10
from O 0 1.1568446938239885e-12
the O 0 8.04581932762477e-13
constitutional O 0 3.5499974487818164e-11
cells O 0 1.457649799474492e-11
of O 0 1.4417727428606142e-11
the O 0 1.3270939035192608e-11
patient O 0 2.7630658872013214e-10
, O 0 3.146446048585966e-13
proving O 0 6.48214593113039e-10
it O 0 7.884445253256676e-15
to O 0 1.7373187307170856e-12
be O 0 1.4499301932702213e-11
of O 0 5.757537779871313e-10
germline O 0 6.823597686889116e-08
origin O 0 2.4646391594274064e-09
. O 0 9.34241661809665e-09

The O 0 2.4708840529186205e-10
initial O 0 9.561147013004145e-11
mutation O 0 1.3807378634531076e-12
was O 0 1.265036794935448e-12
shown O 0 1.3868560163124433e-12
to O 0 2.22586510854883e-12
have O 0 6.611267658546485e-14
occurred O 0 1.579123082295908e-10
in O 0 1.0012281802251888e-13
the O 0 2.4874932842700037e-12
paternally O 0 8.069535262222871e-09
derived O 0 1.4594031538806007e-10
RB1 O 0 4.912885742669459e-07
allele O 0 5.867515362467657e-09
. O 0 1.3182408942213897e-08

The O 0 9.779340670590386e-10
mutation O 0 1.4862748184962804e-11
is O 0 1.433571584195676e-14
in O 0 2.5284948221011676e-14
an O 0 2.4114462190321165e-14
area O 0 2.471937368339616e-12
of O 0 2.332636579553682e-13
the O 0 3.151491383395627e-13
gene O 0 2.887299842030573e-15
that O 0 1.6950331002552467e-15
encodes O 0 1.753469500945671e-14
the O 0 9.162712906116144e-13
protein O 0 1.8760761173741702e-12
- O 0 8.061826488499346e-13
binding O 0 3.9754198197239354e-12
region O 0 7.623807363188462e-09
known O 0 1.4990406485559937e-11
as O 0 1.854254597088989e-12
the O 0 2.2374355840293347e-11
pocket O 0 1.8093402331942343e-07
region O 0 2.027791090597475e-08
and O 0 2.9928493711084414e-11
has O 0 4.752157326502748e-13
been O 0 1.126423173486435e-11
detected O 0 1.5678418285869355e-10
in O 0 9.051400850623031e-14
other O 0 2.5266870843851374e-14
cases O 0 2.6769889473546304e-13
of O 0 1.1974925218094512e-10
retinoblastoma B-Disease 0 5.0794444206303524e-08
. O 0 5.213659504121892e-10
. O 0 1.4820816574001583e-08

Low O 0 8.05580597784683e-08
levels O 0 2.9641561427595775e-10
of O 0 2.771076076935053e-11
beta O 0 1.309616165512395e-10
hexosaminidase O 0 8.54479242917705e-09
A O 0 2.0165229208668478e-10
in O 0 3.992690238759783e-13
healthy O 0 5.528184247177714e-12
individuals O 0 1.048755368302217e-14
with O 0 3.281690918359795e-14
apparent O 0 1.0667262273500455e-07
deficiency O 0 0.02986055612564087
of O 0 1.6955347348357463e-07
this O 0 2.0686750923371022e-10
enzyme O 0 1.033715751885822e-10
. O 0 2.322027681245231e-09

Appreciable O 0 7.481988006929896e-08
beta O 0 4.679782672489807e-10
hexosaminidase O 0 1.4915029566964222e-07
A O 0 8.805365325770254e-08
( O 0 8.118240238039198e-13
hex O 0 2.088603423544555e-08
A O 0 6.023892495932159e-09
) O 0 8.976954786075672e-14
activity O 0 3.097308173827251e-11
has O 0 2.197992052851549e-15
been O 0 4.891983628081686e-13
detected O 0 1.9872788137309527e-10
in O 0 9.211225532324008e-11
cultured O 0 0.002970269648358226
skin O 0 6.090055831009522e-05
fibroblasts O 0 6.051638047210872e-05
and O 0 8.358143621656211e-10
melanoma B-Disease 0 9.67922642303165e-06
tissue O 0 6.151698528356064e-08
from O 0 2.499498524821675e-11
healthy O 0 5.0603163152806996e-12
individuals O 0 3.0141924184906414e-16
previously O 0 6.158360496902326e-14
reported O 0 6.430535222151298e-14
as O 0 1.6801183111859325e-14
having O 0 4.166039388464604e-11
deficiency B-Disease 0 1.6393448376561537e-08
of I-Disease 0 1.3552543087769209e-08
hex I-Disease 0 6.775327676677989e-08
A I-Disease 0 1.0300816200015106e-08
activity O 0 7.88110757210525e-11
indistinguishable O 0 4.859062596729302e-10
from O 0 7.491118727935564e-14
that O 0 8.749280715479894e-16
of O 0 2.617430232244259e-14
patients O 0 1.2533632917882502e-14
with O 0 2.9316653271660442e-12
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.6193915652884527e-10
TSD B-Disease 1 0.9913915395736694
) O 0 1.0828946246654869e-11
. O 0 4.383229335047645e-10

Identification O 0 7.027349369082003e-08
and O 0 1.3056621755991316e-11
quantitation O 0 0.0001437478349544108
of O 0 7.359586220445635e-07
hex O 0 9.2431781695268e-07
A O 0 8.032652942802088e-08
, O 0 2.0708312994076328e-13
amounting O 0 3.155556371758905e-10
to O 0 7.707431221026795e-11
3 O 0 3.6323712926389362e-09
. O 0 4.996973945736727e-09

5 O 0 3.0584146770706866e-08
% O 0 6.549085895812823e-08
- O 0 2.8866753432055248e-09
6 O 0 1.0489601409702232e-09
. O 0 1.4807330916966066e-09

9 O 0 1.118865555760351e-09
% O 0 1.6280042591798605e-10
of O 0 1.0105028792894988e-12
total O 0 1.5708372103073742e-11
beta O 0 1.2277311112196543e-11
hexosaminidase O 0 1.3331917791958858e-09
activity O 0 3.504933149267586e-11
, O 0 3.796343054913824e-14
has O 0 6.438678067510609e-16
been O 0 7.170330410151415e-15
obtained O 0 1.9101823530050244e-13
by O 0 2.1764667433761542e-14
cellulose O 0 4.7877889153280506e-11
acetate O 0 9.56530167572911e-12
gel O 0 4.475957451899326e-11
electrophoresis O 0 1.465033303005292e-11
, O 0 2.950637780982368e-12
DEAE O 0 4.928474481857847e-06
- O 0 1.556059947560584e-09
cellulose O 0 4.719341362147134e-09
ion O 0 5.6707216700147e-09
- O 0 2.127376719229801e-09
exchange O 0 6.04227501366239e-11
chromatography O 0 3.2833002983068127e-10
, O 0 7.00572886920374e-14
radial O 0 2.8102175534533425e-12
immunodiffusion O 0 1.7964676413129155e-09
, O 0 2.3074006897869093e-13
and O 0 2.0295204319203952e-12
radioimmunoassay O 0 1.8262267076352146e-06
. O 0 5.270364766829516e-08

Previous O 0 1.2176918744444265e-06
family O 0 7.114299427346538e-11
studies O 0 3.5367490186510864e-12
suggested O 0 1.5243774124928944e-13
that O 0 1.842932596733034e-16
these O 0 6.279673042652032e-16
individuals O 0 3.3747329983410592e-15
may O 0 1.061063671821405e-13
be O 0 2.563322546843966e-13
compound O 0 1.568984525635031e-10
heterozygotes O 0 1.0819233287051588e-09
for O 0 9.050404197775974e-13
the O 0 1.5833478625437714e-11
common O 0 3.987630971952205e-12
mutant O 0 2.251408261211285e-11
TSD B-Disease 0 4.792428853761521e-08
gene O 0 1.5084761781705702e-12
and O 0 1.3823294722423163e-12
a O 0 2.045525034077844e-11
rare O 0 1.1247957426574473e-11
( O 0 1.470016193190829e-14
allelic O 0 2.7704312802190323e-11
) O 0 3.291181414314011e-14
mutant O 0 3.5191461290190462e-12
gene O 0 2.4876450725741517e-12
. O 0 4.668477826541562e-10

Thus O 0 8.19245382643885e-09
, O 0 2.9918376803772517e-12
the O 0 5.476695919687247e-12
postulated O 0 7.962244752413028e-11
rate O 0 1.5855984060453299e-12
mutant O 0 1.569203615789036e-13
gene O 0 6.300551663648022e-15
appears O 0 3.8162642533937086e-14
to O 0 5.563635964152096e-14
code O 0 5.1025393491607035e-14
for O 0 9.546408937877518e-14
the O 0 2.3049121205404033e-12
expression O 0 3.4594098419216124e-12
of O 0 6.2176392506829714e-12
low O 0 2.5957973617818375e-11
amounts O 0 4.4480212698858046e-13
of O 0 2.3578361485476762e-11
hex O 0 1.5136208730837097e-08
A O 0 9.028718039871819e-08
. O 0 4.0771691800500776e-08

Heterozygotes O 0 3.901998752553482e-06
for O 0 2.0260802757743335e-10
the O 0 1.5799214714284915e-10
rare O 0 1.3847156928037396e-11
mutant O 0 1.1753454112750639e-11
may O 0 1.3280420871081972e-13
be O 0 2.971986263859694e-13
indistinguishable O 0 9.454393934404948e-10
from O 0 1.0335491143487197e-12
heterozygotes O 0 2.493400208525287e-10
for O 0 8.949058941803978e-13
the O 0 3.1985782078525204e-11
common O 0 1.615667738485982e-10
TSD B-Disease 0 6.522483317894512e-07
mutant O 0 1.766619961429683e-09
. O 0 2.537768217791836e-09

However O 0 1.5017888321811057e-10
, O 0 9.853352671545385e-14
direct O 0 6.316299479974807e-12
visualization O 0 5.6436491036038205e-09
and O 0 4.788551825028742e-13
quantitation O 0 4.664662992581725e-05
of O 0 1.329614747191954e-07
hex O 0 1.9241636550759722e-07
A O 0 1.3227385853298301e-09
by O 0 2.1316603945322962e-14
the O 0 1.1985624623865598e-13
methods O 0 5.6771441714342785e-11
described O 0 3.912687502553164e-13
may O 0 8.75385850504333e-15
prevent O 0 5.924685790798315e-14
false O 0 5.614102390437414e-13
- O 0 1.0567924573628984e-12
positive O 0 6.285047487878184e-14
prenatal O 0 1.597517951257288e-10
diagnosis O 0 1.2606304888862496e-10
of O 0 2.5197016782080306e-12
TSD B-Disease 0 8.040731103164944e-08
in O 0 9.435811507141345e-12
fetuses O 0 4.426567112858493e-09
having O 0 8.657742491674503e-13
the O 0 1.7646102678028908e-12
incomplete O 0 1.0197035216208405e-08
hex B-Disease 0 3.5060759273619624e-07
A I-Disease 0 1.2016531627523364e-06
deficiency I-Disease 0 1.642854476813227e-05
of O 0 2.3790352798869208e-08
the O 0 6.027612853287678e-10
type O 0 5.691048965417167e-09
described O 0 4.882701448022386e-12
in O 0 1.103229053250887e-12
the O 0 1.3907427293124996e-11
four O 0 3.2060850502224625e-11
healthy O 0 6.236184901808883e-10
individuals O 0 1.4581337873242894e-11

The O 0 4.734253433724689e-09
tumor B-Disease 0 2.6989783741271367e-09
suppressor O 0 1.2338635668740494e-10
gene O 0 1.0670410952387521e-12
Smad4 O 0 2.871181834507297e-07
/ O 0 9.609279061351117e-08
Dpc4 O 0 7.28306190467265e-07
is O 0 1.638895250522139e-15
required O 0 4.580716773776305e-13
for O 0 1.3461997121699213e-14
gastrulation O 0 1.9758090719079746e-09
and O 0 5.4124901344946175e-15
later O 0 1.4264596448487765e-12
for O 0 1.5521617194660942e-13
anterior O 0 4.2486978379940865e-09
development O 0 3.7146541398414e-09
of O 0 1.2421091932779404e-10
the O 0 1.0459367399962005e-10
mouse O 0 8.593375316889862e-11
embryo O 0 7.27715387949246e-10
. O 0 3.06453284970587e-09

Mutations O 0 1.2264639304149227e-09
in O 0 7.565852458424338e-12
the O 0 1.1125660809296889e-10
SMAD4 O 1 0.9999560117721558
/ O 0 1.3936790310253855e-05
DPC4 O 0 0.21422739326953888
tumor B-Disease 0 9.973838421828418e-10
suppressor O 0 2.382255677446654e-11
gene O 0 1.286379992327183e-13
, O 0 3.3749794002254155e-14
a O 0 9.931717991421007e-13
key O 0 7.998703921430206e-10
signal O 0 1.0390187554776276e-07
transducer O 0 6.172440336627005e-09
in O 0 2.2509532432435364e-11
most O 0 8.960784891876017e-11
TGFbeta O 0 0.00013334852701518685
- O 0 1.869356669459421e-09
related O 0 8.231952897119754e-10
pathways O 0 3.0645822685082535e-11
, O 0 9.347872546557404e-16
are O 0 2.4521190232705718e-17
involved O 0 8.374142952151647e-15
in O 0 3.0898170849148754e-13
50 O 0 1.9077139867818005e-09
% O 0 1.0584916054767746e-07
of O 0 2.6993967949806574e-08
pancreatic B-Disease 1 0.9934138655662537
cancers I-Disease 1 0.9998013377189636
. O 0 0.00024443850270472467

Homozygous O 0 1.7742952422850067e-06
Smad4 O 0 2.9917177926108707e-06
mutant O 0 1.828904139244969e-09
mice O 0 1.741420202483468e-11
die O 0 4.4619974381987504e-10
before O 0 2.923090589024291e-11
day O 0 5.518402956816715e-10
7 O 0 6.734303337196934e-09
. O 0 1.8215412511679574e-09

5 O 0 8.557758945926253e-09
of O 0 2.4140569543362744e-09
embryogenesis O 0 9.791957381821703e-06
. O 0 1.972042014131148e-07

Mutant O 0 1.6187694740210645e-08
embryos O 0 3.895523903452158e-09
have O 0 4.972661822241764e-13
reduced O 0 1.5076247542045174e-12
size O 0 1.8646381368201542e-13
, O 0 2.0656113064042476e-14
fail O 0 1.6722639939459327e-09
to O 0 3.1160696245535746e-10
gastrulate O 0 7.411562364723068e-06
or O 0 1.3239873086767773e-10
express O 0 1.6712421377351738e-11
a O 0 1.9862462369291123e-12
mesodermal O 0 3.2284511064517574e-08
marker O 0 3.9351913394547466e-10
, O 0 8.807645368244521e-13
and O 0 6.43100427511617e-13
show O 0 2.2487240958213306e-09
abnormal O 0 4.092000072120072e-09
visceral O 0 2.9686271219020455e-09
endoderm O 0 1.441499222210041e-07
development O 0 1.0084023394085762e-08
. O 0 3.838934947708594e-09

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 1.347239031446179e-08
the O 0 9.024010982905395e-10
Smad4 O 0 3.0376309041457716e-06
- O 0 2.533319110042953e-09
deficient O 0 2.224225109648259e-10
embryos O 0 2.0682390262233286e-12
results O 0 3.35582663003528e-13
from O 0 4.2826004786715444e-13
reduced O 0 4.920865798174745e-12
cell O 0 5.584458243057533e-12
proliferation O 0 5.067283051496396e-11
rather O 0 1.0127140012000657e-12
than O 0 4.9847197767030615e-14
increased O 0 5.2314274440190545e-11
apoptosis O 0 1.695280804625554e-09
. O 0 5.362167154743247e-09

Aggregation O 0 2.1151982387834778e-09
of O 0 5.794863477959211e-10
mutant O 0 6.603970703622508e-10
Smad4 O 0 2.028040398727171e-06
ES O 0 3.845239149313784e-08
cells O 0 1.2478019919409666e-12
with O 0 2.5392616273003064e-15
wild O 0 1.2751088975925667e-13
- O 0 9.724790417386941e-13
type O 0 9.300864115338592e-13
tetraploid O 0 2.16080398018903e-09
morulae O 0 3.063032920636033e-07
rescues O 0 2.0674306711043755e-08
the O 0 1.5059421765162284e-10
gastrulation B-Disease 0 4.431631168699823e-06
defect I-Disease 0 7.281726084329421e-06
. O 0 1.205871136278347e-08

These O 0 2.1403783259654752e-11
results O 0 2.3787867509117433e-11
indicate O 0 1.9758146507786734e-11
that O 0 5.940538859439126e-14
Smad4 O 0 6.025020837796546e-08
is O 0 4.056660589450657e-15
initially O 0 6.231702030486466e-14
required O 0 1.6544326672529586e-11
for O 0 3.7242523518235537e-13
the O 0 1.0332007818747435e-11
differentiation O 0 1.0322503962711949e-09
of O 0 1.7724850753797483e-10
the O 0 1.4339025800058636e-10
visceral O 0 3.7904468452865103e-10
endoderm O 0 2.008613364523626e-08
and O 0 4.0904470565913953e-13
that O 0 3.873625239878475e-15
the O 0 3.1294961739224136e-13
gastrulation B-Disease 0 4.390887653471509e-09
defect I-Disease 0 1.5900466499019217e-09
in O 0 7.441762592437506e-13
the O 0 8.941932264083796e-12
epiblast O 0 4.716473611665606e-08
is O 0 3.13421977173739e-14
secondary O 0 5.485399912075195e-10
and O 0 1.1722858740594727e-13
non O 0 2.5896792266166813e-08
- O 0 6.236961613836911e-09
cell O 0 1.6500798949437012e-08
autonomous O 0 1.0755557013908401e-06
. O 0 1.1356450890787073e-08

Rescued O 0 9.066267011803575e-06
embryos O 0 3.229011724670272e-08
show O 0 5.034914707380267e-10
severe O 0 6.46838693718621e-10
anterior O 0 4.410019755596295e-06
truncations O 0 6.5680178522598e-05
, O 0 3.7371195547863945e-12
indicating O 0 2.176836488843037e-10
a O 0 1.7819408058492026e-12
second O 0 4.924927132776702e-10
important O 0 9.489528607353748e-11
role O 0 5.266728719810487e-11
for O 0 7.56620252562179e-11
Smad4 O 0 0.00030238504405133426
in O 0 2.3061545728619848e-10
anterior O 0 3.1780643894308014e-06
patterning O 0 5.648244609801623e-07
during O 0 8.163893880919204e-07
embryogenesis O 0 0.0001892447762656957
. O 0 1.2410262684170448e-07

Prevalence O 0 3.16702852387607e-07
of O 0 2.191313797084149e-09
p16 O 0 5.443994410825326e-08
and O 0 3.011185190082699e-10
CDK4 O 1 0.9999910593032837
germline O 0 2.3928960217745043e-05
mutations O 0 8.763370029640782e-10
in O 0 1.4422898639288029e-11
48 O 0 2.9300053938641213e-08
melanoma B-Disease 0 0.0002934458607342094
- O 0 6.14048019542679e-07
prone O 0 2.6911099126891713e-08
families O 0 2.1013791401403026e-11
in O 0 6.195399054886863e-11
France O 0 5.2869646438580276e-09
. O 0 2.352153138929225e-08

The O 0 5.2922338511507405e-08
French O 0 1.1678142755044973e-06
Familial B-Disease 1 0.9902353882789612
Melanoma I-Disease 1 0.9998910427093506
Study O 0 1.0483860446441895e-09
Group O 0 1.04165001277301e-11
. O 0 4.4769671303512837e-10

Germline O 0 0.00013581548410002142
mutations O 0 2.0970729597280524e-09
in O 0 4.854842656359937e-12
the O 0 2.456948706985873e-11
p16 O 0 3.079074772927015e-09
and O 0 4.173457586464924e-12
CDK4 O 0 0.0016574186738580465
genes O 0 1.930114748582845e-11
have O 0 4.5372885136563124e-14
been O 0 5.913633027276183e-14
reported O 0 2.4695940821842233e-13
in O 0 7.944241374761504e-14
a O 0 4.305995230519111e-12
subset O 0 1.5962843546990513e-10
of O 0 1.4902183653742185e-10
melanoma B-Disease 0 6.301943500375273e-08
pedigrees O 0 4.079129212186672e-08
, O 0 2.096770023232719e-12
but O 0 1.5876654374871735e-12
their O 0 2.093354309340434e-11
prevalence O 0 6.05624994598486e-10
is O 0 1.722652409445486e-15
not O 0 5.925397976100366e-14
well O 0 7.709191791882564e-12
known O 0 9.959310459661808e-11
. O 0 2.3626927969644385e-08

We O 0 2.3809316740397435e-09
searched O 0 1.55730095485751e-09
for O 0 1.7282035177923483e-12
such O 0 2.764106868738403e-12
germline O 0 1.114060310669629e-07
mutations O 0 4.048274562795662e-11
in O 0 5.463779168685123e-12
48 O 0 5.0633875758876457e-08
French O 0 3.731400610718083e-08
melanoma B-Disease 0 0.0032414987217634916
- O 0 3.3200936400135106e-07
prone O 0 4.116313956359363e-09
families O 0 2.406953217466701e-13
selected O 0 1.3049737885347662e-13
according O 0 1.1386260722256666e-14
to O 0 2.3655893799270737e-14
two O 0 2.8344479507372202e-15
major O 0 8.538531210203204e-14
criteria O 0 4.297068343511734e-12
families O 0 1.7935402241067017e-13
with O 0 5.450031905266349e-15
at O 0 7.18175562422485e-12
least O 0 3.3434450412254957e-13
three O 0 9.640281194850386e-13
affected O 0 3.53077914128086e-11
members O 0 5.831425186481054e-12
( O 0 1.2027079636031668e-12
n O 0 7.620978847988624e-11
= O 0 3.349844707178917e-11
20 O 0 4.937547246064433e-11
) O 0 1.4812434455000953e-14
or O 0 1.2845460643524237e-13
families O 0 1.0229970624948959e-13
with O 0 2.293331540295651e-15
two O 0 1.0058660583059029e-13
affected O 0 2.464629520436412e-13
members O 0 5.4876174676414535e-14
, O 0 1.4128328295151017e-14
one O 0 3.8790910587838123e-14
of O 0 1.071875552725865e-12
them O 0 2.46936802603126e-13
affected O 0 4.782053117206864e-13
before O 0 1.2844903092557036e-12
the O 0 4.678873933260108e-13
age O 0 1.3386967749606793e-11
of O 0 9.283889629285724e-12
50 O 0 5.548151868484119e-11
( O 0 3.793158549845327e-14
n O 0 6.150803607760102e-13
= O 0 1.5304078805015303e-13
28 O 0 3.0303335795539565e-12
) O 0 3.425811837917572e-15
, O 0 2.3280783140996802e-15
and O 0 2.2494552336278784e-15
one O 0 1.3119210511241923e-14
additional O 0 1.0190826183137727e-13
minor O 0 6.137200990463665e-12
criterion O 0 1.2492095358140887e-08
. O 0 1.9400461681584602e-08

Sixteen O 0 1.5995692592696287e-07
different O 0 5.594122942653712e-10
p16 O 0 1.9184060562338345e-08
germline O 0 3.885804389369696e-08
mutations O 0 2.7784432740651788e-11
were O 0 1.1779352666885234e-11
found O 0 2.437351806928306e-13
in O 0 2.3171108044436894e-14
21 O 0 7.382839999070523e-12
families O 0 1.7390359985380854e-12
, O 0 4.369430639246212e-14
while O 0 1.049923277658682e-12
one O 0 4.1225308756998036e-12
germline O 0 3.924566271962249e-08
mutation O 0 2.1204473940605872e-11
, O 0 4.428164866038253e-12
Arg24His O 0 1.3056466741545592e-05
, O 0 1.340193928056621e-11
was O 0 5.436808225844914e-10
detected O 0 2.9380609056772755e-10
in O 0 1.0937817492007174e-12
the O 0 1.5666611064002467e-10
CDK4 O 0 0.0001385030773235485
gene O 0 2.0640243680869474e-10
. O 0 6.12382233811104e-09

The O 0 8.290675784783375e-11
frequency O 0 2.6423441559786376e-11
of O 0 7.424555761859075e-12
p16 O 0 1.2206009813997554e-10
gene O 0 3.8435410859875493e-14
mutation O 0 1.1231218964558292e-14
in O 0 2.2010556016151782e-14
our O 0 3.869717480481372e-12
sample O 0 7.848378929175767e-14
( O 0 3.6690259137768565e-16
44 O 0 1.0875726534631536e-11
% O 0 4.292532648775271e-11
) O 0 7.689384576932325e-15
is O 0 2.5434690517075554e-15
among O 0 6.273928994599345e-15
the O 0 3.7094638341908515e-13
highest O 0 9.95967058825542e-11
rates O 0 7.904298418050237e-13
yet O 0 3.476273021068947e-14
reported O 0 3.943284772062877e-13
and O 0 4.77628902411948e-14
the O 0 1.1947337216766662e-11
CDK4 O 0 8.26620525913313e-05
mutation O 0 1.4211159159172038e-11
is O 0 2.0470517980903692e-14
the O 0 1.140087481886487e-12
second O 0 5.794101309852806e-10
mutation O 0 6.982607547723063e-11
detected O 0 1.4459614929018816e-11
in O 0 1.1968856082015394e-13
this O 0 3.563330728574565e-13
gene O 0 2.199916247433431e-12
worldwide O 0 8.093044463752808e-12
. O 0 3.2961524620844784e-09

In O 0 3.725550978828096e-10
summary O 0 6.348651604426436e-10
, O 0 1.4008506811144517e-12
our O 0 1.491061961400586e-11
results O 0 5.148570805801889e-12
show O 0 9.849041721077256e-12
frequent O 0 2.832343192447906e-13
involvement O 0 7.024254441989619e-12
of O 0 9.410756895977812e-12
the O 0 6.675469899075637e-11
p16 O 0 3.272760729089441e-09
gene O 0 2.861722360816832e-12
in O 0 8.653900512856083e-12
familial B-Disease 0 1.0478648171385885e-08
melanoma I-Disease 0 4.15097247241647e-07
and O 0 7.69868543915031e-12
confirm O 0 1.1711931424684963e-09
the O 0 2.7786550838015955e-11
role O 0 1.7077511280105817e-11
of O 0 1.1321833748301202e-10
the O 0 2.6993426938126674e-10
CDK4 O 1 0.9971631169319153
gene O 0 4.4023530480774564e-12
as O 0 4.0257326552189943e-13
a O 0 1.0347528389687e-11
melanoma B-Disease 0 1.9645072768526006e-07
- O 0 4.3925716397552605e-09
predisposing O 0 5.750491194334018e-10
gene O 0 9.795754702182635e-13
. O 0 6.414812257771185e-12
. O 0 3.9475350765982853e-10

Progression O 0 6.909669991728151e-07
of O 0 6.324015089376189e-08
somatic O 0 2.480304885921214e-07
CTG O 0 1.3973961358715314e-05
repeat O 0 9.712458615140918e-10
length O 0 6.21560233837748e-11
heterogeneity O 0 7.514298211441783e-11
in O 0 4.171766353048591e-14
the O 0 1.478455351850913e-13
blood O 0 2.984154806942585e-12
cells O 0 1.2297238227709784e-10
of O 0 3.135489201611108e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 2.0111153276047844e-07
. O 0 2.2193876958453984e-08

The O 0 3.617964608459978e-11
genetic O 0 2.369999812720791e-12
basis O 0 4.3187793619114956e-11
of O 0 1.2224603274102464e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.9117417366109066e-09
DM B-Disease 1 1.0
) O 0 1.8274229785647522e-12
is O 0 1.9176567580788447e-15
the O 0 5.695896770734066e-15
expansion O 0 1.217809793979674e-11
of O 0 4.9199273127742416e-12
an O 0 9.244833631266713e-13
unstable O 0 5.207592224110158e-08
CTG O 0 1.955751400828376e-07
repeat O 0 1.950409625472993e-11
in O 0 2.405558120321255e-13
the O 0 4.2655213128989233e-13
34 O 0 5.722871482261027e-11
UTR O 0 2.8729238010782865e-07
of O 0 3.6858696650377e-11
the O 0 5.005471037655695e-10
DM B-Disease 1 1.0
protein O 0 4.477917592282665e-09
kinase O 0 1.4712421558815691e-10
gene O 0 1.1513021438980253e-12
on O 0 1.383966552470639e-10
chromosome O 0 5.925522295058272e-10
19 O 0 7.0266228391346885e-09
. O 0 2.2452795178651286e-08

One O 0 1.9368498471727946e-10
of O 0 7.776301130801855e-11
the O 0 9.835074595010429e-12
principal O 0 8.9451092366577e-11
features O 0 3.5032032477807715e-14
of O 0 4.3289184086317545e-13
the O 0 2.6010310225088595e-11
DM B-Disease 1 1.0
mutation O 0 4.2188471466308997e-11
is O 0 8.398332349652746e-14
an O 0 1.9381513809233614e-13
extraordinarily O 0 8.493620251570633e-10
high O 0 3.28130966842366e-10
level O 0 5.522620583064963e-08
of O 0 3.45323603045955e-10
somatic O 0 1.2120294767825612e-09
mosaicism O 0 3.212548094211343e-08
, O 0 5.333704804861769e-14
due O 0 1.2548011241175772e-10
to O 0 1.1692100412852291e-11
an O 0 1.724162804715712e-13
extremely O 0 1.0249648352278484e-11
high O 0 3.4754677434578607e-12
degree O 0 1.3720321545562797e-09
of O 0 6.377268713109174e-10
somatic O 0 1.0513502068931757e-08
instability O 0 6.253662476751742e-09
both O 0 4.3450347486651e-12
within O 0 1.1626895626837275e-11
and O 0 1.1328637917887904e-14
between O 0 5.085425136552857e-12
different O 0 1.2585683363541822e-11
tissues O 0 5.250863632788594e-10
. O 0 9.68934821266032e-10

This O 0 4.0847636384455654e-09
instability O 0 1.391991304444673e-07
appears O 0 2.861100028769825e-12
to O 0 2.9734212054349785e-13
be O 0 1.3450530836692232e-13
biased O 0 2.8217452680001642e-11
towards O 0 5.934907426619063e-11
further O 0 1.112679501487357e-12
expansion O 0 2.7700085281079367e-11
and O 0 2.1534172828154702e-14
continuous O 0 3.8754086051362435e-10
throughout O 0 3.374808895881265e-12
the O 0 5.987739058917196e-13
life O 0 2.276660414010645e-12
of O 0 2.0938366058348423e-12
an O 0 6.1184560971308186e-15
individual O 0 5.888982335632009e-14
, O 0 1.2727373408655263e-13
features O 0 1.191201136211198e-13
that O 0 2.018045197163293e-15
could O 0 2.80557261450598e-13
be O 0 1.858821527690041e-13
associated O 0 2.4559037095639447e-11
with O 0 9.102647021558274e-14
the O 0 7.954533559617616e-11
progressive O 0 1.2465014265217178e-07
nature O 0 1.9063443532085778e-11
of O 0 1.1198124025280087e-11
the O 0 3.778073340288124e-11
disease O 0 2.8874175272974867e-10
. O 0 3.396399828048402e-10

Although O 0 1.9475258905554682e-10
increasing O 0 9.267754098873926e-12
measured O 0 5.9681079522810876e-12
allele O 0 7.233086525559873e-12
size O 0 9.742500859874492e-13
between O 0 1.0342359781090327e-11
patients O 0 1.278075908994758e-11
clearly O 0 3.35344816151939e-12
correlates O 0 6.693434001503462e-11
with O 0 7.808627334147944e-15
an O 0 5.893856417320395e-15
increased O 0 1.9590724170941848e-13
severity O 0 7.4222648860367e-11
of O 0 3.8189477621908274e-12
symptoms O 0 4.98371699811373e-12
and O 0 1.1569356211168103e-15
an O 0 1.2641322198637131e-16
earlier O 0 1.7705834628317652e-13
age O 0 4.448821519509316e-12
of O 0 1.0590766544998909e-12
onset O 0 1.6964986707113106e-11
, O 0 9.53279423850312e-15
this O 0 9.3700851385662e-15
correlation O 0 2.202492000087132e-14
is O 0 2.186875751270461e-16
not O 0 3.860820219298358e-15
precise O 0 1.1742160195560292e-11
and O 0 9.635496475137936e-14
measured O 0 1.1053801970972721e-11
allele O 0 1.4324503389007148e-11
length O 0 1.320906838769842e-11
cannot O 0 2.5126912703288262e-11
be O 0 4.2881009073431064e-13
used O 0 3.212650143743362e-13
as O 0 3.864284584052628e-14
an O 0 5.812560736141769e-15
accurate O 0 9.756202512534173e-10
predictor O 0 1.6842557570839745e-08
of O 0 1.1905094965403151e-11
age O 0 1.629648527234906e-09
of O 0 3.7395331276002253e-10
onset O 0 1.5925431284813385e-07
. O 0 1.1498077157057196e-08

In O 0 8.840304877022476e-11
order O 0 6.884636090387364e-12
to O 0 4.3013734934982395e-12
further O 0 3.290280591386474e-12
characterize O 0 3.6659383861881167e-10
the O 0 5.950660103559713e-12
dynamics O 0 2.1156258966925634e-09
of O 0 1.8592983508369798e-07
DM B-Disease 1 1.0
CTG O 0 4.566080679069273e-05
repeat O 0 6.222916404396983e-09
somatic O 0 2.112683361588097e-08
instability O 0 9.854392857278071e-09
, O 0 6.888608607147351e-14
we O 0 6.956966198869846e-14
have O 0 2.0783037563056744e-15
studied O 0 7.738219245066735e-14
repeat O 0 1.8451020333994095e-13
length O 0 1.0548545815048521e-13
changes O 0 4.731097444691211e-15
over O 0 1.6109719623829538e-14
time O 0 7.582751158745349e-13
in O 0 3.2866929663977196e-12
111 O 0 1.3812127974688337e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 3.527254044399797e-10
with O 0 3.565640418015138e-14
varying O 0 6.294888113371477e-13
clinical O 0 3.290092590729765e-12
severity O 0 4.9143026453757344e-11
and O 0 5.121313529504734e-12
CTG O 0 6.648248529472767e-08
repeat O 0 4.1874774481254207e-11
size O 0 3.814228663814867e-13
over O 0 1.9916433411336365e-13
time O 0 3.5784324722148986e-12
intervals O 0 4.811722131847773e-10
of O 0 1.2443754360269565e-11
1 O 0 1.917144915042357e-11
- O 0 8.055486833136172e-11
7 O 0 2.5254045382672174e-11
years O 0 2.5490788299609157e-11
. O 0 3.850541552274933e-10

We O 0 3.252099978201528e-10
have O 0 1.1937598533382637e-13
found O 0 8.22945193706872e-15
a O 0 8.08654678507596e-16
direct O 0 2.5053367719166456e-14
progression O 0 5.569717950737463e-11
of O 0 3.2269256711181526e-11
the O 0 5.257555155124827e-11
size O 0 5.180726334041985e-11
heterogeneity O 0 8.791394834339883e-10
over O 0 2.123254913902195e-12
time O 0 4.838572251197881e-12
related O 0 4.9135997354232686e-11
to O 0 7.849794599057436e-12
initial O 0 5.891825916037874e-10
CTG O 0 4.2029591895698104e-07
repeat O 0 8.230362918970613e-11
size O 0 7.971125929456813e-13
and O 0 4.3373545179732284e-14
the O 0 6.062840117102009e-13
time O 0 1.4378347470977992e-11
interval O 0 1.5708141731796132e-10
and O 0 2.4212812879892756e-14
always O 0 1.1219748952606343e-13
biased O 0 2.200751516787114e-12
towards O 0 2.4550091126673834e-11
further O 0 6.594272437127069e-12
expansion O 0 4.3060155441310144e-10
. O 0 2.435256218902282e-09

Attempts O 0 1.2190089648811409e-07
to O 0 3.147429539218649e-10
mathematically O 0 1.2797780613027498e-08
model O 0 2.447649895265247e-11
the O 0 9.841511286468041e-12
dynamics O 0 4.263746300470217e-10
have O 0 6.230765686385253e-13
proved O 0 1.3728200798368562e-09
only O 0 6.374267433328917e-13
partially O 0 1.833212054380695e-11
successful O 0 4.46470031084667e-12
suggesting O 0 2.1754314929317564e-12
that O 0 1.1890790126876737e-16
individual O 0 2.50290909078652e-15
specific O 0 1.7123220972647263e-13
genetic O 0 6.8714907895672805e-12
and O 0 3.361041100383849e-13
/ O 0 1.8481568275774407e-08
or O 0 9.16395865441233e-12
environmental O 0 4.1369633413390616e-11
factors O 0 5.524379131233159e-12
also O 0 6.991655586191699e-15
play O 0 2.583227382002562e-11
a O 0 2.3467004381383383e-11
role O 0 8.965024556051304e-11
in O 0 2.998341575022323e-10
somatic O 0 5.8264117086537226e-08
mosaicism O 0 4.766352503793314e-07
. O 0 2.5548918536344445e-10
. O 0 4.341206505387163e-09

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 1.6997384055805753e-10
Palestinian O 0 1.613715880921518e-06
Arabs O 0 1.0050290200069867e-07
. O 0 3.6756371279977884e-09

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 8.858122555466252e-07
AGU B-Disease 1 1.0
) O 0 1.5718263496333762e-11
is O 0 2.2218769250674508e-13
a O 0 2.4914818472221434e-12
rare O 0 3.7663134833110234e-09
disorder B-Disease 1 0.9999998807907104
of I-Disease 0 0.18139450252056122
glycoprotein I-Disease 0 1.3657462716309965e-07
metabolism I-Disease 1 0.9993694424629211
caused O 0 8.788909183765625e-11
by O 0 4.2249125882911145e-14
the O 0 1.7195635540478982e-11
deficiency B-Disease 0 3.668229737741058e-07
of I-Disease 0 1.6557855087029338e-09
the I-Disease 0 1.7154107301298183e-10
lysosomal I-Disease 0 7.358474718444086e-09
enzyme I-Disease 0 3.0229846403884153e-12
aspartylglucosaminidase I-Disease 0 8.468465373390188e-10
( O 0 1.4936221205165412e-13
AGA O 0 7.066394687171851e-07
) O 0 8.695031673833231e-12
. O 0 8.434211662411428e-10

AGU B-Disease 1 1.0
is O 0 2.108865526651016e-09
inherited O 0 0.00022667889425065368
as O 0 7.358214038077904e-11
an O 0 4.028338426720346e-12
autosomal O 1 0.9444247484207153
recessive O 0 1.3333381502889097e-05
trait O 0 4.934068265072256e-09
and O 0 2.0650597185489956e-14
occurs O 0 2.0112496466450497e-13
with O 0 2.2901044506457306e-16
a O 0 9.190888203497796e-14
high O 0 1.3502253785532825e-12
frequency O 0 4.9557278419820605e-11
in O 0 1.1827751235024553e-12
Finland O 0 3.012800897650436e-09
because O 0 3.261810851799829e-13
of O 0 1.483618089492822e-11
a O 0 1.6054100757112444e-11
founder O 0 3.061709497043097e-10
effect O 0 6.031106170034661e-11
. O 0 1.261097448690407e-09

While O 0 1.6593588725299924e-08
very O 0 7.229890991444776e-11
few O 0 6.414530798887208e-12
patients O 0 1.7007807922436724e-12
with O 0 8.516214941361663e-14
AGU B-Disease 1 1.0
have O 0 6.515430014085444e-13
been O 0 4.539989193505338e-14
reported O 0 8.388054790683941e-14
from O 0 2.0935479099013637e-13
non O 0 9.658659289035754e-11
- O 0 3.9257564213301954e-12
Finnish O 0 3.728680919579119e-09
origin O 0 6.286016152046159e-11
, O 0 4.428804057429042e-13
we O 0 3.6261564497624965e-12
diagnosed O 0 8.906235962058417e-07
the O 0 1.9779903409622435e-11
disorder O 0 4.556579558112617e-09
in O 0 2.431788765581283e-13
8 O 0 2.949091665316317e-11
patients O 0 9.78210093764871e-14
originating O 0 3.040959845046487e-11
from O 0 2.2087962969069563e-12
3 O 0 8.95208473322695e-12
unrelated O 0 2.5536628367461844e-11
families O 0 4.263984185268882e-13
, O 0 5.955011349079208e-15
all O 0 1.810898165362923e-14
Palestinian O 0 1.5269529285433237e-07
Arabs O 0 3.4588214514741367e-09
from O 0 2.2790326483640433e-12
the O 0 1.556966036132812e-12
region O 0 1.2650093472732493e-10
of O 0 2.7421164297547485e-11
Jerusalem O 0 2.3553509436169406e-06
. O 0 1.1522033815936084e-07

The O 0 1.0487100077227751e-09
clinical O 0 7.370273280571382e-09
diagnosis O 1 0.9999393224716187
of O 1 0.9438796043395996
AGU B-Disease 1 1.0
is O 0 2.497222151287559e-10
often O 0 1.053481846029214e-12
difficult O 0 5.457017504539863e-09
, O 0 6.113163496463195e-14
in O 0 3.5810984304893503e-14
particular O 0 3.4710519099820716e-14
early O 0 7.085573013737578e-12
in O 0 4.8302135132339413e-14
the O 0 3.260915029754813e-13
course O 0 8.23012769046727e-11
of O 0 8.39614662517807e-12
the O 0 4.158749299792985e-12
disease O 0 6.2416408846965865e-12
, O 0 7.42621567538515e-15
and O 0 2.663440045499576e-14
most O 0 1.695500565033342e-13
of O 0 6.204891201538887e-12
the O 0 4.7054925060574515e-12
patients O 0 1.6668479747503073e-12
are O 0 1.4093662624751688e-14
diagnosed O 0 2.4719325978500573e-12
after O 0 5.809496221760579e-13
the O 0 8.083105582437633e-13
age O 0 6.388466144979787e-11
of O 0 7.021883074997959e-12
5 O 0 4.2016060769478614e-11
years O 0 4.926878696687176e-11
. O 0 2.527623665926626e-09

However O 0 4.576079959406343e-09
, O 0 6.305102382038463e-13
since O 0 4.080846446354036e-13
these O 0 4.690353127049206e-14
patients O 0 4.471939921775643e-14
excrete O 0 4.880429827630595e-12
early O 0 1.868134770141583e-12
large O 0 6.846597382326137e-15
amounts O 0 7.941711117941466e-14
of O 0 5.002728786784871e-11
aspartylglucosamine O 0 1.3655846942128846e-07
in O 0 2.5359378486022877e-10
urine O 0 9.238431686320325e-10
, O 0 4.865416880148188e-13
biochemical O 0 4.782702879568834e-12
screening O 0 2.311032441804084e-11
is O 0 1.6501292790949834e-13
easy O 0 4.1656421367886054e-11
by O 0 9.039638612304279e-13
urine O 0 2.8360774839697456e-10
chromatography O 0 4.229807337718938e-10
. O 0 4.4866242665531075e-11
. O 0 9.85946435605456e-10

Detection O 0 3.124071668025863e-07
of O 0 3.629308797936659e-10
heterozygous O 0 1.4564179940182442e-12
carriers O 0 1.632612468339175e-14
of O 0 3.5721637236738046e-13
the O 0 1.6578007022705066e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 5.36787142513262e-11
ATM O 0 9.90615262708161e-06
) O 0 5.6109495305198265e-15
gene O 0 8.744104417729884e-17
by O 0 5.324043060021442e-16
G2 O 0 5.5242237867458854e-11
phase O 0 3.186960972900721e-10
chromosomal O 0 6.543964037319938e-09
radiosensitivity O 0 7.534631407679626e-08
of O 0 3.7399559005280025e-09
peripheral O 0 1.2753354212691193e-06
blood O 0 6.67983428570551e-08
lymphocytes O 0 2.449567215734305e-09
. O 0 2.858433312269426e-08

In O 0 9.894245067698648e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.266110238404508e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.3842594435888988e-14
patients O 0 3.577737573161235e-15
, O 0 6.311321899330597e-17
mutations O 0 2.000186910368755e-16
in O 0 3.382373817860444e-16
a O 0 8.580676160350965e-16
single O 0 7.35432714211873e-15
gene O 0 1.0695457496409265e-15
, O 0 6.7084886602763235e-15
ATM O 0 7.352525699388934e-09
, O 0 2.0557852159963294e-14
result O 0 4.5270902369713706e-13
in O 0 4.31166560788121e-12
an O 0 8.68281357924161e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 2.269741686267146e-11
embraces O 0 3.920247373251362e-13
a O 0 1.2705537407494815e-14
variety O 0 3.332732657893218e-15
of O 0 4.861972505371473e-14
clinical O 0 2.2678623302213596e-12
features O 0 9.428047941959991e-14
and O 0 3.086540625949624e-14
manifests O 0 3.1223133887398058e-12
extreme O 0 1.7438829894023122e-11
radiosensitivity O 0 1.674965410813911e-08
and O 0 8.834918473893394e-13
a O 0 1.304397735657492e-11
strong O 0 5.286068891635631e-12
pre O 0 1.5405089470732491e-07
- O 0 4.9803443147311555e-08
disposition O 0 6.105455696570061e-08
to O 0 6.4940914867861466e-09
malignancy B-Disease 0 2.2363959942595102e-05
. O 0 4.300002132140435e-09

Heterozygotes O 0 2.707167112703246e-08
for O 0 5.971011445699004e-12
the O 0 4.23810708749528e-11
ATM O 0 1.146577346844424e-06
gene O 0 4.673870340234088e-13
have O 0 3.0485976156707784e-14
no O 0 3.3810596991823384e-15
clinical O 0 1.146602412083371e-14
expression O 0 8.20619156530417e-15
of O 0 1.1172608845033682e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
but O 0 2.520178857268185e-11
may O 0 2.404650914153428e-12
be O 0 1.0779812372602171e-12
cancer B-Disease 0 2.8755116343592846e-11
prone O 0 1.5402547293152935e-11
with O 0 3.3740248787971546e-15
a O 0 2.379838513755228e-12
moderate O 0 8.904318254954191e-12
increase O 0 6.88331932684888e-13
in O 0 5.763989546075932e-13
in O 0 7.78229564124544e-11
vitro O 0 2.9752140751071465e-09
radiosensitivity O 0 2.0271690459594538e-07
. O 0 1.7463388957139614e-08

We O 0 3.0612773427307616e-10
performed O 0 1.9862479716525883e-10
a O 0 1.2227673734654942e-11
blind O 0 1.067818389266506e-09
chromosomal O 0 1.1568729307853687e-09
analysis O 0 6.8679012130146155e-12
on O 0 5.973244034812586e-12
G2 O 0 8.482287650046771e-10
- O 0 5.404616858217803e-12
phase O 0 2.9359883968460565e-10
lymphocytes O 0 3.745195072037827e-13
from O 0 1.988018988796289e-13
7 O 0 7.463184258961475e-13
unrelated O 0 1.7365717197570518e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.885180177576331e-09
, O 0 1.8737568191918436e-14
13 O 0 2.167198278474336e-12
obligate O 0 3.7112266593197774e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 2.642418550635739e-08
( O 0 1.8349794814599522e-14
parents O 0 2.3593081224034147e-14
of O 0 3.185410716124472e-14
the O 0 2.1426992667140932e-14
patients O 0 4.186310840489189e-15
) O 0 7.464066242605715e-17
, O 0 2.1559218586553387e-16
and O 0 1.3179345615332242e-15
14 O 0 1.0288170055466894e-12
normal O 0 2.8732530243935628e-11
controls O 0 1.2136354204592137e-12
following O 0 6.956821186829276e-14
X O 0 8.663880030068682e-11
- O 0 1.9668995598909333e-11
irradiation O 0 2.177590139457175e-12
with O 0 1.488547749417448e-14
1 O 0 2.15079234804072e-12
Gy O 0 5.7099838746133e-11
in O 0 1.0452242573517033e-15
order O 0 3.3070368546470746e-15
to O 0 3.678250737847166e-14
evaluate O 0 1.311552103901159e-12
this O 0 2.1172110288916746e-14
cytogenetic O 0 2.852157843236114e-09
method O 0 1.3931912568043714e-10
as O 0 2.850803089687187e-13
a O 0 1.4248442920319904e-12
tool O 0 1.1145631084730212e-09
for O 0 1.609989675214682e-13
detection O 0 4.808174303150281e-09
of O 0 2.555759492928189e-10
ATM O 0 2.6489694846532075e-06
carriers O 0 1.9003298934450186e-10
. O 0 7.241518051870344e-09

Both O 0 1.936922089385007e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 1.369753306335042e-07
and O 0 1.6970016429411483e-13
heterozygotes O 0 4.124089958423838e-11
showed O 0 5.027364700753434e-13
significantly O 0 1.1838849399512658e-13
increased O 0 4.5017730998042974e-14
levels O 0 5.1858252934910976e-12
of O 0 8.941966091191578e-12
radiation O 0 5.029698399994231e-07
- O 0 4.1274407891478404e-08
induced O 0 7.193474260702715e-09
chromatid O 0 2.407444412710902e-07
damage O 0 2.1477701839245356e-09
relative O 0 4.108499651600539e-10
to O 0 6.203326155702904e-13
that O 0 5.3965536331085015e-15
of O 0 2.0072843127244555e-12
normal O 0 1.3501219031653022e-09
controls O 0 1.6458890916837277e-09
. O 0 9.574765424957832e-10

These O 0 1.7506708973116791e-12
results O 0 1.0973173324851926e-12
show O 0 4.251120939643971e-13
that O 0 2.2517290935747825e-16
the O 0 4.2356275550738814e-14
G2 O 0 8.643615267978078e-10
- O 0 1.4043880641745332e-11
phase O 0 2.9103204290947815e-09
chromosomal O 0 7.284062775170241e-08
radiosensitivity O 0 3.317561336757535e-08
assay O 0 1.0953125559320931e-11
can O 0 5.777150269671918e-14
be O 0 5.188092472042114e-15
used O 0 5.7921523243106236e-15
for O 0 2.236432737338554e-15
the O 0 2.0206462235860742e-14
detection O 0 3.0452565469296644e-10
of O 0 1.144258909846485e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 1.5718549093435286e-06
. O 0 1.333810484283049e-08

In O 0 6.747439829091206e-10
combination O 0 7.902255932945579e-11
with O 0 1.7259989010948162e-13
molecular O 0 7.239850212392707e-12
genetic O 0 4.4239603300133545e-12
analyses O 0 1.1717550540968347e-11
, O 0 2.3221711063255287e-15
this O 0 1.7368257058727739e-15
test O 0 1.5685243631279738e-13
may O 0 1.6978296007064304e-14
be O 0 1.9904308642916188e-14
of O 0 1.5898977826552668e-13
value O 0 7.219052829479655e-13
in O 0 3.2805643645399465e-14
studies O 0 9.126295639344528e-13
of O 0 8.039101068862964e-13
familial B-Disease 0 3.022449998613119e-11
and I-Disease 0 3.6191156408543756e-12
sporadic I-Disease 0 1.604604449312319e-08
cancers I-Disease 0 1.4925808144994335e-08
aimed O 0 1.3159918710314855e-09
at O 0 5.4008887639955816e-11
determination O 0 1.3442863489032675e-09
of O 0 9.732221972758026e-11
the O 0 3.6166174222085345e-12
potential O 0 4.931875762816118e-13
involvement O 0 2.2996963708332707e-11
of O 0 1.7475808578026886e-09
ATM O 0 0.00020172646327409893
mutations O 0 7.614183172854894e-10
in O 0 2.0620410934313327e-10
tumor B-Disease 0 4.784108753597138e-08
risk O 0 2.7578729230870458e-11
or O 0 2.733064967917753e-13
development O 0 2.839303236967794e-10
. O 0 1.0911401990276737e-11
. O 0 3.4312158669891346e-10

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 1.1650626643988637e-11
identification O 0 2.671500798356874e-09
and O 0 4.278398991965256e-15
detection O 0 5.96811142172804e-11
of O 0 3.819647289432515e-12
founder O 0 6.841624489162257e-11
- O 0 2.4158649039596192e-11
effect O 0 2.8865760693178033e-13
mutations O 0 3.601607469834629e-14
in O 0 4.708447783681631e-15
the O 0 3.3030308631450123e-13
ATM O 0 1.7312192568397222e-08
gene O 0 5.707492990595156e-14
in O 0 1.5755766916841774e-13
ethnic O 0 1.4052721659940648e-11
populations O 0 9.70063222457962e-13
. O 0 4.6750697063613345e-11

To O 0 2.543135979582445e-10
facilitate O 0 1.4464180964068873e-09
the O 0 4.660137727097169e-12
evaluation O 0 4.799662445265085e-09
of O 0 1.6279212422531941e-09
ATM O 0 1.178749789687572e-05
heterozygotes O 0 1.0631265645599797e-08
for O 0 1.847900304996486e-11
susceptibility O 0 2.915758468002849e-10
to O 0 7.254201406237115e-11
other O 0 1.7249509112748918e-11
diseases O 0 8.217183733449929e-08
, O 0 2.8230881716530265e-13
such O 0 1.815997574755937e-13
as O 0 9.656853788841957e-11
breast B-Disease 0 2.437886559292224e-09
cancer I-Disease 0 3.6048466434124293e-09
, O 0 1.6828084065112492e-11
we O 0 9.197982653308401e-12
have O 0 4.5552554377202917e-14
attempted O 0 5.733228822246694e-11
to O 0 7.526974703242484e-12
define O 0 3.467009734858806e-10
the O 0 2.2991161925667303e-12
most O 0 4.8508943308609234e-14
common O 0 7.516852944125865e-14
mutations O 0 6.957281295126225e-15
and O 0 9.449083454633636e-16
their O 0 8.144074065304097e-14
frequencies O 0 3.040263873987925e-11
in O 0 2.564974344032578e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.5088501821055615e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.8109510202188317e-13
homozygotes O 0 5.85442194722674e-10
from O 0 4.9822481345629735e-14
10 O 0 1.397175425485106e-13
ethnic O 0 3.9144043366932946e-13
populations O 0 9.480613451413877e-14
. O 0 7.416544808847014e-12

Both O 0 4.957498855873155e-10
genomic O 0 1.1186399362372867e-08
mutations O 0 2.873559896976463e-11
and O 0 5.955445961684444e-14
their O 0 3.4684347408053817e-12
effects O 0 3.977126353943428e-12
on O 0 5.610187661653221e-12
cDNA O 0 2.1358579349595175e-09
were O 0 4.947935811072668e-11
characterized O 0 2.6761391713758798e-11
. O 0 6.230347349145404e-10

Protein O 0 1.1358913809544902e-09
- O 0 7.467691048868019e-11
truncation O 0 3.0213159751824037e-10
testing O 0 1.7970885196616493e-12
of O 0 2.1169859214156123e-13
the O 0 1.9756420078457376e-14
entire O 0 2.368924067325251e-12
ATM O 0 7.60303417446373e-11
cDNA O 0 5.8098456601207715e-11
detected O 0 4.3837177811367756e-12
92 O 0 4.6910138967737325e-11
( O 0 1.427495139238663e-14
66 O 0 1.2515223302145273e-09
% O 0 7.806454094261284e-11
) O 0 6.835249597228477e-14
truncating O 0 5.330725305618955e-10
mutations O 0 2.7730682333748646e-12
in O 0 4.2290102626393877e-13
140 O 0 3.05701054748031e-11
mutant O 0 4.261272584793474e-11
alleles O 0 7.495671618118482e-12
screened O 0 9.850685822598848e-10
. O 0 1.5457723989698025e-08

The O 0 8.099496184854615e-09
haplotyping O 0 0.03170236200094223
of O 0 2.897686313119152e-09
patients O 0 5.455472185111887e-11
with O 0 1.5235984132319635e-13
identical O 0 1.2544701388783608e-11
mutations O 0 1.393155230934584e-12
indicates O 0 8.738886892768749e-13
that O 0 3.22626675741222e-15
almost O 0 2.536156506159626e-13
all O 0 4.1506142462897563e-14
of O 0 1.6682666532930046e-12
these O 0 1.03081795486612e-13
represent O 0 1.9341236511677407e-12
common O 0 1.3101894786107793e-12
ancestry O 0 5.205796904661497e-11
and O 0 8.935891306419141e-13
that O 0 1.2617302493599103e-13
very O 0 6.9074698218207775e-12
few O 0 4.659766322800962e-11
spontaneously O 0 5.565475635904704e-09
recurring O 0 5.8130691371616194e-08
ATM O 0 1.996525861613918e-05
mutations O 0 1.047383246799427e-08
exist O 0 7.080210195908876e-08
. O 0 7.456984718601234e-08

Assays O 0 4.232860284503204e-09
requiring O 0 1.3853082569958985e-10
minimal O 0 2.3464868936784455e-10
amounts O 0 3.452671091738746e-13
of O 0 4.20760865385561e-13
genomic O 0 5.127738164634188e-11
DNA O 0 1.1028814528302178e-09
were O 0 7.514710208267328e-12
designed O 0 1.1478947133103379e-12
to O 0 1.5416354174138669e-12
allow O 0 4.1104944968617385e-12
rapid O 0 1.1987738926522162e-11
screening O 0 1.8443991993410958e-12
for O 0 2.0663452773937024e-13
common O 0 4.501159427822143e-12
ethnic O 0 3.470675136174606e-10
mutations O 0 1.2682756234116965e-10
. O 0 8.839837195573352e-10

These O 0 1.6065687669097883e-10
rapid O 0 2.6294147414951397e-10
assays O 0 1.6847555295296246e-10
detected O 0 3.4281327776497506e-11
mutations O 0 8.043206671439623e-14
in O 0 2.6667339872248584e-14
76 O 0 5.5338206239596843e-11
% O 0 4.690262067619244e-11
of O 0 4.5879936134973764e-12
Costa O 0 1.912533048598064e-10
Rican O 0 7.0601950952209336e-09
patients O 0 4.1543830875401255e-11
( O 0 6.251374201279858e-16
3 O 0 1.8377360654834966e-14
) O 0 1.3285797804467406e-16
, O 0 9.109198117309149e-17
50 O 0 2.4403181840722266e-14
% O 0 6.268576695049599e-13
of O 0 1.0933875332908016e-12
Norwegian O 0 1.3858971215086058e-06
patients O 0 1.8738832707754227e-09
( O 0 1.5725197158962187e-14
1 O 0 2.207253612740781e-13
) O 0 1.5571655708371637e-15
, O 0 1.2424329033511729e-15
25 O 0 1.3628250546300624e-13
% O 0 2.3267590111564207e-12
of O 0 6.411176385785755e-13
Polish O 0 1.3226690498413518e-07
patients O 0 1.8014428837531682e-09
( O 0 1.712030616286917e-14
4 O 0 6.663886564957366e-13
) O 0 2.494302389009469e-15
, O 0 8.514680117661239e-16
and O 0 4.710188224630002e-16
14 O 0 3.726405306287567e-13
% O 0 2.8893207271174504e-12
of O 0 3.391694748406532e-13
Italian O 0 1.605848787278319e-10
patients O 0 3.5597630398953584e-10
( O 0 7.11113805373139e-15
1 O 0 3.0674564993095343e-13
) O 0 8.430490971934792e-15
, O 0 1.8132691799888773e-14
as O 0 2.8425056904611556e-14
well O 0 2.977535481629018e-13
as O 0 7.270313501618955e-14
in O 0 3.216095738247521e-13
patients O 0 2.789566320993142e-12
of O 0 2.1900715962974715e-10
Amish O 0 1.3176217805721535e-07
/ O 0 3.2163844920773954e-09
Mennonite O 0 1.0207815925866726e-08
and O 0 5.680041398163638e-13
Irish O 0 1.5566559152802029e-10
English O 0 2.0456353277964467e-10
backgrounds O 0 7.362865317439571e-10
. O 0 1.0965616192848415e-09

Additional O 0 4.962325661495015e-09
mutations O 0 3.3913766239734855e-10
were O 0 5.364227811943678e-11
observed O 0 1.3191034636123034e-12
in O 0 2.194659655830461e-13
Japanese O 0 2.550738509299322e-10
, O 0 1.7384913495767373e-13
Utah O 0 7.43453493212698e-11
Mormon O 0 5.031705607727588e-11
, O 0 6.190366229737393e-15
and O 0 2.2647348609633987e-14
African O 0 3.9279753061283174e-11
American O 0 7.75233696681532e-12
patients O 0 3.2413603051617557e-11
. O 0 5.172356432048275e-10

These O 0 3.3321910768852048e-12
assays O 0 8.041063474795163e-13
should O 0 2.31325138352282e-14
facilitate O 0 7.115735084495256e-12
screening O 0 1.1277361423173149e-12
for O 0 2.258749610961619e-12
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 4.119457841511576e-08
in O 0 8.00116429274661e-13
the O 0 4.214564352893191e-13
populations O 0 3.354889133969259e-15
studied O 0 2.0196172479617497e-14
. O 0 1.4651073323296293e-13
. O 0 7.776983917961999e-11

The O 0 1.7109716310415024e-08
von B-Disease 0 0.4836639165878296
Hippel I-Disease 1 0.9903472661972046
- I-Disease 0 0.04480208829045296
Lindau I-Disease 0 9.009256609715521e-05
tumor I-Disease 0 1.0360420077404342e-08
suppressor O 0 5.2034838243786297e-11
gene O 0 1.1218673559576509e-14
is O 0 1.1744594887158605e-16
required O 0 2.6600347358823884e-13
for O 0 2.6769978242599177e-14
cell O 0 5.413675150528485e-12
cycle O 0 2.923124242659725e-11
exit O 0 1.2910958760437019e-11
upon O 0 4.335647292574851e-12
serum O 0 2.6153595955591413e-10
withdrawal O 0 5.701368266386453e-10
. O 0 2.8294708798171087e-09

The O 0 1.2655794190408187e-09
inactivation O 0 4.255867214197906e-09
of O 0 7.51487538863671e-10
the O 0 3.5774618822870252e-09
von B-Disease 1 0.9999991655349731
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999990463256836
( I-Disease 0 1.4677898896309216e-09
VHL I-Disease 0 0.00015123259800020605
) I-Disease 0 3.588775804308497e-11
tumor I-Disease 0 1.1362408791626422e-08
suppressor O 0 4.366292660762383e-09
gene O 0 1.3154409853055604e-11
predisposes O 0 6.39251940270924e-09
affected O 0 4.532641970089735e-11
individuals O 0 1.0963099155434416e-14
to O 0 5.506041044107957e-13
the O 0 4.888376595874044e-12
human O 0 1.192908771763257e-09
VHL B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
syndrome I-Disease 0 0.0002353116578888148
and O 0 6.043187732998265e-14
is O 0 1.1965191648078983e-15
associated O 0 6.700822622468516e-13
with O 0 2.1843780311035094e-13
sporadic B-Disease 0 0.3320160508155823
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 8.234842252541341e-10
RCC B-Disease 0 0.08678274601697922
) O 0 7.644884725266365e-11
and O 0 1.028649831980033e-09
brain B-Disease 0 0.38956332206726074
hemangioblastomas I-Disease 0 5.8869668464467395e-06
. O 0 1.0218568213815615e-08

VHL O 0 4.358210935606621e-05
- O 0 4.256990564499574e-07
negative O 0 1.4354596677979004e-10
786 O 0 4.4087821038374386e-07
- O 0 9.922766253112059e-08
0 O 0 2.0014016485769837e-11
RCC B-Disease 0 1.1115664477756582e-07
cells O 0 7.468901885854251e-11
are O 0 2.8657298430968814e-13
tumorigenic O 0 4.800394304282918e-09
in O 0 1.741858740578195e-11
nude O 0 9.713237991704204e-10
mice O 0 1.0298953530274435e-11
which O 0 1.8934735439182608e-14
is O 0 1.508946674479584e-14
suppressed O 0 8.444951552291635e-13
by O 0 1.0644868877150975e-14
the O 0 7.680674672660981e-12
reintroduction O 0 1.000320182242831e-08
of O 0 6.358443216392118e-10
VHL B-Disease 0 1.8019716208073078e-06
. O 0 8.346871993580862e-08

Remarkably O 0 6.576576197403483e-06
, O 0 4.3691997719461084e-13
this O 0 3.955628955897711e-14
occurs O 0 1.4216323159909477e-13
without O 0 1.098202407376174e-13
affecting O 0 1.994872149413407e-12
the O 0 8.186813857044561e-13
growth O 0 1.4424823314984625e-11
rate O 0 3.943392053867845e-12
and O 0 2.705739176819561e-14
cell O 0 3.390534034086734e-11
cycle O 0 3.7868916336059044e-10
profile O 0 9.926193547671325e-12
of O 0 1.5528000760212102e-11
these O 0 3.9935741345809017e-13
cells O 0 3.904667821713614e-12
in O 0 2.3695025976044892e-12
culture O 0 5.067903874333979e-10
. O 0 6.142676922671342e-10

The O 0 1.2578407648788925e-08
786 O 0 3.175137635480496e-06
- O 0 1.6978550831936445e-07
0 O 0 5.960178964953267e-12
cell O 0 4.8281389303239663e-11
line O 0 1.7391107998143696e-10
, O 0 1.928581026702878e-14
like O 0 6.974846640869911e-15
many O 0 4.845011094119179e-15
cancer B-Disease 0 1.4736608743189106e-13
cells O 0 3.0649240740851513e-13
, O 0 6.026011344783958e-15
fails O 0 4.818256037208979e-12
to O 0 1.0039887324286845e-11
exit O 0 4.7557957572053056e-08
the O 0 8.337345397402274e-11
cell O 0 1.4376325130349699e-10
cycle O 0 4.2362401780904335e-11
upon O 0 8.302302421936414e-12
serum O 0 7.754277081550853e-11
withdrawal O 0 7.843756200109908e-10
. O 0 2.9888647112841227e-09

Here O 0 9.387271404648345e-08
, O 0 3.562979121810028e-12
it O 0 1.3021728665715978e-15
is O 0 6.353086579330644e-17
shown O 0 4.675461356100233e-15
that O 0 1.9472452335829931e-16
reintroduction O 0 4.7108830725228756e-11
of O 0 2.223996811365203e-13
the O 0 3.6348728931281937e-13
wild O 0 2.7085148360250777e-12
- O 0 3.104713014456806e-11
type O 0 1.5304035816399164e-11
VHL B-Disease 0 7.045601790878209e-08
gene O 0 1.1294645774206913e-12
restores O 0 3.7428279225926175e-11
the O 0 7.622570651934224e-13
ability O 0 2.800288126381112e-11
of O 0 3.8131434121346786e-10
VHL O 0 1.7375698007526807e-05
- O 0 3.4001050153165124e-07
negative O 0 5.336256783672333e-11
RCC B-Disease 0 7.251887979009553e-08
cancer I-Disease 0 6.511196963543409e-12
cells O 0 3.703045086279194e-13
to O 0 2.0351633518624762e-13
exit O 0 3.985078586565827e-11
the O 0 2.673233542079684e-13
cell O 0 3.5228532330872087e-12
cycle O 0 1.370249833737569e-11
and O 0 7.486490539911766e-14
enter O 0 9.40707334251556e-09
G0 O 0 0.00020866270642727613
/ O 0 4.83625683500577e-07
quiescence O 0 1.5775991641930887e-06
in O 0 2.3381593883264884e-10
low O 0 4.596707459114668e-09
serum O 0 1.1421612544637583e-09
. O 0 4.724391433619246e-10

Both O 0 2.8453874811873447e-09
VHL O 0 1.298381334891019e-06
- O 0 1.1472747196705768e-09
positive O 0 5.892603028787025e-13
and O 0 9.387476419039226e-14
VHL O 0 2.88942576531781e-08
- O 0 8.443671456470625e-11
negative O 0 2.056146865183489e-13
RCC B-Disease 0 3.9482883629204935e-10
cells O 0 5.624941484816404e-12
exit O 0 1.5065455827301122e-10
the O 0 4.36333667764785e-13
cell O 0 3.1699343670810176e-12
cycle O 0 2.7175291097275567e-12
by O 0 1.2446393606512993e-14
contact O 0 6.258237678080647e-11
inhibition O 0 7.559484149766149e-10
. O 0 7.968523618728796e-10

The O 0 1.7519035111490666e-08
cyclin O 0 1.6644518154862453e-06
- O 0 7.828829780009983e-07
dependent O 0 9.382063126395224e-08
kinase O 0 4.896397731712909e-10
inhibitor O 0 4.416164309239967e-11
, O 0 3.0491923005623867e-13
p27 O 0 1.928122328465065e-09
, O 0 2.903272172910358e-14
accumulates O 0 3.4612297836883466e-13
upon O 0 2.7751564067590717e-13
serum O 0 1.938884599747559e-12
withdrawal O 0 1.8308080745876865e-11
, O 0 2.817535159176099e-14
only O 0 1.227518622501627e-14
in O 0 2.0156997205806985e-14
the O 0 7.45082435419514e-13
presence O 0 6.495824386200388e-13
of O 0 1.1294485485757733e-10
VHL B-Disease 0 1.6805067843961297e-06
, O 0 9.189495518702184e-12
as O 0 3.589114411488986e-13
a O 0 2.358967513514665e-13
result O 0 3.6156657095415268e-12
of O 0 1.9959464636620794e-11
the O 0 5.094764887747516e-12
stabilization O 0 1.9463248790430043e-08
of O 0 1.647392638970402e-10
the O 0 3.937962178568455e-10
protein O 0 6.956794584844772e-10
. O 0 2.842451551909875e-10

We O 0 2.277878996537197e-10
propose O 0 4.9613362029798935e-11
that O 0 7.715563824233114e-15
the O 0 3.8611187814716064e-13
loss O 0 1.527405806001081e-11
of O 0 8.653701887018084e-12
wild O 0 1.8626413345740334e-12
- O 0 3.3719585283698006e-12
type O 0 5.301494920145755e-13
VHL B-Disease 0 2.1960333551618305e-09
gene O 0 6.921363032404496e-14
results O 0 1.9508801854788843e-13
in O 0 6.52144489668785e-14
a O 0 1.132531636288854e-13
specific O 0 2.1601084636280188e-12
cellular O 0 3.4542704807627445e-10
defect O 0 7.900692877704785e-10
in O 0 1.0238608572077368e-11
serum O 0 3.1868165883963684e-09
- O 0 2.677254862248901e-09
dependent O 0 1.530721327469564e-08
growth O 0 4.705456944226194e-12
control O 0 5.545644152227247e-11
, O 0 1.144801704740803e-14
which O 0 8.05637229512121e-16
may O 0 1.4765475626031532e-13
initiate O 0 1.1698708668461677e-10
tumor B-Disease 0 3.5607972126427967e-09
formation O 0 5.439539041418584e-09
. O 0 2.916340058334299e-08

This O 0 3.214352672920029e-10
is O 0 6.029949217896402e-13
corrected O 0 3.138329873753065e-10
by O 0 9.859475364501318e-15
the O 0 3.141930617588107e-13
reintroduction O 0 3.4713704133437773e-10
of O 0 1.8553583149005792e-12
wild O 0 6.474157581565221e-12
- O 0 8.54084095114338e-11
type O 0 4.168145689709135e-11
VHL B-Disease 0 1.1431664006522624e-06
, O 0 1.633206764273254e-11
implicating O 0 6.519026101159398e-07
VHL B-Disease 0 0.007205369416624308
as O 0 6.495010258789069e-12
the O 0 4.066714413136774e-12
first O 0 7.503681703768805e-12
tumor B-Disease 0 1.0371714771750806e-11
suppressor O 0 1.79652657767565e-12
involved O 0 5.567673058703981e-13
in O 0 4.628608152139335e-13
the O 0 1.1014088946437184e-11
regulation O 0 1.6038560757269948e-10
of O 0 1.2136359625603e-11
cell O 0 7.873441482120214e-12
cycle O 0 1.279003153387137e-10
exit O 0 6.540092356566163e-10
, O 0 2.813668453771883e-14
which O 0 4.697737475580074e-15
is O 0 3.3902555123742047e-15
consistent O 0 1.1834888104245156e-11
with O 0 6.919406216889749e-15
its O 0 2.038442114757344e-13
gatekeeper O 0 4.4547607269684875e-10
function O 0 3.0756011886595713e-12
in O 0 7.752597934278238e-13
the O 0 6.871229280003277e-12
kidney O 0 3.060103836993733e-10
. O 0 2.5219003968457443e-11
. O 0 9.008086498951684e-10

Piebaldism B-Disease 1 1.0
with O 0 6.331077020149678e-05
deafness B-Disease 1 1.0
: O 0 7.379799028817136e-12
molecular O 0 3.564202535541461e-12
evidence O 0 2.806691240097442e-13
for O 0 8.001647846915538e-14
an O 0 1.7116624957680404e-13
expanded O 0 5.894411070350714e-10
syndrome O 0 2.537925070100755e-07
. O 0 1.867008547762339e-09

In O 0 2.9455798911115494e-10
a O 0 1.9992306421467987e-11
South O 0 1.3454143354962866e-10
African O 0 2.0623705868083597e-11
girl O 0 2.007171373552552e-10
of O 0 3.5193757630391787e-11
Xhosa O 0 0.0008161989971995354
stock O 0 4.6733285644084965e-12
with O 0 2.7502519440439008e-14
severe O 0 2.7242381683834083e-09
piebaldism B-Disease 0 0.00031004156335256994
and O 0 1.386376791145949e-09
profound O 0 5.860986857442185e-05
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 1.3203514948045836e-09
identified O 0 2.471591995737571e-13
a O 0 3.0923415310888953e-16
novel O 0 1.8922141978315958e-17
missense O 0 6.955510386402741e-13
substitution O 0 4.4609013206443893e-13
at O 0 4.695155722544975e-12
a O 0 3.035428353982683e-13
highly O 0 1.795801181370127e-11
conserved O 0 2.2863580473320155e-10
residue O 0 8.814767249454292e-10
in O 0 2.257819148657192e-12
the O 0 3.474117174495639e-11
intracellular O 0 2.2979669278555548e-09
kinase O 0 1.6461361440622824e-10
domain O 0 5.078005793635043e-10
of O 0 3.2662172966269054e-10
the O 0 8.876894774800803e-09
KIT O 1 0.9998294115066528
proto O 0 0.00011163284943904728
- O 0 7.216839321699808e-07
oncogene O 0 1.1110598308050612e-07
, O 0 4.736522372233987e-12
R796G O 0 7.817461522563462e-08
. O 0 5.797848867672428e-10

Though O 0 1.6061943597378558e-07
auditory B-Disease 0 0.0005373995518311858
anomalies I-Disease 0 3.7293943933036644e-07
have O 0 1.0688300938754836e-11
been O 0 1.0788805612782504e-11
observed O 0 1.4840586442035897e-12
in O 0 7.838868443243996e-13
mice O 0 7.718456949967756e-13
with O 0 5.7194368327778e-14
dominant O 0 4.811082199296379e-09
white O 0 4.752975357041889e-12
spotting O 0 7.891468101206556e-08
( O 0 2.4787030067363602e-12
W O 0 1.667620885825727e-08
) O 0 1.77026606264577e-13
due O 0 1.1938790400733978e-08
to O 0 4.800593256248931e-10
KIT O 1 0.9988841414451599
mutations O 0 3.8893418263796775e-07
, O 0 3.6331315733661995e-10
deafness B-Disease 1 1.0
is O 0 2.0305979120394113e-11
not O 0 1.111538378700816e-12
typical O 0 3.4029341844377115e-11
in O 0 7.172648434396189e-13
human O 0 2.644986313304898e-11
piebaldism B-Disease 0 4.5119128344595083e-07
. O 0 4.111912144111329e-09

Thus O 0 4.032111533547322e-09
, O 0 6.39714138866293e-13
the O 0 1.2455479356243693e-12
occurrence O 0 2.2747974615100475e-09
of O 0 1.7793121642739607e-08
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 6.082731829337717e-08
this O 0 5.979037404069132e-11
patient O 0 8.04360689166117e-10
extends O 0 2.9959474029221667e-13
considerably O 0 5.298785498916714e-13
the O 0 2.9138682162673304e-14
phenotypic O 0 3.564379260495576e-12
range O 0 1.5467012436445882e-12
of O 0 1.5648923129552017e-11
piebaldism B-Disease 0 6.555619602721663e-09
due O 0 2.194438186720049e-09
to O 0 2.674104548905376e-10
KIT O 0 8.024098860914819e-06
gene O 0 4.6153976474005987e-11
mutation O 0 1.2106442584536303e-11
in O 0 9.369343408754949e-13
humans O 0 2.6771754951804283e-11
and O 0 7.821588429018922e-13
tightens O 0 1.3460708242485353e-11
the O 0 4.064037517972907e-13
clinical O 0 1.0621257345855284e-11
similarity O 0 1.8903865018488064e-12
between O 0 1.1784386834412519e-11
piebaldism B-Disease 0 4.015043408855945e-09
and O 0 1.1627726776222702e-13
the O 0 2.2107423042812963e-13
various O 0 5.036501272460969e-13
forms O 0 3.955175076342243e-11
of O 0 3.243305402023111e-09
Waardenburg B-Disease 1 0.9992706179618835
syndrome I-Disease 0 2.934889380412642e-07
. O 0 1.1974012059656758e-10
. O 0 6.304369470910842e-09

Cycloheximide O 0 5.5146806516859215e-06
facilitates O 0 4.676356524235814e-10
the O 0 5.0217989489009796e-12
identification O 0 1.7647080241545154e-08
of O 0 3.436201323481214e-09
aberrant O 0 1.234843560737886e-09
transcripts O 0 8.037487897460949e-10
resulting O 0 6.167135378765121e-12
from O 0 5.552740342182338e-13
a O 0 1.1872135761460678e-13
novel O 0 1.321318813911343e-13
splice O 0 7.04598912548704e-09
- O 0 4.549461848912806e-11
site O 0 1.675582762816763e-11
mutation O 0 4.581782544511859e-13
in O 0 4.934077777428436e-13
COL17A1 O 1 0.9999104738235474
in O 0 6.132091362465175e-11
a O 0 2.46087067390377e-10
patient O 0 1.2995465681342466e-07
with O 0 1.1228972612853383e-10
generalized O 0 2.1089823349029757e-05
atrophic B-Disease 1 0.9999411106109619
benign I-Disease 1 0.9995273351669312
epidermolysis I-Disease 1 0.5497010946273804
bullosa I-Disease 0 0.0016350290970876813
. O 0 1.3910370455505472e-07

Patients O 0 2.648514737302321e-06
with O 0 4.151652355233182e-10
generalized O 0 1.249064825969981e-05
atrophic B-Disease 1 0.9999885559082031
benign I-Disease 1 0.9999358654022217
epidermolysis I-Disease 1 0.998308539390564
bullosa I-Disease 0 0.009868452325463295
often O 0 7.991224001968611e-12
show O 0 8.011522001361016e-12
decreased O 0 3.274293336463785e-11
expression O 0 9.801529162953293e-13
of O 0 5.7803748766682705e-12
type O 0 1.2236493068806809e-11
XVII O 0 1.2374377966750671e-08
collagen O 0 4.2623479745707016e-10
, O 0 4.141785438921408e-12
a O 0 3.513808688460074e-11
transmembrane O 0 2.512243524321889e-09
hemidesmosomal O 0 8.628202152749509e-09
protein O 0 1.9725152500954524e-12
encoded O 0 1.0951318112984235e-13
by O 0 5.236772929358147e-13
COL17A1 O 0 0.0003225739055778831
. O 0 1.6329536833836755e-08

This O 0 4.555088597979484e-11
report O 0 1.9740621897551547e-12
documents O 0 1.0167382560877236e-11
a O 0 4.696022216921225e-13
novel O 0 2.563043906885637e-13
splice O 0 6.717548739487711e-09
- O 0 2.2889794226710336e-11
site O 0 1.092266728452973e-11
mutation O 0 2.575672693790748e-13
in O 0 2.045210788920171e-13
COL17A1 O 1 0.9999977350234985
in O 0 2.667470584694076e-11
a O 0 1.3628427553147304e-10
patient O 0 3.1867330108070746e-08
with O 0 1.4814519402883697e-11
generalized O 0 6.537479180224182e-07
atrophic B-Disease 1 0.9483511447906494
benign I-Disease 0 0.042822178453207016
epidermolysis I-Disease 0 0.0008190481457859278
bullosa I-Disease 0 6.967614172026515e-05
, O 0 1.1593010622659716e-12
and O 0 3.6051260446975236e-14
applies O 0 2.507594555178211e-13
a O 0 4.571008895286506e-14
new O 0 1.618073147799555e-14
methodology O 0 1.8143167523909653e-11
to O 0 2.6021910320972452e-12
define O 0 4.770563388767357e-10
and O 0 2.7405046548051315e-12
characterize O 0 1.9296197972806794e-09
the O 0 1.3294854800394162e-11
resulting O 0 1.3850387503566708e-10
mRNA O 0 2.393215625673406e-09
splice O 0 1.781162772829248e-08
variants O 0 3.6054770280458115e-10
. O 0 8.3853564092351e-09

Mutational O 0 9.557110161040328e-07
analysis O 0 2.201774040866411e-10
of O 0 9.273316003977072e-10
COL17A1 O 1 0.9999786615371704
identified O 0 6.982370792663062e-10
a O 0 1.3232924304940052e-11
maternally O 0 3.2974163399757117e-09
inherited O 0 2.420728728580457e-09
G O 0 3.5558883615394166e-10
- O 0 5.815733311598237e-11
to O 0 3.09276840249062e-11
- O 0 1.4537058223851318e-09
T O 0 8.8926123409383e-11
transversion O 0 2.1143189421479747e-09
at O 0 3.899165875159011e-13
the O 0 2.710031262169888e-14
- O 0 4.0313320173387956e-14
1 O 0 1.5329312594140367e-14
position O 0 2.03893325834148e-12
of O 0 4.169853264762713e-12
exon O 0 2.813266286594285e-10
32 O 0 1.939801208550307e-09
. O 0 4.444866696928784e-09

This O 0 8.607017876194334e-12
acceptor O 0 5.328390173531261e-09
splice O 0 8.116059007079457e-07
- O 0 3.74843311945483e-09
site O 0 2.082960193217076e-10
mutation O 0 3.176374311145147e-12
led O 0 9.694380714853068e-13
to O 0 1.0441737535379914e-12
the O 0 5.336417072121513e-12
formation O 0 1.8025908543606306e-09
of O 0 6.280821196469333e-09
aberrant O 0 2.7922908429900417e-09
transcripts O 0 9.004518020105934e-09
present O 0 2.953309541364746e-10
at O 0 2.5007886872430163e-09
extremely O 0 3.1705680303417694e-09
low O 0 1.3248248720287847e-08
levels O 0 2.52480152340695e-08
. O 0 8.329786638228143e-09

Based O 0 1.3140567627079047e-11
on O 0 2.8364113141554625e-11
our O 0 1.7820505487931015e-11
recent O 0 9.101118974121428e-14
finding O 0 7.245980074635505e-13
that O 0 4.7179591166463496e-15
cycloheximide O 0 1.155607054492691e-09
stabilized O 0 1.4440372453350392e-08
mutant O 0 1.0962766805455715e-10
COL17A1 O 0 3.509638872856158e-07
transcripts O 0 3.209102983348089e-10
in O 0 2.1864550101002855e-12
keratinocytes O 0 3.006608295663682e-08
homozygous O 0 1.909099961450167e-10
for O 0 7.844177781282657e-13
a O 0 2.3186882969206124e-11
frameshift O 0 8.618435742846486e-08
mutation O 0 1.9895838448968917e-11
, O 0 1.6380156237470744e-13
the O 0 1.1917243450745851e-12
effects O 0 8.91934529706484e-12
of O 0 4.467357907211866e-12
the O 0 1.209896332426963e-11
splice O 0 1.7034196275744762e-09
- O 0 8.374667279098524e-12
site O 0 1.5374655758584876e-12
mutation O 0 1.0089437186384335e-14
on O 0 1.5678423999614804e-13
splicing O 0 3.169561141325161e-11
of O 0 8.678036761411434e-11
COL17A1 O 0 4.561658715829253e-05
transcripts O 0 5.62129010006629e-10
were O 0 1.9834662883487508e-13
determined O 0 1.2753495904748585e-13
using O 0 6.7517479034420215e-15
reverse O 0 3.9171378814206737e-13
transcriptase O 0 1.9752212018775417e-13
polymerase O 0 4.2915269862081606e-14
chain O 0 1.1523597797291531e-14
reaction O 0 1.0022492996189275e-15
of O 0 1.9559882684892782e-13
total O 0 4.779976327945468e-12
RNA O 0 4.843718134917019e-11
from O 0 4.504389049253543e-12
keratinocytes O 0 5.2644374193278054e-08
incubated O 0 7.17105874681323e-10
for O 0 9.088946500805661e-13
2 O 0 2.656576070236838e-10
. O 0 1.9537178541639832e-09

5 O 0 5.946196313111329e-10
h O 0 2.2360278559285796e-11
in O 0 4.374670114007384e-13
the O 0 9.527968691802613e-13
presence O 0 4.70751638625283e-14
or O 0 3.5086885653845545e-13
absence O 0 7.706082438829753e-10
of O 0 1.0211056999942514e-10
10 O 0 8.484581093259891e-11
microg O 0 5.544645187427477e-09
cycloheximide O 0 5.02219954512384e-09
per O 0 1.3612386773331764e-08
ml O 0 7.578316285616893e-08
. O 0 7.221793829614853e-09

Using O 0 3.819641825053566e-11
this O 0 6.481356792410742e-13
approach O 0 8.13397960097717e-11
, O 0 5.453250698228551e-13
an O 0 2.0722063388128875e-13
abnormally O 0 2.8244427630053082e-11
spliced O 0 3.364041267772677e-10
transcript O 0 1.2824823425461318e-09
was O 0 1.6842919420279046e-11
identified O 0 1.0459084119618378e-11
that O 0 1.7319694542279281e-15
contains O 0 2.2858626684645587e-16
an O 0 7.948760994337287e-17
extra O 0 2.627009666657937e-13
264 O 0 6.685000469852653e-11
bases O 0 1.9137737228280827e-10
upstream O 0 9.547988788494166e-11
from O 0 1.1093318971755473e-11
exon O 0 8.766145032090833e-10
32 O 0 1.7198769075577047e-09
, O 0 7.136036553334613e-13
resulting O 0 1.1869226088090379e-11
in O 0 3.296820282050472e-12
a O 0 3.7090146925988776e-11
premature O 0 5.586512141775302e-09
termination O 0 1.5907511752288883e-08
codon O 0 3.9742754864846574e-08
27 O 0 3.544698401469759e-08
bp O 0 9.7519134101276e-08
downstream O 0 8.14013816352599e-08
from O 0 2.2348010941808383e-10
the O 0 6.119198481258081e-09
cryptic O 0 1.1523813725489163e-07
splice O 0 9.473985187469225e-07
site O 0 2.2047261794000406e-08
. O 0 1.6620575138404092e-08

Three O 0 5.643032707780549e-10
other O 0 1.9423304110921524e-12
splice O 0 2.0395354294322487e-09
variants O 0 2.8945940696439854e-12
, O 0 1.689994884757507e-14
including O 0 2.1204995496060947e-15
one O 0 2.4840296581284636e-14
derived O 0 2.887060436638361e-13
from O 0 2.8240574483952285e-13
the O 0 2.7213671854181554e-12
skipping O 0 3.0339641909904458e-09
of O 0 8.85214213042218e-09
exon O 0 9.467301609333845e-09
32 O 0 1.4664194303293243e-08
, O 0 1.410433315279791e-11
were O 0 4.3617293110642663e-10
also O 0 3.673501173390159e-12
identified O 0 7.575664540127036e-10
. O 0 8.224517955568444e-09

These O 0 8.550550024966075e-12
results O 0 4.7768408152626396e-12
indicate O 0 4.492419457269303e-12
the O 0 1.2699390150583412e-13
usefulness O 0 5.114720313947885e-10
of O 0 8.018202421467002e-12
cycloheximide O 0 2.800002674163693e-09
treatment O 0 2.1731307725536553e-11
in O 0 3.3850252787424873e-13
evaluating O 0 1.0062777000552359e-11
the O 0 3.6692016612549505e-12
abnormal O 0 1.732303363255472e-11
processing O 0 1.7336272417622922e-09
of O 0 3.3149184786029906e-11
mRNA O 0 2.788723141300409e-10
due O 0 3.4066458542980627e-09
to O 0 1.1699406998744166e-09
splice O 0 8.485756666232191e-07
- O 0 2.807510668390023e-09
site O 0 2.152353989481881e-10
mutations O 0 1.2284995069833382e-11
, O 0 5.426654473548488e-14
because O 0 2.7404928370014514e-13
( O 0 4.711684804792858e-14
i O 0 1.630312204681239e-11
) O 0 2.5709791148234226e-14
aberrant O 0 4.624506940581474e-12
splicing O 0 1.02601177554007e-10
often O 0 1.7497886006887647e-13
generates O 0 6.145793238470504e-14
a O 0 4.7587754320888714e-14
premature O 0 6.968687345926261e-12
termination O 0 5.7382175400189084e-11
codon O 0 3.5619789340302077e-09
, O 0 4.707755019150994e-12
( O 0 2.7059404318478288e-14
ii O 0 1.1149006023947194e-10
) O 0 1.298959963029478e-12
transcripts O 0 5.66384439348866e-10
with O 0 3.822064735016506e-13
premature O 0 4.042073342702679e-10
termination O 0 2.474010718511721e-10
codons O 0 1.153097173300921e-09
can O 0 1.6005976058441895e-11
occur O 0 1.932426441086932e-09
at O 0 1.2076749600353764e-09
low O 0 2.2975943370084906e-09
or O 0 8.580812449476838e-11
undetectable O 0 3.8640199373496387e-10
levels O 0 4.163273024937464e-12
due O 0 1.8963461009824378e-11
to O 0 5.5655632012763245e-12
nonsense O 0 1.131680374411026e-10
- O 0 5.6105944543083375e-12
mediated O 0 1.0134628553037928e-10
mRNA O 0 1.4633137757069647e-10
decay O 0 4.3259537618745014e-10
, O 0 9.560689574555047e-15
and O 0 3.85512476976102e-15
( O 0 1.2823219082988644e-15
iii O 0 1.4602433845434248e-11
) O 0 9.629654658307313e-14
the O 0 1.879091500456287e-12
levels O 0 5.388171853137891e-11
of O 0 1.1799028767911501e-11
these O 0 1.1149313893996093e-12
transcripts O 0 1.6071512176640823e-10
can O 0 9.877613050407463e-13
be O 0 6.848380911840535e-13
increased O 0 4.944744266821566e-12
by O 0 3.64142526895761e-12
cycloheximide O 0 7.163409350141592e-07
. O 0 2.9093286002535024e-08

A O 0 3.4051930697387434e-07
deletion O 0 1.552461803555616e-08
mutation O 0 1.947071844032866e-11
in O 0 4.941953964110457e-12
COL17A1 O 0 0.33605337142944336
in O 0 2.3032773605047296e-12
five O 0 3.9199949709856075e-12
Austrian O 0 1.4177387042124678e-09
families O 0 1.020162947173997e-11
with O 0 4.323672930101052e-12
generalized O 0 4.6078844206931535e-07
atrophic B-Disease 1 0.9928079843521118
benign I-Disease 1 0.9971668124198914
epidermolysis I-Disease 1 0.7770767211914062
bullosa I-Disease 0 6.594452861463651e-05
represents O 0 1.2759762864356095e-11
propagation O 0 1.213250722109649e-09
of O 0 1.7388586404099016e-10
an O 0 2.0332711209158916e-12
ancestral O 0 4.114846241520809e-09
allele O 0 1.2370289237395582e-09
. O 0 2.7799196278266436e-09

Patients O 0 1.432923545507947e-05
with O 0 1.109288660927632e-09
generalized O 0 2.7188776584807783e-05
atrophic B-Disease 1 0.9999978542327881
benign I-Disease 1 0.9999957084655762
epidermolysis I-Disease 1 0.9998503923416138
bullosa I-Disease 1 0.5088921189308167
, O 0 2.1156035256986172e-11
a O 0 3.389963223326964e-12
usually O 0 2.064384470659708e-12
nonlethal O 0 1.709083186085536e-08
form O 0 1.28914896535548e-08
of O 0 2.9329572498681955e-05
junctional B-Disease 1 0.9999319314956665
epidermolysis I-Disease 1 0.979576587677002
bullosa I-Disease 0 0.006146682426333427
, O 0 1.529960741430969e-10
have O 0 4.5792336936245626e-12
generalized O 0 1.235318930481455e-10
blistering B-Disease 0 6.674810704154766e-10
, O 0 3.876336317903961e-12
nail B-Disease 1 0.9999723434448242
dystrophy I-Disease 1 0.9911796450614929
, O 0 3.0193358924179847e-09
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 3.386234936897381e-08
and O 0 4.524676478467882e-05
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.9568140506744385

Skin B-Disease 1 1.0
fragility I-Disease 1 1.0
in O 0 2.0533674760514486e-10
most O 0 8.239931767505329e-14
cases O 0 9.31815016043825e-15
is O 0 1.9457972042898823e-16
due O 0 2.9977207782055926e-12
to O 0 1.1433191633020146e-12
mutations O 0 1.406823605092783e-13
in O 0 2.7794247751868756e-14
the O 0 1.0234420597240654e-13
gene O 0 8.041300508495122e-15
encoding O 0 1.9678451576576883e-11
type O 0 1.405465882564627e-10
XVII O 0 2.6899354566012335e-07
collagen O 0 3.804210280122788e-09
( O 0 1.6241513342563074e-11
COL17A1 O 0 0.2105053961277008
) O 0 9.927822453015267e-12
. O 0 3.777577972652324e-10

Recently O 0 3.1837181779792445e-09
, O 0 3.0016215749918695e-13
we O 0 7.155482261399226e-14
reported O 0 1.3891744200279776e-13
five O 0 7.602065136246006e-14
Austrian O 0 2.0455105664840545e-10
families O 0 5.304865921540447e-12
with O 0 6.402466230792658e-12
generalized O 0 6.654845492448658e-07
atrophic B-Disease 1 0.988658607006073
benign I-Disease 1 0.9960715770721436
epidermolysis I-Disease 1 0.9949623346328735
bullosa I-Disease 1 0.910658597946167
who O 0 7.586491157507425e-11
share O 0 7.670708512819147e-11
the O 0 2.36035600786888e-11
same O 0 1.7319605472021493e-10
COL17A1 O 0 0.005732518155127764
mutation O 0 6.534530694324303e-10
. O 0 8.336522583363148e-10

Affected O 0 9.055636240873355e-09
individuals O 0 1.0244151447263983e-12
in O 0 1.7849536139511596e-13
three O 0 8.63703775383709e-14
families O 0 3.068420558328781e-14
are O 0 1.4250814765038146e-15
homozygous O 0 1.1241575975217549e-13
for O 0 4.3969358319226326e-14
4003delTC O 0 2.5280575410846495e-09
, O 0 6.564177370063651e-13
whereas O 0 4.595834823817313e-11
those O 0 1.2150435822408379e-12
in O 0 9.62976985478814e-13
two O 0 5.404122028346281e-12
others O 0 4.505651927944054e-12
are O 0 4.0672632904865946e-13
compound O 0 6.484791592598071e-10
heterozygotes O 0 1.3061176140638509e-08
. O 0 2.1927489157747004e-08

To O 0 3.3992531012216887e-09
determine O 0 4.736511183267567e-09
if O 0 2.161105712786271e-12
the O 0 1.9728350897363356e-12
occurrence O 0 2.9879498181228925e-11
of O 0 8.529761640931055e-13
4003delTC O 0 1.145859240825331e-10
in O 0 7.999020011899977e-15
these O 0 2.363197994158738e-15
unrelated O 0 3.160231408158576e-13
families O 0 2.8474420714228116e-15
signifies O 0 6.094257043454121e-14
propagation O 0 6.939033375674697e-11
of O 0 1.9798548217542233e-11
an O 0 5.853798890932682e-13
ancestral O 0 1.9157040398454228e-08
allele O 0 5.341710629380714e-09
or O 0 2.839736501503154e-10
a O 0 2.6439901379404773e-09
mutational O 0 3.8784671119174163e-07
hot O 0 6.693273935098887e-09
spot O 0 1.4358555233684456e-08
, O 0 5.779599888955378e-13
haplotypes O 0 1.7365907323263485e-11
were O 0 5.013290997613051e-12
determined O 0 1.5804157982302058e-10
for O 0 3.415705565612548e-11
polymorphisms O 0 1.849355868444036e-08
both O 0 2.7815197367608846e-10
within O 0 8.069812373889818e-09
and O 0 1.219293277454625e-10
flanking O 0 1.4111694781604456e-06
COL17A1 O 1 0.9995181560516357
. O 0 4.4747264382749563e-07

Five O 0 9.038156889573656e-09
intragenic O 0 2.83579364435127e-08
polymorphisms O 0 2.2413920719444036e-10
were O 0 2.7106802046039657e-12
chosen O 0 1.5758750641220454e-12
based O 0 1.0409829939782116e-14
on O 0 4.758853467540236e-12
their O 0 3.016431548985565e-11
informativeness O 0 8.388861942876247e-07
. O 0 1.370377233911313e-08

One O 0 1.6879179165485425e-09
of O 0 7.904848997597469e-11
these O 0 1.080046899896818e-13
, O 0 7.712003744755804e-15
not O 0 1.2676345264000643e-14
previously O 0 8.002720664965213e-13
reported O 0 2.318420520668052e-13
, O 0 2.162034021932946e-15
was O 0 1.0573367268534861e-12
2988 O 0 9.550475965625083e-09
A O 0 8.937869999670056e-09
or O 0 1.9292388866998245e-11
C O 0 1.720521680681486e-07
that O 0 2.0514774774771372e-13
introduces O 0 4.291750602906236e-13
a O 0 1.7579375997424374e-13
new O 0 3.277562479774877e-14
restriction O 0 2.7196016163903713e-13
site O 0 8.615685747302704e-13
for O 0 4.407164737318947e-13
Eco0109 O 0 2.0057237293258368e-07
I O 0 3.0492617497657193e-07
. O 0 8.134501072731837e-09

All O 0 4.176445994596989e-11
the O 0 3.4436229909284855e-12
4003delTC O 0 1.0451316478921058e-09
alleles O 0 4.82011078186545e-13
showed O 0 1.1626180703924738e-12
the O 0 1.2009003580242764e-14
same O 0 4.8867028181126884e-14
haplotype O 0 5.6857673950971854e-12
for O 0 2.4699426531826774e-13
these O 0 3.2752641744571154e-13
five O 0 1.473188238065859e-10
polymorphic O 0 3.332717435355903e-09
markers O 0 2.286838940435132e-09
. O 0 4.949548326749209e-08

Fourteen O 0 1.1237510477712931e-08
microsatellite O 0 1.97096494680693e-09
polymorphisms O 0 3.824708605382199e-11
were O 0 1.434355238749685e-12
selected O 0 9.198504588234235e-13
based O 0 5.050271317677893e-15
on O 0 2.6418288130020118e-12
their O 0 7.996255567410682e-12
high O 0 5.027772295718158e-11
heterozygosity O 0 3.626765376907315e-08
and O 0 5.497877001749141e-13
their O 0 2.926605485731315e-11
location O 0 1.6156656013066595e-09
within O 0 2.353210959427088e-09
10q23 O 0 7.766349767734937e-07
- O 0 3.492439404340075e-08
q25 O 0 4.036168945731333e-07
near O 0 4.631401395727153e-08
COL17A1 O 0 0.0014389860443770885
. O 0 7.186208961229568e-08

Three O 0 1.4074134913055758e-10
families O 0 1.6498938716982825e-12
shared O 0 1.4887147070652418e-11
microsatellite O 0 1.920297698632112e-09
polymorphisms O 0 8.341087265328895e-10
covering O 0 4.588770696756228e-09
at O 0 1.335128230195437e-09
most O 0 2.363895971330132e-12
19 O 0 2.571774182502651e-10
cM O 0 2.622529082785263e-09
, O 0 2.846206885627478e-13
whereas O 0 1.9453270591607286e-11
the O 0 2.2477098307605026e-11
others O 0 1.0769212778483084e-11
shared O 0 1.7284229603120593e-10
smaller O 0 2.826408595016372e-12
regions O 0 3.637442430592941e-11
consistent O 0 2.8812873961725494e-11
with O 0 5.256725095362583e-14
cross O 0 2.0582688331494126e-10
- O 0 2.2320885140203472e-09
over O 0 4.5134963475024215e-12
events O 0 4.4293786845804595e-13
during O 0 4.7300878491807197e-11
passage O 0 1.4361429797118963e-12
of O 0 9.431807412993085e-14
this O 0 1.2573283377176423e-14
mutation O 0 2.9924281504329145e-14
through O 0 4.6892262344161786e-14
several O 0 2.385868466767832e-13
generations O 0 6.735019209003212e-10
. O 0 4.856600455127591e-09

These O 0 6.3033497692266405e-12
results O 0 7.735586476931289e-12
indicate O 0 8.091037388691102e-12
that O 0 3.0617424658693337e-15
4003delTC O 0 2.358808981473004e-10
occurs O 0 5.416582574179277e-14
on O 0 7.244539305473544e-14
a O 0 2.5514582241144106e-14
single O 0 1.4681124154911074e-12
ancestral O 0 4.744230563957785e-10
allele O 0 1.282202954921985e-10
. O 0 4.2496662439051036e-11
. O 0 4.632821681838095e-09

The O 0 2.9794731126742136e-09
haptoglobin O 0 5.352697485250246e-07
- O 0 2.464385362443977e-09
gene O 0 5.436883040131624e-13
deletion O 0 2.4667812931200572e-11
responsible O 0 1.0127627902978276e-11
for O 0 1.393214536793419e-11
anhaptoglobinemia B-Disease 0 1.8607739548315294e-05
. O 0 1.1465227878204587e-08

We O 0 6.325890367087084e-10
have O 0 1.9256708586653376e-13
found O 0 2.0190395714917223e-14
an O 0 2.7289193980914775e-16
allelic O 0 1.1093743111645349e-11
deletion O 0 9.696406177983619e-11
of O 0 3.0328115019351287e-10
the O 0 2.4132098541684854e-09
haptoglobin O 0 4.237735538481502e-06
( O 0 9.949749357751614e-13
Hp O 0 8.388036099038487e-11
) O 0 4.0732703126232506e-14
gene O 0 2.9167704899578026e-14
from O 0 8.359996180561102e-13
an O 0 6.543794115111039e-15
individual O 0 6.045954481417176e-14
with O 0 3.1840292121637637e-12
anhaptoglobinemia B-Disease 0 3.0130925097182626e-06
. O 0 3.949165616745631e-08

The O 0 2.6751569848215695e-09
Hp O 0 7.100801058257389e-10
gene O 0 2.4690571310583e-13
cluster O 0 7.285420639165097e-13
consists O 0 8.324143783121352e-14
of O 0 2.4849562511863876e-12
coding O 0 1.2395949511301296e-07
regions O 0 3.159713601874614e-09
of O 0 2.964926526516365e-09
the O 0 3.6418870696941497e-10
alpha O 0 5.65503069718809e-12
chain O 0 2.4611943274968455e-14
and O 0 2.2644182823993624e-15
beta O 0 1.1669947777223633e-12
chain O 0 7.383973125866042e-14
of O 0 2.7678507814703213e-13
the O 0 6.083064824427553e-13
haptoglobin O 0 8.489084435403527e-10
gene O 0 8.465783954934858e-14
( O 0 2.6929540615137047e-15
Hp O 0 4.708769398703572e-12
) O 0 4.029039268557168e-15
and O 0 3.044042272480445e-14
of O 0 1.297014665807561e-11
the O 0 1.2261257113788115e-11
alpha O 0 6.369880209237955e-13
chain O 0 7.806482646725496e-15
and O 0 4.5329611917353796e-15
beta O 0 1.337591170637309e-12
chain O 0 6.336129673234839e-14
of O 0 2.557213338652553e-13
the O 0 1.487748726297644e-12
haptoglobin O 0 5.326429075580563e-09
- O 0 5.538952976835709e-11
related O 0 7.077864683235902e-11
gene O 0 1.773794598616124e-13
( O 0 1.8087302692377204e-14
Hpr O 0 3.6398546399141196e-09
) O 0 3.069767001901737e-14
, O 0 1.3225334422170467e-14
in O 0 6.772904584178771e-14
tandem O 0 4.65967986418292e-10
from O 0 1.7489364123601803e-11
the O 0 7.939603141604579e-11
5 O 0 1.2014670369708824e-09
side O 0 1.0445936338143724e-09
. O 0 9.737541439847064e-09

Southern O 0 9.663717719377019e-07
blot O 0 3.7387314932857407e-07
and O 0 4.1023408628437785e-12
PCR O 0 1.5856007617998102e-09
analyses O 0 5.4400938614973526e-11
have O 0 4.43537664346458e-15
indicated O 0 6.886126461798717e-14
that O 0 1.0107219815931326e-17
the O 0 8.98914456427455e-16
individual O 0 1.5247248442320344e-15
with O 0 5.403412905915367e-15
anhaptoglobinemia B-Disease 0 1.3885176342043337e-09
was O 0 2.5251445032181685e-11
homozygous O 0 6.359237355452185e-12
for O 0 5.793172067275823e-14
the O 0 3.1630130372523046e-12
gene O 0 5.413920180219467e-13
deletion O 0 9.736821592054579e-12
and O 0 1.1937341204773261e-14
that O 0 1.1338791725343115e-15
the O 0 9.744150473479929e-14
gene O 0 1.0720502143077206e-14
deletion O 0 1.6845930032871603e-12
was O 0 6.019136469630204e-13
included O 0 2.1933373357558433e-13
at O 0 4.039926379539871e-12
least O 0 9.784657621896703e-14
from O 0 1.5017922615125773e-13
the O 0 1.7263520257423948e-12
promoter O 0 7.717529726392058e-09
region O 0 2.979679258885426e-08
of O 0 1.0261223870600134e-08
Hp O 0 4.656484087206536e-09
to O 0 2.1528641092061207e-09
Hpr O 0 1.3342079796530015e-07
alpha O 0 7.622385361782946e-12
but O 0 2.1019461399294365e-13
not O 0 1.2066687709796908e-13
to O 0 4.865115948993193e-11
Hpr O 0 5.429248872701464e-08
beta O 0 1.0767473024309027e-10
( O 0 1.5924876434897373e-12
Hpdel O 0 3.074646031109296e-07
) O 0 7.612840045856384e-12
. O 0 1.6983910944290415e-09

In O 0 3.178001473091996e-10
addition O 0 3.664894776544969e-11
, O 0 3.587526597407381e-13
we O 0 2.4220171224512144e-13
found O 0 2.7125342445290246e-14
seven O 0 7.536462773294339e-14
individuals O 0 1.9995546796829685e-15
with O 0 1.3966810970570884e-15
hypohaptoglobinemia B-Disease 0 6.722390422098101e-10
in O 0 3.925559692845998e-13
three O 0 2.233345669858111e-12
families O 0 6.398471162627484e-13
, O 0 2.0083007183798428e-14
and O 0 1.5858054276739024e-14
the O 0 6.170924014836654e-12
genotypes O 0 1.8102604970593461e-09
of O 0 3.956490135514912e-10
six O 0 8.272735274594822e-10
of O 0 1.4674532422542796e-10
the O 0 1.559508078230465e-11
seven O 0 8.068075721401335e-12
individuals O 0 8.040998287139542e-14
were O 0 1.4723109884040575e-11
found O 0 1.866250860446672e-12
to O 0 3.9479544633458374e-11
be O 0 1.463694165870777e-09
Hp2 O 0 0.0010451414855197072
/ O 0 0.0003353418142069131
Hpdel O 0 0.0005237659788690507
. O 0 8.555380048846928e-08

The O 0 2.368025420196318e-08
phenotypes O 0 8.056181832749587e-10
and O 0 2.06628724547242e-12
genotypes O 0 1.3620865546570826e-10
in O 0 2.911758291077038e-13
one O 0 1.101731282159707e-13
of O 0 4.619486284923764e-14
these O 0 1.4439825932053207e-15
three O 0 1.6797530705790764e-14
families O 0 7.878732016027446e-15
showed O 0 1.405571080533019e-13
the O 0 4.2858501713956623e-14
father O 0 5.1094592966316466e-12
to O 0 4.4274067051430777e-11
be O 0 6.717801870337325e-10
hypohaptoglobinemic B-Disease 0 0.0001456202007830143
( O 0 5.904737115924874e-11
Hp2 O 0 1.722904016787652e-05
) O 0 2.8559368411840147e-12
and O 0 2.0291034477648573e-11
Hp2 O 0 3.305273276055232e-05
/ O 0 1.6938813018896326e-07
Hpdel O 0 2.2128735963633517e-06
, O 0 5.572726999368387e-14
the O 0 7.070786556089004e-13
mother O 0 3.840157358769858e-13
to O 0 2.685725556880736e-12
be O 0 4.013232801636235e-11
Hp2 O 0 7.94935185695067e-05
- O 0 4.078100079851765e-09
1 O 0 1.147549902325018e-10
and O 0 1.6766185662042687e-11
Hp1 O 0 5.493379831023049e-06
/ O 0 1.152833739581638e-08
Hp2 O 0 1.3864560344245547e-07
, O 0 1.6763154720659396e-14
one O 0 5.958010692745435e-15
of O 0 1.2965137589828618e-13
the O 0 1.968263605486159e-13
two O 0 9.69308184065043e-14
children O 0 1.4706724743183616e-14
to O 0 6.941475389279916e-13
be O 0 3.040745433224856e-11
hypohaptoglobinemic B-Disease 0 7.712184924457688e-06
( O 0 2.4750854143995582e-11
Hp2 O 0 2.986501931445673e-05
) O 0 3.762581392285913e-12
and O 0 4.14362849587846e-11
Hp2 O 0 0.00020005961414426565
/ O 0 8.516141178915859e-07
Hpdel O 0 4.597947554429993e-05
, O 0 2.914080652130502e-13
and O 0 1.1526412487775257e-14
the O 0 1.1896167644714906e-12
other O 0 7.891188651956357e-14
child O 0 3.798346186190127e-12
to O 0 5.017786967181914e-12
be O 0 1.2110791536290577e-10
Hp1 O 0 2.8563474188558757e-05
and O 0 4.4548459365856274e-10
Hp1 O 0 0.004142618738114834
/ O 0 1.7279855455853976e-05
Hpdel O 0 7.233190262923017e-05
, O 0 1.3323407047766134e-12
showing O 0 1.2933246140711674e-10
an O 0 3.09215164324278e-13
anomalous O 0 1.5856129742530811e-09
inheritance O 0 3.2956643281067954e-07
of O 0 2.1651178485626588e-06
Hp O 0 1.2377947200548078e-07
phenotypes O 0 4.180680246435031e-10
in O 0 4.405771754367738e-12
the O 0 7.8545269246999e-12
child O 0 3.58076242268357e-11
with O 0 9.825394621174044e-13
Hp1 O 0 2.943706704172655e-06
. O 0 1.5354466142980527e-08

The O 0 3.254423930343364e-08
Hp2 O 0 0.00012142882769694552
/ O 0 2.4016679844862665e-07
Hpdel O 0 9.993400453822687e-07
individuals O 0 3.907534018576797e-13
had O 0 9.3192311506618e-12
an O 0 5.5382259921740035e-14
extremely O 0 1.63503325462111e-11
low O 0 7.930616718887507e-10
level O 0 1.676040000120338e-07
of O 0 8.743005430744688e-09
Hp O 0 9.424664521029413e-11
( O 0 1.2087135593363395e-14
mean O 0 4.2100971688920075e-13
+ O 0 3.1630717467999447e-13
/ O 0 1.115074439034247e-11
- O 0 1.0485750288891094e-11
SD O 0 7.643620181241317e-10
= O 0 9.385297443723073e-13
0 O 0 9.794436786679343e-15
. O 0 4.5842956235037265e-15
049 O 0 7.565780467400085e-12
+ O 0 6.81291720087962e-13
/ O 0 3.3469324534074474e-11
- O 0 6.156252157357711e-12
0 O 0 1.1587824070517089e-14
. O 0 3.80486793330817e-14
043 O 0 1.208483174641728e-10
mg O 0 2.3575876494097425e-12
/ O 0 8.825795129452363e-12
ml O 0 8.036897536367604e-12
; O 0 3.923609077612425e-15
n O 0 8.725824424994644e-14
= O 0 1.859458903042191e-14
6 O 0 7.392330291736832e-14
) O 0 1.1057506244892048e-16
, O 0 8.859842205549324e-17
compared O 0 1.9802973009238473e-14
with O 0 9.86078699502014e-16
the O 0 2.236453210124889e-12
level O 0 6.5611862609671334e-09
( O 0 2.8257895799503868e-15
1 O 0 3.131447263494437e-14
. O 0 5.141615350709797e-15
64 O 0 1.156897711310223e-12
+ O 0 1.757821210639221e-12
/ O 0 1.15178200310595e-10
- O 0 7.834477858126299e-12
1 O 0 6.77042447170921e-14
. O 0 5.360343652239738e-14
07 O 0 7.576828053856843e-12
mg O 0 3.5852982908923803e-12
/ O 0 2.539604377488347e-12
ml O 0 8.900289901782321e-13
) O 0 6.830599418111786e-17
obtained O 0 1.2231184218659125e-13
from O 0 2.0199110667504933e-13
52 O 0 6.481289116511135e-11
healthy O 0 3.503068668475606e-11
volunteers O 0 3.0873502539219277e-12
having O 0 7.2289353322818606e-12
phenotype O 0 5.976620587322401e-11
Hp2 O 0 1.7037039867773274e-07
, O 0 1.0970390177875156e-12
whereas O 0 1.667962122586797e-11
the O 0 3.133346013206584e-11
serum O 0 4.10468325995339e-11
Hp O 0 4.7831343052973097e-11
level O 0 9.44648026468542e-10
of O 0 1.3656523828453615e-11
an O 0 9.0693342321823e-15
individual O 0 2.371557404666838e-14
with O 0 2.849824597226519e-13
Hp1 O 0 2.652200009833905e-06
/ O 0 3.4313768537685974e-07
Hpdel O 0 1.1207883972019772e-06
was O 0 3.4375238766592986e-10
0 O 0 3.967105116631231e-11
. O 0 2.887263206297064e-10

50 O 0 2.6969317445946217e-08
mg O 0 2.7984756734156235e-09
/ O 0 3.647311341836712e-09
ml O 0 2.175883029309489e-09
, O 0 5.969388801622608e-14
which O 0 9.021400637697179e-16
was O 0 2.4364592374898075e-13
approximately O 0 1.429416752064122e-13
half O 0 2.7249082439236016e-13
the O 0 5.141874881604835e-13
level O 0 1.1030040880655179e-08
of O 0 8.229284476080068e-10
Hp O 0 2.64507860059382e-10
in O 0 3.693554143091582e-11
control O 0 5.499106947581822e-08
sera O 0 2.7221813692079877e-09
from O 0 3.1637854228799833e-12
the O 0 1.4480673604655436e-11
Hp1 O 0 1.09492361843877e-06
phenotype O 0 1.2417347705628856e-10
( O 0 1.0540535593872927e-14
1 O 0 2.597795839120315e-13
. O 0 4.5122176936703007e-14
26 O 0 1.2415536264007154e-12
+ O 0 1.292583444792439e-12
/ O 0 2.727526711432393e-11
- O 0 2.92359105674711e-12
0 O 0 2.8239144607634025e-15
. O 0 5.20359232794392e-15
33 O 0 1.5823265007292031e-12
mg O 0 9.212656679191689e-13
/ O 0 5.047794213869361e-12
ml O 0 4.264995041164399e-12
; O 0 2.6738632094320137e-15
n O 0 8.273050078116614e-14
= O 0 3.9232519685218625e-14
9 O 0 7.386189099581331e-13
) O 0 2.6054847806990158e-15
, O 0 1.0045535468728144e-15
showing O 0 1.7256533116523365e-13
a O 0 8.71681307863803e-13
gene O 0 1.4695888820095981e-12
- O 0 7.397305684664346e-11
dosage O 0 6.464563329089401e-10
effect O 0 1.2154961932797637e-11
. O 0 4.4722306413724766e-10

The O 0 3.57587737198628e-10
other O 0 5.694827205290909e-13
allele O 0 2.2190416171241623e-11
( O 0 7.35065627073192e-14
Hp2 O 0 3.194029716269142e-07
) O 0 5.282435255817182e-14
of O 0 3.918216012060993e-12
individuals O 0 2.887941621954049e-13
with O 0 8.143647214908789e-12
Hp2 O 1 0.9999828338623047
/ O 1 0.9258874654769897
Hpdel O 0 0.013541127555072308
was O 0 1.2138774707626254e-10
found O 0 4.0965215703132885e-13
to O 0 6.388484034315633e-13
have O 0 1.2141718565891052e-13
, O 0 8.240038154843504e-15
in O 0 9.641269174080064e-14
all O 0 1.0519057413310717e-12
exons O 0 5.180531559290102e-10
, O 0 8.38021939710866e-14
no O 0 3.639810349821693e-14
mutation O 0 5.998786858826257e-15
, O 0 1.0709701281859632e-16
by O 0 1.1798711557460886e-15
DNA O 0 1.4361607736379511e-10
sequencing O 0 1.708215346951647e-09
. O 0 5.947220049762336e-09

On O 0 9.815219748077197e-10
the O 0 1.2959160654302249e-12
basis O 0 3.890322092248155e-11
of O 0 1.8946892665905324e-12
the O 0 3.837536300017874e-13
present O 0 4.393015085816382e-13
study O 0 2.2873565698857193e-14
, O 0 5.090597073989012e-16
the O 0 1.8851743151010632e-14
mechanism O 0 2.152714118075494e-11
of O 0 3.011522281548551e-11
anhaptoglobinemia B-Disease 0 8.054100675281006e-08
and O 0 3.16331466229669e-12
the O 0 1.2379890168556784e-10
mechanism O 0 1.1943391164948025e-08
of O 0 3.111294832880418e-10
anomalous O 0 1.4002977444249609e-08
inheritance O 0 3.693799399684394e-08
of O 0 6.666813590072707e-08
Hp O 0 7.609584962153804e-09
phenotypes O 0 1.7426736442782698e-10
were O 0 8.072651574986267e-11
well O 0 8.856231720200114e-12
explained O 0 2.489384809400974e-10
. O 0 1.2662916271111158e-09

However O 0 6.283529696560208e-09
, O 0 1.141175370346359e-12
the O 0 2.7726711985393004e-12
mechanism O 0 8.746937618653305e-10
of O 0 1.2122530756997207e-10
hypohaptoglobinemia B-Disease 0 1.1280801118118688e-05
remains O 0 3.2586228826403385e-08
unknown O 0 7.310727596632205e-06

ATM O 0 0.0013739941641688347
mutations O 0 6.083228143438646e-09
and O 0 2.1783888928816886e-11
phenotypes O 0 6.732347457294452e-10
in O 0 2.164929346903932e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 5.411989967285535e-09
in O 0 6.19098630867676e-13
the O 0 2.605109595925359e-13
British O 0 1.3542386613149549e-12
Isles O 0 4.674528542025769e-10
: O 0 6.69713217191513e-16
expression O 0 1.7604197450910714e-14
of O 0 4.562301057775553e-13
mutant O 0 1.4243661588739243e-12
ATM O 0 1.4344566423574179e-08
and O 0 2.612075323833035e-13
the O 0 1.3708144862289995e-11
risk O 0 5.343406273006224e-11
of O 0 2.2831682378043894e-10
leukemia B-Disease 1 0.999998927116394
, O 0 7.900365694979428e-09
lymphoma B-Disease 1 1.0
, O 0 6.138536718935939e-07
and O 0 1.9504429360495124e-07
breast B-Disease 1 0.9993036985397339
cancer I-Disease 1 0.9993032217025757
. O 1 0.9988359808921814

We O 0 2.2395117704743228e-10
report O 0 6.405651291514769e-13
the O 0 5.47320266094508e-14
spectrum O 0 2.8891678979792168e-11
of O 0 5.4178484615308165e-12
59 O 0 1.656682568906831e-09
ATM O 0 1.957182121259393e-06
mutations O 0 4.3890748674391133e-11
observed O 0 9.841342150929133e-12
in O 0 5.59469859329198e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.8415474301036738e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.566891993898001e-14
patients O 0 3.4351946336325448e-15
in O 0 1.8339138134271438e-16
the O 0 8.775791576179533e-15
British O 0 1.1363973130562588e-11
Isles O 0 4.762022598470139e-08
. O 0 2.285783784472528e-09

Of O 0 6.043908911124163e-07
51 O 0 8.841497219691519e-06
ATM O 1 0.9882379174232483
mutations O 0 1.5215888549136025e-09
identified O 0 1.0480415840730117e-10
in O 0 1.7089167537662209e-12
families O 0 4.662689071649462e-12
native O 0 1.654329884887007e-13
to O 0 3.618002436273776e-13
the O 0 2.8055366189938535e-12
British O 0 1.6612730635578998e-10
Isles O 0 1.3410711119377083e-07
, O 0 4.629959068046252e-13
11 O 0 1.5894325786081076e-11
were O 0 7.815795233234724e-11
founder O 0 2.1471792399641032e-10
mutations O 0 3.781308599570821e-12
, O 0 7.657233408540215e-14
and O 0 4.925481002877527e-14
2 O 0 9.906522650815486e-12
of O 0 5.490379331729578e-11
these O 0 2.8851834116272457e-13
11 O 0 3.8062218307710616e-12
conferred O 0 5.846990114299899e-10
a O 0 8.889894029251444e-12
milder O 0 2.1790442714109126e-12
clinical O 0 6.280880221302965e-13
phenotype O 0 6.896381794622986e-13
with O 0 3.4550524740479746e-15
respect O 0 5.081100904608116e-12
to O 0 2.0649694454366596e-10
both O 0 7.146208624853045e-10
cerebellar B-Disease 1 0.9998612403869629
degeneration I-Disease 1 0.9999998807907104
and O 0 8.812346963260609e-10
cellular O 0 6.68816957372087e-09
features O 0 6.82252102035541e-11
. O 0 1.6576277017676944e-09

We O 0 1.7790772188774895e-09
report O 0 5.992437882712531e-12
, O 0 9.991343359553998e-16
in O 0 1.0720087096933052e-15
two O 0 6.196204573732933e-14
A B-Disease 1 1.0
- I-Disease 1 0.6640854477882385
T I-Disease 1 1.0
families O 0 3.0551203927808857e-12
, O 0 2.427513417601994e-15
an O 0 1.2660150417565614e-15
ATM O 0 2.9451432403959643e-09
mutation O 0 7.686077794187562e-13
( O 0 4.322546687989329e-14
7271T O 0 5.09753554922554e-08
- O 0 3.1949234369221813e-09
- O 0 9.466827322057725e-10
> O 0 3.988920860287237e-10
G O 0 6.55906509661186e-11
) O 0 1.6440422462261298e-15
that O 0 4.8029213255209536e-17
may O 0 1.0614248212591259e-15
be O 0 1.1384690323172457e-15
associated O 0 1.5076843582189497e-13
with O 0 1.9730726181035364e-15
an O 0 5.43583012735621e-15
increased O 0 6.562553018368833e-12
risk O 0 7.173982935482215e-11
of O 0 3.882098642549181e-09
breast B-Disease 0 1.9606255818871432e-07
cancer I-Disease 0 8.765012715628018e-09
in O 0 1.082214318159913e-09
both O 0 2.506933827195468e-10
homozygotes O 0 1.5869511926780433e-08
and O 0 4.208991662146833e-12
heterozygotes O 0 3.7372588357342806e-10
( O 0 4.3910380431548546e-13
relative O 0 4.780117968117281e-10
risk O 0 5.3615965833753165e-12
12 O 0 1.6101317328043319e-12
. O 0 2.7824178508092934e-13
7 O 0 4.814030684502368e-12
; O 0 9.893464763795559e-14
P O 0 4.566608480249812e-10
= O 0 3.098782081628615e-13
. O 0 6.732449612991548e-14
0025 O 0 4.775014827984592e-10
) O 0 8.453935996881844e-15
, O 0 1.859628224928347e-15
although O 0 8.71597241537854e-15
there O 0 7.192327008758662e-15
is O 0 6.289310160009418e-16
a O 0 2.828810861769948e-14
less O 0 1.1315777958750828e-12
severe O 0 1.2941698379620448e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 8.048441912933413e-10
in O 0 8.566931208485104e-14
terms O 0 6.531443680173055e-13
of O 0 5.6590383014408843e-14
the O 0 3.9577499263976357e-14
degree O 0 3.1644523112994705e-10
of O 0 5.158867777410592e-10
cerebellar B-Disease 0 1.2229871572344564e-05
degeneration I-Disease 0 0.00019420056196395308
. O 0 1.8669493329070974e-07

This O 0 2.265364805464909e-11
mutation O 0 2.0254356189203931e-13
( O 0 2.1275081119699136e-15
7271T O 0 3.1565616787077033e-10
- O 0 2.4412531024475825e-11
- O 0 8.210525141716385e-12
> O 0 5.001924655717582e-12
G O 0 4.440987508291805e-12
) O 0 6.221799119484188e-17
also O 0 7.153216400619718e-18
allows O 0 1.2180895437152762e-17
expression O 0 4.4248799994239677e-16
of O 0 1.3773487558821351e-14
full O 0 5.944961862201781e-13
- O 0 2.20518332869242e-13
length O 0 4.4194739014236095e-12
ATM O 0 2.0364466024602734e-07
protein O 0 1.0045753118248513e-10
at O 0 2.9183887945150033e-11
a O 0 4.030736681925884e-12
level O 0 2.2644758290724099e-10
comparable O 0 3.528194056356959e-11
with O 0 7.188432351267187e-15
that O 0 5.567178679453987e-15
in O 0 3.2681940920903374e-13
unaffected O 0 4.73078465290655e-10
individuals O 0 1.7553853336182978e-12
. O 0 1.8332209084093165e-09

In O 0 2.506135299285006e-10
addition O 0 4.148782446061761e-12
, O 0 7.535600154940855e-14
we O 0 8.34473007187142e-14
have O 0 8.9945973388725e-16
studied O 0 6.797364185190044e-14
18 O 0 3.9869108015011534e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 9.59414325762964e-10
, O 0 2.662576580113145e-14
in O 0 9.071721171027662e-15
15 O 0 2.025516798558058e-13
families O 0 4.7495261711180334e-14
, O 0 1.074346859440906e-14
who O 0 1.335031396413125e-13
developed O 0 5.66421187730981e-10
leukemia B-Disease 1 0.999972939491272
, O 0 3.805995518746386e-09
lymphoma B-Disease 1 1.0
, O 0 1.5305811729149355e-08
preleukemic O 1 0.9998251795768738
T O 0 1.59551727847429e-05
- O 0 3.4623610645212466e-08
cell O 0 2.3928596881717112e-09
proliferation O 0 7.91821321399766e-07
, O 0 2.053204828378341e-12
or O 0 9.054043070833018e-10
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 3.377143287242035e-10
mostly O 0 2.5695881511987595e-13
in O 0 1.0232375927468618e-12
childhood O 0 9.734144157391711e-09
. O 0 3.635961753900574e-09

A O 0 1.6804394817881985e-06
wide O 0 9.944148837703892e-10
variety O 0 6.283135903922821e-12
of O 0 1.7419060638346195e-10
ATM O 0 1.1150675163662527e-05
mutation O 0 1.5278457318745886e-11
types O 0 3.884551534605318e-12
, O 0 1.8674284666363172e-13
including O 0 4.23125347693426e-13
missense O 0 2.1677649897355877e-08
mutations O 0 7.021310616250886e-11
and O 0 5.744872459689798e-12
in O 0 8.759660219403997e-10
- O 0 1.0818309803539705e-08
frame O 0 8.250190752789877e-09
deletions O 0 2.651463215652683e-10
, O 0 4.508613060259965e-14
were O 0 1.0044286366181487e-12
seen O 0 1.1299042214016342e-12
in O 0 6.768100890928302e-14
these O 0 6.677054742443289e-13
patients O 0 2.0421258434266676e-11
. O 0 1.1957425050113102e-09

We O 0 6.479488057209437e-10
also O 0 5.2604561060886484e-14
show O 0 4.543367838525346e-14
that O 0 2.8292491933792183e-17
25 O 0 1.630994127190151e-14
% O 0 2.577500929704102e-13
of O 0 4.6861237221369756e-14
all O 0 1.378948279347203e-12
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.359173412180837e-10
carried O 0 1.6225196533548036e-11
in O 0 1.8746320468165933e-11
- O 0 4.168036749074844e-10
frame O 0 3.206143572853648e-09
deletions O 0 1.2263328130757145e-09
or O 0 8.29211092151505e-12
missense O 0 2.4667037301639994e-09
mutations O 0 7.554388538333345e-12
, O 0 3.8901529702617746e-14
many O 0 1.1275005485733656e-14
of O 0 1.2266538696251161e-12
which O 0 9.115881233732765e-15
were O 0 1.3793743708009898e-12
also O 0 2.357453628468696e-15
associated O 0 8.552156921005916e-14
with O 0 4.6522081841157345e-15
expression O 0 1.2092728077575665e-12
of O 0 6.299075150373312e-11
mutant O 0 4.309565204696497e-10
ATM O 0 1.9936303488066187e-06
protein O 0 1.4933011271978103e-08
. O 0 1.0344308520870982e-08

The O 0 3.3346503336417754e-09
DMPK O 1 0.9957571625709534
gene O 0 1.8862536532715524e-10
of O 0 6.401789098831046e-10
severely O 0 0.0031283472198992968
affected O 0 1.6190340375032974e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 2.0045488824393942e-08
is O 0 2.1271775573622476e-13
hypermethylated O 0 2.516463704083094e-09
proximal O 0 1.4690868965772097e-06
to O 0 6.483827363901185e-10
the O 0 1.0328018440475262e-09
largely O 0 1.3607655002800811e-09
expanded O 0 3.1907620989812813e-10
CTG O 0 8.148384722517221e-07
repeat O 0 5.347429166135953e-09
. O 0 1.7884477898633122e-08

Using O 0 8.756953495669961e-10
methylation O 0 1.0567325148258533e-07
- O 0 9.953247115390695e-08
sensitive O 0 3.457218511471183e-09
restriction O 0 2.219620320875748e-12
enzymes O 0 8.937250624892895e-14
, O 0 1.4442579847922968e-15
we O 0 5.6056437161382255e-15
characterized O 0 5.220930668857742e-15
the O 0 9.438677019601906e-15
methylation O 0 4.825926550738879e-12
pattern O 0 5.934813838287534e-12
on O 0 4.323796529148716e-12
the O 0 8.431400109337739e-13
5 O 0 4.3302418942237075e-12
side O 0 8.644364737908639e-12
of O 0 8.404690832186645e-11
the O 0 5.239798595013667e-10
CTG O 0 7.131930601644854e-07
repeat O 0 3.6672859193842555e-11
in O 0 7.82491584548628e-13
the O 0 6.650988353812393e-12
DMPK O 0 1.0427654160594102e-05
gene O 0 9.13413116844508e-13
of O 0 4.554600186584823e-12
normal O 0 1.2114786951400447e-10
individuals O 0 2.4122464957606823e-14
and O 0 3.7698614168508657e-14
of O 0 1.374332288597846e-12
patients O 0 2.9677380886973526e-13
affected O 0 8.888872168703876e-13
with O 0 8.032510203856424e-13
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 9.591425743915583e-12
showing O 0 2.0244026940896553e-11
expansions O 0 4.5710354945605047e-10
of O 0 4.034868966718008e-11
the O 0 2.4520234800928797e-11
repetitive O 0 2.640387020136359e-09
sequence O 0 1.8466363160829502e-10
. O 0 4.254649965673707e-09

The O 0 6.48125553226464e-10
gene O 0 3.690397813727042e-12
segment O 0 2.5929336455732255e-10
analyzed O 0 1.2108722228024171e-12
corresponds O 0 1.2110963273914699e-12
to O 0 2.6298117871727256e-13
the O 0 1.5363983956601102e-12
genomic O 0 9.547994617165045e-10
SacI O 0 1.0282368378966567e-07
- O 0 1.9357491998217569e-10
HindIII O 0 2.124400433345386e-09
fragment O 0 1.0055027123423432e-11
carrying O 0 1.2125115148031718e-11
exons O 0 1.0006765416292751e-09
11 O 0 2.106034652227251e-10
- O 0 4.957801391647365e-10
15 O 0 4.172658052414846e-10
. O 0 1.3589344094455669e-09

There O 0 1.5998169455855304e-10
is O 0 1.557817731149408e-13
constitutive O 0 8.550070096369211e-10
methylation O 0 7.850999850234075e-10
in O 0 9.575752413226724e-10
intron O 0 1.4383914503923734e-07
12 O 0 1.743988065072699e-09
at O 0 4.37884867254823e-11
restriction O 0 4.1877365832866664e-13
sites O 0 4.2541729687595176e-12
of O 0 6.539187594190032e-12
SacII O 0 1.826606705890299e-07
and O 0 1.826818418759757e-10
HhaI O 0 6.537087756441906e-05
, O 0 1.707972652198464e-11
localized O 0 1.7203058422232687e-10
1 O 0 1.094287247621617e-11
, O 0 1.1644461436755016e-13
159 O 0 3.3912472829911167e-10
- O 0 2.0021855007268385e-10
1 O 0 7.416204803045723e-12
, O 0 2.668653601052562e-13
232 O 0 4.573143599917451e-11
bp O 0 5.722612939074168e-10
upstream O 0 1.1065350857819567e-09
of O 0 5.664535507321489e-10
the O 0 4.306855760916051e-09
CTG O 0 1.532093301648274e-05
repeat O 0 1.289003925819543e-08
, O 0 7.553423164718964e-12
whereas O 0 2.3805718507574625e-10
most O 0 1.7274422994470462e-12
, O 0 6.757033897252657e-14
if O 0 3.007304759492131e-14
not O 0 1.5295937801952653e-13
all O 0 2.1063218443723164e-12
, O 0 2.313932194724505e-13
of O 0 2.9907875221529823e-12
the O 0 1.4187806745419307e-12
other O 0 1.0034707168937035e-13
sites O 0 6.575611583015117e-11
of O 0 9.884426610540231e-11
SacII O 0 3.741299678949872e-07
, O 0 3.214320476452315e-11
HhaI O 0 2.4999037577799754e-06
, O 0 9.083370340612351e-12
and O 0 1.5708852621476588e-11
HpaII O 0 1.5895213437033817e-05
in O 0 1.6546977330000878e-11
this O 0 5.389689996387892e-12
region O 0 1.1432423896451382e-09
are O 0 4.2319153823605626e-13
unmethylated O 0 3.131504655584649e-08
, O 0 1.2632784900622196e-13
in O 0 2.7381574655219176e-13
normal O 0 2.2614933536946324e-10
individuals O 0 1.0654664135559613e-13
and O 0 2.1082823529507133e-13
most O 0 2.9441824412473894e-13
of O 0 1.3967665565828291e-11
the O 0 6.459975609995894e-11
patients O 0 3.880673213330077e-11
. O 0 1.7898530435545013e-09

In O 0 2.3771690171869864e-10
a O 0 3.142411461251604e-12
number O 0 5.330676763719289e-13
of O 0 9.754926900973349e-12
young O 0 2.5958469748732504e-11
and O 0 3.583835485321263e-12
severely O 0 1.4257612690471433e-07
affected O 0 1.7740002522526055e-10
patients O 0 2.645847733614981e-12
, O 0 1.2070686213527717e-14
however O 0 3.992583715896336e-13
, O 0 6.113463261423228e-15
complete O 0 2.143692862111024e-10
methylation O 0 4.3311715325344835e-10
of O 0 7.47779685394967e-11
these O 0 4.281170958107122e-13
restriction O 0 1.092757828669022e-12
sites O 0 7.317762715230991e-12
was O 0 2.763990859105947e-12
found O 0 2.928321918716642e-13
in O 0 6.889568803696358e-14
the O 0 1.4661171582330823e-12
mutated O 0 2.3844650212656582e-11
allele O 0 6.723198109348516e-10
. O 0 5.187237306358838e-09

In O 0 6.29213736669243e-10
most O 0 6.158201986544709e-12
of O 0 1.3900293242830042e-11
these O 0 2.839623881086689e-13
patients O 0 3.7004893507081027e-13
, O 0 1.1418964452591918e-15
the O 0 9.993675029499553e-15
onset O 0 7.482333502784044e-11
of O 0 1.3462402199959644e-11
the O 0 3.2673699856822225e-10
disease O 0 2.2140102373668924e-07
was O 0 1.1426961066263175e-07
congenital O 1 0.9999998807907104
. O 0 9.878598211798817e-05

Preliminary O 0 5.1227577735346586e-09
in O 0 6.972031285634728e-10
vivo O 0 1.7360669346544455e-08
footprinting O 0 6.465778028541536e-07
data O 0 4.9765573606475044e-11
gave O 0 1.729492064969293e-13
evidence O 0 6.646200652543968e-14
for O 0 4.0282884585527215e-14
protein O 0 1.21838541859709e-12
- O 0 6.587769609336935e-13
DNA O 0 1.6640637479081732e-10
contact O 0 1.1268470878622594e-10
in O 0 1.0317291725819855e-12
normal O 0 5.7580233914222845e-09
genes O 0 1.2496860100560947e-12
at O 0 2.8254976483510497e-12
an O 0 1.5547565879593488e-14
Sp1 O 0 8.104927146090901e-11
consensus O 0 9.734524297755343e-11
binding O 0 1.1021317539161579e-11
site O 0 2.562788592452847e-10
upstream O 0 6.073277436513536e-10
of O 0 3.2837246810579757e-11
the O 0 2.626016348816762e-10
CTG O 0 3.939802809327375e-06
repeat O 0 4.13213907535237e-10
and O 0 2.0484433376974365e-13
for O 0 2.1070962357740142e-13
a O 0 1.2128618693141996e-13
significant O 0 1.507152421528074e-13
reduction O 0 1.4020040683959678e-10
of O 0 1.941635047186807e-11
this O 0 2.0924978600973115e-13
interaction O 0 3.3786879544139836e-11
in O 0 5.855496209433708e-13
cells O 0 2.7714130903383483e-12
with O 0 2.7630180858117387e-14
a O 0 1.9727221158699626e-12
hypermethylated O 0 1.3186735259296256e-08
DMPK O 0 3.0287678782769945e-06
gene O 0 2.3883510186922807e-12
. O 0 1.6127666910281668e-11
. O 0 7.468678453470545e-10

The O 0 2.729617598618006e-08
hemochromatosis B-Disease 1 1.0
gene O 0 4.154230345138066e-12
product O 0 1.8462328020552032e-12
complexes O 0 1.3534038798522496e-13
with O 0 4.4299974019143637e-16
the O 0 3.757344099481613e-13
transferrin O 0 3.4377316965317206e-11
receptor O 0 5.6225013658544806e-14
and O 0 2.2523510021053156e-13
lowers O 0 1.2058267524674843e-13
its O 0 7.049421962645021e-15
affinity O 0 3.5842006039553745e-14
for O 0 1.6630142087633443e-13
ligand O 0 2.3832101223031366e-11
binding O 0 2.678790800292319e-10
. O 0 1.2222423073637856e-08

We O 0 2.727834902405135e-10
recently O 0 2.5625710321081074e-12
reported O 0 2.2362046567768468e-13
the O 0 2.944910957344664e-14
positional O 0 1.4072677918808285e-11
cloning O 0 2.718192641457118e-12
of O 0 7.982932349014094e-13
a O 0 5.18677169356746e-13
candidate O 0 1.6098632149574854e-10
gene O 0 4.2558713497786727e-11
for O 0 3.0041835685779006e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 4.11027722293511e-05
HFE O 0 0.26170870661735535
. O 0 6.190833623520575e-09

The O 0 8.528033834664939e-10
gene O 0 6.442422008194615e-13
product O 0 3.78757398708518e-12
, O 0 1.2115247769849818e-14
a O 0 2.100523531153864e-13
member O 0 7.287703426839265e-12
of O 0 4.540671658115336e-11
the O 0 9.468610617791029e-11
major O 0 6.09681194418954e-11
histocompatibility O 0 3.496161971039413e-10
complex O 0 3.540078299946181e-11
class O 0 4.265643556693871e-13
I O 0 2.7190212303906947e-09
- O 0 7.495489645625852e-11
like O 0 3.9289884144538476e-14
family O 0 6.567893473009845e-14
, O 0 1.85182006346232e-15
was O 0 3.491837895219785e-13
found O 0 3.229272792638731e-14
to O 0 1.988200999235995e-13
have O 0 3.6480604507279496e-14
a O 0 8.700451925754138e-13
mutation O 0 5.52474515788659e-13
, O 0 2.6491035385288464e-13
Cys O 0 9.277641055405184e-08
- O 0 3.047859742366654e-10
282 O 0 9.006582502024685e-08
- O 0 2.0056290850334335e-06
- O 0 2.056670638239666e-07
> O 0 1.7379056416189087e-08
Tyr O 0 1.647853054009829e-08
( O 0 4.760298058514856e-15
C282Y O 0 2.1399018668155634e-10
) O 0 4.3223588372574514e-17
, O 0 1.3793393051457509e-17
in O 0 2.469900957985849e-16
85 O 0 1.5670189104644017e-11
% O 0 7.514628502791609e-11
of O 0 2.8571041366109995e-11
patient O 0 2.6883433257296474e-09
chromosomes O 0 1.0390976079577285e-08
. O 0 1.2571624097290623e-07

This O 0 8.960038266891956e-10
mutation O 0 1.1259806455277133e-11
eliminates O 0 2.4607286694400266e-11
the O 0 5.16350634124918e-13
ability O 0 3.3723333153767854e-11
of O 0 3.007723792247674e-10
HFE O 0 2.4237175239250064e-05
to O 0 1.298753049550072e-10
associate O 0 3.7505030331397293e-11
with O 0 7.477724595940632e-15
beta2 O 0 1.240207581076902e-07
- O 0 1.0672081884877116e-08
microglobulin O 0 7.059011863930209e-07
( O 0 6.327676284421241e-14
beta2m O 0 3.610297838463339e-08
) O 0 4.1026633723325115e-15
and O 0 8.498265466176397e-15
prevents O 0 4.577904353340878e-13
cell O 0 1.733289956007411e-09
- O 0 5.839110861494134e-10
surface O 0 4.984085588688458e-09
expression O 0 2.6018871501776175e-09
. O 0 2.07705785904011e-09

A O 0 1.4588319174890785e-07
second O 0 2.433408363700096e-09
mutation O 0 1.7107046682007798e-11
that O 0 1.622207854428282e-14
has O 0 3.627070889591693e-15
no O 0 6.144676425529549e-15
effect O 0 3.2915562687448182e-15
on O 0 2.3915418256859056e-12
beta2m O 0 1.1866142735073026e-08
association O 0 6.402780866263114e-13
, O 0 1.1484552458335129e-12
H63D O 0 8.143829472828656e-05
, O 0 6.885433521085227e-13
was O 0 4.396772876336108e-12
found O 0 1.3040134564604872e-13
in O 0 1.4195642003469316e-14
eight O 0 1.971232638925402e-12
out O 0 7.703568821260456e-14
of O 0 1.216541624382561e-12
nine O 0 2.4596774270135846e-11
patients O 0 2.1797166393881795e-13
heterozygous O 0 7.619949728707512e-14
for O 0 9.702718365084753e-14
the O 0 9.689399282919453e-11
C282Y O 0 1.9367971049177868e-07
mutant O 0 2.4204931392546314e-09
. O 0 7.933102175172735e-09

In O 0 4.186241631121135e-10
this O 0 7.293624254903208e-13
report O 0 4.45941298211211e-13
, O 0 3.98536667331321e-15
we O 0 7.032286486122067e-15
demonstrate O 0 4.815674768676725e-12
in O 0 1.997983159127137e-12
cultured O 0 9.74820335564175e-10
293 O 0 1.0349468504422532e-10
cells O 0 6.780708633469246e-11
overexpressing O 0 2.665479614805122e-09
wild O 0 2.5309645004800707e-11
- O 0 5.7748018172931737e-11
type O 0 4.9913649602384424e-12
or O 0 3.388385926006432e-12
mutant O 0 3.542543342005544e-11
HFE O 0 1.0809362294139646e-07
proteins O 0 2.3953893881455135e-13
that O 0 1.7833253794573116e-15
both O 0 1.0681273506191018e-14
the O 0 5.60423560856671e-14
wild O 0 7.102655865797586e-14
- O 0 1.400422339941157e-13
type O 0 6.605595248305313e-14
and O 0 8.783047260405713e-14
H63D O 0 1.3045266314293258e-05
HFE O 0 6.959189136068744e-07
proteins O 0 7.922985184594111e-13
form O 0 3.177378336566977e-13
stable O 0 9.127945066467191e-10
complexes O 0 2.3136275339140366e-13
with O 0 5.414139307642922e-16
the O 0 2.9008601618897567e-13
transferrin O 0 4.711404530399754e-11
receptor O 0 1.0185249318213005e-13
( O 0 3.65417467335441e-14
TfR O 0 1.95787364098976e-09
) O 0 3.0523229343354386e-13
. O 0 2.627785211650746e-10

The O 0 1.183811182414729e-08
C282Y O 0 6.0711513469868805e-06
mutation O 0 6.993911005892528e-11
nearly O 0 7.905961475762613e-12
completely O 0 1.912747217558408e-11
prevents O 0 1.047584328311979e-13
the O 0 1.8272060568150922e-13
association O 0 2.544149515625732e-14
of O 0 4.1880721438590507e-13
the O 0 4.3032176671835287e-13
mutant O 0 8.751134365769797e-12
HFE O 0 2.702900872009195e-07
protein O 0 1.1657229001538205e-11
with O 0 3.424650767505123e-14
the O 0 2.6799699612278793e-11
TfR O 0 6.489177621915587e-07
. O 0 1.807762384231637e-09

Studies O 0 1.0157741314742452e-09
on O 0 9.212279550308011e-11
cell O 0 1.1903897312315337e-10
- O 0 1.3693092666688944e-11
associated O 0 4.0932118805514506e-12
transferrin O 0 1.266446281178446e-09
at O 0 3.335919041003166e-11
37 O 0 2.3895916495542124e-11
degrees O 0 1.0873864308980075e-10
C O 0 1.092771984012586e-09
suggest O 0 4.851655644073916e-13
that O 0 5.817238052076507e-16
the O 0 5.270100219938179e-13
overexpressed O 0 3.9430952947228093e-10
wild O 0 5.367521097726646e-12
- O 0 1.900988914893542e-11
type O 0 4.8371907174216133e-11
HFE O 0 1.0281440836479305e-06
protein O 0 1.8212648403292953e-11
decreases O 0 5.985763642558928e-13
the O 0 5.015217706188721e-14
affinity O 0 5.962200134643214e-13
of O 0 1.2825005814287582e-11
the O 0 2.379458262369294e-11
TfR O 0 1.2525903869686772e-08
for O 0 1.6847408884634874e-12
transferrin O 0 3.881136301231436e-09
. O 0 6.037074395948139e-09

The O 0 3.7154714505049924e-07
overexpressed O 0 1.2470176443457603e-05
H63D O 1 0.9999377727508545
protein O 0 1.2358237766463276e-09
does O 0 2.419545548073762e-14
not O 0 8.554272978714746e-15
have O 0 1.1262490997454447e-15
this O 0 4.857499959651733e-16
effect O 0 1.9796845572898035e-15
, O 0 2.141406096219564e-16
providing O 0 1.522859698858004e-14
the O 0 7.222212872236636e-15
first O 0 1.359891068026045e-13
direct O 0 1.1314115876820408e-12
evidence O 0 1.735464094480832e-12
for O 0 4.273754473146235e-13
a O 0 7.734465845565808e-12
functional O 0 3.980860796559682e-08
consequence O 0 9.040786175251725e-11
of O 0 6.589799539380436e-11
the O 0 5.964017613102612e-10
H63D O 0 0.0005396323977038264
mutation O 0 2.3026482942611892e-09
. O 0 4.989288093781852e-09

Addition O 0 5.345492049002587e-09
of O 0 5.728362495460715e-08
soluble O 0 5.083589993404303e-09
wild O 0 4.681851434318318e-11
- O 0 5.189709217923166e-10
type O 0 1.6283364934199795e-10
HFE O 0 0.00028873689007014036
/ O 0 2.9081691081955796e-06
beta2m O 0 1.1620649047472398e-06
heterodimers O 0 2.5522530755495154e-09
to O 0 3.2170072161719077e-11
cultured O 0 2.0256048227640377e-10
cells O 0 1.986765136088864e-12
also O 0 1.1511553624056286e-15
decreased O 0 7.395813291215941e-14
the O 0 3.035539766343818e-16
apparent O 0 5.697986570421532e-14
affinity O 0 1.4005291338551468e-13
of O 0 7.663626677700819e-12
the O 0 3.1363635646930454e-12
TfR O 0 6.061184887329318e-10
for O 0 1.4539657658733073e-14
its O 0 3.1218322536969746e-15
ligand O 0 6.134094019403027e-14
under O 0 5.737678561434922e-12
steady O 0 2.8432500798203364e-09
- O 0 1.271869935759451e-11
state O 0 3.2250271246939133e-13
conditions O 0 1.5092078628486938e-11
, O 0 5.085359234001429e-15
both O 0 3.1195228183662858e-15
in O 0 2.5922708126119645e-14
293 O 0 1.8835948425999227e-12
cells O 0 4.898790791421637e-13
and O 0 2.8584147310391217e-13
in O 0 4.0400287282249536e-11
HeLa O 0 4.849318102628786e-08
cells O 0 1.1783725106795373e-09
. O 0 8.262395212454976e-09

Furthermore O 0 1.7880317670915247e-08
, O 0 2.0584003251888916e-12
at O 0 4.916540698868266e-12
4 O 0 1.533938991452044e-12
degrees O 0 1.3272870302838413e-10
C O 0 3.852842933582679e-09
, O 0 3.0713848348309924e-13
the O 0 2.9319337756239516e-12
added O 0 8.904968429312987e-11
soluble O 0 7.63963683980684e-11
complex O 0 7.640420414400939e-12
of O 0 7.61278540206689e-11
HFE O 0 1.892347540888295e-06
/ O 0 1.1755085793652142e-08
beta2m O 0 6.6206475857200076e-09
inhibited O 0 2.2542873817643638e-11
binding O 0 1.4300146353521392e-12
of O 0 7.474516838801293e-11
transferrin O 0 1.1300395064139934e-09
to O 0 1.825997242299593e-09
HeLa O 0 2.935421150596085e-07
cell O 0 3.0479891943713255e-09
TfR O 0 7.48428252705935e-09
in O 0 9.97338604931397e-13
a O 0 5.2980003197034e-12
concentration O 0 2.471248095048395e-09
- O 0 1.6265184754615802e-09
dependent O 0 1.8926116229778245e-09
manner O 0 9.69226920943811e-10
. O 0 2.5886504051442216e-09

Scatchard O 0 2.9472092137439176e-05
plots O 0 3.5113622232074704e-08
of O 0 1.0059366534198588e-10
these O 0 1.9992907069471544e-12
data O 0 2.6825526175389136e-11
indicate O 0 2.9847697664148187e-12
that O 0 3.987313155026e-15
the O 0 6.435572127289069e-12
added O 0 9.909684184350454e-11
heterodimer O 0 2.2722465575775175e-10
substantially O 0 2.6896844126933495e-11
reduced O 0 8.313093269318728e-12
the O 0 3.160624973547188e-12
affinity O 0 9.249710719583248e-11
of O 0 5.266571068140991e-10
TfR O 0 7.188128137158856e-08
for O 0 5.588745091711367e-11
transferrin O 0 4.2285368095917875e-08
. O 0 2.7585084438896956e-08

These O 0 1.562243910624428e-11
results O 0 2.8061910434251658e-11
establish O 0 1.9905109505113927e-10
a O 0 8.49480587868795e-13
molecular O 0 1.7255586065925699e-12
link O 0 1.1605006018655661e-11
between O 0 3.351090585579364e-11
HFE O 0 0.0005166564951650798
and O 0 2.6372787634287853e-11
a O 0 1.2118046843756503e-10
key O 0 2.6016701681896848e-08
protein O 0 3.354044819658952e-11
involved O 0 1.7875447649862153e-11
in O 0 1.7865358498125872e-11
iron O 0 8.063442358263728e-09
transport O 0 9.267167477844396e-09
, O 0 4.3400463886796026e-13
the O 0 6.096471851652074e-12
TfR O 0 4.176388301857514e-08
, O 0 4.124508690855379e-14
and O 0 3.6016898014371024e-14
raise O 0 2.363290769677451e-13
the O 0 2.1053327809404665e-13
possibility O 0 1.3835850867782717e-12
that O 0 2.4520853351820728e-14
alterations O 0 2.1361206206660377e-11
in O 0 3.6564425532487066e-13
this O 0 2.7979254655328967e-13
regulatory O 0 1.0714473752670983e-10
mechanism O 0 3.1093491670297624e-10
may O 0 1.1243168939259474e-12
play O 0 3.7197570024183335e-10
a O 0 4.5949497678998696e-11
role O 0 2.2469897470456246e-11
in O 0 7.503781450368674e-12
the O 0 7.696090292830249e-11
pathogenesis O 0 3.532263917804812e-06
of O 0 3.309053681732621e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 2.000157337533892e-07
. O 0 2.1991559684408912e-09

Genomic O 0 2.6539856534668615e-08
organization O 0 1.628578001622305e-11
of O 0 6.348648690090997e-11
the O 0 1.1207917233191367e-10
UBE3A O 0 2.0938558009220287e-05
/ O 0 6.791941586925532e-08
E6 O 0 1.0569139163862928e-07
- O 0 5.286702631224216e-09
AP O 0 6.944915185158607e-07
gene O 0 5.021075447238753e-14
and O 0 3.479495092048655e-15
related O 0 1.3425785656828726e-11
pseudogenes O 0 1.0147903628521249e-09
. O 0 1.0519068255332442e-10

The O 0 1.6519149381721832e-09
UBE3A O 0 1.0908879630733281e-06
gene O 0 6.841408949770367e-13
encodes O 0 1.3447093915805453e-13
the O 0 3.091149298334317e-13
E6 O 0 4.349867133157659e-09
- O 0 4.150229493404822e-09
AP O 0 6.552372155965713e-07
ubiquitin O 0 1.6931480661952492e-09
- O 0 1.393050397258122e-10
protein O 0 1.8737293075617167e-13
ligase O 0 8.43605987474981e-14
and O 0 1.3809577938637962e-14
has O 0 4.348110227040758e-16
recently O 0 1.3158699187242918e-15
been O 0 9.652667823506207e-16
shown O 0 7.107450072279045e-15
to O 0 4.7787498242378434e-14
be O 0 4.4141979568118606e-13
mutated O 0 2.413263755496331e-10
in O 0 1.2599795651269119e-09
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.3000135129791488e-10
who O 0 6.599906168455738e-13
lack O 0 2.7896609466893096e-09
15q11 O 0 1.285727989852603e-06
- O 0 1.9757761648975247e-08
q13 O 0 1.7769778537513048e-07
deletions O 0 4.152048427297217e-10
or O 0 1.5195101036799552e-12
chromosome O 0 1.3339364335340775e-10
15 O 0 4.819014631785024e-10
paternal O 0 4.460410707451956e-08
uniparental B-Disease 0 3.9201950130518526e-05
disomy I-Disease 0 1.4346805983223021e-05
. O 0 1.9283520202861837e-07

Previous O 0 1.3765545148203273e-08
UBE3A O 0 5.20856588082097e-07
cDNA O 0 1.1431993129917828e-08
analysis O 0 1.5464955704924677e-11
has O 0 7.268171080009641e-16
shown O 0 6.4439886464525385e-15
a O 0 2.591450037686075e-14
coding O 0 2.2227164553356715e-09
region O 0 2.4839871826110027e-10
of O 0 3.101564491347908e-11
approximately O 0 2.0238003980987962e-11
2 O 0 5.781792267178787e-10
. O 0 2.7742730335234e-09

6 O 0 3.102918100239549e-08
kb O 0 3.8031423628126504e-06
and O 0 1.0223739389803033e-11
a O 0 1.729655481341741e-11
3 O 0 5.393089308469712e-10
- O 0 2.93435107323603e-08
untranslated O 0 0.008872776292264462
region O 0 1.0731827870813504e-08
( O 0 3.6552434256459376e-13
UTR O 0 1.0144636917175376e-06
) O 0 2.9860096058091645e-13
of O 0 8.199980972012355e-11
< O 0 3.256210634461354e-09
50 O 0 8.012110419564067e-10
bp O 0 3.5734432080047895e-10
, O 0 5.905700191030649e-13
whereas O 0 3.7383117434952595e-11
Northern O 0 8.887864055839856e-11
analysis O 0 3.547707700529701e-12
has O 0 1.2901184230618666e-15
indicated O 0 3.971257188113003e-13
mRNA O 0 1.8107211910423082e-11
sizes O 0 1.40805188689197e-11
of O 0 2.500978035779866e-10
5 O 0 3.25831051029013e-09
- O 0 1.7376370564647914e-08
8 O 0 3.684959004601751e-09
kb O 0 1.4576543208022485e-06
. O 0 1.163143892313201e-08

We O 0 2.013268884937247e-09
have O 0 2.2731968217504228e-13
analyzed O 0 9.392819638395777e-13
additional O 0 1.4212581307161687e-13
cDNA O 0 1.4266304804166907e-09
clones O 0 5.3325531490511224e-11
and O 0 9.766422696608212e-14
provide O 0 2.0493433339208167e-12
evidence O 0 7.280642018089867e-13
for O 0 1.3505726214040753e-13
an O 0 5.954037854112929e-14
additional O 0 5.845010239702297e-12
0 O 0 7.042408323165716e-11
. O 0 2.5585844554143478e-09

5 O 0 2.203884186258165e-09
kb O 0 7.474420158359862e-07
of O 0 9.83482184579998e-10
5 O 0 1.8422362524361802e-09
- O 0 1.2969078255764543e-08
UTR O 0 1.5175615999396541e-06
and O 0 1.764294786654741e-11
> O 0 1.3570015944264213e-10
2 O 0 1.0863494132040685e-11
kb O 0 1.6572174743600954e-08
of O 0 1.8140271229594163e-10
3 O 0 7.483254904627756e-09
- O 0 9.871891393231635e-08
UTR O 0 3.2637151889503e-05
. O 0 1.8039399307667736e-08

We O 0 4.212143966952908e-10
have O 0 1.377953740694382e-13
established O 0 1.523101577586422e-13
the O 0 1.0001721842498468e-14
genomic O 0 1.819875196720777e-12
organization O 0 2.809078382230712e-14
of O 0 2.598818079138643e-12
UBE3A O 0 1.7528805074107368e-07
and O 0 1.0095101973328982e-13
the O 0 5.706972980128178e-13
sequence O 0 5.056177698747888e-12
of O 0 5.063343633260331e-10
intron O 0 1.6141362380039936e-07
- O 0 3.476231142940378e-07
exon O 0 2.9308161231256236e-08
borders O 0 6.9939716240696725e-09
. O 0 6.124933804585453e-08

We O 0 1.7128024554224908e-09
have O 0 1.7185364459618158e-12
also O 0 3.087971772817305e-14
mapped O 0 6.082769704596203e-11
two O 0 4.245100636030702e-13
highly O 0 9.008111097330573e-12
homologous O 0 1.6048162798654175e-11
processed O 0 1.9080287697037512e-11
pseudogenes O 0 8.401293549731292e-11
, O 0 1.426246680437046e-13
UBE3AP1 O 0 2.82908422377659e-06
and O 0 7.451141266490158e-12
UBE3AP2 O 1 0.9999803304672241
, O 0 1.4790400891875888e-12
to O 0 1.5349407508913337e-11
chromosomes O 0 4.779942067156817e-11
2 O 0 2.4724278614024486e-12
and O 0 1.0506459119591707e-13
21 O 0 1.3631280999792939e-11
, O 0 4.937991340695294e-14
respectively O 0 3.416292249092123e-11
, O 0 5.898875002829582e-14
and O 0 1.6366782264859957e-14
determined O 0 6.940645107256227e-12
their O 0 3.4433473867362396e-12
genomic O 0 1.0405939998570091e-10
organization O 0 1.703524994678407e-11
. O 0 1.433187013510917e-09

These O 0 2.5301486600293188e-11
results O 0 1.0150409159026541e-11
will O 0 2.2019637903412242e-13
form O 0 1.3639511341114602e-13
the O 0 4.527347057360978e-14
basis O 0 1.2950957580665223e-12
for O 0 1.6769031011730972e-15
studies O 0 4.676338119903936e-14
of O 0 1.4111692229253764e-13
mutation O 0 1.209087016162784e-14
and O 0 7.534593879799517e-14
imprinting O 0 2.666355669589393e-08
of O 0 1.607201660647206e-08
UBE3A O 0 0.00010714399832068011
. O 0 2.206939910820438e-07

Mutation O 0 4.673389675247108e-09
spectrum O 0 2.1130046601314234e-09
and O 0 7.707398087808404e-12
genotype O 0 4.236860817741217e-08
- O 0 2.1567450048110004e-08
phenotype O 0 6.037991773233387e-10
analyses O 0 5.420435281178193e-11
in O 0 3.242657227800483e-12
Cowden B-Disease 0 1.2406468385961489e-06
disease I-Disease 0 2.9548080648922337e-10
and O 0 4.17515371234356e-12
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.978406142192027e-12
two O 0 3.786571750596934e-11
hamartoma B-Disease 0 5.310049527906813e-05
syndromes I-Disease 0 7.322048389823976e-08
with O 0 2.78763845340535e-10
germline O 0 7.38385715521872e-05
PTEN O 0 0.00010224475408904254
mutation O 0 7.664690215847259e-09
. O 0 7.474895369341539e-09

The O 0 2.057452547887806e-06
tumour B-Disease 1 1.0
suppressor O 0 1.3815792954119388e-06
gene O 0 8.839799031656881e-11
PTEN O 0 4.0172363213741846e-08
, O 0 4.3114085435461136e-13
which O 0 2.6579982823299406e-15
maps O 0 1.4439240818633903e-12
to O 0 7.161733012184257e-11
10q23 O 0 1.036188223224599e-06
. O 0 9.551422763820483e-09

3 O 0 5.1473166007287574e-11
and O 0 1.961884295428526e-13
encodes O 0 2.5419861934784446e-14
a O 0 1.6385263676736098e-15
403 O 0 2.875002617702335e-14
amino O 0 7.140553475110459e-14
acid O 0 1.492192023969715e-14
dual O 0 4.5106328394606265e-11
specificity O 0 1.2782330749416815e-09
phosphatase O 0 7.77838948806675e-08
( O 0 1.2870150778443445e-10
protein O 0 1.4511662982386042e-08
tyrosine O 0 4.676592979535599e-08
phosphatase O 0 8.930934214390618e-09
; O 0 4.236235656967374e-13
PTPase O 0 9.551536805929572e-08
) O 0 9.472654899248065e-15
, O 0 2.035797948946559e-15
was O 0 5.905202000132392e-14
shown O 0 3.1910677442473223e-13
recently O 0 1.934347457601196e-13
to O 0 1.5983332279229101e-12
play O 0 3.693556294148692e-10
a O 0 1.1500631696970132e-10
broad O 0 6.631484250618769e-11
role O 0 3.773327830747242e-11
in O 0 3.047381444409858e-11
human O 0 2.632220885701031e-09
malignancy B-Disease 0 2.6703550247475505e-05
. O 0 1.6286611170812648e-08

Somatic O 0 0.00020394823513925076
PTEN O 0 3.726917930180207e-05
deletions O 0 5.64113378231923e-08
and O 0 2.8688610514970847e-11
mutations O 0 7.216141573174184e-11
were O 0 5.649424070913733e-12
observed O 0 2.597666819061789e-13
in O 0 1.5076067022383455e-13
sporadic B-Disease 0 6.186749335057584e-09
breast I-Disease 0 4.240100270891389e-09
, I-Disease 0 6.863896950815018e-11
brain I-Disease 1 0.9999994039535522
, I-Disease 0 1.37591849025398e-09
prostate I-Disease 1 1.0
and I-Disease 1 0.9171920418739319
kidney I-Disease 1 1.0
cancer I-Disease 0 0.012172428891062737
cell O 0 6.558047402904776e-07
lines O 0 8.863385025925652e-11
and O 0 1.8346015353588874e-14
in O 0 1.783565293069292e-13
several O 0 1.183296299486769e-12
primary O 0 1.800647311256398e-07
tumours B-Disease 1 1.0
such O 0 3.674470103187666e-11
as O 0 1.1421313672599354e-08
endometrial B-Disease 1 0.6776055097579956
carcinomas I-Disease 1 1.0
, O 1 0.9999642372131348
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9930546879768372

In O 0 1.5987922097338014e-10
addition O 0 1.20274519510577e-11
, O 0 1.0414209642220507e-12
PTEN O 0 4.941077946796213e-08
was O 0 4.331648581490377e-11
identified O 0 9.31997708175647e-12
as O 0 2.043494259711901e-14
the O 0 2.5637868564243327e-13
susceptibility O 0 3.774742020692945e-13
gene O 0 1.9529937020888732e-14
for O 0 3.1086919605356755e-13
two O 0 5.250183066074499e-10
hamartoma B-Disease 1 0.9996933937072754
syndromes I-Disease 0 0.0029349890537559986
Cowden B-Disease 0 0.007348202168941498
disease I-Disease 0 1.0873776545849978e-07
( O 0 2.3606236323331364e-13
CD B-Disease 0 0.06748062372207642
; O 0 3.772600634666112e-11
MIM O 0 5.643974532176799e-07
158350 O 0 3.7075615910708848e-09
) O 0 2.0391256025831424e-14
and O 0 6.319537449762935e-13
Bannayan B-Disease 0 0.0005083597498014569
- I-Disease 0 3.188842129020486e-06
Zonana I-Disease 0 7.322369492612779e-05
( I-Disease 0 2.4076339880108044e-12
BZS I-Disease 0 3.1580225368088577e-07
) I-Disease 0 1.2557801308966509e-14
or I-Disease 0 5.0451711628958854e-14
Ruvalcaba I-Disease 0 1.5955942123113687e-09
- I-Disease 0 2.5162033567838193e-10
Riley I-Disease 0 5.629975703413947e-07
- I-Disease 1 1.0
Smith I-Disease 1 0.9999947547912598
syndrome I-Disease 1 1.0
( O 0 4.074478601734377e-12
MIM O 0 0.0003628902486525476
153480 O 0 1.0916105708247414e-07
) O 0 1.5604564081866945e-12
. O 0 3.677381454902928e-10

Constitutive O 0 1.149974906411444e-07
DNA O 0 9.069741402356613e-09
from O 0 8.220396585656431e-12
37 O 0 9.619571805785654e-11
CD B-Disease 0 9.021364100192386e-09
families O 0 3.0544197813370255e-13
and O 0 1.1447712115547019e-14
seven O 0 9.580784950113941e-12
BZS B-Disease 0 2.847132236638572e-07
families O 0 7.499342943514953e-13
was O 0 4.967536364891556e-12
screened O 0 3.15344313162047e-11
for O 0 2.0842876036208935e-10
germline O 0 1.0765803381218575e-05
PTEN O 0 9.680805305833928e-06
mutations O 0 2.1926068072275484e-08
. O 0 2.186642866774946e-08

PTEN O 0 1.013764449453447e-05
mutations O 0 8.148705599175798e-10
were O 0 1.6747938105798887e-11
identified O 0 3.072745616977679e-12
in O 0 5.065149281989825e-14
30 O 0 2.801301725308125e-12
of O 0 9.556037385005656e-12
37 O 0 7.572847904313562e-10
( O 0 1.9952441120737324e-13
81 O 0 1.0715154319385078e-09
% O 0 7.901260895559759e-11
) O 0 6.044014183044901e-15
CD B-Disease 0 2.092510165141448e-09
families O 0 9.024185478739843e-13
, O 0 3.3666852536059014e-14
including O 0 9.804086524827643e-14
missense O 0 1.5135652731146365e-09
and O 0 1.5058645996823827e-10
nonsense O 0 3.1532979960502416e-07
point O 0 1.2698113671660849e-08
mutations O 0 5.085611792798872e-11
, O 0 2.2155894740388815e-12
deletions O 0 1.2399267723672835e-10
, O 0 1.914699301885925e-12
insertions O 0 2.818240973923025e-09
, O 0 1.1506698371910318e-12
a O 0 4.6468436737390206e-11
deletion O 0 2.1651986870097062e-08
/ O 0 4.973405225427996e-07
insertion O 0 2.454625018799561e-07
and O 0 1.9233146186792283e-09
splice O 0 1.227022130478872e-05
site O 0 4.7659845847647375e-08
mutations O 0 3.2356928247878614e-09
. O 0 6.282905751220369e-09

These O 0 1.5325016256007018e-10
mutations O 0 1.565686469362504e-11
were O 0 5.3826218655850244e-12
scattered O 0 3.686302998961999e-12
over O 0 3.934522588918028e-14
the O 0 5.943621381740774e-14
entire O 0 8.412357616061072e-11
length O 0 1.9539170628690705e-11
of O 0 4.668805272944887e-11
PTEN O 0 6.513741546143592e-09
, O 0 1.5753663564627152e-13
with O 0 3.5063837294427693e-15
the O 0 9.577966674986782e-13
exception O 0 1.2642361116310674e-12
of O 0 2.493611653969774e-12
the O 0 1.1959984868789575e-12
first O 0 1.0868426818244625e-11
, O 0 7.821364541270304e-13
fourth O 0 3.5211389359801615e-09
and O 0 2.1006819547753075e-11
last O 0 1.613584466042539e-08
exons O 0 5.723676963498292e-07
. O 0 2.3164021811794555e-08

A O 0 2.2150434233481064e-05
hot O 0 1.4573767970205154e-08
spot O 0 5.905825162244582e-09
for O 0 7.248637887841136e-12
PTEN O 0 2.7097655674879206e-08
mutation O 0 1.177833655260918e-12
in O 0 1.4786499661408742e-13
CD B-Disease 0 4.189057278836117e-08
was O 0 1.8697943193757283e-10
identified O 0 8.330509893017535e-11
in O 0 2.394870760036305e-11
exon O 0 1.1981122760573726e-09
5 O 0 1.63924238766322e-11
that O 0 8.715374410117778e-15
contains O 0 1.1499572343017374e-15
the O 0 7.167998833379485e-13
PTPase O 0 1.6345560993613617e-07
core O 0 5.718251205877323e-09
motif O 0 1.9136340081993275e-11
, O 0 2.3014306999307073e-14
with O 0 3.3455721950659354e-15
13 O 0 4.873362477453291e-11
of O 0 2.625660799893126e-10
30 O 0 7.365937720882343e-11
( O 0 3.95654239622803e-14
43 O 0 3.3004285415749735e-10
% O 0 2.4084390731760053e-11
) O 0 4.2933447189129684e-14
CD B-Disease 0 8.005607732286535e-09
mutations O 0 9.304169414081631e-12
identified O 0 4.5927740777162995e-12
in O 0 2.6979449490455165e-12
this O 0 7.862595297059016e-11
exon O 0 3.298487527558791e-08
. O 0 3.827173600257083e-08

Seven O 0 2.6207752412688023e-08
of O 0 6.814045439007543e-10
30 O 0 1.937551924457992e-10
( O 0 4.844920715703707e-14
23 O 0 4.5261367570548217e-11
% O 0 6.145228076404052e-11
) O 0 1.6401532638554012e-14
were O 0 3.247856844579289e-12
within O 0 1.047136405363247e-10
the O 0 3.3133572274746115e-11
core O 0 4.670519970773057e-09
motif O 0 2.0814341569752592e-11
, O 0 4.976189138484674e-14
the O 0 1.3932403408051242e-12
majority O 0 4.395598902223741e-12
( O 0 2.8114582059993176e-14
five O 0 3.5616495863699527e-11
of O 0 2.2834893698142622e-11
seven O 0 5.884500525743519e-11
) O 0 6.56269675647185e-14
of O 0 6.034071679816844e-12
which O 0 9.028743735723516e-14
were O 0 7.10004277593157e-10
missense O 0 2.5491019073342613e-08
mutations O 0 5.83433232281827e-11
, O 0 1.277022541532058e-12
possibly O 0 2.2177617520213744e-09
pointing O 0 2.69701416755197e-08
to O 0 3.1079852580440104e-10
the O 0 1.5121340846135922e-09
functional O 0 6.784352990507614e-07
significance O 0 7.972806442824165e-11
of O 0 4.76132241272742e-12
this O 0 1.039638752690919e-12
region O 0 7.863379392070158e-10
. O 0 3.732971709524691e-09

Germline O 0 0.0008689259993843734
PTEN O 0 1.1355429705872666e-05
mutations O 0 7.573410787387047e-10
were O 0 1.0401589312092341e-11
identified O 0 5.84069413927385e-13
in O 0 6.689603637200815e-15
four O 0 8.153399559240188e-14
of O 0 4.4938141749439886e-13
seven O 0 2.821932141086614e-12
( O 0 2.050162103072687e-14
57 O 0 6.782666095439538e-10
% O 0 8.214605662359986e-10
) O 0 4.973822135406758e-12
BZS B-Disease 0 1.5673492725909455e-06
families O 0 4.312317516963482e-11
studied O 0 3.8272083280332936e-09
. O 0 2.1821431772650612e-08

Interestingly O 0 2.196357229422574e-08
, O 0 1.0366962279947933e-12
none O 0 8.726066744180194e-12
of O 0 2.3213067752714256e-12
these O 0 2.1653047464851444e-13
mutations O 0 1.939472671005915e-12
was O 0 4.727225989126227e-12
observed O 0 2.5791532538149697e-13
in O 0 5.502219773551031e-13
the O 0 1.1212556577655519e-10
PTPase O 0 6.9876523411949165e-06
core O 0 2.0429806113497762e-07
motif O 0 6.351367431989274e-09
. O 0 6.383674033827447e-09

It O 0 1.602797235211728e-11
is O 0 6.824371661306658e-14
also O 0 7.438690776632312e-15
worthy O 0 6.934270518899055e-11
of O 0 1.0779658415893678e-10
note O 0 9.322998970051621e-12
that O 0 5.9622166348450266e-15
a O 0 1.5378520126178158e-13
single O 0 3.6835569316995276e-11
nonsense O 0 1.4925886082650663e-09
point O 0 1.0715167642061374e-10
mutation O 0 4.668016732704838e-13
, O 0 1.0623616651097775e-13
R233X O 0 1.949107364396241e-08
, O 0 2.714000356916768e-13
was O 0 6.172642692120478e-12
observed O 0 2.1006796562667018e-13
in O 0 5.687887904811187e-14
the O 0 1.551245134949475e-12
germline O 0 3.083470812015321e-09
DNA O 0 2.1325525789706035e-09
from O 0 2.22860098431088e-12
two O 0 3.6102476802350736e-13
unrelated O 0 2.624913481019675e-11
CD B-Disease 0 3.930079728320379e-08
families O 0 3.1501108145592926e-12
and O 0 3.344707865705898e-13
one O 0 2.0893018218282045e-11
BZS B-Disease 0 8.87902297108667e-06
family O 0 1.877760585911048e-10
. O 0 3.389670988340754e-09

Genotype O 0 1.478599642723566e-06
- O 0 6.894897097708963e-09
phenotype O 0 3.6490404448086267e-11
studies O 0 1.1406509417555277e-12
were O 0 1.1654015968400044e-13
not O 0 4.631649847452925e-15
performed O 0 1.394899603809896e-12
on O 0 1.7550807812280467e-12
this O 0 3.1738212725269596e-14
small O 0 2.6542609188567705e-14
group O 0 2.6887878452593397e-14
of O 0 1.1190742776889806e-10
BZS B-Disease 0 3.122238922514953e-05
families O 0 1.2784964198431226e-09
. O 0 6.456313883518305e-08

However O 0 9.300027414838041e-10
, O 0 2.9443749955532228e-12
genotype O 0 3.0756059921088763e-09
- O 0 4.911568929344412e-10
phenotype O 0 5.682712980736859e-11
analysis O 0 4.509400231694771e-12
inthe O 0 2.9595998540798973e-08
group O 0 8.054598248140657e-14
of O 0 4.0547018867465034e-12
CD B-Disease 0 0.00011398600327083841
families O 0 1.4419598327874983e-11
revealed O 0 2.828728744297404e-11
two O 0 7.575631440247862e-15
possible O 0 2.7159095014172435e-14
associations O 0 8.973286625194293e-15
worthy O 0 1.9869368303448987e-11
of O 0 5.283471576911225e-11
follow O 0 2.7412863645714936e-10
- O 0 3.0601390865747646e-10
up O 0 9.863252575792458e-12
in O 0 2.9568686908676423e-12
independent O 0 2.31871591371835e-10
analyses O 0 2.1767379010384502e-09
. O 0 8.813220708780989e-10

The O 0 4.675776432705447e-10
first O 0 7.66050278766528e-11
was O 0 7.169318611000008e-11
an O 0 2.6594400171094622e-14
association O 0 2.480138219362188e-14
noted O 0 3.686763757780251e-14
in O 0 6.879112859588862e-15
the O 0 1.1329248628642874e-13
group O 0 7.898589644684639e-16
of O 0 3.989766958652219e-13
CD B-Disease 0 7.13857070877566e-06
families O 0 7.078701513840713e-11
with O 0 4.935673050820988e-11
breast B-Disease 0 9.088947081181686e-06
disease I-Disease 0 7.149320936150616e-06
. O 0 4.6023072286516253e-07

A O 0 8.274605534097645e-08
correlation O 0 1.8883775099176603e-10
was O 0 4.985333326712471e-12
observed O 0 9.206222887974888e-14
between O 0 7.969920703216823e-14
the O 0 7.245838315201453e-14
presence O 0 5.773757394498397e-14
/ O 0 1.6248927203754704e-10
absence O 0 2.861534065257132e-10
of O 0 3.5814452098437144e-11
a O 0 1.0253794341386069e-11
PTEN O 0 8.242231785970944e-09
mutation O 0 3.626472765746319e-13
and O 0 4.746173360602917e-15
the O 0 2.3604334903771368e-14
type O 0 2.0453601919795394e-12
of O 0 3.4031420043101335e-11
breast O 0 5.586538523449924e-11
involvement O 0 3.0400812978115255e-09
( O 0 5.3246430702091896e-12
unaffected O 0 5.8643855993523175e-08
versus O 0 1.53838045662269e-05
benign O 0 3.6905114484397927e-06
versus O 0 1.3187838021622156e-06
malignant O 0 3.6171772421766946e-07
) O 0 2.790222219939409e-11
. O 0 4.822042320995479e-09

Specifically O 0 9.533067391043204e-11
and O 0 5.623512181092416e-13
more O 0 2.2511171122703913e-14
directly O 0 3.2588899027269358e-12
, O 0 9.417708718992626e-15
an O 0 3.013274605352732e-15
association O 0 4.410762120127254e-14
was O 0 1.5790561566642047e-11
also O 0 1.909693208418644e-14
observed O 0 5.732345614893955e-14
between O 0 1.1942501024556074e-12
the O 0 1.0730168923528405e-12
presence O 0 5.383143475250207e-13
of O 0 9.943570272730184e-12
a O 0 1.9541901430386588e-10
PTEN O 0 6.0392612795112655e-05
mutation O 0 2.941544323675771e-07
and O 0 4.845786065743596e-07
malignant B-Disease 1 1.0
breast I-Disease 1 0.9999812841415405
disease I-Disease 1 0.9996734857559204
. O 0 9.311444841841876e-07

Secondly O 0 2.2616393380303634e-06
, O 0 3.131338244255488e-11
there O 0 6.812319805482581e-13
appeared O 0 2.598050030319654e-12
to O 0 2.2474170961739315e-12
be O 0 2.0128751096470943e-11
an O 0 7.052539975627159e-12
interdependent O 0 2.3481776167955104e-07
association O 0 3.332803130695616e-11
between O 0 4.90861218338523e-09
mutations O 0 4.3081843648096196e-10
upstream O 0 2.1793125637437072e-10
and O 0 4.1878322641283883e-13
within O 0 2.7101348942792924e-10
the O 0 2.1475601852394277e-10
PTPase O 0 2.692080897759297e-06
core O 0 2.3185772590750275e-07
motif O 0 1.4283348948040953e-09
, O 0 1.6229491708874555e-12
the O 0 4.4922589953477754e-11
core O 0 3.570510642703084e-08
motif O 0 6.212046849141117e-11
containing O 0 1.7457350398163846e-13
the O 0 6.350530453065606e-13
majority O 0 2.982129517284382e-12
of O 0 1.8799251044754328e-10
missense O 0 2.2340872263271194e-08
mutations O 0 2.6891610466206473e-11
, O 0 3.515119239520109e-13
and O 0 1.3474925385573155e-13
the O 0 7.702959797795117e-12
involvement O 0 9.90099890962881e-10
of O 0 5.097863464698094e-09
all O 0 6.400171191633941e-12
major O 0 5.802592087378322e-11
organ O 0 9.878993267875558e-08
systems O 0 1.2318599146965425e-05
( O 0 1.0119542703801443e-10
central O 1 0.9103503227233887
nervous O 0 8.366913561985712e-07
system O 0 9.133996354648843e-05
, O 0 2.1563067997831808e-10
thyroid O 0 1.8261907825944945e-05
, O 0 1.493192236523555e-09
breast O 1 0.7836430668830872
, O 0 1.3393945437201182e-06
skin O 1 1.0
and O 1 1.0
gastrointestinal O 1 1.0
tract O 0 0.050770726054906845
) O 0 4.0375425225391837e-10
. O 0 1.648400740350553e-07

However O 0 3.6479235188124903e-09
, O 0 2.0885118721253315e-12
these O 0 1.3675017607010787e-13
observations O 0 4.6344408345666555e-12
would O 0 1.5078194769146958e-13
need O 0 1.5408240005079787e-12
to O 0 7.414786558183895e-13
be O 0 6.455694269089096e-13
confirmed O 0 6.977531833568529e-12
by O 0 4.653408599208583e-14
studying O 0 8.096440184957032e-12
a O 0 1.3969756612348255e-13
larger O 0 3.310648603134167e-14
number O 0 7.147911142103489e-14
of O 0 1.6834496036760571e-12
CD B-Disease 0 1.0517457127434682e-07
families O 0 1.547210137786692e-10
. O 0 5.858837415217977e-09

Molecular O 0 2.2006001927366015e-06
defects O 1 0.8841410279273987
leading O 0 2.0630503527740984e-08
to O 0 5.948212061790414e-11
human O 0 3.068691523111511e-09
complement B-Disease 1 0.9501643776893616
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.60110449204387e-11
an O 0 1.7818776307438645e-14
African O 0 2.6072486183914556e-12
- O 0 7.212638689427231e-13
American O 0 6.47094140424076e-14
family O 0 2.1645531233290688e-13
. O 0 1.8931585465953304e-11

Complement B-Disease 0 2.6343819627072662e-05
component I-Disease 1 0.9999505281448364
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 8.045179106241918e-12
C6D B-Disease 1 0.999731719493866
) O 0 5.205285529864823e-13
was O 0 2.0231788466773537e-11
diagnosed O 0 5.620743315226662e-10
in O 0 3.01695788577222e-13
a O 0 8.191808098826844e-14
16 O 0 9.549054255653111e-13
- O 0 3.825257371601297e-14
year O 0 4.695932770241995e-13
- O 0 1.1855916639061381e-12
old O 0 7.890869208049267e-11
African O 0 5.76971196514231e-12
- O 0 6.189708169840671e-14
American O 0 7.554416335413575e-16
male O 0 7.222763443652351e-15
with O 0 5.776813934064387e-16
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.6939459834830473e-09

The O 0 3.6556113691688097e-10
patients O 0 1.989568579330303e-11
father O 0 5.775980388422752e-11
and O 0 2.051070630611912e-13
two O 0 1.5070555480639625e-12
brothers O 0 6.271139423724703e-12
also O 0 1.2131672077510258e-13
had O 0 8.052302748196016e-12
C6D B-Disease 0 0.015184455551207066
, O 0 1.9175927393286912e-13
but O 0 4.0658648729719957e-14
gave O 0 2.700471682208494e-13
no O 0 1.9456656812489974e-14
history O 0 3.798027430751416e-12
of O 0 5.529094196377038e-11
meningitis B-Disease 1 1.0
or O 0 2.156190677393699e-11
other O 0 1.5271872308431078e-11
neisserial B-Disease 0 2.188651478718384e-06
infection I-Disease 0 1.2037083934046677e-06
. O 0 1.167912841992802e-07

By O 0 1.2745059456593932e-13
using O 0 8.185986610786955e-13
exon O 0 3.899073078295068e-11
- O 0 1.3634907547639685e-13
specific O 0 5.28940947099499e-15
polymerase O 0 1.9553531970667448e-14
chain O 0 3.80559155355501e-15
reaction O 0 5.374135198858632e-17
( O 0 1.911861515818047e-18
PCR O 0 2.127480964563954e-14
) O 0 8.9725538358158e-18
/ O 0 3.423865144446545e-15
single O 0 6.613710755676251e-15
- O 0 2.6506068610739628e-15
strand O 0 2.1795980971272113e-15
conformation O 0 1.3701065394798161e-14
polymorphism O 0 3.301116162108403e-13
as O 0 5.195020883913299e-16
a O 0 3.5939179141570416e-16
screening O 0 9.94522389788366e-15
step O 0 2.5077476987350744e-13
and O 0 1.7140457076684351e-15
nucleotide O 0 9.799380274247427e-13
sequencing O 0 8.710804993983245e-11
of O 0 1.89527577659776e-11
target O 0 3.4716018948444116e-10
exons O 0 7.358246234545618e-10
, O 0 6.745753451274303e-14
we O 0 3.431646920836265e-14
determined O 0 6.8740343278639315e-12
that O 0 4.5040040998840705e-15
the O 0 1.3256916181134115e-12
proband O 0 2.6270010167195323e-08
was O 0 1.0338217261429694e-11
a O 0 4.88944659499807e-13
compound O 0 1.7825536186011348e-11
heterozygote O 0 5.014290649363318e-10
for O 0 1.698336566866021e-12
two O 0 5.989744117362861e-11
C6 O 0 1.1646015991573222e-05
gene O 0 5.34749799996348e-10
mutations O 0 3.5735459036345674e-10
. O 0 9.105830756084288e-09

The O 0 1.1827904211614282e-09
first O 0 4.71715930205896e-11
, O 0 8.203570201620325e-13
1195delC O 0 4.674316489428065e-09
located O 0 4.595823721587067e-12
in O 0 2.34479341325311e-12
exon O 0 4.2428324742438406e-10
7 O 0 1.4687420168968401e-09
, O 0 8.046008304063434e-12
is O 0 1.4352356651238518e-13
a O 0 1.4697591017506784e-13
novel O 0 1.9131860334799418e-14
mutation O 0 1.9358829589279786e-13
, O 0 1.4083183133128258e-14
while O 0 3.8367236904895963e-13
the O 0 6.343391523860875e-12
second O 0 5.722350926440356e-10
, O 0 9.085618542237217e-13
1936delG O 0 8.286779262789423e-09
in O 0 5.500211050502024e-11
exon O 0 7.784897726459405e-10
12 O 0 1.3087696204561183e-10
, O 0 1.8264962025477116e-12
has O 0 4.1942896367424404e-14
been O 0 9.52200883246046e-13
described O 0 9.903174200825982e-13
before O 0 1.885641122412185e-11
to O 0 1.1936795996092542e-10
cause O 0 7.161631287999626e-09
C6D B-Disease 1 0.9999878406524658
in O 0 3.444387136619653e-11
an O 0 5.887682919328285e-13
unrelated O 0 1.6855460083231577e-10
African O 0 4.846908985278731e-10
- O 0 2.99461358488351e-11
American O 0 4.765135768608486e-13
individual O 0 5.613377384444673e-12
. O 0 1.2289179673885542e-09

Both O 0 2.5193642727572296e-09
mutations O 0 1.3753984062780944e-10
result O 0 2.4868208187145413e-11
in O 0 1.582589961857117e-11
premature O 0 2.388372832839991e-09
termination O 0 5.999248875454555e-10
codons O 0 7.82603204463328e-10
and O 0 4.289193306084016e-11
C6 O 0 6.752363788109506e-07
null O 0 1.6271398450840024e-08
alleles O 0 2.1084785306602072e-10
. O 0 1.2428805540309895e-08

Allele O 0 6.044516887016016e-09
- O 0 1.526293327835937e-11
specific O 0 4.435668954534677e-13
PCR O 0 3.765139242051241e-11
indicated O 0 9.390525466598798e-13
that O 0 8.306304189285168e-17
the O 0 5.227008130254292e-15
probands O 0 4.1532841055236247e-10
two O 0 7.160656616267413e-14
brothers O 0 1.6867408077908541e-12
also O 0 1.903736195107194e-14
inherited O 0 2.4325985670259342e-11
the O 0 2.3737457312267285e-12
1195delC O 0 6.556278853153685e-10
mutation O 0 4.171076190603168e-13
from O 0 1.759574609497619e-13
their O 0 2.773835197991681e-12
heterozygous O 0 3.187822575356769e-11
mother O 0 9.317252915377883e-13
and O 0 2.898342441157338e-14
the O 0 3.454200901004123e-12
1936delG O 0 2.753576255898338e-09
mutation O 0 4.552547575031873e-13
from O 0 7.736345608187409e-14
their O 0 8.156607442418029e-13
homozygous O 0 7.1263017188683e-12
father O 0 1.3037162495399546e-11
. O 0 6.332152857613238e-11
. O 0 1.7604007140903377e-09

PAX6 O 0 0.0008251520921476185
mutations O 0 1.8468249152192584e-08
reviewed O 0 1.0773091752014352e-08
. O 0 1.4631255318420244e-08

Mutations O 0 4.465288228061581e-08
in O 0 4.674501341561665e-10
PAX6 O 0 6.49852809146978e-05
are O 0 2.9099609007154914e-12
responsible O 0 2.314693575700133e-11
for O 0 1.2001574864126119e-12
human O 0 2.850649993835219e-10
aniridia B-Disease 1 1.0
and O 0 6.677745596067597e-12
have O 0 2.816696935371496e-14
also O 0 9.21120060414437e-16
been O 0 2.848693096734259e-14
found O 0 1.4014370176493318e-14
in O 0 6.3655860063052596e-15
patients O 0 5.439359290130945e-14
with O 0 8.858842479031459e-14
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 5.109445089246378e-10
with O 0 7.463412998731656e-09
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 1.9389239241718315e-05
with O 0 3.40099930440374e-08
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 8.298887271829258e-11
and O 0 1.2245365312024692e-11
with O 0 1.3022959377551047e-09
isolated B-Disease 1 0.9999974966049194
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9571216106414795

No O 0 1.7843242439141704e-09
locus O 0 2.683203936815204e-10
other O 0 2.044111001341456e-13
than O 0 8.33660126608321e-14
chromosome O 0 1.2745247912615554e-10
11p13 O 0 1.1455156112560871e-07
has O 0 1.0353795999815812e-13
been O 0 2.3723833227767832e-12
implicated O 0 1.3999572334721933e-10
in O 0 2.1373076919406486e-10
aniridia B-Disease 1 1.0
, O 0 6.1837436213241226e-12
and O 0 4.298183337025918e-12
PAX6 O 0 0.0021364293061196804
is O 0 1.7359671642888652e-12
clearly O 0 2.866371202892015e-12
the O 0 2.7424288968208588e-12
major O 0 3.3233700513779496e-11
, O 0 2.6684500420946777e-13
if O 0 9.685873251456117e-14
not O 0 7.16675051010314e-14
only O 0 2.6492753845731853e-13
, O 0 1.81619842320839e-13
gene O 0 9.619122989454332e-13
responsible O 0 3.167012763150012e-10
. O 0 2.4638273643518005e-08

Twenty O 0 2.9421634906157124e-08
- O 0 1.643375574511552e-10
eight O 0 2.5204095754904898e-11
percent O 0 8.848600671629292e-12
of O 0 3.1282965042185584e-13
identified O 0 1.3332794070175513e-11
PAX6 O 0 4.7469960406942846e-08
mutations O 0 3.1886721995472156e-12
are O 0 7.763040698553075e-14
C O 0 2.0600921857294452e-07
- O 0 8.996710221254034e-08
T O 0 3.628112921205684e-09
changes O 0 2.687868851103392e-11
at O 0 2.1672336147915416e-10
CpG O 0 9.381342813696847e-09
dinucleotides O 0 1.0064041155999348e-08
, O 0 7.79158096549104e-14
20 O 0 4.133545936091387e-12
% O 0 5.790195579946644e-12
are O 0 1.1145426808979167e-15
splicing O 0 5.726758997570691e-11
errors O 0 9.156669200649503e-09
, O 0 3.442585409449417e-12
and O 0 2.5680008792182407e-13
more O 0 8.082268442835203e-14
than O 0 1.0350281151897886e-13
30 O 0 7.309089444795802e-11
% O 0 5.476628595069144e-10
are O 0 9.757113465704709e-14
deletion O 0 3.439705811847382e-11
or O 0 2.390310605698831e-12
insertion O 0 1.5007464715388608e-10
events O 0 2.0444962389731813e-10
. O 0 8.449225674667105e-08

There O 0 1.0243580428337395e-09
is O 0 1.315962204657961e-12
a O 0 1.5136589898157027e-11
noticeably O 0 8.657050187821369e-09
elevated O 0 3.815614837976433e-11
level O 0 4.5594369946222457e-10
of O 0 2.4099968548574324e-11
mutation O 0 1.6098053608453594e-13
in O 0 3.674956660596612e-13
the O 0 2.78803434332342e-12
paired O 0 2.688349326138151e-12
domain O 0 2.8401142548872826e-11
compared O 0 2.4865526304651553e-13
with O 0 7.454849730046201e-16
the O 0 2.0719810958115537e-13
rest O 0 5.0976250998147066e-11
of O 0 2.740943756684988e-12
the O 0 7.240596143487377e-12
gene O 0 4.1838667946825225e-12
. O 0 1.1404763800015871e-09

Increased O 0 4.661893648894022e-10
mutation O 0 2.8546678909613377e-12
in O 0 3.7664785027848036e-13
the O 0 1.1611160817548427e-11
homeodomain O 0 1.3746181082296971e-08
is O 0 3.418124886866297e-14
accounted O 0 3.070193058118953e-11
for O 0 1.225829299991623e-14
by O 0 9.565784308326192e-14
the O 0 5.3219352535993636e-11
hypermutable O 0 3.182745729191083e-07
CpG O 0 8.30488389169659e-08
dinucleotide O 0 8.333206835686724e-08
in O 0 2.6651122975174246e-10
codon O 0 1.7174421884647018e-08
240 O 0 1.0396408178792171e-08
. O 0 1.5417031207221044e-08

Very O 0 2.6094812977106585e-09
nearly O 0 2.589212177994682e-10
all O 0 2.9924081875604136e-12
mutations O 0 6.542406373599707e-12
appear O 0 1.2403541735372947e-11
to O 0 4.4712280752867706e-12
cause O 0 2.5904275946508903e-10
loss O 0 9.246757137759687e-09
of O 0 9.099458964101359e-09
function O 0 1.0593772525879785e-09
of O 0 3.913937923760713e-11
the O 0 1.3900657968440866e-12
mutant O 0 8.115635442319802e-14
allele O 0 2.756760477447967e-13
, O 0 1.1238113389232468e-15
and O 0 7.166579536502737e-16
more O 0 4.902568465192767e-16
than O 0 1.2045426844007646e-15
80 O 0 5.30360130812646e-12
% O 0 3.550769400728626e-11
of O 0 4.961201588438158e-12
exonic O 0 4.333355452246224e-09
substitutions O 0 3.446536112061693e-11
result O 0 8.601176194888982e-12
in O 0 4.258177491167636e-11
nonsense O 0 5.589283258444766e-09
codons O 0 4.468881709129846e-09
. O 0 8.186892941353108e-09

In O 0 3.561949901698114e-10
a O 0 7.122972350837031e-12
gene O 0 1.711107655306271e-13
with O 0 3.529036736232491e-14
such O 0 4.651823089056595e-13
extraordinarily O 0 1.5805704522975361e-09
high O 0 2.6454151369481593e-11
sequence O 0 3.3786025192827918e-12
conservation O 0 1.0162143479139352e-12
throughout O 0 1.4947343493151855e-12
evolution O 0 4.643395043468779e-12
, O 0 4.2886142093091426e-14
there O 0 1.3806740039451482e-13
are O 0 5.179337861371813e-13
presumed O 0 3.889841536874883e-06
undiscovered O 0 2.1555668354267254e-05
missense O 0 5.042512611908023e-07
mutations O 0 6.735074276065234e-09
, O 0 1.1449213972725136e-11
these O 0 8.529473134732957e-12
are O 0 8.169690618453629e-12
hypothesized O 0 1.3272211107917542e-10
to O 0 3.768932735348507e-11
exist O 0 4.294502087276442e-09
in O 0 8.610569202094354e-11
as O 0 1.746700145632829e-10
- O 0 9.455205507435949e-10
yet O 0 1.274007149776324e-10
unidentified O 0 7.524363354605157e-08
phenotypes O 0 7.912803190457396e-10
. O 0 8.828725077403288e-12
. O 0 9.971726777635581e-10

Genetic O 0 4.925927754584336e-08
heterogeneity O 0 6.5089098555404235e-09
and O 0 3.0774146252132706e-12
penetrance O 0 3.4896439160547743e-07
analysis O 0 2.823435582555156e-11
of O 0 5.278867967750678e-11
the O 0 2.935305332130156e-10
BRCA1 O 0 1.0645301307121713e-09
and O 0 3.203658172079571e-11
BRCA2 O 0 2.958176370526644e-09
genes O 0 9.5783363879276e-12
in O 0 3.170262663498846e-11
breast B-Disease 0 1.1700856950014327e-09
cancer I-Disease 0 9.176363835461387e-11
families O 0 5.656931520436892e-11
. O 0 2.099046980674757e-08

The O 0 2.3207076083053835e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 1.942158633028157e-06
Consortium O 0 9.891668734107739e-11
. O 0 1.8631050868744836e-10

The O 0 1.5478714143757344e-10
contribution O 0 7.595109541291833e-10
of O 0 6.628351756354789e-10
BRCA1 O 0 7.503685867105148e-11
and O 0 1.16393158132444e-12
BRCA2 O 0 7.02836588928335e-09
to O 0 2.0269293088404083e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 1.0731501021155054e-08
assessed O 0 1.426106715357589e-11
by O 0 1.5521848265248953e-14
linkage O 0 5.009240938713688e-11
and O 0 2.926221344770087e-14
mutation O 0 4.669457163053621e-14
analysis O 0 8.270395815673098e-15
in O 0 5.161915765840167e-15
237 O 0 1.976443097725933e-12
families O 0 5.114722122397108e-13
, O 0 7.694754765817918e-15
each O 0 1.334102235151305e-13
with O 0 2.8342225552699558e-14
at O 0 2.5573331646766562e-11
least O 0 1.1277426475303498e-12
four O 0 7.644526830129228e-13
cases O 0 2.25504315741476e-12
of O 0 5.797716196020986e-10
breast B-Disease 0 1.2139010907574743e-09
cancer I-Disease 0 1.9834456993494953e-11
, O 0 1.1447980963804477e-13
collected O 0 1.0378674916017294e-12
by O 0 4.164049205272746e-13
the O 0 1.7149838882346558e-08
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 1.7214038194879322e-08
Consortium O 0 5.113946766055477e-11
. O 0 2.946861366037723e-10

Families O 0 2.4900781436798525e-10
were O 0 7.34211649811023e-12
included O 0 4.707644322109183e-13
without O 0 1.3598190498967377e-12
regard O 0 6.807624602922502e-11
to O 0 9.203774894994687e-12
the O 0 1.1752339379444976e-10
occurrence O 0 4.009179065178614e-06
of O 0 6.259322253754362e-05
ovarian B-Disease 1 0.9999998807907104
or I-Disease 0 1.797821198579186e-07
other I-Disease 0 2.7180062645015823e-08
cancers I-Disease 1 0.998559296131134
. O 0 4.486736361286603e-05

Overall O 0 7.953940803417936e-05
, O 0 6.44230890856079e-10
disease O 0 2.0944597167726897e-08
was O 0 2.8293076215213375e-10
linked O 0 2.2472308736087854e-10
to O 0 4.632180750085979e-11
BRCA1 O 0 2.113882263676814e-10
in O 0 7.058632107634355e-13
an O 0 8.107797782931387e-16
estimated O 0 8.364948409509201e-15
52 O 0 4.4676393660958436e-12
% O 0 1.9625375977105897e-11
of O 0 5.34038525207281e-13
families O 0 6.24587675416427e-13
, O 0 2.0119095191922787e-13
to O 0 2.3794809872468292e-11
BRCA2 O 0 7.743088809020193e-11
in O 0 3.6294433170686036e-12
32 O 0 5.431781135989411e-10
% O 0 1.8024730319421423e-10
of O 0 1.529083934123654e-12
families O 0 5.089488401034681e-13
, O 0 3.7297239136122734e-14
and O 0 4.021484158184133e-15
to O 0 5.061810345874385e-13
neither O 0 2.2024868040482204e-11
gene O 0 2.288347259620828e-14
in O 0 4.983923430207371e-13
16 O 0 1.9733740683203216e-11
% O 0 3.931346567731531e-12
( O 0 3.436359462753697e-16
95 O 0 2.7594935017583033e-11
% O 0 2.9671185647339726e-11
confidence O 0 4.85492146484745e-10
interval O 0 3.1907074204973185e-10
[ O 0 4.3917123410119885e-11
CI O 0 3.866027054044707e-09
] O 0 1.7950408520706063e-11
6 O 0 7.898756301805143e-12
% O 0 1.5922726678829768e-11
- O 0 1.3988107547269202e-12
28 O 0 6.804609393312733e-12
% O 0 1.1085303681934722e-11
) O 0 7.20366793288945e-15
, O 0 2.855400242423797e-14
suggesting O 0 4.860176388947479e-13
other O 0 1.399509956707956e-12
predisposition O 0 2.0034316428052534e-09
genes O 0 2.870319981695957e-09
. O 0 1.6411226511081622e-07

The O 0 6.937740382184643e-10
majority O 0 1.497715285125878e-10
( O 0 2.7518052330625757e-14
81 O 0 3.624874012064794e-10
% O 0 2.7698199289716285e-10
) O 0 9.602614317312345e-15
of O 0 2.3202544052747243e-11
the O 0 2.86340508637295e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.972357884966641e-09
were O 0 5.86335580782249e-12
due O 0 8.491833625168255e-11
to O 0 7.342886715333563e-12
BRCA1 O 0 3.2402212423593424e-12
, O 0 4.955500612857872e-15
with O 0 2.68306765177203e-16
most O 0 6.619667514877817e-15
others O 0 1.8370534585719633e-13
( O 0 5.743286146550576e-15
14 O 0 1.3472523444080231e-11
% O 0 1.18768571366612e-11
) O 0 6.209523573905444e-15
due O 0 9.066239425870037e-11
to O 0 1.6584404960440224e-09
BRCA2 O 0 1.3831662215579854e-07
. O 0 7.489326492304826e-08

Conversely O 0 3.7317278156479006e-08
, O 0 2.6145676335770363e-13
the O 0 1.6389843583881902e-13
majority O 0 1.342152029706195e-13
of O 0 5.278993388257991e-13
families O 0 1.627849602076764e-13
with O 0 1.0640727733071849e-14
male B-Disease 0 1.1089051205059874e-10
and I-Disease 0 1.2820653393086356e-11
female I-Disease 0 8.358257218787912e-06
breast I-Disease 0 8.57413411381458e-08
cancer I-Disease 0 0.00010015068255597726
were O 0 2.319700797670521e-05
due O 1 0.999458372592926
to O 0 9.086679852998714e-08
BRCA2 O 0 3.012019522685705e-09
( O 0 4.164589409005187e-13
76 O 0 6.067780944363221e-09
% O 0 5.244757961264668e-10
) O 0 5.634571043251768e-13
. O 0 1.6856650797425488e-10

The O 0 6.754512060780371e-09
largest O 0 1.300994312281034e-10
proportion O 0 6.555325032797654e-11
( O 0 2.7529392407723598e-14
67 O 0 8.687916164262788e-09
% O 0 5.757976873077553e-10
) O 0 2.5819082115352554e-14
of O 0 1.8102783811910217e-12
families O 0 1.1011856574164036e-12
due O 0 3.357037314799527e-09
to O 0 4.323097782532592e-11
other O 0 6.185890341625644e-12
genes O 0 1.4107104373550783e-11
was O 0 2.1738564073836564e-11
found O 0 1.650506988026823e-13
in O 0 4.567888764722e-14
families O 0 2.865369074823987e-13
with O 0 6.0398662627021964e-15
four O 0 1.0572017436830117e-12
or O 0 1.2052655423179515e-13
five O 0 2.8375991335295725e-13
cases O 0 1.73214293928102e-13
of O 0 5.194957797272082e-10
female O 0 2.9868658657505875e-08
breast B-Disease 0 3.4955900396482775e-09
cancer I-Disease 0 1.6448126194390511e-09
only O 0 3.943909643311372e-09
. O 0 3.423342889163905e-07

These O 0 1.3801119101708448e-11
estimates O 0 2.3992186709564933e-11
were O 0 3.966021087931093e-12
not O 0 3.9298000075425887e-13
substantially O 0 1.9779903409622435e-11
affected O 0 1.6373908522451797e-13
either O 0 8.517287623886066e-14
by O 0 4.274353562609169e-15
changing O 0 3.796853890319918e-12
the O 0 4.714455822257824e-13
assumed O 0 5.7487344745643654e-11
penetrance O 0 9.861080840778413e-10
model O 0 4.705239019589524e-13
for O 0 2.9316975821806757e-13
BRCA1 O 0 3.862507536034343e-11
or O 0 7.210104366849046e-14
by O 0 2.2500569658336078e-14
including O 0 2.9870748344436315e-13
or O 0 1.2005770509693203e-11
excluding O 0 5.92997706494458e-10
BRCA1 O 0 5.367590372173936e-09
mutation O 0 1.1233041580238634e-10
data O 0 2.3585942088288903e-09
. O 0 1.3116197905560512e-08

Among O 0 7.49008771672166e-11
those O 0 6.123529417909057e-13
families O 0 1.7000802892200295e-12
with O 0 3.2450669077864133e-14
disease O 0 3.759527411606456e-11
due O 0 2.2656275078247745e-08
to O 0 2.748936078766917e-10
BRCA1 O 0 3.592037500776968e-10
that O 0 3.551617279353575e-14
were O 0 7.71344861355723e-14
tested O 0 3.871926091786283e-15
by O 0 2.5067299505324657e-16
one O 0 4.094892268557927e-15
of O 0 4.3378098828856723e-14
the O 0 1.270684692043127e-14
standard O 0 5.1740428212493014e-14
screening O 0 1.1904327248621078e-14
methods O 0 8.821688171622988e-12
, O 0 8.127501357471298e-14
mutations O 0 1.0897606601834031e-12
were O 0 6.009010563440276e-12
detected O 0 5.854091950779905e-12
in O 0 1.5675725352644852e-14
the O 0 7.659004723839513e-13
coding O 0 1.5254101315420598e-09
sequence O 0 7.384783756725355e-12
or O 0 2.092838489314852e-12
splice O 0 1.9071209056420457e-09
sites O 0 1.1852642999021779e-11
in O 0 9.309485691014197e-14
an O 0 4.805455078998877e-15
estimated O 0 4.556335777422538e-13
63 O 0 4.871618108914788e-10
% O 0 9.175873949551772e-11
( O 0 1.286914266828993e-14
95 O 0 6.541801544912573e-10
% O 0 1.4851249396929944e-10
CI O 0 1.8244863397853806e-09
51 O 0 2.892521777653201e-10
% O 0 1.2271371419014798e-10
- O 0 2.3567885490405338e-11
77 O 0 3.676053905721233e-11
% O 0 1.3617722227632356e-10
) O 0 3.009853922087552e-13
. O 0 2.0098146757963065e-10

The O 0 1.9146720320328825e-10
estimated O 0 7.244450265370128e-12
sensitivity O 0 1.3844040497312804e-11
was O 0 5.963473530094798e-13
identical O 0 2.2086463720752923e-14
for O 0 5.921956735345556e-16
direct O 0 2.2968523174442083e-14
sequencing O 0 1.1333366536914191e-11
and O 0 6.092838771487238e-14
other O 0 1.3032673898405456e-13
techniques O 0 2.1943430184023782e-08
. O 0 3.115328439662335e-09

The O 0 8.031698861543646e-09
penetrance O 0 5.840380708832527e-06
of O 0 5.741616959653584e-09
BRCA2 O 0 2.1725734544730813e-09
was O 0 1.0281818799140474e-11
estimated O 0 2.611637035104808e-13
by O 0 8.17080083470199e-15
maximizing O 0 5.060466490292015e-10
the O 0 3.168914436413317e-11
LOD O 0 1.3331144828043762e-06
score O 0 9.757727958970008e-10
in O 0 3.594859479538748e-11
BRCA2 O 0 4.083221760708966e-09
- O 0 2.9796648481905663e-10
mutation O 0 1.2979395119447346e-12
families O 0 4.2398652947903126e-13
, O 0 1.516546423488939e-14
over O 0 5.835624680965851e-14
all O 0 5.252435720517687e-14
possible O 0 2.9783793487059285e-11
penetrance O 0 1.196852537077575e-07
functions O 0 3.0366158476624605e-09
. O 0 5.0942770002393445e-09

The O 0 8.361424053138222e-11
estimated O 0 1.0050923635041009e-11
cumulative O 0 1.1038974595534157e-10
risk O 0 4.18780531086238e-11
of O 0 5.747727849225726e-10
breast B-Disease 0 2.001919074956504e-09
cancer I-Disease 0 7.725932393842783e-11
reached O 0 7.568258908463577e-09
28 O 0 1.983280067952009e-10
% O 0 1.013491287421564e-11
( O 0 2.573096040741024e-16
95 O 0 2.2651833533893218e-11
% O 0 1.0407622680341788e-11
CI O 0 1.8703970317002216e-10
9 O 0 2.181447947627313e-12
% O 0 9.112762627827564e-13
- O 0 1.6647056996776932e-13
44 O 0 1.6579974697859823e-13
% O 0 1.1261319974404868e-13
) O 0 3.682371099840583e-18
by O 0 2.9560381141823663e-17
age O 0 6.620908248738955e-14
50 O 0 1.150695478572411e-13
years O 0 5.933993666449103e-14
and O 0 5.585621551331028e-15
84 O 0 5.591418387324021e-12
% O 0 1.8060570400324494e-12
( O 0 2.9590630144207992e-16
95 O 0 8.358932469809677e-12
% O 0 3.511074027004457e-12
CI O 0 1.0081802059858092e-10
43 O 0 5.4218001616090916e-11
% O 0 6.520269133641898e-12
- O 0 7.575002365818595e-13
95 O 0 1.1084858725363134e-11
% O 0 4.570069908442498e-13
) O 0 1.4495774443452824e-17
by O 0 2.111530582425415e-16
age O 0 1.7617247721410378e-12
70 O 0 1.476926567156589e-11
years O 0 4.3342933409018514e-11
. O 0 1.4112365720464481e-09

The O 0 2.0314034543389425e-07
corresponding O 1 0.9999998807907104
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 2.8171623256412204e-08
were O 0 5.329461871816932e-11
0 O 0 7.147649833116887e-11
. O 0 5.366052047151015e-10

4 O 0 5.789759782715009e-10
% O 0 1.2172857166703466e-10
( O 0 5.3945567529353495e-15
95 O 0 2.608434856998798e-10
% O 0 3.037684687123843e-11
CI O 0 1.012142036849184e-09
0 O 0 2.0229724471097776e-13
% O 0 8.681111385300255e-12
- O 0 3.790267253701851e-13
1 O 0 3.3899210614149813e-14
% O 0 1.4253112850127342e-13
) O 0 1.7130887738506358e-18
by O 0 2.2906975391449312e-17
age O 0 1.4254900428459227e-14
50 O 0 3.963657472984966e-14
years O 0 3.329189137910027e-14
and O 0 1.2821409608855072e-15
27 O 0 1.2333023057670145e-12
% O 0 7.443551526022107e-13
( O 0 2.2077723187770206e-16
95 O 0 8.282911682921945e-12
% O 0 1.0962300511785372e-11
CI O 0 2.7151486614584996e-10
0 O 0 9.310515683078058e-14
% O 0 1.4893925936315666e-12
- O 0 4.1755815927309314e-13
47 O 0 4.822945428445413e-12
% O 0 6.344308216797712e-13
) O 0 2.013260665386278e-17
by O 0 3.4835039931088913e-16
age O 0 1.4546106289967109e-12
70 O 0 7.248333877551971e-12
years O 0 1.2951827978169295e-11
. O 0 4.888987548135049e-10

The O 0 9.272060341736221e-10
lifetime O 0 4.848929791023693e-08
risk O 0 5.667880742521447e-08
of O 0 1.5661733243632625e-07
breast B-Disease 0 9.385779776494019e-06
cancer I-Disease 0 1.0966923014166241e-07
appears O 0 7.893774522926833e-11
similar O 0 5.430923180789471e-13
to O 0 5.012164988604795e-11
the O 0 1.6467453789470454e-10
risk O 0 4.7535936992249006e-11
in O 0 9.232732633979168e-12
BRCA1 O 0 1.6158243146269236e-11
carriers O 0 8.432746281860151e-14
, O 0 2.250726630081707e-14
but O 0 2.8949444837861327e-14
there O 0 4.319184306001908e-14
was O 0 5.209416882243079e-13
some O 0 1.0819762546034149e-14
suggestion O 0 1.3472773244260772e-12
of O 0 2.663621927190274e-11
a O 0 8.817840901897966e-11
lower O 0 4.070065173777948e-09
risk O 0 5.575436293203673e-11
in O 0 4.443404325038536e-11
BRCA2 O 0 3.9415914976359545e-10
carriers O 0 6.100845523215881e-12
< O 0 4.741209091996268e-10
50 O 0 2.1814907519290827e-11
years O 0 7.992230141584677e-12
of O 0 2.5785163934588518e-11
age O 0 2.3352544342714054e-09
. O 0 2.501198803628313e-09

Eye B-Disease 1 0.9991814494132996
movement I-Disease 0 1.6677980738677434e-06
abnormalities I-Disease 0 0.00010283602750860155
correlate O 0 4.876287373889454e-09
with O 0 1.3403102412656853e-13
genotype O 0 9.935239297931275e-10
in O 0 3.6530306557480685e-11
autosomal O 1 0.6880419850349426
dominant O 0 8.929439354687929e-05
cerebellar B-Disease 1 0.9999998807907104
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999998807907104
I I-Disease 1 1.0
. O 0 2.0647162557452248e-07

We O 0 2.7818396475254303e-09
compared O 0 3.233114442835472e-09
horizontal O 0 4.145727761084572e-09
eye O 0 4.7184979479197864e-08
movements O 0 4.151828658649492e-09
( O 0 3.52947120314806e-12
visually O 0 1.2134282467712865e-10
guided O 0 7.268941559779307e-10
saccades O 0 2.1968387997617356e-08
, O 0 1.1602964682805306e-12
antisaccades O 0 2.1219394241711598e-08
, O 0 1.3783138313409188e-13
and O 0 4.002249310501409e-14
smooth O 0 4.546374041125567e-11
pursuit O 0 2.6112323414650973e-10
) O 0 1.4059510256318394e-14
in O 0 1.5118714114838172e-13
control O 0 5.500958577542292e-10
subjects O 0 2.8146525110628318e-09
( O 0 2.6603024660563565e-14
n O 0 1.8884468099521212e-13
= O 0 8.674845916470733e-14
14 O 0 2.234737731237474e-13
) O 0 1.2583881453412469e-15
and O 0 1.792813207257744e-15
patients O 0 9.62997941073929e-15
with O 0 1.955418307430609e-16
three O 0 2.7958648376601343e-14
forms O 0 1.7139314273384443e-11
of O 0 3.5670715270441633e-09
autosomal O 1 0.6647635698318481
dominant O 0 0.07333631068468094
cerebellar B-Disease 1 0.9998764991760254
ataxias I-Disease 0 0.02279585413634777
type I-Disease 0 6.257328641368076e-05
I I-Disease 1 0.9999853372573853
spinocerebellar B-Disease 0 0.011324351653456688
ataxias I-Disease 0 4.594825895765098e-06
1 I-Disease 0 1.3043535695977937e-10
and I-Disease 0 1.0015437914775993e-12
2 I-Disease 0 6.9350740428131274e-12
( O 0 1.132531636288854e-13
SCA1 B-Disease 0 1.0330840041206102e-06
, O 0 4.158572629048979e-13
n O 0 2.311276712553545e-13
= O 0 4.7273203553728146e-14
11 O 0 2.9009485243668143e-13
; O 0 6.85898862731152e-15
SCA2 B-Disease 0 1.7136015628693713e-07
, O 0 1.5587777921731438e-13
n O 0 2.4945521451442965e-13
= O 0 1.547733295692577e-13
10 O 0 2.8196870294379395e-13
) O 0 5.499674812239029e-15
and O 0 1.999477623401691e-12
SCA3 B-Disease 1 1.0
/ O 0 3.628592182280954e-08
Machado B-Disease 0 4.617022764108469e-09
- I-Disease 0 4.2418696333257344e-10
Joseph I-Disease 0 2.602719706423784e-10
disease I-Disease 0 7.037460836301079e-09
( O 0 1.0792849768201038e-13
MJD B-Disease 1 1.0
) O 0 1.0478727260898602e-12
( O 0 1.54822850503486e-14
n O 0 1.6298760301472481e-12
= O 0 7.165087208445275e-13
16 O 0 6.64746252834747e-12
) O 0 1.1155093911302885e-13
. O 0 4.345037177277966e-11

In O 0 2.0511530252065313e-09
SCA1 B-Disease 0 0.0002949174668174237
, O 0 1.6821655830431825e-12
saccade O 0 1.0753650414585536e-08
amplitude O 0 8.930142042506972e-11
was O 0 9.816520860073119e-12
significantly O 0 1.27799056059974e-11
increased O 0 9.745846707778782e-13
, O 0 1.2076166516696452e-14
resulting O 0 1.8529038980225065e-12
in O 0 5.2663849843537225e-12
hypermetria B-Disease 0 1.5152708954246918e-07
. O 0 9.096837949584824e-09

The O 0 8.503706183660142e-09
smooth O 0 1.8816345814798296e-08
pursuit O 0 4.898130612218665e-08
gain O 0 1.0389751992079255e-07
was O 0 2.815026822755584e-10
decreased O 0 8.543080909362288e-09
. O 0 7.279639113733083e-10

In O 0 6.609341962615645e-09
SCA2 B-Disease 0 0.00023485753627028316
, O 0 2.874172254363483e-12
saccade O 0 1.5141724318823435e-08
velocity O 0 2.0624160157467486e-09
was O 0 4.757723104376055e-10
markedly O 0 2.558746992065153e-08
decreased O 0 9.551714974520564e-09
. O 0 1.028208407305442e-09

The O 0 4.376729811905733e-10
percentage O 0 3.902484557727348e-09
of O 0 1.950789009497189e-11
errors O 0 4.643997897346708e-08
in O 0 1.6926014756446506e-10
antisaccades O 0 1.4005722732690629e-06
was O 0 4.225523403400544e-11
greatly O 0 1.7485827022434286e-11
increased O 0 2.6119473337665733e-12
and O 0 4.3017872657048414e-14
was O 0 3.1397874751537547e-12
significantly O 0 4.6949679387287e-12
correlated O 0 9.86520934387336e-12
with O 0 5.930867098434198e-15
age O 0 6.220252091182488e-11
at O 0 1.0035335756830577e-10
disease O 0 8.464218770320997e-10
onset O 0 9.7883356975359e-10
. O 0 1.2578977859334373e-09

In O 0 2.8298527410264285e-10
addition O 0 2.5427271399536266e-11
, O 0 1.281604488333199e-13
a O 0 1.7337626018014418e-13
correlation O 0 6.749810671329015e-13
between O 0 5.8988473827792376e-12
smooth O 0 3.233482648301589e-10
pursuit O 0 4.7377404222004316e-09
gain O 0 7.727074091690156e-09
and O 0 2.122885336486649e-13
the O 0 1.5611530080825164e-12
number O 0 1.0279577753249947e-12
of O 0 1.4569383893769938e-11
trinucleotide O 0 2.652956965221165e-09
repeats O 0 4.9824269710008195e-11
was O 0 4.5165128581547975e-11
found O 0 3.231458850505575e-11
. O 0 1.3004343157874132e-09

In O 0 8.53932178301875e-08
SCA3 B-Disease 1 1.0
, O 0 1.5662681818184865e-08
gaze B-Disease 0 0.00045959651470184326
- I-Disease 0 1.0034867727881647e-06
evoked I-Disease 0 1.263659399342032e-09
nystagmus I-Disease 0 2.748747340852731e-10
was O 0 9.665213941689732e-12
often O 0 2.929203239557601e-14
present O 0 4.1368547042813786e-14
as O 0 1.6801814363163266e-15
was O 0 5.643293449729414e-13
saccade O 0 6.394738960580071e-09
hypometria O 0 3.648635171771275e-08
and O 0 1.6850429471887418e-12
smooth O 0 1.7094801130213e-09
pursuit O 0 2.722805803045958e-08
gain O 0 1.0410283124429043e-07
was O 0 6.566829302556698e-10
markedly O 0 2.460920001112754e-08
decreased O 0 1.5516773643753368e-08
. O 0 1.2552278105815162e-09

Three O 0 1.5278056597622935e-10
major O 0 1.1721976687917302e-11
criteria O 0 8.102964133005486e-11
, O 0 1.2538326496849828e-13
saccade O 0 2.2959689705004394e-09
amplitude O 0 1.9812904789029417e-11
, O 0 1.448751058355513e-13
saccade O 0 1.9173480581002877e-09
velocity O 0 4.10688566487849e-10
, O 0 4.3763639088513495e-13
and O 0 9.428209894659506e-14
presence O 0 4.074641665741119e-12
of O 0 2.372328999911133e-08
gaze B-Disease 0 5.0576956709846854e-05
- I-Disease 0 7.177441716521571e-07
evoked I-Disease 0 5.270489600306405e-10
nystagmus I-Disease 0 3.142131346778321e-11
, O 0 5.580829462431937e-15
permitted O 0 5.309205765996472e-13
the O 0 1.8114163801200532e-14
correct O 0 6.020276725055007e-12
assignment O 0 3.144415630651487e-11
of O 0 1.3853939696828466e-12
90 O 0 5.1664769684656164e-11
% O 0 2.088688076662404e-11
of O 0 3.4747896292090796e-13
the O 0 2.2278403080666642e-12
SCA1 B-Disease 0 1.047866703629552e-06
, O 0 1.2362363194760861e-13
90 O 0 4.5438423856847265e-11
% O 0 2.3560469547545537e-11
of O 0 1.0042506106214266e-12
the O 0 7.000847384447395e-12
SCA2 B-Disease 0 2.7278695142740617e-06
, O 0 1.6845215272589392e-13
and O 0 5.281639383659942e-14
93 O 0 1.0696055846581842e-10
% O 0 1.1490174089967553e-10
of O 0 1.956653589152424e-12
the O 0 6.431421150851491e-13
patients O 0 6.222203199728049e-13
with O 0 1.1906565143549042e-12
SCA3 B-Disease 1 1.0
to O 0 9.67215862957005e-10
their O 0 8.495656261819917e-11
genetically O 0 6.497187770432289e-13
confirmed O 0 1.482543081354759e-11
patient O 0 2.758694939153372e-10
group O 0 7.356912117267161e-14
and O 0 2.4903023436786964e-13
, O 0 1.7842253011417925e-13
therefore O 0 1.6813517592084715e-11
, O 0 4.982383863122442e-13
may O 0 3.190924954821206e-11
help O 0 3.0993674293711138e-09
orient O 0 1.8841562621219055e-07
diagnoses O 0 8.936867601505583e-08
of O 0 5.2330619837448467e-08
SCA1 B-Disease 1 0.9983755350112915
, O 0 6.072255198663612e-11
SCA2 B-Disease 1 0.9884926676750183
, O 0 4.483816096190196e-12
and O 0 2.296943538149243e-11
SCA3 B-Disease 1 1.0
at O 0 1.1225508300682918e-09
early O 0 2.5846862844458585e-11
clinical O 0 5.393947875159677e-12
stages O 0 9.100681319651471e-11
of O 0 4.619219937107566e-11
the O 0 1.3154566325113137e-10
diseases O 0 3.651290936268481e-10
. O 0 3.1645356474152564e-11
. O 0 2.247771968555412e-09

Genetic O 0 1.537520666339276e-09
basis O 0 2.1247682779890198e-10
and O 0 3.024146484988978e-14
molecular O 0 2.0962140443586685e-12
mechanism O 0 4.4483017269669745e-09
for O 0 4.681008025642086e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9999693632125854

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 0.9999947547912598
causes O 0 8.038446708269475e-08
more O 0 6.265397272178785e-13
than O 0 4.838435577349644e-15
300 O 0 2.2642394144518907e-13
, O 0 5.1621127010004035e-15
000 O 0 1.1436845220869074e-10
sudden O 0 1.7973284536024203e-12
deaths O 0 7.006614255802845e-13
each O 0 5.78315946021292e-14
year O 0 1.97415261221634e-12
in O 0 9.75648489949521e-13
the O 0 8.893676593790811e-12
USA O 0 1.925593157148242e-10
alone O 0 4.814760812266172e-10
. O 0 1.493152379516971e-09

In O 0 2.0331305528031862e-09
approximately O 0 7.271157287380703e-11
5 O 0 7.18327966553467e-11
- O 0 3.551243674126958e-11
12 O 0 2.6066431998983397e-11
% O 0 1.3989188973884126e-10
of O 0 1.3762096659746675e-13
these O 0 3.77286643563784e-15
cases O 0 1.021822600491551e-14
, O 0 1.0475079428807956e-14
there O 0 2.7237326977180842e-14
are O 0 1.614173746923575e-14
no O 0 1.0690700711843415e-12
demonstrable O 0 4.239081530243993e-09
cardiac O 0 7.833579616089992e-07
or O 0 8.706025900195868e-10
non O 1 1.0
- O 1 0.9999996423721313
cardiac O 1 0.9999995231628418
causes O 0 2.061915360673794e-10
to O 0 2.360071122906038e-12
account O 0 2.492583233999063e-13
for O 0 1.909533119191613e-14
the O 0 1.1312670635324484e-12
episode O 0 2.2865227072843552e-11
, O 0 5.913223402142891e-15
which O 0 9.57531637771625e-17
is O 0 6.198487846333464e-17
therefore O 0 3.032672379822861e-14
classified O 0 2.2853498607422473e-11
as O 0 1.343493649663685e-10
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 4.5660212322218285e-07
IVF B-Disease 1 1.0
) O 0 3.016765309782343e-11
. O 0 2.937758369903065e-10

A O 0 1.4656643898547372e-08
distinct O 0 3.743299073488693e-11
group O 0 2.9963019370325694e-13
of O 0 3.845506690858258e-10
IVF B-Disease 1 1.0
patients O 0 5.125423419016784e-10
has O 0 2.9375828941531406e-15
been O 0 1.2491533686338069e-14
found O 0 5.838716690036508e-15
to O 0 5.79018983367513e-14
present O 0 5.2387139765075474e-12
with O 0 8.246393612453343e-14
a O 0 3.5337302528581915e-11
characteristic O 0 1.011175365661643e-09
electrocardiographic O 0 1.423810118694746e-07
pattern O 0 9.96496307692496e-09
. O 0 2.336271265335199e-08

Because O 0 8.415057539679083e-10
of O 0 4.83234474657479e-09
the O 0 1.0401043359919981e-09
small O 0 4.0659370401791017e-13
size O 0 4.582464507678352e-13
of O 0 3.5054396451544845e-12
most O 0 3.1331512904964054e-13
pedigrees O 0 1.9876209567115666e-09
and O 0 9.214941093169116e-13
the O 0 4.475974799134086e-11
high O 0 8.554242036939996e-11
incidence O 0 1.785562531164686e-10
of O 0 6.2107555209856e-11
sudden B-Disease 0 5.279381445899567e-11
death I-Disease 0 6.003973707091603e-11
, O 0 5.084762905865903e-13
however O 0 3.641772647333674e-12
, O 0 5.882112559616598e-14
molecular O 0 1.4222378700093352e-12
genetic O 0 1.9983756403135766e-12
studies O 0 5.004883226605861e-12
of O 0 8.778153898214569e-11
IVF B-Disease 1 1.0
have O 0 2.175364922918366e-12
not O 0 1.1303023810969523e-13
yet O 0 3.316839641484548e-12
been O 0 5.086317651781247e-12
done O 0 1.361201595884154e-09
. O 0 5.671435765464139e-09

Because O 0 1.0801736038956733e-07
IVF B-Disease 1 1.0
causes O 0 6.4454643506905995e-06
cardiac O 1 1.0
rhythm O 1 0.9995449185371399
disturbance O 0 2.3633677237455686e-09
, O 0 6.20784483930728e-14
we O 0 9.896522891548326e-14
investigated O 0 2.103812566864316e-12
whether O 0 3.2792399438236197e-13
malfunction O 0 1.0481270606987891e-07
of O 0 8.744776604230342e-12
ion O 0 7.159415282842474e-10
channels O 0 1.3056038472569753e-09
could O 0 5.843293730822818e-12
cause O 0 3.396734976623961e-11
the O 0 2.384672971242341e-12
disorder O 0 4.909054066026819e-12
by O 0 2.885679785639831e-16
studying O 0 7.699294354195432e-14
mutations O 0 2.4153681509844933e-14
in O 0 3.0873944351604565e-14
the O 0 6.063965302116614e-12
cardiac O 0 5.016474347030453e-09
sodium O 0 6.524589202250297e-11
channel O 0 2.0056023508630005e-10
gene O 0 4.316998147846363e-12
SCN5A O 0 4.473114586289739e-06
. O 0 1.7055596046589017e-08

We O 0 2.1542772010718636e-09
have O 0 9.538369443243266e-13
now O 0 1.4322439447541496e-13
identified O 0 8.807225782003769e-13
a O 0 3.8199510828812455e-13
missense O 0 4.739942882636683e-10
mutation O 0 7.154093940517359e-13
, O 0 1.2429361468009603e-14
a O 0 2.7952369151956757e-13
splice O 0 3.4380893687568914e-09
- O 0 4.884333909549454e-11
donor O 0 8.844133064789261e-11
mutation O 0 1.6609016245672237e-11
, O 0 7.36387540571995e-14
and O 0 1.3662606202641259e-13
a O 0 3.249796265425431e-12
frameshift O 0 1.7053344292250472e-09
mutation O 0 2.8029249928007705e-13
in O 0 3.659189786028513e-14
the O 0 1.2373927837233678e-12
coding O 0 1.7176583710920568e-08
region O 0 8.39661951079762e-10
of O 0 9.298904701804389e-11
SCN5A O 0 0.003872507717460394
in O 0 1.53091168214603e-11
three O 0 8.549005947600108e-11
IVF B-Disease 1 1.0
families O 0 1.1122556868581324e-11
. O 0 3.0834457209749644e-10

We O 0 4.610569703800138e-10
show O 0 4.5756540917318844e-12
that O 0 3.9683435345348847e-16
sodium O 0 7.72893847447026e-15
channels O 0 1.2772558889446312e-13
with O 0 1.7314655424162057e-17
the O 0 1.7583994021052804e-14
missense O 0 1.2049869435593052e-10
mutation O 0 2.6630822113488106e-12
recover O 0 2.9816391577952572e-09
from O 0 3.966461881166339e-11
inactivation O 0 1.9517141236491398e-09
more O 0 1.976645708006916e-13
rapidly O 0 4.329978216255359e-12
than O 0 5.231037889500854e-15
normal O 0 1.3526439517075328e-11
and O 0 1.3335928125961672e-14
that O 0 2.5108847530178665e-15
the O 0 2.4915956884502544e-12
frameshift O 0 4.1569312436706696e-09
mutation O 0 6.18939198938212e-13
causes O 0 5.5256909209941765e-14
the O 0 1.1586112928438363e-12
sodium O 0 1.4403921848663015e-12
channel O 0 4.212043040741076e-12
to O 0 9.46648792340965e-13
be O 0 3.896075302656232e-12
non O 0 1.3916602092933772e-08
- O 0 4.147696852641047e-09
functional O 0 1.898628987362372e-08
. O 0 9.69931468475238e-10

Our O 0 2.907668328333557e-09
results O 0 1.2693688114517876e-11
indicate O 0 1.5265544904552453e-12
that O 0 1.5318198039564732e-15
mutations O 0 2.4906144922604186e-14
in O 0 3.95924477014295e-14
cardiac O 0 1.170958052743032e-10
ion O 0 2.6029481348111005e-10
- O 0 3.3807991961509742e-09
channel O 0 4.1040199016961765e-10
genes O 0 1.3571048378493468e-14
contribute O 0 3.004461100481609e-14
to O 0 9.451503639522178e-15
the O 0 2.230231482076763e-14
risk O 0 2.034938244386414e-13
of O 0 3.594348668527203e-13
developing O 0 2.8007490771031485e-10
IVF B-Disease 1 1.0
. O 0 4.348245721819133e-11
. O 0 3.060454112358002e-10

Molecular O 0 5.1255067745614724e-08
heterogeneity O 0 5.06839263891834e-08
in O 0 1.317993936211792e-09
mucopolysaccharidosis B-Disease 0 0.0001700208376860246
IVA I-Disease 1 0.9999998807907104
in O 0 8.544124519005436e-09
Australia O 0 7.221098718979135e-11
and O 0 7.60566577166083e-13
Northern O 0 1.642893709963289e-09
Ireland O 0 2.1077989353912585e-10
: O 0 4.684298450838937e-15
nine O 0 6.584918157623298e-13
novel O 0 1.514526080503148e-14
mutations O 0 4.320257530627397e-13
including O 0 1.5870377928495216e-13
T312S O 0 8.349658031647778e-08
, O 0 5.000119784361046e-13
a O 0 7.297881916834559e-13
common O 0 4.573716839290087e-12
allele O 0 5.091153887359923e-11
that O 0 1.2541770194000185e-13
confers O 0 1.6674825409346283e-10
a O 0 1.4775104750786028e-10
mild O 0 1.4154087624174139e-10
phenotype O 0 2.2388166875941806e-09
. O 0 6.661231122251365e-09

Mucopolysaccharidosis B-Disease 0 0.0030208530370146036
IVA I-Disease 1 1.0
( O 0 3.1715980952640166e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.3984439994896292e-10
is O 0 4.952144597170083e-12
an O 0 1.310175717916806e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 3.54719209560983e-09
by O 0 2.570323511322248e-13
a O 0 3.2044297770816854e-10
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 3.6495622496302005e-11
N O 0 4.864245672919765e-10
- O 0 9.764909714160552e-11
acetylgalactosamine O 0 1.5763621519226945e-08
- O 0 1.1989186032845822e-10
6 O 0 9.512397813882245e-11
- O 0 4.612476373067054e-11
sulfate O 0 1.4028773802354788e-12
sulfatase O 0 5.1703218095777714e-11
( O 0 1.6095958726568445e-14
GALNS O 0 3.498063563256437e-07
) O 0 9.649810247744361e-13
. O 0 2.8048866007601703e-10

Previous O 0 7.515065902907736e-09
studies O 0 3.666544845515318e-11
of O 0 4.63646525686312e-12
patients O 0 3.899983905698151e-13
from O 0 2.2712724984195326e-13
a O 0 1.2785939299507498e-13
British O 0 1.1457384520296987e-11
- O 0 6.809520308737049e-11
Irish O 0 3.730911066202047e-11
population O 0 2.8771627634760705e-15
showed O 0 9.131647905012957e-15
that O 0 8.574548439460397e-18
the O 0 1.510250935811766e-14
I113F O 0 5.845754991185004e-09
mutation O 0 3.397102694632781e-12
is O 0 1.061409193501249e-14
the O 0 7.193596846671868e-13
most O 0 7.51318359739836e-14
common O 0 3.554926535434544e-13
single O 0 8.739491769160779e-12
mutation O 0 4.046435062021736e-12
among O 0 1.3166200985362253e-12
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.8274934632245277e-07
and O 0 6.6710361193433876e-12
produces O 0 1.7388636103926602e-12
a O 0 3.854645335560347e-12
severe O 0 4.12801154370257e-10
clinical O 0 7.829824566485399e-10
phenotype O 0 8.1364831538977e-10
. O 0 5.410421444196345e-09

We O 0 6.01124394705721e-09
studied O 0 6.285348352896847e-10
mutations O 0 4.0945315714358e-12
in O 0 1.368106881038597e-13
the O 0 1.6046010006820488e-12
GALNS O 0 5.129368219058961e-06
gene O 0 1.7279126534545247e-13
from O 0 2.2530599348008495e-13
23 O 0 5.112442587329458e-12
additional O 0 5.483032777808816e-11
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.0343225770602658e-08
( O 0 1.1394565033271548e-13
15 O 0 1.2965941688369842e-11
from O 0 4.950538676912197e-12
Australia O 0 7.227639927526175e-12
, O 0 2.7953742361770846e-14
8 O 0 9.243141191675464e-13
from O 0 1.8608161886368713e-12
Northern O 0 6.973760457995581e-10
Ireland O 0 8.680988150544522e-10
) O 0 9.893464763795559e-14
, O 0 1.6237804557981544e-14
with O 0 4.83799257911823e-15
various O 0 1.5020163932066843e-12
clinical O 0 6.20525020256224e-11
phenotypes O 0 1.1447647690898677e-10
( O 0 3.309778666416019e-13
severe O 0 2.5956700677731703e-10
, O 0 7.381879395945701e-13
16 O 0 1.3042833306442514e-11
cases O 0 4.1683301097881695e-14
; O 0 2.566245132384513e-15
intermediate O 0 8.616857227750074e-12
, O 0 1.0999460585794148e-14
4 O 0 1.5974423389977788e-13
cases O 0 3.6691417455323935e-14
; O 0 4.062634831412254e-13
mild O 0 5.258114256501134e-12
, O 0 3.646501910105002e-14
3 O 0 2.4313249981020024e-13
cases O 0 4.3654573770972316e-14
) O 0 1.9567122444899554e-13
. O 0 1.4137684078985302e-10

We O 0 3.8673175772885315e-09
found O 0 8.057434060237956e-12
two O 0 6.208815877878013e-14
common O 0 2.5375489266809582e-14
mutations O 0 3.3497226565074815e-15
that O 0 2.6389311471707727e-17
together O 0 6.191641437839485e-15
accounted O 0 1.5027049049542995e-11
for O 0 5.279473689820402e-14
32 O 0 7.1930630340943935e-09
% O 0 8.211930691004454e-09
of O 0 1.7164636031963276e-11
the O 0 8.005198066929342e-12
44 O 0 7.521110123587249e-11
unrelated O 0 4.1570382552924556e-11
alleles O 0 1.2835718815953912e-12
in O 0 4.28118955217438e-12
these O 0 3.7438132455269724e-11
patients O 0 2.8633412307854655e-10
. O 0 5.278097958694161e-09

One O 0 6.77481737376695e-10
is O 0 1.9817948551745929e-13
the O 0 4.292956181511931e-12
T312S O 0 2.5937333703041077e-07
mutation O 0 2.760725502370942e-11
, O 0 4.3600068894882396e-14
a O 0 1.0904254929555712e-13
novel O 0 1.661663428381699e-13
mutation O 0 4.7932968358366246e-12
found O 0 3.464228144796355e-13
exclusively O 0 2.0227739622180607e-11
in O 0 1.7564538148592823e-12
milder O 0 6.648319117452672e-10
patients O 0 1.1531624960481324e-10
. O 0 2.5394435443359953e-09

The O 0 3.0025895103591438e-09
other O 0 5.853779700554229e-12
is O 0 1.0428794329844782e-13
the O 0 7.43123824194919e-13
previously O 0 7.468731189064215e-11
described O 0 6.6575755325315455e-12
I113F O 0 3.507513213207858e-08
that O 0 3.4260358357804735e-14
produces O 0 1.1366932108026681e-13
a O 0 9.332851332033432e-13
severe O 0 1.1869712990275616e-09
phenotype O 0 7.82702169743743e-09
. O 0 1.1846061909182026e-08

The O 0 1.4076888099623375e-08
I113F O 0 5.547857995225058e-07
and O 0 5.0476020932443966e-12
T312S O 0 1.4275185478140884e-08
mutations O 0 1.6086276191304427e-12
accounted O 0 2.503121043773149e-10
for O 0 2.248011889485757e-13
8 O 0 1.0261952745893588e-11
( O 0 6.927408560658934e-15
18 O 0 9.773327112883035e-12
% O 0 2.9470323750779848e-12
) O 0 6.771735128140144e-16
and O 0 1.2090963335252038e-14
6 O 0 7.544161692921159e-13
( O 0 3.0441570030931503e-15
14 O 0 1.031001347663596e-12
% O 0 2.098198134334317e-12
) O 0 8.165654368393592e-16
of O 0 1.327188819998451e-13
44 O 0 2.356328890687487e-12
unrelated O 0 1.2186369968691935e-11
alleles O 0 4.912198577587679e-13
, O 0 1.4622772393987904e-12
respectively O 0 3.913561030799428e-09
. O 0 8.372767013042903e-08

The O 0 6.735998869800142e-09
relatively O 0 1.968545548791667e-09
high O 0 4.3804692512194876e-11
residual O 0 5.682523784855675e-09
GALNS O 0 2.2892679680808214e-06
activity O 0 9.676392499768927e-12
seen O 0 1.0494122254121538e-13
when O 0 1.990012430015675e-15
the O 0 4.080035056553202e-14
T312S O 0 1.692116412266298e-11
mutant O 0 2.670705724714534e-13
cDNA O 0 3.067391063371616e-10
is O 0 2.4726295772166396e-13
overexpressed O 0 5.990478113560016e-10
in O 0 6.531667567921673e-13
mutant O 0 5.061931429573008e-11
cells O 0 1.3668198517446939e-11
provides O 0 7.807051852866051e-14
an O 0 6.151967473381277e-16
explanation O 0 8.140848021739866e-13
for O 0 1.6197598275667635e-13
the O 0 1.81592310632972e-11
mild O 0 2.1946033532116438e-11
phenotype O 0 4.4497738826976274e-11
in O 0 2.801043902031508e-13
patients O 0 1.2740149376005289e-13
with O 0 2.529612863239896e-15
this O 0 3.8138651850365413e-13
mutation O 0 2.089492988355257e-11
. O 0 5.400088709528461e-10

The O 0 3.782889973491521e-11
distribution O 0 7.44273219444036e-12
and O 0 2.8895919131858433e-15
relative O 0 4.264002345655271e-12
frequencies O 0 1.2790000829265846e-11
of O 0 1.0130173609679272e-12
the O 0 1.407352966803499e-12
I113F O 0 3.243330048974258e-09
and O 0 7.221490115963403e-13
T312S O 0 3.250639935004074e-08
mutations O 0 6.662234240846499e-13
in O 0 8.955530002470458e-13
Australia O 0 2.38050594861261e-12
corresponded O 0 2.744659360898183e-11
to O 0 4.643616220711966e-12
those O 0 2.488261983610296e-12
observed O 0 9.93109847829965e-12
in O 0 6.851624302639525e-12
Northern O 0 1.1617648176809325e-08
Ireland O 0 1.0556020058061222e-08
and O 0 1.6540666405995275e-11
are O 0 2.3901464574899167e-12
unique O 0 2.3398890464099154e-11
to O 0 2.490067353699832e-11
these O 0 1.5227682396284914e-12
two O 0 5.488806024273041e-12
populations O 0 6.486242207399961e-13
, O 0 2.0162303020188586e-14
suggesting O 0 1.2535582381151267e-12
that O 0 6.529281899625731e-15
both O 0 2.9256662197052474e-12
mutations O 0 1.5416301915593955e-11
were O 0 3.4716268054735266e-11
probably O 0 4.516312237384801e-12
introduced O 0 7.786144369222384e-14
to O 0 1.76272635810798e-12
Australia O 0 1.5016669548464923e-12
by O 0 1.0725867080358525e-13
Irish O 0 3.02520258843586e-10
migrants O 0 1.951906691832761e-10
during O 0 6.781886163764739e-11
the O 0 1.4331082978311094e-12
19th O 0 7.706637411564188e-11
century O 0 2.0033313896661298e-10
. O 0 2.10926787147514e-09

Haplotype O 0 7.652482025832796e-08
analysis O 0 1.442307107080154e-10
using O 0 1.4121748909134979e-11
6 O 0 3.913979362835107e-09
RFLPs O 0 1.1781271496147383e-05
provides O 0 4.547514166446109e-13
additional O 0 1.0220589565651528e-13
data O 0 3.5279769557139407e-12
that O 0 2.4078139723477006e-15
the O 0 1.796125639712265e-12
I113F O 0 5.802401759069653e-08
mutation O 0 4.314059526278058e-12
originated O 0 8.24690576245457e-12
from O 0 1.6181734771580913e-12
a O 0 3.8710020432153325e-12
common O 0 4.445464482638606e-11
ancestor O 0 4.5976191742624906e-09
. O 0 2.1045751807946544e-08

The O 0 5.74583491896874e-09
other O 0 2.2147106197578648e-12
9 O 0 5.011237952379233e-11
novel O 0 1.2357741783000642e-13
mutations O 0 2.808652616037577e-12
identified O 0 4.031326596327933e-13
in O 0 1.8880135695402596e-14
these O 0 1.0049603767973807e-14
23 O 0 5.985515902362515e-12
patients O 0 2.7722575212003886e-13
were O 0 1.440331794805294e-12
each O 0 7.210214819945368e-14
limited O 0 1.0188810515773805e-12
to O 0 2.3343469084807777e-12
a O 0 1.7452306960707986e-11
single O 0 5.701389915735433e-10
family O 0 1.2964018747396722e-10
. O 0 1.3252191344292896e-08

These O 0 4.41974790099664e-10
data O 0 4.765525196681608e-10
provide O 0 3.5543299531891337e-13
further O 0 1.867606546843148e-13
evidence O 0 5.736307154106945e-13
for O 0 2.1967536568013452e-13
extensive O 0 1.6477130770908843e-10
allelic O 0 2.8277715724556174e-09
heterogeneity O 0 6.3238072556259795e-09
in O 0 1.5384916673966131e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 5.732127550395205e-10
British O 0 1.5133263531197372e-08
- O 0 9.103368370233511e-08
Irish O 0 1.0101941505524792e-09
patients O 0 1.2322254761693019e-12
and O 0 3.988529917854731e-15
provide O 0 8.01808706235585e-14
evidence O 0 1.366573412590888e-13
for O 0 9.667818066559034e-15
their O 0 3.0211861658246963e-12
transmission O 0 2.4730034908770904e-08
to O 0 2.701415697040077e-12
Australia O 0 8.677829505324142e-13
by O 0 3.2639750548613816e-14
British O 0 2.405515786563228e-10
- O 0 3.3569330648575146e-10
Irish O 0 1.0919672110976109e-10
migrants O 0 1.8865190659633768e-11
. O 0 7.964256966593031e-13
. O 0 5.972130429077183e-11

Identification O 0 3.575424898372148e-07
of O 0 1.2545917194017875e-08
constitutional O 0 1.0749737811011073e-07
WT1 O 0 0.1605803519487381
mutations O 0 3.33180838474334e-09
, O 0 2.183769793684745e-13
in O 0 1.9733005377289836e-13
patients O 0 6.280991785706513e-12
with O 0 1.421386337623065e-12
isolated O 0 5.174956640985329e-08
diffuse B-Disease 0 2.2720229026162997e-05
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 1.8790116760713377e-13
and O 0 2.73654110642999e-15
analysis O 0 5.871758157818818e-13
of O 0 9.482069643351743e-12
genotype O 0 1.0792763210920597e-10
/ O 0 3.6958625049265947e-09
phenotype O 0 8.757947492221696e-12
correlations O 0 6.002627323149767e-13
by O 0 3.1825185644777194e-15
use O 0 7.626177250460997e-13
of O 0 1.2614859677684276e-11
a O 0 1.1214860637376312e-11
computerized O 0 5.080604825735691e-09
mutation O 0 4.11612931239258e-11
database O 0 2.248023989182002e-10
. O 0 1.2096322832277906e-09

Constitutional O 0 1.9306185095047113e-08
mutations O 0 3.9766960557852116e-11
of O 0 3.1742199146922445e-11
the O 0 8.412657723222416e-12
WT1 O 0 1.3228653727992423e-08
gene O 0 3.895974458301664e-14
, O 0 2.8284424871411872e-15
encoding O 0 2.007055632802235e-11
a O 0 7.264779749993622e-11
zinc O 0 2.300611257055607e-09
- O 0 3.4255347447498252e-09
finger O 0 6.986171641187866e-09
transcription O 0 1.9220898206384618e-09
factor O 0 3.356291286560342e-11
involved O 0 7.129976470343635e-11
in O 0 3.1049041115949194e-10
renal O 1 0.9999818801879883
and O 0 7.435960736046354e-09
gonadal O 1 0.9997804760932922
development O 0 4.168663508608006e-06
, O 0 1.4471906203787632e-13
are O 0 4.802174943910635e-15
found O 0 3.1029798413899357e-14
in O 0 1.1926190863055606e-14
most O 0 1.0278234901096688e-14
patients O 0 1.763649481718952e-14
with O 0 8.239032726735113e-15
Denys B-Disease 1 0.9999985694885254
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.315251323992129e-10
DDS B-Disease 1 1.0
) O 0 1.8069814741727974e-11
, O 0 4.3190546083170245e-13
or O 0 7.58559465241504e-11
diffuse B-Disease 0 0.010534919798374176
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 2.954277100730707e-11
DMS B-Disease 0 3.746361798562248e-08
) O 0 3.2570576755943347e-15
associated O 0 1.7214256008060008e-13
with O 0 3.018775618477028e-14
pseudohermaphroditism B-Disease 1 1.0
and O 0 1.7916886724256287e-11
/ O 0 1.653014862768032e-07
or O 0 8.262024397964751e-11
Wilms B-Disease 0 5.721063189412234e-06
tumor I-Disease 0 3.122569935953834e-08
( O 0 4.9802961234191034e-12
WT B-Disease 1 1.0
) O 0 6.354799499119768e-12
. O 0 2.947074806414207e-10

Most O 0 1.0281496765074394e-09
mutations O 0 9.338064765884724e-10
in O 0 4.0130967993157185e-10
DDS B-Disease 1 1.0
patients O 0 3.3733073223629617e-07
lie O 0 3.7240914707581396e-07
in O 0 1.3318618430346874e-10
exon O 0 6.551728604087259e-10
8 O 0 1.2271347826775525e-10
or O 0 4.188492261358867e-11
exon O 0 3.075469323654545e-10
9 O 0 5.367554317681211e-11
, O 0 8.286541483375209e-13
encoding O 0 1.4799121927921988e-08
zinc O 0 2.722225076468021e-07
finger O 0 4.0585986425867304e-05
2 O 0 4.032020939348513e-08
or O 0 9.212045881668018e-08
zinc O 0 2.5740592946021934e-07
finger O 0 2.800971287797438e-06
3 O 0 9.181581189787735e-11
, O 0 1.754366915412628e-13
respectively O 0 1.2133219429166786e-10
, O 0 2.932741804398051e-14
with O 0 9.482163691113942e-15
a O 0 3.6151966836817095e-12
hot O 0 9.555022051355166e-11
spot O 0 8.565690934325687e-10
( O 0 6.386873045412592e-14
R394W O 0 2.8078641634010637e-09
) O 0 7.1967361540623e-14
in O 0 4.027800662442793e-12
exon O 0 5.492759580505435e-10
9 O 0 2.510978758252236e-09
. O 0 8.9765999078395e-09

We O 0 1.269186089558616e-09
analyzed O 0 6.63187629812434e-11
a O 0 5.758140817456459e-14
series O 0 5.345672025153757e-14
of O 0 3.1396302116286356e-13
24 O 0 1.4958702679312985e-11
patients O 0 3.808238988912971e-13
, O 0 5.250469672343815e-15
10 O 0 1.0280048296992805e-12
with O 0 5.90315502643074e-13
isolated B-Disease 0 1.7726222267810954e-08
DMS I-Disease 0 5.062951458967291e-06
( O 0 1.1362239274448349e-11
IDMS B-Disease 0 6.109146488597617e-05
) O 0 4.2047284707844024e-13
, O 0 2.3349633790597894e-14
10 O 0 8.766800761901561e-13
with O 0 2.528573596165262e-13
DDS B-Disease 1 1.0
, O 0 3.3473772798747747e-12
and O 0 1.127505342779847e-13
4 O 0 7.807298210704694e-12
with O 0 4.972074184664277e-13
urogenital B-Disease 0 5.452140499073721e-07
abnormalities I-Disease 0 1.2410312592692208e-05
and O 0 3.671277448713539e-10
/ O 0 0.0004841136105824262
or O 0 2.1517983839203225e-07
WT B-Disease 1 1.0
. O 0 1.4739822695730709e-08

We O 0 1.2697847218134939e-08
report O 0 3.3044600389331436e-10
WT1 O 0 8.632828780719137e-07
heterozygous O 0 3.0439673004423184e-10
mutations O 0 1.4924325881029987e-12
in O 0 1.8374704698325556e-13
16 O 0 9.376682069683895e-11
patients O 0 6.707884681739218e-12
, O 0 4.2313801930631695e-14
4 O 0 3.855116312984075e-12
of O 0 7.284562709986009e-12
whom O 0 5.1463149713937284e-11
presented O 0 5.279887638209857e-10
with O 0 3.2217614687191087e-10
IDMS B-Disease 0 0.14463196694850922
. O 0 2.50512783850354e-07

One O 0 3.054307640137921e-10
male O 0 1.9935266978854393e-11
and O 0 2.5076076672482343e-14
two O 0 6.436133635594199e-13
female O 0 1.1490963042204427e-10
IDMS B-Disease 1 0.7819918394088745
patients O 0 9.126303879281039e-11
with O 0 2.0410353962496686e-11
WT1 O 1 0.9996650218963623
mutations O 0 9.28227876784149e-08
underwent O 0 1.0513450661164825e-06
normal O 0 8.333809660143743e-07
puberty O 0 1.2008335659174918e-07
. O 0 6.808744679176471e-10

Two O 0 6.522058004776454e-09
mutations O 0 2.1574053654660474e-10
associated O 0 9.938208589410635e-11
with O 0 2.6741122337303747e-12
IDMS B-Disease 1 0.9991723299026489
are O 0 2.45671047388726e-14
different O 0 1.3963462649330387e-14
from O 0 9.630095115439885e-14
those O 0 5.2783061396059067e-14
described O 0 3.91163750695922e-12
in O 0 2.465813386809401e-10
DDS B-Disease 1 1.0
patients O 0 2.048307834456864e-08
. O 0 1.0275247319668779e-08

No O 0 1.619467404623265e-08
WT1 O 0 6.2610197346657515e-06
mutations O 0 1.402782473514108e-10
were O 0 5.961588861458367e-12
detected O 0 5.141975820827094e-12
in O 0 1.081448044857507e-14
the O 0 4.928603098558471e-13
six O 0 5.619611980617334e-12
other O 0 1.186200118165337e-12
IDMS B-Disease 1 0.9997699856758118
patients O 0 5.79409020762256e-10
, O 0 3.3770046221209826e-12
suggesting O 0 3.091949751787837e-10
genetic O 0 6.863953294633518e-10
heterogeneity O 0 7.0410322017266935e-09
of O 0 1.5739459735542027e-09
this O 0 7.263259993450788e-10
disease O 0 1.5704988243214757e-07
. O 0 5.076235876089186e-09

We O 0 2.8932183315788507e-09
analyzed O 0 1.624487655504936e-09
genotype O 0 1.5745224013485881e-09
/ O 0 1.2475896982167e-09
phenotype O 0 1.1964850984980124e-11
correlations O 0 1.2021076842283485e-11
, O 0 7.344122089170211e-15
on O 0 3.1792572589318946e-13
the O 0 8.971922055116266e-14
basis O 0 2.3727146983287817e-11
of O 0 5.393883581970849e-13
the O 0 2.5413766685696004e-13
constitution O 0 1.4271637799496972e-13
of O 0 3.2067744726999026e-12
a O 0 1.7814387118231245e-11
WT1 O 0 3.05735966321663e-07
mutation O 0 3.6898293448439645e-11
database O 0 9.392004535202503e-11
of O 0 3.225436584486374e-11
84 O 0 7.889553010897998e-09
germ O 0 1.2298349247430451e-05
- O 0 1.0151313745154766e-06
line O 0 1.3871392923192616e-08
mutations O 0 9.50735063592889e-12
, O 0 7.085765181796388e-15
to O 0 9.990935894354722e-14
compare O 0 1.0294220337270232e-11
the O 0 2.0548139741376897e-13
distribution O 0 2.6133127779826015e-12
and O 0 9.39087471522361e-15
type O 0 1.5684242099522905e-11
of O 0 1.635051816162303e-11
mutations O 0 1.5715788316984086e-13
, O 0 1.6798354233573732e-15
according O 0 2.779654219471628e-13
to O 0 9.340758418477368e-13
the O 0 2.2067243865553365e-12
different O 0 6.560878923478342e-11
symptoms O 0 5.5866400394677385e-09
. O 0 5.36792554850507e-10

This O 0 1.9141679907797027e-10
demonstrated O 0 2.5095854283563312e-09
( O 0 8.213899395717594e-14
1 O 0 2.3879136515359e-12
) O 0 7.392467341667697e-15
the O 0 8.447750284674635e-14
association O 0 3.285950138831768e-14
between O 0 1.6095729350046328e-12
mutations O 0 2.0467015669073385e-13
in O 0 7.206711898251339e-13
exons O 0 2.665538102741838e-11
8 O 0 2.661294795647251e-12
and O 0 3.1452219843332296e-13
9 O 0 8.812308521788381e-11
and O 0 8.479419943974165e-11
DMS B-Disease 0 1.1558257710930775e-06
; O 0 2.993869692088924e-12
( O 0 7.798271170521634e-14
2 O 0 7.696728454228974e-13
) O 0 1.9201574534490236e-14
among O 0 1.1808398226245687e-14
patients O 0 1.9676958223609556e-14
with O 0 4.523083432317679e-14
DMS B-Disease 0 1.1639428088017212e-08
, O 0 8.22415703247148e-13
a O 0 1.4769427000849156e-12
higher O 0 1.6188234086556008e-10
frequency O 0 5.786822687703363e-10
of O 0 3.8597772200610336e-10
exon O 0 2.2535834309778124e-10
8 O 0 1.4593920516503545e-10
mutations O 0 3.933221370128193e-12
among O 0 2.9872515593977467e-13
46 O 0 2.5817362137026123e-10
, O 0 4.192837917138537e-12
XY O 0 0.00011344512313371524
patients O 0 3.120266892087109e-11
with O 0 5.995084393110514e-14
female O 0 2.83043970206176e-11
phenotype O 0 7.807026509640269e-13
than O 0 7.347036729541713e-15
among O 0 2.671703021306631e-14
46 O 0 5.840714578653206e-10
, O 0 7.991315942312838e-12
XY O 1 0.867340624332428
patients O 0 1.398894888815505e-10
with O 0 5.886511709931458e-14
sexual O 0 9.44547608530688e-13
ambiguity O 0 3.802579778833248e-12
or O 0 3.2441093539802013e-13
male O 0 2.1135738558636374e-12
phenotype O 0 9.134096473975561e-13
; O 0 7.900555481100274e-14
and O 0 1.5091273716794085e-11
( O 0 5.972556975895882e-13
3 O 0 6.046205897058954e-11
) O 0 3.521521182298093e-13
statistically O 0 3.885718583376309e-14
significant O 0 1.7730351996975927e-15
evidence O 0 1.6114944123048203e-14
that O 0 3.8026747956011395e-15
mutations O 0 1.5291941161694328e-13
in O 0 1.831282087777497e-12
exons O 0 3.0563007680228793e-10
8 O 0 1.4214277324620106e-11
and O 0 7.089963924115927e-13
9 O 0 1.676498107006097e-10
preferentially O 0 2.0932595934386455e-10
affect O 0 2.382865849082094e-10
amino O 0 1.1781425834911374e-10
acids O 0 3.054186406819398e-13
with O 0 4.547076148768425e-15
different O 0 3.458180736128774e-13
functions O 0 2.255930511840809e-11
. O 0 7.678433409930019e-12
. O 0 5.617463716411919e-10

The O 0 6.447131273290552e-09
185delAG O 0 4.081005329226173e-07
BRCA1 O 0 2.1091068891365694e-09
mutation O 0 5.950328120854498e-13
originated O 0 1.0658485948217625e-13
before O 0 1.2589199973288279e-13
the O 0 1.1328903039200394e-13
dispersion O 0 5.212284423516955e-11
of O 0 6.063236718256704e-12
Jews O 0 2.5178342050180547e-11
in O 0 1.095395584134462e-12
the O 0 2.4935544080950667e-12
diaspora O 0 1.7943023455924134e-10
and O 0 4.289180501656359e-13
is O 0 2.7357598879427375e-14
not O 0 3.719623892749213e-13
limited O 0 7.001010882135006e-11
to O 0 4.31367119801962e-09
Ashkenazim O 0 9.903687896439806e-05
. O 0 2.4482238814016455e-07

The O 0 1.116654768651415e-09
185delAG O 0 7.692506187595427e-08
mutation O 0 1.3426220205059458e-11
in O 0 9.038194671850963e-12
BRCA1 O 0 5.246278966808404e-10
is O 0 5.995372926413667e-13
detected O 0 9.971792488960851e-12
in O 0 4.907946878768277e-13
Ashkenazi O 0 3.6852121354513656e-09
Jews O 0 1.7877152883039038e-11
both O 0 1.3550034575274261e-12
in O 0 6.787214453657375e-12
familial B-Disease 0 2.132446206815075e-05
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.93217938210455e-08
in O 0 1.5739173853113186e-11
the O 0 4.092852792791923e-12
general O 0 6.808863911057783e-13
population O 0 8.302479729649197e-15
. O 0 3.1819406050986876e-12

All O 0 1.1732994575908151e-09
tested O 0 2.792411857299726e-10
Ashkenazi O 0 6.361900450890801e-10
mutation O 0 3.750769294219754e-14
carriers O 0 5.629666417555305e-15
share O 0 2.545199294379241e-13
the O 0 7.757830429487925e-14
same O 0 1.3736981387471592e-12
allelic O 0 1.3132261944548418e-09
pattern O 0 1.2059020448873525e-10
at O 0 1.1749426431784116e-10
the O 0 4.7419845827789686e-11
BRCA1 O 0 1.4687187577244742e-10
locus O 0 3.6349874499297385e-11
. O 0 2.9383875332911202e-09

Our O 0 3.666186643158653e-08
previous O 0 1.2466001564348517e-09
study O 0 4.80655988101264e-13
showed O 0 7.863457064313795e-13
that O 0 1.826178814431936e-16
this O 0 2.7581949108034833e-14
Ashkenazi O 0 1.6793544332927013e-08
mutation O 0 1.0955215033747745e-11
also O 0 1.6225915603533883e-14
occurs O 0 1.1850462560032693e-13
in O 0 4.0020812591646734e-14
Iraqi O 0 4.4192049131197564e-07
Jews O 0 2.95139496175878e-10
with O 0 5.635416924234214e-14
a O 0 1.7120739504924987e-13
similar O 0 1.3675433669594478e-13
allelic O 0 7.785996847253784e-10
pattern O 0 1.122516524176831e-09
. O 0 5.9633493698640905e-09

We O 0 4.66775729179858e-10
extended O 0 8.30984794863987e-11
our O 0 9.011067066133638e-12
analysis O 0 2.0392354796970602e-13
to O 0 6.021970574109081e-14
other O 0 1.7096004787612445e-13
non O 0 2.2401536181604342e-09
- O 0 4.197915348669312e-10
Ashkenazi O 0 7.529283863050296e-09
subsets O 0 2.1099337554897346e-11
354 O 0 4.299645015026776e-11
of O 0 3.0632892056292604e-12
Moroccan O 0 1.343496980332759e-09
origin O 0 7.671304563805492e-12
, O 0 1.3303865387809255e-14
200 O 0 6.806241226002541e-13
Yemenites O 0 2.1628130397743917e-08
and O 0 4.741561012095233e-14
150 O 0 2.0632430226125154e-12
Iranian O 0 2.4845618895597e-09
Jews O 0 2.514026542499437e-09
. O 0 8.461316980401534e-09

Heteroduplex O 0 6.360061775012582e-07
analysis O 0 1.7333344828895925e-11
complemented O 0 1.1088892391125649e-12
by O 0 4.196765821096708e-16
direct O 0 1.055867090808682e-13
DNA O 0 1.3488986316811946e-10
sequencing O 0 2.5198689801442242e-09
of O 0 1.5923282137286776e-10
abnormally O 0 8.156425188032834e-12
migrating O 0 3.193296050762323e-13
bands O 0 2.0619053339721027e-12
were O 0 1.1097720832575764e-11
employed O 0 9.322373983877696e-09
. O 0 6.124406315421993e-09

Four O 0 5.736316421867116e-10
of O 0 3.6350725207690004e-10
Moroccan O 0 4.881287054558925e-07
origin O 0 1.5351991899947848e-10
( O 0 3.533332082659665e-15
1 O 0 1.77236751750659e-13
. O 0 1.395701757563473e-14
1 O 0 9.733357918479194e-14
% O 0 4.038137012274401e-13
) O 0 7.312999901696381e-17
and O 0 1.250082352018708e-15
none O 0 8.292933180442663e-12
of O 0 1.1262255017463474e-11
the O 0 1.677386354814736e-11
Yemenites O 0 1.540320937465367e-07
or O 0 1.6887173083512952e-12
Iranians O 0 4.2140264611134626e-09
was O 0 9.561361251353429e-12
a O 0 1.2734973665884386e-13
carrier O 0 3.484240619546636e-13
of O 0 4.094430090112455e-12
the O 0 2.3824556910634342e-11
185delAG O 0 5.112969603260353e-08
mutation O 0 1.9650631122303253e-10
. O 0 1.5476567805094987e-09

BRCA1 O 0 3.1673002354182245e-07
allelic O 0 3.792967362414856e-08
patterns O 0 1.1975770375372008e-10
were O 0 1.746135571203955e-12
determined O 0 4.293979668362757e-12
for O 0 6.22347022549187e-14
four O 0 4.391867186766263e-13
of O 0 8.671852163221958e-14
these O 0 1.2967200919736482e-15
individuals O 0 1.0828716954836047e-15
and O 0 2.909323757450369e-15
for O 0 8.708366737138554e-14
12 O 0 2.4001616666380343e-11
additional O 0 1.744914455981128e-11
non O 0 1.4115873803177692e-08
- O 0 3.5208433946110063e-09
Ashkenazi O 0 3.920748614660852e-09
185delAG O 0 5.010580839126533e-10
mutation O 0 2.706096794129892e-13
carriers O 0 5.184613114804677e-14
who O 0 1.7909567058549403e-12
had O 0 4.6325016000992036e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9993723034858704

Six O 0 9.745627949087066e-08
non O 0 1.53389441948093e-06
- O 0 4.0093674158470094e-08
Ashkenazi O 0 2.4947965471255884e-08
individuals O 0 1.6910831459118758e-12
shared O 0 3.5170810708251565e-11
the O 0 2.9935270842024186e-12
common O 0 5.142682286962685e-12
Ashkenazi O 0 2.0517800791708396e-08
haplotype O 0 2.9103259802099046e-09
, O 0 5.017997736084245e-12
four O 0 1.2005135774373343e-10
had O 0 2.549146831121174e-11
a O 0 9.733660275360045e-13
closely O 0 5.695077113891667e-13
related O 0 3.1560365432170556e-11
pattern O 0 4.415467436125198e-10
, O 0 2.268855337438612e-14
and O 0 4.500622829061926e-14
the O 0 3.774322798744123e-10
rest O 0 9.483486564931809e-07
( O 0 1.0558495267334878e-12
n O 0 2.559909922927872e-11
= O 0 1.5525542657046643e-11
6 O 0 1.2222404512096663e-11
) O 0 3.2427467151372943e-14
displayed O 0 1.306987179074126e-12
a O 0 1.1709948332175313e-12
distinct O 0 7.2100151370102505e-12
BRCA1 O 0 8.756013969435372e-11
allelic O 0 6.633208426976012e-10
pattern O 0 8.683107011187019e-10
. O 0 8.567721643260029e-09

We O 0 2.2314487757579826e-10
conclude O 0 4.91095342169956e-09
that O 0 2.4766116823895894e-14
the O 0 1.0375467845991082e-12
185delAG O 0 3.3367388851957e-08
BRCA1 O 0 1.9363042280673426e-09
mutation O 0 6.785786125715343e-13
occurs O 0 1.4572758689872234e-13
in O 0 1.5313656375956497e-13
some O 0 1.5420881802410968e-12
non O 0 2.270967797812773e-06
- O 0 1.5150242688832805e-05
Ashkenazi O 0 0.02199040912091732
populations O 0 5.648804757285575e-10
at O 0 5.36693987862602e-11
rates O 0 4.231465438458981e-12
comparable O 0 2.857348038731722e-12
with O 0 5.2152974762420274e-15
that O 0 8.862424411958808e-14
of O 0 3.073135634856783e-10
Ashkenazim O 0 1.0409463584437617e-06
. O 0 2.5639304013225228e-08

The O 0 7.388948342068602e-10
majority O 0 4.5604259951703696e-11
of O 0 3.382769758752957e-11
Jewish O 0 5.461190388800219e-10
185delAG O 0 5.706639072400321e-08
mutation O 0 8.104537006781154e-12
carriers O 0 5.695446284731398e-13
have O 0 4.219935422693048e-14
a O 0 2.3801368319829874e-13
common O 0 5.024967529750068e-13
allelic O 0 4.745877579814817e-10
pattern O 0 5.150479001625463e-11
, O 0 7.153040096005703e-14
supporting O 0 2.274117309394863e-12
the O 0 5.9664606588683e-11
founder O 0 6.162344523552576e-10
effect O 0 4.8084145172488935e-12
notion O 0 7.93938786242121e-12
, O 0 1.855773970908456e-14
but O 0 3.4974733663541277e-15
dating O 0 2.5470084374923374e-11
the O 0 1.3740012816745861e-13
mutations O 0 6.788347011246754e-14
origin O 0 1.7180275756721597e-13
to O 0 5.242769651574164e-13
an O 0 1.6254287819135113e-14
earlier O 0 1.950148376117511e-12
date O 0 4.776335993383896e-10
than O 0 1.5272411970062433e-13
currently O 0 8.605782644659221e-13
estimated O 0 3.4415369859486233e-11
. O 0 6.096411375722255e-09

However O 0 1.351495138024461e-09
, O 0 2.637708844746567e-13
the O 0 1.4630073682467964e-13
different O 0 6.540453671276952e-14
allelic O 0 1.001598387562197e-10
pattern O 0 1.575181825252958e-11
at O 0 3.8136941521438317e-11
the O 0 6.488252990433097e-11
BRCA1 O 0 4.674385323255592e-10
locus O 0 5.6972013912082176e-11
even O 0 1.4325234791792707e-12
in O 0 8.809745467852625e-13
some O 0 2.0651828771395264e-13
Jewish O 0 7.53286807930742e-11
mutation O 0 5.3187359030926196e-12
carriers O 0 1.4192569645563036e-12
, O 0 2.1078490515524795e-12
might O 0 2.0856306265359947e-11
suggest O 0 7.851116284873783e-11
that O 0 4.364200041390327e-14
the O 0 6.7443450997572985e-12
mutation O 0 1.6049713641441699e-12
arose O 0 1.219250742034994e-11
independently O 0 1.368338636842381e-10
. O 0 2.7589357881607768e-11
. O 0 4.20633305964202e-09

Crystal O 0 2.9071551921333594e-07
structure O 0 1.1612220518486538e-08
of O 0 2.2443032321461942e-08
the O 0 4.9246501987454394e-08
hemochromatosis B-Disease 1 1.0
protein O 0 6.664281126944616e-09
HFE O 0 8.233168387050682e-07
and O 0 2.573045671926816e-13
characterization O 0 2.1344020301183875e-11
of O 0 2.629323148095608e-11
its O 0 3.081377384153705e-13
interaction O 0 8.757211969467882e-12
with O 0 1.76392957857395e-13
transferrin O 0 3.5567515599410626e-09
receptor O 0 5.059093768911005e-11
. O 0 6.660922369228217e-10

HFE O 0 0.0013435513246804476
is O 0 1.1500340610370863e-11
an O 0 1.0548872973054069e-12
MHC O 0 8.998851441788247e-09
- O 0 4.995906799365457e-09
related O 0 8.985785626691722e-08
protein O 0 1.277243033559472e-10
that O 0 7.794100719102533e-16
is O 0 2.7382508887561372e-17
mutated O 0 4.633715443173923e-16
in O 0 2.4574592086609856e-15
the O 0 7.267271420058341e-12
iron B-Disease 1 0.6479664444923401
- I-Disease 1 0.999998927116394
overload I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.8659198758541606e-05

HFE O 0 2.1857645151612815e-06
binds O 0 4.110394316581001e-11
to O 0 3.5692660632635764e-11
transferrin O 0 9.245517684774995e-10
receptor O 0 2.412486985355067e-13
( O 0 1.3954463771298758e-14
TfR O 0 1.3903143081250846e-09
) O 0 4.0314067256447435e-15
and O 0 8.22490167607607e-15
reduces O 0 6.607964230052193e-14
its O 0 8.922223243969067e-15
affinity O 0 2.9265186194532555e-13
for O 0 5.7099151795636516e-12
iron O 0 3.722171904030347e-09
- O 0 3.168946216547397e-10
loaded O 0 2.8860300260724614e-10
transferrin O 0 1.878263100607569e-09
, O 0 1.1030444786730431e-11
implicating O 0 5.4190479659155244e-08
HFE O 0 2.9083217668812722e-05
in O 0 1.4860331631894041e-08
iron O 0 1.8210532289231196e-05
metabolism O 0 1.4947972886147909e-05
. O 0 3.959415195708971e-08

The O 0 8.334447443303361e-08
2 O 0 5.821746285050722e-08
. O 0 1.691990014762723e-08

6 O 0 2.153173852548207e-07
A O 0 1.4030856618774123e-06
crystal O 0 4.7589352902832616e-08
structure O 0 3.8258523460399374e-08
of O 0 6.132005836434473e-08
HFE O 1 0.9979572296142578
reveals O 0 5.84878590004223e-10
the O 0 5.334847147375754e-13
locations O 0 1.1909955660582838e-11
of O 0 6.402033347896463e-10
hemochromatosis B-Disease 1 1.0
mutations O 0 1.2487188172372043e-08
and O 0 1.3227901413115362e-11
a O 0 3.5232330941603607e-10
patch O 0 0.001664790092036128
of O 0 4.7018111217767e-06
histidines O 0 0.014065055176615715
that O 0 7.541413782514994e-13
could O 0 1.6220423441903886e-12
be O 0 4.775544651565433e-13
involved O 0 3.2900501767407775e-11
in O 0 1.2902257040536824e-09
pH O 0 7.074162112985505e-06
- O 0 1.0903201008716223e-08
dependent O 0 7.744544561205657e-09
interactions O 0 4.0930911437975226e-10
. O 0 1.1078444828171996e-09

We O 0 1.3822788469397551e-09
also O 0 7.976753480833099e-13
demonstrate O 0 4.509809192754233e-10
that O 0 1.538022747354928e-12
soluble O 0 3.473277498944327e-10
TfR O 0 1.7094310411636116e-09
and O 0 2.545412882207221e-13
HFE O 0 1.5439786693605129e-07
bind O 0 2.50567649962008e-10
tightly O 0 3.4332992004948437e-09
at O 0 6.142005654075078e-11
the O 0 5.045869104491896e-12
basic O 0 1.8600816886760185e-08
pH O 0 1.1881220451925856e-09
of O 0 1.205161057754589e-11
the O 0 2.48708519057228e-12
cell O 0 1.2042557055724767e-11
surface O 0 2.2927577805059718e-12
, O 0 3.040676841174414e-14
but O 0 5.001976887157242e-14
not O 0 1.2009428824663604e-12
at O 0 1.9682300234080685e-09
the O 0 3.2619432488445455e-08
acidic O 0 2.1539760837185895e-06
pH O 0 5.965661671325506e-07
of O 0 1.3519991171051515e-07
intracellular O 0 1.9712955179329583e-07
vesicles O 0 5.64603624297888e-07
. O 0 8.429763909134635e-08

TfR O 0 1.7588294213055633e-05
HFE O 0 9.78124444372952e-05
stoichiometry O 0 1.9503573867041268e-07
( O 0 3.5004820223005773e-12
2 O 0 1.6693020229996414e-11
1 O 0 5.29020447240236e-12
) O 0 8.365842029268555e-15
differs O 0 3.6674921996895926e-13
from O 0 7.128826608887584e-13
TfR O 0 2.08196038187225e-09
transferrin O 0 1.6972859229191783e-10
stoichiometry O 0 9.543260626188044e-10
( O 0 1.4171571359987423e-13
2 O 0 1.8722226460127223e-12
2 O 0 1.0769166591470536e-12
) O 0 2.145914095562102e-14
, O 0 2.66140886049206e-14
implying O 0 2.0094026269290577e-12
a O 0 2.3175217848296972e-14
different O 0 3.133795577637405e-14
mode O 0 1.4029992445596662e-10
of O 0 1.465130317415686e-12
binding O 0 2.436037699685145e-12
for O 0 2.3494236070509267e-11
HFE O 0 1.0513227607589215e-05
and O 0 3.270373555297468e-11
transferrin O 0 4.317531665520846e-09
to O 0 6.376855155032501e-10
TfR O 0 3.0409617579607584e-07
, O 0 9.654703116623517e-14
consistent O 0 2.528613169544558e-12
with O 0 2.5158225315838854e-15
our O 0 9.022556139715032e-12
demonstration O 0 5.346707018100139e-12
that O 0 3.71575024167483e-14
HFE O 0 4.7775799316696066e-08
, O 0 3.503365674818737e-13
transferrin O 0 7.285806402634876e-10
, O 0 7.767784354108243e-13
and O 0 6.97919153025417e-13
TfR O 0 4.8240043071245964e-08
form O 0 5.80360716082029e-12
a O 0 6.4894378933033625e-12
ternary O 0 3.728753839027377e-08
complex O 0 1.1608920935657352e-08
. O 0 2.0012139501091042e-08

Identification O 0 5.527731516963286e-08
of O 0 1.9780894977561303e-10
three O 0 1.0006006440077542e-12
novel O 0 7.924730140228091e-15
mutations O 0 1.4470415425800465e-13
and O 0 1.0648036780373706e-14
a O 0 2.2253291603099162e-13
high O 0 1.5897592487226775e-12
frequency O 0 5.197373781351544e-11
of O 0 3.388980502477823e-12
the O 0 5.551472476161834e-12
Arg778Leu O 0 4.347431215023789e-08
mutation O 0 3.986572085900447e-13
in O 0 7.493148218877185e-14
Korean O 0 9.354930163851805e-10
patients O 0 1.8452576706212698e-12
with O 0 1.2036758308825446e-13
Wilson B-Disease 0 7.608700336447782e-09
disease I-Disease 0 1.5180031676109706e-09
. O 0 4.108938744806778e-10

Four O 0 3.586783137166094e-08
mutations O 0 6.889924186737062e-10
- O 0 2.249114228192184e-09
- O 0 1.0273341066735497e-09
R778L O 0 7.19704251750386e-09
, O 0 5.2241404155080676e-14
A874V O 0 3.3492200679496875e-10
, O 0 4.5646639408852135e-15
L1083F O 0 5.2892086543909755e-11
, O 0 4.628221375719795e-16
and O 0 7.961601484422071e-16
2304delC O 0 9.227719977022986e-11
- O 0 4.553158197695417e-12
- O 0 2.827918238121341e-12
in O 0 5.675493170050061e-13
the O 0 1.2243216856999695e-11
copper O 0 2.9462019629500347e-11
- O 0 2.2189037716599525e-13
transporting O 0 4.470673831136196e-12
enzyme O 0 2.1790681509637616e-13
, O 0 6.270391785011611e-14
P O 0 3.893126532261704e-08
- O 0 2.4158058886669664e-10
type O 0 5.6439557888365854e-11
ATPase O 0 2.4550832478098528e-08
( O 0 1.0172591257849237e-13
ATP7B O 0 2.7394959033699706e-05
) O 0 3.8278824961114274e-15
, O 0 3.52993516290382e-16
were O 0 4.344315519437059e-15
identified O 0 1.1814796713129246e-14
in O 0 3.760867790423509e-15
Korean O 0 1.8552469283061868e-10
Patients O 0 9.040867013365705e-12
with O 0 2.837041582562372e-13
Wilson B-Disease 0 1.0647382708839359e-07
disease I-Disease 0 4.3353335854590114e-07
. O 0 9.711504134202187e-08

Arg778Leu O 0 0.009538122452795506
, O 0 2.2895950760326578e-11
the O 0 4.692425267793787e-12
most O 0 3.241182414690305e-14
frequently O 0 2.8676097141387e-14
reported O 0 2.468981779007312e-13
mutation O 0 1.9031054943746684e-13
of O 0 2.44917584477089e-12
this O 0 4.898407525953663e-13
enzyme O 0 8.65282292431685e-13
, O 0 5.720953360566564e-14
was O 0 6.668784881952439e-12
found O 0 1.6434420556203644e-13
in O 0 3.4979153904976523e-14
six O 0 7.607842307522095e-13
of O 0 3.183736098106432e-13
eight O 0 2.9831191770274268e-12
unrelated O 0 1.153183971924765e-11
patients O 0 1.9563053976247302e-13
studied O 0 2.431111681324566e-13
, O 0 3.361127531625787e-15
an O 0 1.2214036163696903e-15
allele O 0 3.0987244020730387e-12
frequency O 0 1.9751185409422334e-10
of O 0 3.6322031493618567e-10
37 O 0 1.1404947741766591e-07
. O 0 7.057990103476186e-08

5 O 0 5.8358957666371225e-09
% O 0 1.303922214646036e-08
, O 0 1.1427516647798813e-13
which O 0 2.0402605420291684e-15
is O 0 2.2047352821446403e-15
considerably O 0 3.0431978551709316e-12
higher O 0 1.2637786650504523e-11
than O 0 1.1843360358176555e-14
those O 0 4.7168367979912376e-14
in O 0 1.8444380137788707e-12
other O 0 2.8494455059369095e-12
Asian O 0 4.532177133587112e-10
populations O 0 2.4909497207958875e-12
. O 0 1.2964612716714896e-10

The O 0 7.653725569989334e-11
novel O 0 8.190339682509484e-14
single O 0 6.035461301741318e-13
nucleotide O 0 3.283423880007241e-11
deletion O 0 9.90561539043755e-12
, O 0 5.797173450918652e-14
2304delC O 0 1.4694762073830248e-09
, O 0 8.034651638672355e-14
was O 0 2.777048339550059e-12
found O 0 3.3710824388043237e-13
in O 0 2.735166422778573e-13
one O 0 3.984217469832352e-12
patient O 0 9.709347770225918e-10
. O 0 4.17292289611737e-09

Since O 0 1.1173743874604014e-10
a O 0 2.3121244502322114e-12
mutation O 0 1.0831661495470588e-13
at O 0 2.155786616928057e-12
cDNA O 0 4.681309229148667e-10
nucleotide O 0 6.185778556044852e-10
2302 O 0 3.7437619226921015e-08
( O 0 6.163978019408517e-14
2302insC O 0 1.0770641045709795e-09
) O 0 8.4835154038395e-14
had O 0 3.003283602712181e-12
been O 0 1.7716789407068445e-12
previously O 0 2.3656472614153046e-11
described O 0 1.2015409283847034e-12
, O 0 5.881548605080316e-15
this O 0 1.2404872051438587e-14
region O 0 8.381478844299295e-11
of O 0 2.536348041315417e-11
the O 0 3.9982747668254603e-10
ATP7B O 1 0.9999948740005493
gene O 0 2.640672680520595e-10
may O 0 1.390318971061788e-10
be O 0 2.8279209529635807e-10
susceptible O 0 3.6683811543980482e-09
to O 0 3.829274675126726e-09
gene O 0 1.7333768198568578e-08
rearrangements O 0 1.0533861313888337e-05
causing O 0 1.6213361959671602e-06
Wilson B-Disease 0 1.7049309235517285e-06
disease I-Disease 0 1.2054597675614787e-07
. O 0 1.7639533167468358e-09

Disruption O 0 4.3069485400337726e-07
of O 0 7.085314113197683e-09
splicing O 0 1.1828603652119796e-09
regulated O 0 1.224816862516187e-11
by O 0 1.6660580724812794e-14
a O 0 1.6356498403966024e-12
CUG O 0 2.28856947614986e-06
- O 0 1.582977082748016e-10
binding O 0 9.688068403068684e-11
protein O 0 4.807493292346976e-10
in O 0 9.147878982096458e-11
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 9.929523230312043e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.374225462313916e-07
DM B-Disease 1 1.0
) O 0 2.362689210944069e-11
is O 0 3.806653817574161e-14
caused O 0 1.590152570165801e-13
by O 0 3.491156745204921e-14
a O 0 3.2360154052918366e-12
CTG O 0 5.46695950731646e-08
expansion O 0 1.1606799722729821e-11
in O 0 4.138695408519716e-13
the O 0 1.299386162903482e-12
3 O 0 5.5584047781165324e-11
untranslated O 0 5.288427473715274e-06
region O 0 4.863439095892375e-10
of O 0 5.5676255272807396e-11
the O 0 2.069433957530009e-09
DM B-Disease 1 1.0
gene O 0 5.007628756104054e-10
. O 0 1.7548533293165747e-08

One O 0 3.6629099059437564e-11
model O 0 3.67540928247756e-11
of O 0 2.016320221898127e-09
DM B-Disease 1 1.0
pathogenesis O 0 6.358012427654103e-08
suggests O 0 1.6232927545559162e-12
that O 0 3.1801763066203245e-15
RNAs O 0 5.125171662935524e-13
from O 0 3.8131886428809103e-13
the O 0 1.399461059189977e-13
expanded O 0 1.8629742930612037e-13
allele O 0 9.364693943263516e-14
create O 0 9.571163136947846e-15
a O 0 5.106161262043163e-14
gain O 0 1.292567580746251e-10
- O 0 8.825861916306188e-12
of O 0 6.344726133367118e-11
- O 0 5.832417881990182e-11
function O 0 6.1297490520917375e-12
mutation O 0 1.1879875948532688e-14
by O 0 1.2609872130003375e-16
the O 0 6.4701971163900075e-15
inappropriate O 0 2.8037791747060996e-14
binding O 0 8.374818715036966e-14
of O 0 4.3799820541312595e-12
proteins O 0 6.978495743509977e-14
to O 0 1.0900142550715475e-12
the O 0 5.455826068700986e-11
CUG O 0 0.0005542304716072977
repeats O 0 2.045976899012203e-08
. O 0 2.5656168300969284e-09

Data O 0 2.0650581689096725e-08
presented O 0 9.23515014461529e-11
here O 0 8.349725771905625e-11
indicate O 0 9.278761092801346e-11
that O 0 8.324615241659793e-15
the O 0 6.095146522916428e-12
conserved O 0 8.00451871452168e-10
heterogeneous O 0 1.633083779317701e-09
nuclear O 0 7.439138638432041e-09
ribonucleoprotein O 0 3.3134552879232615e-09
, O 0 4.1215460406564264e-13
CUG O 0 4.5004992443864467e-07
- O 0 4.0086961528018605e-11
binding O 0 1.2811218232100519e-11
protein O 0 3.5068909581825736e-12
( O 0 9.454604627142076e-15
CUG O 0 2.560887332947459e-05
- O 0 6.3169358632819694e-09
BP O 0 1.0344701983910909e-08
) O 0 1.1691374864758464e-13
, O 0 6.157303399784153e-14
may O 0 9.735257305160117e-13
mediate O 0 4.439046463744489e-09
the O 0 2.404277332779259e-10
trans O 0 6.355533321844575e-10
- O 0 3.635878709218332e-09
dominant O 0 6.49573905775469e-09
effect O 0 4.449531563512077e-13
of O 0 1.761744938301446e-12
the O 0 3.712707658670711e-12
RNA O 0 2.365333706677575e-09
. O 0 1.1513476838587167e-09

CUG O 1 0.9996583461761475
- O 0 0.00015147087106015533
BP O 0 2.050115426754928e-06
was O 0 2.354125505643623e-10
found O 0 1.5195121907691372e-13
to O 0 2.5213096110161988e-14
bind O 0 7.931704609515783e-14
to O 0 4.83786892924859e-13
the O 0 8.769677150265165e-13
human O 0 3.3984050382823705e-12
cardiac O 0 2.804740688588936e-07
troponin O 0 8.096437298377168e-09
T O 0 1.267644322844319e-10
( O 0 7.751762624266974e-15
cTNT O 0 7.756540548742308e-11
) O 0 6.642024208366765e-16
pre O 0 7.941840761416241e-12
- O 0 7.69851955621792e-13
messenger O 0 9.72280524320912e-13
RNA O 0 3.699305618776183e-12
and O 0 4.658977332617012e-14
regulate O 0 1.4057579868231602e-14
its O 0 1.5448708876077675e-15
alternative O 0 2.942185340845671e-12
splicing O 0 2.9363467213272543e-10
. O 0 7.902833387696262e-10

Splicing O 0 3.3298341861609515e-08
of O 0 1.4078069376921576e-08
cTNT O 0 1.3143343494448345e-05
was O 0 4.640842821146407e-09
disrupted O 0 1.8374844046320504e-07
in O 0 1.9173176935005642e-10
DM B-Disease 1 1.0
striated O 0 1.0215279644398834e-07
muscle O 0 1.5904288996893001e-09
and O 0 1.575337083004058e-12
in O 0 6.281817947761947e-12
normal O 0 2.7869273555580776e-09
cells O 0 3.904729317660838e-11
expressing O 0 4.3652516497350025e-13
transcripts O 0 4.624121571761286e-11
that O 0 2.3405104284247684e-14
contain O 0 7.218271119713293e-12
CUG O 0 2.816211690515047e-06
repeats O 0 5.085607046595442e-09
. O 0 4.991334900950051e-09

Altered O 0 8.941637652526424e-09
expression O 0 1.3275046339966678e-10
of O 0 3.7115360784767404e-10
genes O 0 2.087054270724642e-12
regulated O 0 1.148258137878555e-12
posttranscriptionally O 0 6.169421223889415e-11
by O 0 1.4596598940392475e-13
CUG O 1 0.9962174296379089
- O 0 1.2522563963557332e-07
BP O 0 1.9443842091959596e-08
therefore O 0 1.0603788680452197e-11
may O 0 1.318580336064079e-12
contribute O 0 5.806101432970223e-11
to O 0 3.882609345140509e-09
DM B-Disease 1 1.0
pathogenesis O 0 5.308464778863708e-07
. O 0 7.686675740359306e-10
. O 0 4.884050053277633e-09

Identification O 0 1.741592967618999e-07
of O 0 3.837293260922081e-10
a O 0 2.6379517060332036e-12
novel O 0 1.4164545729909717e-13
nonsense O 0 1.4421586147506105e-10
mutation O 0 9.122739998319862e-14
and O 0 2.590766736207525e-15
a O 0 2.818067265273564e-14
missense O 0 9.132602660222311e-12
substitution O 0 1.3649330147039174e-12
in O 0 1.4448049690234804e-13
the O 0 2.33223748473399e-12
vasopressin O 0 3.1622077178994346e-10
- O 0 4.749264315151436e-10
neurophysin O 0 1.9072046164581025e-09
II O 0 8.632449421952515e-09
gene O 0 1.967858249398921e-13
in O 0 7.485691618435916e-14
two O 0 4.4122257930601094e-14
Spanish O 0 2.897688859693215e-11
kindreds O 0 2.009487154452927e-08
with O 0 7.695014764275143e-12
familial B-Disease 0 2.4324399419128895e-05
neurohypophyseal I-Disease 1 0.9997386336326599
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9987626075744629
. O 0 4.800406713911798e-06

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 8.56660631320949e-10
FNDI B-Disease 1 1.0
) O 0 4.607409072321378e-12
is O 0 3.219101282194922e-14
an O 0 2.4653112125523624e-13
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
caused O 0 2.108153873692231e-09
by O 0 3.2613024694011505e-12
deficiency O 0 0.3356221616268158
in O 0 3.22611493075442e-10
the O 0 1.6677156322586484e-09
antidiuretic O 0 7.092756937332467e-11
hormone O 0 1.305611163886916e-13
arginine O 0 2.4253618211012018e-11
vasopressin O 0 1.893320916712682e-11
( O 0 1.0397288769965068e-14
AVP O 0 6.925467838092558e-11
) O 0 3.5446838594000894e-16
encoded O 0 5.022912153481579e-15
by O 0 2.1543444450795347e-15
the O 0 7.899690450396957e-12
AVP O 0 1.6891209497771342e-07
- O 0 7.408030189282044e-09
neurophysin O 0 2.614683758395131e-08
II O 0 1.231159529879733e-07
( O 0 6.635226222628798e-12
AVP O 0 1.3944681995781139e-06
- O 0 3.8371872790321504e-08
NPII O 0 0.00012296185013838112
) O 0 4.44061020593578e-14
gene O 0 9.449051479139877e-15
on O 0 1.0472293605207073e-12
chromosome O 0 2.0436298486803395e-11
20p13 O 0 3.717888219512133e-08
. O 0 1.405375482654847e-09

In O 0 1.2822519435129465e-10
this O 0 1.6916702413882767e-12
study O 0 1.4983244408638824e-13
, O 0 3.0988499204973605e-15
we O 0 3.565965085743821e-15
analyzed O 0 2.0063491883506868e-13
two O 0 2.010376796133563e-15
families O 0 3.341745935484951e-15
with O 0 2.711508529981547e-15
FNDI B-Disease 1 1.0
using O 0 2.2166123103684043e-12
direct O 0 9.115443642959686e-12
automated O 0 3.0946167850487427e-10
fluorescent O 0 4.870200596973628e-12
, O 0 9.402703530332016e-15
solid O 0 1.1242589975299366e-12
phase O 0 2.8694397118805837e-12
, O 0 3.3861049979930994e-16
single O 0 5.412510463285352e-15
- O 0 3.4788316534927182e-15
stranded O 0 7.60749021286658e-14
DNA O 0 2.6763969729684534e-13
sequencing O 0 2.136490420343029e-12
of O 0 7.388869897873018e-12
PCR O 0 2.3610429167320035e-09
- O 0 9.159970559835529e-09
amplified O 0 4.802161779338121e-09
AVP O 0 1.4442115343626938e-06
- O 0 4.0830990144513635e-08
NPII O 0 3.263372855144553e-05
DNA O 0 7.00015263532805e-08
. O 0 1.113632408511478e-09

In O 0 4.672299769303834e-10
one O 0 7.876791233152325e-12
of O 0 3.4466722011183837e-12
the O 0 1.3429671871095783e-12
families O 0 6.037268666762852e-13
, O 0 8.535954197164478e-15
affected O 0 4.675401301464273e-14
individuals O 0 1.1253815262492195e-15
presented O 0 2.850139829008169e-13
a O 0 1.514367786985965e-13
novel O 0 1.3172625425335316e-13
nonsense O 0 4.0792960676050427e-10
mutation O 0 6.482358595218118e-13
in O 0 9.78599319634288e-12
exon O 0 2.3182207542493671e-10
3 O 0 1.6838037908417647e-11
of O 0 5.833074301353491e-11
the O 0 7.0281142017236675e-12
gene O 0 4.266194263634858e-14
, O 0 1.3669299118177283e-14
consisting O 0 2.0383090628219892e-14
in O 0 4.650117367988732e-14
a O 0 6.466256024552364e-13
G O 0 1.1378243833237711e-11
to O 0 7.541651331210986e-11
T O 0 8.501302439789526e-10
transition O 0 7.153702341611279e-08
at O 0 5.896840238328593e-10
nucleotide O 0 1.4179596385943682e-10
2101 O 0 3.772433743165493e-08
, O 0 2.757537274423235e-14
which O 0 9.77826216315593e-17
produces O 0 6.826014190540282e-17
a O 0 7.536800697088646e-16
stop O 0 1.1611637215983017e-13
signal O 0 4.145209522854465e-11
in O 0 2.1163329335521786e-12
codon O 0 8.824019848141518e-10
82 O 0 5.113113044075135e-09
( O 0 6.144756144882413e-12
Glu O 0 4.821851717906611e-08
) O 0 7.915493347582236e-13
of O 0 8.151674335543646e-10
NPII O 1 0.7279312610626221
. O 0 1.0846785869489395e-07

The O 0 4.5561536765603705e-09
premature O 0 1.6539493330469668e-08
termination O 0 2.093771822586632e-09
eliminates O 0 3.389331523773187e-11
part O 0 7.707687569788457e-13
of O 0 2.1102154745822332e-11
the O 0 7.080875469300807e-11
C O 0 2.873301809813711e-07
- O 0 3.4904049095452194e-10
terminal O 0 3.4356340689045695e-11
domain O 0 2.259366652102024e-11
of O 0 3.377139930552109e-12
NPII O 0 0.00035149892210029066
, O 0 2.508407977858118e-13
including O 0 1.3803625838117606e-14
a O 0 4.785995276306021e-13
cysteine O 0 4.699057809531837e-10
residue O 0 2.7822974146829438e-08
in O 0 1.1396097607252464e-11
position O 0 2.6486035586970047e-09
85 O 0 8.088473002487717e-09
, O 0 3.917362040219835e-13
which O 0 5.011734706709611e-15
could O 0 3.5014683210168873e-13
be O 0 7.042521947553393e-13
involved O 0 1.75948925568159e-11
in O 0 1.9026790559761864e-11
the O 0 1.3200260329249147e-10
correct O 0 6.68586395136117e-08
folding O 0 6.747031378040447e-09
of O 0 2.678790800292319e-10
the O 0 2.797781784025233e-09
prohormone O 0 1.5763082046760246e-05
. O 0 3.4823887773427487e-08

In O 0 4.746581253045612e-11
the O 0 5.262127972943675e-12
second O 0 7.351649150555417e-11
family O 0 3.3999205902891794e-13
, O 0 2.191988495079647e-15
a O 0 7.824729430475248e-15
G279A O 0 3.1474638867434734e-11
substitution O 0 2.624641823323337e-12
at O 0 4.289452907452196e-12
position O 0 3.0596719602371536e-10
- O 0 1.602424269664393e-11
1 O 0 3.921587880817423e-12
of O 0 4.9457256866281e-12
the O 0 8.110470845271167e-13
signal O 0 1.7431382726140754e-11
peptide O 0 2.892881518102436e-13
was O 0 3.148913963781086e-13
observed O 0 1.9200302968629818e-13
in O 0 5.747102961714198e-14
all O 0 8.971391473678106e-14
affected O 0 1.86700199571177e-12
individuals O 0 4.307101550415915e-13
. O 0 1.343732680680887e-09

This O 0 2.7201882968341806e-09
missense O 0 3.690740015827032e-07
mutation O 0 1.368181956618031e-10
, O 0 1.294974761104073e-12
which O 0 7.50634092643726e-13
replaces O 0 1.0213253176516446e-07
Ala O 0 7.686374488002912e-07
with O 0 1.2345174361938493e-11
Thr O 1 0.9759138226509094
, O 0 2.0320767638026815e-12
is O 0 8.221987543924336e-14
frequent O 0 1.7469816825793627e-12
among O 0 9.871534145666772e-12
FNDI B-Disease 1 1.0
patients O 0 4.2782920672834734e-07
and O 0 9.214770439747166e-12
is O 0 7.363443622204757e-13
thought O 0 8.054622073483397e-12
to O 0 2.6265663255475857e-11
reduce O 0 1.3693804423731137e-10
the O 0 2.5801350639342857e-11
efficiency O 0 7.620115205497768e-09
of O 0 4.0795585659614275e-11
cleavage O 0 1.2654574436943289e-11
by O 0 7.739950715936195e-13
signal O 0 1.7764197224323652e-08
peptidases O 0 4.07061918394902e-07
. O 0 3.1626301577603044e-10
. O 0 6.151848364055468e-09

Genetic O 0 3.067113141241862e-08
heterogeneity O 0 9.410806356413559e-09
of O 0 3.6963367477937936e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.450921307409296e-14
due O 0 3.6408891457284653e-09
to O 0 9.0803087271496e-11
TWIST O 0 4.847388845519163e-05
and O 0 3.3042205083155807e-10
FGFR O 1 0.9999555349349976
mutations O 0 1.396281223975393e-08
. O 0 7.366998566737948e-09

Thirty O 0 2.6566007363726385e-05
- O 0 3.5715732593644134e-08
two O 0 6.118030344490211e-13
unrelated O 0 2.8865240059294806e-11
patients O 0 4.199644579034982e-14
with O 0 9.642137351087264e-17
features O 0 6.154262212690331e-14
of O 0 2.0730832328563764e-10
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 7.205771396234795e-11
a O 0 4.959898464163004e-11
common O 0 3.6973502037795924e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999407529830933
condition I-Disease 1 1.0
of O 1 0.999125063419342
craniosynostosis B-Disease 1 1.0
and O 0 2.1902121716266265e-07
limb B-Disease 1 0.9999997615814209
anomalies I-Disease 0 0.010341634042561054
, O 0 1.19020297090211e-11
were O 0 1.3467725545890374e-10
screened O 0 2.9526658895662194e-11
for O 0 2.565074671764811e-12
mutations O 0 9.17663514621303e-13
in O 0 2.552458678445335e-12
TWIST O 0 1.8452445260663808e-07
, O 0 3.753836217562645e-12
FGFR2 O 0 0.028922000899910927
, O 0 4.385265154477347e-12
and O 0 1.220949643471192e-11
FGFR3 O 1 0.9987126588821411
. O 0 7.935511092682646e-08

Nine O 0 1.1453468395927757e-08
novel O 0 1.0438631296155743e-12
and O 0 2.9077068986090027e-13
three O 0 3.648649091192446e-12
recurrent O 0 5.29788701797429e-09
TWIST O 0 1.2361408607830526e-07
mutations O 0 2.962368544912053e-11
were O 0 1.0054796405201127e-11
found O 0 1.967025040029366e-13
in O 0 5.543933300172603e-14
12 O 0 3.12849086914202e-11
families O 0 1.3720385071136487e-11
. O 0 2.5889270727219582e-09

Seven O 0 8.811544383036107e-09
families O 0 1.6233243915753093e-11
were O 0 4.618601074507511e-12
found O 0 1.8239816395541203e-13
to O 0 3.702748285934476e-13
have O 0 5.759481162392194e-14
the O 0 1.0303846317838428e-11
FGFR3 O 0 0.0002843465772457421
P250R O 0 1.3217814398558403e-07
mutation O 0 6.267097951706546e-12
, O 0 5.2604561060886484e-14
and O 0 4.7421037908078334e-14
one O 0 1.3809479005189723e-13
individual O 0 9.026780652164959e-14
was O 0 2.5206980600045448e-11
found O 0 2.9080839299144845e-13
to O 0 8.717477694569764e-13
have O 0 3.364810939100217e-14
an O 0 1.907168135440243e-13
FGFR2 O 0 1.619944305275567e-05
VV269 O 0 1.3664539437741041e-06
- O 0 9.856122140661228e-09
270 O 0 1.8700422543815876e-08
deletion O 0 1.1443156466839355e-07
. O 0 1.5648765838705003e-08

To O 0 1.6123923030075815e-10
date O 0 3.0575151299672143e-09
, O 0 4.971154239120923e-13
our O 0 1.1234878478927346e-11
detection O 0 6.749344416689951e-10
rate O 0 5.282478556141446e-13
for O 0 5.25453712455653e-15
TWIST O 0 3.496003708747253e-09
or O 0 1.661135985708828e-11
FGFR O 0 0.00010309366189176217
mutations O 0 1.7418719244766123e-11
is O 0 4.54198141499728e-14
68 O 0 7.850805561204766e-10
% O 0 1.4096218636794333e-10
in O 0 6.690886993759859e-13
our O 0 2.4994915026610443e-09
Saethre B-Disease 1 0.9999909400939941
- I-Disease 1 0.9999995231628418
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 0.9999264478683472
patients O 0 6.130555698508067e-12
, O 0 4.9221160797912646e-15
including O 0 1.8803157341156125e-14
our O 0 9.312949855733166e-10
five O 0 1.792645719367325e-11
patients O 0 2.592885216430585e-13
elsewhere O 0 2.7528825573275295e-13
reported O 0 4.830381971146491e-13
with O 0 1.3313822429510819e-13
TWIST O 0 8.609594033259782e-07
mutations O 0 2.4324058323088593e-09
. O 0 1.1821956746871365e-08

More O 0 1.7090676096565005e-11
than O 0 9.736124666898105e-14
35 O 0 4.722308308280354e-11
different O 0 1.212321259005944e-12
TWIST O 0 1.909990388071492e-08
mutations O 0 1.0825228734245851e-11
are O 0 2.4842381976400776e-14
now O 0 6.619393076202906e-14
known O 0 1.0290003576865839e-14
in O 0 8.995842943173085e-14
the O 0 2.6854078856441976e-12
literature O 0 5.038274658586417e-11
. O 0 2.6125888119565843e-09

The O 0 4.9313612748846936e-08
most O 0 8.969774575873224e-12
common O 0 2.20776847324744e-12
phenotypic O 0 2.7444709699286918e-11
features O 0 3.368568987117959e-13
, O 0 1.7073055276939537e-14
present O 0 9.488397480911237e-13
in O 0 3.518144434631887e-13
more O 0 1.9396851204216137e-14
than O 0 1.6922495170565086e-14
a O 0 1.9209753145815744e-13
third O 0 1.6685490766832345e-09
of O 0 2.910130192379512e-10
our O 0 7.81926257076293e-09
patients O 0 3.3286227940632074e-11
with O 0 1.6109549675139001e-12
TWIST O 0 4.2037530079142016e-07
mutations O 0 2.938980170341665e-10
, O 0 2.126180958725299e-12
are O 0 2.110987383160956e-12
coronal B-Disease 0 4.434766864847006e-08
synostosis I-Disease 0 7.105643362592673e-07
, O 0 1.7308972311003146e-10
brachycephaly B-Disease 0 4.584645012073452e-06
, O 0 8.171787135857755e-10
low B-Disease 0 3.36052903548989e-06
frontal I-Disease 1 0.998635470867157
hairline I-Disease 1 1.0
, O 0 1.9211104245187016e-06
facial B-Disease 1 1.0
asymmetry I-Disease 1 1.0
, O 0 1.1026044077766528e-08
ptosis B-Disease 1 0.9946731925010681
, O 0 8.020489272730913e-10
hypertelorism B-Disease 0 5.9912772485404275e-06
, O 0 8.712566085256057e-11
broad B-Disease 0 1.2573627694578704e-09
great I-Disease 0 9.463693828593023e-08
toes I-Disease 0 0.00012342892296146601
, O 0 2.6832997629400168e-11
and O 0 1.1116157994095488e-10
clinodactyly B-Disease 0 6.487184145953506e-05
. O 0 3.0168166631483473e-07

Significant O 0 9.564133307549127e-08
intra O 0 0.02987714111804962
- O 0 1.5385415963464766e-06
and O 0 1.9499792058841336e-10
interfamilial O 0 0.39897340536117554
phenotypic O 0 3.489676103640704e-08
variability O 0 1.049730635749313e-09
is O 0 4.4052612340579e-15
present O 0 3.862641340134955e-14
for O 0 6.088993241906704e-14
either O 0 1.3186771119499952e-10
TWIST O 0 1.1891597750945948e-06
mutations O 0 3.495055078683862e-10
or O 0 1.6645240741297584e-10
FGFR O 0 0.0011381296208128333
mutations O 0 1.0812946982241556e-08
. O 0 3.166410245114548e-09

The O 0 2.5419598870257687e-08
overlap O 0 1.9683136898152043e-08
in O 0 4.527075329191499e-12
clinical O 0 1.8872109430745354e-10
features O 0 4.0639984866946977e-13
and O 0 8.103230136587494e-14
the O 0 5.669653548728837e-12
presence O 0 3.8201698206695445e-13
, O 0 3.09802402102214e-14
in O 0 7.931553498837993e-14
the O 0 4.296230255232403e-13
same O 0 8.643931382300296e-13
genes O 0 3.6770323656558357e-13
, O 0 5.2866182433239026e-14
of O 0 2.7005190618434316e-12
mutations O 0 6.021008344681e-13
for O 0 5.724503445055096e-13
more O 0 8.290141170113133e-14
than O 0 2.325222805098226e-13
one O 0 1.8316036621418563e-12
craniosynostotic B-Disease 0 3.326406528003645e-08
condition I-Disease 0 7.218146720333607e-07
- O 0 1.1523231258081523e-09
such O 0 1.6281082385050105e-12
as O 0 8.092769510081865e-11
Saethre B-Disease 0 4.550492303678766e-05
- I-Disease 0 2.504269502878742e-08
Chotzen I-Disease 0 4.524694759311387e-06
, I-Disease 0 4.900120240125538e-12
Crouzon I-Disease 0 2.044966458925046e-05
, I-Disease 0 4.460487101204391e-12
and I-Disease 0 6.794911855401153e-11
Pfeiffer I-Disease 0 8.857472857926041e-05
syndromes I-Disease 0 2.6157271349802613e-05
- O 0 4.954393943989999e-07
support O 0 4.668436304200441e-09
the O 0 3.704831164075273e-10
hypothesis O 0 9.414239353355836e-12
that O 0 1.1063672247701366e-15
TWIST O 0 2.634856777206096e-10
and O 0 4.927491859094309e-14
FGFRs O 0 9.17728684157737e-08
are O 0 8.928625118984415e-15
components O 0 3.399672765524997e-10
of O 0 2.6309282877279294e-11
the O 0 1.7803474623365179e-12
same O 0 1.7940054823639695e-13
molecular O 0 3.822458300405118e-13
pathway O 0 2.1860451274689774e-13
involved O 0 1.1492698882408642e-13
in O 0 1.5472432363106137e-13
the O 0 1.9010966845894872e-12
modulation O 0 1.932257021053374e-09
of O 0 1.7070036495425711e-09
craniofacial O 0 0.00014557427493855357
and O 0 1.960397355560417e-07
limb O 1 0.7846924662590027
development O 0 1.1161930615344318e-06
in O 0 8.463273484804468e-12
humans O 0 3.202153819881204e-12
. O 0 1.133859282506644e-12
. O 0 1.1699713420298963e-10

Mutation O 0 1.320021036921304e-10
analysis O 0 8.069800036536456e-12
of O 0 1.2761132428540378e-10
UBE3A O 1 0.9999967813491821
in O 0 3.862952144118026e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 3.123866942900122e-09
. O 0 2.8562502363271847e-10

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.57095269518004e-08
AS B-Disease 1 1.0
) O 0 3.00729623495255e-12
is O 0 6.100999171604381e-15
caused O 0 3.9152088824679146e-14
by O 0 2.0752549459153273e-14
chromosome O 0 2.7340737313030772e-11
15q11 O 0 1.2189508424853557e-07
- O 0 2.1137946948357467e-09
q13 O 0 1.2568982299399067e-08
deletions O 0 4.2689525525663186e-11
of O 0 1.2819938253333385e-12
maternal O 0 9.109256751682615e-12
origin O 0 1.707211981375259e-13
, O 0 2.6164007060485188e-15
by O 0 3.1375093088913467e-14
paternal O 0 5.0153263764229905e-09
uniparental B-Disease 0 3.4326250897720456e-05
disomy I-Disease 0 8.220471499953419e-05
( O 0 6.802526875127057e-10
UPD B-Disease 1 1.0
) O 0 2.0922597421951794e-12
15 O 0 3.0065634010201236e-11
, O 0 2.173255980286292e-14
by O 0 2.7016203944102424e-13
imprinting O 0 5.257310476736166e-06
defects O 0 8.798213457339443e-06
, O 0 3.5071096959708725e-13
and O 0 5.947306991500867e-14
by O 0 2.5023724954144344e-13
mutations O 0 2.1789195881610768e-12
in O 0 2.237980850985921e-12
the O 0 2.6986374246362743e-10
UBE3A O 0 2.9502214147214545e-06
gene O 0 1.5029751054829177e-10
. O 0 5.80400394412095e-09

UBE3A O 0 0.00017500011017546058
encodes O 0 1.6720982376483562e-09
a O 0 7.500108867297683e-11
ubiquitin O 0 2.218527361819156e-09
- O 0 2.426770784325072e-09
protein O 0 2.882759135569568e-12
ligase O 0 1.3723361639780829e-12
and O 0 1.1590793429216983e-13
shows O 0 1.6561470944642664e-11
brain O 0 9.826520930289462e-09
- O 0 2.3425324180426088e-11
specific O 0 1.2981035517334316e-11
imprinting O 0 4.573988121592265e-08
. O 0 7.324109096984444e-10

Here O 0 1.2022974615888415e-08
we O 0 2.0056319452455007e-11
describe O 0 3.2702004992835043e-10
UBE3A O 0 9.927583050739486e-06
coding O 0 2.4245666736533167e-06
- O 0 3.812752780163464e-09
region O 0 4.663610053690093e-10
mutations O 0 1.9688662158956483e-11
detected O 0 3.838489855828575e-12
by O 0 4.691022198374242e-15
SSCP O 0 9.607813262846321e-05
analysis O 0 1.6030592651927744e-12
in O 0 5.715292469973474e-14
13 O 0 2.5812869203223343e-11
AS B-Disease 1 1.0
individuals O 0 4.5420186166843235e-13
or O 0 2.8860600975039175e-12
families O 0 1.5636152095321876e-11
. O 0 3.0513571669388284e-09

Two O 0 3.355064004395558e-10
identical O 0 1.5991213908606028e-10
de O 0 1.9251927829699866e-10
novo O 0 2.7064221974626435e-09
5 O 0 3.0108247006666033e-09
- O 0 2.9045035265795605e-09
bp O 0 6.727110535287295e-10
duplications O 0 4.69814587233941e-09
in O 0 8.534310758090413e-11
exon O 0 2.88224644151569e-09
16 O 0 1.855087750080031e-10
were O 0 1.8857355954526867e-10
found O 0 7.055436096470302e-11
. O 0 2.531304721387073e-09

Among O 0 1.4404109016652455e-09
the O 0 2.3464856793720124e-11
other O 0 5.964668320888877e-13
11 O 0 3.4469500170830614e-11
unique O 0 9.703431634588977e-12
mutations O 0 3.098003407628336e-12
, O 0 7.518515839207915e-14
8 O 0 1.034571803226747e-10
were O 0 5.590816143374866e-10
small O 0 8.611501269017996e-12
deletions O 0 1.0969396918580898e-10
or O 0 2.990914807488032e-11
insertions O 0 6.2335363537613375e-09
predicted O 0 9.870245731846694e-10
to O 0 3.229636558188531e-10
cause O 0 1.5627112048832714e-08
frameshifts O 1 0.9327712655067444
, O 0 7.652437711280768e-12
1 O 0 8.125714684448226e-11
was O 0 1.4244783304306896e-11
a O 0 4.639541788947765e-13
mutation O 0 6.388090739977564e-14
to O 0 3.6953122853344844e-13
a O 0 2.396152124373857e-13
stop O 0 1.8861376002710095e-11
codon O 0 5.8556421933531055e-09
, O 0 1.7398522943537498e-12
1 O 0 1.520969461488164e-11
was O 0 9.9286360383255e-12
a O 0 1.4550713064998e-12
missense O 0 6.260631568721919e-09
mutation O 0 5.0014571477408065e-12
, O 0 2.9229594547715287e-13
and O 0 2.468539153470395e-13
1 O 0 1.8345411995079886e-11
was O 0 3.080963609236598e-11
predicted O 0 3.161048853228543e-11
to O 0 7.276796352984061e-13
cause O 0 6.250802826734958e-12
insertion O 0 8.390088068743751e-10
of O 0 1.6965714388916808e-09
an O 0 1.551624800866236e-11
isoleucine O 0 1.3424854614640935e-06
in O 0 2.2883028805154026e-11
the O 0 1.1062644550419165e-10
hect O 0 6.372982142011097e-08
domain O 0 4.796200658852001e-10
of O 0 1.3485866069695707e-11
the O 0 6.591659856836074e-11
UBE3A O 0 2.971891944980598e-06
protein O 0 8.886508195971032e-11
, O 0 4.6486096493426193e-14
which O 0 8.729244680508186e-16
functions O 0 9.040500553031405e-13
in O 0 2.848292348506254e-13
E2 O 0 4.924041382969868e-11
binding O 0 2.3566209747527544e-12
and O 0 1.3158218004766242e-12
ubiquitin O 0 4.4888526229414083e-10
transfer O 0 1.9871139400606808e-08
. O 0 2.9526027844894998e-08

Eight O 0 8.673168139239351e-08
of O 0 3.437195805755522e-10
the O 0 4.037931447542498e-12
cases O 0 1.0486278729029963e-13
were O 0 1.1643356634741253e-12
familial O 0 7.571453880528267e-12
, O 0 4.70153159026071e-14
and O 0 4.6920085682413196e-14
five O 0 2.5355195373832906e-12
were O 0 1.068542736931688e-11
sporadic O 0 3.6907834566335396e-09
. O 0 1.4180583818301784e-08

In O 0 1.252102421744894e-09
two O 0 4.495636155010807e-11
familial O 0 1.6784120759893995e-09
cases O 0 7.654072688156877e-12
and O 0 1.0387012430723708e-12
one O 0 4.654866986655848e-13
sporadic O 0 8.491250758080326e-11
case O 0 1.6726946433856527e-13
, O 0 1.214931746786746e-13
mosaicism O 0 4.927823482603344e-09
for O 0 4.608378262327406e-11
UBE3A O 0 2.8185035262140445e-05
mutations O 0 3.2182606579667095e-10
was O 0 2.3759029466052795e-11
detected O 0 5.013615824583928e-12
in O 0 9.92112411646838e-15
the O 0 1.0539697370068324e-13
mother O 0 5.072189955372675e-13
of O 0 1.3619786722041116e-12
three O 0 1.7530031246049127e-12
AS B-Disease 1 1.0
sons O 0 2.140299049102623e-09
, O 0 3.2829431718690155e-14
in O 0 2.865275291336067e-14
the O 0 2.333268398369698e-13
maternal O 0 1.0151150059423131e-10
grandfather O 0 2.806395671406392e-10
of O 0 4.5011383509319103e-10
two O 0 1.0419922563675854e-10
AS B-Disease 1 1.0
first O 0 1.898743828832039e-09
cousins O 0 1.7541430530343405e-09
, O 0 7.469546492834891e-14
and O 0 6.090675110526772e-15
in O 0 1.1858850219089584e-13
the O 0 5.377214298829536e-12
mother O 0 2.1499965436461155e-12
of O 0 8.253456251772207e-11
an O 0 2.701808568539299e-11
AS B-Disease 1 1.0
daughter O 0 1.5249053149091196e-06
. O 0 4.956917791787419e-07

The O 0 2.3506943058748675e-09
frequencies O 0 4.773457740192555e-10
with O 0 1.4525854409824616e-14
which O 0 3.0051356775208024e-15
we O 0 1.3073530702022856e-13
detected O 0 1.753029904398573e-12
mutations O 0 1.5214930281382683e-13
were O 0 1.1364683066145131e-12
5 O 0 5.127655028011602e-13
( O 0 9.761458617669181e-16
14 O 0 6.747648230095993e-13
% O 0 2.6862531296578673e-12
) O 0 1.062713264251018e-15
of O 0 2.698973314806119e-13
35 O 0 4.2483450785057997e-11
in O 0 7.137670446008548e-13
sporadic O 0 6.436193245029642e-10
cases O 0 9.205735132522541e-13
and O 0 1.2127237148523706e-12
8 O 0 3.4802057069516223e-11
( O 0 2.4866180214086833e-14
80 O 0 7.650160886718549e-12
% O 0 8.958149326498965e-12
) O 0 2.3140179906917325e-15
of O 0 3.035740875258902e-13
10 O 0 2.077264792468836e-12
in O 0 7.594011682508783e-13
familial O 0 2.0168267056419609e-10
cases O 0 1.1687946617489064e-12
. O 0 1.1002084659983424e-10
. O 0 5.65087709958334e-09

The O 0 1.5593653301948507e-07
hemochromatosis B-Disease 1 1.0
845 O 0 1.2788069270186497e-08
G O 0 1.813287631158289e-09
- O 0 8.629909009627568e-10
- O 0 1.5148757248617528e-10
> O 0 9.494158063894087e-12
A O 0 3.2230119181159145e-12
and O 0 8.765143922046293e-17
187 O 0 5.810540139046094e-16
C O 0 2.957163333650037e-11
- O 0 4.4988443526072786e-11
- O 0 2.6346858028603037e-10
> O 0 2.9551592284349226e-09
G O 0 1.1693678914070915e-08
mutations O 0 8.458852542025941e-12
: O 0 7.717595856273577e-15
prevalence O 0 1.6728995575962524e-12
in O 0 1.0308671505396966e-13
non O 0 3.933384729037925e-09
- O 0 4.937570352581133e-09
Caucasian O 0 8.932809691941657e-07
populations O 0 4.648669990614529e-11
. O 0 1.9341106494152882e-10

Hemochromatosis B-Disease 1 0.9990423321723938
, O 0 3.0777932980008416e-10
the O 0 4.579147230288072e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 3.823149574699869e-10
leads O 0 3.201230613925077e-09
, O 0 2.9148159580438815e-12
if O 0 4.04764138872693e-11
untreated O 1 0.9066345691680908
, O 0 7.991402678486637e-13
to O 0 2.2314383230082058e-08
progressive O 1 1.0
iron B-Disease 1 0.9999998807907104
overload I-Disease 1 0.9998680353164673
and O 0 5.357472243616712e-10
premature B-Disease 0 7.921387634723942e-08
death I-Disease 0 3.0135938189346234e-09
. O 0 8.730873801710004e-09

The O 0 1.451550474484975e-06
hemochromatosis B-Disease 1 1.0
gene O 0 5.974321037882646e-10
, O 0 4.2837951068352975e-12
HFE O 0 4.7081739467103034e-05
, O 0 2.8342037917961083e-12
recently O 0 1.7031831674174658e-12
has O 0 7.729847976097374e-16
been O 0 4.451479586824831e-15
identified O 0 1.0927282028446589e-13
, O 0 1.7948249105074728e-15
and O 0 2.8986445778096236e-15
characterization O 0 1.9948655574641982e-11
of O 0 8.977460268233539e-12
this O 0 5.02944582682352e-13
gene O 0 1.8617736746804475e-13
has O 0 3.72082642542443e-15
shown O 0 5.179544943986758e-13
that O 0 1.2268203920673816e-15
it O 0 4.743887761308759e-17
contains O 0 1.1094301885516367e-17
two O 0 1.1504442782464086e-15
mutations O 0 5.73527321486955e-15
that O 0 1.9389877211384478e-16
result O 0 2.3655277498098315e-13
in O 0 4.153089330771742e-12
amino O 0 9.338447549966933e-12
acid O 0 2.8098300053867875e-13
substitutions O 0 1.5160332841532287e-12
- O 0 3.278639566870606e-13
cDNA O 0 3.849105929820684e-12
nucleotides O 0 1.5983872211911e-13
845 O 0 8.264510603650521e-12
G O 0 4.865205894405422e-12
- O 0 1.1011867806498543e-10
- O 0 9.454623889348923e-11
> O 0 2.4179437965732298e-11
A O 0 4.748068604953914e-10
( O 0 9.831941288001396e-16
C282Y O 0 8.059036771257411e-11
) O 0 8.719717809782841e-18
and O 0 3.842201336621855e-17
187 O 0 1.0634194567949676e-14
C O 0 1.0638598335610538e-10
- O 0 1.6959883497591477e-10
- O 0 3.3197986026856086e-10
> O 0 7.319360673108122e-10
G O 0 2.015197342331021e-09
( O 0 3.7655160023061796e-13
H63D O 0 0.00018187671958003193
) O 0 1.395458401609595e-12
. O 0 5.842226702412745e-11

Although O 0 5.9966964727209415e-06
hemochromatosis B-Disease 1 1.0
is O 0 3.3598009790969385e-11
common O 0 2.676040812554792e-12
in O 0 5.472728173416819e-12
Caucasians O 0 4.556049315596056e-09
, O 0 1.1848168279815496e-11
affecting O 0 3.264790937596018e-10
> O 0 8.112370220025866e-10
= O 0 2.7251189152477373e-11
1 O 0 6.222408005518432e-12
/ O 0 1.2435164876978266e-11
300 O 0 3.229298881253506e-13
individuals O 0 9.891125597608422e-14
of O 0 7.38274198719413e-12
northern O 0 1.3700982189057687e-11
European O 0 5.5710327843960794e-12
origin O 0 9.435312253724959e-11
, O 0 3.5780143496470795e-13
it O 0 3.2580893617240904e-15
has O 0 3.364075788617383e-16
not O 0 1.4348902450879615e-14
been O 0 5.133438162399639e-13
recognized O 0 6.821242789362136e-12
in O 0 3.0932209918455023e-12
other O 0 4.3373507910282605e-12
populations O 0 1.263460603501132e-11
. O 0 5.286376891788791e-10

The O 0 3.088955480290423e-10
present O 0 1.0065056427199792e-12
study O 0 9.52261120841123e-16
used O 0 2.601996804901341e-16
PCR O 0 2.0826074968293556e-13
and O 0 2.8736088249876283e-15
restriction O 0 2.3368359656182613e-13
- O 0 1.631274867790189e-13
enzyme O 0 8.758234277248846e-15
digestion O 0 2.7834809110394154e-12
to O 0 1.5215713617452303e-13
analyze O 0 1.1074920277728828e-12
the O 0 3.157609061916512e-14
frequency O 0 1.378401299351184e-12
of O 0 9.804684868901584e-14
the O 0 3.551238147406384e-14
845 O 0 8.848595684299299e-13
G O 0 1.4556515715025142e-12
- O 0 8.848988382326173e-12
- O 0 5.070064593853951e-12
> O 0 7.956513594677139e-13
A O 0 2.927932635926611e-12
and O 0 5.861834866145038e-16
187 O 0 1.4240497480224115e-14
C O 0 2.121426298518081e-11
- O 0 6.949188620375413e-12
- O 0 9.307435898386895e-12
> O 0 2.2323629056408834e-11
G O 0 4.26598964486935e-11
mutations O 0 3.922384267970695e-14
in O 0 7.909783396840842e-14
HLA O 0 4.0436209935990064e-11
- O 0 1.8071045961715049e-12
typed O 0 1.5994493056392667e-12
samples O 0 5.04040033452377e-14
from O 0 5.6441623700080254e-14
non O 0 2.5621726962299363e-10
- O 0 1.3827844425051694e-10
Caucasian O 0 1.0633683444893904e-07
populations O 0 1.6027108026145376e-12
, O 0 3.025402634849756e-15
comprising O 0 7.911352779485514e-14
Australian O 0 9.71354732759444e-11
Aboriginal O 0 1.016992001723338e-08
, O 0 1.2318623768617365e-14
Chinese O 0 1.6918582854130726e-11
, O 0 4.696738874557238e-13
and O 0 3.4852392239576035e-12
Pacific O 0 9.956732105464994e-10
Islanders O 0 3.198760367695286e-08
. O 0 7.83602960297003e-09

Results O 0 4.353336802154217e-09
showed O 0 3.3092534268419627e-10
that O 0 7.3149883909494e-15
the O 0 8.479423218264726e-14
845 O 0 3.3675367182295357e-12
G O 0 4.2403872080321037e-11
- O 0 2.3254659309301928e-10
- O 0 1.3536770315791813e-10
> O 0 8.353549102446678e-11
A O 0 7.970677590174446e-11
mutation O 0 3.1794621731424944e-14
was O 0 1.3827948389198014e-14
present O 0 1.1946134253798708e-14
in O 0 2.7804201659548415e-15
these O 0 5.583278234682449e-15
populations O 0 1.1665568566064351e-15
( O 0 7.861336771704925e-18
allele O 0 6.934868125715518e-14
frequency O 0 1.4352201068226766e-12
0 O 0 2.179412046340347e-14
. O 0 6.944689642145521e-14
32 O 0 7.701200788190476e-11
% O 0 2.38441506122955e-11
) O 0 3.803821254695248e-15
, O 0 9.4422421812769e-15
and O 0 1.6221336543421026e-14
, O 0 1.1553749629114943e-14
furthermore O 0 1.6611034379596101e-12
, O 0 4.928109261409562e-15
it O 0 7.95522703209839e-16
was O 0 2.796875795199605e-12
always O 0 1.974419976472075e-12
seen O 0 2.669647706024514e-12
in O 0 7.73401850374944e-13
conjunction O 0 7.695415138453399e-11
with O 0 3.340771409510168e-11
HLA O 0 1.452569790671987e-06
haplotypes O 0 9.517706622830246e-09
common O 0 4.361194738677909e-11
in O 0 3.135743401050384e-11
Caucasians O 0 1.2811034455495474e-09
, O 0 5.349989114916687e-13
suggesting O 0 4.447098939097671e-12
that O 0 1.2676781485968479e-14
845 O 0 3.722793254223866e-11
G O 0 1.9704462506098253e-09
- O 0 5.374620926090756e-08
- O 0 1.44327913176312e-07
> O 0 1.6345032349818212e-07
A O 0 1.2191601683753106e-07
may O 0 2.3139686781276092e-12
have O 0 2.0319508947067196e-14
been O 0 2.823598221012545e-14
introduced O 0 1.1142797195194416e-14
into O 0 2.1772971744776423e-14
these O 0 1.9492527810773246e-15
populations O 0 2.0891768535517819e-16
by O 0 1.8726339923169633e-15
Caucasian O 0 3.762845590671304e-09
admixture O 0 3.501008372097658e-09
. O 0 2.229553608401602e-08

187 O 0 3.244452970174727e-11
C O 0 1.9976167386914767e-09
- O 0 1.5435963618415371e-10
- O 0 2.0806958586638835e-11
> O 0 7.949403288409762e-12
G O 0 7.292946628545405e-12
was O 0 1.1254212351537868e-13
present O 0 7.391001974668947e-15
at O 0 4.877946699723742e-15
an O 0 2.850056797610898e-18
allele O 0 2.640017551628921e-14
frequency O 0 6.639226494964401e-12
of O 0 2.9857848832248735e-11
2 O 0 4.029466538213455e-09
. O 0 2.5153756411100403e-08

68 O 0 1.7313698208454298e-06
% O 0 1.3633122186718083e-08
in O 0 4.902557309768851e-13
the O 0 9.899585491635055e-13
two O 0 1.918236619893876e-13
populations O 0 3.8950657613558495e-15
analyzed O 0 1.1186562879359277e-13
( O 0 1.5642086497935832e-15
Australian O 0 4.8646146139086355e-11
Aboriginal O 0 8.054557021353048e-09
and O 0 5.4861419362473365e-14
Chinese O 0 1.3864553949360925e-10
) O 0 2.6583370921207106e-12
. O 0 1.2458586384767045e-09

In O 0 4.024364452792639e-10
the O 0 1.4942675569118435e-11
Australian O 0 1.1928170950969985e-10
Aboriginal O 0 1.9030683973131346e-10
samples O 0 1.7831424203407047e-14
, O 0 3.9455939501073083e-17
187 O 0 2.486977036323377e-15
C O 0 1.7323835421745315e-10
- O 0 2.0780238640938364e-10
- O 0 2.2747963235314472e-10
> O 0 5.461179841681485e-10
G O 0 5.602387442849022e-10
was O 0 2.2309072991721912e-11
found O 0 1.7132989634221357e-13
to O 0 1.324217699470026e-13
be O 0 1.1158200828153414e-13
associated O 0 2.936804618935973e-11
with O 0 5.117223051548381e-12
HLA O 0 4.673472631111508e-06
haplotypes O 0 3.5322511582336347e-09
common O 0 1.609923826195736e-11
in O 0 4.7270277969690966e-12
Caucasians O 0 4.559854438479505e-10
, O 0 1.6448657485981094e-13
suggesting O 0 8.542970150737794e-12
that O 0 1.405672267088898e-14
it O 0 3.3525223121563938e-15
was O 0 2.155864679484476e-12
introduced O 0 1.4377043934706013e-13
by O 0 2.882618799150867e-14
recent O 0 7.882197498865207e-13
admixture O 0 7.183516559372549e-10
. O 0 2.4672919263224458e-09

In O 0 3.889389643685348e-10
the O 0 1.5343200668316292e-11
Chinese O 0 2.3162836232382134e-11
samples O 0 2.818998561058411e-13
analyzed O 0 6.874656280440178e-14
, O 0 1.2541176434492071e-16
187 O 0 6.939654539493863e-15
C O 0 1.383992920267474e-10
- O 0 9.908889680998456e-11
- O 0 9.104222931100026e-11
> O 0 1.2707890295615698e-10
G O 0 1.0230064018124096e-10
was O 0 4.106897547734301e-12
present O 0 4.1977009433528945e-13
in O 0 1.40048588435286e-14
association O 0 1.7890906245095033e-14
with O 0 4.765149439720255e-15
a O 0 5.06317156170194e-13
wide O 0 2.7410482737744157e-12
variety O 0 5.783415196400354e-13
of O 0 7.33005808828402e-11
HLA O 0 2.6725572865871072e-08
haplotypes O 0 7.071957464077627e-10
, O 0 9.784700176831973e-13
showing O 0 1.535122202966921e-11
this O 0 2.976115989934691e-13
mutation O 0 1.991290297801221e-13
to O 0 1.8082355274576245e-12
be O 0 1.1440329586442921e-11
widespread O 0 3.670505219210973e-11
and O 0 1.7626414108677657e-13
likely O 0 1.53641700056939e-11
to O 0 1.1922865472691058e-11
predate O 0 3.292899108942038e-08
the O 0 1.0594731689184123e-11
more O 0 3.606075399224806e-14
genetically O 0 1.6080125986718367e-14
restricted O 0 1.2006130681654903e-12
845 O 0 2.949103114491258e-11
G O 0 8.283267405317929e-10
- O 0 2.155914380352897e-08
- O 0 1.1983368963797147e-08
> O 0 5.05306152476237e-09
A O 0 2.7987423489861385e-09
mutation O 0 1.0606701281168363e-11
. O 0 2.1490014628922083e-11

Genotype O 0 3.2460910006193444e-05
- O 0 8.919308811528026e-07
phenotype O 0 6.159597720767351e-09
correlations O 0 3.639847756531367e-09
in O 0 1.55402823942552e-09
attenuated B-Disease 1 0.9332245588302612
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 1.0
. O 0 4.66694336864748e-06

Germ O 0 3.886623017024249e-05
- O 0 1.391447312926175e-06
line O 0 8.379249294421243e-09
mutations O 0 2.5776313375414084e-11
of O 0 2.3889457079206977e-10
the O 0 3.45637934939802e-10
tumor B-Disease 0 3.4169211904355734e-09
suppressor O 0 8.563991737986498e-10
APC O 0 1.3759448025396637e-09
are O 0 2.6255619857071255e-13
implicated O 0 6.490743498233087e-10
in O 0 1.1039006153623632e-08
attenuated B-Disease 1 0.9999985694885254
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 4.878957238219073e-09
AAPC B-Disease 1 1.0
) O 0 3.097895746352608e-13
, O 0 1.3547584718821577e-15
a O 0 3.618295628258139e-15
variant O 0 8.9689242144253e-11
of O 0 7.758163889093339e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 9.447701648790385e-11
FAP B-Disease 0 3.7159866295155553e-09
) O 0 2.6084124010034015e-12
. O 0 3.0808355866440706e-10

AAPC B-Disease 1 1.0
is O 0 1.847125057075072e-11
recognized O 0 5.106205389071583e-12
by O 0 1.411276067661343e-14
the O 0 1.3199289751464338e-12
occurrence O 0 1.5867980540651416e-10
of O 0 3.5480816201749477e-11
< O 0 6.0347828956253124e-09
100 O 0 4.515575691144136e-10
colonic B-Disease 0 2.2390356235746367e-08
adenomas I-Disease 0 2.388743070014243e-08
and O 0 1.249683001395066e-13
a O 0 9.019862764678144e-14
later O 0 5.955065433826956e-12
onset O 0 2.7363662411517e-06
of O 0 0.00016982704983092844
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 7.241807522574695e-13
age O 0 1.2180722576415892e-11
> O 0 9.646999345191976e-12
40 O 0 9.537713500928913e-13
years O 0 1.8032611807852067e-13
) O 0 7.461686027084372e-14
. O 0 1.065010926670773e-10

The O 0 1.0597733801631648e-09
aim O 0 3.105351709109527e-08
of O 0 7.467634149938007e-11
this O 0 2.839623881086689e-13
study O 0 6.322199030571116e-14
was O 0 2.273777954114875e-13
to O 0 7.445000020124548e-13
assess O 0 1.277794425824652e-09
genotype O 0 1.2455355147267255e-07
- O 0 3.475361864957449e-08
phenotype O 0 1.280180184082269e-09
correlations O 0 1.5343685211277602e-09
in O 0 2.7758279008693876e-10
AAPC B-Disease 1 1.0
families O 0 4.334956837936943e-10
. O 0 2.3379285174485176e-09

By O 0 1.0819160671526884e-11
protein O 0 6.539237901170836e-12
- O 0 2.303918774509972e-12
truncation O 0 2.503130480668858e-10
test O 0 1.305533459117214e-10
( O 0 8.561214752530674e-14
PTT O 0 2.004984800407783e-08
) O 0 4.2707841657694395e-15
assay O 0 1.6439852951188882e-12
, O 0 1.0152169505249172e-15
the O 0 6.1326400873490654e-15
entire O 0 9.735539631405832e-12
coding O 0 2.2169202029687085e-09
region O 0 4.032038244949909e-11
of O 0 3.314796787751151e-12
the O 0 6.7023088468065595e-12
APC B-Disease 0 2.7431130700250606e-09
gene O 0 1.7840491453938179e-12
was O 0 1.8887440222936647e-11
screened O 0 1.4206444180764333e-11
in O 0 2.948858334166776e-13
affected O 0 4.312126610644951e-12
individuals O 0 1.3156561343846684e-12
from O 0 5.772577207907581e-11
11 O 0 3.327389919149937e-08
AAPC B-Disease 1 1.0
kindreds O 0 3.836313226202037e-06
, O 0 4.423977677248114e-12
and O 0 1.47366168747054e-12
their O 0 5.909368133716342e-11
phenotypic O 0 3.375367541025298e-09
differences O 0 1.8170337456879793e-09
were O 0 8.046537880446181e-10
examined O 0 1.252315673383464e-08
. O 0 1.8589714656513934e-08

Five O 0 6.1721108224332966e-09
novel O 0 3.376888829328961e-12
germ O 0 4.698784650258858e-08
- O 0 1.0734280131430296e-09
line O 0 2.462467174613181e-10
APC B-Disease 0 1.79507697595227e-09
mutations O 0 9.431960421024677e-12
were O 0 1.460030989337835e-12
identified O 0 2.278780462938723e-12
in O 0 1.1095382154279604e-13
seven O 0 5.835834593348466e-11
kindreds O 0 5.3207354966389175e-08
. O 0 5.248163237325798e-09

Mutations O 0 3.3544466759849456e-08
were O 0 8.732801703992266e-10
located O 0 2.238988508485029e-12
in O 0 1.1455836855577082e-14
three O 0 8.278540037460948e-15
different O 0 3.263887979874404e-14
regions O 0 2.9022893029834185e-12
of O 0 2.132646923641568e-12
the O 0 7.330726303766966e-12
APC B-Disease 0 1.6868333396757862e-09
gene O 0 2.9986930907138776e-12
( O 0 1.4714132893340302e-14
1 O 0 3.0372385162458215e-11
) O 0 3.395578360588375e-13
at O 0 2.0428514435621992e-10
the O 0 1.337706508064418e-11
5 O 0 3.669215539042758e-12
end O 0 4.4855144598621166e-10
spanning O 0 6.097222726708651e-10
exons O 0 3.749658916696319e-11
4 O 0 3.725666151456475e-13
and O 0 1.5305888067390638e-13
5 O 0 3.205991678731368e-12
, O 0 8.627262858100504e-13
( O 0 6.518108264502026e-15
2 O 0 4.661290884527824e-13
) O 0 2.013559268322987e-14
within O 0 2.1595985416622554e-11
exon O 0 7.521650836894711e-12
9 O 0 7.155803293662499e-12
, O 0 5.211086553588706e-13
and O 0 2.0605294814152186e-12
( O 0 3.326827610053082e-14
3 O 0 8.914684962446628e-12
) O 0 2.526510088380479e-13
at O 0 2.7171468200415383e-11
the O 0 2.675479412669879e-12
3 O 0 1.3886936739426758e-11
distal O 0 2.5803606362728715e-08
end O 0 1.4338713327788355e-08
of O 0 6.291612564268689e-09
the O 0 5.850283812947055e-09
gene O 0 1.1706699498681417e-10
. O 0 3.328627684595631e-08

Variability O 0 1.213170094160887e-06
in O 0 3.06370588620819e-11
the O 0 2.0166103162355675e-11
number O 0 5.60420147788232e-11
of O 0 7.353006026278308e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 6.0739413498822614e-09
most O 0 1.884017844077518e-13
apparent O 0 6.442818500929093e-12
in O 0 3.0858648969456226e-13
individuals O 0 2.86486654711704e-13
with O 0 9.498531925193274e-14
mutations O 0 4.452046804132026e-12
in O 0 9.15583928118302e-11
region O 0 2.409029207228741e-07
1 O 0 4.460127822625282e-09
, O 0 1.3303631633820867e-11
and O 0 4.0365721876156613e-10
upper O 1 0.9999967813491821
- O 0 5.480344407260418e-05
gastrointestinal O 0 1.5173034384474704e-08
manifestations O 0 4.005744003166001e-08
were O 0 2.0210241813423124e-10
more O 0 2.936968159991671e-14
severe O 0 1.6108905659048545e-12
in O 0 2.1781010155208502e-12
them O 0 1.6924845205879002e-11
. O 0 4.883724091797603e-09

In O 0 1.3926466924107928e-10
individuals O 0 1.4450675898947107e-12
with O 0 2.1723122161764613e-13
mutations O 0 2.5139747054925277e-12
in O 0 1.8256045546810595e-12
either O 0 2.5511959211854673e-10
region O 0 4.5487578148595276e-08
2 O 0 2.799824816435148e-10
or O 0 2.784283914536445e-11
region O 0 1.722881060040038e-09
3 O 0 9.577423056017498e-12
, O 0 1.8828061803871296e-14
the O 0 8.428437255850879e-14
average O 0 1.888173862055198e-12
number O 0 3.5919650500509936e-12
of O 0 2.398551912641267e-10
adenomas B-Disease 0 1.0640114567195269e-07
tended O 0 1.6193060226044054e-09
to O 0 3.253030345096164e-10
be O 0 2.670373644431123e-10
lower O 0 4.322327384898017e-09
than O 0 6.136203199204326e-13
those O 0 4.786104780725442e-13
in O 0 3.8491624709639793e-13
individuals O 0 2.6337975854093254e-13
with O 0 4.324437401052872e-13
mutations O 0 4.322559671310344e-12
in O 0 4.809708187281103e-12
region O 0 7.562167003705156e-10
1 O 0 8.348193664131642e-12
, O 0 2.3134807600449364e-14
although O 0 7.630465134527906e-14
age O 0 3.3625882026738774e-12
at O 0 2.1324678134426733e-12
diagnosis O 0 3.3138011779065835e-10
was O 0 1.7450301186688888e-12
similar O 0 2.4846338094602904e-12
. O 0 1.6777400579925938e-09

In O 0 3.226302780490187e-08
all O 0 5.5973945478626774e-08
AAPC B-Disease 1 1.0
kindreds O 0 6.693980139971245e-06
, O 0 8.659443062782046e-13
a O 0 6.148575030194559e-13
predominance O 0 8.766384063108035e-09
of O 0 2.580163638299382e-08
right O 1 0.9980706572532654
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.00047190504847094417
rectal B-Disease 1 1.0
polyp I-Disease 0 3.5550383472582325e-06
sparing O 0 8.179007471298405e-10
was O 0 6.32073768325192e-11
observed O 0 4.076913806549953e-11
. O 0 9.122479438516962e-10

No O 0 1.6833811287142453e-06
desmoid B-Disease 1 0.9997931122779846
tumors I-Disease 1 1.0
were O 0 1.1121831455795927e-08
found O 0 8.934073099375883e-12
in O 0 1.1367674379939019e-12
these O 0 8.572841221632377e-12
kindreds O 0 5.113252399269186e-08
. O 0 6.002651264935821e-09

Our O 0 7.126858463379904e-07
data O 0 4.17132328678349e-09
suggest O 0 1.3325726806734384e-11
that O 0 3.0058694198113614e-15
, O 0 1.673226681720482e-14
in O 0 2.701693903317537e-12
AAPC B-Disease 1 1.0
families O 0 4.9127188428421675e-11
, O 0 4.667515763538514e-14
the O 0 3.5564728787830513e-13
location O 0 1.1557717977117576e-10
of O 0 1.15698657252028e-11
the O 0 2.483797889585304e-10
APC B-Disease 0 5.610128823718696e-07
mutation O 0 7.795223910811444e-10
may O 0 1.8491352893335034e-10
partially O 0 2.204304738739893e-09
predict O 0 2.328075232593818e-10
specific O 0 1.1598639410026479e-10
phenotypic O 0 3.192255348949402e-09
expression O 0 1.4269135872879701e-09
. O 0 3.5747628857052405e-08

This O 0 4.6206826559425096e-11
should O 0 2.7855734212323124e-12
help O 0 1.44259181423384e-12
in O 0 2.0439152350866865e-14
the O 0 3.0196392532700483e-14
design O 0 1.7364772814110196e-12
of O 0 1.0365301282219685e-12
tailored O 0 9.455231736454905e-12
clinical O 0 8.478918955834303e-11
- O 0 7.060228790489731e-11
management O 0 5.656497405887029e-12
protocols O 0 6.351094650192124e-11
in O 0 2.194566482206263e-14
this O 0 4.18805191671227e-15
subset O 0 2.1102374405182478e-13
of O 0 1.5591107777653684e-13
FAP B-Disease 0 1.5345755222107016e-10
patients O 0 2.708566444048488e-12
. O 0 1.025805829169002e-11
. O 0 1.7063072066392238e-09

Wilms B-Disease 0 0.012680886313319206
' I-Disease 0 9.332069907941332e-07
tumor I-Disease 0 6.6665948317279344e-09
1 O 0 2.5651003890403423e-11
and O 0 3.242508908943287e-12
Dax O 0 5.426450115919579e-06
- O 0 6.204495806017007e-10
1 O 0 8.508398846585052e-12
modulate O 0 1.7627743015280473e-11
the O 0 6.014489037017845e-13
orphan O 0 4.573243910302449e-13
nuclear O 0 1.3396930266529328e-11
receptor O 0 6.298272043877076e-14
SF O 0 4.243077444954224e-09
- O 0 1.702048224583308e-10
1 O 0 2.46148668938892e-13
in O 0 2.1556527721698637e-14
sex O 0 1.2114885917374751e-13
- O 0 1.491198962542354e-14
specific O 0 8.511307232465272e-15
gene O 0 9.653334650193933e-15
expression O 0 9.784177591384835e-13
. O 0 1.2042562780312238e-10

Products O 0 6.2949734314088346e-09
of O 0 8.472913037849139e-09
steroidogenic O 0 2.45086624772739e-07
factor O 0 1.0080354086172694e-11
1 O 0 1.5474329716907986e-12
( O 0 1.1183123586780246e-14
SF O 0 1.1677363076501024e-08
- O 0 1.7961239440200671e-10
1 O 0 4.904465505592426e-13
) O 0 1.315845524175411e-14
and O 0 3.1077154738490265e-12
Wilms B-Disease 0 1.300646999879973e-05
tumor I-Disease 0 1.7782697536716796e-09
1 O 0 3.059921413472999e-11
( O 0 2.1427740766639947e-13
WT1 O 0 1.1438035407707048e-08
) O 0 2.7198495598746916e-14
genes O 0 4.207060521894783e-14
are O 0 1.3565478289832324e-15
essential O 0 4.685485072847273e-12
for O 0 6.847100469074829e-13
mammalian O 0 2.6893998139598807e-09
gonadogenesis O 0 9.358253727498322e-09
prior O 0 6.830939813795567e-09
to O 0 8.991984934425545e-10
sexual O 0 4.3022066464892816e-10
differentiation O 0 1.0663190330717498e-08
. O 0 9.235652242978176e-09

In O 0 4.659269151052747e-11
males O 0 4.7032516770073585e-11
, O 0 1.9252485619191545e-13
SF O 0 4.954648602506495e-07
- O 0 4.526080843447744e-09
1 O 0 7.734200432873983e-12
participates O 0 3.0702267984905607e-12
in O 0 2.6986627247650198e-14
sexual O 0 1.5293683000247062e-14
development O 0 1.4194728563138997e-13
by O 0 8.770461700768274e-17
regulating O 0 3.005939681194336e-14
expression O 0 3.2451289105981523e-14
of O 0 5.157118764149982e-13
the O 0 2.936007773707283e-12
polypeptide O 0 7.468801965782035e-11
hormone O 0 9.172995479519996e-13
Mullerian O 0 4.6106843343274306e-10
inhibiting O 0 2.0848274495666175e-11
substance O 0 1.23934501550238e-10
( O 0 5.309023077930408e-13
MIS O 0 1.540757352813671e-07
) O 0 2.5864850625861857e-12
. O 0 9.93211290989393e-10

Here O 0 3.014457661265624e-08
, O 0 2.580714504943349e-12
we O 0 2.3134819797723805e-13
show O 0 5.06625340637723e-13
that O 0 5.3243097695207086e-15
WT1 O 0 2.0027226810270804e-07
- O 0 2.6607354097762936e-09
KTS O 0 4.6087106397862954e-07
isoforms O 0 2.1324944587952643e-10
associate O 0 2.859552178380298e-11
and O 0 1.2679489450300851e-14
synergize O 0 2.430058376745592e-10
with O 0 2.3433167841042934e-13
SF O 0 6.862728127998707e-07
- O 0 8.150664032591237e-10
1 O 0 4.94957590538303e-12
to O 0 1.4007711657271216e-11
promote O 0 3.464539322095561e-09
MIS O 0 1.2180228168290341e-06
expression O 0 1.1678287503702478e-10
. O 0 1.9980918308792894e-10

In O 0 4.29915703037409e-09
contrast O 0 6.563561361083714e-10
, O 0 4.5919268387706325e-11
WT1 O 0 2.483194975866354e-06
missense O 0 4.292825650509258e-08
mutations O 0 6.83666448106357e-12
, O 0 1.7771462741070915e-14
associated O 0 2.6684464100174e-12
with O 0 1.306470665159154e-13
male B-Disease 0 8.493020731137335e-10
pseudohermaphroditism I-Disease 1 1.0
in O 0 6.59179288931e-09
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 7.018883738107995e-12
fail O 0 5.265649694052854e-09
to O 0 5.3585524906196724e-11
synergize O 0 1.0406724371136988e-08
with O 0 8.0063889545956e-12
SF O 1 0.9720402359962463
- O 0 1.1510296644701157e-06
1 O 0 7.3782340237471544e-09
. O 0 1.2448657660257822e-09

Additionally O 0 6.667383090075418e-09
, O 0 1.787198725599834e-13
the O 0 2.779171749504872e-13
X O 0 8.13564859925009e-09
- O 0 5.66177049687866e-10
linked O 0 1.06379079156671e-10
, O 0 1.335501855452689e-14
candidate O 0 1.6238749711225409e-12
dosage O 0 2.572033974690413e-10
- O 0 9.086125081492202e-12
sensitive O 0 8.653603007779953e-12
sex O 0 5.79823786640149e-13
- O 0 1.820909742433763e-12
reversal O 0 5.560565462942035e-12
gene O 0 2.6156136853855774e-14
, O 0 5.258329714577861e-14
Dax O 0 4.1893930102787635e-08
- O 0 1.3617099114959785e-10
1 O 0 9.714264982696452e-12
, O 0 4.904502910567377e-13
antagonizes O 0 2.283934708025015e-10
synergy O 0 4.325027835871964e-11
between O 0 5.0186892835979435e-11
SF O 0 1.207261419722272e-07
- O 0 4.6335790759854945e-10
1 O 0 1.6122676110841283e-12
and O 0 3.307317527484477e-13
WT1 O 0 1.5454133972525597e-07
, O 0 1.6833322930009942e-14
most O 0 8.357193399360615e-16
likely O 0 2.604541948325427e-14
through O 0 4.9577434713989066e-14
a O 0 3.4255459119237816e-14
direct O 0 1.742336201530914e-12
interaction O 0 2.5117330090806966e-11
with O 0 5.1451351859577166e-12
SF O 0 0.00010885206575039774
- O 0 3.7320378964977863e-07
1 O 0 2.1058750299118856e-09
. O 0 1.8044415961426807e-09

We O 0 1.6773432642835928e-09
propose O 0 5.551837878314814e-10
that O 0 3.567343089764391e-13
WT1 O 0 3.972138813423953e-07
and O 0 8.683798818909239e-11
Dax O 0 1.6255495211225934e-05
- O 0 2.4769297723992167e-09
1 O 0 4.420909124891459e-11
functionally O 0 6.817204023512602e-10
oppose O 0 1.0431366057397917e-12
each O 0 1.9189895644213494e-14
other O 0 6.0241499898823665e-15
in O 0 2.0808325223477253e-13
testis O 0 7.90403506534254e-11
development O 0 2.1986663791689898e-12
by O 0 1.5413339956573888e-14
modulating O 0 3.666334943974725e-11
SF O 0 9.734054629007005e-08
- O 0 2.6767594807353134e-09
1 O 0 6.856111511854834e-11
- O 0 8.711669580163672e-11
mediated O 0 4.143401455269924e-10
transactivation O 0 1.9696731357043973e-08
. O 0 2.020112592829304e-12
. O 0 1.6548680828454287e-11

A O 0 1.0177021891877303e-08
mouse O 0 2.8372757702316287e-12
model O 0 1.5198289675388832e-12
for O 0 1.7698567611468263e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 0 4.395505311549641e-05
centre O 0 3.4333316190071628e-09
mutations O 0 4.4532021299670266e-12
. O 0 3.3880368129068916e-12

Imprinting O 0 9.230669775206479e-07
in O 0 1.9732385864168478e-11
the O 0 4.3343096473025255e-11
15q11 O 0 1.7812077146572847e-07
- O 0 7.00654478880125e-10
q13 O 0 7.796715273400423e-09
region O 0 8.061462088149174e-12
involves O 0 8.329071481995298e-13
an O 0 5.142941804305197e-14
imprinting O 0 1.7262543394735985e-07
centre O 0 2.295247725214722e-08
( O 0 1.575504592239707e-13
IC O 0 1.4523952813760843e-06
) O 0 3.374852209758056e-13
, O 0 3.4527746330462183e-14
mapping O 0 1.862347429049116e-11
in O 0 1.6576812893274312e-13
part O 0 7.022240861714879e-13
to O 0 1.6771870350873463e-12
the O 0 9.092557436141124e-12
promoter O 0 2.538155463582825e-09
and O 0 3.479414239365708e-12
first O 0 1.2220319201006191e-09
exon O 0 2.0242628906430582e-08
of O 0 7.604753271550635e-09
SNRPN O 1 0.9988731741905212
. O 0 4.920340757053054e-07

Deletion O 0 6.794947182697797e-08
of O 0 1.5313570411734645e-09
this O 0 4.528943192694257e-11
IC O 0 8.847553544910625e-06
abolishes O 0 1.4683610993770913e-09
local O 0 2.844722547801215e-11
paternally O 0 1.445551456313865e-10
derived O 0 1.4341631181247205e-13
gene O 0 1.7492930779442915e-15
expression O 0 5.897207279659733e-15
and O 0 1.074243381131509e-16
results O 0 8.662544965197527e-14
in O 0 1.2758162581949506e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.285754500761186e-09
PWS B-Disease 1 1.0
) O 0 2.8272509333682194e-11
. O 0 1.614876010691546e-10

We O 0 1.3676165755427405e-09
have O 0 4.383640802782529e-13
created O 0 7.312619748015697e-14
two O 0 2.993810982541284e-13
deletion O 0 5.240515660309697e-11
mutations O 0 1.2498886474421322e-12
in O 0 9.070450011743059e-13
mice O 0 6.5918329822389765e-12
to O 0 2.708598796641315e-11
understand O 0 4.632143557614654e-08
PWS B-Disease 1 1.0
and O 0 1.9980260501650804e-11
the O 0 1.5423126317748448e-11
mechanism O 0 1.030227916865023e-10
of O 0 2.7977349170010823e-12
this O 0 2.443898165435665e-12
IC O 0 1.4757089275008184e-06
. O 0 1.2513702074556932e-08

Mice O 0 2.1865642452212342e-07
harbouring O 0 2.466644900778192e-06
an O 0 5.170972677825958e-11
intragenic O 0 3.044739059987478e-06
deletion O 0 6.372107463903376e-08
in O 0 4.275293730149343e-10
Snrpn O 0 0.048114579170942307
are O 0 3.0695491287646703e-11
phenotypically O 0 6.630810389651742e-08
normal O 0 6.5059184706228734e-09
, O 0 2.556486923196988e-13
suggesting O 0 1.90611437224375e-12
that O 0 2.054714905164179e-14
mutations O 0 1.3734471893123157e-11
of O 0 2.0773026354614643e-10
SNRPN O 1 0.9990690350532532
are O 0 3.968109694996169e-12
not O 0 2.963056232666017e-12
sufficient O 0 5.31091792765892e-09
to O 0 3.770374679135102e-09
induce O 0 7.65233016863931e-06
PWS B-Disease 1 1.0
. O 0 1.566584160173079e-06

Mice O 0 2.1043975451107144e-09
with O 0 2.550437888226148e-13
a O 0 1.0276343578169422e-12
larger O 0 7.602504238125862e-13
deletion O 0 4.696311048379975e-12
involving O 0 3.247200034903197e-12
both O 0 7.862921251600152e-12
Snrpn O 0 1.5282145113815204e-06
and O 0 3.0598307633293576e-13
the O 0 1.0917667811471965e-11
putative O 0 1.484401490614573e-08
PWS O 1 1.0
- O 0 6.038101219019154e-08
IC O 0 8.25054394226754e-06
lack O 0 6.097457649900662e-09
expression O 0 5.84509957796131e-12
of O 0 4.568224704765145e-12
the O 0 2.5754530886407112e-12
imprinted O 0 4.7371932765383207e-11
genes O 0 1.1475399623595006e-12
Zfp127 O 0 5.6774318579755345e-09
( O 0 3.566171338266477e-14
mouse O 0 2.4265637242615323e-12
homologue O 0 5.521656465390379e-10
of O 0 2.381599362166753e-09
ZNF127 O 1 0.9999997615814209
) O 0 9.056871225210372e-11
, O 0 1.412345379536717e-10
Ndn O 0 3.7664239016521606e-07
and O 0 1.6100835942278735e-11
Ipw O 0 8.494114211998749e-08
, O 0 7.050626358792722e-13
and O 0 3.852526750305202e-13
manifest O 0 3.773763079806258e-09
several O 0 4.023838554023662e-12
phenotypes O 0 4.0113368182659315e-10
common O 0 4.545801582378495e-11
to O 0 1.1718478276634414e-07
PWS B-Disease 1 1.0
infants O 0 1.5440387869603e-05
. O 0 7.120744527355782e-08

These O 0 2.2726440521148028e-11
data O 0 1.5216107887572328e-11
demonstrate O 0 2.316574015948092e-12
that O 0 1.2325338410548487e-15
both O 0 9.615516323164923e-15
the O 0 1.2245236834067252e-13
position O 0 2.2834806961968823e-11
of O 0 9.406552143112479e-13
the O 0 1.1933893543508711e-12
IC O 0 2.757394099717203e-07
and O 0 1.330808428951294e-13
its O 0 3.661241977453121e-14
role O 0 2.4264788854415353e-13
in O 0 1.0034496427139758e-13
the O 0 5.274283071919628e-13
coordinate O 0 7.031680793190276e-12
expression O 0 7.602465532108305e-12
of O 0 1.1241465397437977e-10
genes O 0 1.4735885038238972e-12
is O 0 3.7658081947916644e-14
conserved O 0 9.225655829558921e-12
between O 0 1.8219667094476755e-11
mouse O 0 1.9408427989753285e-11
and O 0 4.913791812680146e-13
human O 0 3.674776628825871e-12
, O 0 1.3345731854699783e-13
and O 0 1.9586230830563253e-14
indicate O 0 2.218685088081762e-12
that O 0 1.3762292747873965e-15
the O 0 3.44113951743219e-13
mouse O 0 9.681519908683045e-13
is O 0 3.2552814475039424e-15
a O 0 5.1981192245552366e-14
suitable O 0 1.758275608443327e-10
model O 0 1.1214497212808094e-11
system O 0 1.5921573087718244e-11
in O 0 7.49586753345105e-13
which O 0 2.0313152811831e-14
to O 0 3.2200993173997494e-12
investigate O 0 3.317524380208603e-11
the O 0 1.3939135436180639e-11
molecular O 0 6.428288457094311e-11
mechanisms O 0 1.2297526330584674e-09
of O 0 2.9068350504424245e-10
imprinting O 0 1.425733664461859e-08
in O 0 2.631458852903057e-12
this O 0 3.2138145768766113e-13
region O 0 1.1462898685810075e-10
of O 0 2.04698757944044e-12
the O 0 2.622018813007443e-13
genome O 0 7.955177857600637e-13
. O 0 3.080080461514978e-12
. O 0 7.408012536735953e-10

Mutations O 0 2.5786273116779057e-09
of O 0 1.3623393524397898e-09
the O 0 5.388030577258007e-10
ATM O 0 1.9487564713926986e-05
gene O 0 2.6585450420973933e-12
detected O 0 5.136339704253645e-12
in O 0 6.687132672687085e-14
Japanese O 0 2.0886745915049687e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 2.675897121662274e-05
: O 0 2.1223054238496408e-14
possible O 0 2.8967353147245356e-13
preponderance O 0 7.700285721556899e-12
of O 0 7.747125288287346e-14
the O 0 1.5414580690435026e-13
two O 0 2.915537277749236e-13
founder O 0 6.314616884939284e-11
mutations O 0 3.8346426728397276e-11
4612del165 O 0 9.314623738987393e-09
and O 0 2.8343348501547183e-11
7883del5 O 0 1.041587779582187e-06
. O 0 1.4470479925421387e-08

The O 0 2.627309203528938e-10
ATM O 0 4.374858235678403e-06
( O 0 1.5959822005640056e-11
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 2.1108894525997263e-13
mutated O 0 4.6431665309202685e-15
) O 0 4.8333212056490124e-17
gene O 0 2.6604214318337984e-16
on O 0 4.362436179980965e-14
human O 0 8.37063437227753e-14
chromosome O 0 3.253301794625685e-11
11q22 O 0 3.095222211868531e-08
. O 0 8.763971770520129e-10

3 O 0 2.9257931632997725e-09
has O 0 2.8746644821497913e-13
recently O 0 1.9393014483778254e-13
been O 0 3.5216404445370664e-14
identified O 0 1.909395493278343e-13
as O 0 7.259331761809451e-16
the O 0 9.298336365736078e-15
gene O 0 2.1525125245728605e-15
responsible O 0 2.7904201098751837e-14
for O 0 1.1645788229163595e-14
the O 0 2.3189867452526325e-13
human O 0 1.3072545650139045e-11
recessive B-Disease 1 0.5961512923240662
disease I-Disease 1 0.999826967716217
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 7.569532272100332e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.909641486763872e-13
. O 0 9.941635188692732e-12

In O 0 4.1099890157880736e-10
order O 0 1.7574565067124404e-11
to O 0 9.686031490763192e-12
define O 0 3.8107423466771095e-11
the O 0 5.706690003361159e-13
types O 0 1.7840900198157206e-12
of O 0 7.435495795460323e-12
disease O 0 2.363591822263089e-10
- O 0 4.596053745919981e-11
causing O 0 9.416717405841268e-12
ATM O 0 1.7224932946646732e-07
mutations O 0 4.804012005907299e-13
in O 0 3.712463415026304e-14
Japanese O 0 2.734128701220584e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 8.131668255417779e-11
as O 0 1.0125179435659624e-14
well O 0 8.51445734799611e-15
as O 0 5.308751997741134e-16
to O 0 5.806845889549939e-14
look O 0 1.8742153011855334e-13
for O 0 2.035209972555893e-13
possible O 0 7.629764181560361e-11
mutational O 0 3.1992119176038614e-08
hotspots O 0 4.662213948236626e-10
, O 0 4.4231294787835246e-14
reverse O 0 1.8765995701830462e-11
- O 0 1.8983908195435717e-11
transcribed O 0 4.6913087997646485e-11
RNA O 0 7.364082954541828e-11
derived O 0 7.287255651342028e-13
from O 0 1.3377128994362247e-13
ten O 0 1.0247635205684613e-11
patients O 0 2.784721780425825e-13
belonging O 0 1.7296159296464886e-11
to O 0 1.22978363603643e-12
eight O 0 9.02207388658871e-12
unrelated O 0 7.969731645462996e-12
Japanese O 0 1.3731873416134022e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 4.1556294516631453e-10
was O 0 5.535528199013262e-12
analyzed O 0 2.03460444564256e-13
for O 0 1.377158893447008e-15
mutations O 0 1.7249802677427777e-15
by O 0 8.240564506410884e-17
the O 0 4.820436550736964e-15
restriction O 0 3.4001245050009014e-15
endonuclease O 0 2.706267013870972e-13
fingerprinting O 0 7.848806674037867e-12
method O 0 5.046172923961478e-10
. O 0 4.756555149754149e-09

As O 0 6.674606978229747e-10
has O 0 1.66894045783815e-13
been O 0 5.375537390434407e-14
reported O 0 9.743791839730061e-15
by O 0 8.801838051065839e-16
others O 0 9.852450750863148e-14
, O 0 8.51721867540416e-15
mutations O 0 1.014354226292315e-14
that O 0 1.809440252254109e-15
lead O 0 2.65915870052702e-12
to O 0 1.3033339685275536e-10
exon O 0 6.867387547515591e-09
skipping O 0 2.1927991866732555e-08
or O 0 1.3938006304670125e-09
premature O 0 1.8173402338561573e-07
protein O 0 1.5405148268143876e-09
truncation O 0 7.606104190926999e-07
were O 0 8.917929505969369e-09
also O 0 2.9350168129216314e-12
predominant O 0 8.251162531003331e-10
in O 0 3.5402182487626055e-12
our O 0 1.5056385027634178e-09
mutants O 0 2.2953428047145508e-09
. O 0 2.8830382525768528e-09

Six O 0 5.224190524621974e-10
different O 0 1.0042026888854028e-12
mutations O 0 3.797069267081482e-13
were O 0 1.8205684355898644e-13
identified O 0 2.6875276635217327e-13
on O 0 3.2877696333651063e-13
12 O 0 4.18235888630103e-12
of O 0 3.9197707579763374e-12
the O 0 4.755858901139831e-12
16 O 0 2.2411783540121633e-10
alleles O 0 9.517765915678655e-12
examined O 0 3.3347775652003975e-09
. O 0 2.203750781859526e-08

Four O 0 2.0336308192980823e-09
were O 0 1.0236153591414165e-10
deletions O 0 1.1539743466348895e-10
involving O 0 1.4291645991648672e-11
a O 0 1.3026425424444987e-11
loss O 0 1.1838157121246695e-08
of O 0 3.102646246588847e-07
a O 0 4.249499863107076e-09
single O 0 1.7343127822755378e-08
exon O 0 1.8773469889765693e-08
exon O 0 4.404753450870658e-09
7 O 0 3.4279661331737543e-09
, O 0 1.0992939197818075e-10
exon O 0 3.723350738837894e-09
16 O 0 1.2625126499798967e-09
, O 0 8.618242230973294e-11
exon O 0 6.315032052839342e-09
33 O 0 9.15273989932075e-09
or O 0 2.3102941781871777e-09
exon O 0 1.0693479879364531e-07
35 O 0 2.077840264291808e-07
. O 0 1.6346855602478172e-07

The O 0 2.0058252836463453e-09
others O 0 2.358034080496285e-11
were O 0 1.2810637273208414e-10
minute O 0 1.5830383670589754e-09
deletions O 0 4.0021203018270057e-10
, O 0 3.7056875580240844e-13
4649delA O 0 1.758263201701027e-09
in O 0 2.999289705485353e-11
exon O 0 1.4052522478991136e-09
33 O 0 2.6632438476781317e-09
and O 0 5.1480625318234274e-11
7883del5 O 0 2.1278815154346375e-07
in O 0 6.082749304248125e-10
exon O 0 2.079365835072622e-08
55 O 0 6.302123978230156e-08
. O 0 3.5211741078455816e-08

The O 0 7.201082041774498e-08
mutations O 0 1.993338605288386e-09
4612del165 O 0 3.185748553846679e-08
and O 0 2.3538000975403817e-12
7883del5 O 0 2.2088554985089104e-08
were O 0 1.808388161439467e-11
found O 0 1.8796604355462987e-13
in O 0 1.1576601730998917e-14
more O 0 4.4414188471147e-16
than O 0 1.955090214512446e-16
two O 0 2.2027178614225174e-15
unrelated O 0 5.762142607675103e-13
families O 0 5.6351269001530743e-14
; O 0 9.971087625411596e-16
44 O 0 1.4489238801818072e-11
% O 0 8.43636271952164e-11
( O 0 1.2506314411267656e-14
7 O 0 4.4674281635126434e-11
of O 0 7.916708955058027e-11
16 O 0 3.834232931154702e-11
) O 0 1.238964985293689e-13
of O 0 1.04193758655724e-12
the O 0 2.5079867653141075e-13
mutant O 0 2.134057768823569e-13
alleles O 0 1.0054747290842714e-13
had O 0 4.19669236428194e-13
one O 0 9.73265250944072e-14
of O 0 1.8853525511619562e-12
the O 0 8.497759787506887e-12
two O 0 4.508009243675559e-11
mutations O 0 3.94028337735719e-10
. O 0 9.499172115567944e-09

The O 0 4.57556765809386e-08
4612del165 O 0 2.3429729480994865e-06
mutations O 0 4.1429568109485615e-11
in O 0 5.481142408979463e-14
three O 0 1.756910995810365e-14
different O 0 2.5361250642966238e-15
families O 0 7.980276019810186e-15
were O 0 1.2290467038197916e-13
all O 0 1.0154538444644406e-14
ascribed O 0 1.1077921349342268e-12
to O 0 1.0196426087358615e-13
the O 0 3.0128403569716633e-13
same O 0 7.575479414774489e-13
T O 0 6.296455717924587e-11
- O 0 3.2625124823937313e-10
- O 0 2.0253267118963691e-10
> O 0 7.938618512559614e-11
A O 0 4.046962071013738e-11
substitution O 0 5.042845481473268e-13
at O 0 8.711423509638605e-14
the O 0 1.618530037371304e-14
splice O 0 8.159650038974675e-11
donor O 0 2.8184249638990577e-12
site O 0 1.7314247258148896e-11
in O 0 1.5539762185379224e-11
intron O 0 3.490008992912408e-08
33 O 0 1.2271048888123914e-07
. O 0 8.938777540379306e-08

Microsatellite O 0 6.100985672219394e-08
genotyping O 0 6.873365521187225e-08
around O 0 1.339879596162774e-11
the O 0 2.810508423212177e-11
ATM O 0 9.911472034218605e-07
locus O 0 1.8506805810059035e-10
also O 0 1.3049762279896543e-13
indicated O 0 1.1787803372298455e-11
that O 0 9.360438280329921e-15
a O 0 1.139152249092501e-13
common O 0 4.3041533336583837e-13
haplotype O 0 1.5379715556651519e-10
was O 0 2.0119307261867725e-11
shared O 0 1.7071778019017714e-11
by O 0 1.4248158046199083e-14
the O 0 3.042221151643848e-13
mutant O 0 3.670893612955223e-13
alleles O 0 4.646428708910029e-14
in O 0 1.450022691978567e-13
both O 0 2.0738809974885086e-11
mutations O 0 3.612291854526717e-10
. O 0 5.2161088781588205e-09

This O 0 1.6788499757058872e-10
suggests O 0 3.2319320830698217e-12
that O 0 1.3107897327440158e-15
these O 0 5.864185700211024e-15
two O 0 1.843983272282676e-13
founder O 0 1.2913052571672523e-11
mutations O 0 3.860701255214982e-12
may O 0 2.502014437646971e-13
be O 0 3.263154991443168e-13
predominant O 0 7.293269460584284e-11
among O 0 3.499570492876587e-14
Japanese O 0 1.2046698361078967e-10
ATM O 0 6.814740771687866e-08
mutant O 0 4.107056014723831e-11
alleles O 0 2.0928274738207797e-11
. O 0 3.5250362628858056e-09

W474C O 0 1.5004108888660994e-07
amino O 0 3.062801401387816e-10
acid O 0 5.521268663620515e-13
substitution O 0 9.922005708359882e-13
affects O 0 5.609986454058798e-15
early O 0 1.708593119417734e-13
processing O 0 4.87336039578512e-12
of O 0 1.775778282015958e-13
the O 0 4.587743894631999e-14
alpha O 0 8.902267147731756e-15
- O 0 1.0930235124113896e-14
subunit O 0 7.234261915911328e-15
of O 0 4.133331318271344e-13
beta O 0 1.2053955056323673e-11
- O 0 4.335790060316924e-11
hexosaminidase O 0 6.019734488660333e-09
A O 0 7.716937644453026e-10
and O 0 5.498712921624127e-14
is O 0 1.4064545867189821e-15
associated O 0 1.1927112943121987e-12
with O 0 2.8103124753535436e-13
subacute O 0 2.6143704872083617e-06
G B-Disease 0 2.4739692516817513e-09
( I-Disease 0 9.02594188625927e-13
M2 I-Disease 0 8.610709478773515e-09
) I-Disease 0 3.2362311615241612e-12
gangliosidosis I-Disease 0 1.0943394102014281e-07
. O 0 4.436778056060575e-09

Mutations O 0 1.5726847601982286e-10
in O 0 4.246817470170833e-13
the O 0 2.3705692357017805e-12
HEXA O 0 7.152975989299648e-09
gene O 0 4.034821962488073e-15
, O 0 2.0811746421314949e-16
encoding O 0 1.5562341522325392e-14
the O 0 4.206595331400151e-14
alpha O 0 2.5913499183917096e-15
- O 0 2.587527046942514e-15
subunit O 0 1.0446301696183228e-15
of O 0 4.856559964838518e-14
beta O 0 7.022776457588087e-13
- O 0 6.1813497029272746e-12
hexosaminidase O 0 3.620734823073235e-10
A O 0 5.355765830827863e-10
( O 0 1.5332813593069605e-15
Hex O 0 4.279095688897172e-10
A O 0 5.803820618544009e-11
) O 0 1.8172498960277936e-15
, O 0 1.9400762378850083e-15
that O 0 1.144644008381848e-15
abolish O 0 3.724499597623776e-10
Hex O 0 2.263484066844512e-09
A O 0 1.5082159132706607e-10
enzyme O 0 7.182659415155834e-12
activity O 0 1.7797882959080802e-11
cause O 0 1.2145337677793577e-06
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 9.191703821687103e-12
TSD B-Disease 1 0.9518731832504272
) O 0 5.630249345629605e-14
, O 0 2.3042756294906503e-15
the O 0 7.348582056450684e-14
fatal O 0 2.400616094799801e-10
infantile B-Disease 0 8.90942430942232e-10
form I-Disease 0 1.8619212074910685e-11
of I-Disease 0 4.450230406405353e-08
G I-Disease 0 5.877660580466681e-10
( I-Disease 0 9.764746248999007e-14
M2 I-Disease 0 5.407096992371407e-10
) I-Disease 0 1.4701937312965735e-13
gangliosidosis I-Disease 0 3.0604556666702365e-09
, I-Disease 0 1.9512410892770504e-13
Type I-Disease 0 4.091871633193911e-11
1 I-Disease 0 1.2087805756344494e-10
. O 0 5.347671194755321e-10

Less O 0 2.3155104145189398e-07
severe O 0 1.910648279590532e-06
, O 0 1.6441718819759643e-10
subacute O 1 0.9991680383682251
( O 0 6.610665248714398e-13
juvenile O 0 1.0932730276635994e-08
- O 0 1.6235893740557117e-09
onset O 0 1.0016443638960482e-06
) O 0 1.06082547260411e-12
and O 0 1.3588559444333015e-10
chronic O 1 1.0
( O 0 2.550370938741997e-12
adult O 0 1.047241404705801e-08
- O 0 5.222942564553357e-11
onset O 0 1.9011590912665355e-11
) O 0 1.8092124003912975e-15
variants O 0 2.015154807345071e-13
are O 0 4.030038343918454e-15
characterized O 0 2.8119933190637455e-15
by O 0 3.0214812958204423e-15
a O 0 1.8675994995290268e-13
broad O 0 2.0371052934786693e-13
spectrum O 0 7.1993929914859756e-12
of O 0 1.2334293742616298e-12
clinical O 0 6.104430762959856e-12
manifestations O 0 1.4364613665218684e-11
and O 0 1.1262243579130554e-13
are O 0 1.4249435371883543e-14
associated O 0 6.122711387369917e-13
with O 0 4.3082660513118e-14
residual O 0 4.0250555666254684e-10
levels O 0 1.0530349509041415e-10
of O 0 1.0620210266765184e-10
Hex O 0 1.0348689016836943e-08
A O 0 5.554330329005097e-09
enzyme O 0 9.330191480527716e-11
activity O 0 4.162896138915073e-10
. O 0 1.836699903279282e-09

We O 0 4.873941805705329e-10
identified O 0 7.885539443641676e-12
a O 0 1.7378779621976537e-13
1422 O 0 8.786060073928681e-11
G O 0 6.290142018361422e-11
- O 0 3.5177402657460277e-10
- O 0 2.722387593134812e-10
> O 0 1.0813100415063559e-10
C O 0 5.379866552246426e-10
( O 0 8.858596670070166e-16
amino O 0 5.167001266952187e-14
acid O 0 1.575845506060318e-15
W474C O 0 5.209397366603974e-13
) O 0 2.353568311500698e-18
substitution O 0 6.235586354175985e-15
in O 0 5.435747118127379e-15
the O 0 1.0239106383504865e-13
first O 0 2.326297574711811e-12
position O 0 2.478743321709942e-10
of O 0 5.608438713444741e-10
exon O 0 7.833619308783568e-10
13 O 0 1.927235593335297e-10
of O 0 4.838081046898424e-09
HEXA O 0 2.8955750167369843e-05
of O 0 1.24375567622792e-08
a O 0 8.587591748820955e-11
non O 0 1.5999590985416035e-08
- O 0 1.0099842073785226e-09
Jewish O 0 4.3278683414804675e-10
proband O 0 8.027235162444413e-05
who O 0 7.002623307605926e-12
manifested O 0 8.257423911306461e-11
a O 0 5.359937211950327e-13
subacute O 0 3.7238550021356787e-09
variant O 0 2.6796377616822298e-11
of O 0 2.9531435075114132e-08
G B-Disease 0 1.2148935013556184e-07
( I-Disease 0 1.2649169038592145e-11
M2 I-Disease 0 9.424694979998094e-08
) I-Disease 0 2.151310553311081e-11
gangliosidosis I-Disease 0 1.2381134695260698e-07
. O 0 4.3928980453245e-09

On O 0 1.576025532301628e-08
the O 0 2.1348711687352306e-10
second O 0 2.920602204525835e-09
maternally O 0 1.6682547254731617e-07
inherited O 0 1.4794775182735975e-08
allele O 0 1.9972052900385506e-09
, O 0 3.212331388304651e-13
we O 0 2.915036647396091e-13
identified O 0 5.478994861973785e-12
the O 0 1.1513108175154052e-12
common O 0 1.7574307287215873e-10
infantile O 0 0.0006549458485096693
disease O 0 3.07982276126495e-07
- O 0 2.266997789490688e-08
causing O 0 1.9317520916217745e-09
4 O 0 3.361992924055812e-07
- O 0 8.350200175755162e-08
bp O 0 6.499675797577709e-10
insertion O 0 1.6421982662606638e-09
, O 0 1.7513488489301343e-12
+ O 0 5.470165986842801e-10
TATC O 0 4.546434411167866e-06
1278 O 0 2.762636519548778e-08
, O 0 1.9403606325851808e-12
in O 0 9.229809624922147e-12
exon O 0 3.233188383688912e-09
11 O 0 1.1784173636897322e-09
. O 0 1.928362713954357e-08

Pulse O 0 1.2476592701204936e-06
- O 0 2.945188315450764e-09
chase O 0 2.116140422614432e-11
analysis O 0 8.910017499199133e-14
using O 0 6.765106460053169e-14
proband O 0 2.4742758952811528e-09
fibroblasts O 0 3.400788262108989e-10
revealed O 0 3.92574167618065e-12
that O 0 4.1589450059084155e-17
the O 0 2.818372112431281e-15
W474C O 0 3.418141637789862e-12
- O 0 7.193918583666553e-15
containing O 0 1.4549413995977784e-15
alpha O 0 2.3052264239739433e-14
- O 0 1.411185350432692e-13
subunit O 0 9.838141992691771e-14
precursor O 0 7.192722112359107e-12
was O 0 5.523094134818329e-12
normally O 0 6.78035665807597e-12
synthesized O 0 1.4188462904574095e-11
, O 0 2.4008630505759423e-14
but O 0 2.727475736312001e-14
not O 0 3.25620390026482e-13
phosphorylated O 0 5.630035326831262e-10
or O 0 2.6224701663718486e-12
secreted O 0 1.7979217290312044e-12
, O 0 1.2542002450434322e-14
and O 0 1.8929643077103715e-14
the O 0 8.704389639624388e-12
mature O 0 2.8150497488610426e-09
lysosomal O 0 9.473731132914054e-09
alpha O 0 1.477075753375523e-11
- O 0 4.75353957585245e-11
subunit O 0 1.379464598105784e-11
was O 0 8.820750380111875e-11
not O 0 9.5523190052349e-12
detected O 0 3.5807250498010035e-09
. O 0 6.594040313778748e-10

When O 0 1.0641677643252745e-11
the O 0 2.9528671174894328e-12
W474C O 0 2.525208375736554e-10
- O 0 1.3193242884897843e-13
containing O 0 2.217708438764787e-15
alpha O 0 3.780430016340347e-15
- O 0 1.6286439495746992e-14
subunit O 0 1.669267480318426e-14
was O 0 1.1503143272986738e-12
transiently O 0 3.712405036160327e-11
co O 0 6.58200490638583e-13
- O 0 2.273357148146679e-13
expressed O 0 1.964841829548477e-14
with O 0 2.8362080984365044e-17
the O 0 2.7239493263943445e-15
beta O 0 1.883854426011004e-15
- O 0 2.0516543527796004e-16
subunit O 0 2.17797499009437e-17
to O 0 1.1407601505604502e-15
produce O 0 8.652966716629976e-14
Hex O 0 5.574099515293085e-10
A O 0 1.142902217310393e-09
( O 0 5.701508872229394e-14
alphabeta O 0 6.72095756826252e-09
) O 0 1.4286093263774814e-14
in O 0 1.7460655317436125e-12
COS O 0 7.554028513823141e-08
- O 0 1.7936317708855398e-10
7 O 0 9.969396835840527e-12
cells O 0 2.0228644334683438e-13
, O 0 4.406989869484569e-16
the O 0 5.148425495605721e-15
mature O 0 9.149615743872519e-13
alpha O 0 1.9174090009417728e-14
- O 0 7.439076346029902e-14
subunit O 0 2.9992508314164584e-14
was O 0 1.0497610810136782e-12
present O 0 1.898980105108361e-12
, O 0 1.036631870431461e-14
but O 0 5.311914712887063e-15
its O 0 9.762059799303495e-15
level O 0 8.914247118241292e-11
was O 0 3.795434886516569e-12
much O 0 7.116273716134547e-13
lower O 0 3.2443648462221475e-12
than O 0 5.237044835404545e-16
that O 0 2.697373508855563e-16
from O 0 6.73914320615393e-14
normal O 0 3.59614178713219e-11
alpha O 0 1.3604546092102487e-12
- O 0 8.943466626998298e-12
subunit O 0 6.307026298793539e-13
transfections O 0 6.859346424192836e-10
, O 0 2.242636110182713e-14
although O 0 6.556061693286123e-15
higher O 0 8.420841064379903e-13
than O 0 1.7778496290906678e-16
in O 0 7.835033586278597e-15
those O 0 2.5401928553225178e-14
cells O 0 6.351936121182233e-13
transfected O 0 2.555738780329886e-11
with O 0 1.1869140652959187e-14
an O 0 5.69927948151222e-14
alpha O 0 2.468135288161144e-12
- O 0 1.4422623685617086e-11
subunit O 0 3.601020089755158e-12
associated O 0 1.1829499879656424e-10
with O 0 6.840228383708791e-11
infantile O 0 0.00015971703396644443
TSD B-Disease 0 2.860526365111582e-05
. O 0 1.2490666279063589e-08

Furthermore O 0 2.269589316483689e-08
, O 0 3.470080668123432e-13
the O 0 1.9654312628358123e-13
precursor O 0 4.284691904662269e-13
level O 0 4.8762542614877447e-11
of O 0 2.125799753241453e-12
the O 0 7.471088634899981e-13
W474C O 0 4.5793430158980186e-10
alpha O 0 9.061388792086511e-13
- O 0 1.3421809236940918e-12
subunit O 0 2.605467382642279e-13
was O 0 4.177017239037628e-12
found O 0 1.4491074898197176e-13
to O 0 6.925037800142864e-13
accumulate O 0 1.2247624789352152e-12
in O 0 4.371823337915616e-14
comparison O 0 6.563901440610753e-13
to O 0 2.0097656449214601e-13
the O 0 2.516949322572959e-12
normal O 0 2.1590076393351865e-09
alpha O 0 5.6911735740738933e-11
- O 0 1.1807431421484438e-10
subunit O 0 4.058200650525201e-11
precursor O 0 4.0929662437072523e-10
levels O 0 1.557913020810986e-09
. O 0 1.5495263960829675e-09

We O 0 1.1847067771242337e-10
conclude O 0 9.329181871464698e-10
that O 0 2.7750584473987218e-15
the O 0 3.503056202861128e-14
1422 O 0 7.070605212433634e-11
G O 0 5.996374230488044e-11
- O 0 1.959336998202943e-10
- O 0 9.810349060890289e-11
> O 0 1.9929612127267404e-10
C O 0 4.5200936327205454e-09
mutation O 0 6.004422084321046e-14
is O 0 3.3188749341783415e-17
the O 0 1.0420393075909087e-15
cause O 0 1.4118752824851533e-12
of O 0 1.0033044395285629e-09
Hex B-Disease 1 0.9865142703056335
A I-Disease 1 0.9999998807907104
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 7.477882202344688e-11
the O 0 5.25533228046271e-10
proband O 0 1.3273233889776748e-06
. O 0 6.0584834926658004e-09

The O 0 2.3957433259447214e-11
resulting O 0 1.0986183317240883e-11
W474C O 0 1.9051603350472845e-10
substitution O 0 1.5658288467917947e-12
clearly O 0 9.238870925893858e-14
interferes O 0 1.1212196806848623e-13
with O 0 1.5087386855393856e-15
alpha O 0 6.084442980914054e-14
- O 0 7.413764291060512e-14
subunit O 0 4.4169413948840636e-14
processing O 0 1.3165704637607689e-11
, O 0 4.1842969667175327e-16
but O 0 8.962227974793177e-17
because O 0 6.289042947584339e-17
the O 0 1.3043104600931124e-15
base O 0 1.6458512883728987e-13
substitution O 0 4.304730183424255e-12
falls O 0 5.7314247098316784e-11
at O 0 2.325836138267201e-12
the O 0 4.897613347862317e-13
first O 0 1.439667829394864e-11
position O 0 1.5699581634720516e-09
of O 0 2.129175058485089e-09
exon O 0 2.316931091428387e-09
13 O 0 1.910039487684756e-10
, O 0 1.5666296385163925e-12
aberrant O 0 2.5555483076922236e-11
splicing O 0 1.3956361621936253e-09
may O 0 2.813372278198667e-11
also O 0 3.957178551852736e-13
contribute O 0 9.115070365162126e-10
to O 0 2.861149539512553e-08
Hex B-Disease 1 0.9980995059013367
A I-Disease 1 0.7714410424232483
deficiency I-Disease 0 2.8663196189882e-06
in O 0 1.5236581094035806e-11
this O 0 3.949444070394659e-12
proband O 0 2.7985624484472282e-08
. O 0 2.3271152366222125e-11
. O 0 4.511150897279492e-10

Two O 0 1.607550426108162e-09
frequent O 0 7.300844373503423e-10
missense O 0 1.690347204430509e-07
mutations O 0 1.4768837708345472e-08
in O 0 4.766548045154195e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 6.112092023613513e-07

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 7.150248393372749e-09
an O 0 0.0035104621201753616
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 7.743517632663455e-11
by O 0 7.921008489216092e-16
early O 0 6.212165504226874e-11
childhood O 0 0.0036694288719445467
deafness B-Disease 1 1.0
and O 0 0.11602096259593964
goiter B-Disease 1 1.0
. O 0 5.56508121007937e-06

A O 0 7.940792023930499e-09
century O 0 1.3775819027173064e-11
after O 0 6.298971760854144e-13
its O 0 2.6675771661722027e-15
recognition O 0 4.1345789639213315e-12
as O 0 1.497579512656222e-12
a O 0 5.1641028259163946e-11
syndrome O 0 1.1891961027021836e-10
by O 0 1.963755255683739e-14
Vaughan O 0 1.3985293478846472e-10
Pendred O 0 6.459309588535689e-06
, O 0 2.9525996448134806e-14
the O 0 9.351056712812722e-14
disease O 0 2.165535952598427e-13
gene O 0 3.7601651765937615e-15
( O 0 2.4535437988623026e-15
PDS O 0 5.998533225692881e-08
) O 0 4.03411638404301e-14
was O 0 1.156796793772008e-11
mapped O 0 4.8713366673780456e-11
to O 0 1.7447448000251775e-11
chromosome O 0 5.460659147082936e-10
7q22 O 0 5.570511802943656e-07
- O 0 6.710303779300375e-08
q31 O 0 4.111954012842034e-07
. O 0 1.1178205028272714e-09

1 O 0 1.6556401805090104e-09
and O 0 1.1036505043193756e-11
, O 0 5.260629713961518e-13
recently O 0 1.532277885303579e-12
, O 0 5.5691111851231476e-15
found O 0 3.274299031235696e-15
to O 0 2.1864831451466615e-13
encode O 0 9.464909411782685e-11
a O 0 1.3083902017374527e-10
putative O 0 6.006479225106887e-08
sulfate O 0 8.71427019433213e-09
transporter O 0 1.4037318862847314e-07
. O 0 9.153267654937736e-08

We O 0 2.8070165636329136e-10
performed O 0 7.386013328725127e-11
mutation O 0 4.968793930991422e-13
analysis O 0 4.60058369438493e-13
of O 0 7.837582037366342e-13
the O 0 6.34386380232721e-12
PDS B-Disease 0 7.733366146567278e-06
gene O 0 5.739568976342868e-13
in O 0 2.8047431998440286e-13
patients O 0 2.1528104006494214e-13
from O 0 7.976814196154758e-13
14 O 0 3.671009329853092e-11
Pendred B-Disease 0 6.405239361129134e-08
families O 0 7.605114454856121e-13
originating O 0 1.882421475640772e-11
from O 0 3.1642060933229077e-13
seven O 0 2.0538236909783958e-12
countries O 0 5.209129026566284e-13
and O 0 4.0440873848475445e-13
identified O 0 9.519222216036738e-11
all O 0 2.654781429412001e-11
mutations O 0 7.468080043260272e-10
. O 0 5.286984627872471e-09

The O 0 1.4760607180974716e-09
mutations O 0 2.100249314740399e-11
include O 0 1.0580302096680622e-13
three O 0 1.5228894805364296e-13
single O 0 6.987413252168562e-12
base O 0 1.7350354486467268e-10
deletions O 0 1.8685786251637637e-10
, O 0 5.044788913867448e-13
one O 0 4.53755262530553e-12
splice O 0 1.5879963655152096e-07
site O 0 9.908253106871712e-10
mutation O 0 3.875354898097427e-11
and O 0 4.082421033169137e-12
10 O 0 1.533266313913373e-08
missense O 0 2.0176462385279592e-06
mutations O 0 2.428689249711624e-08
. O 0 3.934047043685496e-08

One O 0 2.2395130194752255e-09
missense O 0 7.047927397252352e-08
mutation O 0 8.289659757243495e-12
( O 0 7.45443068167137e-14
L236P O 0 1.0106378844909614e-08
) O 0 2.670179717254289e-14
was O 0 1.2265889692830712e-11
found O 0 1.0235318452164743e-13
in O 0 3.0468771223483154e-14
a O 0 1.2617638596272573e-13
homozygous O 0 1.4089376366988038e-12
state O 0 1.3531432647550384e-13
in O 0 1.5648159851222587e-13
two O 0 1.1374572074160372e-12
consanguineous O 0 6.316878398138215e-08
families O 0 4.215499043586091e-12
and O 0 1.2518205059781212e-13
in O 0 6.74413541505714e-13
a O 0 1.1022762563817068e-12
heterozygous O 0 2.656958420638178e-12
state O 0 2.544500255028531e-13
in O 0 1.7583401097989726e-13
five O 0 2.103222760882484e-12
additional O 0 1.4124038744123268e-11
non O 0 1.6200667474208785e-08
- O 0 1.0149611817666937e-08
consanguineous O 0 6.75242745273863e-07
families O 0 3.5611483206743344e-10
. O 0 8.891094083196549e-09

Another O 0 5.08205832971953e-09
missense O 0 1.4672900761070196e-07
mutation O 0 7.310149013894929e-11
( O 0 2.8989240478602407e-13
T416P O 0 2.7743908503907733e-08
) O 0 7.387960279355357e-14
was O 0 8.183289983143549e-12
found O 0 1.1995778177210925e-13
in O 0 1.1573422816347871e-14
a O 0 3.35230669991967e-14
homozygous O 0 8.190218251866166e-13
state O 0 7.892152236637154e-14
in O 0 2.739243836098748e-13
one O 0 4.0524519503981615e-12
family O 0 1.1011436987923284e-12
and O 0 1.1040915225265721e-13
in O 0 6.300305329526301e-13
a O 0 6.068463331669605e-13
heterozygous O 0 7.970836989577845e-13
state O 0 7.151375845670938e-14
in O 0 1.891366430877353e-13
four O 0 2.2718541457800168e-12
families O 0 1.0454317099506394e-11
. O 0 2.0374124609645605e-09

Pendred B-Disease 0 0.000582056469283998
patients O 0 1.8304187054951626e-09
in O 0 6.070781464334596e-12
three O 0 1.938937205236968e-11
non O 0 1.5962456911822187e-09
- O 0 2.6146812492910954e-10
consanguineous O 0 2.2092725870948016e-08
families O 0 6.728973389776016e-13
were O 0 3.31390351358124e-13
shown O 0 1.0648819066122472e-12
to O 0 1.4490226509997206e-12
be O 0 1.7872303029881076e-12
compound O 0 7.176323424396003e-11
heterozygotes O 0 8.466123357919741e-10
for O 0 1.7256814033306256e-11
L236P O 0 2.9061570216981636e-07
and O 0 5.806832445443e-11
T416P O 0 1.647022600081982e-06
. O 0 8.938211060183221e-09

In O 0 5.513532408407684e-10
total O 0 9.34712218736422e-09
, O 0 1.9756668089704332e-12
one O 0 5.389924075636932e-13
or O 0 1.5413992510756452e-13
both O 0 4.667927828126694e-13
of O 0 3.240406857771272e-12
these O 0 7.46436129594498e-14
mutations O 0 2.0817973267559658e-13
were O 0 1.0943201639995737e-12
found O 0 9.819600780289553e-14
in O 0 5.264400907930601e-14
nine O 0 3.1899028557491604e-11
of O 0 8.245112925742148e-12
the O 0 3.813459530793706e-12
14 O 0 5.103676509188304e-11
families O 0 1.3859285247219688e-11
analyzed O 0 2.548235400468002e-09
. O 0 5.751087162053636e-09

The O 0 1.5492855262588812e-11
identification O 0 1.0929283034144532e-09
of O 0 1.4851787855096887e-10
two O 0 2.449994720987725e-11
frequent O 0 6.746638664401061e-11
PDS B-Disease 0 3.211941657355055e-05
mutations O 0 3.439758547441052e-11
will O 0 8.152937418064166e-13
facilitate O 0 5.334733210737852e-10
the O 0 6.503514306949176e-12
molecular O 0 2.702371659779601e-10
diagnosis O 0 5.524818789126584e-06
of O 0 8.546024901079363e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.4871679354655498e-07

Insertional O 0 4.561480454867706e-05
mutation O 0 1.8985185645803426e-10
by O 0 6.004035701771826e-13
transposable O 0 2.0758001539888937e-07
element O 0 7.715910577132945e-09
, O 0 8.437324623689069e-12
L1 O 0 0.00019110813445877284
, O 0 9.696650221050623e-14
in O 0 7.363257410481633e-14
the O 0 1.003712998132178e-11
DMD B-Disease 1 1.0
gene O 0 6.265182600148633e-13
results O 0 1.3997449033187337e-12
in O 0 6.73740230272557e-12
X B-Disease 1 0.9996259212493896
- I-Disease 1 0.8775201439857483
linked I-Disease 0 2.864544694602955e-05
dilated I-Disease 0 0.00014450492744799703
cardiomyopathy I-Disease 1 1.0
. O 0 6.355708705996221e-07

X B-Disease 0 0.2364356815814972
- I-Disease 1 0.9214216470718384
linked I-Disease 0 1.0708798072300851e-05
dilated I-Disease 0 0.0005553192459046841
cardiomyopathy I-Disease 1 1.0
( O 0 4.7449339596328244e-11
XLDCM B-Disease 1 1.0
) O 0 8.369480882809959e-15
is O 0 7.736835336167732e-17
a O 0 1.6897771284686357e-16
clinical O 0 1.3111262292878068e-13
phenotype O 0 2.3195540540393855e-12
of O 0 6.64617250123456e-11
dystrophinopathy B-Disease 0 3.9233771076396806e-07
which O 0 1.403369065920701e-13
is O 0 8.658707905946465e-15
characterized O 0 8.272134604907222e-14
by O 0 1.3473410213037107e-13
preferential O 0 4.038861689537043e-09
myocardial B-Disease 0 2.072166125799413e-06
involvement I-Disease 0 7.768388710083229e-10
without O 0 1.96466488910918e-11
any O 0 4.717261737480216e-13
overt O 0 9.677126721480134e-13
clinical O 0 2.999928647509642e-12
signs O 0 4.423724407620622e-12
of O 0 4.9398503065845034e-09
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 1.3265312190924305e-05

To O 0 5.532799773888541e-10
date O 0 1.3576603841158885e-08
, O 0 2.520975615760701e-12
several O 0 9.783245177516497e-13
mutations O 0 3.119505348481155e-11
in O 0 8.896374088795955e-12
the O 0 7.077672137256741e-08
Duchenne B-Disease 1 0.9998770952224731
muscular I-Disease 0 9.099760063691065e-05
dystrophy I-Disease 0 0.05402638018131256
gene O 0 2.7037303951260583e-08
, O 0 2.4976329893178217e-09
DMD O 1 1.0
, O 0 2.766492070149784e-11
have O 0 2.8165465023200636e-14
been O 0 1.8776851885946196e-14
identified O 0 7.303016427272907e-14
in O 0 4.44984947191784e-15
patients O 0 1.9921249301861274e-14
with O 0 7.704652345806584e-15
XLDCM B-Disease 0 4.711780638899654e-05
, O 0 1.3191236297727116e-12
but O 0 1.3534633754464648e-13
a O 0 4.4024430368577727e-13
pathogenic O 0 3.968936637677167e-11
correlation O 0 5.4397584527132725e-12
of O 0 3.0238843113511438e-12
these O 0 3.6687937843976615e-13
cardiospecific O 0 1.0921933579766119e-08
mutations O 0 1.437379555657703e-11
in O 0 1.5384108917326778e-11
DMD O 1 1.0
with O 0 2.518063448725405e-12
the O 0 3.208227850048928e-10
XLDCM B-Disease 1 0.9999350309371948
phenotype O 0 1.3607766469192484e-08
has O 0 2.023443397428451e-13
remained O 0 3.100915080267441e-10
to O 0 1.7952292430400973e-11
be O 0 1.889213230299447e-10
elucidated O 0 2.1502323761524167e-06
. O 0 3.659451763837751e-08

We O 0 6.199220026203989e-10
report O 0 1.3214480508103033e-12
here O 0 3.413798581384901e-14
the O 0 2.0787082145379884e-15
identification O 0 8.5250652023805e-12
of O 0 9.581475153216945e-13
a O 0 8.389498947977692e-13
unique O 0 1.645346619366661e-12
de O 0 3.5647960278106794e-11
novo O 0 8.138313911665307e-10
L1 O 0 8.210836313082837e-07
insertion O 0 1.489318224301428e-09
in O 0 6.348018638524522e-11
the O 0 7.923707245893752e-10
muscle O 0 1.0208185408089321e-08
exon O 0 2.690939027161221e-09
1 O 0 3.5584580421188505e-11
in O 0 6.584421896604908e-11
DMD O 1 1.0
in O 0 3.9035102927797993e-10
three O 0 1.4420925564806453e-10
XLDCM B-Disease 1 0.9874559044837952
patients O 0 4.3796897532255574e-12
from O 0 2.0177471347394837e-13
two O 0 3.9095073342933565e-14
unrelated O 0 1.5700755582812032e-12
Japanese O 0 4.426951166758286e-11
families O 0 5.026120578760507e-12
. O 0 2.043655022987423e-09

The O 0 3.5915714846623814e-10
insertion O 0 1.1577382386107615e-09
was O 0 1.5428282262863746e-10
a O 0 1.7092949234839838e-12
5 O 0 5.534556753866715e-12
- O 0 1.998341379524926e-12
truncated O 0 4.61883873162372e-12
form O 0 1.814134915423607e-13
of O 0 3.657951545832372e-12
human O 0 1.3105569147270346e-12
L1 O 0 1.4184783481141494e-07
inversely O 0 2.9265620482554766e-10
integrated O 0 2.599088166910235e-10
in O 0 1.0774652654463313e-12
the O 0 8.452658711854966e-12
5 O 0 2.9903060583258423e-10
- O 0 1.6456943585652084e-09
untranslated O 0 2.036889418377541e-05
region O 0 1.8552576142027988e-10
in O 0 1.4313599134077593e-12
the O 0 1.670891550120679e-11
muscle O 0 7.249374017748167e-11
exon O 0 2.7481286690722584e-10
1 O 0 6.028090353271676e-12
, O 0 1.5286399533340211e-13
which O 0 6.929945847852434e-15
affected O 0 6.888309909448831e-13
the O 0 6.993156054235783e-13
transcription O 0 7.581193485484139e-12
or O 0 8.226807906783207e-13
the O 0 4.4858373959844045e-11
stability O 0 0.0014961701817810535
of O 0 3.1735387651110614e-09
the O 0 9.206886641965895e-11
muscle O 0 3.942130649692288e-11
form O 0 1.6780200493005104e-11
of O 0 3.536536896664444e-10
dystrophin O 0 1.2894139089780765e-09
transcripts O 0 1.233802365829817e-10
but O 0 1.4257619404219914e-14
not O 0 2.455191489702949e-15
that O 0 1.4132687550214061e-15
of O 0 1.1154297104021271e-11
the O 0 5.243637746232821e-10
brain O 0 7.709300575697853e-07
or O 0 1.4460864450338562e-10
Purkinje O 0 1.0109869208463351e-06
cell O 0 7.154804304576601e-09
form O 0 1.6338867758758369e-10
, O 0 3.5406842388563398e-12
probably O 0 8.522631211871357e-11
due O 0 1.9962349995239492e-08
to O 0 2.3575752461368893e-11
its O 0 9.741274627217411e-13
unique O 0 6.427549898574414e-12
site O 0 2.7859945253561058e-11
of O 0 1.245099596342003e-11
integration O 0 4.8419583897896246e-09
. O 0 1.4315539864639959e-08

We O 0 5.965576366229186e-10
speculate O 0 2.998827852707109e-10
that O 0 7.415736924915549e-16
this O 0 1.9547481190808737e-15
insertion O 0 1.5285132534681445e-11
of O 0 1.039056427704077e-11
an O 0 4.978935016011765e-13
L1 O 0 1.7692902929411503e-06
sequence O 0 5.611217740453256e-11
in O 0 7.420580816486222e-11
DMD O 1 1.0
is O 0 1.788000845472093e-12
responsible O 0 1.3978026635469432e-12
for O 0 2.290973129519952e-13
some O 0 2.024658279844039e-14
of O 0 2.4276270555421975e-13
the O 0 7.42492954055804e-14
population O 0 1.308526672467189e-15
of O 0 1.6901455083913526e-15
Japanese O 0 3.191373814520615e-12
patients O 0 7.205388765025092e-14
with O 0 4.231186391924838e-14
XLDCM B-Disease 0 3.0462495033134473e-06
. O 0 3.819942417937483e-10
. O 0 5.476620934530274e-09

Severe O 0 1.6720881831133738e-05
early O 1 0.9999089241027832
- O 1 0.9999954700469971
onset O 1 0.9999994039535522
obesity B-Disease 1 1.0
, O 0 3.333516795933633e-10
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.643972780129843e-08
red O 0 1.0695887198153287e-07
hair O 0 0.4618968367576599
pigmentation O 0 1.8149514744436601e-06
caused O 0 1.84406534486925e-08
by O 0 2.5203486520020135e-10
POMC O 0 0.0001829971733968705
mutations O 0 1.4602643538808024e-09
in O 0 2.7098389504542908e-11
humans O 0 8.320029387665073e-11
. O 0 3.380372093353401e-10

Sequential O 0 2.624365613712598e-09
cleavage O 0 7.041404126439943e-10
of O 0 8.195617795525578e-11
the O 0 6.9156958805438595e-12
precursor O 0 1.6315028755070626e-12
protein O 0 2.6488697235540863e-14
pre O 0 1.6660287732728207e-11
- O 0 5.486314961361538e-12
pro O 0 4.3908690572358466e-10
- O 0 3.13176573563112e-09
opiomelanocortin O 0 2.603943904944117e-08
( O 0 5.559093326455971e-15
POMC O 0 5.089275223468803e-09
) O 0 1.2635108947271225e-15
generates O 0 9.185136341566171e-15
the O 0 2.826890807485112e-14
melanocortin O 0 9.988206789435239e-11
peptides O 0 3.418350021447414e-12
adrenocorticotrophin O 0 9.77155245607264e-09
( O 0 7.446473315351684e-14
ACTH O 0 2.6136404152055093e-09
) O 0 2.740920182064e-14
, O 0 1.3954309441895768e-13
melanocyte O 0 5.872217823110759e-09
- O 0 2.5172472106760324e-08
stimulating O 0 1.0292929703004106e-10
hormones O 0 1.0244894125752135e-12
( O 0 8.443714638549089e-16
MSH O 0 6.08010169989015e-11
) O 0 1.7000639465663452e-16
alpha O 0 1.0184558986360993e-15
, O 0 3.298919036464377e-17
beta O 0 7.408668434970712e-16
and O 0 9.81679951527804e-16
gamma O 0 1.3666978247901806e-14
as O 0 1.70509172238301e-15
well O 0 5.8001343392890745e-15
as O 0 1.287119820549468e-15
the O 0 7.460647225877859e-14
opioid O 0 1.7849818845228071e-12
- O 0 3.553259032493261e-13
receptor O 0 2.1757186862287866e-15
ligand O 0 7.191350379770478e-12
beta O 0 2.249504804652247e-09
- O 0 1.430650531375477e-08
endorphin O 0 7.131414037075956e-08
. O 0 1.2335771293336961e-09

While O 0 2.522970721230422e-09
a O 0 2.435895062047333e-11
few O 0 1.5903839660144636e-12
cases O 0 4.37987130287934e-13
of O 0 1.417305939277469e-09
isolated O 0 9.139084511389228e-08
ACTH B-Disease 1 0.6085808873176575
deficiency I-Disease 0 1.236796947523544e-06
have O 0 4.008339883967982e-13
been O 0 1.9545935779196472e-13
reported O 0 1.7136821475749464e-12
( O 0 6.35561685203255e-14
OMIM O 0 6.219857340283852e-08
201400 O 0 6.3605694045065775e-09
) O 0 5.625335809146537e-13
, O 0 1.8300181248848135e-12
an O 0 9.557130260795521e-12
inherited O 1 0.8755189776420593
POMC O 1 1.0
defect O 1 0.9999957084655762
has O 0 2.340003841735938e-12
not O 0 3.421596773273139e-13
been O 0 3.191398317489713e-12
described O 0 2.2167307052456398e-12
so O 0 3.8579388164997064e-13
far O 0 1.3503755405541717e-11
. O 0 3.152512417781139e-10

Recent O 0 8.047792293686129e-11
studies O 0 3.8202154113708975e-12
in O 0 6.859410365015958e-14
animal O 0 2.2098222232126707e-14
models O 0 5.700975580285803e-14
elucidated O 0 3.093081346605686e-11
a O 0 1.7711273257465382e-13
central O 0 2.0315391729974763e-11
role O 0 3.765266310545856e-12
of O 0 6.438820032705905e-10
alpha O 0 3.884496335704313e-10
- O 0 1.2947772631832777e-08
MSH O 0 9.81311131909024e-07
in O 0 1.884335135843296e-12
the O 0 1.7689978171545051e-12
regulation O 0 3.808364214263893e-12
of O 0 9.12584244283643e-13
food O 0 5.646014661657081e-14
intake O 0 2.625397413558221e-16
by O 0 5.106520929437924e-18
activation O 0 5.840858666953525e-14
of O 0 5.862148006602341e-12
the O 0 1.6276875680620861e-10
brain O 0 1.0192717780910243e-08
melanocortin O 0 3.086071620472808e-09
- O 0 5.636406341658073e-10
4 O 0 5.081200737944158e-11
- O 0 8.250843064327995e-11
receptor O 0 7.275221041108757e-15
( O 0 2.3361382561092785e-15
MC4 O 0 5.9521479300883584e-08
- O 0 1.2027487894528122e-09
R O 0 7.463490242498594e-11
; O 0 4.045626291246775e-15
refs O 0 7.652704858696069e-11
3 O 0 6.655527908308589e-13
- O 0 4.436481021961869e-13
5 O 0 5.260353276288852e-15
) O 0 1.4672743118063644e-17
and O 0 5.2321301252514487e-17
the O 0 4.5961346030075e-14
linkage O 0 1.2715800634666152e-09
of O 0 2.915668054215281e-11
human O 0 2.9138307322540413e-09
obesity B-Disease 1 1.0
to O 0 2.6787208007306162e-09
chromosome O 0 5.37145883328094e-10
2 O 0 1.1919892850542624e-10
in O 0 7.40809358301675e-11
close O 0 6.344105685229806e-08
proximity O 0 2.2722910220096537e-09
to O 0 5.420042539783232e-11
the O 0 2.723400394089026e-10
POMC O 0 3.8420799342020473e-07
locus O 0 3.634585341028007e-11
, O 0 4.677158386610057e-14
led O 0 5.7651739014241e-14
to O 0 8.213022547210597e-14
the O 0 4.0444270111780756e-13
proposal O 0 4.781378201354491e-13
of O 0 1.4179636197847456e-12
an O 0 3.743721980098598e-14
association O 0 6.572595657831914e-13
of O 0 2.2895700613201342e-10
POMC O 0 1.811595939216204e-05
with O 0 1.1324960934311346e-11
human O 0 9.854881355408907e-09
obesity B-Disease 1 1.0
. O 0 1.5278743603630573e-08

The O 0 3.64455375601036e-11
dual O 0 1.1158690638168878e-09
role O 0 3.9884948122015373e-10
of O 0 3.457939783402253e-07
alpha O 0 4.0649933197300925e-08
- O 0 6.996975798756466e-07
MSH O 0 6.610331183765084e-05
in O 0 1.6436851879575443e-11
regulating O 0 4.7245964085451675e-11
food O 0 1.1704522984504195e-12
intake O 0 2.1820793869725685e-13
and O 0 1.0703463228310239e-14
influencing O 0 3.758527711283932e-09
hair O 0 1.1601487415191514e-07
pigmentation O 0 3.704481343902444e-08
predicts O 0 2.207769383977265e-11
that O 0 1.086343556479458e-14
the O 0 2.4361063296826635e-13
phenotype O 0 9.10847439139495e-12
associated O 0 5.051762393820658e-12
with O 0 5.066308700688027e-14
a O 0 1.8543298840878464e-11
defect O 0 1.407098721983857e-07
in O 0 5.210277001510555e-11
POMC O 0 1.7211292288266122e-05
function O 0 7.532469092907945e-10
would O 0 3.814318218914314e-12
include O 0 1.152968345796701e-11
obesity B-Disease 1 1.0
, O 0 2.6510458325107455e-12
alteration O 0 2.4760106498433743e-07
in O 0 2.073432314730894e-09
pigmentation O 0 0.42870262265205383
and O 0 8.152039043807235e-08
ACTH B-Disease 1 0.9999717473983765
deficiency I-Disease 0 0.00013742486771661788
. O 0 3.542576010318044e-08

The O 0 2.2007422550984757e-09
observation O 0 3.218141841898614e-07
of O 0 5.478875131359473e-10
these O 0 9.179545144843981e-12
symptoms O 0 5.289442772671293e-10
in O 0 3.963009662186906e-13
two O 0 1.6673758727880905e-12
probands O 0 1.4429909711566324e-08
prompted O 0 1.5067594524506567e-12
us O 0 2.1496018398452221e-13
to O 0 6.184215466109588e-12
search O 0 1.4643727341834278e-09
for O 0 3.478228122189009e-11
mutations O 0 6.735584312522747e-10
within O 0 1.7161773113727463e-09
their O 0 1.4046144247714665e-09
POMC O 0 1.4468362678599078e-05
genes O 0 2.598921078345029e-09
. O 0 3.2702396346451224e-09

Patient O 0 5.483187851496041e-05
1 O 0 1.2640691826604211e-09
was O 0 6.505204708240342e-11
found O 0 2.6250711131735327e-13
to O 0 1.0598520758936525e-13
be O 0 6.411527802814912e-14
a O 0 3.2595830196232786e-14
compound O 0 2.1626188253381917e-12
heterozygote O 0 1.6309724404361958e-10
for O 0 1.54345855757701e-13
two O 0 5.266033269168968e-12
mutations O 0 2.341513051160038e-12
in O 0 1.9588726474228935e-11
exon O 0 2.23688206846262e-10
3 O 0 1.9780318008533193e-11
( O 0 6.954714582008137e-13
G7013T O 0 2.0560188218610165e-08
, O 0 1.1115002147843445e-12
C7133delta O 0 1.2208191435547633e-07
) O 0 1.8839415433496293e-14
which O 0 8.184052982799139e-16
interfere O 0 3.772951569225302e-12
with O 0 2.835496789284158e-15
appropriate O 0 6.059259431007158e-12
synthesis O 0 2.347753935705299e-10
of O 0 1.5709819556342097e-10
ACTH O 0 1.6322436735549672e-08
and O 0 1.6189461229942914e-11
alpha O 0 2.0665071875924923e-09
- O 0 2.0253247967616517e-08
MSH O 0 8.069167165558611e-07
. O 0 1.6294993132603963e-09

Patient O 0 6.882351044623647e-06
2 O 0 1.7868298507472957e-10
was O 0 6.749981650011616e-12
homozygous O 0 7.128785951306116e-13
for O 0 2.198378808095265e-14
a O 0 2.0265873126781159e-13
mutation O 0 4.256668531110036e-14
in O 0 1.7465884424514022e-12
exon O 0 1.8850955518789902e-10
2 O 0 3.0816807439215665e-11
( O 0 5.788458904906757e-13
C3804A O 0 2.872818960497625e-08
) O 0 6.184445045919612e-14
which O 0 6.038762832881808e-14
abolishes O 0 8.590232969396538e-10
POMC O 0 3.2591518106528383e-07
translation O 0 1.1179765557756127e-08
. O 0 3.70904871260791e-08

These O 0 1.9768285966503818e-11
findings O 0 2.0648964309255557e-12
represent O 0 1.6485531201867326e-13
the O 0 6.786831838710705e-14
first O 0 8.074101689970956e-14
examples O 0 1.0238969502980588e-13
of O 0 3.645400387802811e-12
a O 0 6.977654565254454e-11
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 5.631248800597177e-10
the O 0 1.3457421808860115e-11
POMC O 0 2.6336670089222025e-07
gene O 0 1.0293743938835642e-12
and O 0 1.2623029791575258e-13
define O 0 1.4918535851116133e-10
a O 0 4.443921272634377e-11
new O 0 3.3672703514397995e-10
monogenic B-Disease 1 1.0
endocrine I-Disease 0 0.005607998929917812
disorder I-Disease 0 7.229900234051456e-07
resulting O 0 2.6351972687299607e-11
in O 0 4.864294188798579e-13
early O 0 7.847706001484767e-06
- O 0 1.6284942830679938e-05
onset O 0 0.00018858785915654153
obesity B-Disease 1 1.0
, O 0 1.8665329698519528e-11
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 5.286722615238659e-09
red O 0 5.701870975372003e-09
hair O 0 6.101649319134594e-07
pigmentation O 0 2.6512079642770914e-08
. O 0 2.8089019998844833e-10
. O 0 2.212742211682439e-09

A O 0 3.8559914372626736e-08
European O 0 3.3442026925456503e-10
multicenter O 0 1.4444013629599795e-07
study O 0 9.132816031209856e-11
of O 0 9.561430260873749e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.840084291535038e-12
classification O 0 1.9261640893386556e-12
of O 0 8.698995516975838e-12
105 O 0 4.3729500576183966e-10
mutations O 0 5.923366181229128e-13
and O 0 3.5418760616469716e-14
a O 0 6.148067352527292e-14
general O 0 2.7644834528104886e-14
system O 0 9.094594787548496e-14
for O 0 3.983117377321776e-15
genotype O 0 2.382354513316698e-12
- O 0 2.3398508608094004e-13
based O 0 6.8514830683659e-15
prediction O 0 5.111969736404376e-10
of O 0 4.662504757280139e-11
metabolic O 0 2.2032631719071105e-08
phenotype O 0 4.4098372176115674e-10
. O 0 1.7582831857154702e-09

Phenylketonuria B-Disease 0 0.000549286778550595
( O 0 4.079792059741294e-11
PKU B-Disease 0 6.048814611858688e-06
) O 0 3.223897277609966e-12
and O 0 4.948471320209702e-12
mild B-Disease 0 1.918570902148531e-08
hyperphenylalaninemia I-Disease 1 1.0
( O 0 3.4720193387016707e-10
MHP B-Disease 1 1.0
) O 0 8.485239420819024e-12
are O 0 4.779809360810905e-13
allelic B-Disease 0 1.5198059699628175e-08
disorders I-Disease 0 8.889801672573583e-10
caused O 0 1.972119163936789e-13
by O 0 4.672555186058204e-15
mutations O 0 3.303873694808848e-14
in O 0 1.0432012038604811e-14
the O 0 9.194605661696706e-14
gene O 0 4.135284644010348e-14
encoding O 0 1.9446419474711263e-10
phenylalanine O 0 1.3714029023503826e-07
hydroxylase O 0 4.267168378646602e-07
( O 0 1.0761252305924174e-10
PAH O 0 2.889458805555023e-08
) O 0 3.1494201777754194e-12
. O 0 8.797450545827701e-10

Previous O 0 2.640514296103902e-08
studies O 0 4.157078153932403e-11
have O 0 1.3754741872665666e-14
suggested O 0 9.830601366582134e-14
that O 0 9.624425098066788e-17
the O 0 5.364332160981769e-14
highly O 0 7.44710959565964e-11
variable O 0 8.576829024775634e-09
metabolic O 0 4.83135636386578e-07
phenotypes O 0 1.616132436765838e-07
of O 0 0.0025917126331478357
PAH B-Disease 1 0.9999884366989136
deficiency I-Disease 1 0.9980523586273193
correlate O 0 3.8342650441336446e-06
with O 0 1.2978969010646324e-09
PAH O 0 4.197373709757812e-05
genotypes O 0 3.890016486707282e-08
. O 0 2.4233295370379437e-09

We O 0 2.1761152879662404e-09
identified O 0 7.241486854603352e-10
both O 0 2.60755809305957e-11
causative O 0 7.05238534237651e-10
mutations O 0 3.978439105933873e-12
in O 0 9.373347367377938e-13
686 O 0 5.529950941607353e-10
patients O 0 4.076602944103058e-11
from O 0 3.8655290773847995e-11
seven O 0 2.389802522539952e-10
European O 0 2.8146401875872584e-10
centers O 0 1.2350508393765836e-09
. O 0 1.0982632581146845e-09

On O 0 4.0526511035920976e-09
the O 0 7.708294939845484e-12
basis O 0 1.0821414597739221e-10
of O 0 2.870009134861573e-12
the O 0 2.993310026927487e-12
phenotypic O 0 1.2693016082643283e-10
characteristics O 0 4.0177285109965766e-11
of O 0 1.1699066715387119e-10
297 O 0 1.2297948215334031e-09
functionally O 0 2.9747049268280534e-08
hemizygous O 0 2.1957706763942042e-08
patients O 0 2.9737004959146107e-12
, O 0 1.24820071067803e-14
105 O 0 4.6169124079398216e-11
of O 0 2.8358274062334488e-11
the O 0 3.3541856792052016e-11
mutations O 0 2.268355425369406e-12
were O 0 2.872429724631864e-12
assigned O 0 6.833848157500322e-12
to O 0 4.451197656990535e-12
one O 0 1.205390279777896e-12
of O 0 1.5160688676685297e-11
four O 0 6.98521492384363e-12
arbitrary O 0 4.813629009281506e-11
phenotype O 0 6.171998329085326e-11
categories O 0 1.5600225972134396e-11
. O 0 1.9421593222546107e-09

We O 0 2.033172380455639e-10
proposed O 0 2.5994972233794877e-12
and O 0 1.1563936047338623e-14
tested O 0 5.731189719852814e-13
a O 0 6.221378223518741e-15
simple O 0 2.9814536951067562e-15
model O 0 2.3088157260879334e-15
for O 0 7.293556657438853e-16
correlation O 0 5.6613916977815357e-14
between O 0 4.643649830979313e-13
genotype O 0 1.0993017260374494e-11
and O 0 9.868121944589525e-13
phenotypic O 0 2.79880507658703e-10
outcome O 0 3.655629043919362e-08
. O 0 7.426962866929898e-08

The O 0 2.2349810890887056e-09
observed O 0 1.1473004490891725e-10
phenotype O 0 3.0034801035139225e-11
matched O 0 4.899776764877295e-11
the O 0 5.693808705770076e-12
predicted O 0 8.630135495124591e-11
phenotype O 0 4.3062333213161885e-12
in O 0 1.5280627512024442e-13
79 O 0 9.562209912772346e-10
% O 0 2.751549654789187e-09
of O 0 2.19063330843261e-12
the O 0 9.37541602512304e-14
cases O 0 3.3591934165940265e-14
, O 0 1.3570608768393843e-14
and O 0 4.585294614161718e-14
in O 0 4.0534936518454856e-13
only O 0 1.3337460747376434e-13
5 O 0 3.660000904778804e-13
of O 0 3.5259504192232394e-13
184 O 0 9.242669130049563e-12
patients O 0 7.05599771319565e-12
was O 0 5.189865204258126e-11
the O 0 1.9264810233177165e-11
observed O 0 2.565046612612587e-11
phenotype O 0 3.364341097378265e-11
more O 0 1.0653561976288646e-14
than O 0 8.650982118434559e-15
one O 0 1.8222280780653966e-14
category O 0 3.189218095341062e-13
away O 0 9.005375113148306e-13
from O 0 5.554075537157754e-13
that O 0 3.259657558522637e-14
expected O 0 5.14207898483221e-10
. O 0 1.263250481997602e-08

Among O 0 4.737520931108463e-10
the O 0 1.3845202762041708e-11
seven O 0 3.20987264545991e-11
contributing O 0 1.829293140576116e-11
centers O 0 4.094227127465766e-12
, O 0 2.1622650501693097e-15
the O 0 1.1209481558032905e-13
proportion O 0 3.3343651190814727e-12
of O 0 9.912623022759193e-13
patients O 0 5.38993437555757e-13
for O 0 1.4814850735067608e-12
whom O 0 2.33752600609094e-10
the O 0 7.873970919725082e-11
observed O 0 7.063295694859084e-12
phenotype O 0 2.3644369882142025e-12
did O 0 4.551332726497603e-13
not O 0 1.0791367121730164e-13
match O 0 5.739947059324457e-11
the O 0 2.916374433614699e-11
predicted O 0 3.4205321908231667e-10
phenotype O 0 1.226177232666048e-11
was O 0 6.69387342864397e-13
4 O 0 1.1583107520016234e-12
% O 0 6.442081243451803e-12
- O 0 1.5194434252463473e-12
23 O 0 6.813778707925877e-12
% O 0 1.1587538567559008e-10
( O 0 3.656233302229417e-13
P O 0 3.966233208529957e-08
< O 0 3.660802494476201e-10
. O 0 5.769478319574139e-13
0001 O 0 4.593461999657933e-10
) O 0 3.0181078177014126e-14
, O 0 1.828746166001108e-14
suggesting O 0 1.850463575772676e-12
that O 0 1.8402428171392484e-15
differences O 0 6.1354337409225135e-12
in O 0 1.168299398196515e-13
methods O 0 2.62211280466218e-10
used O 0 6.854630578423393e-12
for O 0 6.86389356810424e-12
mutation O 0 3.354424238377618e-10
detection O 0 3.983226974924037e-07
or O 0 1.0091387725452705e-09
phenotype O 0 5.4324265086336254e-09
classification O 0 6.476359032392409e-11
may O 0 2.1245188767948786e-12
account O 0 4.762919117266839e-13
for O 0 5.5943673359180185e-14
a O 0 2.0323238263727367e-13
considerable O 0 1.741100427894715e-12
proportion O 0 6.956947171121719e-12
of O 0 2.7427546345215603e-11
genotype O 0 2.0932003508278285e-07
- O 0 1.4000528381075128e-06
phenotype O 0 7.950282565616362e-08
inconsistencies O 0 1.0062220923146015e-07
. O 0 4.359105432172328e-08

Our O 0 2.309251279086766e-08
data O 0 2.7288546422532534e-10
indicate O 0 1.0364985779387492e-12
that O 0 2.6991851005715034e-16
the O 0 2.349492670729314e-13
PAH O 0 3.1635713493294304e-10
- O 0 4.562965023185983e-12
mutation O 0 5.666026323255732e-14
genotype O 0 5.376342600282857e-12
is O 0 2.6537434240776455e-15
the O 0 1.1024459746792822e-13
main O 0 1.429893287108186e-10
determinant O 0 4.182779900219202e-09
of O 0 1.4450227681095384e-09
metabolic O 0 1.433725856259116e-06
phenotype O 0 1.3155124767294524e-09
in O 0 8.286640471033557e-12
most O 0 7.202771799136309e-12
patients O 0 5.537222902418648e-10
with O 0 2.0624040253380826e-09
PAH B-Disease 1 0.9983983635902405
deficiency I-Disease 1 0.9736797213554382
. O 0 9.378534855386533e-07

In O 0 2.4720012148371495e-10
the O 0 1.3277572617764744e-11
present O 0 5.113144716656359e-12
study O 0 1.1377625729579177e-13
, O 0 1.2220468320140116e-15
the O 0 1.2852119000116013e-14
classification O 0 1.0564014940595001e-12
of O 0 3.419264871240557e-11
105 O 0 5.807904130961106e-07
PAH O 0 6.760494102309167e-07
mutations O 0 2.5564614314355083e-10
may O 0 1.0538898313067202e-12
allow O 0 2.652694904015096e-12
the O 0 6.792368750785371e-12
prediction O 0 2.5179041074352426e-09
of O 0 3.394792086330867e-11
the O 0 4.353074845031557e-11
biochemical O 0 1.2526345238850212e-10
phenotype O 0 3.017927921455943e-11
in O 0 1.7974151680921757e-11
> O 0 4.583222690257571e-10
10 O 0 7.378785950307165e-12
, O 0 6.32697629639363e-14
000 O 0 2.379382524342333e-10
genotypes O 0 4.428762689911991e-09
, O 0 3.291998834989429e-13
which O 0 1.0472242715467601e-14
may O 0 3.0677313445602594e-13
be O 0 5.081776470981791e-13
useful O 0 5.2317667559309555e-11
for O 0 3.2852244687651966e-13
the O 0 1.6368085706264246e-11
management O 0 2.1705357511336842e-09
of O 0 2.2110504538375153e-09
hyperphenylalaninemia B-Disease 1 1.0
in O 0 6.6080065863616255e-09
newborns O 0 2.8188447132038164e-08
. O 0 4.938097930562435e-09

Somatic O 0 1.6061825590441003e-05
instability O 0 0.0005639298469759524
of O 0 3.837271833617706e-06
the O 0 7.715538004049449e-07
CTG O 0 0.0008077698294073343
repeat O 0 1.491683554455392e-09
in O 0 1.0650185594540673e-11
mice O 0 3.918550325800879e-13
transgenic O 0 5.4074159836240906e-14
for O 0 2.0589558297244917e-14
the O 0 1.8923427061445786e-11
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 8.497566028609072e-08
is O 0 7.580751754414014e-14
age O 0 4.5854392331790006e-12
dependent O 0 1.050414616399209e-11
but O 0 4.788583453238992e-15
not O 0 5.106326602874467e-14
correlated O 0 1.6199840080499683e-11
to O 0 4.830566285515814e-13
the O 0 3.757790519726134e-12
relative O 0 2.4584463353960473e-09
intertissue O 0 1.117118060278699e-07
transcription O 0 8.339957613401339e-10
levels O 0 2.2458221948795654e-09
and O 0 1.5429429955915452e-10
proliferative O 0 2.1617177026200807e-06
capacities O 0 1.006973434414249e-06
. O 0 1.9176562560119237e-08

A O 0 6.3887214309943374e-06
( O 0 1.4147333478320423e-11
CTG O 0 4.823884296456526e-07
) O 0 3.1502594586771404e-13
nexpansion O 0 6.0330913598249936e-09
in O 0 3.528365479562451e-13
the O 0 1.0849449593938743e-12
3 O 0 4.257877037061597e-11
- O 0 1.988049280754467e-09
untranslated O 0 4.0838804125087336e-05
region O 0 5.130969538136299e-10
( O 0 2.3447552493366386e-14
UTR O 0 1.1533423105447582e-07
) O 0 5.359073272225446e-15
of O 0 2.3421650903465707e-12
the O 0 2.6469962333131036e-10
DM O 1 1.0
protein O 0 3.983253193950986e-08
kinase O 0 6.06267591685139e-10
gene O 0 1.1700487800858639e-11
( O 0 7.558823901000766e-13
DMPK O 1 0.9999412298202515
) O 0 1.4257300581018567e-13
is O 0 2.498883354946457e-15
responsible O 0 3.276732726299747e-13
for O 0 1.2841718790776446e-12
causing O 0 1.513646111561684e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.1004529731906132e-08
DM B-Disease 1 1.0
) O 0 8.985396454663785e-11
. O 0 6.83494982833821e-10

Major O 0 9.964887794922106e-07
instability O 0 0.0011705640936270356
, O 0 6.24016463501853e-12
with O 0 1.6021232463522134e-13
very O 0 3.026282837607225e-13
large O 0 8.40473862923942e-15
expansions O 0 3.1815947446056647e-12
between O 0 2.244983712818005e-12
generations O 0 5.374192410534384e-11
and O 0 7.230210218511432e-14
high O 0 2.457228647986809e-12
levels O 0 2.383632874414232e-11
of O 0 1.8150160194241316e-11
somatic O 0 8.713418320205335e-10
mosaicism O 0 4.018079380330164e-08
, O 0 2.5302535674315285e-12
is O 0 1.0316263631109795e-13
observed O 0 3.2487552144994103e-12
in O 0 7.215655590392389e-12
patients O 0 9.25186316447224e-11
. O 0 4.33345448414002e-09

There O 0 7.207588970103984e-10
is O 0 1.3318395052173276e-13
a O 0 5.388711395507007e-13
good O 0 1.3110624565160212e-11
correlation O 0 1.5455215232607067e-12
between O 0 1.5208931119711777e-12
repeat O 0 5.1145615520553633e-11
size O 0 3.4323312421424834e-12
( O 0 1.7466734167966708e-14
at O 0 6.173487285612844e-13
least O 0 2.93790938300266e-14
in O 0 1.9487493216341356e-13
leucocytes O 0 3.2720239850903e-09
) O 0 6.637320359124954e-14
, O 0 2.39527381897019e-14
clinical O 0 7.82300548125836e-13
severity O 0 5.887012231864386e-12
and O 0 5.797992023558879e-14
age O 0 1.299372553997813e-10
of O 0 1.4281680005279185e-10
onset O 0 5.066517871910037e-08
. O 0 1.9761380087857106e-08

The O 0 9.55603468355548e-07
trinucleotide O 0 0.0010453962022438645
repeat O 0 8.896228109733784e-07
instability O 0 6.475271220551804e-06
mechanisms O 0 2.534664034214984e-08
involved O 0 3.579178273205308e-11
in O 0 1.487248102449712e-10
DM B-Disease 1 1.0
and O 0 2.00902516844792e-10
other O 0 1.0798275468237861e-11
human O 0 5.120051937979042e-09
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 8.704875436736561e-15
unknown O 0 1.767703691757383e-11
. O 0 6.315098444176215e-11

We O 0 3.849317309345679e-09
studied O 0 2.5673398962311467e-09
somatic O 0 3.136633353051366e-08
instability O 0 1.411807337703408e-09
by O 0 1.6903179431235898e-13
measuring O 0 2.46448625396134e-11
the O 0 1.2287150463752283e-11
CTG O 0 1.352551208810837e-07
repeat O 0 3.2413974282441416e-11
length O 0 9.86788255274984e-12
at O 0 1.3222397352366522e-12
several O 0 2.133499133654196e-14
ages O 0 3.703259053577934e-12
in O 0 9.491469025665888e-14
various O 0 8.253482966513737e-12
tissues O 0 6.428582666195837e-11
of O 0 3.3946494920611414e-11
transgenic O 0 2.748398513982564e-12
mice O 0 2.949375769653595e-13
carrying O 0 9.447048178456985e-12
a O 0 5.1217557972549344e-11
( O 0 5.91439484193268e-12
CTG O 0 1.645928335847202e-07
) O 0 1.251782965477899e-12
55expansion O 0 4.103356765483568e-09
surrounded O 0 4.857808946767683e-11
by O 0 5.745437356126717e-14
45 O 0 2.3569696194769563e-10
kb O 0 2.7107694222650025e-07
of O 0 1.7134421659292798e-10
the O 0 3.635403436619278e-11
human O 0 3.491323619098097e-10
DM B-Disease 1 1.0
region O 0 9.763727604195083e-09
, O 0 6.309285505070455e-14
using O 0 6.326037783888072e-13
small O 0 2.495019815751398e-12
- O 0 6.36948549459504e-11
pool O 0 1.821536810275859e-10
PCR O 0 2.223734085760043e-09
. O 0 2.5940478654007393e-09

These O 0 2.3137855520438677e-10
mice O 0 4.464308697021968e-12
have O 0 4.622736096232495e-15
been O 0 4.333127061236777e-15
shown O 0 1.3287990296311815e-14
to O 0 2.0142238503734027e-14
reproduce O 0 3.768190620645484e-12
the O 0 2.0149318682733536e-13
intergenerational O 0 5.995474117170829e-10
and O 0 5.265879962981779e-13
somatic O 0 7.308622596013947e-09
instability O 0 9.68863673733722e-08
of O 0 1.8432695370051988e-09
the O 0 1.7500426663374924e-09
55 O 0 1.2244828440088895e-07
CTG O 0 4.154114776611095e-06
repeat O 0 7.230832044236024e-10
suggesting O 0 1.5907497541434168e-10
that O 0 5.41065537642757e-14
surrounding O 0 2.99113555105035e-12
sequences O 0 1.0600872393448646e-12
and O 0 1.1057564504876952e-13
the O 0 7.328769535686064e-12
chromatin O 0 2.1419925555488106e-10
environment O 0 1.216274303494913e-09
are O 0 4.7110556287196376e-14
involved O 0 7.371330108807417e-12
in O 0 3.382369731519397e-11
instability O 0 1.1604696226186206e-07
mechanisms O 0 1.00305264538747e-07
. O 0 6.077209402377548e-09

As O 0 5.840580796778738e-10
observed O 0 1.887170454628606e-11
in O 0 6.639096282283485e-13
some O 0 2.041281470840494e-14
of O 0 1.4210148899587716e-12
the O 0 4.703716149218051e-12
tissues O 0 1.5676265840980363e-10
of O 0 6.068900937350463e-10
DM B-Disease 1 1.0
patients O 0 1.2981760111330232e-10
, O 0 2.2455564426156205e-13
there O 0 1.0123118435092365e-13
is O 0 3.0736204088886807e-15
a O 0 5.5673940799324736e-14
tendency O 0 6.496642416739529e-13
for O 0 6.233615647320903e-14
repeat O 0 9.517583769713678e-12
length O 0 9.204704706777811e-12
and O 0 3.614229954814613e-13
somatic O 0 1.6087091381233876e-10
mosaicism O 0 2.766125550834886e-09
to O 0 2.5396624907247922e-12
increase O 0 4.3876726796114596e-13
with O 0 1.5048300520042806e-15
the O 0 1.9886181460218588e-13
age O 0 9.616357189712321e-12
of O 0 3.8566385328342445e-12
the O 0 1.2261444463923521e-11
mouse O 0 8.977275867128043e-11
. O 0 2.432563706022961e-09

Furthermore O 0 1.533497417938179e-08
, O 0 7.645211503801153e-13
we O 0 1.2552635255021205e-13
observed O 0 1.9511432739123015e-14
no O 0 7.805913122947586e-16
correlation O 0 1.172754384923258e-15
between O 0 3.507092696019621e-15
the O 0 4.2121193414689645e-14
somatic O 0 8.850681298966379e-11
mutation O 0 7.424569639646883e-12
rate O 0 8.992803030016816e-11
and O 0 8.249722086017819e-12
tissue O 0 5.4136424232353875e-09
proliferation O 0 4.686728161118481e-08
capacity O 0 1.2520099623714032e-08
. O 0 2.0024537583651636e-09

The O 0 7.121855549740985e-09
somatic O 0 9.430340952576444e-08
mutation O 0 3.94398055880707e-11
rates O 0 8.29973297120784e-13
in O 0 3.027388291836357e-15
different O 0 1.044685103940117e-13
tissues O 0 9.304915345176301e-12
were O 0 1.7615299410106422e-12
also O 0 2.0986670636323783e-15
not O 0 6.5065068777399575e-15
correlated O 0 1.966178305237709e-12
to O 0 5.431876194499086e-13
the O 0 4.671065183953216e-12
relative O 0 8.560566477910925e-09
inter O 0 9.073289675143315e-07
- O 0 1.0981469245052722e-07
tissue O 0 7.827872572363503e-09
difference O 0 6.609814778846257e-11
in O 0 1.1883599844181997e-13
transcriptional O 0 2.2616808599551508e-12
levels O 0 3.292854704184389e-12
of O 0 1.6991555460820623e-13
the O 0 6.325588517612848e-14
three O 0 3.0643280339408274e-13
genes O 0 9.936431018264802e-14
( O 0 6.901743885873602e-15
DMAHP O 0 3.874840501794097e-07
, O 0 1.5467542611308227e-12
DMPK O 0 9.056735143531114e-05
and O 0 9.5347176334859e-12
59 O 0 7.371145471779528e-09
) O 0 5.757880066833976e-13
surrounding O 0 2.8388454781369532e-12
the O 0 1.1370341517283333e-12
repeat O 0 5.749161910428846e-11
. O 0 1.711455283048835e-11
. O 0 5.882628828501879e-10

A O 0 2.3941666427163e-08
novel O 0 2.091574309581734e-11
missense O 0 3.8239118538285766e-08
mutation O 0 2.3993192849181e-11
in O 0 3.494642997290548e-13
patients O 0 2.1067878344660507e-12
from O 0 1.5835704058816957e-12
a O 0 1.6489313170095499e-12
retinoblastoma B-Disease 0 2.2903936525153767e-08
pedigree O 0 9.330516359540297e-10
showing O 0 5.121325932777587e-11
only O 0 6.366078454320134e-13
mild O 0 4.115591602325136e-13
expression O 0 1.086746794984328e-12
of O 0 7.012072780060441e-12
the O 0 4.84783116427856e-11
tumor B-Disease 0 1.513106417938559e-09
phenotype O 0 7.869496720935842e-11
. O 0 8.411367158345229e-10

We O 0 9.496047004287078e-11
have O 0 6.935764117167124e-15
used O 0 5.018161992713377e-15
single O 0 3.836305052925745e-14
strand O 0 9.123713747396026e-14
conformation O 0 1.2393763044928757e-13
polymorphism O 0 6.204631426698359e-12
analysis O 0 1.8903179802715053e-12
to O 0 1.3410270073219155e-12
study O 0 6.35696627716148e-13
the O 0 1.7416916433393714e-12
27 O 0 1.4704967243872602e-09
exons O 0 8.786102512203797e-09
of O 0 4.199643410807141e-11
the O 0 3.653629829236671e-11
RB1 O 0 1.1423671253396606e-07
gene O 0 6.051838988708341e-14
in O 0 3.754799138169611e-14
individuals O 0 9.384147240743337e-14
from O 0 7.034819341639187e-12
a O 0 2.1226161453502534e-11
family O 0 1.1606644464978721e-11
showing O 0 1.3921958030849169e-09
mild O 0 9.50406940647408e-12
expression O 0 2.259633972989672e-11
of O 0 9.00799504433003e-11
the O 0 9.44698139160316e-11
retinoblastoma B-Disease 0 7.550945468892678e-08
phenotype O 0 1.1433776148095376e-09
. O 0 4.626031557819488e-09

In O 0 2.67717681357027e-10
this O 0 3.896491636290467e-12
family O 0 3.291548674247413e-12
affected O 0 1.2616152697195182e-12
individuals O 0 6.634456286620403e-15
developed O 0 1.0286349896859726e-11
unilateral B-Disease 0 3.665148462506096e-10
tumors I-Disease 1 1.0
and O 0 8.09768016529766e-11
, O 0 6.527645177861752e-13
as O 0 1.3764564574941796e-13
a O 0 2.2569652310261423e-13
result O 0 1.2380449963822482e-11
of O 0 1.3750101057752318e-10
linkage O 0 1.2565571916312024e-09
analysis O 0 2.2531396887126576e-11
, O 0 6.028891036576056e-13
unaffected O 0 4.162433592247439e-11
mutation O 0 1.1871048848782761e-13
carriers O 0 4.2007423337346236e-14
were O 0 8.148743832481209e-12
also O 0 6.181027369621395e-13
identified O 0 1.1753639728162568e-10
within O 0 1.3293061096320002e-10
the O 0 5.2314774040551626e-11
pedigree O 0 6.221871906575416e-09
. O 0 6.6368817108752864e-09

A O 0 3.3879388183777337e-09
single O 0 2.4825603378575423e-11
band O 0 3.9159168963021074e-11
shift O 0 1.0454461601971943e-10
using O 0 2.7776893198744323e-12
SSCP O 0 6.74846232868731e-05
was O 0 9.721424359954156e-11
identified O 0 3.0161727282429496e-11
in O 0 3.736256963537965e-12
exon O 0 1.0047113835343069e-10
21 O 0 5.987821783542957e-12
which O 0 7.34411817164283e-16
resulted O 0 6.906227976652413e-13
in O 0 5.67588036575091e-14
a O 0 1.1498382541247354e-12
missense O 0 8.322192379672799e-10
mutation O 0 1.2571451041623605e-12
converting O 0 3.5325189995383255e-10
a O 0 3.82265920306768e-11
cys O 0 3.818078312178841e-06
- O 0 1.0367022014179383e-06
- O 0 3.221058477720362e-07
> O 0 6.433164667640767e-09
arg O 0 4.820832621987847e-11
at O 0 2.7515455192084204e-12
nucleotide O 0 2.404192513474901e-12
position O 0 6.0294464733490205e-12
28 O 0 1.2182651588921178e-11
in O 0 9.523462747573763e-13
the O 0 1.6963894178267935e-10
exon O 0 3.7987014422924403e-08
. O 0 2.0940124301205287e-08

The O 0 2.3245001479210714e-09
mutation O 0 3.501707812603172e-10
destroyed O 0 3.259118530607452e-09
an O 0 5.034119280288019e-13
NdeI O 0 6.301294774857524e-08
restriction O 0 6.608856517598127e-11
enzyme O 0 4.501745504148502e-11
site O 0 3.0317240384825084e-10
. O 0 1.2022763895558342e-09

Analysis O 0 4.6163974865010005e-09
of O 0 4.836427369703244e-10
all O 0 2.3285182809695826e-11
family O 0 1.7563030023370896e-12
members O 0 3.504981339343648e-14
demonstrated O 0 2.1444022772765248e-12
that O 0 4.41535532569033e-15
the O 0 2.872747179027968e-12
missense O 0 1.101982061157969e-08
mutation O 0 1.0010559048367895e-10
co O 0 3.252250690977121e-09
- O 0 7.864406370572397e-08
segregated O 0 2.1401466709924932e-10
with O 0 1.4713795774227295e-14
patients O 0 2.0765318718002357e-12
with O 0 2.9440645342611316e-13
tumors B-Disease 1 1.0
or O 0 1.7660876094893752e-09
who O 0 7.188035583416408e-11
, O 0 1.417179524773604e-12
as O 0 9.760281775503254e-13
a O 0 4.244882169292946e-13
result O 0 1.3496493853071279e-11
of O 0 3.056936093148721e-10
linkage O 0 2.292857459451625e-09
analysis O 0 2.4601655781997245e-11
had O 0 1.4111431207580738e-12
been O 0 1.5178727415590676e-13
predicted O 0 1.7474182907942226e-12
to O 0 4.907506692686248e-13
carry O 0 6.00588606625152e-11
the O 0 2.821529815344448e-11
predisposing O 0 3.401920523060653e-08
mutation O 0 1.0615130996427524e-09
. O 0 8.315722332952191e-09

These O 0 1.5449160006841822e-10
observations O 0 2.1041918207842514e-10
point O 0 4.8261502433311065e-11
to O 0 3.1811017578778356e-13
another O 0 1.3070022494843236e-12
region O 0 1.046733116849552e-10
of O 0 8.691914375746901e-12
the O 0 2.279351013489972e-11
RB1 O 0 1.2439957686183334e-07
gene O 0 1.2033223809743143e-13
where O 0 3.4548566400305694e-14
mutations O 0 7.763455405884051e-14
only O 0 3.652648658796637e-14
modify O 0 1.8310594360193555e-11
the O 0 9.162192705913785e-12
function O 0 2.1414861550717035e-10
of O 0 7.14540093760263e-11
the O 0 4.251741667071762e-11
gene O 0 3.925200279825819e-13
and O 0 1.2473873388200996e-13
raise O 0 2.6656077518893984e-12
important O 0 6.44908909261388e-12
questions O 0 3.5965928586040308e-12
for O 0 3.214090235278966e-13
genetic O 0 2.3516291344782836e-11
counseling O 0 8.775303400598844e-12
in O 0 1.1840107751659099e-14
families O 0 2.263690808152613e-13
with O 0 5.501710655927755e-15
these O 0 1.5932432239837424e-13
distinctive O 0 1.3671581228225094e-12
phenotypes O 0 1.3871795205566695e-11
. O 0 3.103931695003226e-11
. O 0 4.098843042754652e-09

Maternal B-Disease 0 2.972903985209996e-06
disomy I-Disease 0 4.5651518121303525e-06
and O 0 1.8844072968704495e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 3.6971056260881596e-07
with O 0 2.317808039614222e-15
gamete O 0 1.7951615194355952e-10
complementation O 0 7.774940691263055e-10
in O 0 9.349702137723473e-14
a O 0 5.731876019827997e-14
case O 0 2.0920060388868178e-14
of O 0 1.179596784833814e-11
familial O 0 2.626332207267268e-10
translocation O 0 4.1259982097585635e-09
( O 0 5.321287301855021e-14
3 O 0 1.9049839830587167e-12
; O 0 2.1738935419856904e-15
15 O 0 2.758743483221443e-13
) O 0 5.79097897192044e-16
( O 0 4.3748634979819893e-16
p25 O 0 2.507515896310597e-11
; O 0 1.109622224155669e-14
q11 O 0 3.107926138667949e-10
. O 0 1.4369997975837573e-13
2 O 0 1.7594346118920967e-12
) O 0 3.542682098199579e-13
. O 0 1.1627546148140766e-10

Maternal B-Disease 0 0.00010888589167734608
uniparental I-Disease 0 0.005512409843504429
disomy I-Disease 1 0.653928816318512
( I-Disease 0 2.2615451178431556e-10
UPD I-Disease 1 1.0
) I-Disease 0 3.9277917940686025e-13
for I-Disease 0 3.6607549673897677e-13
chromosome I-Disease 0 2.416302574692608e-11
15 I-Disease 0 3.920323701084305e-12
is O 0 4.1157203852144365e-15
responsible O 0 1.0636720454079707e-12
for O 0 9.018524859197297e-13
an O 0 4.21354913308393e-14
estimated O 0 2.039781321280798e-12
30 O 0 2.8287558059836293e-11
% O 0 3.3844153174422686e-11
of O 0 1.9677220803823205e-14
cases O 0 8.124706995778306e-15
of O 0 6.846565980822561e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.879056637539179e-07
PWS B-Disease 1 1.0
) O 0 1.9356854660812495e-11
. O 0 1.1396256160978169e-10

We O 0 1.4032649486850346e-09
report O 0 1.188068653873442e-11
on O 0 4.056512070693685e-12
an O 0 4.216618526374895e-15
unusual O 0 6.8320394270616775e-15
case O 0 3.35344511220078e-14
of O 0 2.046106339914644e-11
maternal B-Disease 0 2.3741897337004048e-08
disomy I-Disease 0 3.701127582189656e-07
15 I-Disease 0 3.594600728185071e-10
in O 0 5.820693579905445e-11
PWS B-Disease 1 1.0
that O 0 1.0243681987723297e-12
is O 0 2.0922692967268244e-14
most O 0 8.659765003064639e-15
consistent O 0 4.985133399831865e-12
with O 0 4.180328839705795e-14
adjacent O 0 7.941314966730673e-11
- O 0 5.509594516728278e-12
1 O 0 7.83629671569086e-13
segregation O 0 9.779424665901093e-12
of O 0 1.912026987476237e-13
a O 0 2.0627146908938632e-13
paternal O 0 2.2894215689905906e-10
t O 0 8.570548784558873e-13
( O 0 3.903127397431342e-15
3 O 0 2.2784752600271685e-13
; O 0 1.1610207551422994e-15
15 O 0 2.2702849257656699e-13
) O 0 2.2512306676248826e-16
( O 0 6.003382409611806e-17
p25 O 0 1.027354590288354e-11
; O 0 3.58698929052762e-15
q11 O 0 1.4162325479016857e-10
. O 0 5.78484370052524e-15
2 O 0 4.8181936074926345e-15
) O 0 2.937154242542271e-17
with O 0 1.622472155177605e-16
simultaneous O 0 7.61943459715031e-12
maternal O 0 6.690437648337877e-10
meiotic O 0 2.864281896108878e-07
nondisjunction O 0 1.9352607694145263e-07
for O 0 6.455565942919961e-11
chromosome O 0 2.3755145073245387e-10
15 O 0 1.45671741336173e-09
. O 0 2.2598172222387802e-09

The O 0 1.1209125183597735e-08
patient O 0 7.997720530283914e-08
( O 0 5.5907511828596004e-14
J O 0 9.873459688725106e-11
. O 0 1.0462384946027456e-13
B O 0 5.1736436315619194e-12
. O 0 4.060267679256539e-15
) O 0 9.215660232611664e-17
, O 0 1.4998605626422988e-16
a O 0 1.6651359077116037e-15
17 O 0 5.3518438460206305e-14
- O 0 3.95255964731004e-14
year O 0 2.495657543469254e-12
- O 0 8.308932986089701e-10
old O 0 1.260627300325723e-07
white O 0 3.5223358518104986e-12
male O 0 4.316018462763305e-12
with O 0 3.375339897447767e-14
PWS B-Disease 1 1.0
, O 0 5.591546323180374e-12
was O 0 1.784541264759909e-10
found O 0 4.501039298221432e-12
to O 0 5.1432337555556984e-11
have O 0 7.471633554911872e-12
47 O 0 2.5241742029891157e-09
chromosomes O 0 3.8648528821738637e-10
with O 0 1.493383650248703e-12
a O 0 5.7707276457374945e-11
supernumerary O 0 2.3404176374697272e-07
, O 0 2.8116326541288705e-12
paternal O 0 4.136423203959794e-09
der O 0 7.52803771320032e-07
( O 0 1.762464198022673e-12
15 O 0 3.725080313654594e-11
) O 0 5.024100117190103e-15
consisting O 0 1.4662199948091426e-13
of O 0 1.0262260876151008e-12
the O 0 1.3596479627939195e-12
short O 0 1.3205290159967742e-11
arm O 0 2.171786528393227e-09
and O 0 7.684934502996676e-13
the O 0 3.000103498962403e-10
proximal O 0 0.0010115650948137045
long O 0 7.287103365172243e-09
arm O 0 7.128924721655494e-07
of O 0 4.460810743012189e-08
chromosome O 0 1.443833408387718e-08
15 O 0 6.887719727899366e-09
, O 0 4.236599406796243e-13
and O 0 1.1179552292586714e-12
distal O 0 2.7791156753664836e-06
chromosome O 0 7.076868087096955e-07
arm O 0 0.23819716274738312
3p O 1 0.9918978214263916
. O 0 1.5637941032764502e-05

The O 0 2.0947818768490833e-07
t O 0 1.662937565427569e-10
( O 0 3.6809317665318156e-14
3 O 0 9.651614360159377e-13
; O 0 1.2371029485305752e-15
15 O 0 3.364665046145382e-13
) O 0 8.143661687313726e-16
was O 0 1.3502969630017209e-13
present O 0 7.055587261358201e-14
in O 0 1.22468419615023e-14
the O 0 2.789410683771282e-13
balanced O 0 2.202007022902852e-12
state O 0 1.3911074169762477e-13
in O 0 2.7185683378386748e-14
the O 0 1.7831501791625015e-13
patients O 0 1.9742794367654665e-13
father O 0 5.116363929746903e-12
and O 0 1.0176846344800428e-12
a O 0 1.3360396122763518e-10
sister O 0 1.0425220686727243e-08
. O 0 4.444182621909931e-08

Fluorescent O 0 1.0935336192119394e-08
in O 0 4.069571762910229e-11
situ O 0 8.009364727001866e-09
hybridization O 0 8.328853232097977e-12
analysis O 0 3.238427863545834e-13
demonstrated O 0 3.342628908040157e-13
that O 0 2.6356643528514497e-15
the O 0 2.2835971395102073e-12
PWS B-Disease 1 1.0
critical O 0 1.1447375491968614e-08
region O 0 4.124896868518135e-09
resided O 0 7.969651605321815e-09
on O 0 2.756984224250303e-11
the O 0 3.39845707998665e-12
derivative O 0 6.100581151358142e-11
chromosome O 0 3.281581603675754e-12
3 O 0 5.01562224912433e-13
and O 0 5.497014112345114e-14
that O 0 1.6643684111580966e-14
there O 0 5.246988621040484e-14
was O 0 2.5633726911944432e-12
no O 0 1.0480779791136388e-13
deletion O 0 2.4021904257431892e-11
of O 0 1.2523113622486814e-11
the O 0 5.86775850131005e-10
PWS B-Disease 1 1.0
region O 0 9.197175643294031e-08
on O 0 3.013161387066532e-10
the O 0 8.547110068313213e-12
normal O 0 5.0771337134492e-10
pair O 0 5.5570482243583186e-11
of O 0 9.938531247977167e-11
15s O 0 6.8793961638391465e-09
present O 0 4.300522438160925e-11
in O 0 1.8543271085302848e-10
J O 0 2.712998536935629e-07
. O 0 1.816778194552171e-08

B O 0 2.5357565391459502e-05
. O 0 7.228921816704315e-08

Methylation O 0 1.0985488074766181e-08
analysis O 0 8.010093144328323e-10
at O 0 1.2876246735515906e-09
exon O 0 4.908665696135017e-10
alpha O 0 4.6760212889240815e-12
of O 0 4.521606700169656e-11
the O 0 5.1184261690151445e-11
small O 0 1.503426506552219e-12
nuclear O 0 1.0313963016983507e-09
ribonucleoprotein O 0 1.899490120749192e-09
- O 0 7.532964703405032e-12
associated O 0 2.391313926389249e-12
polypeptide O 0 1.4912097598407392e-11
N O 0 3.980756002608388e-11
( O 0 8.519781373586078e-16
SNRPN O 0 5.276993064740054e-08
) O 0 1.8738774366835326e-15
gene O 0 4.7389185234096836e-15
showed O 0 1.3550984878478445e-13
a O 0 3.5786403408764184e-14
pattern O 0 1.0016628151920948e-11
characteristic O 0 3.2023433384209543e-12
of O 0 2.603928791339305e-12
only O 0 8.632047713338226e-14
the O 0 7.058591992153973e-13
maternal O 0 9.303570414065376e-11
chromosome O 0 4.896429615930398e-12
15 O 0 4.2462793697906065e-11
in O 0 1.0990109516884061e-10
J O 0 2.330686186269304e-07
. O 0 5.1942002698979195e-08

B O 0 4.175415961071849e-05
. O 0 8.459126377147186e-08

Maternal B-Disease 0 7.3182195592380594e-06
disomy I-Disease 0 1.728769575493061e-06
was O 0 2.046453805026882e-11
confirmed O 0 4.1455529872606867e-13
by O 0 8.223234609356755e-16
polymerase O 0 1.569446070499858e-13
chain O 0 1.3688162541912637e-14
reaction O 0 4.579119405163055e-16
analysis O 0 2.0806529174815895e-14
of O 0 1.3870033051775754e-13
microsatellite O 0 5.004637676497836e-11
repeats O 0 1.171909271013849e-11
at O 0 6.297674512954765e-13
the O 0 2.858551340512855e-13
gamma O 0 4.589796858550654e-12
- O 0 3.575118673326827e-11
aminobutyric O 0 1.843811103796611e-09
acid O 0 1.490837314710447e-11
receptor O 0 1.2640618261318404e-13
beta3 O 0 1.170786689819181e-09
subunit O 0 4.272860277404478e-12
( O 0 3.765106444935523e-13
GABRB3 O 0 4.1446173781878315e-06
) O 0 3.0562509988063535e-12
locus O 0 1.2023605722166764e-10
. O 0 8.473248214180273e-10

A O 0 1.0339474556531059e-06
niece O 0 8.3908801684629e-08
( O 0 1.992771995595194e-13
B O 0 8.48660378083288e-11
. O 0 1.0303201197217008e-14
B O 0 9.558858695898897e-13
. O 0 3.7807164722951966e-16
) O 0 4.43144642382421e-18
with O 0 2.666506205506963e-17
45 O 0 1.5707187883250845e-13
chromosomes O 0 1.903099206002068e-12
and O 0 7.122897242731532e-14
the O 0 3.213019477213419e-12
derivative O 0 6.346901736814514e-12
3 O 0 4.706261964339264e-13
but O 0 7.387956891223568e-15
without O 0 4.515655156658166e-13
the O 0 3.2968894541490767e-12
der O 0 1.5928705465739768e-08
( O 0 1.6529988911950094e-13
15 O 0 6.641658143596851e-12
) O 0 1.6433723278681464e-14
demonstrated O 0 1.4561041174893097e-12
a O 0 1.2697168620331989e-12
phenotype O 0 4.330087677306693e-11
consistent O 0 2.070177883284341e-11
with O 0 4.958639293443923e-15
that O 0 1.5890536084442095e-15
reported O 0 1.2475038905536417e-13
for O 0 1.406330022053759e-13
haploinsufficiency O 0 1.8150261382743338e-07
of O 0 1.55428026005211e-09
distal O 0 6.853074410173576e-07
3 O 0 5.4485234102230606e-08
p O 0 2.133351557631613e-07
. O 0 1.584549558231174e-08

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 1.7545788821848873e-08
with O 0 6.920551371553119e-12
unbalanced O 0 2.420342752884608e-07
segregation O 0 8.237139859090803e-09
of O 0 1.6994313734031152e-09
non O 0 1.4361123703565681e-06
- O 0 7.430519843865113e-08
Robertsonian O 0 3.626563920988701e-05
translocations O 0 1.6207597752782021e-07
has O 0 8.695183685754077e-15
been O 0 1.1912459611947666e-14
reported O 0 2.8315164882913857e-13
previously O 0 1.3998035586562652e-12
but O 0 5.62464393569456e-15
has O 0 1.4900801114283699e-16
not O 0 2.627232139861533e-15
, O 0 5.285758758992324e-15
to O 0 1.684441973924533e-12
our O 0 2.0428436720010268e-10
knowledge O 0 2.82099588133633e-08
, O 0 7.500701990938163e-13
been O 0 3.0792933307377535e-12
observed O 0 1.773836177769439e-12
in O 0 2.94696911188122e-13
a O 0 1.2537685733365889e-12
case O 0 6.945121127505116e-12
of O 0 3.4099287837818792e-09
PWS B-Disease 1 1.0
. O 0 4.384956469039025e-07

Furthermore O 0 2.2851970982173953e-07
, O 0 1.751085908219263e-11
our O 0 2.147859251566686e-10
findings O 0 1.065150029809503e-12
are O 0 1.984993124528483e-15
best O 0 2.526075187784041e-14
interpreted O 0 4.493083558205005e-14
as O 0 2.7131241182734925e-14
true O 0 6.93659496162069e-12
gamete O 0 1.6140338843229074e-08
complementation O 0 3.324915454072652e-08
resulting O 0 5.719840712181679e-10
in O 0 6.091050441803247e-10
maternal B-Disease 0 0.00010013922292273492
UPD I-Disease 1 1.0
15 I-Disease 0 7.526529657297942e-07
and O 0 1.5658834229270724e-07
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999985694885254
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 1.412448491500129e-09
2 I-Disease 0 2.6584501960913443e-11
and O 0 3.235155741389273e-13
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 1.2390122836134637e-13
a O 0 5.0681545548866835e-14
case O 0 1.1394987067437517e-15
for O 0 3.764226699575846e-15
" O 0 4.038291240033437e-13
lumping O 0 9.06652877774583e-12
" O 0 2.106065842555349e-11
. O 0 2.2065414773120295e-10

Recent O 0 1.6529730362258022e-10
studies O 0 3.733813605522052e-12
demonstrated O 0 1.5976077882493e-12
the O 0 1.5131609344427172e-13
existence O 0 8.069711565639182e-11
of O 0 7.0633499049677084e-12
a O 0 1.8280158203126673e-12
genetically O 0 5.47622331596026e-13
distinct O 0 2.2368157673313682e-12
, O 0 1.7260869586400128e-14
usually O 0 7.072613724740844e-15
lethal O 0 4.673502253596529e-14
form O 0 6.736264649385981e-14
of O 0 1.922200463036483e-12
the O 0 2.0442068177084494e-11
Schwartz B-Disease 1 0.999990701675415
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.5560100910815287e-12
SJS B-Disease 1 0.9999691247940063
) O 0 3.465578084921317e-12
of O 0 6.255740458982473e-08
myotonia B-Disease 1 1.0
and O 0 1.724281446513487e-06
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 8.148638708238565e-11
which O 0 7.512212965403442e-13
we O 0 7.148358988073866e-11
called O 0 1.9404005069389996e-09
SJS B-Disease 1 0.9999924898147583
type I-Disease 0 2.454526004669333e-08
2 I-Disease 0 3.3107721009173474e-08
. O 0 4.5282737559659836e-09

This O 0 1.403353877549307e-08
disorder O 1 0.9968324303627014
is O 0 3.3277703509471124e-12
reminiscent O 0 9.083327423553555e-10
of O 0 3.8568115368065037e-10
another O 0 4.778098056101854e-12
rare O 0 1.627720202547478e-12
condition O 0 3.872885301348106e-08
, O 0 3.626671513557063e-14
the O 0 9.491225513857948e-12
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.9037011966815953e-09
SWS B-Disease 1 1.0
) O 0 3.0886090126441834e-13
, O 0 1.3476974358272564e-14
which O 0 2.576043609518351e-15
comprises O 0 2.547968075677226e-13
campomelia B-Disease 0 6.452347101060241e-09
at O 0 9.043994025903501e-11
birth O 0 7.518936584460789e-09
with O 0 6.678169128804257e-11
skeletal B-Disease 1 0.71779465675354
dysplasia I-Disease 1 0.9198178052902222
, O 0 7.366840470979241e-10
contractures B-Disease 1 0.9989732503890991
, O 0 5.2688391843913607e-11
and O 0 2.5557177901758266e-12
early B-Disease 0 2.7537405244970614e-08
death I-Disease 0 3.8663738877176e-09
. O 0 9.110381782306831e-09

To O 0 1.8277952484879734e-09
test O 0 7.963232157015554e-11
for O 0 8.003178740383088e-13
possible O 0 1.0492137020312597e-10
nosologic O 0 6.157145548968401e-07
identity O 0 1.371872615507641e-09
between O 0 3.6561951383129454e-11
these O 0 6.874358395893287e-13
disorders O 0 1.7600261525974048e-11
, O 0 5.2140637727543515e-15
we O 0 6.829850270409499e-15
reviewed O 0 3.811901423851627e-13
the O 0 1.8019606125166746e-14
literature O 0 3.2435940868977275e-14
and O 0 1.8195390025677483e-15
obtained O 0 6.026683600952876e-13
a O 0 6.862341776639816e-14
follow O 0 3.0993157259379123e-12
- O 0 8.110103734415564e-12
up O 0 3.3752790059432547e-12
of O 0 4.3104981389818775e-12
the O 0 1.6728069667307222e-12
only O 0 1.789692255071279e-13
two O 0 6.374483325086513e-14
surviving O 0 7.650310940299221e-11
patients O 0 7.713026181285776e-13
, O 0 2.473241168885875e-14
one O 0 4.360641351047051e-13
with O 0 6.074290809926497e-12
SJS B-Disease 1 0.9492104053497314
type I-Disease 0 1.852699149651471e-08
2 I-Disease 0 5.068041986078242e-09
at O 0 8.391080053016253e-10
age O 0 6.532733382025313e-11
10 O 0 6.940839504705754e-13
years O 0 3.493554864885187e-14
and O 0 1.2403445436197174e-15
another O 0 2.925607415289917e-14
with O 0 2.9435311067922687e-13
SWS B-Disease 0 0.00012863296433351934
at O 0 4.3735397248223506e-11
age O 0 1.796822239608087e-11
7 O 0 4.416273943763649e-11
years O 0 8.912407270522671e-12
. O 0 6.457317458519185e-10

Patients O 0 1.091177193046633e-08
reported O 0 2.8456343184601884e-11
as O 0 1.7531158816308512e-13
having O 0 9.427554223395695e-12
either O 0 5.569022576423777e-09
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 1.885845435367628e-08
SWS B-Disease 1 0.999964714050293
presented O 0 1.4453155469315582e-12
a O 0 3.9273922655680416e-14
combination O 0 4.138914349595922e-14
of O 0 4.944336498384494e-13
a O 0 4.425502661813824e-13
severe O 0 1.999184845447033e-11
, O 0 4.821306114760615e-13
prenatal O 0 0.0001611331827007234
- O 0 7.29323062387266e-07
onset O 0 0.0013877487508580089
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 6.312683123628482e-13
with O 0 4.6774398590465616e-12
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9359727501869202
respiratory O 1 1.0
and O 0 2.1736441979669507e-08
feeding O 0 5.116100965096848e-08
difficulties O 0 0.00012835471716243774
, O 0 1.311387630431593e-11
tendency O 0 2.3486004807615757e-10
to O 0 7.795045720015992e-10
hyperthermia B-Disease 0 3.185132663929835e-05
, O 0 1.787646202941473e-12
and O 0 1.181268489058515e-13
frequent O 0 7.118228532651538e-13
death O 0 6.532876453343994e-13
in O 0 5.47297558835258e-13
infancy O 0 4.820276622297115e-09
) O 0 2.469685493979891e-15
with O 0 2.7219745220173803e-16
a O 0 1.399733464985814e-13
distinct O 0 1.739965810321209e-11
campomelic B-Disease 0 2.8115478016843554e-06
- I-Disease 0 6.073654003557749e-05
metaphyseal I-Disease 0 8.777921175351366e-05
skeletal I-Disease 1 0.9500991702079773
dysplasia I-Disease 1 0.9988515377044678
. O 0 1.5990428892109776e-06

The O 0 6.375189265384051e-10
similarity O 0 2.9778028931559675e-09
of O 0 1.540667593502576e-09
the O 0 4.921377749766975e-10
clinical O 0 1.3494705353167546e-09
and O 0 3.099447434817826e-11
radiographic O 0 1.4859104169318016e-07
findings O 0 3.0633157122039734e-10
is O 0 1.9029965320563336e-13
so O 0 1.8908327323579471e-13
extensive O 0 8.447860466720414e-11
that O 0 1.231195863576201e-13
these O 0 2.3558750436580844e-12
disorders O 0 3.959690908494906e-10
appear O 0 8.55908486446788e-12
to O 0 3.7027082788743115e-12
be O 0 5.490564600196812e-12
a O 0 7.408598040603565e-12
single O 0 2.45499204298838e-10
entity O 0 2.7030806037942057e-08
. O 0 8.812271090619106e-08

The O 0 6.836358146244947e-10
follow O 0 3.942508819410051e-10
- O 0 2.436890689239135e-10
up O 0 1.998383229728784e-12
observation O 0 6.544010333620065e-10
of O 0 4.357300978363732e-12
an O 0 3.0868627102278176e-15
identical O 0 1.9567122444899554e-13
and O 0 3.887050712092456e-15
unique O 0 1.442021550996167e-13
pattern O 0 1.5004145148544978e-10
of O 0 9.680407586643014e-10
progressive O 1 0.8860905766487122
bone B-Disease 1 0.9999381303787231
dysplasia I-Disease 0 0.13233493268489838
in O 0 2.5863397534742205e-10
the O 0 1.9772369852510963e-10
two O 0 5.527383238612682e-12
patients O 0 1.7117744938524582e-12
( O 0 4.464369734216147e-15
one O 0 1.3651613747864971e-13
with O 0 2.1135041416639466e-13
SJS B-Disease 0 4.055437239003368e-05
type I-Disease 0 1.4982239060490343e-10
2 I-Disease 0 1.7499648952146174e-10
, O 0 2.451076451179257e-13
one O 0 1.4173354872561161e-13
with O 0 4.0603184334707387e-13
SWS B-Disease 1 0.9976455569267273
) O 0 4.229397593865508e-13
surviving O 0 1.3635975681935975e-09
beyond O 0 8.139746654478586e-09
infancy O 0 3.5563130040827673e-07
adds O 0 3.351996414810432e-12
to O 0 1.3002538499021221e-12
the O 0 9.674099629014554e-13
evidence O 0 1.6884692428942305e-12
in O 0 1.6841745825637439e-13
favor O 0 6.3809855836705065e-12
of O 0 2.0331245367821715e-11
identity O 0 2.4651575003531434e-08
. O 0 2.961028400250143e-08

The O 0 2.5182353979857908e-09
hypothesis O 0 1.1605150174176515e-09
that O 0 3.8809528507544044e-12
SWS B-Disease 1 0.9979591369628906
and O 0 3.098118983579923e-10
SJS B-Disease 1 0.9999415874481201
type I-Disease 0 1.2806784521757208e-09
2 I-Disease 0 1.4688646132743344e-10
are O 0 1.1823774923556962e-13
the O 0 2.0686731407731918e-12
same O 0 3.229905926049881e-11
disorder O 0 5.470956326858456e-11
should O 0 1.489727124211887e-13
be O 0 2.617102227205764e-13
testable O 0 5.742878828735032e-12
by O 0 1.2031564302792883e-14
molecular O 0 1.3351186475829557e-12
methods O 0 7.602033585962786e-11
. O 0 2.5805042130899736e-11
. O 0 1.1271592548212084e-09

A O 0 1.935440963052315e-08
mouse O 0 1.7097587234893297e-11
model O 0 4.2930706732613455e-12
of O 0 1.1062807787898254e-11
severe O 1 0.9990105628967285
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 2.1673179162462475e-06
defects O 1 0.9999997615814209
in O 0 2.291257406028535e-09
hemostasis O 1 0.6007125973701477
and O 0 1.9574543375089348e-10
thrombosis B-Disease 0 2.8581334845512174e-06
. O 0 1.9048104604735272e-07

von B-Disease 1 0.9999997615814209
Willebrand I-Disease 1 0.9999799728393555
factor I-Disease 0 0.00411362387239933
( I-Disease 0 1.5451068691163528e-07
vWf I-Disease 1 0.9997513890266418
) I-Disease 0 1.3540519830712583e-05
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.6490071415901184
humans O 0 1.5697015243176793e-08
. O 0 4.933031205744953e-10

We O 0 1.9178700294553153e-10
generated O 0 3.5221745225272327e-12
a O 0 6.248400776821816e-14
mouse O 0 5.491177377712174e-14
model O 0 6.136621565717634e-14
for O 0 1.0997697910230912e-14
this O 0 3.7463508315536964e-14
disease O 0 1.7973403866025812e-14
by O 0 1.0422931660121788e-16
using O 0 7.265905542161444e-14
gene O 0 1.4830392231109102e-13
targeting O 0 4.1792191235456855e-11
. O 0 5.902353605868882e-10

vWf B-Disease 0 0.0003123983333352953
- I-Disease 1 0.7224041223526001
deficient I-Disease 0 6.0612259403569624e-05
mice O 0 8.200375933853365e-10
appeared O 0 2.1712912717797295e-11
normal O 0 3.7012076736786526e-10
at O 0 1.6639636717108441e-12
birth O 0 1.2545125528673484e-12
; O 0 4.593590963066895e-15
they O 0 5.532798882674356e-14
were O 0 4.9158190539022595e-12
viable O 0 5.0790180949888963e-08
and O 0 2.911878030364967e-11
fertile O 0 5.933592319706804e-07
. O 0 9.000224565625103e-09

Neither O 0 8.072445893958502e-07
vWf O 0 3.908724920620443e-06
nor O 0 1.8988251326845784e-07
vWf O 0 4.8781271289044525e-06
propolypeptide O 0 2.820640838763211e-05
( O 0 1.0260039345899585e-10
von B-Disease 0 1.0847518751688767e-05
Willebrand I-Disease 0 2.474669713592448e-07
antigen O 0 3.8236017130266475e-10
II O 0 0.005737178027629852
) O 0 1.198486587750125e-10
were O 0 2.756392891711812e-09
detectable O 0 7.431590343109917e-10
in O 0 2.1346969060042492e-13
plasma O 0 1.3562271097833367e-11
, O 0 3.992535875475475e-14
platelets O 0 1.0504526935795067e-11
, O 0 7.510808923590073e-13
or O 0 2.7983004368542508e-12
endothelial O 0 3.514140476008898e-13
cells O 0 7.07459438253899e-12
of O 0 1.1902490104631624e-10
the O 0 9.517552024274067e-11
homozygous O 0 7.930473118478165e-12
mutant O 0 2.0707583217594028e-11
mice O 0 3.5561917993698344e-11
. O 0 5.117325452275168e-10

The O 0 3.9555563269288996e-09
mutant O 0 6.070142610781204e-09
mice O 0 5.077731984881595e-11
exhibited O 0 1.1963070291332034e-11
defects O 0 5.164159944115454e-08
in O 0 3.205320731058947e-11
hemostasis O 0 0.00029546598671004176
with O 0 1.823335536374482e-12
a O 0 8.570458925882818e-11
highly O 0 6.151954057287412e-09
prolonged O 0 8.976789445114264e-07
bleeding O 0 0.10531730949878693
time O 0 5.662799118510975e-09
and O 0 1.1076320416414376e-11
spontaneous O 0 9.525275013189116e-10
bleeding O 0 5.5658926356727534e-08
events O 0 9.941744693112153e-13
in O 0 2.478399159077521e-13
approximately O 0 7.237688502996151e-14
10 O 0 1.3506633962309667e-12
% O 0 1.7901105944795326e-11
of O 0 3.3229942235368792e-12
neonates O 0 1.0011214079952424e-09
. O 0 9.666151434828407e-09

As O 0 2.917878161312615e-10
in O 0 3.3211504293223504e-12
the O 0 3.1024028832038475e-12
human O 0 2.0470539326133963e-12
disease O 0 7.744533313258639e-12
, O 0 6.527734582189334e-16
the O 0 6.187016637947476e-14
factor O 0 1.0850106484929997e-13
VIII O 0 9.001456247048623e-10
level O 0 1.7813938768540538e-08
in O 0 3.9647200453241105e-12
these O 0 6.266772040533497e-13
mice O 0 2.8387467615291484e-13
was O 0 5.390571886434992e-13
reduced O 0 1.375250065736855e-12
strongly O 0 7.581040423242438e-14
as O 0 2.510330539360478e-14
a O 0 1.5742850003209324e-13
result O 0 7.627752596217618e-12
of O 0 2.4215853280940003e-11
the O 0 8.473837950773166e-12
lack O 0 2.118629160996477e-10
of O 0 3.441561272077287e-12
protection O 0 1.3747865693081174e-11
provided O 0 1.8893771096262224e-12
by O 0 2.3577179705108753e-12
vWf O 0 2.113086239319273e-08
. O 0 8.2575271065366e-09

Defective O 0 0.0004219854308757931
thrombosis B-Disease 0 2.6691827770264354e-06
in O 0 1.4227854450155064e-09
mutant O 0 4.4357600925692964e-10
mice O 0 3.607193320084856e-12
was O 0 1.1794228788053474e-12
also O 0 5.621490432031933e-15
evident O 0 1.1373730950114957e-11
in O 0 3.131578723007851e-14
an O 0 1.340569611224464e-15
in O 0 3.667196619072319e-14
vivo O 0 1.3672735686698356e-11
model O 0 2.2677684383132224e-11
of O 0 9.043308324407917e-10
vascular B-Disease 0 4.863490516981983e-07
injury I-Disease 1 0.515774667263031
. O 0 2.26516431212076e-06

In O 0 2.069415992733692e-11
this O 0 1.0608551661911089e-13
model O 0 5.152438805472448e-13
, O 0 3.581875329108572e-15
the O 0 1.527678130481755e-13
exteriorized O 0 4.4296921686282076e-09
mesentery O 0 1.205089272815485e-08
was O 0 2.8935466869772775e-11
superfused O 0 3.703096851381815e-08
with O 0 1.253307136891979e-12
ferric O 0 1.0860718191452179e-07
chloride O 0 3.2236915914474196e-10
and O 0 8.924352229433552e-11
the O 0 1.2463750032054577e-08
accumulation O 0 1.286192741645209e-06
of O 0 2.138355284841964e-06
fluorescently O 0 1.5637986905403523e-07
labeled O 0 2.6297056199275914e-10
platelets O 0 6.037807476211299e-10
was O 0 1.6319401385800347e-10
observed O 0 1.1303741146231894e-12
by O 0 1.8550176043678757e-13
intravital O 0 2.570913615329573e-08
microscopy O 0 2.1856801879494014e-07
. O 0 1.2170825236523797e-08

We O 0 3.2907376823487766e-09
conclude O 0 2.658277082900895e-07
that O 0 8.856295146027204e-13
these O 0 1.4680115846890662e-12
mice O 0 1.661180394629813e-11
very O 0 9.578606354268548e-13
closely O 0 4.976844492077248e-10
mimic O 0 1.1370304520141872e-07
severe O 0 1.3450544145143795e-07
human O 0 0.3494065999984741
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 7.997609685617135e-09
will O 0 3.567700648798855e-11
be O 0 1.2130822605108116e-12
very O 0 1.86478995900562e-14
useful O 0 2.0802730740267228e-13
for O 0 1.480776539763745e-15
investigating O 0 1.748534178775199e-13
the O 0 4.4205001529899757e-13
role O 0 1.0279367634868919e-11
of O 0 9.637569214904218e-11
vWf O 0 5.535071956330739e-09
in O 0 5.794949589632559e-11
normal O 0 1.629730945751362e-07
physiology O 0 6.8773231554075664e-09
and O 0 1.3827724772499939e-12
in O 0 9.688059816187478e-13
disease O 0 1.2051466595497384e-12
models O 0 3.7093364404355844e-13
. O 0 2.2741778078760877e-12
. O 0 3.207964449636336e-10

Oral O 0 1.3473589206114411e-05
contraceptives O 0 1.9053464939133846e-07
and O 0 2.377605219910234e-13
the O 0 9.290408720108445e-12
risk O 0 1.510151648176361e-08
of O 1 0.9918625354766846
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.036128655076026917

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 0 5.207908088777913e-06
Study O 0 2.7535104404896593e-11
Group O 0 1.3528548940822116e-12
. O 0 9.201321649054961e-11

BACKGROUND O 0 3.8049620343372226e-05
Women O 0 3.40698025347308e-11
with O 0 8.596935825982283e-14
mutations O 0 3.1718318293030845e-13
in O 0 1.0829388736666515e-13
either O 0 7.428889968463803e-12
the O 0 5.964389399037984e-11
BRCA1 O 0 9.69196875533207e-11
or O 0 5.895739625672025e-13
the O 0 4.074999452458039e-12
BRCA2 O 0 1.5611567594220332e-11
gene O 0 2.243876844043851e-14
have O 0 6.41211140851557e-15
a O 0 2.4607625101003353e-14
high O 0 2.415350905393687e-13
lifetime O 0 1.8154322489749575e-10
risk O 0 6.3020255680612536e-09
of O 0 5.216477347858017e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.8426715087116463e-06

Oral O 0 0.000956041447352618
contraceptives O 0 0.004873569589108229
protect O 0 8.180185062656165e-08
against O 1 0.9999982118606567
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 4.018416532858282e-08
general O 0 5.739115085945379e-11
, O 0 1.729652797941364e-14
but O 0 1.8599331567893587e-15
it O 0 8.305829056741318e-17
is O 0 7.403578825748898e-17
not O 0 2.248065464319671e-15
known O 0 1.9966973834419956e-14
whether O 0 2.2514061199119945e-13
they O 0 3.3052130910676825e-12
also O 0 7.724199968875411e-13
protect O 0 9.008695699141978e-12
against O 0 3.9488284170330346e-11
hereditary B-Disease 1 1.0
forms I-Disease 1 0.9999984502792358
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.097932833246887e-05

METHODS O 0 4.245792126766901e-07
We O 0 1.1817659351098797e-10
enrolled O 0 1.2773697377621573e-10
207 O 0 5.255740634368955e-11
women O 0 6.021685971038804e-13
with O 0 8.11864724753475e-12
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 6.36374741964929e-13
161 O 0 1.5597370617292938e-11
of O 0 4.3463074805849544e-10
their O 0 1.0387092075347937e-08
sisters O 0 2.7602320429309657e-10
as O 0 1.7109191667585844e-12
controls O 0 2.939479215591234e-10
in O 0 2.640544250268051e-12
a O 0 3.0335662367514393e-12
case O 0 1.813281404368372e-12
- O 0 1.1751891126898784e-10
control O 0 2.2210328021188275e-10
study O 0 6.074650331366893e-12
. O 0 2.8867882043148718e-11

All O 0 1.0837589159429228e-10
the O 0 4.8054993144475144e-12
patients O 0 2.423925860375875e-13
carried O 0 2.099017709861553e-13
a O 0 1.4190660602706514e-14
pathogenic O 0 7.029973391609046e-13
mutation O 0 1.174898123668805e-13
in O 0 3.2856885072950204e-13
either O 0 2.1542925776607547e-10
BRCA1 O 0 2.6809479636291655e-10
( O 0 8.09429766593893e-15
179 O 0 2.8738830759600376e-11
women O 0 3.691818172783107e-13
) O 0 2.8205893905773084e-14
or O 0 1.942463767959368e-12
BRCA2 O 0 1.4616317878246576e-10
( O 0 4.229492326030329e-14
28 O 0 1.457656217951353e-10
women O 0 1.2471501695948684e-12
) O 0 1.4937939123507715e-12
. O 0 1.0416668638768556e-09

The O 0 9.695986236124554e-10
control O 0 1.6151910919859347e-09
women O 0 4.649762291777243e-14
were O 0 2.2580202952652423e-13
enrolled O 0 3.6363030642139194e-12
regardless O 0 1.5335068284660913e-11
of O 0 6.942869456433298e-12
whether O 0 6.994943903618212e-13
or O 0 1.6017940012574838e-12
not O 0 1.3754100939775138e-12
they O 0 3.3534353679337547e-12
had O 0 9.568767653234111e-12
either O 0 2.388617637016921e-10
mutation O 0 3.616193733346762e-10
. O 0 1.433329122058069e-09

Lifetime O 0 4.237062611878173e-08
histories O 0 1.0566695962666017e-08
of O 0 6.362519400227029e-10
oral O 0 4.8946372288583007e-08
- O 0 4.3003522964824015e-10
contraceptive O 0 1.6289818452475124e-11
use O 0 2.1296610579635972e-14
were O 0 7.871346396947157e-14
obtained O 0 1.849915619994702e-13
by O 0 3.497246785040737e-15
interview O 0 1.7901710929607573e-12
or O 0 1.2323833868275926e-15
by O 0 1.1952730734633688e-16
written O 0 2.3965325522814574e-16
questionnaire O 0 1.0641087510316195e-15
and O 0 4.5458921555268414e-17
were O 0 5.6145067300851156e-14
compared O 0 5.59562921172152e-13
between O 0 6.189852775305427e-13
patients O 0 3.50503670141708e-13
and O 0 1.1948168149311655e-13
control O 0 1.0683135487354889e-09
women O 0 1.8844600630386205e-13
, O 0 2.8833376336615544e-15
after O 0 1.5431995687830574e-13
adjustment O 0 4.3841805186239924e-11
for O 0 9.67556587692757e-15
year O 0 2.960117502677495e-13
of O 0 1.9904139100801466e-12
birth O 0 1.8274387558747662e-10
and O 0 1.2521943551502268e-11
parity O 0 5.099305511180319e-08
. O 0 1.0411886464112285e-08

RESULTS O 0 6.341674207988035e-08
The O 0 6.984076095228886e-10
adjusted O 0 4.872326542226801e-09
odds O 0 1.6280081727160223e-09
ratio O 0 2.388117925633537e-09
for O 0 1.816233163864922e-09
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.048454101315599e-09
with O 0 1.299954931975036e-14
any O 0 2.8194059161434047e-14
past O 0 8.181815142928317e-14
use O 0 8.314047658609849e-15
of O 0 7.005715316676583e-14
oral O 0 3.9466298284995815e-11
contraceptives O 0 7.193302897778864e-11
was O 0 7.41258443515136e-12
0 O 0 1.446755996253879e-11
. O 0 5.449889983744072e-10

5 O 0 3.3621874728773093e-10
( O 0 1.5208430489358632e-13
95 O 0 2.1915647074877143e-09
percent O 0 7.511737343257607e-10
confidence O 0 2.0437838088582794e-09
interval O 0 1.4093106681656309e-09
, O 0 1.2553209882172622e-13
0 O 0 1.5924890258475072e-14
. O 0 1.4332708874994007e-14
3 O 0 5.4113367297303414e-14
to O 0 9.076836504640085e-13
0 O 0 1.6770959282235397e-14
. O 0 1.8643169758078733e-14
8 O 0 7.045208600536812e-13
) O 0 1.0339706114958006e-13
. O 0 5.4301004664969454e-11

The O 0 4.614276072345547e-09
risk O 0 5.605316211187983e-10
decreased O 0 6.258094736866227e-11
with O 0 6.662579580414259e-16
increasing O 0 9.073387115428322e-14
duration O 0 2.94663626831948e-10
of O 0 2.741043069603988e-12
use O 0 7.789059653338926e-13
( O 0 4.540803361574239e-14
P O 0 7.672789625878806e-10
for O 0 5.631175322047544e-13
trend O 0 1.022740572786951e-11
, O 0 1.0595968818073037e-14
< O 0 2.344905086076876e-12
0 O 0 5.682072769518402e-15
. O 0 1.3886650313541578e-14
001 O 0 2.4160444478393828e-11
) O 0 3.0735485169672825e-16
; O 0 2.029747367611195e-17
use O 0 3.318777154812493e-15
for O 0 1.4919870419964794e-14
six O 0 4.214421780307509e-12
or O 0 9.862302760479252e-14
more O 0 1.4069160079169989e-15
years O 0 9.956009676620817e-14
was O 0 1.7086875805320118e-13
associated O 0 2.590591586734692e-13
with O 0 6.64425815188603e-15
a O 0 4.722645885468779e-13
60 O 0 9.424520192036212e-11
percent O 0 7.020212189345898e-11
reduction O 0 1.9713249088670892e-10
in O 0 2.1255412360754455e-11
risk O 0 2.429373591184003e-09
. O 0 1.3884998040225582e-08

Oral O 0 0.004252920858561993
- O 0 1.0085957455885364e-06
contraceptive O 0 3.157148853460967e-08
use O 0 1.891949270860227e-11
protected O 0 2.990839576000326e-08
against O 0 0.15861618518829346
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 1.9896140290853737e-11
for O 0 2.7594893465534773e-14
carriers O 0 6.201829973645533e-15
of O 0 7.331365874628515e-13
the O 0 2.3179630090353065e-11
BRCA1 O 0 4.916749646310947e-11
mutation O 0 4.945421784759152e-13
( O 0 1.1440989215044661e-14
odds O 0 1.152099082801783e-09
ratio O 0 1.473763472370493e-11
, O 0 2.260781419385384e-14
0 O 0 1.540205408958467e-14
. O 0 1.3883207971643937e-14
5 O 0 1.584345142872836e-14
; O 0 3.428710953763338e-17
95 O 0 6.0578729532689835e-12
percent O 0 5.894731317651614e-12
confidence O 0 1.8254912859116956e-10
interval O 0 3.638554457729981e-10
, O 0 6.184421328997089e-14
0 O 0 4.896422182369253e-15
. O 0 1.0051213977606537e-14
3 O 0 2.892698152410014e-14
to O 0 1.3864434773858125e-12
0 O 0 1.1033837417958464e-14
. O 0 9.068157703418563e-15
9 O 0 5.663813602146961e-13
) O 0 4.4326176453971357e-16
and O 0 1.4153883490927916e-16
for O 0 2.488428850794971e-15
carriers O 0 5.759481162392194e-14
of O 0 6.461031796384242e-12
the O 0 1.852764469623125e-10
BRCA2 O 0 5.438895556153511e-09
mutation O 0 1.348923663740953e-11
( O 0 8.433759333265067e-14
odds O 0 1.3519548147655769e-08
ratio O 0 1.403842320168991e-10
, O 0 5.502807411128519e-13
0 O 0 1.3584030005443087e-13
. O 0 7.439374501627335e-14
4 O 0 9.187680997946313e-14
; O 0 5.0540269558869e-16
95 O 0 5.7837522965398236e-11
percent O 0 6.774646121865402e-11
confidence O 0 8.81330508573086e-10
interval O 0 5.860421592451814e-10
, O 0 2.861633456238688e-13
0 O 0 3.044211001443538e-14
. O 0 3.474807992883376e-14
2 O 0 8.200875417120612e-14
to O 0 1.4040926624506178e-12
1 O 0 1.2012452664522666e-12
. O 0 2.561230849802698e-13
1 O 0 2.8217977000172256e-12
) O 0 2.7962289601835e-13
. O 0 1.2039025332200026e-10

CONCLUSIONS O 0 7.418435870931717e-06
Oral O 0 0.0020812388975173235
- O 0 1.3191636298870435e-06
contraceptive O 0 1.1484137196760003e-08
use O 0 1.3910205452771773e-12
may O 0 2.9782228658063736e-13
reduce O 0 4.299593667211887e-12
the O 0 1.7694364853534927e-12
risk O 0 1.605510568936097e-08
of O 1 0.9997729659080505
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.088983847015058e-10
women O 0 2.888843813686828e-14
with O 0 9.769765893299378e-16
pathogenic O 0 1.619522116240446e-13
mutations O 0 1.6691719350019757e-14
in O 0 3.94748185419784e-14
the O 0 9.824931666846393e-12
BRCA1 O 0 5.141216341542076e-10
or O 0 4.958302657342983e-10
BRCA2 O 0 5.1170864878713473e-08
gene O 0 1.3990216096715358e-08

A O 0 1.6025918370132786e-08
Japanese O 0 3.3537987942366954e-09
family O 0 6.4711200807587854e-12
with O 0 2.428113320216557e-13
adrenoleukodystrophy B-Disease 1 1.0
with O 0 3.2529263570973965e-13
a O 0 1.3440125748442888e-12
codon O 0 2.8699915777252727e-09
291 O 0 7.209624008908122e-10
deletion O 0 3.8452077077977265e-09
: O 0 3.2974347536317283e-13
a O 0 3.151126495154477e-12
clinical O 0 7.34133587254604e-11
, O 0 5.952110007124978e-13
biochemical O 0 8.469640960795388e-11
, O 0 5.246553625576356e-12
pathological O 0 1.1456528170583624e-08
, O 0 5.357974806018129e-13
and O 0 4.775153254581166e-13
genetic O 0 2.433684330449548e-11
report O 0 1.2595337967047371e-11
. O 0 8.093978265399926e-10

We O 0 2.0841682546457463e-10
report O 0 3.937873247969459e-13
a O 0 5.732408125925462e-15
Japanese O 0 1.82102098157666e-12
family O 0 1.1583676997207332e-13
with O 0 1.4048044140718002e-13
adrenoleukodystrophy B-Disease 1 1.0
( O 0 1.0363295638304848e-10
ALD B-Disease 1 1.0
) O 0 1.3663127974936767e-13
with O 0 1.7381247367765067e-15
a O 0 1.8770549960818624e-14
three O 0 2.6027043950496535e-14
base O 0 7.801488947044299e-13
pair O 0 5.503314384064373e-12
deletion O 0 2.5232909511840873e-11
( O 0 4.9039297741939464e-14
delGAG O 0 7.758383269163005e-09
291 O 0 2.1631686025758157e-11
) O 0 2.6098877426621384e-14
in O 0 8.145554001269539e-13
the O 0 8.0271161939649e-10
ALD B-Disease 1 1.0
gene O 0 1.625222179058028e-09
. O 0 7.089436593332721e-09

A O 0 7.315431815868578e-08
variety O 0 1.6707767114265692e-11
of O 0 5.976939776441981e-11
phenotypes O 0 1.509441877045603e-10
were O 0 3.913676674405231e-11
observed O 0 2.1542164753418636e-12
within O 0 4.003253891576852e-12
this O 0 1.0413806590062885e-13
family O 0 4.022602997227898e-12
. O 0 1.3401392218170827e-09

While O 0 1.0468748784520088e-10
the O 0 5.003740477516061e-11
proband O 0 0.08100418746471405
( O 0 1.99410757004137e-12
patient O 0 1.0703203878748013e-09
1 O 0 9.210166483641924e-12
) O 0 2.108096107346271e-14
was O 0 1.1610358941621657e-12
classified O 0 2.2093227854819153e-12
as O 0 4.905903699774228e-14
having O 0 1.2645302556804627e-12
a O 0 1.6147626042285063e-13
rare O 0 6.899996795716595e-14
intermediate O 0 4.2185716725429145e-12
type O 0 6.304865050182906e-12
of O 0 6.89013082699752e-11
adult O 0 4.376748741208303e-09
cerebral O 0 9.0293177379408e-09
and O 0 7.663396306423209e-11
cerebello O 1 0.9853678345680237
- O 0 0.00010906432726187631
brain O 0 5.574986516876379e-07
stem O 0 3.232525358498606e-11
forms O 0 1.1440777795621027e-13
, O 0 1.643125994805217e-16
his O 0 3.700642562027602e-14
younger O 0 1.808139749037707e-11
brother O 0 1.7159350607087731e-09
( O 0 1.1675863997428343e-13
patient O 0 1.846435504493371e-10
2 O 0 4.306279996219714e-13
) O 0 1.3549186669883071e-15
and O 0 2.306915238264179e-14
nephew O 0 4.51015758073936e-08
( O 0 4.214082153976978e-13
patient O 0 5.089029753158059e-10
3 O 0 5.551007136589403e-12
) O 0 9.214057603923811e-14
had O 0 1.5210033753321195e-12
a O 0 8.982512650357322e-12
childhood O 0 1.5599721336911898e-07
ALD B-Disease 1 1.0
type O 0 1.5366161676411139e-07
. O 0 2.6152724430517083e-08

Another O 0 2.806975318847549e-09
nephew O 0 6.785350706195459e-06
( O 0 4.2729578556000014e-12
patient O 0 4.699239219974061e-09
4 O 0 1.7640592112067033e-11
) O 0 4.9163577804092404e-14
of O 0 1.3665643269766825e-11
patient O 0 1.69854341702802e-09
1 O 0 2.562288749230479e-11
was O 0 7.513907898659689e-12
classified O 0 4.000941071502506e-12
as O 0 5.433656047890492e-14
having O 0 1.7519268371082863e-12
an O 0 1.5415345052966628e-13
adolescent O 0 1.167410196289964e-10
form O 0 1.0933234352583643e-11
. O 0 3.5856186908489462e-09

The O 0 4.101785933130486e-08
tau O 0 2.4509412277495812e-09
level O 0 5.532686309095425e-09
in O 0 4.381720247054188e-12
the O 0 8.703863324521777e-11
cerebrospinal O 0 2.7656943402121215e-08
fluid O 0 2.0283432711210025e-09
( O 0 3.2404933771046363e-12
CSF O 0 1.530189547338523e-05
) O 0 2.6900009997277152e-12
in O 0 1.357164519655285e-10
patient O 0 4.4189226855451125e-07
1 O 0 6.205986835539079e-10
was O 0 3.96464860941137e-10
as O 0 1.0716173635310147e-13
high O 0 3.9799318896950597e-13
as O 0 5.634024825585402e-16
that O 0 1.8420048309579945e-16
of O 0 7.566392851892159e-14
patients O 0 8.231657543100734e-13
with O 0 3.709472833068883e-12
Alzheimers B-Disease 0 0.0002853511250577867
disease I-Disease 0 2.8353945927261925e-11
( O 0 4.716861361946708e-15
AD B-Disease 0 1.1969861768434953e-09
) O 0 6.280209100158196e-13
. O 0 4.703011868834039e-10

His O 0 1.4726138530818389e-08
brain O 0 2.571781720916988e-08
magnetic O 0 1.8388021660875609e-10
resonance O 0 1.952063094501355e-10
image O 0 2.8710382595636963e-12
( O 0 3.2995893174583412e-15
MRI O 0 1.8325093265048054e-07
) O 0 1.4404657208786503e-13
showed O 0 2.79375828027284e-11
abnormalities B-Disease 0 1.996396659098565e-10
in I-Disease 0 7.965619808723845e-14
the I-Disease 0 8.304377151213682e-12
bilateral I-Disease 0 1.628093741601333e-05
cerebellar I-Disease 1 0.9629635810852051
hemispheres I-Disease 0 1.5633511793566868e-05
and O 0 2.320955871937258e-09
brain O 0 5.153002575752907e-07
stem O 0 2.0073015472021893e-10
, O 0 2.3034154675327136e-14
but O 0 8.605954693991467e-15
not O 0 5.542368322099256e-14
in O 0 3.6345696417805495e-12
the O 0 2.8068669610803454e-10
cerebral O 0 1.5817600740319904e-07
white O 0 4.989290230961174e-12
matter O 0 5.997460861273396e-11
, O 0 1.2539945854438388e-14
where O 0 4.5127230335266326e-15
marked O 0 2.406053600714081e-13
reductions O 0 1.908153357543796e-10
of O 0 3.4902519763235773e-10
the O 0 4.659004848583947e-10
cerebral O 0 1.587680742431985e-08
blood O 0 4.243884688115429e-10
flow O 0 5.488120513597039e-10
and O 0 1.5410297820803165e-12
oxygen O 0 5.2346613155229704e-11
metabolism O 0 1.3479393989879185e-10
were O 0 7.195175445035007e-13
clearly O 0 7.962335014954393e-15
demonstrated O 0 9.896586842535844e-16
by O 0 1.8596626885813885e-16
positron O 0 6.16471240375005e-12
emission O 0 1.517648506865754e-11
tomography O 0 2.700885204376391e-08
( O 0 3.7382905798688526e-11
PET O 0 4.772488750859338e-07
) O 0 9.240959560063988e-12
. O 0 9.204784157113011e-10

In O 0 8.982337540430763e-09
patients O 0 4.078489101999594e-09
2 O 0 7.633344650814777e-11
and O 0 6.253673251986613e-13
3 O 0 1.6440111424986803e-11
, O 0 1.8019606125166746e-14
the O 0 1.7035453790345025e-14
autopsy O 0 2.4749532284706888e-11
findings O 0 1.1924929359946601e-12
showed O 0 1.42638140882001e-11
massive O 0 2.1182817999676473e-10
demyelination B-Disease 1 1.0
of I-Disease 0 3.173846926074475e-05
the I-Disease 0 3.3323492516501574e-06
cerebral I-Disease 0 0.002999823074787855
white I-Disease 0 1.4408270583576854e-11
matter I-Disease 0 1.721887216143969e-11
with O 0 3.741692658563566e-15
sparing O 0 4.015690557856999e-11
of O 0 6.367351090830198e-10
the O 0 6.2334177819423076e-09
U O 0 0.0003969218232668936
- O 0 8.250194838410607e-08
fibers O 0 3.6547973536471545e-09
, O 0 9.53758217694077e-14
compatible O 0 6.486474135591891e-10
with O 0 1.7129541998367795e-15
the O 0 1.1220818924625314e-13
findings O 0 2.6150465798867317e-13
of O 0 5.767753896018801e-12
childhood O 0 1.0825910123912763e-07
ALD B-Disease 1 1.0
. O 0 3.1024214308672526e-07

Oleic O 0 0.0003880443109665066
and O 0 4.158685840138787e-08
erucic O 1 0.9890796542167664
acids O 0 1.1050318882155352e-08
( O 0 6.580071773912288e-13
Lorenzos O 0 8.407877771787753e-08
Oil O 0 2.374037633146031e-10
) O 0 6.737211547517717e-15
were O 0 3.1676180775597196e-13
administered O 0 5.658353126325455e-12
to O 0 5.552913164008633e-12
patients O 0 1.902707158496497e-12
1 O 0 3.4310811570376076e-12
and O 0 3.2655708649340087e-13
4 O 0 1.5695314839470065e-11
, O 0 4.67571368721522e-14
but O 0 7.831477741966023e-15
sufficient O 0 1.4844664126406615e-12
effectiveness O 0 2.183162721783316e-12
was O 0 5.615912465964379e-13
not O 0 2.6922686085714687e-13
obtained O 0 4.6003711950959314e-10
. O 0 5.084181520231823e-09

The O 0 3.822817973286874e-08
findings O 0 2.707050694716884e-10
in O 0 1.1324673837576071e-12
this O 0 3.011300789886734e-13
family O 0 2.6233494001236257e-13
suggest O 0 5.799986142404623e-13
that O 0 1.0460379383766595e-15
delGAG291 O 0 6.770928817623201e-10
is O 0 5.782372905418099e-15
part O 0 3.249714137110865e-13
of O 0 2.0109639647936106e-11
the O 0 1.6516831305435353e-11
cause O 0 7.138862417876979e-11
of O 0 1.609031380356285e-10
Japanese O 0 5.421600803856563e-07
ALD B-Disease 1 1.0
with O 0 1.487988031401155e-11
phenotypic O 0 1.1702575575256446e-09
variations O 0 1.6674539526917442e-10
. O 0 5.168473204975044e-09

Moreover O 0 2.0831528502185392e-08
, O 0 3.772805635612886e-13
although O 0 4.890097048538926e-14
the O 0 4.4025414959675616e-14
scale O 0 6.626423368349954e-12
of O 0 2.779427512797361e-12
the O 0 1.6528327101070217e-12
study O 0 3.291534254358519e-13
is O 0 1.6631426274284775e-15
limited O 0 6.98358634376034e-13
, O 0 1.4724639151204866e-13
there O 0 1.1035532297004602e-12
is O 0 6.67581563488541e-14
a O 0 1.2702158118729767e-12
possibility O 0 6.46478218180313e-11
that O 0 8.004587444265798e-12
PET O 0 6.481745913333725e-06
can O 0 8.231607617759096e-10
detect O 0 3.928288947463443e-07
an O 0 2.56012600008404e-10
insidious B-Disease 0 1.1319453108171729e-07
lesion I-Disease 0 1.5369503216788871e-06
which O 0 2.8887900101540187e-13
is O 0 2.7858361369712328e-14
undetectable O 0 3.006526234569651e-13
by O 0 4.4118510445084204e-16
computed O 0 7.495275233804222e-11
tomogram O 0 2.164426504691619e-08
( O 0 1.7174247592642577e-13
CT O 0 1.2607518584673016e-08
) O 0 7.522877042446738e-14
or O 0 2.2208726828051861e-13
MRI O 0 1.6432048610681704e-08
analysis O 0 2.738686230921439e-12
, O 0 2.154829371441838e-15
and O 0 8.00105998487432e-16
that O 0 1.8006532118686316e-16
the O 0 1.144596553360978e-14
higher O 0 6.374429196293052e-12
level O 0 2.0943378975513127e-10
of O 0 1.4023376210259286e-11
tau O 0 6.462264317413924e-12
reflects O 0 2.2001083138482869e-13
the O 0 2.7492241542657024e-14
process O 0 5.653515433579059e-10
of O 0 2.3693118578194117e-09
neuronal B-Disease 0 6.639620551140979e-06
degeneration I-Disease 0 0.4858497381210327
in O 0 3.361582230354543e-07
ALD B-Disease 1 1.0
. O 0 1.5048976820253301e-06

Lorenzos O 0 0.0003165144589729607
Oil O 0 1.7977228594645567e-08
should O 0 3.196808052649547e-12
be O 0 1.189865941235782e-13
given O 0 1.8458753744802527e-14
in O 0 1.1635485767426141e-14
the O 0 3.144183250889353e-14
early O 0 4.422720002728031e-12
stage O 0 3.2469416044733634e-11
. O 0 1.1689491388744422e-11
. O 0 2.0553905244469206e-09

Nonsense O 0 4.228370471537346e-06
mutation O 0 2.3850030284044976e-10
in O 0 1.855190445709809e-10
exon O 0 6.274367692071792e-09
4 O 0 1.702177981899311e-10
of O 0 1.0090189100919744e-10
human O 0 1.757902504118114e-11
complement O 0 1.8152600533838381e-09
C9 O 0 2.8502605346147902e-05
gene O 0 3.448894815571979e-12
is O 0 1.1878697725703057e-14
the O 0 8.862019191396842e-14
major O 0 1.4783801353251969e-12
cause O 0 1.1756727535949807e-11
of O 0 7.893578846118743e-11
Japanese O 0 7.685613212515818e-08
complement B-Disease 0 3.3400377219550137e-07
C9 I-Disease 1 0.8587113618850708
deficiency I-Disease 0 4.0911156247602776e-05
. O 0 1.1167238511688993e-07

Deficiency B-Disease 0 0.15880770981311798
of I-Disease 0 1.5034647731226869e-06
the I-Disease 0 6.075053349263726e-09
ninth I-Disease 0 7.982668648764957e-06
component I-Disease 0 6.438897415250722e-09
of I-Disease 0 5.583162057676283e-11
human I-Disease 0 1.8471170773470824e-12
complement I-Disease 0 1.813833250263741e-10
( O 0 1.1388612763344602e-13
C9 O 0 1.342894847766729e-05
) O 0 3.873141499362298e-13
is O 0 5.669233867620395e-15
the O 0 6.553790035624882e-14
most O 0 5.917762482300637e-14
common O 0 3.5091624051020176e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.707653794040368e-11
Japan O 0 4.3759953993749434e-10
but O 0 5.155604133715019e-13
is O 0 1.6291347204643383e-14
rare O 0 1.5339030772550805e-13
in O 0 2.1510783876788758e-13
other O 0 2.897950976410435e-13
countries O 0 1.8915343250047734e-11
. O 0 7.825827985641354e-09

We O 0 5.114456635979536e-10
studied O 0 1.461201819263902e-11
the O 0 1.9286814170477867e-13
molecular O 0 1.0954081608796629e-12
basis O 0 1.1053111897973977e-10
of O 0 9.452573168644562e-10
C9 B-Disease 1 0.9977772831916809
deficiency I-Disease 0 1.4876899001592392e-07
in O 0 9.492745998984642e-12
four O 0 3.83324448571809e-12
Japanese O 0 1.4618471988470105e-09
C9 B-Disease 0 0.0426674410700798
- I-Disease 0 2.587458141078969e-07
deficient I-Disease 0 4.022496113975649e-08
patients O 0 1.3683019994825685e-10
who O 0 2.1922134246787905e-12
had O 0 1.8013998279164944e-11
suffered O 0 6.572206530108815e-06
from O 0 6.737158031455692e-08
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 3.429823536293952e-09

Direct O 0 3.896723568819205e-11
sequencing O 0 2.2962350076927152e-10
of O 0 2.556529710151523e-10
amplified O 0 4.937565981077974e-11
C9 O 0 8.368995274565805e-09
cDNA O 0 4.664152952749134e-10
and O 0 1.5138941261618605e-13
DNA O 0 2.2380002018262957e-10
revealed O 0 1.5782913170836466e-11
a O 0 1.2248764556885977e-13
nonsense O 0 6.982923354131865e-12
substitution O 0 2.652501157086873e-13
( O 0 7.907065268113102e-15
CGA O 0 1.2130962900869235e-08
- O 0 2.0724832960894446e-09
- O 0 7.662435685951152e-10
> O 0 2.349989369765382e-10
TGA O 0 2.3762452006081958e-09
) O 0 3.998569375862062e-15
at O 0 9.355521999460104e-13
codon O 0 3.646626056674762e-11
95 O 0 6.619835790644402e-10
in O 0 8.383749944274044e-11
exon O 0 5.506364808560704e-10
4 O 0 1.5487448129514192e-11
in O 0 2.2574617956211407e-12
the O 0 8.208238776175047e-12
four O 0 1.8986306971058298e-10
C9 B-Disease 0 0.007423136383295059
- I-Disease 0 1.5750811144243926e-06
deficient I-Disease 0 8.401769946431159e-08
individuals O 0 9.824466934427178e-11
. O 0 1.5133899466945877e-08

An O 0 5.1965974925960445e-12
allele O 0 6.472703623083831e-11
- O 0 7.364893417349805e-12
specific O 0 5.812588366356508e-13
polymerase O 0 6.623020816672043e-13
chain O 0 6.007632542479047e-13
reaction O 0 1.9687881560497347e-14
system O 0 1.69183482327806e-12
designed O 0 4.937080475345135e-13
to O 0 1.5376767784416878e-12
detect O 0 9.450904468744081e-12
exclusively O 0 5.7247353558997904e-12
only O 0 2.0650754733618146e-14
one O 0 2.0976516828868572e-14
of O 0 2.6858728999559767e-13
the O 0 2.731563890009947e-13
normal O 0 1.7966506754563127e-11
and O 0 3.725654936740253e-15
mutant O 0 6.485422279507019e-14
alleles O 0 1.5845084508250666e-14
indicated O 0 3.0855941174530443e-13
that O 0 1.863853860543962e-15
all O 0 3.257506772462969e-14
the O 0 1.71604944880846e-13
four O 0 2.2787880523539306e-13
patients O 0 1.6867392289214404e-14
were O 0 6.374462047618878e-13
homozygous O 0 8.57520814339513e-13
for O 0 1.6149536948614068e-13
the O 0 2.0525362659506996e-11
mutation O 0 5.170506384155615e-12
in O 0 5.101836661469683e-11
exon O 0 2.0365888975248936e-09
4 O 0 1.7904589269535087e-11
and O 0 3.1193057577032224e-13
that O 0 7.978875874348375e-15
the O 0 1.2860470067349583e-12
parents O 0 1.1064701672253152e-12
of O 0 9.497491335053176e-12
patient O 0 1.6126351642942183e-10
2 O 0 5.2518826093583826e-11
were O 0 2.2783480657651012e-10
heterozygous O 0 9.935043759901063e-11
. O 0 7.255506195846806e-10

The O 0 7.312746519438917e-10
common O 0 5.1387036986705326e-11
mutation O 0 1.2989005487504257e-12
at O 0 1.4316118603086014e-11
codon O 0 2.60831051202004e-10
95 O 0 2.2598786841854235e-08
in O 0 7.881487684713306e-10
exon O 0 8.300921727766308e-09
4 O 0 6.387491230386289e-11
might O 0 2.4850512272966974e-12
be O 0 4.855238390152894e-13
responsible O 0 1.6005212780112466e-11
for O 0 2.3349924424542756e-12
most O 0 5.6040810013369136e-12
Japanese O 0 8.758064495850704e-08
C9 B-Disease 0 0.11096084862947464
deficiency I-Disease 0 9.957519608860821e-08
. O 0 6.32363189589924e-11
. O 0 1.0698999464153758e-09

BRCA1 O 0 2.2717351610967995e-10
required O 0 1.169681296264713e-10
for O 0 5.2330219151019985e-12
transcription O 0 1.3549415811553445e-08
- O 0 1.1251579223880981e-08
coupled O 0 4.246356599679757e-09
repair O 0 0.01550703402608633
of O 0 2.094171280830892e-09
oxidative O 0 6.771890781465117e-08
DNA O 0 1.196484390675323e-06
damage O 0 5.890718739465228e-07
. O 0 6.52370024667448e-09

The O 0 7.62200524917489e-09
breast B-Disease 1 0.9986851811408997
and I-Disease 1 0.9999682903289795
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 1.8029278070486043e-09
gene O 0 2.0641364052026434e-12
BRCA1 O 0 2.481106986529369e-11
encodes O 0 3.301241929560411e-13
a O 0 8.367701063299871e-13
zinc O 0 8.974275315931646e-12
finger O 0 1.5478035519933542e-10
protein O 0 4.2162549493407475e-12
of O 0 1.5305663637540934e-12
unknown O 0 2.9127973366627202e-09
function O 0 1.8631736153906786e-09
. O 0 1.1588693338282496e-09

Association O 0 3.771365442162278e-10
of O 0 1.485413875235153e-10
the O 0 1.4566604866761423e-11
BRCA1 O 0 6.9332747008876705e-12
protein O 0 2.8611082280487546e-14
with O 0 5.212149412119108e-17
the O 0 1.6347967969035544e-14
DNA O 0 2.2773836982903362e-10
repair O 0 2.5739784632605733e-06
protein O 0 8.379784366407961e-11
Rad51 O 0 1.5068508663063085e-09
and O 0 1.1007771673072608e-14
changes O 0 4.6358570601019375e-15
in O 0 3.072330801226486e-15
the O 0 1.786546815162309e-14
phosphorylation O 0 3.095515109432373e-13
and O 0 3.0032806753663155e-14
cellular O 0 8.995409972456514e-11
localization O 0 5.0239837179333335e-08
of O 0 7.188944439739942e-10
the O 0 3.380436486288829e-10
protein O 0 1.8964907769203343e-11
after O 0 4.028799429484087e-12
exposure O 0 5.1080363897004766e-12
to O 0 3.1220156668232413e-12
DNA O 0 2.622531098950276e-07
- O 0 9.046206561613701e-10
damaging O 0 5.105467784649598e-11
agents O 0 1.978751580991589e-12
are O 0 8.738444199469196e-15
consistent O 0 1.7938557540439493e-12
with O 0 4.775225664251453e-17
a O 0 3.721252059480425e-15
role O 0 2.440662926481759e-14
for O 0 2.985923953837538e-13
BRCA1 O 0 2.998871984072338e-11
in O 0 6.976480157461218e-12
DNA O 0 2.717524978379515e-07
repair O 0 0.0001936404878506437
. O 0 7.353455089287309e-08

Here O 0 4.7404363101577474e-08
, O 0 1.3494195994986913e-12
it O 0 1.3950889927536055e-15
is O 0 1.4951077813659162e-16
shown O 0 3.562160467854639e-14
that O 0 5.224476772291422e-15
mouse O 0 2.3129978835023657e-12
embryonic O 0 9.546240881119772e-11
stem O 0 1.34312214128407e-10
cells O 0 4.148786592050868e-10
deficient B-Disease 0 5.046704387723366e-09
in I-Disease 0 1.7885143366314082e-10
BRCA1 I-Disease 0 4.4260919929151044e-10
are O 0 2.6904102860478285e-13
defective O 0 3.1505631437056536e-11
in O 0 1.9238572594813125e-13
the O 0 1.8271572677173303e-13
ability O 0 1.7756302071042507e-12
to O 0 3.2231086289497e-13
carry O 0 1.4922512878157157e-11
out O 0 9.213007960695574e-13
transcription O 0 2.9260218692428452e-09
- O 0 3.142446303172619e-09
coupled O 0 4.356060845367438e-09
repair O 0 0.0008944890578277409
of O 0 9.880436468989728e-10
oxidative O 0 3.5674387888207093e-09
DNA O 0 1.8808080426424567e-07
damage O 0 5.162216876186676e-09
, O 0 5.788997211285396e-14
and O 0 1.5673633181265134e-14
are O 0 1.474760255321811e-13
hypersensitive O 0 1.3192137382489477e-09
to O 0 3.904911949348389e-09
ionizing O 0 3.284448666818207e-06
radiation O 0 5.052129949945083e-07
and O 0 2.4436008771999695e-11
hydrogen O 0 8.84724182803609e-10
peroxide O 0 5.936306113341061e-09
. O 0 1.059636467459768e-08

These O 0 1.5289514099237067e-10
results O 0 2.8489921533036977e-10
suggest O 0 3.440119369924055e-11
that O 0 1.5534591028907446e-13
BRCA1 O 0 1.4161048202121496e-11
participates O 0 4.638886930835584e-13
, O 0 7.454117618294065e-14
directly O 0 1.4286440086497265e-11
or O 0 4.506864065972893e-12
indirectly O 0 2.9144853197493603e-10
, O 0 7.783144517336388e-14
in O 0 3.96465976368332e-12
transcription O 0 1.14407834317376e-08
- O 0 5.4371946944797855e-09
coupled O 0 1.9247274885003662e-09
repair O 0 1.491618877480505e-05
of O 0 7.377695676602514e-10
oxidative O 0 2.5904485223549045e-09
DNA O 0 4.145832122048887e-08
damage O 0 2.1084394230541648e-09
. O 0 4.3145882699935356e-11
. O 0 3.483787147651185e-10

Truncation O 0 1.956499181687832e-05
mutations O 0 2.3384949532356814e-09
in O 0 7.698876258732668e-12
the O 0 2.3952955938155718e-11
transactivation O 0 7.885237209848128e-07
region O 0 3.3780920283277283e-09
of O 0 1.4377210533211837e-09
PAX6 O 0 9.587577551428694e-06
result O 0 2.4409421706117485e-10
in O 0 4.579567974838383e-11
dominant O 0 8.430166786865811e-08
- O 0 1.2113893221865624e-09
negative O 0 4.811524442760451e-12
mutants O 0 1.653947673263545e-10
. O 0 1.0779904746627267e-10

PAX6 O 0 0.001202664221636951
is O 0 2.2814781314162147e-11
a O 0 7.51496781470351e-12
transcription O 0 3.720819832797595e-11
factor O 0 4.219341889766248e-13
with O 0 4.689570383902648e-16
two O 0 4.1327770876732964e-14
DNA O 0 4.34124514114842e-10
- O 0 1.6558154153356597e-11
binding O 0 5.4846405195263515e-12
domains O 0 3.3144650912753093e-10
( O 0 1.1597952043467408e-14
paired O 0 6.3691664789478075e-12
box O 0 1.019542523322814e-11
and O 0 3.2038995480092314e-13
homeobox O 0 1.3299553125456498e-10
) O 0 4.9422475118486575e-15
and O 0 2.701783702362473e-14
a O 0 6.535097983595417e-12
proline O 0 2.3947420046965817e-08
- O 0 3.2772706770600735e-09
serine O 0 8.950736685164884e-08
- O 0 4.0988762606275486e-08
threonine O 0 1.8604121976295573e-07
( O 0 9.720111678436852e-14
PST O 0 1.664331080064585e-06
) O 0 5.553397368698865e-13
- O 0 2.5268499098674013e-11
rich O 0 5.653649857301213e-12
transactivation O 0 2.3305706520204694e-07
domain O 0 1.0094530544790814e-08
. O 0 3.0325161826105784e-10

PAX6 O 1 0.9999792575836182
regulates O 0 7.260482703941307e-08
eye O 0 3.0151022656355053e-07
development O 0 3.892607480793231e-07
in O 0 3.1458675942008796e-11
animals O 0 4.161325960466006e-13
ranging O 0 3.7492283583295816e-12
from O 0 2.4648987278358403e-12
jellyfish O 0 1.495052996333679e-13
to O 0 6.34888712783277e-12
Drosophila O 0 1.099126137327211e-10
to O 0 1.0993064791797735e-10
humans O 0 9.091838393260332e-10
. O 0 3.1031177627482975e-09

Heterozygous O 0 4.526255636960741e-08
mutations O 0 1.2927030279552554e-10
in O 0 7.540133339749289e-13
the O 0 2.2086824556788454e-12
human O 0 6.9644615595387815e-12
PAX6 O 0 2.2455935777543345e-06
gene O 0 3.3142657455270674e-12
result O 0 3.807441775055542e-12
in O 0 1.6620945342705334e-13
various O 0 5.928701540119929e-13
phenotypes O 0 2.9986358448391703e-12
, O 0 3.499034871592391e-15
including O 0 3.0018603705203595e-14
aniridia B-Disease 1 1.0
, O 0 5.956116710947867e-10
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 5.378994472060583e-10
autosomal B-Disease 1 0.9990271329879761
dominant I-Disease 0 0.0002732789143919945
keratitis I-Disease 1 0.9999990463256836
, O 0 1.8612085483926677e-10
and O 0 5.33105060096517e-10
familial B-Disease 1 0.9999979734420776
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9999988079071045

It O 0 3.65277816674614e-12
is O 0 3.796719815168763e-14
believed O 0 1.5744120417104934e-12
that O 0 1.2900340903440556e-16
the O 0 2.018152982105831e-15
mutated O 0 7.0998619276210675e-15
allele O 0 2.618521718900091e-12
of O 0 1.1386993778450538e-11
PAX6 O 0 9.415834369974618e-07
produces O 0 2.8846181086145117e-12
an O 0 4.08308674685557e-14
inactive O 0 3.315242802504059e-10
protein O 0 1.1718362391555104e-10
and O 0 9.986143856277607e-12
aniridia B-Disease 1 1.0
is O 0 9.0567284574683e-12
caused O 0 2.8510400637560274e-11
due O 0 3.043968632709948e-09
to O 0 1.765487339655536e-10
genetic O 0 1.8777401855629705e-09
haploinsufficiency O 0 1.1687964018847197e-07
. O 0 1.1367762731140374e-08

However O 0 4.138167142286875e-09
, O 0 1.4942440730927875e-12
several O 0 3.833907204296022e-13
truncation O 0 1.327252885374719e-08
mutations O 0 2.6287213725217917e-11
have O 0 1.0649544668426408e-13
been O 0 2.424383664743207e-13
found O 0 1.0324053454312514e-14
to O 0 6.680158542212572e-14
occur O 0 2.400792238621552e-12
in O 0 9.837147914824873e-14
the O 0 2.443972758545132e-12
C O 0 1.9318855848382555e-08
- O 0 2.0081325491361213e-10
terminal O 0 1.3328173287252554e-10
half O 0 1.0976465396328461e-11
of O 0 3.059838190114239e-12
PAX6 O 0 9.224019237308312e-08
in O 0 1.3994726601532226e-12
patients O 0 4.624153924354113e-12
with O 0 7.245976550978445e-14
Aniridia B-Disease 1 1.0
resulting O 0 1.5905554651141074e-10
in O 0 9.309455333353367e-13
mutant O 0 1.6925159190828154e-12
proteins O 0 4.1860256444958485e-14
that O 0 2.2548504099854146e-15
retain O 0 7.2475593235199476e-12
the O 0 2.4078451905940046e-12
DNA O 0 1.950478667467337e-09
- O 0 2.1076813905285263e-11
binding O 0 1.7524356965559207e-11
domains O 0 1.3139076493473567e-09
but O 0 5.996047842266039e-13
have O 0 7.79592183993913e-14
lost O 0 1.2065691501472742e-10
most O 0 2.4854514876337247e-14
of O 0 8.951722284440689e-13
the O 0 7.581048636073895e-12
transactivation O 0 4.884183226749883e-07
domain O 0 2.7245045330914763e-08
. O 0 5.5366560225422745e-09

It O 0 2.685726814555256e-11
is O 0 1.205608150204457e-13
not O 0 1.036244996603132e-13
clear O 0 3.8787770738346605e-12
whether O 0 1.2042889472110851e-13
such O 0 2.995877268594134e-14
mutants O 0 1.563031648554869e-10
really O 0 4.91177020930933e-12
behave O 0 2.0410344421517568e-12
as O 0 1.3866596130888975e-13
loss O 0 1.464841303810971e-10
- O 0 2.5084978538814084e-10
of O 0 2.2658522169649586e-08
- O 0 1.895379853067425e-08
function O 0 3.8685402103944e-10
mutants O 0 1.5232920827501495e-11
as O 0 1.5922520260288654e-14
predicted O 0 9.651982988898022e-13
by O 0 9.231015203527843e-14
haploinsufficiency O 0 5.175874662199931e-08
. O 0 2.0748089912814294e-09

Contrary O 0 3.497886069681044e-08
to O 0 4.357020647050014e-11
this O 0 5.983594696112871e-13
theory O 0 2.3045615762939953e-11
, O 0 3.0551055392111226e-14
our O 0 2.9662002021257905e-12
data O 0 2.057961613621817e-11
showed O 0 1.0276283947049936e-12
that O 0 4.100767871415234e-16
these O 0 2.4595598503701762e-15
mutants O 0 4.662769302610226e-12
are O 0 1.8092100286990452e-14
dominant O 0 5.723507223720503e-10
- O 0 3.098897527475941e-11
negative O 0 7.15954043013084e-13
in O 0 1.6170751803573635e-12
transient O 0 1.6941713310014705e-10
transfection O 0 7.622000808282792e-10
assays O 0 3.499814587443195e-12
when O 0 1.5921496705675192e-13
they O 0 7.990393150738781e-14
are O 0 3.659845728342867e-14
coexpressed O 0 2.7946456260252717e-09
with O 0 1.4264425144544512e-13
wild O 0 3.900783862587076e-11
- O 0 3.0126845462774554e-10
type O 0 1.6884621478752138e-09
PAX6 O 0 5.5361638260365e-06
. O 0 1.1890794127111803e-08

We O 0 2.279104405200627e-10
found O 0 6.338018217894037e-13
that O 0 2.7366231627467554e-16
the O 0 2.8108578290463038e-14
dominant O 0 7.448274635946106e-11
- O 0 1.0427705790863606e-12
negative O 0 1.401495886439166e-14
effects O 0 7.064379463350701e-14
result O 0 8.142800127751426e-14
from O 0 2.8197984312111624e-14
the O 0 1.3864790934271787e-14
enhanced O 0 6.090297537120204e-13
DNA O 0 1.0718535434217635e-11
binding O 0 1.1987893316911524e-12
ability O 0 4.8532521751409874e-11
of O 0 5.7077627346746596e-11
these O 0 5.334870132461811e-12
mutants O 0 7.48719142240617e-10
. O 0 6.499948912441766e-10

Kinetic O 0 1.5774931583223406e-08
studies O 0 2.0540872822105705e-11
of O 0 4.690644574145697e-12
binding O 0 8.036130788591223e-12
and O 0 9.251995870818153e-13
dissociation O 0 5.4816946121194476e-11
revealed O 0 2.2151256523494922e-11
that O 0 3.4324684051522476e-16
various O 0 3.031793159623611e-14
truncation O 0 2.3501417478755116e-10
mutants O 0 9.605926297451273e-12
have O 0 2.6141971074845893e-14
3 O 0 2.6790846017338277e-12
- O 0 5.574752898890312e-12
5 O 0 5.727848317177431e-12
- O 0 5.353911758376739e-12
fold O 0 1.6225126710928128e-12
higher O 0 1.2953575928911776e-12
affinity O 0 5.373341118705471e-15
to O 0 1.49825237530073e-14
various O 0 1.181106265308457e-13
DNA O 0 9.636907938315176e-11
- O 0 6.88446207593868e-13
binding O 0 4.792242991324969e-13
sites O 0 8.04080272417268e-13
when O 0 1.2901584877202717e-14
compared O 0 2.298286615274453e-13
with O 0 5.836665282117376e-16
the O 0 2.5141461178559976e-13
wild O 0 3.478823566022138e-12
- O 0 6.352039727541836e-11
type O 0 3.443560991911454e-10
PAX6 O 0 4.755569079861743e-06
. O 0 1.3442665647289687e-08

These O 0 6.452164757336787e-12
results O 0 1.491187034963204e-11
provide O 0 4.49734910770716e-12
a O 0 2.125778394458655e-13
new O 0 5.815868484504091e-14
insight O 0 4.08870203319478e-12
into O 0 1.4603810240092219e-13
the O 0 1.5107904619178492e-13
role O 0 6.269249876178495e-12
of O 0 4.704363981700155e-11
mutant O 0 3.613421784010029e-10
PAX6 O 0 5.828612188452098e-07
in O 0 9.46104652954638e-11
causing O 0 4.661851349396784e-09
aniridia B-Disease 1 1.0
. O 0 3.728517050660685e-09
. O 0 1.2341613953026354e-08

Reversal O 0 4.989243507225183e-07
of O 0 1.8051309780275915e-08
severe O 0 0.003927422687411308
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 2.6211651515950507e-08
excellent O 0 6.030004828794233e-10
neuropsychologic O 0 4.5523115832502015e-10
outcome O 0 5.915130885103537e-11
in O 0 2.2063403079357335e-13
very B-Disease 0 3.733311267550485e-14
- I-Disease 0 4.2768208679405673e-13
long I-Disease 0 3.014657208762206e-13
- I-Disease 0 1.4221835514804937e-12
chain I-Disease 0 8.444597018181232e-13
acyl I-Disease 0 2.937084603304996e-11
- I-Disease 0 4.660797789379778e-11
coenzyme I-Disease 0 5.319836793304944e-10
A I-Disease 0 4.940860662827617e-07
dehydrogenase I-Disease 0 1.3832773220201489e-06
deficiency I-Disease 0 2.7679668619384756e-06
. O 0 3.04950109608626e-09

Very B-Disease 0 1.70948574740315e-10
- I-Disease 0 2.167836049560279e-11
long I-Disease 0 1.0501255897840678e-12
- I-Disease 0 7.73241117402873e-13
chain I-Disease 0 2.6268126467944054e-14
acyl I-Disease 0 1.0981103179541485e-13
- I-Disease 0 7.097089842894588e-14
coenzyme I-Disease 0 3.253981285811225e-13
A I-Disease 0 5.6946669602098154e-12
dehydrogenase I-Disease 0 6.317456106852415e-12
( I-Disease 0 4.477282666793744e-14
VLCAD I-Disease 1 0.9999984502792358
) I-Disease 0 1.2116883885138208e-11
deficiency I-Disease 0 1.5100501968845492e-06
is O 0 1.1470449698576524e-13
a O 0 2.5924427535239936e-11
disorder O 1 0.9998352527618408
of O 0 0.07319764792919159
fatty O 0 1.918073166962131e-08
acid O 0 7.945413216248198e-09
beta O 0 1.7332436597072842e-09
oxidation O 0 1.4448630070162949e-09
that O 0 3.560708314569866e-13
reportedly O 0 6.369798351973932e-12
has O 0 2.7188728461832127e-15
high O 0 1.3156202472927592e-13
rates O 0 3.190739230989059e-13
of O 0 3.7260429117114136e-13
morbidity O 0 3.0917510773775803e-09
and O 0 6.6877254602248914e-12
mortality O 0 4.915360207746744e-08
. O 0 6.67519639563352e-09

We O 0 2.126888942743932e-10
describe O 0 1.5281984011572547e-11
the O 0 5.696565181373403e-13
outcome O 0 1.0789495963337004e-09
of O 0 1.2632297985426533e-10
a O 0 8.873626659855471e-13
5 O 0 3.4680626968298933e-13
- O 0 1.1757292493373098e-14
year O 0 8.254844968387867e-14
- O 0 1.256737444145506e-12
old O 0 2.2368254817828337e-11
girl O 0 7.93947806804196e-12
with O 0 7.907852161721102e-14
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 8.296841512434039e-12
was O 0 1.4863653710617264e-11
first O 0 5.87983273181436e-11
seen O 0 4.1923842869495687e-11
at O 0 2.1819807245748724e-12
5 O 0 7.485181094737947e-13
months O 0 2.710385518453484e-12
of O 0 1.4043123218107634e-12
age O 0 1.203208713218551e-11
with O 0 3.760298279351093e-13
severe O 0 3.7685143894350404e-08
hypertrophic B-Disease 1 0.9999762773513794
cardiomyopathy I-Disease 1 1.0
, O 1 0.9999866485595703
hepatomegaly B-Disease 1 1.0
, O 0 0.0012590668629854918
encephalopathy B-Disease 0 7.795448254910298e-06
, O 0 8.077345216295218e-12
and O 0 2.617693735385007e-11
hypotonia B-Disease 0 2.4384141283917415e-07
. O 0 7.407072644127766e-08

Biochemical O 0 1.0311002540674963e-07
studies O 0 4.008524179255346e-09
indicated O 0 1.2256702575541567e-05
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 4.594603364438399e-09
by O 0 6.457698552330207e-14
a O 0 1.4428751162615105e-12
stable O 0 1.2530755100215174e-08
yet O 0 1.668973986790334e-11
inactive O 0 5.711381367845547e-10
enzyme O 0 4.231499872719979e-11
. O 0 7.907446919475092e-10

Molecular O 0 5.342410958064647e-10
genetic O 0 2.4414708536119045e-12
analysis O 0 2.364906230914454e-12
of O 0 4.936931939647504e-12
her O 0 4.528805108705569e-11
VLCAD O 1 0.9999998807907104
gene O 0 1.7539262143345669e-12
revealed O 0 3.0355707530960174e-11
a O 0 2.8803172412265876e-13
T1372C O 0 3.2508364888883534e-09
( O 0 4.277112179511787e-14
F458L O 0 1.8308272675682247e-09
) O 0 3.8674868429317e-13
missense O 0 3.807810511347043e-09
mutation O 0 4.167676967425926e-11
and O 0 1.1117169684826678e-11
a O 0 2.3578026198123325e-09
1668 O 0 6.497477897937642e-06
ACAG O 1 0.9935479760169983
1669 O 0 1.6789988876553252e-05
splice O 0 7.665045814064797e-06
site O 0 8.476889412634137e-09
mutation O 0 1.4843214435344976e-09
. O 0 3.1473827988293124e-09

After O 0 1.44128417534084e-10
initial O 0 1.0377656373128374e-10
treatment O 0 7.641112742540201e-10
with O 0 5.08479217932456e-13
intravenous O 0 5.303302796910714e-10
glucose O 0 2.827214851119919e-10
and O 0 5.968229925025492e-13
carnitine O 0 4.4647025659871886e-11
, O 0 2.4921921758279744e-14
the O 0 3.120097225289137e-13
patient O 0 3.0580309118288795e-11
has O 0 2.4615874354876662e-15
thrived O 0 4.826479060165978e-12
on O 0 7.859199402382444e-13
a O 0 1.82389910466374e-12
low O 0 8.166770038009474e-10
- O 0 4.623126881320161e-10
fat O 0 1.0059170510445803e-11
diet O 0 4.388392318803447e-13
supplemented O 0 7.18700001855338e-13
with O 0 7.822431430089347e-15
medium O 0 1.451790493378624e-10
- O 0 6.626072607263112e-11
chain O 0 3.5194210826899885e-12
triglyceride O 0 2.7924595968897847e-10
oil O 0 7.070093122063525e-11
and O 0 7.435874832539824e-13
carnitine O 0 6.331440233209307e-11
and O 0 5.659987994781346e-14
avoidance O 0 3.4933086978661265e-10
of O 0 1.8080303920697816e-10
fasting O 0 2.6286150145438114e-08
. O 0 5.642561973218108e-09

Her O 0 1.7622880477574654e-05
ventricular O 1 0.9978450536727905
hypertrophy O 1 0.9999512434005737
resolved O 0 0.001754187629558146
significantly O 0 4.206533787964872e-09
over O 0 1.1892085623535498e-12
1 O 0 5.168167326388695e-13
year O 0 6.739505871780627e-13
, O 0 1.6325626628018765e-14
and O 0 5.977477627455707e-14
cognitively O 0 1.647598502074743e-08
, O 0 3.8206945745210275e-13
she O 0 2.6172269104556e-13
is O 0 8.017318464659511e-15
in O 0 3.559511287608806e-14
the O 0 1.4113637559001746e-12
superior O 0 3.228366185492604e-11
range O 0 6.995534793802216e-12
for O 0 6.151108268570571e-13
age O 0 9.30247545660734e-10
. O 0 4.988174762132758e-09

Clinical O 0 4.197837633057588e-09
recognition O 0 5.252331192195925e-08
of O 1 0.9999754428863525
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 7.895264997337392e-11
important O 0 5.228073616386775e-12
because O 0 9.35601168614757e-15
it O 0 3.7147119592759973e-16
is O 0 1.3584688997076051e-15
one O 0 3.378728029236784e-14
of O 0 2.5715801016401585e-12
the O 0 3.083238525602994e-11
few O 0 5.627294810683914e-11
directly O 0 1.0438686581792922e-09
treatable O 0 3.4482359296816867e-06
causes O 0 2.4121687980382944e-10
of O 0 8.16010992110705e-09
cardiomyopathy B-Disease 1 1.0
in O 0 3.125209246945815e-08
children O 0 3.4139274740496717e-11
. O 0 2.217518356439907e-11
. O 0 5.45314460254076e-10

Cloning O 0 3.754429211966226e-09
of O 0 9.251828470002721e-11
a O 0 4.337861450251501e-13
novel O 0 1.082876396516462e-14
member O 0 8.596809245378645e-13
of O 0 6.099658972358313e-12
the O 0 3.60085711248459e-11
low O 0 1.6405201641589429e-09
- O 0 1.1834984381398073e-10
density O 0 3.3660484122233214e-11
lipoprotein O 0 1.611368538600999e-10
receptor O 0 1.2251322352441196e-11
family O 0 8.334928580655543e-11
. O 0 5.264243707614469e-09

A O 0 8.030393572333594e-10
gene O 0 2.8229157835076013e-13
encoding O 0 1.2236258881137552e-11
a O 0 1.7764354440577557e-13
novel O 0 3.084068983809536e-14
transmembrane O 0 1.376552431070488e-11
protein O 0 3.181731205001599e-14
was O 0 1.0785841205837219e-15
identified O 0 9.44911442427577e-17
by O 0 7.332769497656883e-19
DNA O 0 1.1357418233963121e-13
sequence O 0 4.2983237479835186e-15
analysis O 0 5.527055681654616e-16
within O 0 4.221205209784277e-15
the O 0 1.4041609062011122e-14
insulin B-Disease 0 1.463948478885868e-06
- I-Disease 1 0.9878965616226196
dependent I-Disease 1 0.9946700930595398
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.1425436118039922e-11
IDDM B-Disease 0 6.117431439633947e-06
) O 0 1.9042955756655607e-14
locus O 0 8.766198487594745e-13
IDDM4 O 0 1.0508890646576674e-08
on O 0 2.2610696301383904e-11
chromosome O 0 6.553649983809251e-11
11q13 O 0 5.0291610875774495e-08
. O 0 2.400434295779519e-09

Based O 0 1.1374425706867086e-11
on O 0 2.6896844126933495e-11
its O 0 4.50347577155355e-13
chromosomal O 0 4.0635805831357175e-09
position O 0 1.0773579806055977e-09
, O 0 4.23725995696983e-14
this O 0 5.171297079247482e-15
gene O 0 2.387682328532071e-15
is O 0 9.206735284674462e-17
a O 0 5.379986515693155e-15
candidate O 0 3.22288875274912e-12
for O 0 1.5995339005137749e-13
conferring O 0 3.5453997515588753e-09
susceptibility O 0 1.4767231881762655e-08
to O 0 5.146153725377189e-09
diabetes B-Disease 0 0.0003818590485025197
. O 0 5.278176331557916e-07

The O 0 2.233624812886248e-10
gene O 0 7.712099730529387e-13
, O 0 1.0123948527380675e-13
termed O 0 4.674115608449547e-11
low O 0 1.0095027036527426e-09
- O 0 1.9304755710658483e-11
density O 0 9.027473863928992e-13
lipoprotein O 0 8.057460406350747e-13
receptor O 0 3.260565239028915e-14
related O 0 3.309277157859114e-11
protein O 0 1.1706196992658513e-12
5 O 0 5.0308178846728e-13
( O 0 9.34462841036942e-16
LRP5 O 0 1.832627383180352e-08
) O 0 1.5480800836866772e-15
, O 0 1.2617432428453212e-15
encodes O 0 4.716969358647483e-15
a O 0 1.5233195022230916e-13
protein O 0 3.2732549309910652e-12
of O 0 1.5668156008730172e-11
1615 O 0 9.416591950639486e-08
amino O 0 1.263573334853163e-08
acids O 0 1.3030625189980327e-11
that O 0 6.618686989538075e-14
contains O 0 1.3475021100296195e-14
conserved O 0 8.593169036584525e-13
modules O 0 9.856469113111999e-11
which O 0 9.945147664918406e-15
are O 0 3.071031791498577e-14
characteristic O 0 2.113111421953029e-11
of O 0 2.579150955306364e-11
the O 0 3.3599820148388915e-10
low O 0 1.9068163936708515e-08
- O 0 1.2183174469271307e-09
density O 0 1.613638250796967e-10
lipoprotein O 0 2.1505854042036532e-10
( O 0 1.2629063593505574e-11
LDL O 0 3.77894204817153e-09
) O 0 2.2771479146754814e-11
receptor O 0 3.611378774151519e-12
family O 0 1.4431924405533536e-11
. O 0 1.159125795346938e-09

These O 0 3.872656102049676e-12
modules O 0 4.268433106968672e-10
include O 0 2.330482913581993e-14
a O 0 7.683318635183858e-14
putative O 0 4.680431736625579e-11
signal O 0 4.326941929755357e-11
peptide O 0 8.400098650516996e-13
for O 0 9.006010455621383e-13
protein O 0 2.7032610091376474e-12
export O 0 5.80541781314281e-10
, O 0 8.475186698275738e-14
four O 0 1.1652116771454502e-11
epidermal O 0 6.666486113138248e-11
growth O 0 9.575742108969276e-12
factor O 0 9.85707934546276e-13
( O 0 4.0986471486724463e-13
EGF O 0 4.5516190816385915e-09
) O 0 1.0022101963429175e-13
repeats O 0 6.623087495105651e-12
with O 0 2.5136461651292102e-14
associated O 0 8.642605381359303e-11
spacer O 0 3.481240753444581e-07
domains O 0 1.8603611984246982e-09
, O 0 2.5598619767972994e-14
three O 0 6.523437931331422e-13
LDL O 0 1.4671340531347e-10
- O 0 2.7313662442907116e-09
receptor O 0 1.369955716793228e-13
( O 0 1.1860525311446074e-13
LDLR O 0 0.2987760305404663
) O 0 1.2022395340545444e-13
repeats O 0 4.992812586979145e-12
, O 0 5.915205882755939e-16
a O 0 2.3798803080549115e-15
single O 0 1.6429602903850204e-12
transmembrane O 0 4.6303169631833896e-11
spanning O 0 1.1770599772642498e-10
domain O 0 1.1269480487685613e-10
, O 0 8.015640153577822e-14
and O 0 2.6459723626547083e-13
a O 0 7.25937782108943e-11
cytoplasmic O 0 8.706449250439618e-08
domain O 0 5.591259011339389e-08
. O 0 9.9087484883853e-09

The O 0 1.7909150828998577e-09
encoded O 0 2.425262435323816e-09
protein O 0 6.718054584853306e-11
has O 0 1.5569637652374803e-15
a O 0 4.066266366588994e-15
unique O 0 5.722339106468272e-14
organization O 0 1.0654949416256249e-13
of O 0 4.7217139920174844e-11
EGF O 0 2.6451619561385087e-08
and O 0 1.7401717219978075e-11
LDLR O 1 0.9895856976509094
repeats O 0 5.52431156375377e-10
; O 0 1.9810454004228623e-14
therefore O 0 1.5816113609762317e-12
, O 0 4.821765816481749e-13
LRP5 O 0 0.00036986719351261854
likely O 0 2.4321636371560373e-10
represents O 0 7.102605179346022e-13
a O 0 3.3900909423428827e-13
new O 0 5.671702460441873e-14
category O 0 6.209887638830569e-12
of O 0 1.8046944147420696e-11
the O 0 2.064268478374487e-10
LDLR O 1 0.8366053700447083
family O 0 5.251725165855703e-10
. O 0 6.169145194689918e-09

Both O 0 2.46886422416992e-09
human O 0 1.1203385441582725e-10
and O 0 3.037823465001921e-11
mouse O 0 2.9312322014085623e-10
LRP5 O 0 0.0010473845759406686
cDNAs O 0 7.359206506407645e-07
have O 0 4.295984683440335e-13
been O 0 1.6728294097156926e-12
isolated O 0 2.524420776583991e-12
and O 0 5.845179974940532e-15
the O 0 5.277905933478988e-13
encoded O 0 4.288487533837815e-12
mature O 0 5.39079024475253e-12
proteins O 0 6.039382183372841e-15
are O 0 1.0246714264030513e-15
95 O 0 4.549236334860929e-11
% O 0 3.401297255997693e-12
identical O 0 1.157670205358119e-12
, O 0 3.782292811197949e-14
indicating O 0 1.5356316912518153e-11
a O 0 2.4944870388038387e-12
high O 0 3.4534125559204654e-11
degree O 0 3.5852083524190448e-09
of O 0 3.1062311056651026e-10
evolutionary O 0 8.428224784751137e-11
conservation O 0 1.840878491310427e-11
. O 0 3.757876388538195e-12
. O 0 8.117091443438085e-10

The O 0 6.4615468531314946e-09
APC B-Disease 0 1.0376439263382053e-08
variants O 0 1.2649561953459454e-10
I1307K O 0 8.837334064537572e-08
and O 0 5.877450219224367e-13
E1317Q O 0 5.738182551340287e-08
are O 0 1.1919737657843654e-13
associated O 0 2.0856645299716092e-09
with O 0 6.65105162056534e-08
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 6.953342068793944e-11
but O 0 6.64963689580439e-14
not O 0 1.3587891120429851e-13
always O 0 1.497301631639414e-13
with O 0 2.5450316157370027e-15
a O 0 6.4000703608319e-13
family O 0 3.802903901072713e-13
history O 0 2.9183125360709994e-10
. O 0 1.8388521816348202e-09

Classical O 0 0.0005707844393327832
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 8.394053507831956e-11
FAP B-Disease 0 9.786772281472622e-09
) O 0 2.3565885028976885e-13
is O 0 1.3305768670841735e-14
a O 0 2.498772889991674e-12
high O 0 3.889861091010971e-07
- O 1 0.9999866485595703
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999998807907104
disease I-Disease 0 7.617597930220654e-06
that O 0 6.058468207366732e-14
predisposes O 0 2.3315105401877645e-10
to O 0 1.1013369036194653e-12
hundreds O 0 8.45573448499809e-13
or O 0 3.792525755247356e-12
thousands O 0 1.2306154706376304e-10
of O 0 1.3369352018344216e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999834299087524
carcinoma I-Disease 1 1.0
and O 0 1.5514635132163335e-09
that O 0 8.973552153082598e-13
results O 0 7.912300675760875e-11
from O 0 1.0395605209989611e-10
truncating O 0 1.4078169741083002e-09
mutations O 0 1.2243538431364054e-12
in O 0 1.2013500816972916e-13
the O 0 1.7051537265500016e-11
APC B-Disease 0 3.1124716137753694e-09
gene O 0 8.446023047614659e-11
. O 0 6.15311579466038e-09

A O 0 1.2056733389442797e-08
variant O 0 1.6547215819784356e-09
of O 0 1.4915584323205167e-09
FAP B-Disease 0 2.7995801588076574e-07
is O 0 4.692403132722234e-10
attenuated B-Disease 0 0.0005294886068440974
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.999998927116394
coli I-Disease 1 1.0
, O 0 3.796144388418243e-12
which O 0 1.5707980367276296e-15
results O 0 1.7977116919653396e-13
from O 0 2.3928560955593925e-12
germ O 0 4.5854462449312905e-09
- O 0 4.0586597971348226e-10
line O 0 9.876737622205312e-11
mutations O 0 1.3377665674437628e-13
in O 0 2.0736060438175663e-13
the O 0 1.0698901617076095e-12
5 O 0 1.4282646246255304e-12
and O 0 2.3620997735909754e-14
3 O 0 2.9537459717704495e-12
regions O 0 8.50508812683115e-12
of O 0 3.1182426432629917e-12
the O 0 2.4263056841444808e-11
APC B-Disease 0 6.560885612572065e-09
gene O 0 2.372189771004951e-11
. O 0 1.0822829743517559e-08

Attenuated B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 1.0675342565491519e-07
have O 0 2.2359230352625437e-13
" O 0 5.641205818446293e-13
multiple O 0 3.036450604843033e-11
" O 0 1.8167509097111179e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 3.1179076790018023e-13
typically O 0 2.2397761881396035e-14
fewer O 0 9.11984704199181e-15
than O 0 1.1611137170082606e-15
100 O 0 1.2971921713872403e-12
) O 0 2.0421771234789207e-14
without O 0 1.2045812481167872e-12
the O 0 1.2229492592219504e-11
florid O 0 3.592244945949119e-09
phenotype O 0 1.328675086620379e-10
of O 0 8.171783388855047e-11
classical O 0 1.845496422347992e-09
FAP B-Disease 0 3.616700894326641e-08
. O 0 1.0072413125783442e-08

Another O 0 2.641903362743392e-09
group O 0 7.056401470084683e-12
of O 0 1.6415585557538748e-10
patients O 0 2.7564545090896786e-10
with O 0 4.2098244920456274e-13
multiple O 0 1.1017324652584648e-07
adenomas B-Disease 1 0.9992448091506958
has O 0 3.032258688931422e-12
no O 0 7.446590002610498e-13
mutations O 0 6.753323215317325e-14
in O 0 2.2219022682932327e-13
the O 0 3.903893267681591e-12
APC B-Disease 0 4.5505232915132865e-10
gene O 0 1.2602534304757135e-13
, O 0 4.96924617882262e-14
and O 0 2.5207998665885412e-14
their O 0 1.7183135339951527e-12
phenotype O 0 1.992096591851844e-12
probably O 0 4.0383836682686414e-13
results O 0 2.0672766883750304e-12
from O 0 2.7353622839010328e-11
variation O 0 5.908455669167978e-11
at O 0 6.971774546560283e-11
a O 0 7.745803998204792e-12
locus O 0 2.7434872082454653e-11
, O 0 8.316149960503616e-13
or O 0 3.761189276696442e-12
loci O 0 1.1594127047320768e-10
, O 0 1.0524737548492369e-12
elsewhere O 0 3.6270350872030788e-12
in O 0 4.211366227534902e-13
the O 0 1.0368807375205069e-11
genome O 0 2.975700519325386e-10
. O 0 2.2373098929051594e-09

Recently O 0 8.909360360576102e-09
, O 0 1.042860134185808e-12
however O 0 7.522105768126286e-13
, O 0 2.8491371961085043e-15
a O 0 9.291456764138478e-15
missense O 0 8.96248960463586e-12
variant O 0 2.2507631609186562e-12
of O 0 1.78457512656216e-10
APC B-Disease 0 1.008192729301527e-08
( O 0 3.172117733415969e-12
I1307K O 0 2.698826051528158e-07
) O 0 1.0667679305013944e-13
was O 0 5.7569608802321426e-12
described O 0 8.297026802585317e-13
that O 0 7.152272514748901e-15
confers O 0 4.554365131553828e-12
an O 0 1.524347596933151e-14
increased O 0 2.145679814380408e-11
risk O 0 2.7897140153498867e-09
of O 0 0.07155139744281769
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.875757105196385e-09
including O 0 2.945380484647986e-12
multiple O 0 5.283879556117199e-09
adenomas B-Disease 0 1.2765449355356395e-06
, O 0 2.386280409383268e-11
in O 0 9.618604801531205e-10
Ashkenazim O 0 4.71652356281993e-06
. O 0 1.799631093035714e-07

We O 0 7.834993764888054e-10
have O 0 2.555375344919647e-13
studied O 0 1.1093249799656868e-12
a O 0 2.010201629720071e-14
set O 0 1.4750275111573286e-13
of O 0 5.246247975431405e-14
164 O 0 3.638282036755314e-11
patients O 0 3.942968998180141e-13
with O 0 1.1660768853868735e-14
multiple O 0 7.777455124369226e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.002082707127556205
/ I-Disease 1 1.0
or I-Disease 1 0.9864872097969055
carcinoma I-Disease 1 1.0
and O 0 8.20402079604321e-10
analyzed O 0 1.683772565819197e-10
codons O 0 3.0732982131409514e-11
1263 O 0 4.362180838768381e-09
- O 0 7.922755229650136e-10
1377 O 0 1.1000663713289782e-09
( O 0 6.937412341638527e-13
exon O 0 5.810469327904855e-10
15G O 0 3.668157333436284e-09
) O 0 1.0875377035284971e-14
of O 0 6.832775989971951e-13
the O 0 1.2802076022541686e-12
APC B-Disease 0 6.287866338716697e-10
gene O 0 1.8130799867097785e-13
for O 0 1.8319188180293544e-11
germ O 0 1.4781625168325263e-06
- O 0 5.355148147145883e-08
line O 0 1.338899990876996e-09
variants O 0 2.4449167690399065e-10
. O 0 8.81201112079566e-10

Three O 0 7.646084321244473e-10
patients O 0 4.185167837289505e-12
with O 0 6.204172019744691e-15
the O 0 1.3025821740675347e-12
I1307K O 0 1.3305574420030553e-09
allele O 0 5.800320727195052e-12
were O 0 9.033829999165188e-13
detected O 0 1.3760686383770815e-12
, O 0 1.0886953646333333e-15
each O 0 1.6209767767427427e-14
of O 0 1.875053931565951e-11
Ashkenazi O 0 4.7386464530063677e-08
descent O 0 5.348400691218558e-07
. O 0 2.6161262667301344e-07

Four O 0 4.949262333298066e-09
patients O 0 1.0743614331509832e-10
had O 0 2.923741544008651e-12
a O 0 1.0988106041373569e-12
germ O 0 2.2769516050402672e-08
- O 0 2.5086903665538784e-09
line O 0 5.363463562169102e-10
E1317Q O 0 2.1289487506237492e-08
missense O 0 3.9248318484119693e-10
variant O 0 2.559684018563213e-12
of O 0 6.055496382106895e-11
APC O 0 4.631540484467678e-09
that O 0 2.5309859459990425e-13
was O 0 1.1965627273735624e-11
not O 0 1.3007691169845959e-13
present O 0 6.285269613798272e-12
in O 0 7.153970883570782e-13
controls O 0 6.46115869140651e-11
; O 0 7.500293788820223e-15
one O 0 7.444541402605587e-14
of O 0 5.690407997235858e-13
these O 0 8.739816054030569e-14
individuals O 0 4.3098050085330075e-13
had O 0 1.1439441061078526e-10
an O 0 2.661787240273994e-12
unusually O 0 4.408949334094858e-12
large O 0 1.0746016300107811e-13
number O 0 6.34518305953069e-12
of O 0 1.319352072037816e-09
metaplastic B-Disease 0 3.6030192859470844e-05
polyps I-Disease 0 3.286849903361144e-08
of I-Disease 0 2.7049464890183117e-09
the I-Disease 0 8.7215861199752e-09
colorectum I-Disease 0 4.2835936255869456e-06
. O 0 1.2247490133177052e-07

There O 0 3.682451010789123e-09
is O 0 1.0847504535241304e-12
increasing O 0 1.4260951360783869e-12
evidence O 0 3.5504951301050525e-13
that O 0 1.250730967498068e-15
there O 0 1.0198793375039601e-14
exist O 0 3.077496807737945e-12
germ O 0 7.252282108183294e-10
- O 0 3.0521965163621267e-12
line O 0 1.8073046314723284e-12
variants O 0 7.546449901606189e-13
of O 0 1.7065714076267002e-12
the O 0 2.716907211361419e-12
APC B-Disease 0 4.5245593383036464e-10
gene O 0 2.4279512319917707e-13
that O 0 7.991608473611501e-15
predispose O 0 1.1622290629897947e-10
to O 0 1.0581377354185184e-12
the O 0 2.7573035001060564e-12
development O 0 6.101739558062036e-09
of O 0 3.2443059350129033e-10
multiple O 0 0.00033790915040299296
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.00017673199181444943
carcinoma I-Disease 1 1.0
, O 0 3.2407545397239446e-11
but O 0 7.17315475681074e-13
without O 0 4.073229947776369e-11
the O 0 1.5749541948384405e-10
florid O 0 1.0191979704643472e-08
phenotype O 0 4.3546777295233596e-11
of O 0 2.069692334183415e-11
classical O 0 8.31442970028462e-11
FAP B-Disease 0 5.020817650525089e-10
, O 0 7.862853028178449e-14
and O 0 7.375454684922095e-15
possibly O 0 1.1687195482223967e-11
with O 0 2.9120955457153166e-14
importance O 0 2.2659557785686957e-08
for O 0 2.494635396033118e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 1.103542768277066e-08
in O 0 1.4249259324555785e-12
the O 0 1.3023387706798117e-12
general O 0 5.83994820817918e-13
population O 0 3.2402286132400494e-15
. O 0 5.5045892973989985e-14
. O 0 2.771076076935053e-11

Genomic O 0 3.8889481857040664e-08
structure O 0 7.182091588120443e-10
of O 0 6.417487097287733e-10
the O 0 4.0241823207054495e-09
human O 1 0.9488109350204468
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 9.475123796676144e-09
CLD B-Disease 1 1.0
) O 0 3.774599990208349e-12
gene O 0 5.942198989805636e-12
. O 0 6.425913690044638e-10

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 8.497336807522515e-07
CLD B-Disease 1 1.0
) O 0 2.1086533127240292e-12
is O 0 3.832762676437033e-15
caused O 0 3.237277592803463e-14
by O 0 1.1170972052118935e-14
mutations O 0 3.8501024742475243e-13
in O 0 7.367836809407668e-14
a O 0 7.631978951811239e-14
gene O 0 2.3422061883851715e-15
which O 0 3.09979563278297e-15
encodes O 0 1.898379023423935e-12
an O 0 1.919108535280989e-12
intestinal O 0 9.601361483646542e-09
anion O 0 4.6909467421585305e-09
transporter O 0 1.067926902464933e-08
. O 0 6.173735300762928e-09

We O 0 4.3313203024197833e-10
report O 0 2.2367090818375956e-12
here O 0 1.1380295577428923e-13
the O 0 5.9152317172608306e-15
complete O 0 2.2553614791726018e-12
genomic O 0 1.9026573719327367e-11
organization O 0 4.5616894999876353e-14
of O 0 1.830632433835744e-12
the O 0 2.263079047076788e-12
human O 0 4.2604600403173265e-11
CLD B-Disease 1 0.9999954700469971
gene O 0 1.9553701106206356e-12
which O 0 1.759862397411778e-14
spans O 0 2.950693942654903e-12
approximately O 0 6.169247241966797e-14
39kb O 0 5.43570122246706e-09
, O 0 1.0849593792827683e-12
and O 0 2.3072787170425046e-12
comprises O 0 2.639251490965666e-11
21 O 0 2.1831161323149217e-09
exons O 0 5.7060081104509663e-08
. O 0 2.3249715042084063e-08

All O 0 4.8865313573287494e-08
exon O 0 2.16806725461538e-07
/ O 0 1.0859785959382862e-07
intron O 0 2.7343700637061374e-08
boundaries O 0 1.2706363738956838e-10
conform O 0 3.0117650040573096e-10
to O 0 1.8184880684612992e-11
the O 0 3.2568406305166775e-11
GT O 0 1.4568021811101062e-07
/ O 0 8.480238875563373e-07
AG O 0 8.913426796652857e-08
rule O 0 4.4821555356122644e-09
. O 0 1.4179934559876983e-08

An O 0 1.0682023841857013e-11
analysis O 0 3.242273853912292e-12
of O 0 3.125036254075786e-12
the O 0 3.1535676847660454e-12
putative O 0 5.454808826854673e-10
promoter O 0 1.5805220465736625e-09
region O 0 1.0949455231390459e-10
sequence O 0 2.8812542629541582e-11
shows O 0 3.073542939255325e-12
a O 0 4.055428735882938e-12
putative O 0 1.5560607025122408e-08
TATA O 0 2.9524451292672893e-06
box O 0 2.9213154117968543e-09
and O 0 3.4822641298282164e-11
predicts O 0 7.038768873313117e-11
multiple O 0 4.8200055058345015e-11
transcription O 0 2.1530562055449565e-10
factor O 0 1.1068295585614507e-11
binding O 0 1.5372149386738698e-10
sites O 0 8.062349898807497e-09
. O 0 1.756996859114679e-08

The O 0 5.353273935249092e-10
genomic O 0 4.284202326232389e-09
structure O 0 2.6263108007795744e-11
was O 0 6.344017650615486e-13
determined O 0 3.6301197508040173e-13
using O 0 3.862641340134955e-14
DNA O 0 1.293398582680183e-10
from O 0 6.62833842175227e-14
several O 0 1.6961780770416977e-15
sources O 0 7.101521519274623e-13
including O 0 7.502034759164185e-16
multiple O 0 1.0892204022408536e-12
large O 0 3.78615108015401e-12
- O 0 3.5391481412183623e-10
insert O 0 1.2716043773508545e-09
libaries O 0 2.1097516622603507e-08
and O 0 3.3293937810700835e-13
genomic O 0 1.4679663040695345e-09
DNA O 0 1.2375794611330093e-08
from O 0 3.91759055751173e-11
Finnish O 0 2.0771973140654154e-05
CLD B-Disease 1 1.0
patients O 0 8.406411122763302e-10
and O 0 9.437683273771924e-12
controls O 0 3.57078278057088e-08
. O 0 1.4337400600084038e-08

Exon O 0 9.61750060923805e-07
- O 0 8.117199690182986e-10
specific O 0 1.051424832615444e-11
primers O 0 2.8396823781307035e-10
developed O 0 2.361633675077024e-12
in O 0 3.496554716771183e-14
this O 0 4.477023982931653e-15
study O 0 2.93395441676534e-15
will O 0 1.9976715136829854e-15
facilitate O 0 1.9597285599859404e-11
mutation O 0 3.3016197740175224e-13
screening O 0 6.849190810863381e-13
studies O 0 1.889369953891884e-12
of O 0 5.550294382081211e-13
patients O 0 2.388887427717118e-13
with O 0 6.4960159511717394e-15
the O 0 9.690614630186722e-12
disease O 0 3.6301531225468864e-10
. O 0 4.0557271430152753e-10

Genomic O 0 3.852943797344466e-10
sequencing O 0 1.1308588510061668e-09
of O 0 2.752981453912895e-10
a O 0 9.55947432323967e-10
BAC O 0 3.6114954127697274e-05
clone O 0 4.407386597904406e-07
H O 1 1.0
_ O 0 7.087103820468954e-11
RG364P16 O 0 1.7122260942414869e-07
revealed O 0 1.778878606917278e-11
the O 0 1.3589109492621182e-13
presence O 0 4.111532823729801e-14
of O 0 6.485214925841531e-13
another O 0 3.216575877179606e-12
, O 0 1.7424816201472987e-13
highly O 0 4.2360034750721365e-12
homologous O 0 2.8865899254215677e-11
gene O 0 2.618899834407745e-13
3 O 0 4.584652102401776e-12
of O 0 1.252459420897356e-11
the O 0 1.2034870322530367e-10
CLD B-Disease 1 0.958939790725708
gene O 0 1.7941363455661885e-12
, O 0 1.70362330606565e-14
with O 0 2.0833272969576029e-16
a O 0 1.0395305865835546e-14
similar O 0 3.699906829209617e-15
genomic O 0 1.3195873213578402e-11
structure O 0 1.3495920960643337e-12
, O 0 2.3028873424901005e-15
recently O 0 1.4646316047451334e-14
identified O 0 2.79350490222513e-13
as O 0 1.536186068217156e-14
the O 0 8.62500140752509e-11
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 2.6789109125457955e-12
( O 0 7.49363407697573e-14
PDS B-Disease 0 8.461110923008164e-08
) O 0 3.7355069124750395e-13
. O 0 2.5229682926175556e-11
. O 0 1.5635810424186047e-09

The O 0 1.1604803340503622e-08
APCI1307K O 1 0.9974018335342407
allele O 0 1.1834052315862209e-07
and O 0 4.1654041327277014e-11
cancer B-Disease 0 2.0395274358264714e-09
risk O 0 8.08835637355898e-11
in O 0 1.1730649004254579e-12
a O 0 9.764788803934277e-13
community O 0 6.717893927775387e-13
- O 0 9.45742304457077e-14
based O 0 1.2638580723563783e-15
study O 0 1.388288948725577e-14
of O 0 1.0531217553826772e-13
Ashkenazi O 0 6.816592845737546e-10
Jews O 0 5.638234323868119e-10
. O 0 8.593809219803461e-09

Mutations O 0 6.985758194133496e-09
in O 0 5.256301990885781e-11
APC O 0 1.6900159494070977e-08
are O 0 3.263360176704311e-13
classically O 0 2.1939923836034048e-11
associated O 0 8.113206217963409e-10
with O 0 2.82803047646496e-09
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.309346546798153e-11
FAP B-Disease 0 2.1472705835634542e-09
) O 0 9.89233245015167e-14
, O 0 6.049826946645433e-15
a O 0 5.895323834138877e-13
highly O 0 3.4627436917844534e-08
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 4.07705025295968e-09
by O 0 2.8949013867497764e-13
multiple O 0 4.393247987621862e-10
intestinal O 0 8.5292303992901e-05
polyps B-Disease 0 4.046591534079269e-11
and O 0 1.0861150905177599e-15
, O 0 2.4263735230132264e-16
without O 0 9.317195046086926e-14
surgical O 0 9.60802992722165e-09
intervention O 0 1.4510327384087418e-09
, O 0 3.464094042540146e-14
the O 0 1.6163073483788093e-12
development O 0 8.595088729634881e-05
of O 1 0.999992847442627
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.4009365596231476e-11
CRC B-Disease 0 3.0248131110965915e-08
) O 0 5.694838047312634e-13
. O 0 2.916553942799993e-10

APC B-Disease 0 3.7560286614279903e-07
is O 0 6.491567266370124e-12
a O 0 7.967182469315048e-11
tumour O 1 1.0
- O 0 1.6510306011241482e-08
suppressor O 0 1.5735661038074333e-11
gene O 0 1.876210165420271e-14
, O 0 1.0221495975608385e-15
and O 0 5.741424368132511e-15
somatic O 0 5.099572430999899e-10
loss O 0 8.122062467030844e-10
occurs O 0 8.243292853871154e-11
in O 0 2.8762042747487726e-10
tumours B-Disease 1 1.0
. O 0 2.382164723258029e-07

The O 0 1.6973225047678397e-09
germline O 0 1.4213728860568153e-08
T O 0 9.284389923536196e-11
- O 0 1.1730252186259449e-11
to O 0 3.2241861090687163e-12
- O 0 3.27677988909425e-11
A O 0 4.995387090089842e-11
transversion O 0 2.119744796358347e-10
responsible O 0 2.6758543297811244e-14
for O 0 5.74179388625575e-16
the O 0 2.7437341949213684e-14
APC O 0 3.683295422135524e-12
I1307K O 0 6.313605194208094e-11
allele O 0 8.845996851691851e-13
converts O 0 7.248731237648187e-13
the O 0 1.8619227524791643e-13
wild O 0 8.753262193848463e-14
- O 0 7.008816134889892e-14
type O 0 3.4142285353089274e-14
sequence O 0 5.468885435656878e-13
to O 0 2.9297536618955178e-12
a O 0 3.1468636724207855e-11
homopolymer O 0 0.0015489181969314814
tract O 0 7.982373517734231e-08
( O 0 7.615057672979986e-13
A8 O 0 1.8399094869891996e-07
) O 0 4.657398598728602e-13
that O 0 4.6179619644318853e-14
is O 0 8.684315067194678e-14
genetically O 0 9.040505323520964e-12
unstable O 0 2.6661072638489713e-07
and O 0 1.0316279080990753e-10
prone O 0 4.256730505858286e-07
to O 0 2.6724654489385102e-08
somatic O 0 1.4162605111778248e-05
mutation O 0 2.5959897342886507e-08
. O 0 2.420328293339935e-08

The O 0 3.111569446545559e-09
I1307K O 0 1.3403627008301555e-07
allele O 0 6.603769198143539e-10
was O 0 4.0599971301569227e-11
found O 0 2.68056692294405e-12
in O 0 1.4479395330294076e-12
6 O 0 1.5310737122575802e-09
. O 0 2.5197970376922285e-09

1 O 0 3.412793603274622e-08
% O 0 2.7548280101541422e-08
of O 0 9.58448653776145e-10
unselected O 0 0.0003435789840295911
Ashkenazi O 0 1.7748401432982064e-06
Jews O 0 1.851882203141031e-09
and O 0 1.3475761305448142e-11
higher O 0 7.073050478645371e-10
proportions O 0 9.651049057146643e-12
of O 0 6.151032461154671e-11
Ashkenazim O 0 7.316869243823021e-08
with O 0 9.659570235701076e-13
family O 0 1.0922082682718326e-11
or O 0 2.0371410721503613e-12
personal O 0 5.644583134234438e-10
histories O 0 5.297414773508535e-08
of O 0 2.536117062845733e-05
CRC B-Disease 0 0.0001312138483626768
( O 0 1.8027093706685093e-11
ref O 0 9.247193011319155e-10
. O 0 1.985814290783594e-12
2 O 0 1.1946470722390412e-11
) O 0 6.020916729597425e-13
. O 0 1.4893061783816108e-10

To O 0 4.387513907744278e-09
evaluate O 0 9.317059124214211e-09
the O 0 4.801964728629038e-11
role O 0 7.180115529914488e-11
of O 0 1.7130442619972541e-09
I1307K O 0 1.2513294223026605e-06
in O 0 2.972395983860676e-12
cancer B-Disease 0 1.4495209720022384e-11
, O 0 2.2733267904858495e-13
we O 0 3.154698507631948e-12
genotyped O 0 1.0340599487790314e-08
5 O 0 2.078134747618421e-10
, O 0 1.4296745211306305e-11
081 O 0 1.703598172753118e-06
Ashkenazi O 0 1.3308530810718366e-07
volunteers O 0 3.6708713846422825e-10
in O 0 1.1411410011374912e-11
a O 0 1.1263157073670982e-11
community O 0 1.7820810799262787e-11
survey O 0 9.846379267486327e-11
. O 0 3.311362295477238e-10

Risk O 0 2.786807635857258e-05
of O 0 2.2400579382519936e-06
developing O 1 0.9999969005584717
colorectal B-Disease 1 1.0
, I-Disease 0 7.004145118116867e-06
breast I-Disease 0 2.3821147010494315e-07
and I-Disease 0 2.0932275357488095e-10
other I-Disease 0 5.0455927630421726e-11
cancers I-Disease 0 0.003912477754056454
were O 0 2.0914100673508074e-08
compared O 0 2.636973417402544e-10
between O 0 3.5920511010090195e-10
genotyped O 0 1.4076109167149298e-08
I1307K O 0 2.20000351269789e-09
carriers O 0 1.2251380194627098e-13
and O 0 1.5050208800569675e-13
non O 0 8.139458551603695e-11
- O 0 6.446183105530967e-13
carriers O 0 1.401330206794683e-14
and O 0 1.1044484833863688e-15
their O 0 7.796368395708922e-14
first O 0 4.498550403714274e-12
- O 0 3.942113996346919e-12
degree O 0 1.0370711234219954e-10
relatives O 0 7.257135864469078e-11
. O 0 1.7739328062038595e-10

Sperm O 0 9.476546214415293e-10
DNA O 0 1.5720916790584738e-09
analysis O 0 3.2819695312130692e-12
in O 0 7.206946085920596e-13
a O 0 8.951936414369754e-11
Friedreich B-Disease 0 0.00022799786529503763
ataxia I-Disease 0 0.0010365761118009686
premutation O 0 8.319823245983571e-05
carrier O 0 7.296404036516435e-10
suggests O 0 1.34254517225596e-11
both O 0 3.131175440457268e-12
meiotic O 0 4.1198515532414604e-07
and O 0 1.0786501900006407e-11
mitotic O 0 1.8465291518054983e-08
expansion O 0 1.0662412064377236e-09
in O 0 2.1428648785959403e-12
the O 0 3.087563885117994e-11
FRDA B-Disease 0 2.1836267478647642e-05
gene O 0 9.035321102413008e-11
. O 0 3.6859997276650347e-09

Friedreich B-Disease 1 0.9999991655349731
ataxia I-Disease 1 1.0
is O 0 1.0772311931361855e-08
usually O 0 3.2381669567982385e-10
caused O 0 4.26781006368504e-12
by O 0 1.4519759160736175e-14
an O 0 5.069090272183515e-15
expansion O 0 3.180692514925809e-11
of O 0 5.675001094052057e-11
a O 0 1.7875526059363267e-10
GAA O 0 2.5747813197085634e-06
trinucleotide O 0 8.216164815166849e-08
repeat O 0 1.9405919926551718e-10
in O 0 8.775710019781613e-11
intron O 0 2.83796763866917e-09
1 O 0 2.7340737313030772e-11
of O 0 3.466690476350287e-11
the O 0 1.0437406494645529e-10
FRDA B-Disease 0 0.00016179398517124355
gene O 0 1.0801412542171818e-10
. O 0 3.605987952681744e-09

Occasionally O 0 2.76359557460637e-08
, O 0 5.310747501485746e-12
a O 0 3.041596271721736e-12
fully O 0 3.361828315728843e-10
expanded O 0 8.620523565816551e-12
allele O 0 9.627354469188276e-11
has O 0 1.8122585426278608e-15
been O 0 4.956410919166286e-14
found O 0 1.806599642562197e-14
to O 0 1.884625268344653e-13
arise O 0 1.0491576357685162e-10
from O 0 1.3855234234222413e-12
a O 0 2.14321637694026e-12
premutation O 0 1.0526427729473653e-07
of O 0 3.273039894668983e-10
100 O 0 3.1407145772988088e-09
or O 0 5.4077131661500744e-11
less O 0 1.3596603842813693e-09
triplet O 0 1.305225737269211e-06
repeats O 0 1.7866135237909475e-08
. O 0 2.143752375616259e-08

We O 0 2.4643559415338245e-10
have O 0 6.832759997989907e-14
examined O 0 6.331639314412218e-13
the O 0 2.746393878375747e-14
sperm O 0 1.1563058182392089e-13
DNA O 0 4.499685346548432e-11
of O 0 1.660084396337691e-11
a O 0 2.5307762829829272e-11
premutation O 0 9.241735199339018e-08
carrier O 0 2.0266572864358068e-09
. O 0 1.5421324661701874e-08

This O 0 5.148494824913641e-11
mans O 0 8.209155022420589e-10
leucocyte O 0 7.371422361401869e-10
DNA O 0 2.583529501443138e-10
showed O 0 4.776440094139689e-12
one O 0 5.458375179796804e-15
normal O 0 3.5940263894314317e-13
allele O 0 8.391478836669922e-14
and O 0 4.721413528763489e-16
one O 0 6.520197047749955e-15
allele O 0 1.522390720432032e-12
of O 0 1.1744977820166147e-12
approximately O 0 9.679691943820234e-13
100 O 0 1.676977723352735e-10
repeats O 0 6.911246019924988e-10
. O 0 1.3980179236483536e-09

His O 0 2.9976225945915758e-09
sperm O 0 2.5513027801515875e-10
showed O 0 5.588361370878481e-11
an O 0 4.687909352293082e-15
expanded O 0 1.0724025291918016e-13
allele O 0 3.6337378418738187e-12
in O 0 4.3661675295202096e-13
a O 0 1.8740455368093656e-11
tight O 0 2.6205440040172334e-09
range O 0 7.377889271742433e-11
centering O 0 6.531415963628717e-10
on O 0 5.179965484325422e-11
a O 0 5.809111438409564e-12
size O 0 2.239150705130033e-12
of O 0 1.1791447158959745e-11
approximately O 0 8.129338348317194e-12
320 O 0 2.9839419823929347e-10
trinucleotide O 0 2.6183727186435135e-07
repeats O 0 1.5582466872388068e-08
. O 0 1.9261094053035777e-08

His O 0 2.2985247483120474e-08
affected O 0 2.4517934349432835e-08
son O 0 5.204891522225807e-07
has O 0 1.2991971593597634e-13
repeat O 0 5.017921408251302e-12
sizes O 0 3.463290038866612e-13
of O 0 1.7508245287595203e-12
1040 O 0 7.270799518011017e-10
and O 0 5.6357986853716735e-12
540 O 0 8.188079547721827e-09
. O 0 7.0972299148763796e-09

These O 0 4.516161611345382e-10
data O 0 7.990683670300314e-10
suggest O 0 7.953361060020203e-12
that O 0 1.7747200541088e-15
expansion O 0 2.405247225348295e-12
occurs O 0 1.932019811062141e-14
in O 0 1.5282477601387835e-15
two O 0 6.180715136336378e-15
stages O 0 2.612386869327299e-11
, O 0 1.2173156024321806e-14
the O 0 4.0808129716119607e-14
first O 0 1.7842796467756883e-13
during O 0 3.446987703950577e-12
meiosis O 0 2.322850523039932e-10
followed O 0 4.787894256411129e-13
by O 0 2.449224566106016e-14
a O 0 5.94596041240264e-13
second O 0 1.953954359423804e-11
mitotic O 0 2.128315301774819e-08
expansion O 0 8.440636634077237e-09
. O 0 2.2654891296269852e-08

We O 0 2.3948869554146768e-09
also O 0 4.547739680497986e-13
show O 0 7.697007636288389e-13
that O 0 3.653509064276546e-16
in O 0 6.7905703880300015e-15
all O 0 1.422339588501905e-14
informative O 0 4.817739631714224e-13
carrier O 0 3.156055603491248e-14
father O 0 3.1254950884351818e-12
to O 0 5.219156270358516e-12
affected O 0 7.525471912295245e-11
child O 0 4.3871663246708437e-11
transmissions O 0 5.7711737611043645e-09
, O 0 4.088320986953128e-15
with O 0 2.430625628408443e-16
the O 0 6.10063079697562e-14
notable O 0 3.2483862605001135e-14
exception O 0 3.744850227984341e-14
of O 0 1.1563323811924348e-13
the O 0 8.809174093307726e-13
premutation O 0 1.9588373145751348e-09
carrier O 0 1.761497198105033e-11
, O 0 1.2322960577307307e-12
the O 0 2.2135461866246153e-11
expansion O 0 3.6885861032232015e-10
size O 0 1.4993267044571823e-11
decreases O 0 4.7558700033700774e-11
. O 0 2.6516844275903395e-11
. O 0 3.5050704561001567e-09

The O 0 5.156421067908923e-09
R496H O 0 1.1489437383715995e-06
mutation O 0 9.060966560392458e-11
of O 0 1.486094025615614e-10
arylsulfatase O 0 0.00016609736485406756
A O 0 1.1116582072645542e-06
does O 0 6.9654711686018e-12
not O 0 5.131543800995786e-11
cause O 0 2.066941851808224e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 4.074774295759198e-08

Deficiency B-Disease 0 0.0011461802059784532
of I-Disease 0 1.8569819530966925e-06
arylsulfatase I-Disease 1 0.9999998807907104
A I-Disease 1 0.9999918937683105
( O 0 9.508620453513306e-12
ARSA O 0 0.020958703011274338
) O 0 7.745473641802836e-13
enzyme O 0 5.835567445933165e-11
activity O 0 5.840057326622627e-10
causes O 0 6.481605030472792e-09
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 3.065396547707877e-10
MLD B-Disease 1 1.0
) O 0 1.7830840970400885e-11
. O 0 1.8937808266006328e-10

A O 0 1.2548501793219202e-08
number O 0 1.1480046947787148e-11
of O 0 2.3897248069282284e-10
ARSA O 0 0.00035418826155364513
gene O 0 4.6893496030708803e-11
mutations O 0 1.1103522615241168e-11
responsible O 0 1.6374549285935736e-11
for O 0 8.780648430573024e-11
MLD B-Disease 1 1.0
have O 0 1.357605868002043e-12
been O 0 1.7182110768898529e-13
identified O 0 1.5595756023417673e-12
. O 0 3.711838822417768e-11

Recently O 0 1.2927628967318583e-09
, O 0 1.556994957225763e-13
the O 0 7.937354658087148e-13
R496H O 0 9.244006449193876e-09
mutation O 0 2.159218767325277e-12
of O 0 1.536382548961157e-10
ARSA O 0 0.0001321555901085958
was O 0 1.415419725869782e-10
proposed O 0 1.0012573452636286e-12
to O 0 1.9430641991224906e-12
be O 0 2.2337505109493172e-12
a O 0 2.8299469972264957e-12
cause O 0 1.0766917912796714e-10
of O 0 1.0165769559478122e-08
MLD B-Disease 1 1.0
( O 0 2.754172064023397e-11
Draghia O 0 8.144936458620577e-08
et O 0 4.2627706919873276e-10
al O 0 3.268354753505065e-10
. O 0 1.5819061284418762e-13
, O 0 2.5961585244332723e-15
1997 O 0 3.912015839307309e-13
) O 0 2.705978345042548e-13
. O 0 3.380423718724046e-10

We O 0 4.070927150934267e-09
have O 0 6.715357436792857e-13
investigated O 0 1.4584229657277348e-11
the O 0 5.160070504564573e-13
R496H O 0 1.1148394429838504e-09
mutation O 0 3.9553199582785525e-14
and O 0 1.3236683393114254e-15
found O 0 7.831956315581222e-15
this O 0 7.920136680555131e-15
mutation O 0 2.0553274793916332e-13
at O 0 6.691196208219452e-12
a O 0 6.60698438233881e-13
relatively O 0 4.540219328968975e-12
high O 0 1.0096218701566642e-13
frequency O 0 2.8597033595312293e-12
in O 0 6.688332071340397e-14
an O 0 6.5151500019337404e-15
African O 0 5.920621523429481e-13
American O 0 6.874394039039708e-14
population O 0 2.2165666383518884e-15
( O 0 5.117850822288063e-18
f O 0 7.987889998973055e-15
= O 0 1.808254406127953e-14
0 O 0 3.0771046789172113e-15
. O 0 6.5438936414823415e-15
09 O 0 3.4347544339979885e-12
, O 0 7.494891751495814e-14
n O 0 3.3757407134384076e-13
= O 0 9.785073142379308e-13
61 O 0 3.1941400913115814e-11
subjects O 0 1.9493842651208126e-10
) O 0 1.5535841927163951e-12
. O 0 4.779360796014487e-10

The O 0 5.226767996191484e-08
ARSA O 0 0.0005109222256578505
enzyme O 0 6.539181418574458e-10
activity O 0 1.8907190049710643e-11
in O 0 6.775359624473093e-14
subjects O 0 2.779164051669447e-11
with O 0 1.5379911801310497e-15
and O 0 2.3119709238164556e-15
without O 0 1.476969994874608e-13
the O 0 8.544399996562868e-13
R496H O 0 9.644304244105228e-10
mutation O 0 4.3513749461293605e-14
was O 0 8.120527904623143e-14
determined O 0 1.404393355081135e-11
and O 0 6.79254612626079e-13
found O 0 1.1130998466696296e-12
to O 0 5.365238201632261e-12
be O 0 2.0757251820158196e-11
normal O 0 6.779490036024072e-08
. O 0 5.912091260995567e-09

It O 0 8.543626917045799e-11
is O 0 4.699131166650827e-13
therefore O 0 1.2928547121759948e-12
concluded O 0 4.621544466565375e-12
that O 0 3.3175112640728213e-15
the O 0 1.466628332452355e-13
R496H O 0 4.721655511019662e-09
mutation O 0 4.0855838677467116e-12
of O 0 1.1456713355784132e-10
ARSA O 0 0.00011213535617571324
does O 0 1.0308322121246882e-12
not O 0 1.0460434601844426e-12
negatively O 0 2.94614020679429e-11
influence O 0 8.626740814754452e-12
the O 0 2.72543988245888e-12
activity O 0 3.676825510723347e-11
of O 0 2.6268367689374905e-11
ARSA O 0 2.254892751807347e-05
and O 0 1.7265891407575173e-12
is O 0 8.511928954648557e-14
not O 0 4.1319438105411055e-13
a O 0 2.976073901206355e-11
cause O 0 9.348708474021805e-09
of O 0 4.750746143145079e-07
MLD B-Disease 1 1.0

Down O 0 6.901623095245668e-08
- O 0 3.736177145441388e-09
regulation O 0 1.8054940875700254e-10
of O 0 3.0021083397002712e-09
transmembrane O 0 7.372793220383755e-08
carbonic O 0 2.1655007742538146e-07
anhydrases O 0 3.6421870390768163e-06
in O 0 4.309666401525192e-09
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.024505240842700005
lines O 0 4.023403138431192e-11
by O 0 5.260539725181201e-13
wild O 0 3.4100163665007344e-11
- O 0 5.706744854450108e-09
type O 0 1.204744961569304e-07
von B-Disease 1 0.9999779462814331
Hippel I-Disease 1 0.9999920129776001
- I-Disease 1 0.9969071745872498
Lindau I-Disease 0 0.0017065141582861543
transgenes O 0 3.631706567830406e-05
. O 0 3.7423699694727475e-08

To O 0 2.56599967940474e-08
discover O 0 8.751043223398369e-10
genes O 0 1.3386553150696034e-12
involved O 0 1.5462057632517623e-12
in O 0 7.844615582119907e-12
von B-Disease 1 0.9998394250869751
Hippel I-Disease 1 0.9999998807907104
- I-Disease 1 0.9999996423721313
Lindau I-Disease 1 0.9999711513519287
( O 0 1.9768561787536498e-10
VHL B-Disease 0 1.432277167623397e-05
) O 0 9.14689678166436e-12
- O 0 1.3833595380319252e-10
mediated O 0 4.506266471082654e-10
carcinogenesis O 0 0.01926400139927864
, O 0 7.263802732047908e-13
we O 0 9.82254167868242e-14
used O 0 3.305919123522405e-12
renal B-Disease 0 0.15685836970806122
cell I-Disease 1 0.9899094104766846
carcinoma I-Disease 1 1.0
cell O 0 0.012657682411372662
lines O 0 2.2898170470853074e-08
stably O 0 9.4507065284688e-08
transfected O 0 1.8318613292933605e-09
with O 0 1.6877761666554691e-13
wild O 0 6.085179669185203e-12
- O 0 1.0992351473504414e-10
type O 0 1.841933133794882e-10
VHL O 0 2.2129916033009067e-06
- O 0 7.473612839703492e-09
expressing O 0 4.9225765824667533e-11
transgenes O 0 1.6032858596304322e-08
. O 0 3.068204301737154e-10

Large O 0 3.311183965903908e-11
- O 0 2.674542011471548e-11
scale O 0 1.326117965438911e-10
RNA O 0 2.4716582114336916e-09
differential O 0 9.52951406674174e-09
display O 0 2.9840199755604147e-11
technology O 0 4.332278702445791e-10
applied O 0 1.2170708234629513e-12
to O 0 3.825682446615547e-13
these O 0 3.4020725960762915e-14
cell O 0 1.4683820132033176e-11
lines O 0 4.531919544498164e-13
identified O 0 1.3803449485857988e-13
several O 0 9.780212562396102e-15
differentially O 0 3.9286199293719903e-11
expressed O 0 9.692933440478071e-14
genes O 0 2.4320579187706026e-13
, O 0 1.0240546170108607e-14
including O 0 2.2604495518766497e-14
an O 0 3.688819540624555e-13
alpha O 0 7.434591831056991e-11
carbonic O 0 8.403032936143973e-09
anhydrase O 0 6.215704395629018e-09
gene O 0 7.411739971763254e-11
, O 0 1.5120957264080914e-10
termed O 0 1.9155986308305728e-07
CA12 O 1 0.9944264888763428
. O 0 3.4380983038317936e-07

The O 0 4.6472095616145737e-10
deduced O 0 8.48023262722819e-10
protein O 0 2.4975527288667587e-12
sequence O 0 7.576592890405631e-13
was O 0 9.7589796486941e-13
classified O 0 1.3777231308922944e-12
as O 0 2.0621430452984202e-14
a O 0 1.735516027764894e-13
one O 0 5.430487873617218e-13
- O 0 6.284961440172765e-11
pass O 0 1.5805591502271454e-08
transmembrane O 0 6.962270049371e-08
CA O 0 3.7070826408580615e-08
possessing O 0 1.5482139181788312e-10
an O 0 1.582389004984447e-13
apparently O 0 1.4574559614732863e-10
intact O 0 4.1361250424643003e-08
catalytic O 0 7.96190313678835e-09
domain O 0 3.319726005202028e-08
in O 0 2.9940325219079966e-10
the O 0 1.65562212828263e-08
extracellular O 0 1.8938386574518518e-06
CA O 0 1.3576415767602157e-05
module O 0 4.4679186430585105e-06
. O 0 3.172995732825257e-08

Reintroduced O 0 5.3070728256443545e-08
wild O 0 1.2132847504453537e-10
- O 0 1.4865703112931783e-10
type O 0 2.6397850919068766e-11
VHL B-Disease 0 8.141333296407538e-08
strongly O 0 2.392746374299537e-12
inhibited O 0 5.006582821931449e-12
the O 0 6.026290442140078e-14
overexpression O 0 1.142949016680328e-11
of O 0 2.975482056924439e-12
the O 0 2.445352947910706e-12
CA12 O 0 9.776027809493826e-07
gene O 0 8.72598603888098e-15
in O 0 2.7989595572362226e-14
the O 0 3.0994692489655362e-12
parental O 0 8.831247733098735e-09
renal B-Disease 1 0.7556196451187134
cell I-Disease 1 0.9999892711639404
carcinoma I-Disease 1 1.0
cell O 1 0.9996761083602905
lines O 0 8.647399596384275e-08
. O 0 6.08113097655405e-08

Similar O 0 7.513205335651918e-12
results O 0 1.467574868053989e-12
were O 0 1.1163379248779748e-12
obtained O 0 5.457120757883238e-13
with O 0 6.3302804025142795e-15
CA9 O 0 1.9398211748011818e-07
, O 0 6.367375024593155e-14
encoding O 0 8.760056569023789e-11
another O 0 4.9093746429251794e-11
transmembrane O 0 2.7227748944369523e-08
CA O 0 2.54655617482058e-07
with O 0 2.912796956758279e-13
an O 0 3.8202061414423227e-13
intact O 0 2.5307317130796037e-08
catalytic O 0 2.120866149368794e-09
domain O 0 3.202563547688442e-08
. O 0 8.125383033075195e-09

Although O 0 1.4597149877726423e-10
both O 0 1.3287859527977286e-11
domains O 0 1.7876556901441631e-09
of O 0 6.300673177639382e-11
the O 0 6.545117919865007e-11
VHL B-Disease 0 7.744326069314411e-08
protein O 0 1.422341671525329e-11
contribute O 0 4.061706700142498e-12
to O 0 2.573523208773687e-12
regulation O 0 1.29515134728031e-10
of O 0 1.5678993658951867e-09
CA12 O 1 0.9999997615814209
expression O 0 7.792454875810151e-11
, O 0 3.900049025591136e-14
the O 0 7.370451091896074e-14
elongin O 0 1.9482912505530692e-10
binding O 0 1.061781391975547e-11
domain O 0 3.2759189805275923e-10
alone O 0 2.4335311543666194e-11
could O 0 3.967339651245183e-11
effectively O 0 3.1329022931458894e-08
regulate O 0 7.8798571223615e-08
CA9 O 0 0.0029631806537508965
expression O 0 4.159328526043282e-08
. O 0 3.8122745849022976e-08

We O 0 7.66148922082266e-09
mapped O 0 1.0093359747997965e-07
CA12 O 0 0.0003470457741059363
and O 0 6.184171230660951e-11
CA9 O 0 2.3840653739171103e-05
loci O 0 1.7504254989919588e-10
to O 0 1.5981266657250082e-11
chromosome O 0 8.741341851747908e-12
bands O 0 1.0817679391150747e-10
15q22 O 0 3.2153678830582066e-08
and O 0 3.054055619511331e-11
17q21 O 0 1.013392306958849e-06
. O 0 1.0899748659198849e-08

2 O 0 1.6920149725763167e-09
respectively O 0 1.0466682631715685e-08
, O 0 1.560373878717325e-11
regions O 0 1.8686614478014008e-09
prone O 0 5.6327555952861985e-09
to O 0 1.3537880538816438e-10
amplification O 0 2.5220147747972987e-08
in O 0 1.6844718328523633e-11
some O 0 7.262948055475338e-12
human O 0 1.1106902064739188e-09
cancers B-Disease 0 2.865769056370482e-05
. O 0 9.400799427794482e-08

Additional O 0 7.966061144060177e-10
experiments O 0 2.2562240964418834e-10
are O 0 1.6505848134140168e-14
needed O 0 6.782351763545691e-11
to O 0 9.86008909069358e-13
define O 0 3.318207861258138e-11
the O 0 2.4415684318074282e-12
role O 0 1.7488963402478852e-11
of O 0 5.888792231623086e-10
CA O 0 1.9447223564839078e-07
IX O 0 1.1372143227106335e-08
and O 0 6.843751954033195e-11
CA O 0 2.1648111214744858e-07
XII O 0 1.4627982158899044e-09
enzymes O 0 1.272781684734381e-12
in O 0 1.2177388817365825e-13
the O 0 6.039387739908975e-13
regulation O 0 2.269659286902037e-11
of O 0 8.661071165816381e-11
pH O 0 4.661466768141054e-10
in O 0 2.2774681446291467e-12
the O 0 1.6172740924247364e-10
extracellular O 0 8.967650622082601e-09
microenvironment O 0 1.8865613071739062e-08
and O 0 9.638222294924836e-13
its O 0 1.3800843334885876e-13
potential O 0 4.834992649305203e-12
impact O 0 2.3275679994494425e-11
on O 0 6.351788539582515e-10
cancer B-Disease 0 1.5520937868274132e-09
cell O 0 3.8286538384113555e-09
growth O 0 7.76808894986658e-11
. O 0 8.160930820011458e-10

A O 0 5.007600445416927e-10
gene O 0 1.3138004139462423e-12
encoding O 0 7.925596290370152e-10
a O 0 1.644887004381701e-10
transmembrane O 0 1.0640597736255586e-08
protein O 0 7.498258958182902e-12
is O 0 2.1082305950024713e-16
mutated O 0 1.6900560405362988e-14
in O 0 2.300885168361028e-15
patients O 0 1.4190783964584952e-12
with O 0 6.952274042917872e-13
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 2.977294207084924e-05
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 1.3747692719334736e-05
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 2.655043502761134e-12
. O 0 1.233520091625806e-10

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.0123051197297173e-07
WFS B-Disease 1 0.9996808767318726
; O 0 3.118208469210515e-11
OMIM O 0 5.768915343651315e-06
222300 O 0 1.1890022300065084e-08
) O 0 2.6642326989316165e-14
is O 0 2.8466398888701144e-14
an O 0 6.3652078399756284e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 4.787930577183908e-13
by O 0 1.1369110210898898e-15
young O 0 1.4508996760108361e-13
- O 0 1.5059061853409106e-12
onset O 0 1.3707428934139898e-06
non O 0 3.1705440051155165e-05
- O 0 1.360727353016955e-08
immune O 0 3.362553013808167e-10
insulin B-Disease 1 0.999997615814209
- I-Disease 1 1.0
dependent I-Disease 0 5.1197698667238e-06
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 7.762645637399146e-09
progressive O 1 0.8382366299629211
optic B-Disease 0 7.382279727607965e-05
atrophy I-Disease 0 2.8605992952179804e-07
. O 0 3.6739638886729153e-08

Linkage O 0 3.118955874015228e-06
to O 0 3.09991143865318e-09
markers O 0 4.179430579398513e-09
on O 0 1.8774319876513346e-09
chromosome O 0 1.26170442982243e-08
4p O 0 2.69720976575627e-06
was O 0 4.566223094082389e-11
confirmed O 0 1.3360440358212156e-11
in O 0 5.065267866602441e-13
five O 0 4.036830331816121e-12
families O 0 1.3098322339949453e-12
. O 0 1.577660085905208e-10

On O 0 1.9542618634460496e-09
the O 0 4.907649807373016e-12
basis O 0 5.258540825003877e-10
of O 0 5.319387985647239e-11
meiotic O 0 9.23943935049465e-06
recombinants O 0 5.464469359139912e-05
and O 0 4.738964776151988e-11
disease O 0 2.9281268520975345e-09
- O 0 1.4079934440580644e-10
associated O 0 3.118079128228146e-10
haplotypes O 0 8.654667538188221e-10
, O 0 3.811797679256247e-14
the O 0 2.995823424403743e-12
WFS B-Disease 0 1.0318591421309975e-06
gene O 0 4.369866556282187e-13
was O 0 7.192680912676552e-12
localized O 0 7.968701393190614e-11
to O 0 2.551739548828369e-11
a O 0 1.8441864702012367e-10
BAC O 0 3.1037584449222777e-06
/ O 0 4.9772673094139464e-08
P1 O 0 2.6506511858315207e-05
contig O 0 3.109672945811326e-07
of O 0 3.430646322577502e-10
less O 0 1.9245199184281248e-11
than O 0 2.0730722097728888e-13
250 O 0 2.347498584409635e-10
kb O 0 3.1952788503986085e-07
. O 0 8.253401517777093e-09

Mutations O 0 7.700998727599995e-10
in O 0 1.0084561224282806e-12
a O 0 6.23295021823754e-14
novel O 0 3.163346397233092e-15
gene O 0 7.911198788895703e-15
( O 0 4.723703694094628e-15
WFS1 O 0 1.6893891370273195e-05
) O 0 3.288534809048338e-13
encoding O 0 2.7842390615262502e-09
a O 0 1.583170400332179e-10
putative O 0 7.549664360340103e-08
transmembrane O 0 9.986959703667253e-09
protein O 0 4.441989137626834e-11
were O 0 2.8281771456001303e-12
found O 0 1.0514779016012818e-13
in O 0 1.8835246337329907e-14
all O 0 9.112740266157757e-14
affected O 0 5.895166624823867e-13
individuals O 0 3.51216858330769e-14
in O 0 6.763897168055033e-13
six O 0 4.443296564016208e-10
WFS B-Disease 0 5.811555183754535e-06
families O 0 4.9794057765950583e-11
, O 0 7.797264895380296e-13
and O 0 6.369648732074129e-13
these O 0 1.2281615611661745e-12
mutations O 0 4.488899269655677e-12
were O 0 3.1307395911839286e-12
associated O 0 3.124531189335755e-11
with O 0 1.5598067000348326e-13
the O 0 1.358824858188612e-10
disease O 0 5.083512277792579e-09
phenotype O 0 2.736683657467154e-10
. O 0 2.258511599961821e-09

WFS1 O 1 0.9994333386421204
appears O 0 1.6560436355561592e-10
to O 0 5.285947894673182e-12
function O 0 2.088042933001688e-11
in O 0 4.744314207986988e-13
survival O 0 1.965478020338196e-07
of O 0 1.46256312616444e-10
islet O 0 3.751907118321185e-10
beta O 0 9.505728426617566e-10
- O 0 1.0307153741617725e-10
cells O 0 3.0786590724668494e-12
and O 0 8.027486553090213e-13
neurons O 0 2.1230465996335823e-10
. O 0 1.497148932605441e-11
. O 0 3.335462739340045e-10

Stable O 1 0.9980512857437134
interaction O 0 9.261619027256529e-09
between O 0 1.6241978248454636e-11
the O 0 3.843938784896944e-13
products O 0 2.365256970317253e-13
of O 0 3.359906482810343e-13
the O 0 7.808739549072796e-13
BRCA1 O 0 2.362651740916988e-12
and O 0 1.0581518300467607e-12
BRCA2 O 0 1.1008969430514881e-10
tumor B-Disease 0 1.5154826005225885e-10
suppressor O 0 4.9078581476624805e-11
genes O 0 4.75363455196276e-13
in O 0 9.241060607706464e-13
mitotic O 0 4.828143662649609e-09
and O 0 3.159645600714356e-10
meiotic O 0 1.4727446796314325e-05
cells O 0 8.427224429397029e-08
. O 0 4.0258736788700844e-08

BRCA1 O 0 4.1315217913506785e-07
and O 0 2.0494898833600672e-10
BRCA2 O 0 8.641789506214081e-09
account O 0 5.894472410172824e-12
for O 0 5.1122615933292884e-14
most O 0 1.469779934526016e-15
cases O 0 9.896361320013637e-16
of O 0 7.555523047486634e-13
familial O 0 7.357597170409846e-11
, O 0 8.119335959859766e-14
early O 0 1.9123141958843348e-10
onset O 0 8.6358120654495e-08
breast B-Disease 0 4.962136035402409e-09
and I-Disease 0 1.146960304510003e-08
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.732506693663538e-09
encode O 0 9.202194561908073e-12
products O 0 7.724318146912212e-13
that O 0 3.579920165308072e-16
each O 0 1.7182814018002987e-15
interact O 0 1.784830387597993e-14
with O 0 7.701126994680112e-15
hRAD51 O 0 1.6496133348198327e-09
. O 0 1.4876687659537424e-09

Results O 0 1.6914017963998162e-09
presented O 0 1.1859614679199382e-10
here O 0 1.0604300076932915e-10
show O 0 1.0252053546377926e-11
that O 0 2.765221896133905e-14
BRCA1 O 0 9.208024100149093e-12
and O 0 3.339041554101946e-13
BRCA2 O 0 2.874558924226278e-10
coexist O 0 2.720436098613277e-10
in O 0 1.1592965086168472e-12
a O 0 2.7863809350103796e-12
biochemical O 0 8.936821421778873e-11
complex O 0 8.092275460835907e-11
and O 0 3.4438990288016003e-12
colocalize O 0 7.098654464243737e-08
in O 0 1.5448865797740297e-10
subnuclear O 0 4.1056219401980343e-07
foci O 0 8.743789692289283e-09
in O 0 1.1022284647499436e-11
somatic O 0 4.0708705850711624e-10
cells O 0 1.1146513399784563e-11
and O 0 1.091253552364807e-13
on O 0 1.828964497213592e-12
the O 0 5.643559621362759e-14
axial O 0 8.176245054267173e-14
elements O 0 1.3189324849297024e-12
of O 0 1.9990896091282018e-11
developing O 0 1.5144056009219753e-09
synaptonemal O 0 1.293146425496161e-07
complexes O 0 9.758360786094045e-10
. O 0 2.529229492509444e-09

Like O 0 1.6715633321950918e-08
BRCA1 O 0 1.2663720738714801e-08
and O 0 3.398408776611461e-10
RAD51 O 0 2.482691161276307e-05
, O 0 3.9825937686588375e-11
BRCA2 O 0 1.5639441131032328e-10
relocates O 0 1.770308379056562e-11
to O 0 2.4907216046587966e-12
PCNA O 0 1.2655057446409046e-07
+ O 0 3.948135221532034e-11
replication O 0 9.290904851022574e-12
sites O 0 1.9552572451744799e-13
following O 0 7.367215595444152e-15
exposure O 0 1.633545403979808e-12
of O 0 1.8333860905134225e-12
S O 0 2.3195741161163852e-10
phase O 0 5.157974936054188e-09
cells O 0 8.773098914005573e-11
to O 0 4.779734941173786e-10
hydroxyurea O 0 2.8605439794660015e-08
or O 0 9.404270695512196e-10
UV O 0 5.510898404281761e-07
irradiation O 0 3.837046236299102e-09
. O 0 4.862687474904703e-10

Thus O 0 2.2370420182937778e-08
, O 0 4.8357241821950225e-11
BRCA1 O 0 4.3346985723058395e-11
and O 0 4.5345134981958357e-13
BRCA2 O 0 1.7485084560786568e-12
participate O 0 6.688108834113082e-12
, O 0 2.5312068521916864e-14
together O 0 1.064838728260728e-13
, O 0 2.926375801228019e-15
in O 0 2.273421014430902e-14
a O 0 1.9851656397288503e-13
pathway O 0 4.842873064375697e-13
( O 0 1.708125582641838e-15
s O 0 2.15917629370517e-13
) O 0 1.309500336840058e-15
associated O 0 1.108264887739012e-13
with O 0 2.249772659224862e-15
the O 0 2.9972850373524706e-13
activation O 0 7.118282742760162e-13
of O 0 3.981832225052884e-12
double O 0 2.7302994934363944e-12
- O 0 5.56648963034867e-11
strand O 0 7.928611760188442e-12
break O 0 1.7521901707340248e-09
repair O 0 2.913601929321885e-05
and O 0 7.65640849331728e-12
/ O 0 8.885275293302186e-10
or O 0 8.476031291768105e-13
homologous O 0 7.417733094428058e-12
recombination O 0 6.090942333836225e-11
. O 0 5.552812654130435e-10

Dysfunction O 1 0.9299562573432922
of O 0 8.707295819476712e-06
this O 0 2.0560568803063006e-09
pathway O 0 4.762310990003016e-09
may O 0 1.188006941085784e-12
be O 0 7.319768706090524e-13
a O 0 6.07330321016758e-13
general O 0 1.9874663980540275e-12
phenomenon O 0 2.4015330197559026e-13
in O 0 7.234345772173106e-15
the O 0 5.839533229797661e-14
majority O 0 2.7360832851219992e-14
of O 0 3.0678235695075565e-14
cases O 0 4.9404409599787535e-14
of O 0 3.689006392026961e-11
hereditary B-Disease 1 0.9793364405632019
breast I-Disease 0 0.0004656833771150559
and I-Disease 0 0.00013552028394769877
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.49318475198379e-07
. O 0 3.0342190981968997e-09

A O 0 1.1685206580125396e-08
novel O 0 4.3056335406743695e-12
Arg362Ser O 0 9.426960900782433e-08
mutation O 0 1.7088376070076294e-13
in O 0 1.70386386342267e-14
the O 0 2.7597222467326543e-13
sterol O 0 9.07270855665665e-11
27 O 0 2.541642452058568e-10
- O 0 2.2227025775478637e-10
hydroxylase O 0 1.185672560133355e-09
gene O 0 4.2328838459511353e-13
( O 0 2.7964194748339964e-14
CYP27 O 1 0.9979385733604431
) O 0 6.758838416243487e-14
: O 0 3.290663178381057e-16
its O 0 8.41262429422012e-16
effects O 0 8.622812343707723e-15
on O 0 1.0720999012604066e-13
pre O 0 1.3420663885765904e-11
- O 0 1.2618896812893743e-12
mRNA O 0 4.7550446219402076e-11
splicing O 0 3.4971071177780644e-11
and O 0 1.8105304581961246e-12
enzyme O 0 2.4605398014215796e-12
activity O 0 3.051290123345929e-11
. O 0 3.2991195886289404e-10

A O 0 2.0137833622868584e-09
novel O 0 2.868962120823604e-13
C O 0 1.0617400292289858e-09
to O 0 1.1425583786375815e-12
A O 0 1.26037555392422e-10
mutation O 0 3.690759720412218e-14
in O 0 2.4924094821305925e-15
the O 0 4.8041743651826285e-14
sterol O 0 3.223173464239615e-11
27 O 0 7.827222897605068e-11
- O 0 4.1017873125825943e-11
hydroxylase O 0 1.992486176050079e-10
gene O 0 1.5138912801311577e-13
( O 0 2.153474711649294e-14
CYP27 O 0 2.7249884624325205e-06
) O 0 6.5618168586462425e-15
was O 0 6.615127418280534e-14
identified O 0 4.120244811702195e-15
by O 0 2.0810238967366632e-16
sequencing O 0 3.5150153621099633e-11
amplified O 0 2.1783430961819228e-11
CYP27 O 0 1.0279701712079259e-07
gene O 0 4.50324998645113e-14
products O 0 1.6641977509598838e-13
from O 0 1.5054056363029283e-13
a O 0 2.4067697162490076e-13
patient O 0 3.5994426189622786e-11
with O 0 6.249893181112243e-13
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 9.039814903577525e-12
CTX B-Disease 0 1.3806332788135478e-07
) O 0 5.703101619430884e-12
. O 0 4.149665333574859e-10

The O 0 1.6098026245359165e-09
mutation O 0 2.0293974833940354e-11
changed O 0 5.352461963231692e-12
the O 0 1.2540915571637723e-12
adrenodoxin O 0 8.788411665072715e-10
cofactor O 0 7.126033790827435e-11
binding O 0 3.67381125521149e-11
residue O 0 6.620016090863601e-09
362Arg O 0 7.072554097931061e-09
to O 0 9.652323385012096e-11
362Ser O 0 1.4121546598744317e-07
( O 0 1.1454719117676149e-11
CGT O 0 2.542431047913851e-07
362Arg O 0 2.0882371387642706e-08
to O 0 4.014628074422433e-10
AGT O 0 7.590968016302213e-05
362Ser O 0 8.979426091570986e-09
) O 0 3.611953807878751e-14
, O 0 5.0996181866355076e-15
and O 0 3.247294138569571e-15
was O 0 2.321005583907909e-12
responsible O 0 1.3717246089006707e-11
for O 0 2.497115882127421e-11
deficiency O 0 5.1739206696765905e-08
in O 0 4.6790908821148225e-12
the O 0 3.938418341453698e-11
sterol O 0 3.4274152960200865e-10
27 O 0 1.8355651443258125e-09
- O 0 4.059039215853488e-10
hydroxylase O 0 2.726504799710483e-09
activity O 0 5.951568231299387e-12
, O 0 1.1817630038337811e-15
as O 0 1.4197577156116437e-16
confirmed O 0 5.293931356383907e-15
by O 0 3.955195200913334e-16
expression O 0 1.819623282346e-14
of O 0 1.5615511813303617e-13
mutant O 0 2.938526022988261e-14
cDNA O 0 2.829344050714333e-11
into O 0 2.2612042793745957e-10
COS O 0 1.6689563153704512e-06
- O 0 1.797712556594888e-08
1 O 0 1.8426782322222834e-10
cells O 0 2.1617674317297997e-10
. O 0 5.322871587942757e-10

Quantitative O 0 8.163472564604035e-09
analysis O 0 1.889961971646148e-11
showed O 0 5.293273198231363e-12
that O 0 1.9347244984357985e-16
the O 0 9.842603315224959e-15
expression O 0 6.440490230973789e-14
of O 0 1.9048495419893285e-12
CYP27 O 0 6.196222557264264e-08
gene O 0 7.103356362044965e-15
mRNA O 0 2.7196550133473663e-12
in O 0 1.5542118102489927e-13
the O 0 1.9707289185960652e-12
patient O 0 7.264253781835706e-11
represented O 0 3.69786666565286e-12
52 O 0 1.7964890020039093e-08
. O 0 1.6304515071396963e-08

5 O 0 1.6733616714503796e-09
% O 0 1.4711588613991466e-09
of O 0 2.061623267934909e-11
the O 0 3.940281434466897e-11
normal O 0 1.5649154860852832e-08
level O 0 1.0333170763487942e-07
. O 0 4.3025618623460105e-09

As O 0 3.3627951118164745e-11
the O 0 7.215587068815088e-12
mutation O 0 7.455117252697097e-13
occurred O 0 4.753684598735042e-11
at O 0 3.0031332238708575e-13
the O 0 1.5906706155163416e-14
penultimate O 0 5.368508970704511e-10
nucleotide O 0 2.0805461520279067e-10
of O 0 2.048971214918538e-09
exon O 0 1.262040805194431e-09
6 O 0 3.5416131138887863e-10
( O 0 1.802117049337637e-12
- O 0 3.8377911959486255e-10
2 O 0 7.482158989602361e-12
position O 0 2.3128690074258884e-09
of O 0 1.6168864025445373e-09
exon O 0 6.326892343366808e-10
6 O 0 2.2685233691532858e-09
- O 0 9.11938791148259e-09
intron O 0 1.0143418549546368e-08
6 O 0 3.0304173059825246e-10
splice O 0 1.495416235286484e-08
site O 0 4.39903148630183e-11
) O 0 3.657835888565622e-14
of O 0 5.9254033971112285e-12
the O 0 2.5372575568338718e-11
gene O 0 1.3167933540433885e-12
, O 0 6.70726712018177e-13
we O 0 3.3906098415026342e-12
hypothesized O 0 1.0221594404224987e-11
that O 0 1.2386329017915533e-15
the O 0 8.59176011586138e-13
mutation O 0 9.252913105856075e-13
may O 0 3.3465713381898576e-13
partially O 0 4.6293455180368426e-11
affect O 0 8.31095348791111e-12
the O 0 5.550223041578262e-12
normal O 0 9.112880450246053e-10
splicing O 0 4.6465006842133505e-10
efficiency O 0 2.863495662808191e-09
in O 0 1.0529948440973769e-10
exon O 0 1.1087238904750052e-09
6 O 0 2.848914507080913e-11
and O 0 6.956996285480133e-13
cause O 0 1.4781827021095872e-12
alternative O 0 1.1155531359774429e-11
splicing O 0 6.76991865344867e-11
elsewhere O 0 1.762878731881301e-11
, O 0 1.6860444924981025e-14
which O 0 4.065860849565496e-16
resulted O 0 4.431950032662835e-12
in O 0 1.1264269681940386e-12
decreased O 0 1.6765172583532717e-10
transcript O 0 9.211668650088711e-10
in O 0 3.543460880620075e-12
the O 0 5.383620979571013e-11
patient O 0 2.923306929858427e-08
. O 0 4.045100254757017e-08

Transfection O 0 0.00014631710655521601
of O 0 9.180227777960681e-08
constructed O 0 1.578531616530654e-08
minigenes O 0 7.01041415140935e-07
, O 0 1.4602083648132536e-13
with O 0 1.5926704391289854e-15
or O 0 4.030686239419809e-14
without O 0 4.2128125532329974e-13
the O 0 5.086770848289346e-13
mutation O 0 4.6212223636524566e-14
, O 0 5.385715423031909e-15
into O 0 2.327621255460155e-11
COS O 0 7.467729687959945e-07
- O 0 9.924897570456892e-10
1 O 0 4.813333325665026e-12
cells O 0 2.2512514855771437e-13
confirmed O 0 3.7248968422524606e-14
that O 0 3.710600706195486e-18
the O 0 2.35860374039239e-16
mutant O 0 3.7013205271985844e-14
minigene O 0 3.7639186906135436e-11
was O 0 4.2610489789374206e-13
responsible O 0 9.482101518895614e-13
for O 0 3.3942057606380083e-13
a O 0 1.4932269830347789e-12
mRNA O 0 1.9785800775551365e-10
species O 0 4.37543296882034e-15
alternatively O 0 3.718916233991232e-12
spliced O 0 7.909050303567255e-09
at O 0 6.459661694435681e-09
an O 0 2.6119283819125982e-11
activated O 0 9.408365642116223e-09
cryptic O 0 2.416931765836239e-09
5 O 0 9.620745866634195e-11
splice O 0 1.1473234806658184e-08
site O 0 1.9653029204036443e-10
88 O 0 2.2380950426281743e-09
bp O 0 4.288625010673286e-09
upstream O 0 2.1723498555559217e-09
from O 0 4.715944648681081e-11
the O 0 6.980770128617309e-11
3 O 0 1.0245412157550149e-10
end O 0 2.3406112603652218e-08
of O 0 2.267616139306483e-08
exon O 0 3.121545688600236e-08
6 O 0 2.5448899876323594e-08
. O 0 4.402152242732882e-08

Our O 0 6.184922796137471e-08
data O 0 5.382422285649113e-10
suggest O 0 7.746079710817255e-13
that O 0 2.459924498053969e-16
the O 0 1.662413967335602e-14
C O 0 6.289878340393074e-11
to O 0 1.4873344526475374e-12
A O 0 4.5771422763074554e-10
mutation O 0 8.152641430871077e-13
at O 0 7.292677746406628e-13
the O 0 1.734000719703574e-13
penultimate O 0 1.6771320998643091e-09
nucleotide O 0 5.96814819786573e-10
of O 0 8.762801595452174e-10
exon O 0 1.4579849549889445e-09
6 O 0 1.0404650752082745e-10
of O 0 5.915763018338183e-11
the O 0 1.339318239645948e-10
CYP27 O 1 0.9330207705497742
gene O 0 7.619928993340963e-12
not O 0 9.33260196553376e-13
only O 0 3.311794848775973e-12
causes O 0 6.956057691659412e-12
the O 0 2.97435999441209e-11
deficiency B-Disease 0 2.5739690379111835e-09
in I-Disease 0 2.4046600214516767e-12
the I-Disease 0 4.5422828692798234e-11
sterol I-Disease 0 3.742439247389484e-09
27 I-Disease 0 9.190876504305834e-09
- I-Disease 0 2.8093214421431867e-09
hydroxylase I-Disease 0 2.0156559088491122e-08
activity I-Disease 0 5.5846317154051306e-11
, O 0 7.444257477161667e-14
but O 0 7.144749337517978e-14
also O 0 3.3550249980539987e-14
partially O 0 1.2356717211947643e-11
leads O 0 5.1626078764613684e-14
to O 0 6.794071598717477e-14
alternative O 0 1.908267814598741e-12
pre O 0 3.182166682935694e-11
- O 0 1.5079324507810687e-12
mRNA O 0 3.4211890265201106e-11
splicing O 0 7.603527529820298e-11
of O 0 1.2441997952750139e-11
the O 0 1.6789163809205476e-11
gene O 0 9.449408269746051e-12
. O 0 9.455854987905354e-10

To O 0 1.8528185652399998e-09
our O 0 1.313952835424459e-09
knowledge O 0 4.8515936157400574e-08
, O 0 1.5176055534861857e-14
this O 0 1.1443253122354435e-15
is O 0 4.161468237648947e-17
the O 0 6.216037574907185e-16
first O 0 1.845160817485949e-14
report O 0 9.129070383754462e-15
regarding O 0 6.669681083468215e-14
effects O 0 5.364967096879031e-14
on O 0 9.332366422611788e-14
pre O 0 2.0169324110169695e-12
- O 0 1.992483191241498e-13
mRNA O 0 6.830590346812437e-12
splicing O 0 2.6557943344496238e-11
of O 0 5.887304099089219e-12
a O 0 1.3129237280695705e-12
mutation O 0 2.3813267438672903e-13
at O 0 7.390335739210219e-12
the O 0 1.921006582972229e-11
- O 0 1.7621935854972293e-10
2 O 0 6.260204160613014e-12
position O 0 2.6704261024690368e-09
of O 0 2.2152536749420193e-10
a O 0 2.3915249988681886e-11
5 O 0 5.582994067054869e-10
splice O 0 3.3929065779148004e-08
site O 0 1.1687028012019596e-09
. O 0 1.4051450003549348e-09

ATM O 0 0.00020172317454125732
germline O 0 3.410985755181173e-06
mutations O 0 4.397875952300012e-10
in O 0 6.6378335120131915e-12
classical O 0 3.0446665277850116e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.31461870670318604
in O 0 2.575408853192074e-12
the O 0 2.898636463233989e-13
Dutch O 0 1.7260038884248097e-11
population O 0 4.209787629171763e-15
. O 0 1.0542316802517049e-12

Germline O 0 1.9444161807768978e-05
mutations O 0 4.797581776294635e-10
in O 0 2.2786239041450163e-12
the O 0 7.332432404305589e-12
ATM O 0 3.020000463038741e-07
gene O 0 2.890982402472056e-14
are O 0 1.0742188304109284e-16
responsible O 0 9.403021802961947e-16
for O 0 1.7458397246183357e-15
the O 0 4.65833815965766e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.513786677762255e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.642876453586468e-13
. O 0 2.3840195442770273e-11

In O 0 1.024561213647246e-09
our O 0 1.3588307146150669e-09
study O 0 5.320579588886931e-13
, O 0 2.991559009925737e-15
we O 0 1.690493638932674e-15
have O 0 2.7284807276690284e-17
determined O 0 5.315120224372652e-14
the O 0 4.857748318182198e-13
ATM O 0 1.1436180891166714e-08
mutation O 0 7.610425961299128e-13
spectrum O 0 2.2285426976020872e-11
in O 0 1.6161091833267333e-13
19 O 0 7.594392996412846e-12
classical O 0 6.249608386355021e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.8641009836304363e-10
, O 0 7.0869819446251186e-15
including O 0 1.5030563914825097e-16
some O 0 1.0054233438305262e-16
immigrant O 0 6.853865348530053e-14
populations O 0 6.19232626397734e-15
, O 0 1.2564599807159409e-15
as O 0 4.1991400862115974e-14
well O 0 2.0240465119919504e-12
as O 0 1.2152336428816746e-12
12 O 0 1.021158366198982e-10
of O 0 1.205777231533256e-11
Dutch O 0 6.234945199024011e-11
ethnic O 0 1.6096658728148583e-11
origin O 0 1.7092183224320934e-10
. O 0 1.303792185325392e-09

Both O 0 4.485563656619895e-11
the O 0 7.655254902205755e-12
protein O 0 4.2933305565220903e-13
truncation O 0 1.308649855147337e-10
test O 0 3.702893547341546e-11
( O 0 4.708093723909679e-13
PTT O 0 1.640212019538012e-07
) O 0 7.084116855681031e-15
and O 0 1.6213903617550633e-15
the O 0 7.654762105213306e-15
restriction O 0 1.3952699401669627e-15
endonuclease O 0 1.5908686857007276e-13
fingerprinting O 0 1.628689717814158e-11
( O 0 1.652015519824565e-13
REF O 0 7.988733008446047e-10
) O 0 1.0865047256734968e-15
method O 0 2.6712575294102203e-12
were O 0 3.5647716332617985e-13
used O 0 2.735750536699e-13
and O 0 3.231022423894579e-14
compared O 0 8.153590107772002e-13
for O 0 3.2707181147478837e-14
their O 0 2.2368242241083136e-12
detection O 0 1.1859976889461166e-10
efficiency O 0 2.3778975316579576e-11
, O 0 2.111298230700071e-15
identifying O 0 1.904995041920876e-12
76 O 0 2.516803154772873e-10
% O 0 3.126927883290165e-11
and O 0 1.2680166229625707e-14
60 O 0 3.408221621592489e-11
% O 0 3.111566213021e-11
of O 0 6.325676202463548e-13
the O 0 1.960508795237348e-12
mutations O 0 3.7213553636186725e-13
, O 0 5.732938537957033e-13
respectively O 0 1.898693202662116e-09
. O 0 1.9401646511596482e-08

Most O 0 1.9875821821724315e-10
patients O 0 2.7686353210043535e-11
were O 0 8.496851659767213e-12
found O 0 3.856526101068958e-13
to O 0 7.482226101716838e-13
be O 0 3.190388057905391e-12
compound O 0 7.410442814936857e-10
heterozygote O 0 6.2818656942909e-08
. O 0 1.0160419172677848e-08

Seventeen O 0 2.1802175353968778e-07
mutations O 0 1.3048612190758035e-10
were O 0 9.429334917043786e-12
distinct O 0 1.1413516616196051e-12
, O 0 2.937730150831021e-14
of O 0 5.790026661248171e-13
which O 0 2.3040382485071823e-15
10 O 0 1.3344235655701753e-12
were O 0 7.625206889516623e-12
not O 0 5.220856299364973e-13
reported O 0 7.674030161330947e-11
previously O 0 4.788433205504816e-09
. O 0 2.4118584462939907e-08

Mutations O 0 5.659098292198905e-07
are O 0 4.210495146983462e-11
small O 0 4.812105228180208e-11
deletions O 0 1.1680058698004814e-08
or O 0 1.0603603328718236e-08
point O 0 8.109598638839088e-06
mutations O 0 1.1828046098116829e-08
frequently O 0 5.768265864958266e-10
affecting O 0 1.4156850136615162e-09
splice O 0 4.084712088570086e-07
sites O 0 2.1710503617100585e-08
. O 0 2.7971376326263453e-08

Moreover O 0 2.0739875594699697e-07
, O 0 2.35902374023933e-11
a O 0 2.899767578834478e-11
16 O 0 1.5879403347796028e-09
. O 0 4.205146009184091e-09

7 O 0 1.301606289416668e-08
- O 0 2.5300448402987286e-09
kb O 0 2.503701068690134e-08
genomic O 0 9.260801570043498e-10
deletion O 0 6.299654131680654e-10
of O 0 8.116797234336559e-10
the O 0 3.249419483486449e-11
3 O 0 2.155984939189448e-11
end O 0 2.1978603381711537e-09
of O 0 1.3098152770729676e-11
the O 0 7.101579307250416e-12
gene O 0 2.301756604327493e-13
, O 0 7.325379452333136e-14
most O 0 2.3978425310860335e-14
likely O 0 6.437045341201042e-12
a O 0 9.176110392361547e-13
result O 0 3.809899271067785e-11
of O 0 1.558506657062253e-10
recombination O 0 1.4527481648207718e-11
between O 0 4.268610118152161e-11
two O 0 5.049373679594238e-12
LINE O 0 1.768852975203572e-08
elements O 0 1.8571789939247907e-11
, O 0 1.8155750069592108e-13
was O 0 5.269851395539593e-12
identified O 0 1.9881203627836186e-10
. O 0 1.1835080693245459e-09

The O 0 4.083938076604454e-09
most O 0 2.730497251912656e-12
frequently O 0 1.4292156867712347e-12
found O 0 4.2641142895295803e-13
mutation O 0 1.2491039019096872e-13
, O 0 2.427309917936416e-15
identified O 0 6.755671326172386e-13
in O 0 4.487233948671267e-14
three O 0 4.6770337033602213e-14
unrelated O 0 8.42768617479589e-13
Turkish O 0 1.9674830653571007e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999306201934814
T I-Disease 1 1.0
individuals O 0 8.869637663222463e-12
, O 0 1.1073267818092689e-13
was O 0 2.8321180036566806e-12
previously O 0 1.244916171018462e-12
described O 0 3.9252260635087334e-15
to O 0 3.309851121614327e-15
be O 0 1.1879597909967752e-15
a O 0 1.9109601155978522e-15
Turkish O 0 7.434822757446113e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 1.1472123162548087e-07
mutation O 0 1.112799963287614e-09
. O 0 2.6457142032754177e-10

The O 0 9.187791860654215e-09
presence O 0 7.428553605581811e-11
of O 0 9.386421639945297e-10
a O 0 3.4725822217751556e-10
founder O 0 7.022818326873903e-09
mutation O 0 7.060350221133049e-11
among O 0 8.432714433421334e-14
relatively O 0 4.4977416973138173e-13
small O 0 3.788962602734513e-15
ethnic O 0 2.2453251009770664e-13
population O 0 7.511943456460285e-16
groups O 0 1.2943423116720278e-16
in O 0 4.253438286262387e-14
Western O 0 1.199083193847983e-10
Europe O 0 2.5260115180114617e-11
could O 0 3.6281644355540266e-11
indicate O 0 5.881159448328788e-10
a O 0 8.020129699248812e-12
high O 0 6.535721183004162e-12
carrier O 0 3.2664942799243146e-12
frequency O 0 1.0627525248718683e-10
in O 0 2.07907606061819e-12
such O 0 1.2264783372933907e-12
communities O 0 1.0726783350456515e-10
. O 0 4.064619307797557e-09

In O 0 1.4713945617472746e-09
patients O 0 1.8178647476219112e-10
of O 0 4.9442002575394994e-11
Dutch O 0 2.3000486237823026e-10
ethnic O 0 8.209397571457e-12
origin O 0 4.361683323544918e-12
, O 0 7.69821828353924e-15
however O 0 2.0280954379000432e-13
, O 0 1.827923019382966e-14
no O 0 5.153281366085741e-14
significant O 0 1.067244708406745e-12
founder O 0 1.2741620258882591e-11
effect O 0 7.488750830390856e-13
could O 0 2.5522106129882705e-12
be O 0 3.1881022127810965e-11
identified O 0 1.1106546793371308e-08
. O 0 1.9469931444859867e-08

The O 0 1.9315089527793816e-09
observed O 0 8.272115631369203e-11
genetic O 0 1.1376551610486896e-11
heterogeneity O 0 3.6296667060842225e-11
including O 0 1.8555686501220414e-14
the O 0 2.8143798055935143e-12
relative O 0 1.3024200606892578e-09
high O 0 7.662023099319626e-11
percentage O 0 1.992083303870018e-10
of O 0 3.667803907814182e-11
splice O 0 5.655872215015734e-08
- O 0 1.1427736534841415e-09
site O 0 1.4109136081685847e-09
mutations O 0 1.400787957850369e-10
had O 0 2.0465200714636644e-11
no O 0 5.275390584438822e-13
reflection O 0 2.144084389199552e-11
on O 0 6.168629409358806e-12
the O 0 8.229401535220227e-12
phenotype O 0 8.408704288420665e-10
. O 0 2.18309126331917e-09

All O 0 6.713955086334877e-11
patients O 0 1.013268570611292e-12
manifested O 0 1.3898139366794182e-12
classical O 0 2.338274018853781e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999667406082153
T I-Disease 1 0.9999996423721313
and O 0 5.973616783519486e-13
increased O 0 1.2421724239486398e-11
cellular O 0 9.026617994734032e-12
radioresistant O 0 1.723281101151386e-10
DNA O 0 9.307977721917382e-10
synthesis O 0 1.7281007735903131e-09
. O 0 1.5985917034555541e-09

Determination O 0 2.906362226440251e-07
of O 0 2.763773432334915e-09
the O 0 2.4772201651090953e-11
genomic O 0 3.22188414836333e-10
structure O 0 4.7190372269578784e-12
of O 0 1.3656151947108452e-12
the O 0 1.5488297493496117e-12
COL4A4 O 0 1.0464781553309876e-05
gene O 0 1.7450891263721263e-13
and O 0 2.6828709813095895e-14
of O 0 4.200282049254822e-12
novel O 0 5.832562210983383e-11
mutations O 0 2.9362666964516393e-07
causing O 0 1.454031553294044e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.2149554322604672e-06

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.1598461774342539e-10
a O 0 1.0705246689113324e-09
progressive O 1 0.9999998807907104
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 3.3028257462319743e-07
by O 0 3.3116845377101356e-10
glomerular B-Disease 1 0.8149321675300598
basement I-Disease 1 0.9984205961227417
membrane I-Disease 0 6.467973889812129e-07
abnormalities I-Disease 0 5.0896185712190345e-05
and O 0 2.30937404616105e-12
associated O 0 2.601429072157657e-10
with O 0 5.442828262744448e-13
mutations O 0 6.597489481813268e-13
in O 0 3.6211024413354553e-13
either O 0 4.078350938213626e-12
the O 0 2.079204169946891e-11
COL4A3 O 0 0.04467437416315079
or O 0 1.1661537620971663e-12
the O 0 1.8859289130368495e-11
COL4A4 O 0 2.1400308469310403e-05
gene O 0 4.621965245428516e-13
, O 0 1.4046965698369558e-14
which O 0 6.60846211601859e-16
encode O 0 9.244221707560563e-12
the O 0 1.6820446077647766e-11
alpha3 O 0 1.9190672162494593e-07
and O 0 2.982301558485112e-11
alpha4 O 0 3.6070429132450954e-07
type O 0 8.726212641363418e-09
IV O 0 4.548904689727351e-05
collagen O 0 1.490564329742483e-07
chains O 0 1.5046049961497943e-09
, O 0 6.613720855697114e-12
respectively O 0 1.0555093687969475e-08
. O 0 1.514689529358293e-08

To O 0 9.85079906534736e-10
date O 0 5.804136726794695e-09
, O 0 5.141561547176987e-13
mutation O 0 5.035595624833765e-14
screening O 0 1.0921593355172829e-13
in O 0 3.6270313331530565e-14
the O 0 7.535978134923238e-13
two O 0 8.043855837490399e-13
genes O 0 1.9011365832294347e-12
has O 0 1.9201163299994344e-15
been O 0 7.603080898156353e-14
hampered O 0 5.3043982539691115e-09
by O 0 1.4418730152985365e-13
the O 0 4.9962989474849895e-12
lack O 0 3.0465693856562837e-10
of O 0 6.989772909776759e-12
genomic O 0 5.580247930403459e-10
structure O 0 1.0255852417317968e-10
information O 0 2.562553780283139e-10
. O 0 1.4375893808704632e-09

We O 0 3.9434561172058125e-10
report O 0 6.257897303650617e-13
here O 0 2.781314132997703e-13
the O 0 4.262483242886347e-15
complete O 0 2.725512740844871e-12
characterization O 0 1.0872739340805904e-11
of O 0 1.3179114917438728e-12
the O 0 2.35844677121122e-12
48 O 0 4.797529484790175e-09
exons O 0 3.926586167324331e-09
of O 0 3.5655915719967624e-11
the O 0 3.987656038706433e-11
COL4A4 O 0 0.003612498054280877
gene O 0 3.741313248789568e-12
, O 0 1.1972691447200562e-13
a O 0 1.0426944409887978e-13
comprehensive O 0 1.6512548273173167e-11
gene O 0 7.124812892445043e-14
screen O 0 2.7102110486398878e-11
, O 0 4.354839785222081e-13
and O 0 1.4895934962941282e-13
the O 0 1.6693550838539628e-12
subsequent O 0 3.182033109228044e-11
detection O 0 3.0069680079236605e-09
of O 0 3.690496259284304e-12
10 O 0 1.5097224685678423e-12
novel O 0 2.2125635606431646e-14
mutations O 0 2.5065618526089184e-13
in O 0 7.027221822020549e-14
eight O 0 3.665586931211884e-11
patients O 0 9.237633574743498e-11
diagnosed O 0 4.38572591576758e-08
with O 0 2.904795293190432e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.322458954040485e-07

Furthermore O 0 1.2075465960492693e-08
, O 0 4.215531135970396e-12
we O 0 1.0980877665489608e-12
identified O 0 5.192476223297993e-12
a O 0 7.258844675513132e-13
glycine O 0 1.2939111587728647e-11
to O 0 9.638851349025312e-12
alanine O 0 1.503336344299555e-10
substitution O 0 1.55432083870366e-10
in O 0 6.495530675831862e-12
the O 0 9.286869884217452e-11
collagenous O 0 6.109859214120661e-07
domain O 0 6.673067098894592e-10
that O 0 5.236268741466623e-15
is O 0 1.5828894320496847e-14
apparently O 0 3.2478582323580696e-11
silent O 0 8.670356099749199e-12
in O 0 1.1798049516509312e-13
the O 0 2.1891590103184644e-12
heterozygous O 0 5.285443957503411e-12
carriers O 0 4.564233106046922e-13
, O 0 2.4858983144540603e-13
in O 0 7.72171476065564e-12
11 O 0 4.2564844981995975e-09
. O 0 2.312499702838977e-08

5 O 0 2.365902140866183e-09
% O 0 1.0555530893796572e-09
of O 0 3.391444243494579e-12
all O 0 2.5793353997799473e-13
control O 0 5.409982531401347e-11
individuals O 0 2.788834633604513e-14
, O 0 3.3675183952128207e-15
and O 0 1.8078740883346357e-15
in O 0 5.971552462583074e-14
one O 0 2.3106188051227536e-14
control O 0 1.727046999334958e-12
individual O 0 1.1310766369733785e-13
homozygous O 0 1.5293522741613441e-12
for O 0 6.821678096534389e-14
this O 0 5.432809150468509e-13
glycine O 0 2.377507565820558e-11
substitution O 0 1.5379862661202282e-10
. O 0 2.45907494367259e-09

There O 0 4.188126512261192e-10
has O 0 2.3946341396884237e-14
been O 0 1.2700570406292116e-14
no O 0 2.2914252926478553e-15
previous O 0 1.089540350301954e-12
finding O 0 7.153893363115449e-12
of O 0 1.74778485954874e-12
a O 0 5.649356850379039e-13
glycine O 0 5.0303979731713966e-12
substitution O 0 5.204732044655769e-12
that O 0 3.126039042829513e-15
is O 0 1.2365320483241258e-15
not O 0 3.945582806330096e-15
associated O 0 1.241179576651208e-12
with O 0 1.3463846194623069e-14
any O 0 6.94494483623187e-13
obvious O 0 5.5911972968170076e-11
phenotype O 0 9.95875430731541e-12
in O 0 3.050705033643547e-13
homozygous O 0 3.2369860264447325e-11
individuals O 0 4.7618133394711215e-12
. O 0 8.70526672969163e-09

Founder O 0 6.342705546558136e-06
BRCA1 O 0 5.314001327860751e-08
and O 0 2.9095753584229556e-10
BRCA2 O 0 3.0523639171775585e-09
mutations O 0 1.8534446980661423e-12
in O 0 9.995552562730436e-13
French O 0 4.0995445926839125e-10
Canadian O 0 5.488926149155304e-07
breast B-Disease 1 0.9998314380645752
and I-Disease 1 0.9999412298202515
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.249417427994786e-09
. O 0 1.23747083691228e-08

We O 0 3.5032038381288544e-10
have O 0 8.946391804459664e-14
identified O 0 7.833965681020016e-13
four O 0 5.451053427000738e-14
mutations O 0 1.2793763512247876e-14
in O 0 1.6032281754209182e-15
each O 0 4.3082579197955065e-14
of O 0 7.177212990594484e-11
the O 0 1.6071037833853552e-08
breast B-Disease 0 9.673103704699315e-07
cancer I-Disease 0 8.89106286194874e-06
- O 0 0.0006179661140777171
susceptibility O 0 4.537490383427212e-09
genes O 0 5.4485881084698207e-11
, O 0 2.9738136866214182e-12
BRCA1 O 0 2.4070233653472606e-12
and O 0 1.5751679474651503e-13
BRCA2 O 0 2.9449027851707887e-12
, O 0 4.027487080681324e-15
in O 0 7.105877132095994e-15
French O 0 1.4101635440952331e-12
Canadian O 0 2.094425605170258e-10
breast B-Disease 0 2.6234986405526683e-10
cancer I-Disease 0 4.663414099326246e-10
and O 0 5.0872010604052775e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.8548901020997164e-09
from O 0 2.2692753232078644e-10
Quebec O 0 3.849515373133272e-09
. O 0 1.1542854450041773e-09

To O 0 8.768762427280308e-08
identify O 0 7.224145406325988e-07
founder O 0 4.386964036484642e-08
effects O 0 7.505282617614739e-09
, O 0 1.2641782152350567e-12
we O 0 4.4457482400311887e-13
examined O 0 9.219446386876662e-12
independently O 0 3.352880820206572e-11
ascertained O 0 2.2047240422207182e-10
French O 0 1.6595073839414942e-12
Canadian O 0 6.93181068101012e-11
cancer B-Disease 0 4.0282156950344206e-12
families O 0 4.677203109949672e-14
for O 0 6.309186317512332e-15
the O 0 3.7225671628343324e-14
distribution O 0 2.1145979932357672e-12
of O 0 3.308693108990818e-13
these O 0 1.2468498455930899e-13
eight O 0 2.4508090001873484e-10
mutations O 0 2.1169406505539e-10
. O 0 4.028083644413982e-09

Mutations O 0 2.0449039794812052e-08
were O 0 1.2202262811289444e-10
found O 0 5.916749295370449e-13
in O 0 9.831332525422204e-14
41 O 0 1.8291615444532283e-10
of O 0 3.078049967686347e-11
97 O 0 2.8336417656760204e-08
families O 0 1.2800746573837785e-10
. O 0 1.3824958067232274e-08

Six O 0 6.210797653949385e-09
of O 0 2.1590107479596554e-10
eight O 0 1.6181225803713062e-10
mutations O 0 4.1571633288550736e-12
were O 0 1.0350884212251277e-11
observed O 0 9.08350434800087e-13
at O 0 4.991422639794019e-12
least O 0 7.521302374316474e-13
twice O 0 1.6906720468057301e-10
. O 0 6.9130425828234365e-09

The O 0 3.698480455227582e-08
BRCA1 O 0 4.118420804388734e-08
C4446T O 0 4.0996667394210817e-07
mutation O 0 4.583010707048807e-11
was O 0 6.93696575876368e-12
the O 0 1.3369610323346603e-12
most O 0 8.186029301247497e-14
common O 0 6.315946572167663e-13
mutation O 0 7.025804634255839e-13
found O 0 1.6766586220535312e-13
, O 0 1.3544898565587596e-15
followed O 0 2.8986131528872805e-14
by O 0 1.8991085153031648e-14
the O 0 2.6620931153908955e-11
BRCA2 O 0 2.2729931270504267e-09
8765delAG O 0 1.9630046921292887e-08
mutation O 0 3.306023510507572e-10
. O 0 1.9983938948087143e-09

Together O 0 4.450236623654291e-09
, O 0 1.578555428732864e-12
these O 0 4.859803423400144e-14
mutations O 0 1.0147689166826318e-13
were O 0 2.954752870328037e-13
found O 0 9.394529662391012e-15
in O 0 4.751626135200866e-15
28 O 0 8.096209466734727e-12
of O 0 3.4810071491975236e-12
41 O 0 2.949841759747329e-10
families O 0 2.1064545507182286e-12
identified O 0 1.6228787411143308e-11
to O 0 3.1540683259612123e-11
have O 0 5.993135241549874e-12
a O 0 7.266941909334079e-11
mutation O 0 3.6698702410298267e-10
. O 0 5.000835745505583e-09

The O 0 5.062110286502275e-09
odds O 0 7.104465282736783e-08
of O 0 1.6732332186464305e-10
detection O 0 4.472533632338127e-08
of O 0 6.035778127300162e-11
any O 0 2.620800061345352e-12
of O 0 2.889448923182325e-11
the O 0 8.033464518608646e-12
four O 0 1.3821666901281393e-11
BRCA1 O 0 3.50143213034837e-11
mutations O 0 1.7406612446996955e-13
was O 0 5.4067817931158224e-12
18 O 0 4.946381637616071e-10
. O 0 2.6393547347680624e-09

7x O 0 6.83203834341839e-05
greater O 0 4.860909452730766e-09
if O 0 2.1021087648342984e-11
one O 0 1.9927880959974553e-12
or O 0 1.2359439914653297e-13
more O 0 9.812718934054643e-16
cases O 0 2.4209502675134886e-13
of O 0 2.279706734498177e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 2.125673193020816e-09
also O 0 3.0990048851750607e-14
present O 0 1.8862292099335737e-13
in O 0 1.78124659119816e-13
the O 0 1.1202695889001024e-11
family O 0 1.4303126391612686e-11
. O 0 2.812859944967272e-09

The O 0 6.062645052651305e-09
odds O 0 7.742539054333974e-08
of O 0 7.721424194473414e-11
detection O 0 2.2641023278424655e-08
of O 0 1.0252977633573579e-10
any O 0 3.5833569184823277e-12
of O 0 2.752691304064303e-11
the O 0 1.8842956708842173e-12
four O 0 6.323520266443561e-12
BRCA2 O 0 5.527744234568033e-11
mutations O 0 1.1572640632243059e-12
was O 0 6.5937064835930315e-12
5 O 0 3.6231667666086764e-10
. O 0 2.382876340689677e-09

3x O 0 2.198198126279749e-05
greater O 0 4.427966326936428e-10
if O 0 1.6163720752485067e-12
there O 0 2.2551752132393688e-13
were O 0 8.405547850635908e-13
at O 0 4.569738684678804e-13
least O 0 1.1985526368043717e-14
five O 0 1.9716140273683645e-14
cases O 0 7.001574342004047e-14
of O 0 2.1587873849648886e-11
breast B-Disease 0 2.1972768049494107e-10
cancer I-Disease 0 2.6539206596232212e-11
in O 0 6.834138116529331e-11
the O 0 8.505588233731487e-09
family O 0 1.0203177192025237e-09
. O 0 4.692953936569211e-08

Interestingly O 0 2.7521075196546008e-08
, O 0 5.948319636329968e-13
the O 0 1.5096908098644057e-12
presence O 0 1.0615034242225652e-12
of O 0 2.4347301952332145e-10
a O 0 4.718945234571947e-09
breast B-Disease 0 7.619882502751807e-09
cancer I-Disease 0 9.9206712289579e-11
case O 0 4.74090601845778e-12
< O 0 1.024699991525324e-09
36 O 0 2.1469172273302917e-10
years O 0 7.150151781418201e-13
of O 0 3.986344132393682e-13
age O 0 8.382445128643501e-13
was O 0 5.396802999608173e-14
strongly O 0 7.175990072546732e-16
predictive O 0 2.235106717762836e-11
of O 0 1.3098121762547543e-12
the O 0 9.35207857336029e-13
presence O 0 1.4708190448995545e-13
of O 0 2.0438858938653937e-12
any O 0 9.81265958245603e-13
of O 0 1.0463234445534653e-11
the O 0 7.989669689734136e-12
eight O 0 1.5073790826658495e-10
mutations O 0 3.756515064290422e-12
screened O 0 6.489737913728533e-11
. O 0 2.589460423862988e-09

Carriers O 0 5.422506332841692e-10
of O 0 2.9968663661783523e-10
the O 0 2.222421725817103e-11
same O 0 8.969091094823689e-12
mutation O 0 2.444754739362037e-13
, O 0 1.0080237349785969e-15
from O 0 6.384019137303408e-15
different O 0 9.719407624651094e-14
families O 0 5.520215903311032e-13
, O 0 1.623675084899516e-14
shared O 0 1.6967954818980502e-12
similar O 0 4.2998701929759797e-13
haplotypes O 0 6.766613658282239e-11
, O 0 5.539675706003888e-13
indicating O 0 1.5589161905804616e-11
that O 0 1.192195993348407e-14
the O 0 4.960092124355053e-13
mutant O 0 1.3728886734051815e-12
alleles O 0 5.143149903359678e-13
were O 0 3.4149874768296673e-12
likely O 0 1.7449170363822986e-12
to O 0 2.6045035269109396e-13
be O 0 1.268476832903473e-13
identical O 0 6.40972138647028e-13
by O 0 1.5252434189781672e-14
descent O 0 1.325324516798787e-09
for O 0 2.1035838002059215e-12
a O 0 4.994688690418414e-12
mutation O 0 8.694563081654283e-13
in O 0 1.6296079069499925e-13
the O 0 3.136351638469148e-12
founder O 0 1.521434367379726e-10
population O 0 3.688861824509282e-13
. O 0 8.150985442156866e-11

The O 0 5.982505463242305e-11
identification O 0 9.002079082165437e-09
of O 0 3.5575095647111254e-10
common O 0 9.518205668079815e-11
BRCA1 O 0 3.9651931738049484e-10
and O 0 3.199023684841151e-11
BRCA2 O 0 3.6189812258058396e-10
mutations O 0 4.850397427452746e-13
will O 0 2.7081879490700733e-13
facilitate O 0 1.0111517179112184e-10
carrier O 0 3.117552657000422e-12
detection O 0 1.3125851516804232e-09
in O 0 1.0202505507095339e-11
French O 0 5.699280491988645e-10
Canadian O 0 2.5256202462742294e-08
breast B-Disease 0 2.5272877124393744e-08
cancer I-Disease 0 2.1139086925359152e-08
and O 0 6.584257789654657e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4472025355871665e-08
. O 0 6.34764951712441e-09

Are O 0 2.0282649171310396e-10
Dp71 O 0 4.105952939426061e-06
and O 0 1.3970630208248735e-10
Dp140 O 0 1.1303889550617896e-05
brain O 0 4.498560429055942e-06
dystrophin O 0 3.807304338465656e-08
isoforms O 0 3.837117568128434e-10
related O 0 1.9705241605105783e-10
to O 0 1.2399503646065568e-10
cognitive B-Disease 0 1.948948010976892e-05
impairment I-Disease 0 0.0005704896757379174
in O 0 1.3887006389268208e-06
Duchenne B-Disease 1 0.9999938011169434
muscular I-Disease 1 0.9998306035995483
dystrophy I-Disease 1 0.9999997615814209
? O 0 0.06510761380195618

Molecular O 0 2.149721289868012e-09
study O 0 5.4185922242211415e-12
and O 0 4.759338200779027e-14
neuropsychological O 0 5.6629988892664684e-11
analysis O 0 1.7494691676236962e-12
were O 0 1.6666182323099576e-13
performed O 0 3.890318243330443e-13
concurrently O 0 3.559447007972505e-12
on O 0 1.0839314472030348e-12
49 O 0 1.6315448991832682e-10
patients O 0 4.164305619086539e-12
with O 0 2.0853553259203572e-12
Duchenne B-Disease 1 0.9482139348983765
muscular I-Disease 1 0.9999786615371704
dystrophy I-Disease 1 1.0
( O 0 2.279094388768499e-07
DMD B-Disease 1 1.0
) O 0 9.229898095819422e-12
in O 0 1.2555269866300345e-13
order O 0 6.349995263768213e-14
to O 0 4.158556908117478e-13
find O 0 1.5765245012233642e-12
a O 0 1.3097307933291821e-14
molecular O 0 1.734781480793035e-13
explanation O 0 3.3120394989961943e-13
for O 0 5.3085953601733626e-14
the O 0 5.994678278081755e-12
cognitive B-Disease 0 5.799093472091954e-08
impairment I-Disease 0 1.199836563436918e-09
observed O 0 1.3203771843245393e-12
in O 0 2.1357364661522826e-12
most O 0 6.563119492319913e-11
DMD B-Disease 1 1.0
patients O 0 4.165328526539724e-09
. O 0 3.2687428319633227e-09

Complete O 0 6.037626842925192e-09
analysis O 0 9.32641464057582e-12
of O 0 2.9508966884611576e-12
the O 0 8.879027070876622e-13
dystrophin O 0 1.5340692605114725e-10
gene O 0 8.314035630741998e-14
was O 0 1.1916811938281202e-12
performed O 0 1.4624333645116283e-12
to O 0 3.958788592078877e-12
define O 0 9.193672212415294e-11
the O 0 2.168241280964267e-11
localization O 0 1.3604519608634291e-06
of O 0 2.420345701636961e-09
deletions O 0 1.5234649097806141e-09
and O 0 1.7768914811755465e-11
duplications O 0 2.145846877965596e-08
in O 0 9.465987022005962e-12
relation O 0 1.2278207617288928e-10
to O 0 8.114157783178921e-12
the O 0 7.917460090323125e-12
different O 0 7.403347379586478e-11
DMD B-Disease 1 1.0
promoters O 0 9.093649566693784e-08
. O 0 1.8565550874427572e-08

Qualitative O 0 8.089679681688722e-08
analysis O 0 8.704925669178465e-11
of O 0 9.6339672350787e-11
the O 0 8.183699551356227e-11
Dp71 O 0 8.034910479182145e-07
transcript O 0 4.283848276109836e-10
and O 0 5.23856631833605e-15
testing O 0 2.3460613741413047e-14
for O 0 5.649283065339004e-16
the O 0 2.138404132045156e-14
specific O 0 8.148330914083818e-14
first O 0 8.789173382151017e-12
exon O 0 9.727699756822972e-10
of O 0 1.9735671430431978e-10
Dp140 O 0 3.148156793031376e-07
were O 0 1.0985183596101677e-10
also O 0 1.1588229291079055e-13
carried O 0 1.2469557504612983e-11
out O 0 2.861569271470077e-12
. O 0 4.447638091154005e-10

Neuropsychological O 0 3.91691685308615e-07
analysis O 0 3.521920949323132e-11
assessed O 0 2.7218527431926987e-10
verbal O 0 3.57555185459546e-09
and O 0 3.032248757639522e-11
visuospatial O 0 0.058472953736782074
intelligence O 0 1.2206394117697528e-08
, O 0 3.1285352997470484e-13
verbal O 0 2.929706199861215e-10
memory O 0 1.3024477993894834e-06
, O 0 5.518552737178439e-13
and O 0 9.48039661097938e-14
reading O 0 1.1614290779116132e-10
skills O 0 3.261297081280645e-07
. O 0 2.0167276737481643e-09

Comparison O 0 1.6043112793795444e-07
of O 0 1.6820440151832372e-08
molecular O 0 3.1025142455121113e-09
and O 0 2.665503928689361e-10
psychometric O 0 6.84941667827843e-08
findings O 0 6.730958151957012e-11
demonstrated O 0 9.459561606250944e-12
that O 0 3.6305610888508547e-14
deletions O 0 1.0863618164769218e-11
and O 0 1.0984496732341364e-13
duplications O 0 2.123606623882779e-09
that O 0 8.987713459758517e-14
were O 0 8.523618443001535e-12
localized O 0 1.0153512752797411e-10
in O 0 1.5797300533665348e-12
the O 0 4.0363237058249624e-11
distal O 0 1.1260444807703607e-06
part O 0 7.618585207147532e-10
of O 0 1.8711626026401973e-08
the O 0 7.505081889291887e-09
gene O 0 1.8572712812137127e-11
seemed O 0 3.2606836675164175e-10
to O 0 7.1268455546780185e-12
be O 0 5.6348211686929606e-12
preferentially O 0 1.0336882044770235e-10
associated O 0 3.739847043160438e-10
with O 0 3.0773810583140104e-11
cognitive B-Disease 0 0.009986520744860172
impairment I-Disease 0 2.5390403607161716e-05
. O 0 6.351528014647556e-08

Two O 0 1.7102399496593534e-09
altered O 0 2.5440396456133385e-09
Dp71 O 0 1.1367716297172592e-06
transcripts O 0 1.0319511911660584e-09
and O 0 1.4286617407762575e-13
two O 0 3.8691987981620546e-13
deleted O 0 2.1427394580886272e-11
Dp140 O 0 7.854471933965712e-11
DNA O 0 1.705384618244654e-11
sequences O 0 1.274676029875202e-13
were O 0 5.044019130324984e-13
found O 0 4.17895766277078e-14
in O 0 1.4943680516112112e-14
four O 0 5.959345972424146e-13
patients O 0 1.5132137079834629e-12
with O 0 8.32446579116658e-13
severe O 0 0.0011786854593083262
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 0.8076720833778381
. O 0 3.851445944746956e-05

These O 0 2.4800392295354357e-10
findings O 0 1.8566195456037882e-11
suggest O 0 5.161901722033901e-13
that O 0 4.812203284610534e-16
some O 0 1.932253809207776e-16
sequences O 0 1.2858794974993093e-13
located O 0 9.334271230303573e-14
in O 0 3.329062082967939e-14
the O 0 7.593595890975635e-12
distal O 0 4.310885231006978e-07
part O 0 5.103279465679122e-10
of O 0 8.337194046248442e-09
the O 0 2.1371291403227133e-09
gene O 0 3.0314607161324725e-12
and O 0 1.3345820976118361e-11
, O 0 4.1656061195924354e-13
in O 0 4.93353188163459e-13
particular O 0 1.5825408474987035e-12
, O 0 2.3129337461675996e-14
some O 0 9.810783506121815e-14
DMD B-Disease 1 1.0
isoforms O 0 1.2552038297641843e-09
expressed O 0 2.923892031270192e-12
in O 0 1.4843482346038606e-11
the O 0 5.475197517590402e-10
brain O 0 3.330863762585068e-07
may O 0 3.283585209290507e-12
be O 0 2.46932547109599e-13
related O 0 8.423933772760961e-11
to O 0 2.8748317962290493e-11
the O 0 1.8022530690053884e-10
cognitive B-Disease 0 1.0523210676183226e-06
impairment I-Disease 0 8.238994375631137e-09
associated O 0 3.067326670436188e-10
with O 0 2.4824135802514746e-11
DMD B-Disease 1 1.0
. O 0 1.1286307444180466e-09
. O 0 1.1474585726034547e-09

I1307K O 0 5.784406312159263e-06
APC O 0 5.387460433325941e-08
and O 0 1.1372126330899679e-11
hMLH1 O 0 9.44459799256947e-08
mutations O 0 1.0072685741047138e-11
in O 0 3.64096502513539e-13
a O 0 3.596693797826289e-13
non O 0 2.4220714323064385e-10
- O 0 1.196923376384218e-11
Jewish O 0 3.3215431273492246e-12
family O 0 1.757012504238764e-13
with O 0 7.227035877838302e-15
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00010696128447307274

We O 0 8.237937554333996e-10
describe O 0 9.734189843069174e-11
a O 0 1.136409759697199e-12
French O 0 4.463968257539808e-12
Canadian O 0 1.242184965999371e-10
hereditary B-Disease 1 0.9999991655349731
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 7.998303408474072e-11
HNPCC B-Disease 1 0.852847695350647
) O 0 1.3932722163489952e-12
kindred O 0 1.774031699319778e-09
which O 0 1.8626534030994658e-14
carries O 0 9.995433300491463e-14
a O 0 8.075237730559813e-15
novel O 0 3.2644233046970686e-14
truncating O 0 5.708505890211768e-10
mutation O 0 8.210179931744666e-12
in O 0 1.6009487138757272e-11
hMLH1 O 0 2.9437583748403995e-07
. O 0 2.7844421879308356e-08

Interestingly O 0 3.120448788251906e-09
, O 0 2.3007732329570485e-13
the O 0 8.963237595714657e-13
I1307K O 0 2.6789863660781066e-09
APC O 0 4.091257055360842e-10
polymorphism O 0 1.1919830678053245e-09
, O 0 8.396090084034774e-14
associated O 0 2.189001410690672e-11
with O 0 9.844298228152415e-14
an O 0 3.041883354904483e-14
increased O 0 2.1804049885054688e-11
risk O 0 2.0108894549508705e-09
of O 0 0.00023554038489237428
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.4142043919539447e-09
is O 0 3.354954524912787e-14
also O 0 2.5582207657586994e-15
present O 0 2.0258065515886547e-13
in O 0 7.54627277007626e-14
this O 0 2.866396898483503e-13
family O 0 5.961020305839115e-12
. O 0 1.0007815687274046e-09

The O 0 6.355330484097976e-09
I1307K O 0 6.980792477406794e-07
polymorphism O 0 1.7488622106043294e-08
has O 0 4.186767984170822e-14
previously O 0 7.553419153170926e-13
only O 0 3.3081219038525074e-15
been O 0 2.7535167478357978e-14
identified O 0 8.875991846894749e-14
in O 0 6.060405964640166e-15
individuals O 0 3.9278720250293664e-14
of O 0 2.8890024053596086e-11
self O 0 2.1231215896477806e-08
- O 0 2.4540005583162383e-09
reported O 0 2.7472690788954424e-10
Ashkenazi O 0 2.2204421412652664e-08
Jewish O 0 2.918913721838834e-10
origins O 0 4.037398415590587e-09
. O 0 2.20653406657334e-09

In O 0 3.54764384535855e-10
addition O 0 2.0714220269613115e-11
, O 0 8.772918101609267e-14
in O 0 5.977272306669293e-14
this O 0 7.346563407530787e-14
family O 0 9.162992630276645e-13
, O 0 2.0990765617107283e-14
there O 0 9.191900746682944e-15
appears O 0 1.0209931180669637e-13
to O 0 6.57796354278789e-13
be O 0 1.1465516903952366e-11
no O 0 5.612114505754162e-12
relationship O 0 3.005990248383661e-11
between O 0 2.670800212933866e-11
the O 0 6.1839791100359864e-12
I1307K O 0 6.732681079313352e-10
polymorphism O 0 2.0286479440745353e-10
and O 0 6.521394752337373e-14
the O 0 2.7680531478058157e-12
presence O 0 1.017028692165689e-12
or O 0 3.495638240674781e-12
absence O 0 1.7645859218262672e-09
of O 0 1.2360235057684577e-10
cancer B-Disease 0 8.965367337410157e-11
. O 0 3.411701129940603e-11
. O 0 8.274566032362429e-10

Identification O 0 2.893347641474975e-07
of O 0 4.730189573365351e-10
a O 0 8.806956357763907e-13
novel O 0 1.2279540821398104e-14
mutation O 0 4.667978921154073e-14
of O 0 2.9352126198339823e-12
the O 0 1.3977180524094024e-11
CPO O 0 3.637309475834627e-08
gene O 0 7.28730701541995e-14
in O 0 2.4003425657705135e-13
a O 0 1.4311906694486343e-12
Japanese O 0 2.4561732647754297e-09
hereditary B-Disease 0 0.4179181754589081
coproporphyria I-Disease 0 0.008190017193555832
family O 0 8.209561919159114e-10
. O 0 9.739993700463856e-09

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 2.7659687873438088e-08
HCP B-Disease 1 0.9999992847442627
) O 0 3.238789444970358e-11
is O 0 3.1273915748752934e-12
an O 0 3.7074728703734294e-11
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 1.3350506464226974e-11
by O 0 3.242709445687615e-14
a O 0 4.082203325372902e-12
deficiency B-Disease 0 6.328515382847399e-07
of I-Disease 0 2.815964990077191e-07
coproporphyrinogen I-Disease 0 3.3628521123318933e-07
oxidase I-Disease 0 1.1224913143079163e-12
( O 0 1.64627104402024e-14
CPO O 0 2.829972922668844e-09
) O 0 3.002454394726269e-15
caused O 0 4.138722835446548e-15
by O 0 6.122235028745875e-16
a O 0 4.89190664972744e-14
mutation O 0 2.8249178983443674e-14
in O 0 3.3505167498955324e-14
the O 0 7.631972311072932e-12
CPO O 0 3.414857374650637e-08
gene O 0 2.4278842825076197e-11
. O 0 2.0641672815457923e-09

Only O 0 3.359777178690848e-10
11 O 0 3.0024391306504583e-10
mutations O 0 1.923921785773608e-11
of O 0 3.588645700047799e-11
the O 0 1.5400198477566462e-11
gene O 0 3.380147724219018e-13
have O 0 4.2372436939372427e-14
been O 0 1.253928195001433e-13
reported O 0 4.736213049354177e-13
in O 0 1.0813693690492343e-11
HCP B-Disease 0 0.000301768712233752
patients O 0 1.149285333568173e-09
. O 0 2.0163902547665202e-08

We O 0 6.634562343954542e-10
report O 0 1.671738593909955e-12
another O 0 5.493638855456895e-14
mutation O 0 4.9460981236268756e-14
in O 0 6.8306058237984496e-15
a O 0 1.0914783887903262e-13
Japanese O 0 1.2066658783282946e-10
family O 0 1.4136867891589855e-11
. O 0 7.89137089007852e-10

Polymerase O 0 1.2744275079690226e-10
chain O 0 9.003984623862094e-13
reaction O 0 1.798924846433715e-14
- O 0 1.7360965096080427e-12
single O 0 1.6482072596937097e-13
strand O 0 6.04500919264804e-14
conformational O 0 1.3436215979883634e-14
polymorphism O 0 5.781739019841692e-13
and O 0 4.146875315805634e-16
direct O 0 3.304680070174634e-14
sequence O 0 1.4458799554774998e-13
analyses O 0 7.115296307876051e-13
demonstrated O 0 4.444866241563872e-13
a O 0 1.9588557121849592e-13
C O 0 2.967503326400944e-11
to O 0 1.4037526566493264e-12
T O 0 3.2346330475219176e-12
substitution O 0 3.2345959678076186e-12
in O 0 3.372814180724326e-12
exon O 0 4.879110657163288e-11
1 O 0 9.731153599937259e-13
of O 0 5.148747313915569e-12
the O 0 5.670172664729023e-12
CPO O 0 8.509288385027958e-09
gene O 0 5.385348403655864e-14
at O 0 2.9125651543338016e-12
nucleotide O 0 7.354941308768126e-12
position O 0 2.0051510452034904e-10
85 O 0 4.457857194495318e-09
, O 0 4.722735874249095e-13
which O 0 3.0209067533723197e-14
lies O 0 1.4010222669502692e-11
in O 0 1.4205779293782056e-13
the O 0 2.230098918032386e-11
putative O 0 1.238249947022041e-08
presequence O 0 1.1984785608376569e-08
for O 0 1.124782905703725e-11
targeting O 0 1.705936170104394e-09
to O 0 1.4422811389636081e-08
mitochondria O 0 5.853696052326995e-07
. O 0 5.832660221471997e-08

This O 0 1.048496467599691e-12
mutation O 0 2.0385733371015326e-14
changes O 0 2.5694287057167683e-15
the O 0 7.307318507612012e-15
codon O 0 2.2517766731094957e-12
for O 0 3.4122559649813616e-14
glutamine O 0 1.3704012750970218e-11
to O 0 1.4503608817412195e-12
a O 0 1.3534898028744191e-12
termination O 0 1.093631074589041e-09
codon O 0 1.5329359115412444e-08
at O 0 1.6230166099973076e-09
amino O 0 1.0859383392514133e-09
acid O 0 8.548876190284105e-11
position O 0 1.862587306611374e-09
29 O 0 4.18022167991694e-08
. O 0 2.849103530877528e-08

MaeI O 0 5.564837465499295e-06
restriction O 0 7.053310019378145e-11
analysis O 0 1.3623690717223802e-11
showed O 0 1.4955222824020176e-11
two O 0 1.3120010110344131e-14
other O 0 1.1253729500406285e-15
carriers O 0 3.178466147099818e-15
in O 0 3.4835741062611e-14
the O 0 4.663498320151005e-12
family O 0 5.451394544109256e-11
. O 0 4.261586195042355e-09

The O 0 2.6648494522163446e-09
C O 0 2.5899910269799875e-06
- O 0 2.3849105446061003e-07
T O 0 5.692482041297353e-09
mutation O 0 3.399001566317672e-12
is O 0 1.2341576667422062e-14
located O 0 1.1338544307019222e-13
within O 0 3.1799489799179403e-13
a O 0 4.0569567968723116e-14
recently O 0 9.008922995351176e-15
proposed O 0 6.850855840468458e-15
putative O 0 9.907632440159242e-13
alternative O 0 1.7925518383012096e-13
translation O 0 6.878541789975823e-13
initiation O 0 1.687324238663912e-11
codon O 0 6.090550841442166e-10
( O 0 2.2333157458781505e-12
TIC O 0 1.9182053279109823e-07
- O 0 1.8499828335905022e-09
1 O 0 2.4201387421873832e-12
) O 0 2.0860877773327046e-15
, O 0 6.26684578745705e-16
supporting O 0 1.2227702405026141e-14
that O 0 4.595100206372313e-14
TIC O 0 2.0208679174515964e-08
- O 0 6.177147682251416e-10
1 O 0 1.1223441447050231e-11
is O 0 2.66513241732819e-14
the O 0 6.515952057431496e-13
real O 0 2.825423402186278e-11
TIC O 0 1.3350570648995586e-09
rather O 0 5.5006485477626654e-12
than O 0 4.605350931337349e-13
TIC O 0 7.192047846160676e-09
- O 0 1.6364723465223108e-10
2 O 0 3.056449190963484e-12
. O 0 2.541048317941663e-12
. O 0 4.597456790267351e-11

Human B-Disease 0 9.541712975291716e-10
complement I-Disease 0 1.855089415414568e-08
factor I-Disease 0 3.2929122539826494e-07
H I-Disease 1 1.0
deficiency I-Disease 0 0.0007240321137942374
associated O 0 5.354941094992682e-06
with O 0 3.265377745265141e-05
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.34910690784454346

This O 0 4.735890065526993e-12
study O 0 1.0320003450978513e-13
reports O 0 1.5036486528010977e-14
on O 0 2.648672703690555e-14
six O 0 3.1840503812111814e-14
cases O 0 2.14576671182928e-14
of O 0 2.7631908913750003e-11
deficiency B-Disease 0 1.7308519062453342e-09
in I-Disease 0 2.0745286998663515e-12
the I-Disease 0 1.2503655879778086e-12
human I-Disease 0 3.8100385612313895e-14
complement I-Disease 0 7.33600951253327e-13
regulatory I-Disease 0 1.0437441709532091e-11
protein I-Disease 0 1.003331640860028e-12
Factor I-Disease 0 6.831528398532072e-12
H I-Disease 0 0.0001855867449194193
( O 0 6.009119390233339e-14
FH O 0 1.2985786668195942e-08
) O 0 3.1416036967517845e-15
in O 0 4.060468849581512e-15
the O 0 2.750428846874935e-15
context O 0 4.974748911423799e-13
of O 0 1.3286077966967458e-12
an O 0 4.783460086366098e-12
acute B-Disease 1 0.9999828338623047
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.213531049870653e-06

Five O 0 7.985384797848383e-09
of O 0 7.997083550925765e-11
the O 0 4.482591327206048e-13
cases O 0 6.07774684665283e-15
were O 0 3.5557657079160476e-14
observed O 0 4.791671311848208e-15
in O 0 9.49529757223583e-16
children O 0 1.7777961601358723e-15
presenting O 0 1.1564636401284467e-11
with O 0 7.860316564300973e-11
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.550559267750941e-05
HUS B-Disease 1 1.0
) O 0 3.0612321566536593e-09
. O 0 5.2751317980437307e-08

Two O 0 1.5716053458625368e-10
of O 0 5.014747297971134e-11
the O 0 2.449541437743452e-11
children O 0 8.088440941328434e-13
exhibited O 0 1.1053612018752101e-11
a O 0 6.16539805320393e-11
homozygous O 0 2.072500038252656e-08
deficiency O 0 2.424445000315245e-08
characterized O 0 5.469302853493285e-13
by O 0 1.7007151709071827e-13
the O 0 9.633196323965976e-11
absence O 0 1.512965575045655e-08
of O 0 1.2238227098393395e-10
the O 0 1.099741500122653e-12
150 O 0 1.9796878979877475e-12
- O 0 7.008726281634847e-13
kD O 0 1.5755001470108e-11
form O 0 5.649507554481015e-13
of O 0 3.943514265136727e-11
Factor O 0 2.292952633320411e-10
H O 1 0.9999996423721313
and O 0 4.548505235651978e-12
the O 0 1.3278408754480164e-11
presence O 0 9.428281723053433e-14
, O 0 5.597350416551659e-16
upon O 0 4.94305442931553e-13
immunoblotting O 0 9.162324232647734e-10
, O 0 1.2439511463816551e-14
of O 0 4.065510677674772e-13
the O 0 9.759239857215496e-13
42 O 0 4.63370938841301e-11
- O 0 2.483217190901721e-12
kD O 0 5.912310918620989e-11
Factor O 0 3.069502291230819e-11
H O 1 0.9704263806343079
- O 0 5.875085751227971e-09
like O 0 1.3771268196974273e-12
protein O 0 1.51744136461969e-13
1 O 0 1.1753083586658192e-13
( O 0 3.745762651875123e-15
FHL O 0 1.1597151683417906e-07
- O 0 1.870610090437541e-11
1 O 0 7.95210929440196e-14
) O 0 4.867869231112902e-16
and O 0 7.476408306740599e-16
other O 0 1.0868991253895621e-14
FH O 0 2.288699008090589e-08
- O 0 9.533281282447792e-12
related O 0 8.1182789657408e-11
protein O 0 3.4774171389639896e-12
( O 0 2.188896613063932e-15
FHR O 0 1.9964792841165035e-07
) O 0 6.114305974502451e-14
bands O 0 1.958406631308307e-10
. O 0 1.7908159399837587e-09

Southern O 0 6.619500680926649e-08
blot O 0 5.500719879591998e-09
and O 0 8.383028327768344e-15
PCR O 0 4.690948584434862e-12
analysis O 0 2.6831933620493145e-14
of O 0 1.252158980343844e-14
DNA O 0 1.9157083905319006e-11
of O 0 1.1917197914254607e-12
one O 0 1.3024970641969946e-13
patient O 0 3.5173898516038804e-11
with O 0 1.2098744857531873e-13
homozygous O 0 2.3435617335643144e-10
deficiency O 0 9.014238799842644e-10
ruled O 0 3.185561189833486e-11
out O 0 1.0338206527828186e-13
the O 0 8.499858396337004e-14
presence O 0 6.06663157209919e-14
of O 0 1.095157384917167e-12
a O 0 9.367123233756242e-14
large O 0 5.755963688672131e-15
deletion O 0 3.853675191456407e-12
of O 0 6.928529364819136e-12
the O 0 3.86774154370606e-11
FH O 0 2.4622688670206117e-06
gene O 0 5.358703064617387e-12
as O 0 1.8085932870694904e-13
the O 0 5.625274551723791e-12
underlying O 0 3.183476948720454e-08
defect O 0 1.5429975519509753e-08
for O 0 5.978669816164572e-12
the O 0 5.334094499431785e-09
deficiency O 0 8.589947356085759e-06
. O 0 3.286066529994969e-08

The O 0 2.5335400444248535e-10
other O 0 2.653553646345813e-13
four O 0 3.418139794646169e-13
children O 0 3.110052778257746e-15
presented O 0 7.151703139201757e-14
with O 0 2.191370796302862e-14
heterozygous O 0 7.611493380021983e-11
deficiency O 0 7.218984521273342e-09
and O 0 6.922188950514441e-12
exhibited O 0 9.011832946548282e-10
a O 0 4.3510743619190606e-11
normal O 0 7.379968280929461e-08
immunoblotting O 0 1.1778049469057805e-07
pattern O 0 2.1100957092734518e-10
of O 0 4.660797789379778e-11
proteins O 0 3.58069070270986e-13
of O 0 1.1969918112253453e-11
the O 0 7.088199471816381e-11
FH O 0 1.0910418950516032e-06
family O 0 6.834725146953602e-11
. O 0 2.518566688536339e-09

Factor B-Disease 0 0.17647352814674377
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999771118164062
is O 0 1.4587727727166655e-12
the O 0 4.2134173754149185e-12
only O 0 1.4053239127953532e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 3.1366571562330137e-08
with O 0 8.643511600903153e-11
HUS B-Disease 1 1.0
. O 0 4.1222608615498757e-07

These O 0 2.5742314530008414e-11
observations O 0 1.1726075666018687e-10
suggest O 0 1.3829044246543853e-12
a O 0 3.5348436553056875e-14
role O 0 4.2517698346442034e-13
for O 0 9.460387117785074e-13
FH O 0 2.1844642105861567e-05
and O 0 8.159821429654102e-11
/ O 0 4.756911664571817e-07
or O 0 1.026471824205899e-10
FH O 0 2.13452881325793e-06
receptors O 0 3.407997083322567e-13
in O 0 1.3904151538891157e-13
the O 0 7.94971781546e-13
pathogenesis O 0 9.31957844230169e-10
of O 0 6.366416283043463e-10
idiopathic O 0 6.881787584234189e-08
HUS B-Disease 0 0.003489626804366708
. O 0 3.1156908164575725e-09
. O 0 1.040144592678871e-08

Further O 0 1.5274248532648471e-09
evidence O 0 2.2066834470813035e-11
for O 0 2.2888505327167685e-13
a O 0 2.0906308639562915e-13
major O 0 6.933244668487493e-13
ancient O 0 9.290719304999584e-10
mutation O 0 8.980333809915919e-09
underlying O 0 1.110612757315721e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 4.197679714934566e-08
linkage O 0 2.6629410854184243e-07
disequilibrium O 0 1.3555123814512626e-06
studies O 0 8.845782613342568e-12
in O 0 1.440324808477545e-14
the O 0 3.4282909762992433e-14
Japanese O 0 2.181936055445366e-11
population O 0 3.3059031857504695e-14
. O 0 1.073226230108304e-11

The O 0 7.327944473445314e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.575590655837459e-09
DM B-Disease 1 1.0
) O 0 1.3864335027258257e-11
mutation O 0 4.714673963734928e-12
is O 0 5.0146054707744456e-14
an O 0 4.189805783132855e-13
unstable O 0 5.96836343902396e-06
( O 0 1.4503617057348706e-11
CTG O 0 4.415987859829329e-06
) O 0 3.083217546290956e-13
n O 0 3.6139834614506983e-12
repeat O 0 2.1273259195875305e-11
, O 0 3.196024377766747e-14
present O 0 1.6297198508243016e-13
at O 0 9.536236410994173e-14
a O 0 1.1681510784922861e-15
copy O 0 3.8270252310061703e-13
number O 0 5.607721318551251e-14
of O 0 5.184151176916563e-13
5 O 0 4.844038798551553e-12
- O 0 2.3214938651983097e-11
37 O 0 7.176651634077658e-11
repeats O 0 9.033369538502534e-12
on O 0 1.2390607637136064e-11
normal O 0 4.246505924676569e-11
chromosomes O 0 7.2299835389422196e-12
but O 0 3.5164132348129706e-13
amplified O 0 3.4264576852932604e-12
to O 0 1.4285289531151824e-12
50 O 0 1.217522471730348e-10
- O 0 2.610214128173638e-12
3000 O 0 1.5722662971909274e-12
copies O 0 1.9760897779219633e-11
on O 0 1.1241770847547627e-09
DM B-Disease 1 0.9999986886978149
chromosomes O 0 2.6681350462354203e-09
. O 0 5.377909673143222e-09

Previous O 0 5.811494929730543e-08
findings O 0 5.998684882158045e-11
in O 0 2.744855666543533e-13
Caucasian O 0 1.3490646821878727e-08
populations O 0 2.1526052153882785e-13
of O 0 4.461559160312545e-12
a O 0 1.323127163388449e-09
DM B-Disease 1 1.0
founder O 0 7.572102731501218e-07
chromosome O 0 1.7491256443236125e-08
raise O 0 2.5988888124883758e-11
a O 0 1.6789602477404464e-12
question O 0 3.664543495041084e-12
about O 0 2.1225874858210765e-15
the O 0 2.174616145792993e-14
molecular O 0 2.465739201359951e-13
events O 0 7.89371755352368e-14
involved O 0 6.35629049394737e-12
in O 0 1.8582837092023796e-12
the O 0 1.1741533960385464e-11
expansion O 0 1.0641038050707152e-09
mutation O 0 3.38289882217957e-11
. O 0 4.988400803540571e-10

To O 0 1.863162957249642e-09
investigate O 0 1.1850638526045287e-10
whether O 0 4.3900332587915036e-13
a O 0 3.8741758282348493e-13
founder O 0 2.7374955600956152e-12
chromosome O 0 5.658526164992184e-12
for O 0 3.8639772804993644e-13
the O 0 3.8939171331797695e-10
DM B-Disease 1 1.0
mutation O 0 2.2950603223437227e-11
exists O 0 1.1374934197685982e-13
in O 0 3.2206227651264277e-15
the O 0 1.4510125007994104e-14
Japanese O 0 6.580727716226642e-12
population O 0 1.917905362248864e-15
, O 0 4.78419878718753e-16
we O 0 4.1837745697352255e-14
genotyped O 0 1.1347827122420995e-09
families O 0 2.554464072993673e-13
using O 0 1.5147731159681488e-12
polymorphic O 0 1.9145332541548044e-10
markers O 0 4.244605222858411e-10
near O 0 1.8704632509525254e-08
the O 0 1.0039514775073144e-09
( O 0 2.909268659312403e-11
CTG O 0 1.5139896731852787e-06
) O 0 6.326693075681122e-12
n O 0 9.117221561050215e-11
repeat O 0 2.778725582963659e-10
region O 0 4.631617589456738e-10
and O 0 1.0074031019102758e-11
constructed O 0 5.5793565323369876e-09
haplotypes O 0 3.381212199116135e-09
. O 0 3.35842065268821e-09

Six O 0 2.6886508575074686e-09
different O 0 5.831781238474498e-12
haplotypes O 0 8.238121990133962e-11
were O 0 4.349379797291553e-12
found O 0 4.210289885828167e-13
and O 0 4.553381326502515e-13
DM B-Disease 1 0.9999998807907104
alleles O 0 1.1135611530099787e-11
were O 0 3.5654285079900205e-11
always O 0 9.827723704280977e-12
haplotype O 0 1.2553666994818968e-09
A O 0 5.3192135140989194e-08
. O 0 3.0037480058808796e-08

To O 0 1.0772511771506288e-09
find O 0 4.6113588642038295e-11
an O 0 9.595358633086165e-16
origin O 0 8.638459413935762e-13
of O 0 9.777205954575319e-12
the O 0 7.408570285027949e-12
( O 0 1.20656970200618e-13
CTG O 0 2.3958383721378596e-08
) O 0 4.6140178402162904e-14
n O 0 1.9538268572483197e-12
repeat O 0 1.5821613116862032e-11
mutation O 0 7.162518191397571e-13
and O 0 2.894127266398622e-14
to O 0 2.868192228860922e-12
investigate O 0 1.4270590785459003e-11
the O 0 2.0765240655445938e-12
mechanism O 0 2.1397017491153747e-10
of O 0 2.9827325505327185e-12
the O 0 2.548318001928396e-13
expansion O 0 2.422891531503324e-12
mutation O 0 5.510700640113438e-15
in O 0 1.2208725267117619e-15
the O 0 2.8583465618275267e-15
Japanese O 0 1.427455701384639e-12
population O 0 2.767784975480649e-15
we O 0 2.4559034208951162e-15
have O 0 7.468085149242641e-16
studied O 0 1.6688385428339364e-13
90 O 0 1.3292623946004056e-11
Japanese O 0 1.2773582191982769e-09
DM B-Disease 1 0.9999980926513672
families O 0 2.7740797506337067e-11
comprising O 0 5.245583047791547e-12
190 O 0 1.0368787425885095e-11
affected O 0 3.852425756872835e-12
and O 0 4.116690712277493e-13
130 O 0 9.384345522889248e-10
unaffected O 0 1.2200715104881965e-08
members O 0 8.530909312298718e-11
. O 0 7.154941084053235e-09

The O 0 6.483088732522901e-09
results O 0 9.973629699899789e-10
suggest O 0 1.0951062973107994e-10
that O 0 1.0967701085436848e-14
a O 0 2.3260123753303386e-13
few O 0 7.489751006894974e-13
common O 0 3.1247799486822103e-12
ancestral O 0 3.2738591837500053e-09
mutations O 0 3.69641383474173e-12
in O 0 4.151978782486465e-13
both O 0 1.046704736773485e-11
Caucasian O 0 1.931745828187559e-06
and O 0 7.322258251118985e-12
Japanese O 0 7.0645729266516355e-09
populations O 0 8.364442222619922e-14
have O 0 3.0546247421344374e-16
originated O 0 1.2787078728228145e-14
by O 0 1.679424532968616e-16
expansion O 0 6.471811368063962e-12
of O 0 6.999045006755855e-12
an O 0 2.348793631378604e-13
ancestral O 0 8.667586093302759e-10
n O 0 2.3224182993386577e-12
= O 0 1.4534348117406504e-12
5 O 0 1.1650287939229953e-12
repeat O 0 4.6241187962037245e-12
to O 0 1.6395863833285063e-11
n O 0 1.7701657197347065e-12
= O 0 1.1518973708907199e-12
19 O 0 1.4895156288941003e-11
- O 0 5.2517196320878146e-12
37 O 0 7.870603474513516e-12
copies O 0 1.0871246611254826e-11
. O 0 1.6475559805328999e-10

These O 0 6.185229411981297e-12
data O 0 3.3820004088913613e-12
support O 0 2.1150083366529987e-13
multistep O 0 1.5374670980783378e-10
models O 0 7.361668219463269e-11
of O 0 9.377904008900373e-10
triplet O 0 5.833572345181892e-07
repeat O 0 6.598292467963063e-10
expansion O 0 2.153076605893034e-10
that O 0 1.4924481667329646e-14
have O 0 2.974512683620481e-15
been O 0 7.689326131658965e-15
proposed O 0 3.606169504585246e-15
for O 0 1.1033962778834658e-14
both O 0 2.8563686138571853e-11
DM B-Disease 1 1.0
and O 0 7.997453810304478e-10
Friedreichs B-Disease 0 0.00015185264055617154
ataxia I-Disease 0 2.2559247554454487e-06
. O 0 9.793994504292414e-10
. O 0 2.2606071681252615e-08

The O 0 2.947333488378945e-10
molecular O 0 1.5775095119074933e-10
basis O 0 1.3975819967981806e-07
of O 0 6.428748019970953e-05
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.8660568363036987e-10
the O 0 3.868154754838038e-11
western O 0 6.090501020183936e-11
Cape O 0 3.2105339220489526e-11
, O 0 6.683383366049359e-14
South O 0 1.5598916255910034e-11
Africa O 0 9.592326932761353e-11
. O 0 1.1478832329103739e-09

Deficiency B-Disease 1 0.9991281628608704
of I-Disease 0 6.083038442739053e-06
the I-Disease 0 9.425932034901052e-09
sixth I-Disease 0 0.00031576817855238914
component I-Disease 0 5.449042816962901e-08
of I-Disease 0 7.44650230366517e-10
human I-Disease 0 6.124165757848132e-11
complement I-Disease 0 1.2797536363962081e-08
( O 0 2.1127355507438716e-12
C6 O 0 1.36257358462899e-06
) O 0 6.465516056569642e-13
has O 0 1.1656493666825705e-15
been O 0 1.526896657884618e-14
reported O 0 3.574602026597089e-14
in O 0 4.303623633134489e-15
a O 0 6.042769044612437e-15
number O 0 1.1010500813228661e-14
of O 0 1.2083846564429207e-13
families O 0 1.7120673097541922e-13
from O 0 7.279864103031108e-13
the O 0 2.3085110212317517e-12
western O 0 7.79785194748861e-11
Cape O 0 2.8589211553686766e-10
, O 0 6.140207157827315e-13
South O 0 7.876239244142269e-11
Africa O 0 2.7035781946516124e-10
. O 0 2.101469442905568e-09

Meningococcal B-Disease 1 0.9986333250999451
disease I-Disease 0 0.012891320511698723
is O 0 8.337754098253214e-12
endemic O 0 5.2675099525278934e-12
in O 0 1.1496139869053568e-13
the O 0 3.091500319629681e-11
Cape O 0 1.3541780197190434e-10
and O 0 3.3336986989695614e-15
almost O 0 3.996459670900336e-14
all O 0 1.5902542776469425e-15
pedigrees O 0 6.592804080440828e-11
of O 0 1.2176246122486134e-10
total O 0 8.558186527807266e-05
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.2954108619123161e-10
C6Q0 O 0 0.05680787190794945
) O 0 6.501203655279175e-13
have O 0 9.169072022908314e-14
been O 0 4.661255105856132e-13
ascertained O 0 2.0180128679214704e-09
because O 0 1.920403804511403e-13
of O 0 9.693872787819302e-11
recurrent O 0 8.5399005911313e-06
disease O 0 3.325264685827278e-08
. O 0 8.377683435867311e-09

We O 0 1.8437398829895812e-10
have O 0 4.4026594029538194e-14
sequenced O 0 1.735481550135809e-11
the O 0 9.65488743099284e-14
expressed O 0 8.371847323457998e-14
exons O 0 4.722184310246291e-10
of O 0 1.745044213297131e-11
the O 0 8.626214326179493e-12
C6 O 0 3.296298700661282e-08
gene O 0 2.583417149908812e-13
from O 0 4.126572401928069e-13
selected O 0 2.803771104176178e-12
cases O 0 2.2580806040110868e-13
and O 0 7.557339086125547e-13
have O 0 4.115246012882656e-13
found O 0 1.6637035716096649e-12
three O 0 7.129003333841699e-13
molecular O 0 2.490524730891508e-10
defects O 0 2.9799521072959578e-08
leading O 0 1.6557435977837542e-10
to O 0 1.0673989470078027e-09
total O 0 6.189860414451687e-06
deficiency O 0 0.0002790616126731038
879delG O 0 0.00218448368832469
, O 0 3.399196072187416e-12
which O 0 8.766227218952316e-14
is O 0 4.3683393219969696e-14
the O 0 4.8361549140341076e-12
common O 0 4.162774985827511e-11
defect O 0 4.557355026690857e-08
in O 0 2.672909983625349e-11
the O 0 1.941770522151387e-09
Cape O 0 2.6668439900845442e-08
and O 0 1.829676861409002e-11
hitherto O 0 3.603830833753818e-08
unreported O 0 1.3230060380564623e-09
, O 0 7.432935695975487e-14
and O 0 2.737838710083207e-13
1195delC O 0 2.278759048124357e-08
and O 0 7.949812683150093e-12
1936delG O 0 5.379553869033771e-08
, O 0 4.0177166064567227e-13
which O 0 2.6145413416743535e-14
have O 0 1.1346202162488758e-13
been O 0 1.908369946443389e-12
previously O 0 2.825944990167417e-12
reported O 0 6.274247072411698e-13
in O 0 3.4410015527057414e-13
African O 0 1.4477753718100672e-10
- O 0 9.405072554091731e-11
Americans O 0 1.474705600690296e-11
. O 0 1.604046562242445e-09

We O 0 1.8267914958514098e-09
also O 0 4.915460399823601e-13
show O 0 5.841017773622337e-13
that O 0 1.685399423969209e-16
the O 0 7.719333120848396e-15
879delG O 0 4.79120597363103e-11
and O 0 4.138598575713186e-14
1195delC O 0 6.466219559797537e-09
defects O 0 1.19839214107742e-07
are O 0 6.236589071778945e-14
associated O 0 1.051780329497376e-10
with O 0 7.725298178939966e-11
characteristic O 0 0.00600671861320734
C6 O 1 1.0
/ O 1 1.0
C7 O 1 0.9999310970306396
region O 0 1.4745397436399799e-07
DNA O 0 3.077879284774099e-07
marker O 0 3.216335420219707e-09
haplotypes O 0 2.6537197439502336e-10
, O 0 2.305113023202965e-13
although O 0 5.204411662913799e-13
small O 0 1.521466871760857e-13
variations O 0 2.1050596975182717e-13
were O 0 9.77623537679051e-12
observed O 0 2.2168006319489564e-10
. O 0 9.926851340935627e-09

The O 0 2.395626808038287e-09
1936delG O 0 1.026265294967743e-06
defect O 0 2.9387531412794488e-06
was O 0 2.941947241374976e-10
observed O 0 3.6305023657506874e-12
only O 0 1.5565198056236712e-13
once O 0 2.8998862772883216e-13
in O 0 7.637061149494764e-14
the O 0 6.596511531453686e-12
Cape O 0 3.5198477466025224e-10
, O 0 2.53526549526175e-14
but O 0 2.135119338275704e-14
its O 0 1.2940030008612696e-14
associated O 0 4.885908691520946e-11
haplotype O 0 1.1262352161978129e-09
could O 0 5.7013213594636625e-11
be O 0 3.9075476188088487e-10
deduced O 0 1.1337755267959437e-07
. O 0 2.58575543199413e-08

The O 0 6.414651032571328e-09
data O 0 3.518158209203648e-09
from O 0 4.731709381949889e-12
the O 0 7.778344808528903e-12
haplotypes O 0 2.2775227537241705e-10
indicate O 0 1.9833473405284074e-11
that O 0 7.151399223780282e-15
these O 0 2.491412736109911e-14
three O 0 1.1150589999953109e-12
molecular O 0 1.0165726038735556e-09
defects O 0 1.0467005751024772e-07
account O 0 4.520413991043748e-12
for O 0 2.124410543313804e-11
the O 0 1.8648774968710313e-08
defects O 1 0.9708113670349121
in O 0 4.8624992921020294e-11
all O 0 5.220062229693845e-12
the O 0 9.204792310313348e-12
38 O 0 2.4574653423314885e-10
unrelated O 0 1.2829344531173348e-10
C6Q0 O 0 8.675202479935251e-06
individuals O 0 2.597376090249237e-12
we O 0 2.2364957108500505e-12
have O 0 9.629213523548383e-14
studied O 0 4.367802126925557e-12
from O 0 6.417354711865664e-13
the O 0 2.716224641041709e-11
Cape O 0 3.3312492764281387e-09
. O 0 1.8083762265419523e-09

We O 0 1.6498398203168563e-09
have O 0 5.935806859057313e-13
also O 0 3.122678016094808e-15
observed O 0 9.343065634581735e-15
the O 0 5.516150619502662e-14
879delG O 0 9.59220369800562e-10
defect O 0 2.2880868311148106e-09
in O 0 6.349153841567201e-12
two O 0 2.7727481421990774e-10
Dutch O 1 0.9525219202041626
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 0.04395041614770889
, O 0 4.614530329030697e-13
but O 0 1.745953947011273e-14
the O 0 3.477043685525677e-13
879delG O 0 5.08155428846635e-09
defect O 0 1.0722232879345484e-08
in O 0 2.2272921354482556e-12
the O 0 3.532896197810942e-10
Cape O 0 3.735186826503423e-09
probably O 0 2.3330783919389697e-12
did O 0 3.7947235956813097e-13
not O 0 4.123535280592394e-13
come O 0 2.028553887367668e-11
from O 0 2.597560708195168e-11
The O 0 3.8583861106111783e-10
Netherlands O 0 1.5476301351569077e-09
. O 0 2.2134374888516106e-10
. O 0 8.802457429624155e-09

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 5.12157989629447e-11
seven O 0 9.206869294731135e-11
further O 0 2.1561330845742965e-11
molecular O 0 4.937568132135084e-10
defects O 0 8.337913470768399e-08
and O 0 1.499211453766247e-12
their O 0 6.762381626890246e-11
associated O 0 5.375356160186584e-09
marker O 0 1.1422402579341906e-08
haplotypes O 0 4.891508531557065e-09
. O 0 1.1379302833347538e-08

Seven O 0 1.9620305380385616e-09
further O 0 2.8051635667103447e-11
molecular O 0 2.931629106139866e-10
bases O 0 9.333120054577648e-09
of O 0 1.6481979400850832e-05
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 4.363509553684253e-10
described O 0 6.885220726893237e-10
. O 0 8.505912418854678e-09

All O 0 1.7630981397065426e-10
these O 0 9.74361650390998e-13
new O 0 3.627240922985525e-13
molecular O 0 1.2219700078197615e-11
defects O 0 7.257827672191297e-11
involve O 0 2.6930416230364074e-11
single O 0 1.259361503969103e-10
- O 0 1.5638189354572063e-10
nucleotide O 0 4.4857198511216723e-10
events O 0 3.0060762906680694e-11
, O 0 8.59290720175987e-13
deletions O 0 5.230998620375793e-11
and O 0 1.5925019007483054e-13
substitutions O 0 1.0285079732330615e-10
, O 0 1.7530356506700873e-13
some O 0 2.979249673026353e-14
of O 0 8.567676082482656e-12
which O 0 4.568117802430938e-13
alter O 0 6.637767668848937e-09
splice O 0 5.255387947045165e-08
sites O 0 8.069376833397257e-10
, O 0 1.1275532374108166e-12
and O 0 7.629843480107257e-13
others O 0 1.566729038171566e-11
codons O 0 5.526400670419207e-09
. O 0 4.2316678161569143e-08

They O 0 7.843767302340154e-11
are O 0 1.0812212094342324e-14
distributed O 0 1.381505739477375e-14
along O 0 6.219411921234985e-14
the O 0 4.759785772988356e-13
C7 O 0 1.5425628419052373e-07
gene O 0 2.596819786114535e-13
, O 0 4.3391502278214075e-14
but O 0 2.204820493659134e-14
predominantly O 0 3.4073083438924956e-13
towards O 0 6.440041642324923e-12
the O 0 1.4828930184479505e-12
3 O 0 2.6009418577221943e-11
end O 0 4.8798227680890705e-09
. O 0 9.201646555823118e-09

All O 0 9.858448501987027e-10
were O 0 1.1293106727539026e-10
found O 0 2.9662215609085885e-13
in O 0 2.2852637208796434e-14
compound O 0 7.75147914605645e-12
heterozygous O 0 9.538914796936027e-13
individuals O 0 1.9946277431386744e-13
. O 0 1.057269827242635e-09

The O 0 5.195476205699379e-06
C6 O 1 0.6239903569221497
/ O 0 0.06883470714092255
C7 O 0 0.0006748606101609766
marker O 0 4.004460762985218e-08
haplotypes O 0 3.6505409806153466e-09
associated O 0 9.66725255402423e-10
with O 0 1.7806098609463028e-11
most O 0 1.7991765854930009e-09
C7 B-Disease 1 1.0
defects I-Disease 1 0.9926924705505371
are O 0 4.530435488564466e-12
tabulated O 0 4.344826276536651e-09
. O 0 6.854974227143984e-11
. O 0 1.891723888647334e-09

A O 0 3.754903588060188e-08
genome O 0 1.8754386932329226e-09
- O 0 2.845093050041214e-10
wide O 0 1.4258067383005057e-12
search O 0 5.040636311126612e-12
for O 0 7.533027885286633e-14
chromosomal O 0 1.6538079705696873e-07
loci O 0 4.288698729482121e-09
linked O 0 3.832264994230172e-08
to O 0 7.436637972091376e-10
mental O 0 0.002265505027025938
health O 0 3.3954541955871775e-10
wellness O 0 5.575938599733377e-10
in O 0 3.817342018115795e-14
relatives O 0 2.9906279275931924e-12
at O 0 2.5110371681263954e-12
high O 0 8.271117298008779e-12
risk O 0 1.0646270670600089e-10
for O 0 5.245478496007649e-10
bipolar B-Disease 1 1.0
affective I-Disease 1 0.5379475355148315
disorder I-Disease 1 0.7997617125511169
among O 0 3.808538553973229e-12
the O 0 1.1744378039524328e-11
Old O 0 3.6764506994302337e-09
Order O 0 7.151086667267492e-11
Amish O 0 2.725944625581178e-08
. O 0 4.71779115773785e-10

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 3.575424045720865e-08
BPAD B-Disease 1 1.0
; O 0 3.128949686015403e-07
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 2.783656118110489e-12
is O 0 7.522070158861183e-15
characterized O 0 1.6907773949700043e-15
by O 0 4.021850870510735e-16
episodes O 0 2.0071016029743483e-11
of O 0 1.1416634998484554e-11
mania B-Disease 0 1.7131807084069806e-10
and O 0 6.949609073977903e-13
/ O 0 1.3682983635021628e-08
or O 0 1.915204106417434e-11
hypomania B-Disease 0 3.9612963576018956e-08
interspersed O 0 1.6176721073790645e-10
with O 0 6.154294061129148e-15
periods O 0 7.67191199457784e-10
of O 0 2.3105660440503328e-10
depression B-Disease 0 4.650410334594568e-10
. O 0 8.536121809399333e-10

Compelling O 0 1.516487557751134e-08
evidence O 0 3.296697914656477e-10
supports O 0 6.93926817049717e-12
a O 0 1.7293700922248884e-13
significant O 0 4.966955666207973e-13
genetic O 0 4.421227706857822e-12
component O 0 1.6037574046556813e-11
in O 0 6.355401773426583e-13
the O 0 2.2706336810784933e-11
susceptibility O 0 5.0633410658695865e-11
to O 0 2.3122546932707877e-10
develop O 0 1.2893826351501048e-05
BPAD B-Disease 1 1.0
. O 0 1.3419631841316004e-06

To O 0 2.5601112896289635e-10
date O 0 8.046818322782201e-09
, O 0 6.739505871780627e-13
however O 0 1.819174151596048e-12
, O 0 5.1480941363167554e-14
linkage O 0 2.081109590212904e-10
studies O 0 8.573883248340353e-13
have O 0 4.155016361219932e-15
attempted O 0 3.160313330474729e-11
only O 0 6.650845239125625e-13
to O 0 2.7385623282971672e-11
identify O 0 1.8620838204697066e-08
chromosomal O 0 1.0921768080152106e-05
loci O 0 4.59217019965763e-08
that O 0 9.77519194061971e-12
cause O 0 7.603124796418115e-10
or O 0 4.776239299897345e-12
increase O 0 1.4217801415361553e-11
the O 0 3.831789486402615e-12
risk O 0 1.5396380351195837e-11
of O 0 8.102964133005486e-11
developing O 0 1.6686016124367598e-07
BPAD B-Disease 1 1.0
. O 0 7.019526151452737e-07

To O 0 4.084670379711497e-09
determine O 0 3.2094717994368693e-09
whether O 0 1.0528717654667563e-11
there O 0 6.978952463675137e-13
could O 0 7.443707651134945e-13
be O 0 6.359027345491375e-13
protective O 0 5.5909170522394636e-12
alleles O 0 2.570491562658983e-12
that O 0 1.1811822780451436e-14
prevent O 0 1.3718973006227042e-11
or O 0 9.130251242550624e-12
reduce O 0 2.2970672586275498e-10
the O 0 1.335661789503284e-11
risk O 0 2.67576655277324e-11
of O 0 1.1501706531635847e-10
developing O 0 4.339966892530356e-07
BPAD B-Disease 1 1.0
, O 0 2.6818952332356705e-13
similar O 0 1.378599738841935e-14
to O 0 2.977058432673124e-13
what O 0 9.987995673588212e-15
is O 0 5.559474914798709e-15
observed O 0 5.095627153735294e-13
in O 0 1.057199683698884e-12
other O 0 7.371109972398315e-11
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 8.011849511732269e-14
we O 0 1.811355021053354e-13
used O 0 1.723323046765035e-11
mental O 0 3.049223451512262e-08
health O 0 5.045984897283917e-12
wellness O 0 1.3436295132063236e-10
( O 0 2.3104545230826336e-15
absence O 0 3.2410064215726564e-12
of O 0 2.001740353335668e-12
any O 0 6.542805359999182e-12
psychiatric B-Disease 0 5.064295578449673e-07
disorder I-Disease 0 9.07102215563782e-09
) O 0 5.594108397946043e-15
as O 0 7.52551419482472e-15
the O 0 1.895078603590672e-13
phenotype O 0 6.847322730520189e-13
in O 0 6.249401630952292e-14
our O 0 4.6237333406473624e-11
genome O 0 1.0989500975888689e-10
- O 0 7.378438138250232e-11
wide O 0 2.2986352404830157e-11
linkage O 0 9.73920943891926e-10
scan O 0 2.2009729594429928e-09
of O 0 2.7746830874586514e-11
several O 0 2.254927147782304e-12
large O 0 1.4315339278564432e-13
multigeneration O 0 1.5489354243669595e-09
Old O 0 7.384537981103279e-10
Order O 0 8.084777985972735e-11
Amish O 0 9.068967443681686e-08
pedigrees O 0 5.780923739706623e-09
exhibiting O 0 1.0330225563848217e-09
an O 0 3.511797189853505e-12
extremely O 0 1.9831489783683764e-09
high O 0 3.850257002113722e-09
incidence O 0 1.1477419548100443e-07
of O 0 1.1696421324813855e-06
BPAD B-Disease 1 1.0
. O 0 2.8810647563659586e-05

We O 0 1.4892103106234345e-09
have O 0 7.347366530290056e-13
found O 0 1.8878488724539955e-13
strong O 0 1.7143465102438288e-15
evidence O 0 1.267170352344969e-14
for O 0 5.467669672327025e-15
a O 0 2.596567438058889e-13
locus O 0 5.612885156658365e-12
on O 0 1.5938231290313354e-10
chromosome O 0 5.298106398043956e-10
4p O 0 2.2131750938569894e-06
at O 0 2.634536366841189e-09
D4S2949 O 0 2.5117799395957263e-08
( O 0 5.981720923708272e-14
maximum O 0 5.52201166736932e-11
GENEHUNTER O 0 4.2962906832144654e-07
- O 0 7.091647408197232e-11
PLUS O 0 2.0051547922061985e-10
nonparametric O 0 2.7715227890467986e-09
linkage O 0 1.981964176112072e-10
score O 0 5.354820753478151e-12
= O 0 1.3119918291972649e-13
4 O 0 3.91644114599958e-14
. O 0 1.4835392436003333e-14
05 O 0 7.097872983807818e-11
, O 0 2.36564484364446e-13
P O 0 2.3879845323371285e-10
= O 0 8.794630605366005e-14
5 O 0 3.4596965862911805e-14
. O 0 2.7746455188369353e-15
22 O 0 5.763063095319543e-14
x O 0 3.052852838147241e-13
10 O 0 5.070306154097981e-12
( O 0 4.278874685668434e-14
- O 0 6.497649640557768e-12
4 O 0 2.7567816193903305e-13
) O 0 1.314550347271588e-15
; O 0 3.4517060586316097e-15
SIBPAL O 0 1.2080792544111318e-07
Pempirical O 0 1.063895460617914e-08
value O 0 6.407722963341911e-11
< O 0 8.937259786401253e-12
3 O 0 5.031995395994755e-14
x O 0 5.235794436897478e-13
10 O 0 6.562164873991083e-12
( O 0 4.2663409697413224e-14
- O 0 6.736387055811255e-12
5 O 0 1.7256039804534884e-13
) O 0 8.809227354739449e-16
) O 0 1.5116362793728241e-15
and O 0 3.601181242855571e-14
suggestive O 0 1.1055614757005117e-11
evidence O 0 4.928678450609458e-13
for O 0 2.3214207791298624e-13
a O 0 5.178234143560223e-12
locus O 0 1.52103329931208e-11
on O 0 6.832812649015807e-10
chromosome O 0 3.2249107828619117e-09
4q O 0 4.57707756140735e-08
at O 0 3.15849657539502e-09
D4S397 O 0 3.708921170186841e-08
( O 0 9.35772997718437e-14
maximum O 0 1.2982527552996004e-10
GENEHUNTER O 0 8.82998619999853e-07
- O 0 2.0862603311577743e-10
PLUS O 0 3.57657348182272e-10
nonparametric O 0 4.971496103678419e-09
linkage O 0 7.41134376092134e-11
score O 0 1.1391837993757203e-11
= O 0 1.8509424949773173e-13
3 O 0 5.72365980023963e-14
. O 0 8.076100857133065e-15
29 O 0 3.727281504273261e-12
, O 0 1.3373480654051834e-13
P O 0 1.321623227523716e-10
= O 0 3.86198573663378e-14
2 O 0 1.2101206504683184e-14
. O 0 2.4811776134917637e-15
57 O 0 3.141678811633547e-13
x O 0 2.8091282555306463e-13
10 O 0 2.0194345327906316e-12
( O 0 2.560242802810385e-14
- O 0 3.1197893660822595e-12
3 O 0 7.28193005027078e-14
) O 0 8.139531342904677e-16
; O 0 1.6616332147164703e-15
SIBPAL O 0 6.856448209191512e-08
Pempirical O 0 7.541399504873425e-09
value O 0 5.017426057962737e-11
< O 0 6.555434146904293e-12
1 O 0 5.992340683987768e-14
x O 0 2.3485441022486064e-12
10 O 0 5.0443902527286255e-11
( O 0 3.185387880116214e-13
- O 0 1.7273609626000663e-11
3 O 0 1.23428543319197e-13
) O 0 4.44426646600425e-16
) O 0 2.385077490461027e-16
that O 0 3.5594399674346473e-16
are O 0 5.6676122230428765e-15
linked O 0 1.1069319905132602e-09
to O 0 5.147410053751855e-09
mental O 1 0.9999934434890747
health O 0 5.036399102209543e-07
wellness O 0 6.317974339253851e-07
. O 0 2.2273551891771604e-09

These O 0 5.81565795521044e-10
findings O 0 4.62435957582219e-11
are O 0 1.3305337531071583e-14
consistent O 0 2.9120818170053075e-12
with O 0 9.465714946552974e-16
the O 0 2.095837202788567e-13
hypothesis O 0 1.2684139491774687e-13
that O 0 1.3672648339390286e-16
certain O 0 1.3502531883390068e-13
alleles O 0 1.5008680062655877e-12
could O 0 1.6965309365679637e-11
prevent O 0 1.266557414503211e-09
or O 0 6.615998859871297e-10
modify O 0 8.316007438224915e-09
the O 0 3.683016391864413e-11
clinical O 0 6.143110464762458e-10
manifestations O 0 1.0242096060153472e-09
of O 0 2.090866590975793e-09
BPAD B-Disease 1 1.0
and O 0 1.2188183622086068e-11
perhaps O 0 3.7528270421804955e-12
other O 0 1.3891725226741758e-12
related O 0 4.3179127828807395e-07
affective B-Disease 0 2.0417139694473008e-06
disorders I-Disease 0 3.763999984585098e-06
. O 0 6.835712440533825e-08

Segregation O 0 1.916580367833376e-05
distortion O 0 2.7950398362008855e-05
in O 0 2.946465293973688e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.0160429155803286e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.3190757499614847e-06
DM B-Disease 1 1.0
) O 0 5.549318782271939e-10
is O 0 3.483996294587066e-12
an O 0 4.341704946952962e-12
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999333620071411
which O 0 9.771937897534375e-14
, O 0 3.849055778693943e-15
in O 0 1.342663519021724e-14
the O 0 4.528161157667243e-13
typical O 0 1.4099377047827044e-12
pedigree O 0 2.5667681955582333e-12
, O 0 4.189682031619261e-15
shows O 0 2.514875243816994e-13
a O 0 1.2370193844951638e-13
three O 0 1.0938547160069256e-12
generation O 0 1.689338335886248e-09
anticipation O 0 1.9293953101851002e-09
cascade O 0 1.6340340192044778e-09
. O 0 1.9049261723580457e-08

This O 0 1.1074117968121189e-12
results O 0 5.318472225124271e-12
in O 0 1.783553513212688e-11
infertility B-Disease 0 0.2949492335319519
and O 0 1.2800361881559752e-09
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.1569473851169576e-10
CDM B-Disease 0 1.0962318810925353e-05
) O 0 8.655207118775463e-15
with O 0 2.5819941218519307e-16
the O 0 2.6461141220887607e-13
disappearance O 0 1.8459989092889373e-10
of O 0 2.821746447612128e-10
DM B-Disease 1 1.0
in O 0 2.0718923104956488e-11
that O 0 1.2296047968880786e-13
pedigree O 0 5.900526595103983e-11
. O 0 3.2463362553691866e-10

The O 0 1.5007063647320962e-10
concept O 0 7.195992413056018e-11
of O 0 8.881238106051015e-11
segregation O 0 1.0417164908460563e-09
distortion O 0 4.4359801942839283e-10
, O 0 5.0208237937501236e-15
where O 0 1.1442510909734404e-15
there O 0 3.4634430765443573e-16
is O 0 2.219026474970274e-17
preferential O 0 3.4207876874019216e-13
transmission O 0 2.4963779307607403e-11
of O 0 1.3745989481221688e-13
the O 0 2.2679564660749857e-13
larger O 0 3.6988381107994073e-13
allele O 0 1.3236003439109911e-11
at O 0 8.561457098821279e-11
the O 0 4.143930754096914e-10
DM B-Disease 1 1.0
locus O 0 5.903806332696604e-10
, O 0 1.336655070481585e-12
has O 0 6.0105148770139404e-15
been O 0 7.791522011997912e-14
put O 0 8.740754431010855e-13
forward O 0 8.502736709159464e-12
to O 0 1.9682431032230774e-11
explain O 0 3.5604963422031233e-10
partially O 0 5.253688595274753e-10
the O 0 1.2505181352234773e-12
maintenance O 0 3.505129768655024e-07
of O 0 6.335614255448263e-09
DM B-Disease 1 1.0
in O 0 6.255302525959294e-11
the O 0 9.719607757530113e-11
population O 0 1.254933765411359e-12
. O 0 8.856523847633468e-11

In O 0 8.33254798493499e-10
a O 0 5.7906072298274935e-11
survey O 0 1.6289701532112844e-10
of O 0 5.264479477351536e-11
DM B-Disease 1 1.0
in O 0 4.658293750736675e-10
Northern O 0 1.8790737854601502e-08
Ireland O 0 5.74790659513269e-09
, O 0 4.070882086287808e-12
59 O 0 2.23142859745451e-09
pedigrees O 0 1.4214353249997203e-08
were O 0 1.325521803430263e-09
ascertained O 0 2.6391955998406047e-07
. O 0 1.2897539924949797e-08

Sibships O 0 3.5658838896779343e-05
where O 0 3.1592027171373216e-12
the O 0 5.170119432400255e-13
status O 0 5.276882229787727e-12
of O 0 2.6257234234106086e-12
all O 0 7.939453944543623e-14
the O 0 6.330802852436146e-14
members O 0 5.972391618123919e-15
had O 0 3.3525367540681444e-14
been O 0 1.478344898754591e-14
identified O 0 3.015646272194056e-13
were O 0 5.833936307132748e-13
examined O 0 3.1048180519632762e-12
to O 0 8.296452582009714e-14
determine O 0 5.0913648297346015e-12
the O 0 1.845046684878504e-12
transmission O 0 6.380267905115033e-07
of O 0 1.312794872809775e-10
the O 0 8.648892158014121e-10
DM B-Disease 1 1.0
expansion O 0 4.640718920256859e-09
from O 0 6.26152992302953e-12
affected O 0 2.3322062597114224e-12
parents O 0 4.877912310186083e-14
to O 0 5.252999641172651e-13
their O 0 1.627839009421539e-11
offspring O 0 8.94057661238179e-10
. O 0 3.4019513872607376e-09

Where O 0 2.3048033967465464e-11
the O 0 2.3279577050783207e-12
transmitting O 0 2.8874409530033063e-09
parent O 0 1.8346454997569817e-12
was O 0 1.8443508872922898e-11
male O 0 1.4939199183272578e-11
, O 0 1.239593687028459e-13
58 O 0 2.9813036483972155e-09
. O 0 1.952042616437666e-08

3 O 0 4.400538156090761e-09
% O 0 4.106120332636465e-09
of O 0 6.355053636108998e-12
the O 0 1.4751465023457588e-12
offspring O 0 2.3882291977361803e-11
were O 0 1.8077975097799404e-12
affected O 0 1.4860245195827404e-12
, O 0 7.349138218283851e-15
and O 0 5.01024350520597e-15
in O 0 7.971000162004804e-14
the O 0 1.8214090988493553e-13
case O 0 1.8544719118619366e-14
of O 0 1.852416440725757e-12
a O 0 2.6777358542312557e-12
female O 0 2.5030288605676354e-11
transmitting O 0 1.1764388352375477e-09
parent O 0 1.514063353857953e-11
, O 0 1.0459124018258326e-11
68 O 0 3.2425219842480146e-07
. O 0 2.536681620313175e-07

7 O 0 2.488314443382933e-08
% O 0 3.2676708006107447e-09
were O 0 2.824146645707959e-11
affected O 0 9.59574919523476e-11
. O 0 8.117013727826361e-10

Studies O 0 4.542909104454651e-10
on O 0 1.8244915994669597e-11
meiotic O 0 4.105918804953035e-08
drive O 0 3.089512290443963e-08
in O 0 5.090765309301304e-11
DM B-Disease 1 1.0
have O 0 5.031786619313916e-13
shown O 0 7.66391073867001e-14
increased O 0 4.909161049676189e-14
transmission O 0 1.542945111954186e-11
of O 0 8.091642217649287e-15
the O 0 1.2031197537526721e-14
larger O 0 2.511106421540163e-14
allele O 0 8.163783234496624e-13
at O 0 1.3150245649351522e-11
the O 0 8.052521843771032e-11
DM B-Disease 1 0.9999964237213135
locus O 0 5.548247278275298e-11
in O 0 7.853512284938802e-11
non O 0 7.573657512693899e-06
- O 0 5.0614296924322844e-05
DM O 1 1.0
heterozygotes O 0 2.1687823092975123e-08
for O 0 7.542543672967028e-11
CTGn O 0 8.136339602060616e-06
. O 0 5.564404048641336e-09

This O 0 1.4842300999351465e-10
study O 0 4.68128660835454e-12
provides O 0 3.7108350788885025e-14
further O 0 6.7488900142779855e-15
evidence O 0 4.2473197268272367e-13
that O 0 2.5309751039773176e-14
the O 0 1.3430966061545035e-10
DM B-Disease 1 1.0
expansion O 0 6.034761668161082e-08
tends O 0 2.913918273339533e-10
to O 0 5.361967120309785e-11
be O 0 7.981052624339569e-11
transmitted O 0 7.978504079630966e-09
preferentially O 0 6.706407651435597e-10
. O 0 1.7696012433177088e-09

Diagnosis O 1 1.0
of O 1 0.5926733016967773
hemochromatosis B-Disease 1 1.0
. O 0 0.0007322318269871175

If O 0 6.456624305428704e-06
untreated O 1 1.0
, O 0 6.683830711118333e-10
hemochromatosis B-Disease 1 1.0
can O 0 4.598954888024309e-07
cause O 0 2.508357397346117e-07
serious O 0 2.524330398046004e-07
illness O 0 0.08447840809822083
and O 0 1.9665375556275622e-13
early B-Disease 0 7.659830408845991e-11
death I-Disease 0 2.734406234425335e-12
, O 0 1.6864656372794773e-14
but O 0 1.6684685588425757e-14
the O 0 4.5275477702881595e-13
disease O 0 5.438659505391241e-12
is O 0 2.668401540988118e-15
still O 0 3.831727348065604e-14
substantially O 0 2.154452866109935e-10
under O 0 3.1677331868706915e-09
- O 0 1.996360651901341e-06
diagnosed O 0 5.199639872444095e-06
. O 0 4.325990943243596e-08

The O 0 8.49955106296818e-10
cornerstone O 0 3.1928053090268804e-07
of O 0 1.8866494477798312e-10
screening O 0 7.066115748077806e-11
and O 0 3.851304989982082e-14
case O 0 1.9376808710618205e-14
detection O 0 6.28074328656858e-11
is O 0 3.4925518931723434e-16
the O 0 7.857541792785985e-15
measurement O 0 4.1528860211803575e-11
of O 0 1.0429958979818466e-11
serum O 0 1.0473018285939162e-11
transferrin O 0 1.3591307246318962e-10
saturation O 0 1.3892056949238452e-10
and O 0 3.9676912471676984e-13
the O 0 3.7751919645945264e-11
serum O 0 2.0594784211347417e-10
ferritin O 0 6.339373914698854e-09
level O 0 4.7743431430546934e-09
. O 0 2.6669138009083326e-09

Once O 0 3.891217126295032e-09
the O 0 4.99064158054896e-12
diagnosis O 0 2.6915770945379336e-08
is O 0 2.813947635831298e-14
suspected O 0 1.3748999161400377e-10
, O 0 6.839868840584351e-13
physicians O 0 4.405135284324402e-11
must O 0 1.9899568104442267e-10
use O 0 2.263013554326676e-09
serum O 0 9.413682278136548e-08
ferritin O 0 3.1983445296646096e-06
levels O 0 2.982704643272882e-07
and O 0 2.9919830502045386e-10
hepatic O 0 5.467167625283764e-07
iron O 0 2.4746677809162065e-06
stores O 0 8.352278313417116e-10
on O 0 4.749337034759549e-10
liver O 0 1.6578395323207928e-09
biopsy O 0 5.382353229776982e-09
specimens O 0 1.830283537576638e-12
to O 0 3.8065271421028335e-12
assess O 0 4.1613876233803637e-10
patients O 0 1.4103391197950454e-11
for O 0 8.836671628806303e-13
the O 0 6.628246562723206e-11
presence O 0 1.172775210278587e-10
of O 0 7.706762339410034e-09
iron B-Disease 0 6.7425830820866395e-06
overload I-Disease 0 7.412947979901219e-06
. O 0 2.441638535799484e-08

Liver O 0 0.07164779305458069
biopsy O 1 0.9999657869338989
is O 0 7.546251817869276e-12
also O 0 9.695849774915468e-15
used O 0 1.3761257758315715e-13
to O 0 2.6173581531285794e-12
establish O 0 7.634717302806848e-10
the O 0 5.597137336943447e-12
presence O 0 3.1579838570550134e-13
or O 0 9.597386904300342e-13
absence O 0 4.233473571702007e-09
of O 0 3.5449128077402747e-09
cirrhosis B-Disease 0 0.013275917619466782
, O 0 7.930877092207633e-13
which O 0 1.6660580724812794e-14
can O 0 1.0962733542133063e-12
affect O 0 8.363449516268773e-11
prognosis O 0 5.111341039309991e-08
and O 0 1.2787049197271472e-11
management O 0 1.8504566767774122e-08
. O 0 1.630227508542248e-08

A O 0 1.644765545982807e-09
DNA O 0 9.54577306089277e-10
- O 0 2.848999898844018e-12
based O 0 1.1471225326646324e-15
test O 0 2.1592906092717315e-14
for O 0 3.585675965942902e-15
the O 0 2.662039696749857e-13
HFE O 0 3.400461707769864e-07
gene O 0 1.4864886123226728e-13
is O 0 1.895083965309228e-15
commercially O 0 1.3943948426464736e-11
available O 0 1.592849116494044e-12
, O 0 9.99763999072565e-15
but O 0 8.71464257365135e-15
its O 0 6.362260554954339e-15
place O 0 2.4308207356715794e-12
in O 0 8.402402173557713e-14
the O 0 8.806184405817097e-13
diagnosis O 0 1.0713503115766798e-06
of O 0 3.0365232550622068e-09
hemochromatosis B-Disease 1 1.0
is O 0 5.944125833906577e-12
still O 0 7.89417836655204e-12
being O 0 1.964357843053932e-11
evaluated O 0 3.4950033978020656e-09
. O 0 9.99763205555837e-09

Currently O 0 1.632270985041373e-09
, O 0 1.7239622273138022e-13
the O 0 7.281253508115149e-13
most O 0 4.205071349721451e-14
useful O 0 1.0953167192684354e-11
role O 0 7.546968150244637e-13
for O 0 7.845445484672836e-14
this O 0 1.1632341411719344e-13
test O 0 2.894494539884551e-12
is O 0 4.1785566773735495e-15
in O 0 2.155233490860973e-14
the O 0 5.605264516428399e-13
detection O 0 4.402807007863885e-08
of O 0 7.846808758316115e-10
hemochromatosis B-Disease 1 1.0
in O 0 1.0597243221832642e-10
the O 0 4.0312076593496116e-11
family O 0 1.4681739981745046e-12
members O 0 3.5708214813842676e-13
of O 0 1.1302928211442964e-11
patients O 0 1.2176281033796088e-12
with O 0 3.0360869390398323e-14
a O 0 4.5589630161269046e-12
proven O 0 4.304178347069865e-09
case O 0 5.489483650630844e-13
of O 0 4.316045090768661e-11
the O 0 2.1362235591571022e-10
disease O 0 1.2242528102390793e-09
. O 0 6.739850899606381e-10

It O 0 1.4147630983396553e-11
is O 0 5.560541176813372e-13
crucial O 0 3.3207777505595004e-07
to O 0 2.8225846904206264e-07
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999996423721313
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 2.7890452614087735e-08
because O 0 1.6555817480834456e-11
phlebotomy O 0 0.0001543993130326271
therapy O 0 1.3383231816987973e-05
can O 0 5.589768578562193e-11
avert O 0 1.861487142207352e-08
serious O 0 1.7384863895131275e-05
chronic O 1 1.0
disease O 0 6.547302291437518e-06
and O 0 7.4248306071098e-14
can O 0 1.4205887713999305e-13
even O 0 3.758080543807274e-14
lead O 0 2.5832901356243054e-12
to O 0 1.7775006726922227e-12
normal O 0 2.2645765263007434e-09
life O 0 5.3693742160798585e-12
expectancy O 0 4.7426718802201506e-11
. O 0 6.958907191809138e-13
. O 0 1.3609179061457866e-10

Prevalence O 0 9.26801590139803e-07
of O 0 3.449279750711298e-10
the O 0 5.141687076104517e-10
I1307K O 0 3.8372976973732875e-07
APC B-Disease 0 5.6332711828588344e-09
gene O 0 3.4102598132565443e-13
variant O 0 4.135696776361164e-13
in O 0 5.920720321352449e-14
Israeli O 0 1.1286845902347409e-09
Jews O 0 2.8729681827988074e-11
of O 0 1.7223988077810781e-12
differing O 0 1.955204119268028e-14
ethnic O 0 3.496447990619829e-14
origin O 0 1.9725818472138973e-13
and O 0 3.801763388149894e-14
risk O 0 6.541835823048459e-11
for O 0 6.020549836449618e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.011892527458258e-05

BACKGROUND O 0 2.6352865461376496e-05
& O 0 7.86365674798617e-08
AIMS O 0 7.031425752757059e-08
Israeli O 0 3.696407091524634e-08
Jews O 0 8.362065484490699e-10
of O 0 3.0160823838443207e-10
European O 0 5.534242508709042e-11
birth O 0 5.249241596949616e-10
, O 0 3.165848117513137e-13
i O 0 1.907809413920214e-12
. O 0 1.950392836602352e-13
e O 0 3.630452329820427e-13
. O 0 2.2786490034253093e-13
, O 0 3.199514763373157e-13
Ashkenazim O 0 2.919607133833324e-08
, O 0 1.4176761977888197e-13
have O 0 9.547992550675705e-14
the O 0 5.850657458505992e-11
highest O 0 0.25903084874153137
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 1.314031692345452e-07
of O 0 1.644874514372674e-10
any O 0 1.1373856500726531e-12
Israeli O 0 6.680850983542541e-09
ethnic O 0 4.1446424070556986e-10
group O 0 1.2111794856980995e-12
. O 0 2.6053420532079485e-10

The O 0 1.2589873588098044e-09
I1307K O 0 7.916327859902594e-08
APC B-Disease 0 1.9498165304554504e-09
gene O 0 3.3992849767655597e-13
variant O 0 6.42774548864633e-12
was O 0 6.323752632653168e-11
found O 0 3.2554650164842713e-13
in O 0 9.632046679350359e-13
6 O 0 2.565988754810178e-09
. O 0 4.9002206736759035e-09

1 O 0 1.120672554755231e-09
% O 0 8.511134019784095e-10
of O 0 2.4255224564950773e-12
American O 0 2.1460910576854425e-13
Jews O 0 1.6757801743483292e-12
, O 0 5.847499151150114e-15
28 O 0 7.624552031404441e-12
% O 0 3.929264205670968e-11
of O 0 2.7894121474442146e-12
their O 0 2.2475490357720673e-09
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 6.957368903215411e-09
, O 0 1.3678981721203937e-13
but O 0 1.2265075192724895e-14
not O 0 1.0765416912138313e-14
in O 0 1.2220440588281423e-12
non O 0 3.0391420491326926e-09
- O 0 1.9392376593430072e-10
Jews O 0 3.022987693501733e-10
. O 0 3.664241576828431e-09

We O 0 1.2590312792326586e-08
assessed O 0 4.922978646959564e-08
the O 0 6.676020292140095e-10
I1307K O 0 9.071144404515508e-07
prevalence O 0 4.672128309235468e-11
in O 0 4.036392361572282e-15
Israeli O 0 1.750919825793673e-10
Jews O 0 2.412586276590023e-11
of O 0 9.42332475072083e-13
differing O 0 1.2188490708798898e-14
ethnic O 0 1.2039691583921788e-14
origin O 0 3.820956951446769e-13
and O 0 5.079593904245942e-14
risk O 0 8.152571673303299e-11
for O 0 9.054876848324511e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.671767187071964e-05

METHODS O 0 1.9180298238552496e-07
DNA O 0 3.4469471721365608e-09
samples O 0 3.733485742785092e-12
from O 0 3.944320727238687e-14
500 O 0 8.156156956415361e-13
unrelated O 0 8.10787634947241e-12
Jews O 0 2.4320323532833754e-11
of O 0 3.4441655083483624e-10
European O 0 7.112838096290375e-10
or O 0 1.0438481329311244e-10
non O 0 2.08886650199247e-08
- O 0 3.228871336968808e-11
European O 0 5.074766128154717e-12
origin O 0 1.0655122617553303e-11
, O 0 7.989047893011952e-15
with O 0 5.914100504759772e-16
or O 0 8.351747401026243e-15
without O 0 7.206612558227285e-14
a O 0 8.188106226034164e-14
personal O 0 1.680817152127645e-10
and O 0 2.5093948186755144e-12
/ O 0 2.5197559807565995e-06
or O 0 6.574771282963354e-11
family O 0 1.744470995608538e-12
history O 0 3.5576163542883066e-11
of O 0 6.713209415448729e-12
neoplasia B-Disease 0 3.493075551030955e-10
, O 0 3.2571154432413374e-14
were O 0 3.172654738752001e-13
examined O 0 2.156288168853049e-12
for O 0 5.713199959780577e-14
the O 0 9.512642409892358e-13
I1307K O 0 1.0432510411106932e-10
variant O 0 9.449773151210938e-15
by O 0 7.487739489992493e-16
the O 0 1.756275246761474e-13
allele O 0 2.5816154769486843e-12
- O 0 6.271710581429168e-13
specific O 0 1.6423139432598932e-13
oligonucleotide O 0 2.7303452831972663e-09
( O 0 4.480789871086355e-12
ASO O 0 0.357047975063324
) O 0 6.824726873043419e-13
method O 0 3.4340454924119967e-09
. O 0 2.220419847986932e-09

RESULTS O 0 8.169815401970482e-08
In O 0 4.219217336620673e-11
persons O 0 1.501158780614631e-10
at O 0 1.480028426203983e-11
average O 0 6.164124766172563e-12
risk O 0 2.0137658901520084e-11
for O 0 7.729812345758091e-10
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.1777298025705818e-09
I1307K O 0 1.4572107431831682e-07
was O 0 1.867946769484874e-11
found O 0 4.465992462995838e-13
in O 0 1.6600859142207325e-13
5 O 0 6.629890386689041e-11
. O 0 4.942006248676023e-10

0 O 0 2.234127466360647e-10
% O 0 4.6026005229293787e-10
of O 0 1.9835203358270492e-12
120 O 0 6.233137617162043e-11
European O 0 8.491121000764323e-11
and O 0 1.8257029568702343e-11
1 O 0 4.879860071582698e-09
. O 0 5.11523001733849e-09

6 O 0 1.708163277491792e-09
% O 0 1.1872923477707076e-10
of O 0 9.76579385934817e-13
188 O 0 8.85395229355268e-12
non O 0 2.896686002173965e-09
- O 0 2.65656580067386e-10
European O 0 9.124684341443867e-11
Jews O 0 2.94078739138115e-09
( O 0 6.570640299213837e-13
P O 0 3.0387712346424678e-09
= O 0 5.642195695029772e-13
0 O 0 1.2038313461316605e-14
. O 0 6.000045549785877e-15
08 O 0 1.0517231616852252e-12
) O 0 1.144678020989845e-13
. O 0 5.6749899918218105e-11

It O 0 2.1729030033612595e-11
occurred O 0 1.4949933513364044e-09
in O 0 2.9710129755694537e-12
15 O 0 3.8471573149401195e-10
. O 0 9.301943104667032e-10

4 O 0 1.2951025807339533e-09
% O 0 2.6100921424188073e-10
of O 0 2.7040138791262214e-12
52 O 0 6.30816371360865e-11
Ashkenazi O 0 1.0080460910444344e-09
Israelis O 0 1.2061774157245964e-07
with O 0 3.617749112436175e-12
familial O 0 1.139540231065439e-07
cancer B-Disease 0 8.021964276849758e-06
( O 0 6.573928033881682e-12
P O 0 4.4935683263247483e-07
= O 0 9.261993082210207e-12
0 O 0 1.1335560040539455e-13
. O 0 1.2267649325851601e-14
02 O 0 1.1410143663237449e-12
) O 0 5.398403553065305e-16
and O 0 2.9803394232646432e-15
was O 0 1.8740294960382237e-13
not O 0 3.1855323500556976e-14
detected O 0 5.343951193018115e-13
in O 0 6.91510854112197e-14
51 O 0 6.324865076123842e-10
non O 0 1.607830490968354e-08
- O 0 5.471355590813687e-10
European O 0 1.8592320738530788e-10
Jews O 0 1.6673276093115419e-09
at O 0 8.56931858805865e-10
increased O 0 2.373856666793017e-10
cancer B-Disease 0 3.5532915498848183e-10
risk O 0 9.155908670122059e-11
. O 0 3.3259925924511435e-09

Colorectal B-Disease 0 0.32315778732299805
neoplasia I-Disease 0 0.0002684812934603542
occurred O 0 1.8775133867166005e-05
personally O 0 7.756666420277725e-09
or O 0 1.0545997668892637e-12
in O 0 1.254995320989702e-13
the O 0 1.6373596814327207e-13
families O 0 5.449369525501596e-14
of O 0 9.802184021065474e-13
13 O 0 2.95103316783063e-11
of O 0 1.7830781295913312e-10
20 O 0 8.675393736723436e-10
Ashkenazi O 0 1.588086639969788e-08
I1307K O 0 8.159456221790151e-09
carriers O 0 1.8711445153724027e-12
, O 0 1.4338621164965842e-13
8 O 0 2.5670091052809596e-11
of O 0 1.3576229029865772e-10
whom O 0 1.1038537861551845e-09
also O 0 1.015242317298215e-11
had O 0 3.026690356677797e-11
a O 0 6.419316467276559e-12
personal O 0 3.016733973737473e-09
or O 0 3.1812382589313515e-11
family O 0 4.7937083989813e-12
history O 0 2.227031198342999e-10
of O 0 2.15861239993842e-09
noncolonic O 0 1.323329342994839e-06
neoplasia B-Disease 0 4.8896308726398274e-06
. O 0 2.459015888689464e-07

CONCLUSIONS O 0 5.782646326224494e-07
The O 0 1.8670192059033752e-09
I1307K O 0 6.972023243179137e-07
APC O 0 1.0915435666447593e-08
variant O 0 3.712272433897823e-10
may O 0 3.725947328447887e-11
represent O 0 2.4346094584792866e-10
a O 0 9.317813187692536e-11
susceptibility O 0 1.6744015896019704e-10
gene O 0 4.85906670802394e-12
for O 0 2.1010355955031201e-10
colorectal B-Disease 1 1.0
, I-Disease 0 2.133001153481473e-08
or I-Disease 0 9.478101636872793e-10
other I-Disease 0 6.680207775833225e-11
, I-Disease 0 1.1573153893551513e-11
cancers I-Disease 0 2.513323806851986e-07
in O 0 1.453990816635553e-10
Ashkenazi O 0 4.510570406068837e-08
Jews O 0 1.0893694835090173e-09
, O 0 3.756980837543722e-12
and O 0 2.760639807031229e-12
partially O 0 3.761353006836998e-09
explains O 0 8.186802798182402e-12
the O 0 8.164269607591201e-12
higher O 0 2.1667798666413773e-09
incidence O 0 1.3635870743655687e-07
of O 0 2.1621547148242826e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.9635317816124598e-09
European O 0 9.659285177265886e-11
Israelis O 0 2.6644445938472927e-07
. O 0 1.368543589563842e-08

Systematic O 0 9.701276448836893e-10
analysis O 0 1.1398756244451747e-10
of O 0 6.4440383584774e-11
coproporphyrinogen O 0 1.3435032997222152e-07
oxidase O 0 1.8155025260924162e-09
gene O 0 4.197787395465724e-10
defects O 0 1.2944542504556011e-07
in O 0 5.240895217806241e-11
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999998807907104
and O 0 4.714399981509132e-10
mutation O 0 1.2736670051971544e-10
update O 0 9.334010009354188e-09
. O 0 1.345166200650283e-09

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 1.6966029969811558e-10
HC B-Disease 1 1.0
) O 0 4.605650083533419e-09
is O 0 6.451553180575331e-11
an O 0 5.765688620984477e-11
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 5.006067112844903e-06
autosomal O 1 1.0
dominant O 1 0.9852942228317261
inheritance O 0 1.6307998507159027e-08
caused O 0 6.59396079405461e-11
by O 0 4.9687345709224784e-14
deficient B-Disease 0 2.8581359501345105e-10
activity I-Disease 0 6.550122423620852e-12
of I-Disease 0 5.646547899390564e-12
coproporphyrinogen I-Disease 0 4.780108531221572e-10
III I-Disease 0 1.0699126917756985e-08
oxidase I-Disease 0 5.8969912286599424e-12
( O 0 2.1095573747055563e-13
CPO O 0 1.0148760054562445e-08
) O 0 1.0686582911992315e-12
. O 0 2.3366747425868084e-10

Clinical O 0 9.215679710905533e-06
manifestations O 0 2.6767002054839395e-06
of O 0 6.186173351352409e-08
the O 0 3.664898606814404e-09
disease O 0 9.346961427070255e-09
are O 0 3.591753850855925e-15
characterized O 0 2.1229114759234013e-15
by O 0 7.335131152072462e-16
acute O 0 3.9016510022804596e-09
attacks O 0 1.2190932985323144e-10
of O 1 0.7995818257331848
neurological B-Disease 1 1.0
dysfunction I-Disease 1 0.9999998807907104
often O 0 2.845585399258166e-11
precipitated O 0 2.7488022708715976e-12
by O 0 4.051077795295304e-15
drugs O 0 7.455757474079949e-13
, O 0 8.721261289101195e-15
fasting O 0 1.86391554968246e-10
, O 0 1.1975255856389033e-12
cyclical O 0 8.66328953019746e-10
hormonal O 0 1.4254772917610126e-09
changes O 0 2.242613907077473e-11
, O 0 4.0031412212870876e-11
or O 0 8.964897268981531e-09
infectious B-Disease 0 3.922666280686826e-07
diseases I-Disease 0 1.1640587871397656e-07
. O 0 1.0048331056111692e-08

Skin O 1 1.0
photosensitivity O 1 0.9999797344207764
may O 0 8.39782554606927e-09
also O 0 2.8725390122108507e-12
be O 0 2.5600795355157357e-12
present O 0 4.359398259046188e-11
. O 0 9.792967547994635e-10

The O 0 1.8108371468983364e-09
seven O 0 2.5257971270065127e-09
exons O 0 1.949649108823337e-09
, O 0 1.1983704230767583e-13
the O 0 2.099775431654849e-12
exon O 0 2.2411698885616005e-10
/ O 0 1.4543798387833817e-09
intron O 0 3.3756186734734683e-09
boundaries O 0 8.092152642413808e-11
and O 0 2.8660361302106085e-13
part O 0 1.896403867274188e-11
of O 0 6.407286368137477e-10
3 O 0 2.642395746654813e-10
noncoding O 0 3.3806832888672034e-09
sequence O 0 5.499326688473971e-12
of O 0 6.331899587985745e-11
the O 0 8.876174795169334e-11
CPO O 0 2.575620605682616e-08
gene O 0 2.2353175083492105e-13
were O 0 5.552087001953199e-12
systematically O 0 6.459454932744579e-12
analyzed O 0 3.6233131295651533e-13
by O 0 4.6052232665315385e-15
an O 0 1.1672651879085765e-14
exon O 0 2.5299350288332523e-12
- O 0 3.9553221266828975e-13
by O 0 5.226993967863414e-13
- O 0 4.878554782372646e-10
exon O 0 1.9199453138440958e-10
denaturing O 0 5.22668530678061e-09
gradient O 0 1.5537902908757673e-10
gel O 0 6.068506808176721e-10
electrophoresis O 0 2.76135891930096e-10
( O 0 3.6704664372992635e-13
DGGE O 0 3.707721771206707e-05
) O 0 5.326178747718825e-15
strategy O 0 8.744389760895199e-13
followed O 0 1.2123887505911812e-15
by O 0 6.786938178403277e-17
direct O 0 1.6855684599817455e-14
sequencing O 0 3.2552634199323194e-11
in O 0 8.226697860262699e-13
seven O 0 5.641953571000613e-11
unrelated O 0 3.7283803822063533e-10
heterozygous O 0 1.2338519095322908e-10
HC B-Disease 0 1.047122168529313e-05
patients O 0 5.006246528438396e-09
from O 0 2.6204041159161306e-09
France O 0 8.478760471497537e-10
, O 0 1.6020872779451412e-12
Holland O 0 4.4151706596329277e-11
, O 0 9.729683150740825e-14
and O 0 4.637044261480809e-14
Czech O 0 9.501618158935798e-09
Republic O 0 1.7145774222626642e-07
. O 0 1.1042990877285774e-07

Seven O 0 1.4215593147071104e-09
novel O 0 5.817479744457676e-13
mutations O 0 1.055768970512072e-12
and O 0 3.6354118771331906e-14
two O 0 1.0904878345804891e-13
new O 0 1.807855216440571e-13
polymorphisms O 0 7.645438448999897e-11
were O 0 9.42703762274455e-11
detected O 0 1.4427975481012822e-09
. O 0 1.77889059038705e-09

Among O 0 3.9480096969413125e-10
these O 0 4.983678834197258e-12
mutations O 0 6.2705175253585654e-12
two O 0 7.963998926475979e-13
are O 0 2.070377154222633e-13
missense O 0 6.650868744628724e-10
( O 0 8.877452809322173e-13
G197W O 0 5.991935125848613e-08
, O 0 2.786179056565863e-12
W427R O 0 1.2625855916326145e-08
) O 0 1.5910992141876523e-13
, O 0 5.5995447401048157e-14
two O 0 6.759022052986452e-13
are O 0 6.99251583285293e-13
nonsense O 0 3.6726306440471035e-09
( O 0 7.850659141869776e-13
Q306X O 0 2.483293570776368e-08
, O 0 9.09664704673574e-13
Q385X O 0 8.371900506176644e-09
) O 0 9.522803823703435e-14
, O 0 7.142187909885481e-14
two O 0 2.562530537156965e-13
are O 0 1.072899703650522e-13
small O 0 1.6468749107489966e-13
deletions O 0 1.1947929624833709e-11
( O 0 5.234836002177001e-13
662de14bp O 0 2.810073063130858e-08
; O 0 1.3435820381615948e-12
1168del3bp O 0 2.4342357463069675e-08
removing O 0 1.7493384518729727e-09
a O 0 1.7858384215863055e-10
glycine O 0 6.053744172618281e-10
at O 0 5.988490814345937e-10
position O 0 3.3451727499134165e-10
390 O 0 1.0522238635957137e-10
) O 0 3.626505495099401e-14
, O 0 7.161090127729818e-15
and O 0 2.0583264842446818e-15
one O 0 1.1382698948713462e-14
is O 0 1.0605137049754558e-16
a O 0 1.1989047484005453e-14
splicing O 0 9.904577158437178e-12
mutation O 0 3.369944297573757e-13
( O 0 1.1040531519340615e-14
IVS1 O 0 1.7845913191649743e-07
- O 0 2.3541749105682186e-10
15c O 0 3.3753420058957317e-09
- O 0 4.957120269821758e-10
- O 0 1.740312061127014e-10
> O 0 3.663930270292326e-11
g O 0 7.045504045628814e-13
) O 0 1.609822326915293e-15
which O 0 2.9413602905209804e-16
creates O 0 9.428493142477068e-15
a O 0 9.183874262474762e-15
new O 0 3.763223389049823e-14
acceptor O 0 2.034321378019399e-09
splice O 0 5.232762987361639e-07
site O 0 1.6987417694735996e-08
. O 0 1.383329362170116e-08

The O 0 2.9295584624833282e-08
pathological O 0 2.0554228541413977e-08
significance O 0 9.160996405910282e-10
of O 0 3.387678471078459e-10
the O 0 1.1661838161813876e-10
point O 0 5.272128844602264e-10
mutations O 0 2.25425190666928e-12
G197W O 0 2.3032018514612673e-09
, O 0 4.460561152212772e-13
W427R O 0 1.705878460711574e-08
, O 0 1.2057714581566875e-13
and O 0 2.272900597388109e-14
the O 0 2.4194650189574007e-12
in O 0 7.59236510466943e-12
- O 0 4.299054515155554e-11
frame O 0 4.1636905034891925e-10
deletion O 0 5.829404320367715e-11
390delGly O 0 1.1620295004011183e-10
were O 0 2.54890103164665e-13
assessed O 0 2.0739264255595358e-13
by O 0 3.3323239644961677e-16
their O 0 6.340409561310725e-14
respective O 0 2.6580457279656855e-10
expression O 0 2.751617564442782e-13
in O 0 1.2073402648189561e-14
a O 0 3.617398196850523e-15
prokaryotic O 0 9.123126516394353e-13
system O 0 9.204453605554663e-13
using O 0 5.610034463886249e-13
site O 0 1.6256234205980213e-11
- O 0 6.989262684234387e-13
directed O 0 4.3786748180193666e-14
mutagenesis O 0 2.990050873563632e-09
. O 0 2.8613118541187532e-09

These O 0 2.8991593847838004e-11
mutations O 0 4.121650503535745e-12
resulted O 0 3.850684528183823e-12
in O 0 6.581901365078358e-14
the O 0 6.082113437021197e-13
absence O 0 1.7129324347830988e-10
or O 0 6.633147264963057e-13
a O 0 1.454224381972763e-13
dramatic O 0 1.934580967644095e-12
decrease O 0 6.402082197709547e-10
of O 0 1.7721952794147455e-09
CPO O 0 5.333548074304417e-07
activity O 0 8.255763184195075e-09
. O 0 1.3076231653030845e-08

The O 0 3.4952482574901467e-10
two O 0 2.6556918556602804e-12
polymorphisms O 0 6.212944655276109e-12
were O 0 6.626027851397431e-13
localized O 0 1.5267525741921584e-12
in O 0 1.8665951217414906e-13
noncoding O 0 1.469643573503987e-10
part O 0 4.596349342800288e-12
of O 0 3.675663662328077e-10
the O 0 4.515143120498166e-11
gene O 0 9.01174107396669e-15
1 O 0 2.491518547465682e-13
) O 0 1.8464731679827774e-15
a O 0 3.5320959481874303e-13
C O 0 3.2414113060319494e-10
/ O 0 9.835360997856313e-11
G O 0 5.343590153694677e-11
polymorphism O 0 5.180252060643653e-11
in O 0 9.12970762358134e-13
the O 0 1.5790561566642047e-11
promotor O 0 1.6064623196143657e-06
region O 0 8.459908884539402e-10
, O 0 3.463290038866612e-13
142 O 0 2.7274552061307133e-10
bp O 0 5.25753829361264e-10
upstream O 0 1.400798504969103e-10
from O 0 8.090277037707538e-13
the O 0 1.280666653453999e-12
transcriptional O 0 2.5964015659685202e-11
initiation O 0 3.474336096598307e-11
site O 0 4.4180600150545146e-11
( O 0 2.6844320630313792e-14
- O 0 6.45231576501537e-11
142C O 0 5.79822767576843e-09
/ O 0 5.29319504893877e-11
G O 0 1.848802708148689e-11
) O 0 8.946012164292704e-15
, O 0 7.501381379124497e-15
and O 0 5.561935545510483e-15
2 O 0 2.328853527123337e-13
) O 0 2.346382484331609e-15
a O 0 4.238989937061302e-14
6 O 0 2.143772572654745e-12
bp O 0 4.356112692782688e-12
deletion O 0 4.362365069870977e-12
polymorphism O 0 4.821090054951682e-11
in O 0 4.778809292727004e-12
the O 0 8.806256071580698e-12
3 O 0 6.315122036415488e-11
noncoding O 0 7.041542460228811e-09
part O 0 1.3456805982026143e-11
of O 0 2.451183145346647e-10
the O 0 4.914989526483282e-10
CPO O 0 1.0746621370572029e-07
gene O 0 3.6598477612219404e-13
, O 0 3.4967433679491955e-13
574 O 0 3.276406368435403e-10
bp O 0 2.2438730040708066e-10
downstream O 0 2.9550278890511095e-10
of O 0 1.3006587994135455e-11
the O 0 1.2309076284286458e-12
last O 0 4.002467194480497e-12
base O 0 2.069463350684586e-11
of O 0 1.3888095317868276e-12
the O 0 6.745164865019915e-13
normal O 0 1.7194595747227481e-10
termination O 0 8.949204571839786e-11
codon O 0 1.20998933095251e-10
( O 0 8.185904617997661e-14
+ O 0 5.640877695500812e-11
574 O 0 2.4648554308726034e-09
delATTCTT O 0 1.1611493988539223e-07
) O 0 1.1301741660585396e-11
. O 0 2.0438033487835128e-09

Five O 0 9.886947793802392e-08
intragenic O 0 4.392273694975302e-06
dimorphisms O 0 3.594135705498047e-06
are O 0 9.47996672481799e-13
now O 0 3.9667756384330344e-13
well O 0 2.311960302023297e-13
characterized O 0 4.524880361893302e-13
and O 0 3.7549997155715206e-14
the O 0 7.129510089937119e-12
high O 0 3.5187902938660365e-12
degree O 0 2.436648938175523e-10
of O 0 1.1238356772969027e-10
allelic O 0 4.841309575454034e-10
heterogeneity O 0 2.5908328260548785e-10
in O 0 2.73681823731442e-11
HC B-Disease 0 4.247379911248572e-05
is O 0 1.077558268308687e-11
demonstrated O 0 5.154488294523141e-11
with O 0 1.2506218696544617e-14
seven O 0 3.2439670524450626e-13
new O 0 9.06600406921061e-17
different O 0 2.457223257045616e-16
mutations O 0 3.1807465715520634e-15
making O 0 1.3249573116989096e-14
a O 0 5.4084059957328415e-14
total O 0 3.673432738549032e-11
of O 0 6.40189568024141e-11
nineteen O 0 4.899158412285942e-08
CPO O 0 2.5302886115241563e-06
gene B-Disease 0 2.768310691791953e-09
defects I-Disease 0 1.6020967663621377e-08
reported O 0 3.755148622608395e-11
so O 0 1.3885341444350163e-12
far O 0 3.009201178169607e-12
. O 0 7.528496923092654e-12
. O 0 1.237408842058585e-09

Coincidence O 0 3.020524559360638e-07
of O 0 3.380230262362005e-10
two O 0 1.5879471132115852e-12
novel O 0 7.262219932401351e-14
arylsulfatase O 0 9.682402657418265e-10
A O 0 3.7679408204649434e-11
alleles O 0 3.1143891719015437e-13
and O 0 1.8615037083394986e-13
mutation O 0 5.318955996133634e-13
459 O 0 6.491220321674929e-12
+ O 0 5.27110299852751e-10
1G O 0 4.3619998280064465e-08
> O 0 1.4243412005399136e-09
A O 0 4.399192954362974e-10
within O 0 5.037082903558421e-11
a O 0 4.688310070027901e-12
family O 0 2.795990435705553e-12
with O 0 1.19831436440343e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 1.596017019716775e-13
molecular O 0 1.4511578787582136e-12
basis O 0 4.76301428853354e-11
of O 0 5.677859224451076e-11
phenotypic O 0 5.880262388124891e-10
heterogeneity O 0 2.557146849824221e-08
. O 0 1.2326091791692306e-07

In O 0 4.122016061813838e-10
a O 0 1.676567565334075e-11
family O 0 2.0835847695625798e-13
with O 0 1.5453365439705206e-15
three O 0 1.1299811862033535e-13
siblings O 0 4.013904660038481e-12
, O 0 1.023847051587136e-15
one O 0 4.2448918508795333e-16
developed O 0 6.101561177964884e-14
classical O 0 4.4615360017541406e-11
late O 0 4.435385562828742e-06
infantile O 1 0.9998533725738525
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 5.6380813212575376e-11
MLD B-Disease 1 1.0
) O 0 2.095422576772754e-12
, O 0 9.480956330350926e-14
fatal O 0 3.7377628769874605e-11
at O 0 3.51851707491857e-11
age O 0 2.176818794663582e-11
5 O 0 9.441674872490147e-13
years O 0 1.989346458831226e-13
, O 0 1.991842656456455e-15
with O 0 2.8818529966632544e-15
deficient O 0 3.0738098177884865e-10
arylsulfatase O 0 1.0931687555171266e-08
A O 0 5.189279050910045e-08
( O 0 1.8412218364544097e-12
ARSA O 0 8.937530537878047e-07
) O 0 2.5318006222877117e-14
activity O 0 1.808063030891982e-12
and O 0 7.888656701070425e-15
increased O 0 3.2438880141066884e-12
galactosylsulfatide O 0 9.754751451040988e-10
( O 0 3.601691427740361e-13
GS O 0 0.0001477513724239543
) O 0 6.035165422968447e-12
excretion O 0 6.159359688950872e-10
. O 0 6.18195661328258e-10

The O 0 5.451387119492779e-10
two O 0 2.037836696264228e-12
other O 0 6.112300878109711e-14
siblings O 0 4.780304190682427e-12
, O 0 5.017511471409886e-15
apparently O 0 1.242601993522996e-10
healthy O 0 1.7488246406571761e-09
at O 0 7.900843868036134e-10
12 O 0 6.194447621510335e-09
( O 0 6.671338286488859e-13
1 O 0 1.8373295940232737e-10
/ O 0 1.3376824092858897e-09
2 O 0 8.449112069708331e-12
) O 0 1.4734576880555232e-14
and O 0 1.1232890160563225e-14
15 O 0 4.5254414365175633e-13
years O 0 4.859852212497906e-13
, O 0 2.388994170809131e-15
respectively O 0 1.1631570272924163e-12
, O 0 2.5730580301375162e-15
and O 0 1.9222415356640954e-15
their O 0 9.667201934793201e-13
father O 0 7.549350727886761e-11
, O 0 1.28058859089758e-12
apparently O 0 5.708604144949447e-10
healthy O 0 6.943217528698753e-11
as O 0 4.4987861228191e-14
well O 0 1.9430483155606637e-13
, O 0 2.6691664964427833e-14
presented O 0 5.278767006844376e-11
ARSA O 0 2.3891113869467517e-06
and O 0 2.8241894933778156e-11
GS O 1 0.9999849796295166
values O 0 9.072501083728923e-11
within O 0 2.0101587061560622e-11
the O 0 6.113679441172026e-13
range O 0 1.407675885578552e-11
of O 0 1.280826694705084e-10
MLD B-Disease 1 1.0
patients O 0 1.8267706236585468e-09
. O 0 4.255494179261632e-09

Mutation O 0 3.7693279053563344e-11
screening O 0 6.236880369797637e-12
and O 0 2.8612772958250265e-14
sequence O 0 4.968102210005376e-13
analysis O 0 1.3520365653874739e-13
disclosed O 0 1.0506510592089846e-11
the O 0 4.269239177673648e-14
involvement O 0 6.682676113867192e-12
of O 0 1.2295326432334996e-12
three O 0 3.73069359693029e-13
different O 0 3.77785519881102e-12
ARSA O 0 1.9852896002703346e-05
mutations O 0 5.661246645083384e-12
being O 0 2.945125968187995e-13
the O 0 1.4859074799582206e-13
molecular O 0 3.7070449791440363e-13
basis O 0 4.685666091241991e-11
of O 0 4.795740540797233e-11
intrafamilial O 0 3.3264575449720724e-07
phenotypic O 0 5.387478019258651e-09
heterogeneity O 0 4.331274894298076e-08
. O 0 9.579962068073655e-08

The O 0 7.955402447912263e-10
late O 0 7.704767313043703e-08
infantile O 0 1.3933613445260562e-05
patient O 0 5.749350995287728e-10
inherited O 0 2.6490685200997177e-09
from O 0 3.783530780343547e-12
his O 0 5.907869332633098e-11
mother O 0 5.924386415473437e-12
the O 0 1.2623837739034194e-11
frequent O 0 1.0982365190870258e-12
0 O 0 2.8173984412821484e-12
- O 0 8.099317050369592e-11
type O 0 3.978858215125669e-11
mutation O 0 3.0494265966518608e-12
459 O 0 2.2194607263159583e-11
+ O 0 4.7014937082368036e-11
1G O 0 1.066818855477436e-09
> O 0 2.024186374072201e-11
A O 0 3.102014131672881e-11
, O 0 2.8882912940953343e-15
and O 0 5.068004587703372e-16
from O 0 7.263480317426865e-14
his O 0 6.549735580285709e-12
father O 0 1.2729425152846474e-11
a O 0 4.443168923062846e-14
novel O 0 1.1267303203386036e-15
, O 0 9.593084879018379e-17
single O 0 2.154920935703436e-14
basepair O 0 2.5192670172202725e-10
microdeletion O 0 3.4830647255290614e-09
of O 0 2.486262307144216e-10
guanine O 0 1.3669039511388092e-10
at O 0 1.865291809899361e-10
nucleotide O 0 2.573004136141588e-11
7 O 0 4.51125213574155e-11
in O 0 2.0279503770703755e-11
exon O 0 1.6868455243734815e-10
1 O 0 1.0362223232251999e-11
( O 0 4.375204083577333e-13
7delG O 0 9.867257233509008e-09
) O 0 7.69767236064034e-12
. O 0 1.6337006192301828e-09

The O 0 1.8880830232603785e-09
two O 0 2.0045468063223382e-10
clinically O 0 8.427660759480204e-06
unaffected O 0 3.186184427406147e-09
siblings O 0 8.937839184042229e-12
carried O 0 2.6985304182186587e-13
the O 0 5.938457191267954e-13
maternal O 0 7.662607354186335e-11
mutation O 0 7.057985923139554e-13
459 O 0 2.1918257139819097e-11
+ O 0 5.233066757703853e-10
1G O 0 2.129915444015751e-08
> O 0 6.179952660723131e-10
A O 0 6.093479054669615e-10
and O 0 1.3960379618808971e-13
, O 0 1.2759791561832348e-14
on O 0 3.295504602714161e-13
their O 0 1.6617680538913437e-13
paternal O 0 1.731226620393933e-11
allele O 0 4.548228113576691e-12
, O 0 8.63607857372762e-15
a O 0 1.3342645097233399e-14
novel O 0 1.3252250588135367e-14
cytosine O 0 1.824623785395829e-11
to O 0 3.6116955780263194e-12
thymidine O 0 2.1023114360474437e-09
transition O 0 4.3964966778275993e-08
at O 0 1.3396816989086346e-09
nucleotide O 0 1.3209282556658763e-09
2435 O 0 8.243461735446544e-08
in O 0 4.4539687910072345e-11
exon O 0 8.97392549159548e-10
8 O 0 3.381711577432611e-11
, O 0 5.968386592239416e-14
resulting O 0 2.2977561693615645e-13
in O 0 6.623485261777681e-14
substitution O 0 1.043967169656046e-11
of O 0 8.765672215860221e-11
alanine O 0 1.5558603017051809e-10
464 O 0 2.6625260329815603e-10
by O 0 2.937017642978823e-11
valine O 0 3.58344391315768e-06
( O 0 7.104126314994019e-12
A464V O 0 5.216231002691529e-08
) O 0 2.2533233959287635e-12
. O 0 2.8289787179502923e-10

The O 0 1.6103616218288153e-09
fathers O 0 5.01239716399482e-10
genotype O 0 7.278844194047451e-11
thus O 0 7.98056152412352e-12
was O 0 8.30823118636026e-11
7delG O 0 4.130446029648738e-07
/ O 0 1.0158926215808606e-06
A464V O 0 1.9589001567510422e-06
. O 0 1.7142928188107476e-09

Mutation O 0 4.192460600904724e-09
A464V O 0 1.414930466125952e-07
was O 0 1.6598755356311834e-11
not O 0 1.6648962482095075e-13
found O 0 8.572865182500389e-14
in O 0 5.4470002049415364e-14
18 O 0 2.2439059291223806e-11
unrelated O 0 4.8509805061769384e-09
MLD B-Disease 1 1.0
patients O 0 1.9492205072246804e-10
and O 0 1.6880023854387582e-12
50 O 0 4.949299636791693e-09
controls O 0 8.735342049703831e-08
. O 0 5.133519564992639e-08

A464V O 0 1.2063736903655808e-05
, O 0 9.43505516770582e-12
although O 0 9.372815891472985e-12
clearly O 0 4.364672859247243e-11
modifying O 0 4.318635227207324e-09
ARSA O 0 0.00011981934949290007
and O 0 5.17024534296695e-10
GS O 1 1.0
levels O 0 4.62857308036746e-09
, O 0 1.8619441654720709e-13
apparently O 0 1.5431366254259338e-11
bears O 0 1.2004808605525774e-11
little O 0 2.4979421742871155e-13
significance O 0 1.0854996372253178e-12
for O 0 6.643500989134479e-14
clinical O 0 4.9845846200602395e-11
manifestation O 0 3.192389241846172e-09
of O 0 2.585858815962183e-08
MLD B-Disease 1 1.0
, O 0 1.562244777986166e-10
mimicking O 0 1.260676674164074e-09
the O 0 7.335681367903746e-11
frequent O 0 1.5811372211516073e-09
ARSA O 0 2.6510610041441396e-05
pseudodeficiency O 0 5.540292136174685e-07
allele O 0 1.1976468705654497e-08
. O 0 1.6024877425024897e-08

Our O 0 1.1339156280598672e-08
results O 0 3.5935431713651766e-11
demonstrate O 0 1.9836802339634474e-11
that O 0 1.074084152172315e-15
in O 0 5.0059448129986545e-15
certain O 0 1.2981815329746876e-13
genetic O 0 3.236132499126465e-12
conditions O 0 8.731897843672343e-11
MLD B-Disease 1 1.0
- O 0 5.3246036912923955e-08
like O 0 3.680605733386022e-12
ARSA O 0 3.564462167560123e-05
and O 0 2.867274646878304e-11
GS O 1 0.9999998807907104
values O 0 4.2818366907670935e-11
need O 0 1.3166903548370024e-12
not O 0 1.9670766412765127e-14
be O 0 8.840966018086246e-14
paralleled O 0 1.806719530927925e-11
by O 0 3.412555137018332e-14
clinical O 0 1.083130599099924e-10
disease O 0 1.70253117159902e-11
, O 0 6.955450009894261e-15
a O 0 8.8006045593364e-14
finding O 0 1.5835379882367384e-11
with O 0 4.488740312064664e-14
serious O 0 2.0701917957666183e-09
diagnostic O 0 3.691123495741522e-08
and O 0 5.827191507101759e-11
prognostic O 0 2.9000373658050194e-08
implications O 0 3.692513794728569e-10
. O 0 6.974867350351133e-09

Moreover O 0 1.4438697348850837e-07
, O 0 3.225128844541736e-11
further O 0 7.109623445522573e-10
ARSA O 0 0.00010759120777947828
alleles O 0 1.0890620627534986e-09
functionally O 0 8.743656465526328e-09
similar O 0 1.2326908157417327e-12
to O 0 9.658290833769456e-11
A464V O 0 2.536637850880652e-07
might O 0 4.406208904683684e-12
exist O 0 2.3023123338350437e-11
which O 0 3.4779558214252573e-15
, O 0 3.911996679422042e-15
together O 0 3.7025788793450254e-13
with O 0 2.1516282137055975e-13
0 O 0 7.226871184817796e-11
- O 0 7.681956737393136e-10
type O 0 5.825230520173363e-09
mutations O 0 4.364477668161726e-09
, O 0 4.071503117292208e-12
may O 0 1.2764587997704524e-10
cause O 0 3.365872025540284e-09
pathological O 0 1.2612358091246278e-07
ARSA O 0 7.164793350966647e-05
and O 0 1.6483511777742876e-10
GS O 1 0.9999998807907104
levels O 0 1.1732994575908151e-09
, O 0 3.612339377276341e-14
but O 0 4.608368723381167e-15
not O 0 9.752939795560408e-15
clinical O 0 2.097782017540517e-12
outbreak O 0 1.192042070521232e-13
of O 0 2.5064374404096257e-13
the O 0 2.3078858702590965e-12
disease O 0 1.5609364495405842e-11
. O 0 5.8748414119569325e-12
. O 0 1.3357804862224043e-09

Human O 0 0.01274099014699459
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 0.006000003311783075
to O 0 5.83545336496627e-08
hematological B-Disease 1 0.9999990463256836
malignancy I-Disease 1 0.9999948740005493
and O 0 1.084644485338515e-09
neurofibromatosis B-Disease 0 0.1585148274898529
type I-Disease 0 2.073158384519047e-06
1 I-Disease 0 5.189058811083669e-06
. O 0 4.9132790280737026e-08

Heterozygous O 0 3.781422286408542e-09
germ O 0 3.673256188108098e-08
- O 0 1.4630716638208696e-09
line O 0 4.0532729950193414e-11
mutations O 0 2.838269001065579e-14
in O 0 4.634318848269724e-15
the O 0 6.522091352233195e-14
DNA O 0 6.07829875320931e-09
mismatch O 0 7.71093436924275e-06
repair O 0 0.0010385127970948815
genes O 0 8.986184713011269e-11
lead O 0 2.547252409001999e-10
to O 0 4.6003383324944025e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.7467304991878336e-06

The O 0 2.3048540853665145e-09
disease O 0 2.8629931758672456e-09
susceptibility O 0 1.4477525081546538e-11
of O 0 1.4944508130998457e-10
individuals O 0 2.7147742387434448e-11
who O 0 3.38242295283564e-10
constitutionally O 0 5.950852937530726e-06
lack O 0 1.7025953980009945e-08
both O 0 2.1850290674030326e-12
wild O 0 4.0751839294576875e-13
- O 0 1.7877816197928165e-13
type O 0 9.758527671913445e-14
alleles O 0 9.36276474102285e-14
is O 0 2.9854826073203713e-15
unknown O 0 2.705440316219665e-10
. O 0 3.2721722553752386e-10

We O 0 2.3466836807095603e-10
have O 0 1.6204150922547594e-13
identified O 0 8.136299793626289e-13
three O 0 2.812863603065402e-14
offspring O 0 4.660881598207711e-13
in O 0 3.58176792533086e-14
a O 0 2.478136966466149e-11
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 3.844686034426559e-06
who O 0 5.891642729238811e-11
developed O 0 6.119210471666747e-09
hematological B-Disease 0 0.06987996399402618
malignancy I-Disease 0 0.00029116595396772027
at O 0 2.5720831020592527e-10
a O 0 4.869102625433552e-13
very O 0 3.822667822474951e-14
early O 0 9.533935273198235e-12
age O 0 1.6270379141203328e-11
, O 0 2.0634061408293658e-14
and O 0 2.3509797556528315e-14
at O 0 2.3657993966641477e-12
least O 0 5.462043848897952e-14
two O 0 2.5224061798697142e-14
of O 0 2.0078689687459683e-13
them O 0 7.059880701961244e-14
displayed O 0 6.117756995438484e-11
signs O 0 3.831221104255711e-11
of O 0 8.159358744208589e-10
neurofibromatosis B-Disease 0 2.0293431646223326e-07
type I-Disease 0 1.2694862938644746e-09
1 I-Disease 0 1.3131535858690313e-09
( O 0 4.714179133863405e-12
NF1 B-Disease 0 3.26861737676154e-07
) O 0 1.6090457091721966e-11
. O 0 1.4606904574776536e-09

DNA O 0 5.633332689214399e-10
sequence O 0 1.6206136909877045e-12
analysis O 0 2.803299313600821e-13
and O 0 3.935001247236522e-15
allele O 0 1.2549146834531233e-12
- O 0 1.0444201520342158e-13
specific O 0 3.1292260042935574e-14
amplification O 0 6.253983333807944e-13
in O 0 9.585851535286183e-15
two O 0 7.874289328219097e-14
siblings O 0 9.02197067054189e-12
revealed O 0 3.640119889541937e-12
a O 0 5.330249588063329e-13
homozygous O 0 2.0324035857055556e-11
MLH1 O 0 9.906198101816699e-07
mutation O 0 3.4446237529017765e-11
( O 0 5.274182783218673e-13
C676T O 0 3.303030382539873e-07
- O 0 4.423792745456012e-07
- O 0 8.756929048558959e-08
> O 0 2.361701589848053e-08
Arg226Stop O 0 1.2072354138581431e-06
) O 0 3.236093847319016e-13
. O 0 3.635306292104623e-11

Thus O 0 5.904833955128197e-09
, O 0 1.8789338574604075e-12
a O 0 2.461027692399198e-12
homozygous O 0 6.418450493317351e-11
germ O 0 3.5042297952259105e-08
- O 0 3.162414774493527e-09
line O 0 1.923641024248468e-09
MLH1 O 1 0.9986785054206848
mutation O 0 5.931866664532492e-10
and O 0 1.919694438135e-12
consequent O 0 9.190018772642361e-07
mismatch O 1 0.9999990463256836
repair O 1 1.0
deficiency O 0 2.5278930479544215e-05
results O 0 6.947407094060054e-10
in O 0 2.1467114544315713e-11
a O 0 3.906204179560113e-11
mutator O 0 1.3106324558975757e-07
phenotype O 0 1.1198749566565525e-10
characterized O 0 7.845295729247762e-14
by O 0 5.529062196827543e-15
leukemia B-Disease 0 0.009707985445857048
and O 0 8.132940848559755e-11
/ O 1 1.0
or O 0 4.361386345408391e-06
lymphoma B-Disease 1 1.0
associated O 1 0.9999985694885254
with O 0 1.65551933273278e-10
neurofibromatosis B-Disease 0 0.001724287518300116
type I-Disease 0 2.805037979669578e-09
1 I-Disease 0 3.3801417220757912e-09
. O 0 2.1152687240677537e-11
. O 0 1.8215541575106187e-10

Missense O 0 2.3193138986243866e-05
mutations O 0 9.819901558572042e-10
in O 0 4.6689986946124584e-12
the O 0 1.0176889712887327e-11
most O 0 9.376203426950808e-14
ancient O 0 5.261728899808027e-11
residues O 0 1.1343304073818672e-09
of O 0 2.6281397197402967e-11
the O 0 6.077203323906488e-11
PAX6 O 0 3.133493464702042e-06
paired O 0 7.64133090136454e-10
domain O 0 2.1427794649753196e-08
underlie O 0 3.5236531914506486e-08
a O 0 8.014670524469913e-12
spectrum O 0 9.728111649565108e-09
of O 0 3.413312299471727e-09
human O 1 0.988223671913147
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9560552835464478

Mutations O 0 2.4649789764907837e-08
of O 0 5.353293919263535e-10
the O 0 3.6908431172433254e-11
human O 0 4.459349209340324e-11
PAX6 O 0 3.575929076760076e-05
gene O 0 8.112308602648e-10
underlie O 0 5.3825892791792285e-06
aniridia B-Disease 1 1.0
( O 0 1.4499896838771065e-09
congenital B-Disease 1 1.0
absence I-Disease 1 0.9999523162841797
of I-Disease 0 1.6573681932641193e-05
the I-Disease 0 3.065678599867283e-09
iris I-Disease 0 2.146237493283465e-10
) O 0 4.3834567594637497e-13
, O 0 1.7269010928275957e-13
a O 0 1.7908678012767965e-12
rare O 0 1.0453230503415512e-09
dominant O 1 0.9999967813491821
malformation B-Disease 1 0.9999998807907104
of I-Disease 1 0.9944235682487488
the I-Disease 1 0.7717859745025635
eye I-Disease 0 0.21247845888137817
. O 0 6.368498475239903e-07

The O 0 2.1822168516649754e-09
spectrum O 0 1.1491894547077663e-08
of O 0 1.235031965585165e-09
PAX6 O 0 7.686742173973471e-05
mutations O 0 2.0022474789271882e-09
in O 0 2.366397633402073e-10
aniridia B-Disease 1 1.0
patients O 0 6.274041286502552e-10
is O 0 7.426784881525705e-14
highly O 0 2.2879786173296557e-12
biased O 0 1.5963109306627032e-11
, O 0 1.2671969491795127e-14
with O 0 7.231581903666216e-16
92 O 0 3.1793595534068686e-10
% O 0 5.289379698125707e-11
of O 0 2.49658963207694e-13
all O 0 1.918865050578103e-14
reported O 0 1.5677834464683515e-12
mutations O 0 1.6248322132206283e-12
leading O 0 2.6865350222227136e-12
to O 0 3.288098959774999e-11
premature O 0 3.4693399264540403e-09
truncation O 0 6.77285868277977e-07
of O 0 1.0322745538360323e-06
the O 0 2.622476245051075e-07
protein O 0 1.0880716327932305e-09
( O 0 2.0468654169606554e-13
nonsense O 0 1.9154462738146805e-10
, O 0 4.001852560268915e-14
splicing O 0 5.048641626287376e-12
, O 0 7.554251142813037e-14
insertions O 0 1.543301250683804e-11
and O 0 1.1337332711091469e-13
deletions O 0 4.931727769219574e-12
) O 0 8.297888811075078e-15
and O 0 4.1229059012312663e-13
just O 0 2.4628885736399653e-11
2 O 0 8.063553297299464e-12
% O 0 2.1363445734667863e-11
leading O 0 5.621600461611781e-14
to O 0 4.534848719955041e-14
substitution O 0 5.171879938203894e-11
of O 0 2.8797614293196716e-10
one O 0 3.4898705453256795e-11
amino O 0 9.493365815682608e-11
acid O 0 2.4650997931287277e-13
by O 0 2.453385869569287e-14
another O 0 7.37308825105032e-12
( O 0 3.6847410431022076e-13
missense O 0 6.590560097663456e-09
) O 0 2.2766213827324355e-12
. O 0 1.196550192261725e-09

The O 0 5.306925454640066e-10
extraordinary O 0 1.3067293080926135e-10
conservation O 0 1.629814685988329e-11
of O 0 1.5629942002118313e-12
the O 0 5.8909205638557616e-12
PAX6 O 0 3.378936298759072e-06
protein O 0 7.969161441856443e-10
at O 0 6.344822583992382e-11
the O 0 2.3928128922712233e-10
amino O 0 1.126541349094623e-07
acid O 0 6.545212372088827e-09
level O 0 3.79770199288032e-07
amongst O 0 1.5398934749555337e-07
vertebrates O 0 1.2225970635881822e-07
predicts O 0 8.710510646103842e-10
that O 0 5.970965909207759e-12
pathological O 0 8.241450188961608e-08
missense O 0 2.8995074785598263e-07
mutations O 0 1.1869571991951489e-10
should O 0 2.601833679061194e-12
in O 0 8.081258752457021e-12
fact O 0 1.3341341920103389e-11
be O 0 8.142731280913473e-12
common O 0 2.4824313611671034e-12
even O 0 4.198117276987129e-13
though O 0 4.615217171106967e-13
they O 0 2.5678439409537734e-13
are O 0 1.7005074106658802e-13
hardly O 0 1.1913710296074242e-10
ever O 0 9.15575115723044e-11
seen O 0 3.359014733028687e-10
in O 0 6.598028234883202e-10
aniridia B-Disease 1 1.0
patients O 0 1.1741690997268961e-07
. O 0 1.6157402527028353e-08

This O 0 3.6019697641220816e-11
indicates O 0 1.0245489873161873e-10
that O 0 2.4665985671069174e-14
there O 0 6.187441509673819e-14
is O 0 1.8565731888458377e-15
a O 0 6.469151793029801e-14
heavy O 0 1.1044766490275748e-10
ascertainment O 0 4.1624804225648404e-07
bias O 0 6.81619968800895e-11
in O 0 3.794708687901438e-13
the O 0 3.2502348252042013e-13
selection O 0 3.108420638942011e-12
of O 0 1.359067155690119e-12
patients O 0 2.4909675017115163e-13
for O 0 2.7284760822227083e-13
PAX6 O 0 3.71086024131273e-08
mutation O 0 3.342235342651545e-12
analysis O 0 1.9339391199579836e-12
and O 0 6.621161003370415e-14
that O 0 1.3828080526337785e-14
the O 0 1.2283401726320697e-11
missing O 0 2.861788743757643e-07
PAX6 O 0 0.021124934777617455
missense O 0 2.6661920855985954e-05
mutations O 0 3.1013914991717684e-08
frequently O 0 1.4782969293136716e-10
may O 0 7.668751744738245e-10
underlie O 0 8.171247714017227e-07
phenotypes O 0 8.461930711689547e-09
distinct O 0 5.0560066550131566e-11
from O 0 9.227472952400007e-11
textbook O 0 4.6660524333219655e-08
aniridia B-Disease 1 1.0
. O 0 1.2026879403492785e-07

Here O 0 1.715909903055035e-08
we O 0 1.0789319958293131e-11
present O 0 6.413649993042281e-12
four O 0 1.5008529358553901e-13
novel O 0 1.1062500335267192e-13
PAX6 O 0 8.04709827662009e-08
missense O 0 1.1341730221658963e-08
mutations O 0 2.1627396054602066e-11
, O 0 1.0260845992315915e-13
two O 0 1.8792446440131505e-13
in O 0 4.286874403635482e-13
association O 0 9.3537016240125e-13
with O 0 1.1579479779547097e-13
atypical O 0 2.6129912122918597e-10
phenotypes O 0 9.156677499566612e-11
ectopia B-Disease 0 1.3551923139232258e-08
pupillae I-Disease 0 4.0358987263289237e-08
( O 0 3.9124614464002005e-14
displaced B-Disease 0 4.8081053027893006e-11
pupils I-Disease 0 5.94791993435706e-10
) O 0 8.54249743859059e-12
and O 0 1.6117320811304126e-09
congenital B-Disease 1 1.0
nystagmus I-Disease 0 3.021814620751684e-08
( O 0 6.061109513594287e-12
searching B-Disease 0 1.0298933972308078e-07
gaze I-Disease 0 7.92366616764184e-09
) O 0 7.840658732081313e-14
, O 0 3.887423830105721e-14
and O 0 1.9970172230828788e-14
two O 0 1.855803244367113e-13
in O 0 2.1405925263676823e-13
association O 0 6.18364341393833e-14
with O 0 1.4650059933078198e-14
more O 0 2.7202762611922005e-13
recognizable O 0 1.613817635082171e-09
aniridia B-Disease 1 0.9999974966049194
phenotypes O 0 6.340742686461454e-08
. O 0 2.602285498198853e-08

Strikingly O 0 7.634039889126143e-08
, O 0 4.068397962270209e-12
all O 0 6.548995287042336e-13
four O 0 3.915018483013899e-12
mutations O 0 1.2481567428918039e-12
are O 0 1.7110350137607144e-14
located O 0 3.397411746462048e-13
within O 0 1.015966737821783e-11
the O 0 2.604406967865458e-11
PAX6 O 0 1.738597234179906e-06
paired O 0 7.753526709564085e-10
domain O 0 7.02300573252046e-09
and O 0 1.1785196082914062e-11
affect O 0 1.5394670427326673e-08
amino O 0 2.3045549912836805e-09
acids O 0 4.480148457081112e-12
which O 0 5.667114591186365e-15
are O 0 4.731909749287628e-15
highly O 0 4.595639840898613e-12
conserved O 0 6.06275099568343e-12
in O 0 4.0817026950197566e-13
all O 0 2.352175312164695e-12
known O 0 2.643643550598318e-12
paired O 0 1.9758120139989899e-10
domain O 0 5.4695852291786196e-09
proteins O 0 1.5456763646781724e-10
. O 0 1.601271004680882e-09

Our O 0 1.4278889182151033e-08
results O 0 4.468433956184015e-11
support O 0 6.1293752191826645e-12
the O 0 1.7573274649698711e-13
hypothesis O 0 2.0410400664505265e-14
that O 0 1.75197494803706e-18
the O 0 3.474042105692469e-16
under O 0 1.4206429815085547e-13
- O 0 2.0147178196594506e-12
representation O 0 6.162741150728124e-11
of O 0 2.969418599896301e-10
missense O 0 9.319600167145836e-07
mutations O 0 4.2217793150278737e-10
is O 0 2.0444307054570676e-13
caused O 0 9.185359937935456e-12
by O 0 1.7187888482275704e-12
ascertainment O 0 5.0691933211055584e-06
bias O 0 8.943953355711187e-10
and O 0 1.0647965799012726e-12
suggest O 0 1.3796118761288945e-11
that O 0 1.6156113735933024e-15
a O 0 5.775960357787616e-14
substantial O 0 3.783176896754448e-12
burden O 0 2.3709616492340047e-09
of O 0 1.28927926112965e-08
PAX6 B-Disease 1 0.999685525894165
- I-Disease 0 1.3167819815862458e-05
related I-Disease 0 4.27758868681849e-06
disease I-Disease 0 1.2018722372886259e-05
remains O 0 1.6041130923571956e-10
to O 0 9.051474305320217e-13
be O 0 1.658659321002176e-12
uncovered O 0 5.220585075349504e-10
. O 0 4.733884725188764e-12
. O 0 4.3246006775632395e-10

The O 0 9.573144943431089e-09
chromosomal O 0 3.025033095127583e-07
order O 0 5.8171197026002375e-11
of O 0 4.620828608636884e-09
genes O 0 2.330047821352821e-10
controlling O 0 2.341780103165547e-09
the O 0 3.4865124676208836e-10
major O 0 1.5894099369972992e-09
histocompatibility O 0 4.278512477640106e-08
complex O 0 4.145656262721786e-09
, O 0 4.54696799960172e-13
properdin O 0 2.020824840798241e-09
factor O 0 3.544508653599565e-12
B O 0 2.079586947090206e-09
, O 0 9.891993636972768e-14
and O 0 8.224345141548406e-13
deficiency B-Disease 0 8.56867427501129e-06
of I-Disease 0 5.581494406214915e-06
the I-Disease 0 1.2665702264769152e-08
second I-Disease 0 2.0706746539644882e-08
component I-Disease 0 2.9416626912137644e-09
of I-Disease 0 1.1762190110786719e-09
complement I-Disease 0 1.1428897828125173e-08
. O 0 5.562910487810768e-08

The O 0 3.251064140119553e-10
relationship O 0 3.334640549801371e-11
of O 0 1.4465988303069555e-11
the O 0 1.196014424650893e-12
genes O 0 2.67407877931709e-14
coding O 0 4.606372141363613e-12
for O 0 2.7209080122455806e-14
HLA O 0 2.6307678258064016e-11
to O 0 7.882974465247064e-14
those O 0 7.0560948882034905e-15
coding O 0 1.0431197572380313e-10
for O 0 1.9711978631407195e-13
properdin O 0 1.1543337397057485e-09
Factor O 0 4.356902425645126e-12
B O 0 8.02472394090259e-11
allotypes O 0 1.2147673977835893e-09
and O 0 1.908724541540164e-14
for O 0 5.534152780137247e-13
deficiency B-Disease 0 2.88612103105379e-08
of I-Disease 0 2.0413333245983267e-09
the I-Disease 0 6.78808537157849e-11
second I-Disease 0 2.918952579644696e-10
component I-Disease 0 6.811927133476559e-10
of I-Disease 0 7.16980086412633e-10
complement I-Disease 0 2.0952128920725954e-10
( O 0 6.401925972850109e-13
C2 O 0 2.907635021642818e-09
) O 0 6.146273675558186e-14
was O 0 1.6423649549721087e-12
studied O 0 7.268210555980148e-13
in O 0 2.4767345021669412e-14
families O 0 2.618385380476901e-13
of O 0 4.297134263003821e-12
patients O 0 1.3481211806609661e-11
with O 0 1.5045067969232662e-10
connective O 1 0.9994279742240906
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.6989817023277283

Patients O 0 4.082022275753161e-09
were O 0 9.187672324328933e-12
selected O 0 5.640399172029964e-13
because O 0 6.9148673908418865e-15
they O 0 3.521826622378873e-15
were O 0 2.649138775099452e-13
heterozygous O 0 1.9056564052460923e-12
or O 0 3.642286992844301e-12
homozygous O 0 1.7725275469615553e-08
for O 0 2.4518899977010733e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 3.3750202419469133e-06

12 O 0 3.683413352106868e-09
families O 0 2.123353229355196e-11
with O 0 1.0726399017049401e-13
15 O 0 2.527646703054387e-10
matings O 0 6.741496235918021e-06
informative O 0 4.494854266567927e-08
for O 0 1.1529217580630302e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 2.5823398530633312e-08
found O 0 1.7381093786461577e-10
. O 0 1.4339197607071696e-09

Of O 0 2.5481017473794054e-06
57 O 0 6.262764145503752e-06
informative O 0 5.581094342232973e-08
meioses O 0 8.350518498900783e-08
, O 0 1.3043318053233832e-13
two O 0 3.473264021227121e-14
crossovers O 0 5.454657992648437e-12
were O 0 5.301636408529264e-13
noted O 0 1.3440401677895786e-13
between O 0 4.622514176988446e-12
the O 0 1.7387269402036054e-09
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999879598617554
gene O 0 8.7363452518259e-15
and O 0 1.948895756690057e-15
the O 0 4.3288937430323304e-13
HLA O 0 2.053794495582295e-10
- O 0 7.318854550186771e-11
B O 0 3.022734007540606e-10
gene O 0 2.992483546387665e-15
, O 0 1.805027078250016e-16
with O 0 8.437974302882992e-18
a O 0 3.2459178688489605e-16
recombinant O 0 7.89807718975155e-16
fraction O 0 6.956770771428256e-13
of O 0 3.548668737335392e-12
0 O 0 2.1672075592449325e-11
. O 0 1.924345571779895e-09

035 O 0 0.0002660123282112181
. O 0 4.1421458263357636e-07

A O 0 4.284637356022358e-08
lod O 0 2.513266110781842e-07
score O 0 3.652697866396437e-10
of O 0 2.1008743356087933e-11
13 O 0 8.73999136952186e-12
was O 0 7.970639122681367e-13
calculated O 0 3.8446134296987733e-13
for O 0 2.493515376816857e-13
linkage O 0 5.598822294672345e-09
between O 0 3.097051060052536e-09
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999529123306274
and O 0 7.92869893004311e-13
HLA O 0 4.541401699142966e-10
- O 0 1.5885241733126776e-10
B O 0 2.1597232335857086e-10
at O 0 2.1552098755824034e-13
a O 0 1.6097293385795522e-16
maximum O 0 2.1190763224964706e-15
likelihood O 0 1.529680516369064e-14
value O 0 4.9364283955010205e-14
of O 0 7.384719870112341e-14
the O 0 5.66045250764962e-14
recombinant O 0 3.214499521599079e-14
fraction O 0 1.5907610298460106e-11
of O 0 7.209097901972328e-11
0 O 0 9.54609585823718e-11
. O 0 5.718753026684453e-09

04 O 0 3.122971611446701e-05
. O 0 9.173189141620242e-07

18 O 0 6.74121691801588e-09
families O 0 1.3432367197696582e-11
with O 0 3.8642110615928066e-14
21 O 0 4.528183036867084e-11
informative O 0 1.1095901107649464e-11
matings O 0 4.75036954217245e-10
for O 0 8.84088646475184e-13
both O 0 2.517738274809833e-11
properdin O 0 7.176593186386526e-08
Factor O 0 3.97147537078979e-10
B O 0 2.3183366337775624e-09
allotype O 0 3.886795774121765e-09
and O 0 1.7949921063409313e-12
HLA O 0 5.146575610126547e-09
- O 0 4.902976358245326e-10
B O 0 1.18733145537675e-09
were O 0 5.941609617504673e-12
found O 0 1.5745380260029362e-12
. O 0 1.9859136904387675e-11

Of O 0 2.222121338490979e-06
72 O 0 8.17621094029164e-06
informative O 0 3.6566401462323483e-08
meioses O 0 8.126161077370853e-08
, O 0 3.581974669132626e-13
three O 0 5.46126566278865e-13
recombinants O 0 4.006108778042972e-09
were O 0 7.915829450255707e-12
found O 0 9.151185668618278e-13
, O 0 5.0670408759676336e-15
giving O 0 3.739939469769339e-14
a O 0 7.056664009640751e-14
recombinant O 0 7.647253598593029e-13
fraction O 0 1.187262788082677e-10
of O 0 9.367713271757339e-10
0 O 0 9.585473526030341e-10
. O 0 2.945650479091455e-08

042 O 0 0.0002420943055767566
. O 0 4.5265275616657163e-07

A O 0 8.535055684433246e-08
lod O 0 1.0101911129822838e-07
score O 0 1.4552566929282307e-09
of O 0 1.0719501675193754e-10
16 O 0 3.19632167955497e-11
between O 0 6.555446723649494e-12
HLA O 0 1.366122076573717e-10
- O 0 6.1687122424047836e-12
B O 0 4.7490965153496045e-12
and O 0 1.228103435224235e-15
Factor O 0 1.3573824952494568e-13
B O 0 5.6511271356862736e-12
allotypes O 0 6.058153284582701e-11
was O 0 2.1445769693515665e-13
calculated O 0 5.734240122665102e-13
at O 0 5.189582487699629e-13
a O 0 1.3342186005375987e-14
maximum O 0 1.7400105878709327e-13
likelihood O 0 4.895399949127188e-13
value O 0 1.0173080910655385e-12
of O 0 9.427495676478381e-13
the O 0 5.06036239387303e-13
recombinant O 0 2.9904781450630635e-13
fraction O 0 3.231952205862143e-11
of O 0 1.3594780856607258e-10
0 O 0 8.383589655824863e-11
. O 0 3.963554373598299e-09

04 O 0 3.592771099647507e-05
. O 0 1.379497689413256e-06

A O 0 1.2990194697692914e-08
crossover O 0 1.6175548400720885e-10
was O 0 3.1457278188568027e-12
shown O 0 4.076132064257526e-13
to O 0 1.6792708716628635e-12
have O 0 4.119005348390478e-14
occurred O 0 8.012763369480425e-11
between O 0 4.3843430947397566e-13
genes O 0 1.996484100545877e-14
for O 0 6.392158276893574e-15
Factor O 0 1.3006747913955896e-13
B O 0 4.099329382889483e-12
and O 0 3.2052014037678433e-13
HLA O 0 7.624792464078212e-10
- O 0 1.5720258428331135e-09
D O 0 1.820581602141047e-10
, O 0 1.442992115228449e-14
in O 0 3.614487791643757e-15
which O 0 5.975739092331468e-16
HLA O 0 6.794247456309854e-12
- O 0 5.035101675876508e-12
D O 0 4.162891819453618e-12
segregared O 0 7.485902175918824e-11
with O 0 1.3635264487323658e-14
HLA O 0 8.804450501997962e-10
- O 0 1.031566984610599e-10
A O 0 2.2877540140076036e-10
and O 0 1.394239134951472e-13
B O 0 4.842152456774329e-09
. O 0 4.575499354397827e-11

These O 0 4.0902638914763756e-11
studies O 0 6.561125774628973e-12
suggest O 0 4.611064134685261e-13
that O 0 6.484620208127396e-17
the O 0 4.848172644594806e-15
genes O 0 1.570559173436504e-14
for O 0 3.7210977300774356e-14
Factor O 0 2.0112411736050717e-10
B O 0 2.014177880482748e-06
and O 0 3.7728983670604066e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.493053762904097e-11
located O 0 1.9787893112271915e-12
outside O 0 2.7145035351450186e-12
those O 0 7.717922302771449e-14
for O 0 1.3291856764546806e-12
HLA O 0 1.6753097797916894e-09
, O 0 6.268024158517446e-14
that O 0 3.767773279465559e-16
the O 0 6.465759595482637e-14
order O 0 3.415102944361037e-13
of O 0 3.571281464997966e-11
genese O 0 7.985019756517886e-09
is O 0 1.15096544491336e-13
HLA O 0 5.28443885872143e-11
- O 0 2.580883076697127e-11
A O 0 4.180903401262981e-10
, O 0 2.7064359461219725e-14
- O 0 5.027796213218083e-13
B O 0 8.162821980850499e-12
, O 0 1.2314958657054596e-14
- O 0 1.9986844210923005e-12
D O 0 4.788864183674635e-12
, O 0 4.529728914008657e-15
Factor O 0 5.6162045500296465e-12
B O 0 7.041703664611987e-09
allotype O 0 4.485074896365404e-06
, O 0 4.6731578606795665e-09
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 4.0786674710378834e-13
that O 0 1.6647675542586665e-15
the O 0 4.397374391701403e-13
genes O 0 3.4284988043031817e-11
coding O 0 4.136047573410906e-05
for O 0 2.0744953417306533e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.749396196821685e-11
Factor O 0 6.55927812065471e-11
B O 0 8.116363692245443e-10
allotypes O 0 3.3910547703186467e-09
are O 0 4.168446915631596e-15
approximately O 0 1.462599403298081e-14
3 O 0 1.2181617205838519e-13
- O 0 1.2372511869196412e-12
- O 0 6.310371604596743e-13
5 O 0 3.642868342049188e-13
centimorgans O 0 3.864528419494917e-10
from O 0 1.2814430777347702e-13
the O 0 6.397238966858454e-13
HLA O 0 5.862654806065848e-11
- O 0 1.0273389777770703e-11
A O 0 7.231986537403756e-11
and O 0 4.611442521243458e-13
HLA O 0 1.2237438840045911e-09
- O 0 2.3053794984129183e-11
B O 0 2.3867310905423267e-11
loci O 0 6.408877877180086e-13
, O 0 3.0493389918457745e-16
and O 0 3.384385653459071e-17
that O 0 5.5336323300072294e-18
the O 0 2.759551179958627e-15
apparent O 0 2.9416354335037864e-12
lack O 0 3.8031924831649633e-10
of O 0 3.0545407869730923e-10
recombinants O 0 3.1950467160868357e-08
between O 0 1.0025114419165426e-11
the O 0 8.29384629551233e-13
Factor O 0 3.110521909488462e-11
B O 0 2.7472719210663854e-08
gene O 0 2.6057594970652076e-10
and O 0 7.75196653535204e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.4832982064838518e-11
suggests O 0 4.962467611314969e-13
that O 0 2.8378653051629177e-16
these O 0 9.212852318391516e-16
two O 0 2.8031588077755305e-14
genes O 0 1.1983436161780436e-12
lie O 0 1.994114429137994e-09
in O 0 7.758460540685519e-12
close O 0 4.805911757443937e-08
proximity O 0 5.9875802094211394e-09
to O 0 2.6184940327134143e-10
one O 0 1.0740377337503659e-10
another O 0 7.700000081989344e-10
. O 0 1.9496352976489106e-08

Distribution O 0 2.3594278530936208e-08
of O 0 3.2369833480316856e-09
emerin O 0 7.877038115111645e-06
and O 0 5.653285825579779e-11
lamins O 0 3.6552987694449257e-06
in O 0 1.7196750967674035e-11
the O 0 1.204109173480461e-10
heart O 0 2.3101796031710364e-09
and O 0 2.867886050167412e-12
implications O 0 6.393362835671601e-12
for O 0 7.623664720346479e-12
Emery B-Disease 1 0.9925691485404968
- I-Disease 1 0.9999998807907104
Dreifuss I-Disease 1 0.9999620914459229
muscular I-Disease 0 0.019029520452022552
dystrophy I-Disease 0 0.3093964755535126
. O 0 2.4682640287210234e-06

Emerin O 1 0.95888751745224
is O 0 2.898871941103831e-11
a O 0 4.906732572335093e-12
nuclear O 0 7.390938971951755e-09
membrane O 0 4.2640066477694916e-10
protein O 0 1.0125947823291792e-11
which O 0 1.4178479210133813e-15
is O 0 2.89298872706257e-15
missing O 0 5.812464398680106e-10
or O 0 4.205460632511482e-12
defective O 0 1.4461698505385812e-09
in O 0 7.477197333516372e-11
Emery B-Disease 1 0.9991600513458252
- I-Disease 1 0.9999998807907104
Dreifuss I-Disease 1 0.9999886751174927
muscular I-Disease 0 0.3103084862232208
dystrophy I-Disease 1 0.9712371230125427
( O 0 4.0432610037832717e-10
EDMD B-Disease 1 1.0
) O 0 6.079046294127366e-11
. O 0 4.0125000544399825e-10

It O 0 3.4444378772813256e-12
is O 0 4.604610692304084e-14
one O 0 9.336051354745523e-14
member O 0 3.0974244436682286e-12
of O 0 4.9217317721339526e-11
a O 0 2.2753417205922943e-11
family O 0 8.261547695953553e-12
of O 0 3.2756816703560787e-10
lamina O 0 0.0008641370804980397
- O 0 1.4630199984821957e-07
associated O 0 4.29891944264682e-09
proteins O 0 1.1109871703163243e-12
which O 0 1.2920096358748486e-15
includes O 0 1.3237693479903855e-15
LAP1 O 0 9.611240159301815e-08
, O 0 2.5088243114923525e-13
LAP2 O 0 4.726676706923172e-05
and O 0 1.1258308868500322e-10
lamin O 0 5.830669351780671e-07
B O 0 1.3999485304339032e-07
receptor O 0 5.841421964192239e-12
( O 0 5.772288029504136e-12
LBR O 0 1.1373618491461457e-08
) O 0 2.2998970349713543e-12
. O 0 1.3056262737620727e-09

A O 0 8.565446478314698e-06
panel O 0 4.0799033595995127e-10
of O 0 9.65602528490983e-11
16 O 0 1.5198269726068858e-11
monoclonal O 0 3.3132259549860724e-14
antibodies O 0 1.476724355319904e-14
( O 0 7.022957265241008e-15
mAbs O 0 4.3611633748774636e-10
) O 0 4.8607670080809406e-14
has O 0 8.763677099209665e-16
been O 0 5.899078290736923e-14
mapped O 0 7.662456606716272e-12
to O 0 2.591797490601039e-13
six O 0 8.530038112485039e-13
specific O 0 6.176313800676514e-13
sites O 0 6.190788333360064e-12
throughout O 0 2.8979969465825484e-12
the O 0 3.451389131089999e-12
emerin O 0 1.3385501596019367e-09
molecule O 0 3.610206209501976e-13
using O 0 8.934357160345074e-13
phage O 0 2.037752258599035e-11
- O 0 5.069436190274779e-12
displayed O 0 8.83654174138604e-12
peptide O 0 2.2464313395587077e-12
libraries O 0 3.6026277447365196e-12
and O 0 2.456973054100909e-14
has O 0 5.229718000410795e-16
been O 0 1.3304576048452001e-14
used O 0 2.4959323345098705e-13
to O 0 1.1715411973867162e-10
localize O 0 5.141063411429059e-06
emerin O 0 1.4758313682250446e-06
in O 0 8.324723722863414e-12
human O 0 1.9505211681924983e-11
and O 0 7.442110816491265e-11
rabbit O 0 1.9177721632956946e-09
heart O 0 2.1922010873254294e-08
. O 0 6.3350370282933e-08

Several O 0 3.0958918761925247e-10
mAbs O 0 1.0390718507835572e-08
against O 0 2.044194024122814e-12
different O 0 5.3983944051094745e-12
emerin O 0 1.8034102211572645e-08
epitopes O 0 1.5174927980865505e-10
did O 0 2.7746075836193596e-12
not O 0 3.413403186405123e-13
recognize O 0 3.107029564186625e-11
intercalated O 0 5.710338424336214e-09
discs O 0 3.8629405452184074e-08
in O 0 5.346228234420769e-12
the O 0 1.466221588586336e-11
heart O 0 2.5728091879173576e-10
, O 0 2.0581991243707326e-13
though O 0 1.50981102078028e-13
they O 0 2.0089070923261232e-13
recognized O 0 4.515565005247524e-11
cardiomyocyte O 0 7.618214681315294e-08
nuclei O 0 5.997844443328404e-09
strongly O 0 3.301698844881962e-11
, O 0 2.919088798805647e-12
both O 0 8.212815844066412e-11
at O 0 1.3390870634566454e-08
the O 0 5.574006145536714e-09
rim O 0 5.653259194104976e-09
and O 0 6.562374341850807e-13
in O 0 2.0551610760422e-11
intranuclear O 0 1.0292806962297618e-07
spots O 0 2.1085851287239166e-08
or O 0 6.172787281322201e-11
channels O 0 7.354040487683733e-09
. O 0 5.702197380941243e-09

A O 0 2.1114047399350966e-07
polyclonal O 0 1.6520070644787666e-08
rabbit O 0 4.6250672736114495e-10
antiserum O 0 8.314168020717716e-09
against O 0 1.968952605124752e-11
emerin O 0 8.609265478298767e-07
did O 0 4.192072730613283e-11
recognize O 0 9.273912887630686e-11
both O 0 1.548198548528834e-11
nuclear O 0 4.020960009398777e-09
membrane O 0 8.620227795463897e-12
and O 0 7.285135561756369e-15
intercalated O 0 6.713439699990165e-12
discs O 0 1.1769051011523146e-10
but O 0 4.4380168451611714e-15
, O 0 2.5249440043997404e-17
after O 0 2.630451288577573e-15
affinity O 0 5.307478801342292e-15
purification O 0 7.877628670910353e-13
against O 0 4.439983062741633e-14
a O 0 5.846233870274165e-13
pure O 0 2.7486737885773493e-10
- O 0 9.710027920606379e-11
emerin O 0 6.084306836129372e-09
band O 0 2.7272092570362894e-11
on O 0 1.403282177958598e-11
a O 0 7.180354943438216e-13
western O 0 4.563697683646062e-11
blot O 0 7.738788809774633e-08
, O 0 1.246881287456092e-12
it O 0 1.1989694447770566e-13
stained O 0 2.8080890945858528e-09
only O 0 2.4903796472935946e-12
the O 0 1.6052723386672518e-11
nuclear O 0 1.5635043482120636e-08
membrane O 0 2.0306232251243728e-09
. O 0 1.7851139455515863e-09

These O 0 2.394446099729386e-11
results O 0 1.1955817412478975e-11
would O 0 2.77251122450875e-13
not O 0 4.868487205175395e-14
be O 0 5.401457615059925e-14
expected O 0 1.7431547524870972e-11
if O 0 1.6543244638761445e-12
immunostaining O 0 7.063929530204405e-08
at O 0 3.755284971873607e-11
intercalated O 0 5.652189272176145e-10
discs O 0 9.73802460890738e-09
were O 0 9.008919478470379e-12
due O 0 1.1240676167645347e-09
to O 0 1.476588469551121e-11
a O 0 3.1744845467585048e-12
product O 0 3.731038741849879e-11
of O 0 4.163433833803687e-11
the O 0 7.125380840911077e-11
emerin O 0 8.679224094976234e-08
gene O 0 1.0073257332432473e-12
and O 0 5.326682020814766e-13
, O 0 5.171516969000589e-14
therefore O 0 2.8058790100399245e-12
, O 0 7.714125562288676e-14
cast O 0 2.039097536654655e-11
some O 0 4.833844235259052e-14
doubt O 0 1.4351605841234072e-11
upon O 0 4.894301110225374e-12
the O 0 6.014675302951078e-12
hypothesis O 0 5.706532468785497e-11
that O 0 3.71741103611517e-13
cardiac B-Disease 0 1.0588933946564794e-05
defects I-Disease 0 8.66590653458843e-07
in O 0 2.024520773247218e-09
EDMD B-Disease 1 1.0
are O 0 8.126501208072234e-12
caused O 0 1.715317341291489e-12
by O 0 3.727633097485271e-14
absence O 0 3.3572868929354627e-09
of O 0 2.840593982256223e-09
emerin O 0 4.7399933578162745e-07
from O 0 4.63570959396975e-10
intercalated O 0 1.7023486620360018e-08
discs O 0 6.296068590927462e-07
. O 0 1.1915290087927133e-08

Although O 0 6.203919156178017e-09
emerin O 0 5.106457138026599e-06
was O 0 9.730853900435932e-10
abundant O 0 1.461921035617042e-11
in O 0 6.957391070596189e-14
the O 0 2.3713845123674027e-11
membranes O 0 1.063700016956659e-09
of O 0 5.401530334125937e-10
cardiomyocyte O 0 4.262027175627736e-08
nuclei O 0 8.395242279135573e-10
, O 0 5.922101459394924e-13
it O 0 1.9229172561977675e-14
was O 0 3.8206836999732374e-11
absent O 0 7.461348872084272e-09
from O 0 9.3992582814173e-12
many O 0 5.007267929284243e-13
non O 0 2.99494971045533e-08
- O 0 1.8086383501980663e-09
myocyte O 0 7.88077372249063e-08
cells O 0 4.240791398602006e-11
in O 0 1.2623614176546227e-12
the O 0 1.5948258338949195e-11
heart O 0 4.05986977369821e-09
. O 0 4.495177563512698e-09

This O 0 3.364493362731369e-12
distribution O 0 6.587235618082943e-11
of O 0 1.1156552244540041e-11
emerin O 0 6.328636459329573e-08
was O 0 1.7838382680712694e-12
similar O 0 2.5726262550926533e-15
to O 0 4.976388360633868e-14
that O 0 3.2417121914471653e-15
of O 0 1.648787530117435e-11
lamin O 0 7.557931169799303e-09
A O 0 1.0599492394902654e-09
, O 0 3.2975402600556383e-14
a O 0 3.99476797669808e-14
candidate O 0 7.427104938007023e-12
gene O 0 1.3192111248880312e-13
for O 0 5.638656317037694e-13
an O 0 2.9949531895299975e-13
autosomal O 0 7.470109153473459e-08
form O 0 4.339790304896951e-09
of O 0 8.782267104834318e-05
EDMD B-Disease 1 1.0
. O 0 4.864816673944006e-06

In O 0 6.779461880768167e-09
contrast O 0 1.0317741105936307e-09
, O 0 7.393949341683026e-11
lamin O 0 2.8626624271055334e-07
B1 O 0 1.452631863685383e-07
was O 0 1.1960002987976281e-09
absent O 0 5.683111581333833e-08
from O 0 1.6577501871228861e-10
cardiomyocyte O 0 1.2879230837370415e-07
nuclei O 0 1.0131135930180335e-09
, O 0 9.335379691499668e-13
showing O 0 1.62739266507117e-10
that O 0 2.1767939881178755e-11
lamin O 0 4.163838127624331e-07
B1 O 0 3.509206436547174e-08
is O 0 3.3352650746472715e-14
not O 0 1.0008630243216275e-14
essential O 0 6.711062261466338e-11
for O 0 1.1901569139938228e-12
localization O 0 5.884694019187009e-06
of O 0 5.981758643969215e-09
emerin O 0 2.358322262807633e-06
to O 0 5.43119049734031e-10
the O 0 1.1732725901936192e-09
nuclear O 0 9.726294365464128e-07
lamina O 0 0.003883211174979806
. O 0 1.260711428585637e-07

Lamin O 1 0.9136267304420471
B1 O 0 0.00013499765191227198
is O 0 3.5567479517162326e-11
also O 0 4.590512540404712e-13
almost O 0 2.7974267000074882e-11
completely O 0 3.291386008186237e-08
absent O 0 1.0658883553560372e-07
from O 0 1.5832428423845357e-10
skeletal O 0 8.437169753960916e-07
muscle O 0 1.3585307989671946e-08
nuclei O 0 2.252271400493555e-07
. O 0 3.271651394243236e-08

In O 0 2.665064258167149e-08
EDMD B-Disease 1 1.0
, O 0 6.995241191853907e-12
the O 0 1.8062008594506296e-13
additional O 0 3.620701828632722e-13
absence O 0 6.700625471145472e-11
of O 0 5.121035262511953e-10
lamin O 0 3.9065608348209935e-07
B1 O 0 5.711500534744118e-07
from O 0 2.4078214977407697e-09
heart O 0 0.028756797313690186
and O 0 2.268895968882134e-06
skeletal O 1 1.0
muscle O 1 0.9650446176528931
nuclei O 0 0.00030139548471197486
which O 0 2.992621081499003e-11
already O 0 8.711099550029466e-12
lack O 0 5.227742239100053e-09
emerin O 0 1.3393916731274658e-07
may O 0 2.6530034679533854e-12
offer O 0 1.0259593738806694e-13
an O 0 4.509539460194377e-15
alternative O 0 5.720653117879948e-12
explanation O 0 5.036773081945611e-12
of O 0 1.4268195999700417e-11
why O 0 9.23500425437096e-12
these O 0 6.222847324238723e-12
tissues O 0 3.006748738876297e-10
are O 0 7.497237016320171e-14
particularly O 0 5.545564550103743e-13
affected O 0 2.7880876860703063e-12
. O 0 1.7101696794807886e-11
. O 0 2.6456550283882052e-09

Genetic O 0 9.797474831430009e-09
mapping O 0 1.8252739764079706e-08
of O 0 1.0374380465805189e-08
the O 0 3.1893964802520713e-08
copper B-Disease 0 3.4481661259633256e-07
toxicosis I-Disease 0 8.963701247921563e-07
locus O 0 4.3061613302919355e-11
in O 0 1.5450331986022192e-11
Bedlington O 0 1.4511989547827397e-06
terriers O 0 1.0145299000896557e-07
to O 0 1.4817614912843169e-09
dog O 0 1.619751621717569e-08
chromosome O 0 4.912355522357359e-10
10 O 0 1.216714645702055e-10
, O 0 2.048920115602787e-13
in O 0 4.737983551501845e-13
a O 0 1.0280131780560087e-11
region O 0 5.439144246111027e-09
syntenic O 0 1.3159168474885519e-06
to O 0 1.0661715260651405e-10
human O 0 3.2298198837654724e-11
chromosome O 0 2.1877379074997094e-10
region O 0 1.3365500928230745e-09
2p13 O 0 5.870618906556047e-07
- O 0 6.273709107773584e-09
p16 O 0 9.348476659454263e-09
. O 0 5.890971599420425e-10

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 0 0.24320539832115173
accumulation I-Disease 0 1.2365197790131788e-06
is O 0 9.734588352419693e-13
recognized O 0 8.51112496452755e-12
as O 0 1.2560018129714745e-12
an O 0 4.1974968639779675e-11
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 2.2977957314651576e-09
man O 0 7.805579516073635e-10
, O 0 2.265967497189561e-13
mouse O 0 6.168652828125731e-12
, O 0 2.648160120008458e-12
rat O 0 1.095948887197551e-09
and O 0 3.697437842009599e-11
dog O 0 4.2423030777172244e-07
. O 0 1.5272500775154185e-07

The O 0 1.5233814210091623e-08
major O 0 5.558222326840223e-08
cause O 0 5.570689245359972e-05
of O 1 0.9999939203262329
hepatic B-Disease 1 1.0
copper I-Disease 1 0.999996542930603
accumulation I-Disease 0 0.0001586306025274098
in O 0 1.6414340997528143e-09
man O 0 9.273692036515513e-09
is O 0 4.683552807735469e-13
a O 0 5.970089006490653e-12
dysfunctional O 0 1.0161136820840966e-08
ATP7B O 0 0.014568564482033253
gene O 0 1.6918971432189345e-11
, O 0 1.6875314080150305e-13
causing O 0 9.172829856796128e-11
Wilson B-Disease 0 2.8249480976683117e-08
disease I-Disease 0 5.781273793026287e-10
( O 0 8.795368540469653e-14
WD B-Disease 0 9.611182072433166e-09
) O 0 8.372490526396825e-13
. O 0 4.286561938737776e-10

Mutations O 0 2.3611791633015855e-08
in O 0 3.882301771729324e-11
the O 0 3.4701191919950247e-10
ATP7B O 1 0.9995817542076111
genes O 0 3.738475848336087e-11
have O 0 7.288849970636668e-14
also O 0 8.946076115280222e-16
been O 0 2.5749149381161344e-14
demonstrated O 0 4.636622574598348e-13
in O 0 9.721562747519452e-13
mouse O 0 4.580458928815645e-11
and O 0 5.183869652980455e-11
rat O 0 9.741220274861462e-09
. O 0 5.3145661205178385e-09

The O 0 3.4795719638935907e-09
ATP7B O 1 0.9911728501319885
gene O 0 9.970917320967221e-12
has O 0 1.2342282245867125e-14
been O 0 5.272128220101813e-14
excluded O 0 2.9254315983551216e-12
in O 0 9.796235545846133e-14
the O 0 3.4052309583199047e-12
much O 0 4.8924274353989716e-11
rarer O 0 2.891140979954798e-07
human O 0 8.361021741620789e-08
copper B-Disease 0 0.3931356966495514
overload I-Disease 0 1.747637361404486e-05
disease O 0 5.749956955014568e-09
non B-Disease 0 1.0724543919593543e-08
- I-Disease 0 9.670350076262935e-10
Indian I-Disease 0 3.916882651555653e-10
childhood I-Disease 0 1.7912340410930483e-07
cirrhosis I-Disease 0 3.7235272429825272e-06
, O 0 2.439751688437103e-13
indicating O 0 2.1063067956461623e-11
genetic O 0 3.43588317519572e-11
heterogeneity O 0 5.255141877213987e-10
. O 0 5.3063411442622055e-09

By O 0 1.1373926106506005e-11
investigating O 0 1.0091421448477078e-10
the O 0 8.492190284314916e-11
common O 0 3.675833415428542e-09
autosomal O 1 0.9998061060905457
recessive O 1 0.9990054965019226
copper B-Disease 0 0.19680115580558777
toxicosis I-Disease 1 0.9980042576789856
( O 0 1.659166380674204e-11
CT B-Disease 0 2.1408588963822694e-06
) O 0 2.220183455484137e-12
in O 0 2.9214630714591294e-11
Bedlington O 0 7.3141100074280985e-06
terriers O 0 8.120939298805752e-08
, O 0 1.7347922143945427e-12
we O 0 7.755393007478906e-13
have O 0 2.1353554910613984e-14
identified O 0 5.268643052218358e-13
a O 0 7.132872919157936e-15
new O 0 4.034066409099122e-16
locus O 0 3.944290572865765e-14
involved O 0 3.6293028044670494e-13
in O 0 2.1409388151205633e-10
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.7581834654833983e-08

We O 0 3.083551747273816e-10
examined O 0 6.01144481415794e-11
whether O 0 3.0097032179855765e-14
the O 0 1.2747684581104063e-13
WD B-Disease 0 2.575442081820256e-09
gene O 0 1.2441636262905398e-12
ATP7B O 0 0.00046995162847451866
was O 0 1.0851695236846481e-10
also O 0 7.264021063260392e-14
causative O 0 1.8396527790703887e-12
for O 0 7.268903361168366e-13
CT B-Disease 0 1.0969993802234512e-08
by O 0 1.5774077736282338e-13
investigating O 0 6.739587186943563e-12
the O 0 9.664476684212442e-12
chromosomal O 0 1.3832949896652735e-08
co O 0 2.2439543279073604e-10
- O 0 1.2388795544993059e-10
localization O 0 5.40306110963229e-08
of O 0 1.0374811010294138e-09
ATP7B O 1 0.9970355033874512
and O 0 2.0852865603975673e-13
C04107 O 0 1.8626147846312335e-10
, O 0 2.389474981120706e-17
using O 0 3.1497981581813186e-16
fluorescence O 0 5.1279314995655856e-12
in O 0 3.218748184652398e-12
situ O 0 1.1074859251891667e-08
hybridization O 0 3.396581071957172e-10
( O 0 5.418651638500194e-13
FISH O 0 8.83732587109165e-10
) O 0 6.456175112752593e-13
. O 0 4.288508159699944e-10

C04107 O 0 0.0001467306719860062
is O 0 8.264873160857e-12
an O 0 1.8800226945971804e-13
anonymous O 0 9.349907133249236e-12
microsatellite O 0 1.5390523300240488e-09
marker O 0 5.123790836059072e-10
closely O 0 2.3949589533778237e-10
linked O 0 7.972160709357468e-09
to O 0 2.1810695471913277e-08
CT B-Disease 1 0.9999885559082031
. O 0 8.956574220064795e-07

However O 0 7.517076028307201e-08
, O 0 1.0642520198445027e-09
BAC O 0 2.9199492928455584e-05
clones O 0 1.1295763213681198e-09
containing O 0 1.6711718814343968e-11
ATP7B O 0 1.1751524652936496e-05
and O 0 2.1534904068309935e-11
C04107 O 0 3.5817723187392403e-07
mapped O 0 9.054630378813044e-10
to O 0 1.457627768486347e-11
the O 0 4.3327556820127455e-11
canine O 0 1.925116510648195e-09
chromosome O 0 6.318535139548942e-10
regions O 0 1.4307288687120945e-09
CFA22q11 O 0 8.184355465346016e-06
and O 0 7.417721992197812e-11
CFA10q26 O 0 7.434288272634149e-05
, O 0 3.8103458647846533e-13
respectively O 0 2.0040574755242346e-10
, O 0 3.863930863093855e-14
demonstrating O 0 2.314164138095265e-11
that O 0 1.6648931311282616e-13
WD B-Disease 0 1.8202318541327145e-09
cannot O 0 2.2663588020166436e-11
be O 0 5.156609948070434e-12
homologous O 0 5.379733325483471e-10
to O 0 5.0258024408833535e-09
CT B-Disease 0 0.0001285993494093418
. O 0 8.560456876693934e-08

The O 0 4.3849857433997386e-07
copper O 0 1.2155507533861964e-07
transport O 0 7.888019126767176e-09
genes O 0 8.344854668385082e-11
CTR1 O 0 1.0231448868580628e-05
and O 0 1.1967773126675407e-11
CTR2 O 1 0.9983154535293579
were O 0 1.9861495781370309e-10
also O 0 1.493807248037493e-13
excluded O 0 1.1115134854189357e-11
as O 0 7.987040933146727e-14
candidate O 0 1.218646850098537e-10
genes O 0 2.752259357918785e-12
for O 0 2.9847357224666027e-12
CT B-Disease 0 2.0864578686996538e-07
since O 0 1.8107767021935395e-11
they O 0 4.628634715092561e-13
both O 0 2.9813217866658803e-12
mapped O 0 2.9534616419191195e-10
to O 0 5.015799234286966e-11
canine O 0 2.2645116892761052e-09
chromosome O 0 1.3388259390012536e-09
region O 0 1.8694501946470155e-08
CFA11q22 O 0 0.0014320551417768002
. O 0 1.4465656761331047e-07

2 O 0 5.325984631099345e-08
- O 0 6.821723985694916e-08
22 O 0 5.90204152217666e-09
. O 0 1.8000827495257e-09

5 O 0 4.476322885693662e-07
. O 0 8.065829604220198e-08

A O 0 1.2662320081346934e-08
transcribed O 0 1.9002500961651236e-10
sequence O 0 3.739828759175001e-12
identified O 0 3.0053177828281985e-12
from O 0 2.6401550758982373e-13
the O 0 1.1068459516982987e-12
C04107 O 0 8.093318903945601e-09
- O 0 7.585243197438807e-12
containing O 0 2.582796173114521e-13
BAC O 0 5.681345527364101e-08
was O 0 3.7183489794145874e-12
found O 0 5.1628148913136773e-14
to O 0 2.1814925625467108e-13
be O 0 3.0311587658274353e-13
homologous O 0 4.955501287096098e-11
to O 0 1.766873431417737e-12
a O 0 2.0342330250833207e-12
gene O 0 2.0904952031594592e-13
expressed O 0 4.558177836913591e-13
from O 0 6.078240124759993e-13
human O 0 1.5602650465032508e-13
chromosome O 0 1.705305818430758e-12
2p13 O 0 6.997436519107225e-10
- O 0 1.4600038192313924e-11
p16 O 0 5.058669108604086e-11
, O 0 9.696071697547649e-15
a O 0 8.575907047220568e-14
region O 0 5.7568099592897326e-11
devoid O 0 1.6183303586103648e-09
of O 0 1.6841175806345254e-12
any O 0 9.555686320342205e-13
positional O 0 3.5586242841390003e-09
candidate O 0 1.9500703274388798e-08
genes O 0 1.8578257821033617e-09
. O 0 6.804463659193516e-09

Molecular O 0 3.189800923397712e-10
analysis O 0 1.4538542245090547e-11
of O 0 2.112482758165335e-11
the O 0 8.766186561370848e-12
APC B-Disease 0 2.504472462749874e-10
gene O 0 8.653689235733984e-15
in O 0 1.3739219993907231e-14
205 O 0 1.4623916227279876e-12
families O 0 7.028629251965707e-14
: O 0 1.0501639417418536e-15
extended O 0 1.0102470075767922e-11
genotype O 0 1.897867640821005e-09
- O 0 6.425325271841587e-10
phenotype O 0 4.034007156095143e-11
correlations O 0 1.7697074708444838e-11
in O 0 5.945733272047504e-13
FAP B-Disease 0 1.751794959092834e-10
and O 0 2.262010803005029e-14
evidence O 0 1.3506806350455092e-13
for O 0 1.932844482339588e-15
the O 0 4.9130204705970584e-14
role O 0 4.297189232053966e-13
of O 0 3.553533856059943e-11
APC B-Disease 0 1.1942388411512184e-08
amino O 0 4.895820637784709e-09
acid O 0 5.850456230582779e-11
changes O 0 6.45995062997784e-11
in O 0 6.850618206044601e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 3.5559671118789993e-07
. O 0 7.683425451432413e-09

BACKGROUND O 0 1.072047780326102e-05
/ O 0 8.343334911842248e-09
AIMS O 0 1.0260950311646866e-08
The O 0 2.366647893284335e-12
development O 0 1.2536032212295822e-09
of O 0 5.149069615129065e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.2827835502041713e-12
a O 0 1.1141294050526218e-13
variable O 0 9.892092570421007e-13
range O 0 1.3829044246543853e-12
of O 0 7.109005658451073e-12
extracolonic O 0 2.8925576600613567e-08
manifestations O 0 4.7140695791370035e-09
in O 0 2.3001692994739642e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.999980092048645
polyposis I-Disease 1 1.0
( O 0 4.816739888890975e-12
FAP B-Disease 0 7.653189748602074e-10
) O 0 2.5124574390910336e-14
is O 0 1.8553404382702274e-16
the O 0 2.3811061764878252e-15
result O 0 2.028668032172387e-13
of O 0 8.797458421472282e-12
the O 0 8.810657065039251e-12
dominant O 0 4.6412678145202335e-09
inheritance O 0 3.157607011416985e-07
of O 0 6.221926014404744e-06
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 1.0
( O 0 2.997526489176283e-12
APC B-Disease 0 2.0776045328574355e-09
) O 0 3.6554405336008955e-12
gene O 0 2.120140001060644e-11
mutations O 0 1.248036535228536e-10
. O 0 3.927259850655673e-09

In O 0 6.379285294455528e-11
this O 0 1.296043892866361e-13
study O 0 1.3858815116828908e-14
, O 0 2.4784329620448637e-16
direct O 0 9.52988552736225e-15
mutation O 0 1.1433827763233863e-15
analysis O 0 5.9318659196856e-14
of O 0 3.190982634376782e-13
the O 0 1.1052636670477733e-12
APC B-Disease 0 2.3962565265378544e-10
gene O 0 1.9379110946168843e-13
was O 0 7.681568055251109e-12
performed O 0 1.6776935743423316e-11
to O 0 1.1968959677532975e-11
determine O 0 1.617170064527329e-09
genotype O 0 4.26379962448209e-08
- O 0 8.714365895556853e-10
phenotype O 0 7.745541014125834e-11
correlations O 0 2.4740801421452296e-11
for O 0 4.924393683623796e-13
nine O 0 5.305296202351428e-10
extracolonic O 0 4.605028891546681e-07
manifestations O 0 6.384306860951483e-09
and O 0 4.3228953945130544e-13
to O 0 1.0488609980541241e-11
investigate O 0 1.4392998945456092e-11
the O 0 1.0514890173840552e-11
incidence O 0 3.0276733897771635e-10
of O 0 1.7141482677729414e-10
APC B-Disease 0 4.360865890618015e-09
mutations O 0 4.966714192700117e-11
in O 0 2.447165525776285e-10
non O 1 0.9998631477355957
- O 1 0.9999992847442627
FAP O 1 0.9999852180480957
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.0363586966377625e-07

METHODS O 0 6.90824748517116e-08
The O 0 2.2541939148634782e-10
APC B-Disease 0 1.0191973931483744e-09
gene O 0 2.466703599192377e-13
was O 0 1.0828222866965387e-11
analysed O 0 4.718175850015882e-11
in O 0 9.021548699056359e-14
190 O 0 4.669942817864259e-12
unrelated O 0 6.381326456833536e-12
FAP B-Disease 0 1.8914623339805203e-11
and O 0 2.3018564186899973e-14
15 O 0 6.222162368674233e-11
non O 0 0.00013059022603556514
- O 1 0.9968336224555969
FAP O 1 0.9999421834945679
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.6915227898928187e-11
using O 0 3.460910892724364e-14
denaturing O 0 4.445498483218735e-11
gradient O 0 1.8173150701308871e-12
gel O 0 1.6302438565762856e-11
electrophoresis O 0 1.128016343526772e-11
, O 0 2.451898310307319e-14
the O 0 3.015266801433686e-13
protein O 0 1.7283939036938367e-13
truncation O 0 6.297572879843116e-11
test O 0 1.3573159523411205e-12
, O 0 3.841281710304043e-15
and O 0 1.6563741989052052e-15
direct O 0 9.33951158597901e-13
sequencing O 0 4.497808236969547e-10
. O 0 3.083182820162733e-09

RESULTS O 0 7.743645369373553e-07
Chain O 0 3.325806852139124e-10
terminating O 0 2.555164690942746e-10
signals O 0 4.5177878799096405e-11
were O 0 1.1041974626313511e-12
only O 0 1.4762398524740747e-14
identified O 0 3.942382444804826e-13
in O 0 4.1996286548155737e-14
patients O 0 3.128069905964509e-13
belonging O 0 2.673878826686682e-11
to O 0 3.961666498325522e-12
the O 0 3.385435334846143e-11
FAP B-Disease 0 3.479864174593672e-09
group O 0 7.328946477480613e-13
( O 0 9.705994688524733e-14
105 O 0 1.1058183702061797e-08
patients O 0 5.816110093537219e-11
) O 0 7.303539717451457e-12
. O 0 4.655542618081654e-09

Amino O 0 8.189049367501866e-07
acid O 0 4.051240592994887e-11
changes O 0 2.1966112197409349e-13
were O 0 4.4274360653379086e-13
identified O 0 3.684382714284201e-13
in O 0 6.77181580802837e-15
four O 0 4.2501619628224074e-14
patients O 0 1.108860572129498e-14
, O 0 1.9950202740882998e-16
three O 0 7.760905497899637e-15
of O 0 6.013700388357579e-12
whom O 0 2.998753467764459e-10
belonged O 0 1.814749884943012e-05
to O 0 1.4392245173411311e-09
the O 0 1.847261721366067e-08
non O 0 8.850760059431195e-05
- O 0 6.834891053131287e-08
FAP O 0 2.7122948154101323e-07
group O 0 2.33677716066083e-10
of O 1 0.9996329545974731
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.7654428979294607e-06
. O 0 6.418885423187248e-09

Genotype O 0 0.00010227273014606908
- O 0 3.7809377317898907e-06
phenotype O 0 2.5716442308976184e-08
correlations O 0 4.122018282259887e-09
identified O 0 5.4434980828466095e-11
significant O 0 1.0122954557933994e-11
differences O 0 1.2768727741807595e-10
in O 0 2.885353902418869e-13
the O 0 4.104821951095294e-12
nature O 0 6.576612084779887e-12
of O 0 6.762842456181639e-12
certain O 0 4.458422173114762e-11
extracolonic O 0 2.772164862108184e-07
manifestations O 0 3.148960536769607e-10
in O 0 5.481691489617191e-12
FAP B-Disease 0 1.0110383641404042e-09
patients O 0 4.134547305217895e-12
belonging O 0 5.935428537551246e-11
to O 0 1.745630202887316e-11
three O 0 7.043859245881023e-11
mutation O 0 4.7313236661850055e-11
subgroups O 0 3.014868632522649e-10
. O 0 3.1294369318146664e-09

CONCLUSIONS O 0 1.4234287846193183e-06
Extended O 0 5.4863050991116324e-08
genotype O 0 9.998627348295486e-08
- O 0 4.620819726852687e-09
phenotype O 0 1.3599138481978912e-10
correlations O 0 1.6191074869720268e-10
made O 0 4.684499858333135e-13
in O 0 2.408602017920508e-13
this O 0 1.2367267854338643e-13
study O 0 9.583406659387228e-14
may O 0 4.1321150467217224e-14
have O 0 1.2027663716070777e-14
the O 0 2.0945262668367604e-13
potential O 0 2.392407561120635e-13
to O 0 1.3729593633868276e-12
determine O 0 6.346944081414563e-10
the O 0 7.515330718854685e-11
most O 0 7.882979208631569e-13
appropriate O 0 7.875322616257563e-11
surveillance O 0 1.7272835384218865e-09
and O 0 2.0275354745830088e-12
prophylactic O 0 6.22156370866378e-09
treatment O 0 1.2647342895188984e-10
regimens O 0 1.9379324533996822e-10
for O 0 5.4228570554393576e-14
those O 0 6.338789356689217e-14
patients O 0 2.0548218346034403e-13
with O 0 1.1304155489338702e-15
mutations O 0 4.4304010872291133e-13
associated O 0 2.950761596870466e-12
with O 0 2.1481429102968713e-13
life O 0 5.84571627215702e-11
threatening O 0 1.3064400949946986e-10
conditions O 0 1.2156858630874012e-08
. O 0 9.817097357256444e-09

This O 0 5.828514754169234e-11
study O 0 3.65740033744788e-12
also O 0 1.8141192622547417e-15
provided O 0 1.60149925412063e-14
evidence O 0 1.5334838637088254e-14
for O 0 6.346165658407087e-15
the O 0 2.007169387294172e-12
pathological O 0 8.851293031852947e-10
nature O 0 4.710790785233954e-12
of O 0 1.1023131019083365e-10
amino O 0 8.467217205154753e-11
acid O 0 7.927852710247485e-13
changes O 0 3.276974638909483e-14
in O 0 1.07578903467756e-13
APC O 0 1.4050852148450588e-10
associated O 0 2.2295290613705276e-11
with O 0 6.852545332385052e-14
both O 0 1.5715197155749538e-12
FAP B-Disease 0 2.479736416205469e-10
and O 0 1.6001144636720865e-12
non O 0 0.09771010279655457
- O 1 0.9998888969421387
FAP O 1 0.9999918937683105
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.5707363187900114e-10
. O 0 1.1078237936376634e-12
. O 0 1.887296395552962e-11

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 2.573799235960905e-07
cancer B-Disease 0 0.00011211631499463692
risk O 0 6.013881836963719e-09
of O 0 2.11474748823548e-08
the O 0 3.712715113124432e-08
APC O 0 1.846054260568053e-07
I1307K O 0 2.2817236811079056e-07
polymorphism O 0 3.852975272167214e-09
. O 0 6.199479818391751e-10

Germ O 0 2.0392157239257358e-05
- O 0 4.848540697821591e-07
line O 0 1.3165567525064148e-09
and O 0 3.5737312089646756e-13
somatic O 0 5.508927758413051e-10
truncating O 0 9.778036158536452e-10
mutations O 0 1.4325835439796264e-12
of O 0 1.919097693259264e-12
the O 0 1.9213940334605883e-12
APC B-Disease 0 1.3199354109705297e-10
gene O 0 1.0188377241480626e-13
are O 0 8.722957896094546e-15
thought O 0 1.5107163566993598e-12
to O 0 1.1165685563641059e-11
initiate O 0 3.3577632052583795e-07
colorectal B-Disease 1 1.0
tumor I-Disease 0 9.893550304695964e-05
formation O 0 1.7139315389158583e-07
in O 0 3.942077171359415e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 5.62780488877479e-09
sporadic O 0 0.0018522558966651559
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 6.343443131884285e-11
respectively O 0 1.7672039831495567e-08
. O 0 1.5945179399068365e-08

Recently O 0 1.1433600732857485e-09
, O 0 1.5244820380025392e-13
an O 0 6.98223691863141e-14
isoleucine O 0 4.325723352849309e-07
- O 0 1.3091458583858184e-07
- O 0 8.942186724425483e-08
> O 0 4.7891848709014084e-08
lysine O 0 9.249261800903241e-09
polymorphism O 0 9.107401638397405e-11
at O 0 6.433215939127823e-12
codon O 0 1.1697816326705635e-10
1307 O 0 5.550144233090748e-10
( O 0 3.6581168324535673e-13
I1307K O 0 1.2277705074836831e-08
) O 0 5.410283698370315e-14
of O 0 1.6325580210613255e-12
the O 0 6.286084933831981e-12
APC B-Disease 0 1.990747122704306e-09
gene O 0 1.2211958874686069e-12
has O 0 1.794764220596802e-14
been O 0 1.609559924578563e-13
identified O 0 2.30669650047588e-13
in O 0 9.865425940362368e-14
6 O 0 8.986179855785537e-12
% O 0 5.2211998613493904e-11
- O 0 8.621670001193737e-13
7 O 0 1.385022131705771e-11
% O 0 9.997278699325207e-11
of O 0 2.365393471370769e-12
the O 0 1.0076894180199858e-11
Ashkenazi O 0 4.1016665619508785e-09
Jewish O 0 1.7234684512867915e-10
population O 0 4.64255370258293e-12
. O 0 3.5034244949549986e-10

To O 0 9.463835048961755e-09
assess O 0 1.7161061904857888e-08
the O 0 1.0003687461734856e-10
risk O 0 2.8755242631461897e-10
of O 0 1.465997809257935e-11
this O 0 7.045638486698202e-13
common O 0 4.672330664728941e-12
APC B-Disease 0 9.568886794042442e-10
allelic O 0 1.1905221253272202e-09
variant O 0 1.6769529098681346e-09
in O 0 2.8500151127985873e-09
colorectal O 1 1.0
carcinogenesis O 1 0.99949049949646
, O 0 3.372695178693874e-10
we O 0 5.2102940018006194e-12
have O 0 1.0017611333556012e-13
analyzed O 0 1.2740787157933253e-12
a O 0 1.8286275813884922e-14
large O 0 1.5869462116472645e-14
cohort O 0 6.23433873969681e-11
of O 0 6.410448560867366e-11
unselected O 0 6.822545401519164e-05
Ashkenazi O 0 8.366858423869417e-07
Jewish O 0 6.908192240473454e-09
subjects O 0 9.494556252320763e-08
with O 0 2.8576547378422745e-11
adenomatous B-Disease 0 1.422218474544934e-06
polyps I-Disease 0 6.053158863039698e-09
and O 0 4.661310833847798e-12
. O 0 1.1494195817363106e-08
or O 1 0.999994158744812
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 9.021265505448905e-12
for O 0 4.1133548932432984e-13
the O 0 1.3091790151964489e-10
APC O 0 1.4275267190555496e-08
I1307K O 0 1.4988948748850817e-07
polymorphism O 0 4.22184811554871e-08
. O 0 6.116024575675283e-09

The O 0 1.9472186085778276e-09
APC O 0 8.713838539620156e-09
I1307K O 0 1.034991292669929e-08
allele O 0 5.868177905404837e-12
was O 0 1.349798094477106e-12
identified O 0 1.3070919130039882e-12
in O 0 1.7197716503918742e-13
48 O 0 1.4083380017737568e-09
( O 0 2.5582512589448006e-14
10 O 0 2.5627176162418275e-12
. O 0 7.489575772718846e-14
1 O 0 1.3712948962116278e-12
% O 0 5.0543358560972695e-12
) O 0 2.493360700130359e-15
of O 0 3.9082720892057166e-13
476 O 0 3.2285896178763096e-10
patients O 0 1.135882221614537e-10
. O 0 9.995726024669693e-09

Compared O 0 1.6551697790134767e-09
with O 0 3.127913442038492e-14
the O 0 9.681777948800097e-13
frequency O 0 4.221968694789746e-12
in O 0 3.6796940819892876e-15
two O 0 2.1087384971334687e-15
separate O 0 6.98113238766819e-14
population O 0 3.7486769216697107e-16
control O 0 9.04656734181282e-14
groups O 0 2.597127953641405e-16
, O 0 1.3252395854285821e-15
the O 0 4.655835179195877e-13
APC O 0 8.933826456392069e-10
I1307K O 0 7.338809560053505e-09
allele O 0 5.218432283515817e-11
is O 0 9.196355292952554e-15
associated O 0 2.1771165599482334e-12
with O 0 1.313849236925322e-14
an O 0 7.017922501402528e-15
estimated O 0 7.016658304728751e-13
relative O 0 2.8082913772209395e-10
risk O 0 9.712713272547191e-11
of O 0 6.301192345681272e-10
1 O 0 4.557363908475054e-08
. O 0 6.241604921797261e-08

5 O 0 2.1220979817826446e-07
- O 0 1.1139648137259428e-07
1 O 0 1.3825161016001175e-09
. O 0 1.1670189259405106e-09

7 O 0 4.29106563615278e-08
for O 0 2.6876922909480072e-09
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 2.1989446395309642e-05
( O 0 6.636896761336164e-12
both O 0 1.207593747221125e-10
P O 0 1.0413976525569524e-07
= O 0 1.0688627934130057e-11
. O 0 4.860510323216605e-13
01 O 0 2.4865279280028574e-10
) O 0 1.6848878520679678e-13
. O 0 3.772528817114207e-11

Furthermore O 0 7.4255015469759655e-09
, O 0 1.0849242511323798e-12
compared O 0 4.0954609495380545e-12
with O 0 8.43828113395069e-14
noncarriers O 0 9.855614990783579e-09
, O 0 1.2295912985710311e-12
APC O 0 1.1882874684232547e-09
I1307K O 0 2.2728512405478796e-08
carriers O 0 1.3058609098573482e-12
had O 0 5.129073164453213e-13
increased O 0 8.662383961174913e-13
numbers O 0 6.084956215117454e-13
of O 0 2.5659958532986415e-11
adenomas B-Disease 0 3.047046845949808e-07
and O 0 1.4457844699222733e-08
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
per O 1 0.9998612403869629
patient O 0 1.701033761491999e-05
( O 0 5.293212049228835e-12
P O 0 3.541035908938284e-08
= O 0 5.1521660202058506e-12
. O 0 3.113759521489873e-13
03 O 0 2.615607730405145e-11
) O 0 4.099862657892415e-15
, O 0 2.372655540531306e-15
as O 0 2.5779604450779873e-15
well O 0 2.0009444066395286e-14
as O 0 5.5310658532642734e-15
a O 0 1.4647664862716542e-13
younger O 0 2.2322223930393292e-11
age O 0 7.492201997694181e-11
at O 0 1.8970779114280134e-10
diagnosis O 0 7.162500992308196e-07
. O 0 1.4534821346501303e-08

We O 0 4.094199979043367e-10
conclude O 0 1.3914798202563361e-08
that O 0 2.5121218446373314e-14
the O 0 1.021917251341209e-12
APC O 0 7.363777920765813e-10
I1307K O 0 7.597765083744434e-09
variant O 0 1.0212634904416262e-10
leads O 0 1.411149062185979e-11
to O 0 3.836881506957823e-11
increased O 0 3.9742754864846574e-08
adenoma B-Disease 1 1.0
formation O 0 1.7207494238391519e-06
and O 0 1.6414521131213888e-10
directly O 0 4.1253589433409843e-10
contributes O 0 9.508311672734582e-12
to O 0 3.639085560669386e-12
3 O 0 1.9475249538047912e-11
% O 0 5.281919693289616e-11
- O 0 6.387996685439101e-13
4 O 0 5.259144899086299e-13
% O 0 1.9559668554963716e-12
of O 0 7.426473173401116e-14
all O 0 2.538334397273606e-13
Ashkenazi O 0 5.699188321273141e-08
Jewish O 0 6.317844963632524e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.8698362914146855e-07

The O 0 9.874369100160152e-10
estimated O 0 1.77952763635858e-10
relative O 0 1.20479914933469e-09
risk O 0 4.284075177940494e-11
for O 0 1.2808670140154743e-12
carriers O 0 6.4294502881423465e-12
may O 0 5.19478427288278e-12
justify O 0 1.3957332685443635e-11
specific O 0 2.4517405250099045e-13
clinical O 0 5.923377565351939e-13
screening O 0 2.4864957098511e-13
for O 0 3.201191956371356e-14
the O 0 5.039672021714403e-13
360 O 0 2.175533225790005e-10
, O 0 4.5595061878627927e-14
000 O 0 1.0573076442144114e-10
Americans O 0 7.260727934686739e-13
expected O 0 1.5758188157133368e-11
to O 0 1.2100855040220182e-11
harbor O 0 7.299977289321191e-11
this O 0 9.30863323705608e-14
allele O 0 2.6936168573410413e-11
, O 0 9.135450235913181e-14
and O 0 1.2211138675742583e-13
genetic O 0 6.4020484876956e-13
testing O 0 6.413729410851415e-14
in O 0 8.78366220632542e-15
the O 0 3.8907320019845176e-14
setting O 0 2.080361490713889e-12
of O 0 2.103780257639576e-12
long O 0 1.4134030317664026e-12
- O 0 3.738844737283253e-12
term O 0 9.423532093544296e-11
- O 0 6.760443333614363e-12
outcome O 0 1.3086298711328936e-10
studies O 0 4.913850142757026e-12
may O 0 6.545620572255204e-14
impact O 0 4.662091025731119e-13
significantly O 0 2.0692275670697313e-10
on O 0 1.3367169060529704e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 4.3617834677434075e-08
in O 0 4.1601731825061106e-14
this O 0 4.8790659690602436e-14
population O 0 1.4790894407152276e-14
. O 0 1.140346844730189e-11

Localization O 0 1.8005106539931148e-05
of O 0 6.4436398439227105e-09
human O 0 5.703039776538965e-11
BRCA1 O 0 3.3750699457435474e-10
and O 0 8.357460773780745e-13
its O 0 2.0298755623419928e-13
loss O 0 4.659959484260012e-12
in O 0 8.622295043746175e-13
high O 0 2.1199458855036823e-11
- O 0 6.114615758168185e-12
grade O 0 2.124598136310496e-10
, O 0 1.6391634143769762e-12
non B-Disease 0 2.898378852478345e-06
- I-Disease 0 0.011154201813042164
inherited I-Disease 1 0.9965338706970215
breast I-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
. O 0 8.72900454851333e-06

Although O 0 9.514104087893216e-11
the O 0 8.050152558447543e-12
link O 0 4.6703193395947196e-11
between O 0 2.2955014625236636e-12
the O 0 1.3703125439912256e-11
BRCA1 O 0 1.8035503090985117e-09
tumour B-Disease 1 1.0
- O 0 2.97585533992617e-09
suppressor O 0 3.5503901901767776e-11
gene O 0 1.902488583338524e-13
and O 0 1.3737766349844471e-12
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 3.0952646695725505e-11
established O 0 1.2744870263314834e-12
, O 0 1.169823333288403e-15
the O 0 1.46326906754618e-14
role O 0 1.455992309140272e-13
, O 0 7.747239468328636e-15
if O 0 3.5753366582722424e-15
any O 0 5.23922810517774e-14
, O 0 8.667271409043206e-14
of O 0 2.1028706553849474e-11
BRCA1 O 0 1.1720731329933898e-10
in O 0 3.968552431121708e-10
non B-Disease 0 0.006285081151872873
- I-Disease 0 0.00917072780430317
familial I-Disease 0 0.00011397556954761967
cancers I-Disease 1 0.9938855767250061
is O 0 1.0171960496130339e-11
unclear O 0 1.1387728093836813e-08
. O 0 7.0804637708477e-09

BRCA1 O 0 2.3651427909499034e-05
mutations O 0 9.796708333453807e-09
are O 0 3.659291186036695e-12
rare O 0 3.515798112710411e-12
in O 0 7.648060136589141e-12
sporadic B-Disease 0 2.099020321111311e-06
cancers I-Disease 0 8.64545363583602e-05
, O 0 2.4070923206054307e-12
but O 0 8.453717868957267e-13
loss O 0 1.2717958908226024e-09
of O 0 1.1112755160525012e-08
BRCA1 O 0 2.357756212489903e-10
resulting O 0 3.290822128687587e-11
from O 0 1.1467960912489583e-12
reduced O 0 2.200604498972525e-12
expression O 0 1.6080194088167327e-13
or O 0 7.905635645904727e-14
incorrect O 0 9.572875478425225e-12
subcellular O 0 9.721341953650153e-09
localization O 0 4.5741973764279464e-08
is O 0 1.5110678550436796e-12
postulated O 0 1.6228608734625283e-10
to O 0 3.3732322490820366e-12
be O 0 2.0923792212745873e-12
important O 0 2.8347456326738296e-11
in O 0 8.977135007581794e-12
non B-Disease 0 4.402209015097469e-05
- I-Disease 0 0.02266605570912361
familial I-Disease 1 0.9999427795410156
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9999998807907104

Epigenetic O 0 5.582868197961943e-06
loss O 0 8.129073307827639e-07
, O 0 1.843345268093266e-11
however O 0 1.0093186703086232e-11
, O 0 2.1418166583830542e-14
has O 0 4.273387428888597e-17
not O 0 9.358500427765281e-17
received O 0 7.331941543630457e-16
general O 0 3.430561024597885e-14
acceptance O 0 2.9943265748844095e-12
due O 0 1.665565879660491e-10
to O 0 6.368729328631861e-12
controversy O 0 5.526800263104537e-13
regarding O 0 8.205307635601733e-13
the O 0 3.289577811538269e-12
subcellular O 0 4.272722264886397e-08
localization O 0 4.5924508640382555e-07
of O 0 1.2029398810398106e-08
BRCA1 O 0 7.232928700418029e-10
proteins O 0 7.336905063527743e-13
, O 0 1.3271424872962363e-14
reports O 0 6.041804697601988e-14
of O 0 1.392623267138654e-13
which O 0 4.541907659603398e-16
have O 0 2.6995674830076295e-15
ranged O 0 1.008471951779999e-11
from O 0 3.137433075926094e-13
exclusively O 0 2.1005055333978007e-11
nuclear O 0 6.045021150313801e-10
, O 0 2.824262091555285e-13
to O 0 8.523765027135255e-12
conditionally O 0 4.2094291941019435e-10
nuclear O 0 2.5929693947546184e-09
, O 0 7.757209046117819e-14
to O 0 3.679840286652247e-12
the O 0 6.109759920214231e-10
ER O 0 8.586015610489994e-06
/ O 0 4.482935977989655e-08
golgi O 0 3.520019902225613e-07
, O 0 1.4334035260826772e-12
to O 0 4.940844261502875e-11
cytoplasmic O 0 1.6289284587855946e-08
invaginations O 0 3.0998304367813034e-08
into O 0 1.074398348066552e-10
the O 0 4.6557713240247267e-10
nucleus O 0 3.455717134670522e-08
. O 0 1.3977787816088494e-08

In O 0 2.160321699307133e-09
an O 0 4.567466630606143e-12
attempt O 0 3.685844962575402e-09
to O 0 2.96035335134448e-10
resolve O 0 3.707832831878477e-07
this O 0 1.0821425136184337e-12
issue O 0 9.222325594165914e-13
, O 0 8.226690609660671e-15
we O 0 3.375932142884487e-14
have O 0 3.659273472883702e-14
comprehensively O 0 2.8174601540698063e-10
characterized O 0 7.767117569772164e-13
19 O 0 4.286657834251528e-11
anti O 0 7.37141944706643e-11
- O 0 1.5186951696222195e-09
BRCA1 O 0 1.2561707229963304e-10
antibodies O 0 6.729127888585595e-13
. O 0 9.5981292358438e-11

These O 0 2.392297193676285e-10
reagents O 0 2.3698348838863126e-10
detect O 0 4.036121697276185e-12
a O 0 1.3718121419630663e-13
220 O 0 6.617661280072795e-11
- O 0 1.679929390041579e-10
kD O 0 4.823008215026903e-09
protein O 0 6.758771320392043e-11
localized O 0 1.9335648360208069e-10
in O 0 2.3357219478860325e-13
discrete O 0 3.545303217666884e-10
nuclear O 0 3.2518489234689696e-08
foci O 0 5.0513396132600974e-08
in O 0 9.827836461306916e-12
all O 0 5.8298236030318584e-12
epithelial O 0 1.5231532701776018e-10
cell O 0 1.5575378486953895e-10
lines O 0 6.25682340139877e-13
, O 0 1.0941577742310579e-15
including O 0 7.661652294722746e-16
those O 0 6.889857472524782e-14
derived O 0 2.426879530670334e-11
from O 0 5.404158232025225e-10
breast B-Disease 0 4.4835861245928754e-08
malignancies I-Disease 0 2.6585104251353187e-07
. O 0 4.021047175228887e-07

Immunohistochemical O 0 3.526963701006025e-05
staining O 0 4.219125912641175e-06
of O 0 2.2025412249604415e-07
human O 0 3.9549021835227904e-08
breast O 0 2.375216581640416e-06
specimens O 0 2.509809027273491e-10
also O 0 8.118054839467703e-13
revealed O 0 1.1065499627704867e-09
BRCA1 O 0 2.524925379887577e-09
nuclear O 0 2.378300401062461e-08
foci O 0 1.9893064973075525e-07
in O 0 1.0784969584065607e-09
benign O 0 0.030403990298509598
breast O 0 0.10658011585474014
, O 0 4.4223412487554015e-08
invasive B-Disease 1 0.9957791566848755
lobular I-Disease 1 0.9999675750732422
cancers I-Disease 1 1.0
and O 0 0.0009645227692089975
low B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
grade I-Disease 1 0.9999996423721313
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 9.113476835409529e-07

Conversely O 0 3.3074396554866325e-08
, O 0 4.446702728255758e-11
BRCA1 O 0 5.825216420340951e-10
expression O 0 2.283088475218964e-11
was O 0 1.3884136895736532e-10
reduced O 0 1.7074253469417933e-11
or O 0 5.040403316079745e-13
undetectable O 0 5.572020709415648e-12
in O 0 1.132004138050622e-14
the O 0 1.5875584809428578e-13
majority O 0 1.6573975265138374e-12
of O 0 5.262050170595778e-11
high O 0 3.0724338628829173e-09
- O 0 1.6404271718784003e-08
grade O 0 5.240693781161099e-07
, O 0 2.7288251658319496e-09
ductal B-Disease 0 0.0007525162654928863
carcinomas I-Disease 1 1.0
, O 0 2.8398977613974807e-11
suggesting O 0 5.6715378921046167e-11
that O 0 9.141027778464261e-14
absence O 0 5.7601323710798624e-09
of O 0 2.2058912918510032e-08
BRCA1 O 0 2.575063939858069e-09
may O 0 3.127224390900296e-12
contribute O 0 1.2966979920370214e-11
to O 0 5.735172753373874e-12
the O 0 2.8841684249214516e-11
pathogenesis O 0 3.3686159639501057e-08
of O 0 8.534379314362184e-10
a O 0 1.567425356174823e-11
significant O 0 8.746332824660641e-11
percentage O 0 7.278587954573368e-09
of O 0 1.5631627936496528e-10
sporadic B-Disease 0 6.101117833168246e-06
breast I-Disease 0 2.496291813258722e-07
cancers I-Disease 0 2.59587636719516e-06
. O 0 2.5371985401534403e-08
. O 0 3.7972350241943786e-07

